Organophosphorus Chemistry 2018 by Keglevich, György
Organophosphorus 
Chemistry 2018
























This is a reprint of articles from the Special Issue published online in the open access
journal Molecules (ISSN 1420-3049) (available at: https://www.mdpi.com/si/molecules/
Organophosphorus Chemistry).
For citation purposes, cite each article independently as indicated on the article page online and as
indicated below:




c© 2020 by the authors. Articles in this book are Open Access and distributed under the Creative
Commons Attribution (CC BY) license, which allows users to download, copy and build upon
published articles, as long as the author and publisher are properly credited, which ensures maximum
dissemination and a wider impact of our publications.
The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons
license CC BY-NC-ND.
Contents
About the Special Issue Editor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Preface to “Organophosphorus Chemistry 2018” . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
György Keglevich
Editorial to the Organophosphorus Chemistry Special Issue of Molecules (2012–2014)
Reprinted from: Molecules 2014, 19, 15408-15410, doi:10.3390/molecules191015408 . . . . . . . . 1
György Keglevich and Erika Bálint
The Kabachnik–Fields Reaction: Mechanism and Synthetic Use
Reprinted from: Molecules 2012, 17, 12821-12835, doi:10.3390/molecules171112821 . . . . . . . . 3
Artur Mucha
Synthesis and Modifications of Phosphinic Dipeptide Analogues
Reprinted from: Molecules 2012, 17, 13530-13568, doi:10.3390/molecules171113530 . . . . . . . . 17
Anne-Marie Caminade, Régis Laurent, Maria Zablocka and Jean-Pierre Majoral
Organophosphorus Chemistry for the Synthesis of Dendrimers
Reprinted from: Molecules 2012, 17, 13605-13621, doi:10.3390/molecules171113605 . . . . . . . . 51
Elise Bernoud, Romain Veillard, Carole Alayrac and Annie-Claude Gaumont
Stoichiometric and Catalytic Synthesis of Alkynylphosphines
Reprinted from: Molecules 2012, 17, 14573-14587, doi:10.3390/molecules171214573 . . . . . . . . 67
Justyna Siemieniec, Pawel Kafarski and Pawel Plucinski
Hydrophosphonylation of Nanoparticle Schiff Bases as a Mean for Preparation of
Aminophosphonate-Functionalized Nanoparticles
Reprinted from: Molecules 2013, 18, 8473-8484, doi:10.3390/molecules18078473 . . . . . . . . . . 81
Lavinia Lupa, Adina Negrea, Mihaela Ciopec and Petru Negrea
Cs+ Removal from Aqueous Solutions through Adsorption onto Florisil R© Impregnated with
Trihexyl(tetradecyl)phosphonium Chloride
Reprinted from: Molecules 2013, 18, 12845-12856, doi:10.3390/molecules181012845 . . . . . . . . 93
Subhadeep Roy and Marvin Caruthers
Synthesis of DNA/RNA and Their Analogs via Phosphoramidite and
H-Phosphonate Chemistries
Reprinted from: Molecules 2013, 18, 14268-14284, doi:10.3390/molecules181114268 . . . . . . . . 105
Vasily P. Morgalyuk
Chemistry of Phosphorylated Formaldehyde Derivatives. Part I
Reprinted from: Molecules 2014, 19, 12949-13009, doi:10.3390/molecules190912949 . . . . . . . . 121
Jarosław Lewkowski, Zbigniew Malinowski, Agnieszka Matusiak, Marta Morawska, Diana
Rogacz and Piotr Rychter
The Effect of New Thiophene-Derived Aminophosphonic Derivatives on Growth of Terrestrial
Plants: A Seedling Emergence and Growth Test
Reprinted from: Molecules 2016, 21, 694, doi:10.3390/molecules21060694 . . . . . . . . . . . . . . 175
v
Jarosław Lewkowski, Maria Rodriguez Moya, Marta Chmielak, Diana Rogacz, Kamila
Lewicka and Piotr Rychter
Synthesis, Spectral Characterization of Several Novel Pyrene-Derived Aminophosphonates and
Their Ecotoxicological Evaluation Using Heterocypris incongruens and Vibrio fisheri Tests
Reprinted from: Molecules 2016, 21, 936, doi:10.3390/molecules21070936 . . . . . . . . . . . . . . 189
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Mehdi Elsayed Moussa, Stefan Welsch, Luis Dütsch, Martin Piesch, Stephan Reichl, Michael
Seidl and Manfred Scheer
The Triple-Decker Complex [Cp*Fe(μ,η5:η5-P5)Mo(CO)3] as a Building Block in
Coordination Chemistry
Reprinted from: Molecules 2019, 24, 325, doi:10.3390/molecules24020325 . . . . . . . . . . . . . . 499
K. Michał Pietrusiewicz’, Katarzyna Szwaczko, Barbara Mirosław, Izabela Dybała, Radomir
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Preface to “Organophosphorus Chemistry 2018”
These days, organophosphorus (OP) chemistry forms an integrant part of synthetic organic
chemistry. OP compounds are used as starting materials, intermediates, reagents, catalysts (phase
transfer catalysts or P(III)-transition metal complexes) and solvents (ionic liquids (IL)) in research
laboratories and in the industry. There are many frequently applied reactions, such as reductions,
the Wittig reaction and its variations, especially the catalytic versions, the Arbuzov reaction, the
Pudovik reaction, the Mitsunobu reaction, or the Kabachnik–Fields reaction, that apply P-containing
reagents. The simple deoxygenation of phosphine oxides is also a challenging field. Other reactions
e.g. homogeneous catalytic transformations or C-C coupling reactions involve P-ligands in the
catalysts. There have been major developments in the field of chiral OP compounds. Methods
have been elaborated for the resolution of tertiary phosphine oxides and for stereoselective OP
transformations. The optically active P(III) species may be used as ligands in transition metal (Pt, Pd,
etc.) complex catalysts, making possible enantioselective transformations. The heterocyclic discipline
may include P-heterocycles and classical O- and N-heterocycles with P-functions. A special field
comprises P-containing or P-functionalized macrocycles and other macromolecules, like dendrimers.
An up-to-date approach is to perform syntheses in the OP discipline in an environmentally-friendly
manner. This may include the use of microwave or ultrasound. Solvent-free accomplishments are also
interesting. At the other end, OP species (e.g., catalysts and ILs) may be tools in organic chemistry.
Monitoring the reactions in order to optimize the conditions, or to observe reactive species, is a
challenging field. Theoretical calculation within OP chemistry is a developing field; these days,
however, stereostructures and mechanisms may be easily evaluated. A very important segment of OP
chemistry, the driving force for development, is the pool of biologically active OP compounds (e.g.,
bisphosphonic derivatives and aminophosphonic species) that are searched for and used as drugs or
plant protecting agents. The natural (e.g., peptide and amino acid) analogue P-compounds should
also be mentioned. Many new phosphine oxides, phosphinates, phosphonates and phosphoric esters
that may achieve different kinds of application have been described.
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The review entitled “Organophosphorus Chemistry for the Synthesis of Dendrimers” gives an
overview of the methods of synthesis of phosphorus-containing dendrimers, with emphasis on the
various roles played by the chemistry of phosphorus [1]. It is demonstrated that the presence of
phosphorus atom(s) at each branching point of the dendrimeric structure is particularly important and
highly valuable.
The review “Stoichiometric and Catalytic Synthesis of Alkynylphosphines summarizes the
possibilities for the preparation of alkynylphosphines that, or their borane complexes, are available
either through C–P bond forming reactions, or through modification of the phosphorus or the alkynyl
function of various alkynyl phosphorus derivatives [2]. The latter strategy involving phosphoryl
reduction is the method of choice for preparing primary and secondary alkynylphosphines, while the
former strategy is employed for the synthesis of tertiary alkynylphosphines, or their borane complexes.
Recently efficient catalytic procedures, involving copper complexes and either an electrophilic or a
nucleophilic phosphorus reagent have emerged.
New developments of the Kabachnik–Fields (K-F) reaction were surveyed in the review “The
Kabachnik-Fields Reaction: Mechanism and Synthetic Use” [3]. The monitoring of a few K–F reactions
by in situ Fourier transform IR spectroscopy has indicated the involvement of the imine intermediate
that was also justified by theoretical calculations. The K–F reaction was extended to >P(O)H species,
comprising cyclic phosphites, acyclic and cyclic H-phosphinates, as well as secondary phosphine oxides.
The synthesis under solvent-free microwave conditions is a good method of choice, as sophisticated
and environmentally unfriendly catalysts suggested by literature methods are completely unnecessary
under microwave conditions. The double K–F reaction made available bis(phosphonomethyl)amines.
The paper “Hydrophosphonylation of Nanoparticle Schiff Bases as a Mean for Preparation of
Aminophosphonate-Functionalized Nanoparticles” describes results on magnetic nanoparticles with
a modified surface that are attractive alternatives to deliver therapeutic agents [4]. The surface of
the iron oxide nanoparticles was modified with aminophosphonic acids by applying the classical
hydrophosphonylation protocol.
Recent achievements in the field of phosphinic dipeptide derivatives bearing appropriate side-chain
substituents are summarized in the review entitled “Synthesis and Modifications of Phosphinic
Dipeptide Analogues” [5]. Improved methods for the formation of the phosphinic peptide backbone,
including stereoselective and multicomponent reactions, are presented. Parallel modifications leading
to the structurally diversified substituents are also described, and selected examples of the biomedical
applications of the title compounds are given.
In the paper “Chemistry of Phosphorylated Formaldehyde Derivatives. Part I.” a few structurally
related compounds, such as thioacetals, aminonitriles, aminomethylphosphinoyl compounds, are
discussed [6]. The halogen aminals and acetals of phosphorylated formaldehyde, and a phosphorylated
gem-diol of formaldehyde were discussed separately.
Molecules 2014, 19, 15408-15410; doi:10.3390/molecules191015408 www.mdpi.com/journal/molecules1
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The chemical synthesis of DNA and RNA is usually carried out using nucleoside phosphoramidites
or H-phosphonates as synthons. The review “Synthesis of DNA/RNA and their Analogs via
Phosphoramidite and H-Phosphonate Chemistries” focuses on the phosphorus chemistry behind these
synthons, and how it has been developed [7]. Additionally, the synthesis and properties of certain
DNA and RNA analogues that are modified at the phosphorus atom were also discussed. These
analogues include boranephosphonates, metallophosphonates, and alkylboranephosphines.
The research “Cesium Ion Removal from Aqueous Solutions through Adsorption onto Florisil®
Impregnated with Trihexyl(tetradecyl)phosphonium Chloride” describes the adsorption performance
of Florisil® impregnated with trihexyl(tetradecyl)phosphonium chloride in the process of cesium ion
removal from aqueous solutions [8]. The adsorption process has been investigated as a function of pH,
solid:liquid ratio, adsorbate concentration, contact time, and temperature.
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Abstract: The Kabachnik–Fields (phospha-Mannich) reaction involving the condensation of primary
or secondary amines, oxo compounds (aldehydes and ketones) and >P(O)H species, especially
dialkyl phosphites, represents a good choice for the synthesis of α-aminophosphonates that are of
significant importance due to their biological activity. In general, these three-component reactions
may take place via an imine or an α-hydroxy-phosphonate intermediate. The monitoring of a
few Kabachnik–Fields reactions by in situ Fourier transform IR spectroscopy has indicated the
involvement of the imine intermediate that was also justified by theoretical calculations. The
Kabachnik–Fields reaction was extended to >P(O)H species, comprising cyclic phosphites, acyclic
and cyclic H-phosphinates, as well as secondary phosphine oxides. On the other hand, heterocyclic
amines were also used to prepare new α-amino phosphonic, phosphinic and phosphine oxide
derivatives. In most cases, the synthesis under solvent-free microwave (MW) conditions is the
method of choice. It was proved that, in the cases studied by us, there was no need for the use of
any catalyst. Moreover, it can be said that sophisticated and environmentally unfriendly catalysts
suggested are completely unnecessary under MW conditions. Finally, the double Kabachnik–Fields
reaction has made available bis(phosphonomethyl)amines, bis(phosphinoxidomethyl)amines and
related species. The bis(phosphinoxidomethyl)amines serve as precursors for bisphosphines that
furnish ring platinum complexes on reaction with dichlorodibenzonitriloplatinum.
Keywords: Kabachnik–Fields reaction; α-aminophosphonates; reaction pathway; environmentally
friendly; microwave; solventless
1. Introduction
The basic method for the preparation of α-aminophosphonates, valuable synthetic equivalents
and biologically active substrates, involves the condensation of a primary or secondary amine, a
carbonyl compound (aldehyde or ketone) and dialkyl phosphite (Scheme 1) [1,2].
−
Scheme 1. General scheme for the Kabachnik–Fields reaction.
α-Aminophosphonic acids, considered as phosphorus analogues of α-amino acids, have attracted
much attention in drug research due to their low mammalian toxicity. They are important targets
Molecules 2012, 17, 12821-12835; doi:10.3390/molecules171112821 www.mdpi.com/journal/molecules3
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in the development of antibiotics, antiviral species, antihypertensives, and antitumour agents based
on their effect as inhibitors of GABA-receptors, enzyme inhibitors and anti-metabolites [3–9]. Diaryl
α-amino-phosphonate derivatives are selective and highly potent inhibitors of serine proteases, and
thus can mediate the patho-physical processes of cancer growth, metastasis, osteoarthritis or heart
failure [10]. Dialkylglycine decarboxylase [9] and leucine aminopeptidase [11] are also inhibited by
α-amino-phosphonates. Cyanoacrylate [12] and amide derivatives [13] of α-aminophosphonates are
active antiviral compounds and inactivators of the tobacco mosaic virus. Certain α-aminophosphonates
were proved to be suitable for the design of continuous drug release devices due to their ability to
increase the membrane permeability of a hydrophilic probe molecule [14].
2. Possible Pathways for the Kabachnik–Fields Reaction
Cherkasov et al. studied the mechanism of the Kabachnik–Fields reaction in detail. One possibility
is that an imine (a Schiff base) is formed from the carbonyl compound and the (primary) amine, and
then the dialkyl phosphite is added on the C=N unit of the intermediate. The other route assumes
the formation of an α-hydroxyphosphonate by the addition of the dialkylphosphite to the carbonyl
group of the oxo component, then the hydroxyphosphonate undergoes substitution by the amine to
furnish the α-aminophosphonate. On the basis of kinetic studies, it was concluded that the mechanism
is dependent on the nature of the reactants. For example, the condensation of aniline, benzaldehyde
and a dialkyl phosphite was assumed to follow the “imine” mechanism. Interestingly it was found
that before the condensation of the aniline and the benzaldehyde, an H-bond is formed between the




Scheme 2. The “imine” mechanism proposed for a Kabachnik–Fields reaction [15,16].
In another case, Cherkasov et al. suggested that the reaction of the more nucleophilic
cyclohexyl-amine, benzaldehyde and a dialkyl phosphite takes place via the “hydroxyphosphonate”
route. Here again an interaction was substantiated to precede the addition of the dialkylphosphite
on the C=O unit of the oxo-compound. According to this, an H-bond is formed between the P(O)H
moiety of the phosphite and the nitrogen atom of the amine (Scheme 3) [15,17].
−
δδ−
Scheme 3. The “α-hydroxyphosphonate” mechanism proposed for a Kabachnik–Fields reaction [15,17].
Later, however, Zefirov and Matveeva proved that the condensation of cyclohexylamine,
benzaldehyde and dialkyl phosphite follows the “imine route”, and concluded that there is no
real experimental evidence for the hydroxyphosphonate route [18]. It is also worth mentioning that
the reaction of cyclohexylamine, benzaldehyde and dibutylphosphine oxide, that may be regarded
as an extended Kabachnik–Fields condensation, was shown to proceed according to the “imine”
mechanism [15,19]. It seems probable that the actual mechanism is dependent on the components
of the reaction, although the “imine” route seems to be more general than the route involving an
4
Molecules 2012, 17, 12821-12835
“α-hydroxy-phosphonate” intermediate [3]. R. Gancarz and I. Gancarz substantiated that a reversible
formation of the α-hydroxyphosphonate may also occur, and if it is rearranged to the corresponding
phosphate, this becomes a “dead-end” route [20]. It can be said that in the Kabachnik–Fields
reaction, a soft nucleophile (the dialkyl phosphite) and a hard nucleophile (the amine) compete for the
electrophilic carbonyl compound. The softer the carbonyl compound is, the faster it reacts with the
softer P-nucleophile and the slower it reacts with the harder amine nucleophile [21].
We wished to investigate the phospha-Mannich condensation of n-propylamine, benzaldehyde
and diethyl phosphite (Scheme 4) by following the reaction utilizing in situ Fourier transform (FT)
Infra Red (IR) spectroscopy [22].
−
Scheme 4. The Kabachnik–Fields reaction studied by us.
The possible reaction paths are shown in Scheme 5. The question was whether the imine




Scheme 5. Possible routes for the Kabachnik–Fields reaction studied by us.
The reaction carried out at 80 ◦C in acetonitrile was monitored by registering a 3D IR diagram. On
the basis of the characteristic νC=N stretching vibration at 1,648 cm–1, the imine 3 could be observed as a
transient species. It was possible to obtain a relative concentration—time diagram for the components
(Figure 1) by deconvolution of the 3D IR diagram. It can be seen that the imine intermediate 3 reaches
its maximum concentration after a 10 min reaction time [22].
5
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Figure 1. Concentration profile for the Kabachnik–Fields reaction studied at 80 ◦C in acetonitrile.
It was shown above that there was also controversy over the mechanism of the Kabachnik–Fields
condensation of cyclohexylamine, benzaldehyde and dialkyl phosphites (Scheme 6) [15,17,18]. We
sought to clarify the situation by in situ FT IR spectroscopy [23].
−
Scheme 6. Another Kabachnik–Fields reaction investigated by us.
From among the two possible intermediates 6 and 7, again the imine 6a could be detected on
the basis of the νC=N = 1,644 cm–1 absorption as the transient species for α-aminophosphonate 5a
(Scheme 7). The intermediacy of imine 6 can be seen in Figure 2.
Scheme 7. Possible pathways for the second model investigated.
6

















Figure 2. Concentration profile for the Kabachnik–Fields reaction studied at 80 ◦C in acetonitrile.
Relative energies for the possible intermediates 6 and 7 and for α-aminophosphonate 5 were
calculated by the B3LYP/6-31G** method and then refined by the the B3LYP/6-311G**++ method
provided that dimethyl phosphite is the reactant. It can be seen from Table 1 that the formation of the
imine 6 goes with significantly lower energy gain than that of the α-hydroxyphosphonate 7. On the
one hand, the imine 6 would like to be stabilized further by reaction with the dimethyl phosphite on
way to the α-aminophosphonate 5. On the other hand, the hydroxyphosphonate 7 is too stable to react
further to the aminophosphonate 5. The conversion of 7 to 5 represents only a slight energy gain of 2.4
kJ/mol. In other words, there is no significant driving force for the substitution [23].
Table 1. Relative energies for the four states calculated.
Species Relative energy (kJ/mol)
Reactants (benzaldehyde, cyclohexylamine and
dimethyl phosphite) 0.0
Imine intermediate 6 –18.6
α-Hydroxyphosphonate intermediate 7 –40.5
Product 5 –42.9
3. Microwave-Assisted Solvent- and Catalyst-Free Approach for the Synthesis of
α-Amino-phosphonates and Related Derivatives
Although a lot of catalytic variations to carry out three-component Kabachnik–Fields condensations
have been described, we found that the most straightforward synthesis is when the reactants are
irradiated with microwave (MW) in the absence of any catalyst or solvent. The solventless and
MW-assisted approach was useful in the synthesis of a few α-aminomethylphosphonates [24]. We used
aniline or benzylamine as the amine, formaldehyde, benzaldehyde, acetophenone and cyclohexanone
as the oxo-component and dialkyl phosphites and diphenylphosphine oxide as the >P(O)H reactant.
The α-aminophosphonates and α-aminophosphine oxide products are represented by structure 8
in general Scheme 8 [25]. The detailed results are listed in Table 2. The comparative results of the
catalytic versions were also included. A detailed account on the conditions of the catalytic reactions
is provided in Table 3.Table InTable aTable partTable ofTable theTable casesTable suchTable asTable
inTable theTable exampleTable coveredTable byTable reference[26], the catalytic versions could already
be carried out at room temperature.
7
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−
Scheme 8. General scheme for the solventless, catalyst-free MW-assisted Kabachnik–Fields
reactions studied.
Table 2. Kabachnik–Fields reactions carried out without the use of a solvent and a catalyst under MW
irradiation [25].





1 Ph H H EtO 8a 80
a
100 b 91
2 Ph H H MeO 8b 80
a
80 b 80
3 Ph H H Ph 8c 80 94
4 Bn H H EtO 8d 100 81
5 Bn H H Ph 8e 80 88
6 Ph H Ph EtO 8f 100 93
98 [27], 85 [28],
~95 [29], 88 [30],
79 [31], 93 [32],
92 [33], ~90 [34],
96 [35], 60 [36],
86 [37], 92 [38]
7 Ph H Ph MeO 8g 100 86 98 [24], 98 [27],92 [33]
8 Ph H Ph Ph 8h 80 87
9 Bn H Ph EtO 8i 100 83
99 [28], 84 [29],
92 [30], 85 [31],
91 [32], 91 [33],
92 [35], 92 [36],
93 [38]
10 Bn H Ph MeO 8j 100 87 95 [27], 82 [33]
11 Ph Me Ph EtO 8k 120 80 75 [27], 74 [30],63 [35], 18 [36]
12 Bn Me Ph EtO 8l 120 84 92 [26], 80 [27],81 [38]
13 Bn Me Ph Ph 8m 100 a120 b 80
14 Ph
Δ
EtO 8n 120 81
92 [27], ~72 [29],




EtO 8o 120 91
85 [26], 90 [27],




MeO 8p 120 85 92 [27]
17 Bn
Δ
Ph 8q 100 a120 b 80
† for details see Table 3; a condensation of the oxo-component and the amine; b addition of the >P(O)H species to
the Schiff-base.
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Table 3. Kabachnik–Fields reactions carried out in the presence of catalysts.





Phthalocyanine-AlClH2Cl2 – 26 a 12 h
92 (8b), 85
(8p) [26]
Mg(ClO4)2 – – 26 2 min/8 h
90–98 (8f, 8g,
8j, 8n-p) [27]
Mg(ClO4)2 – Δ 50–80 45 min–12 h
80–99 (8f, 8i,
8l, 8n-p) [27,28]




M = Li, Mg,
Al, Cu, Ce
– Δ 80 20 min–3.5 h 72–95 (8f, 8i,
8n) [29]
GaI3 CH2Cl2 – 26 3–6 h
74–92 (8f, 8i,
8k, 8n) [30]
In(OTf)3 THF Δ 66 21–35 h
47–85 (8f, 8i,
8n, 8o) [31]
BiNO3 – – b 26 10 h
93 (8f), 91
(8i) [32]
BiCl3 MeCN Δ 80 6–15 h
80–92 (8f, 8g,
8i, 8j, 8o) [33]
FeCl3
EtOH (or
solvent free) – 26 ~90 (8f) [34]
YbCl3 MeCN – 26 24 h
63–96 (8f, 8i,
8k) [35]
SmI2 (+ 4 Å
mol sieves)





MeCN – 26 3 h 86 (8f), 87(8n) [37]
InCl3 THF Δ 66 9–12 h
81–93 (8f, 8i,
8l, 8o) [38]
InCl3 DMF MW no data 2 min 82 (8f) c [39]
InCl3 [bmim][PF6] MW no data 2 min 91 (8f) c [39]
Ln(OTf)3 Ln
= Yb, Sc, Dy,
Sm
DMF MW no data 2 min 72 (8f) c [39]
Ln(OTf)3 Ln
= Yb, Sc, Dy,
Sm
[bmim][PF6] – 26 27 h 92 (8f) c [40]
Ln(OTf)3 Ln
= Yb, Sc, Dy,
Gd




[bmim][BF4] – 26 5 h/8 h
90 (8f), 84
(8f) [41]
a Diethyl phosphite was added to preformed imines; b Was also performed under MW; c The product was extracted
with benzene.
On the basis of our experimental data, there is no need to use exotic (expensive and environmentally
unfriendly) catalysts. In most cases, the solvent- and catalyst-free MW-assisted reactions give excellent
results. Further exploration of catalysts does not seem to be justified in this field. Next, our method
was extended to phospha-Mannich condensations involving heterocyclic amines (Scheme 9) [42].
Diphenylphosphine oxide was also used as the P-component.
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Δ
−
Scheme 9. Kabachnik–Fields reactions applying N-heterocycles as the amine component.
In another series of reactions, 1,3,2-dioxaphosphorine oxide (10) was used as the phosphite
(Scheme 10) [43]. In this way “double” heterocyclic derivatives were prepared. These reactions were




Scheme 10. Kabachnik–Fields reactions applying 1,3,2-dioxaphosphorine oxide as the P-reactant.
Applying 1,3,2-dioxaphosphorine oxide (10) together with benzaldehyde, the steric hindrance
prevented the efficient condensation. It was better to prepare the imine 12 first and to react it separately
with the cyclic phosphite 10 (Scheme 11) [43].
n n
Scheme 11. Synthesis of α-aminophosphonates via the imine intermediate.
Dibenzo[c.e][1,2]oxaphosphorine (14) was also utilized in the synthesis of P-heterocyclic derivatives.
In this case, the primarily formed product 15 underwent opening of the hetero ring by reaction with
the water formed (Scheme 12) [43].
n n
Scheme 12. Kabachnik–Fields reaction applying a dibenzooxaphosphorine oxide as the P-reactant.
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For the preparation of diethyl α-diethylaminophenylmethylphosphonate (17), the two-step
approach led to better results. The aldehyde–amine adduct formed primarily was reacted with diethyl
phosphite to afford product 17 (Scheme 13) [43].
Scheme 13. Synthesis of an α-aminophosphonates in two steps.
The MW-assisted solventless procedure was useful in the synthesis of a series of
bis(phosphonomethyl)amines and related derivatives marked as 18 (Scheme 14) [44–46]. Product
18 could be obtained in yields, mostly above 80%. The double Kabachnik–Fields reaction was then
extended to the synthesis of bis(phosphinoxidomethyl)amines 19. In these cases, heterogenity of the
reaction mixture requested the use of a solvent that was acetonitrile (Scheme 15) [44–46]. The use of
aniline as the amine component led to by-product 20 besides the expected product 19 (Y = Ph) [46].
nn n n
n n n n
cc c c
Scheme 14. Synthesis of bis(phosphonomethyl)amines and related derivatives by the double
Kabachnik–Fields reaction.
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n n
Scheme 15. Bis(phosphinoxidomethyl)amines by the double phospha-Mannich reaction.
The bis(phosphinoxidomethyl)amines 19 served as precursors for bis(phosphinomethyl)amine
bidentate P-ligands 21 by double deoxygenation. The bisphosphines 21 so formed were reacted
with half an equivalent of dichlorodibenzonitriloplatinum to furnish ring platinum complexes 22
(Scheme 16) [45,46].
Scheme 16. Synthesis of ring platinum complexes from bis(phosphinoxidomethyl)amines.
The bidentate P-ligands may be stored as their phosphine-borane complexes. This is shown in
the example of the 23→ 24 conversion (Scheme 17). In general, the phosphine can be regenerated
from the phosphine-borane by heating with a secondary amine, such as diethylamine, in an aromatic
solvent [47].
⋅
Scheme 17. Stabilization of a bis(phosphinomethyl)amine as a bis(borane complex).
The MW-assisted catalytic addition of dialkyl phosphites on the carbonyl group of a series of
benzaldehyde derivatives was also elaborated (Scheme 18) [48]. The α-hydroxyphosphonates (25, Y =
RO) are potential intermediates of the Kabachnik–Fields reaction. The use of diphenylphosphine oxide
in the addition led to the formation of α-hydroxyphosphine oxides (25, Y = Ph).
12
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⋅
Scheme 18. MW-assisted synthesis of α-hydroxyphosphonates and α-hydroxyphosphine oxides.
The addition of dialkyl phosphites to α-ketophosphonates led to
1-hydroxymethylene-bisphosphonates [49,50]. It was interesting to find that, as a consequence of the
neighboring group effect of the P=O moiety, α-hydroxyphosphonate 25 (Y = EtO) could be readily
converted to the corresponding α-aminophosphonates (26) (Scheme 19) [51]. Quantum chemical
calculations justified the beneficial neighboring group effect of the P=O moiety [51].
⋅
i i c
Scheme 19. Preparation of α-aminophosphonates by substitution of α-hydroxyphosphonates.
4. Conclusions
In conclusion, recent results obtained in the study of the Kabachnik–Fields reaction have been
summarized. This mini-review sheds light on the new developments regarding mechanistic and
synthetic aspects showing that the phospha-Mannich reaction remains an evergreen topic for organic
chemists. On the one hand, the mechanism of the Kabachnik–Fields reaction still reserves some
surprises, on the other hand, the 3-component condensation is an ideal subject for green chemical
reactions. In addition, the α-aminophosphonate and α-aminophosphine oxide products are biologically
active substrates.
Acknowledgments: The authors are grateful for Hungarian Scientific Research Fund (No: OTKA K 83118).
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Abstract: Pseudopeptides containing the phosphinate moiety (-P(O)(OH)CH2-) have been studied
extensively, mainly as transition state analogue inhibitors of metalloproteases. The key synthetic aspect
of their chemistry is construction of phosphinic dipeptide derivatives bearing appropriate side-chain
substituents. Typically, this synthesis involves a multistep preparation of two individual building
blocks, which are combined in the final step. As this methodology does not allow simple variation
of the side-chain structure, many efforts have been dedicated to the development of alternative
approaches. Recent achievements in this field are summarized in this review. Improved methods for
the formation of the phosphinic peptide backbone, including stereoselective and multicomponent
reactions, are presented. Parallel modifications leading to the structurally diversified substituents
are also described. Finally, selected examples of the biomedical applications of the title compounds
are given.
Keywords: phosphinic peptides; P-C bond formation; multicomponent reactions; side-chain
diversification; enzyme inhibition
Abbreviations: Aa1ψ[P(O)(OH)X]-Aa2: phosphorus-containing dipeptide analogues (X =
NH, phosphonamidates; X = O, phosphonates; X = CH2, phosphinates); AaPH:
α-amino-H-phosphinic (phosphonous) acid; Ac: acetyl; Ad: 1-adamantyl; Alk: alkyl;
Alloc, allyloxycarbonyl; APN: alanyl aminopeptidase; Ar: aryl; ATP: adenosine
triphosphate; Boc: t-butyloxycarbonyl; BOP: (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium
hexafluorophosphate; BSA: N,O-bis(trimethylsilyl)-acetamide; i-Bu: isobutyl; n-Bu: n-butyl;
sec-Bu: sec-butyl; t-Bu: tert-butyl; Bz: benzoyl; Bzl: benzyl; Cbz: benzyloxy-carbonyl;
CPB: carboxypeptidase B; dba: dibenzylideneacetone; DEAD: diethyl azodicarboxylate; DCC:
N,N’-dicyclohexylcarbodiimide; de: diastereomeric excess; DIPEA: diisopropylethylamine;
DMAP: 4-dimethylaminopyridine; DME: 1,2-dimethoxy-ethane; DMF: dimethylformamide;
EDC: 1-ethyl-3-(3’-dimethylaminopropyl)carbo-diimide; Et: ethyl; EWG: electron withdrawing
group; Fmoc: 9-fluorenylmethoxy-carbonyl; HMDS: 1,1,1,3,3,3-hexamethyldisilazane; HOBt:
1-hydroxybenzotriazole; HPLC: high performance liquid chromatography; LAP: leucine
aminopeptidase; Me: methyl; MurD: UDP-N-acetylmuramoyl-L-alanyl:D-glutamate ligase; Nu:
nucleophile; Pac: phenacyl; PG: protecting group; Ph: phenyl; Phth: phthaloyl; i-Pr: isopropyl; PyBOP:
(benzotriazol-1-yloxy)tris(pyrrolidino)phosphonium hexafluorophosphate; SPPS: solid-phase peptide
synthesis; Su: succinimide; TAFIa: thrombin-activatable fibrinolysis inhibitor; TFA: trifluoroacetic
acid; THF: tetrahydrofuran; Tl: triflate (trifluoromethane- sulfonate); TLC: thin layer chromatography;
TMSCl: chlorotrimethyl-silane; Tr: trityl (triphenylmethyl); TS: transition state; Ts: tosyl; Trs:
2,4,6-triisopropylphenylsulfonyl.
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1. Introduction
Phosphinic pseudodipeptides (Figure 1) are typically defined as dipeptide analogues that replace
the amide bond with the phosphinate moiety. The rationale behind the replacement is not to mimic the
peptide linkage alone, explicitly in its ground state, but the assumed analogy concerns isosteric and
isoelectronic resemblances to the high-energy tetrahedral transition state (TS) of the amide hydrolysis.
 
Figure 1. A general structure for phosphinic dipeptide analogues and the resemblance of this structure
to the tetrahedral transition state of peptide hydrolysis postulated for thermolysin [1]. Side chains
R1 and R2 are specific to the S1 and S1’ binding pocket and are also referred to as the P1 and P1’
substituents, according to the nomenclature proposed by Schechter and Berger [2].
Translation of the TS arrangement into the inhibitor structure is one of the fundamental concepts
in drug design, originating directly from the early suggestion of evolutionary orientation of the enzyme
active sites to bind substrates optimally in this state, which diminishes the energy of activation of the
catalyzed reaction [3]. Formally, the binding of TS inhibitors should be tighter than the binding of the
substrates by the factor of the enzymatic rate enhancement [4].
Three different types of phosphorus-containing peptide analogues, which comprise the structural
fragment Aa1ψ[P(O)(OH)X]-Aa2, have been constructed to follow this idea. The phosphorus-containing
peptide analogues include: phosphonamidates (X =NH, the closest TS analogues), phosphonates (X
= O, pseudodepsipeptides) and phosphinates (X = CH2). All these compounds appear particularly
effective in regulating the activity of metalloproteases. Nevertheless, investigation of other proteases
(e.g., aspartyl) and, in general, other classes of enzymes (e.g., ligases) also brought inhibition to
an impressive level [5–7]. In the early period of these studies (during the 80s of the 20th century),
phosphonamidate and phosphonate pseudopeptides attracted major attention. These pseudopeptides
emerged as invaluable tools in fundamental structural and mechanistic studies carried out on
prototypical metalloproteases, thermolysin and carboxypeptidase A [1,8–14]. Certain drawbacks, such
as hydrolytic instability of the P-N bond and frequent limited activity of the P-O derivatives excluded
them however from later practical applications.
Phosphinic compounds avoid these inconveniences. Phosphinates are stable over the whole
pH range and equipotent with or only slightly less potent than the corresponding phosphonamidate
species [15]. The utility potential of phosphinic peptides in drug design was greatly increased
by development of a synthetic procedure leading to the Fmoc-Aa1ψ[P(O)(OAd)CH2]-Aa2 building
block [16]. This synthon is compatible with standard methodologies of solid-phase peptide synthesis
(SPPS) and combinatorial synthesis. Since then, numerous active sequences have been obtained, and
this progress is relevantly and comprehensively reviewed elsewhere [5–7,17–20]. The phosphinate
chemistry was also historically systematized in an excellent paper by Yiotakis et al. in 2004 [21]. Despite
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considerable achievements, construction of a fundamental phosphinic α,α’-dipeptide, which comprises
appropriate side-chains remains the main challenge in the field. The current review is dedicated
entirely to this synthetic aspect with particular attention to diversification of the P1 and P1’ substituents.
The contents are limited to recent achievements. In principle, the literature data published after 2000
are discussed, and earlier papers are only selectively highlighted to give the proper background.
2. Synthesis of the Phosphinic α,α’-Dipeptide Backbone
2.1. Retrosynthetic Analysis
Approaches based on a phospha-Michael addition to obtain the C-P-C pseudodipeptide skeleton
predominate. The most traditional approach involves the addition of a suitably N-protected
α-amino-H-phosphinic (phosphonous, AaPH) acid or its ester (alkyl H-phosphinate) to an acrylate
(P-C disconnection, synthetic direction from the N to C terminus, Scheme 1). The H-phosphinic acid
component requires activation to the more nucleophilic tervalent ester form that is typically achieved
in the presence of a silylation agent. On the other hand, the reaction of alkyl H-phosphinate esters can
also be catalyzed with a strong base. α-Amino-H-phosphinic substrates are conveniently available
from appropriate aldehydes, amino components and hypophosphorous acid. Acrylates (α-substituted
α,β-unsaturated esters) also need to be synthesized separately, typically by a Knoevenagel reaction of
α-substituted malonate monoesters and formaldehyde.
 
Scheme 1. Retrosynthetic analysis of the phosphinic dipeptide scaffold.
Alternatively, a Michael-type addition can precede incorporation of the N-terminal fragment. The
essential substrate, β-substituted β-alkoxycarbonylethyl-H-phosphinic acid, is readily obtained in
the addition of bis(trimethylsilyl) phosphonite to an acrylate, similarly to the reactions previously
mentioned. The product is then subjected to a three-component condensation with an aldehyde
and amino/amido component (C-P disconnection, C → N, Scheme 1). Depending on the exact
structures of the reactants, this reaction is a variant of the Kabachnik-Fields, phospha-Mannich or
amidoalkylation reaction.
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2.2. N→ C Strategy
Historically, addition of α-amino-H-phosphinates (acids and esters) to acrylates has been the
most commonly recognized approach to construct phosphinic dipeptide analogues (Scheme 2). This
popularity has been stimulated by an easy access to suitably protected phosphorus substrates. Different
variations for obtaining these P-H substrates, suggested originally by Baylis et al., are based mainly on
a three-component condensation of an aldehyde, hypophosphorous acid and diphenylmethylamine as
the nitrogen source, or addition of H3PO2 to diphenylmethylimines [22]. The diphenylmethyl group
can be hydrolyzed from the adduct under acidic conditions to obtain free α-aminophosphonous acids.
The main advantages of the approach are simplicity and low cost, even though the preparative yield is
not high. The amino group can subsequently be protected by the benzyloxycarbonyl group (Cbz) in a
water solution [22]. The procedure is particularly convenient for alkyl and aryl substituents with a
single and unpredictable exception of GlyPH. An additional side-chain functionality needs attention
with respect to its orthogonal protection during the synthesis of α-aminophosphonous acids and their
further transformations.
 
Typical reaction conditions: (a) Ph2CHNH3+ H2PO2·−, EtOH or dioxane, reflux; (b) HClaq, reflux or
HBraq, 100 ◦C; (c) CbzCl, NaOH (pH = 9), H2O/dioxane, 0 ◦C→ rt; (d) HMDS, heating or TMSCl, Et3N,
CH2Cl2, 0 ◦C→ rt, then acrylate; (e) MeOH or EtOH; (f) CH2N2, Et2O; (g) MeONa, MeOH.
Scheme 2. A general overview of the synthetic strategies leading to phosphinic dipeptide analogues
by addition of α-amino-H-phosphinates (acids or esters) to acrylates.
Benzyloxycarbonyl is a standard group used for N-protection, but other carbamates are compatible
with the phospha-Michael addition conditions, particularly with the mild TMSCl/tertiary amine
version. These other carbomates commonly include t-butyloxycarbonyl (Boc) [23] and 9-fluorenyl-
methoxycarbonyl (Fmoc) [24]. Other specific protecting groups will be also mentioned in the text.
The H-phosphinic component requires activation to the tervalent nucleophilic ester form, typically
accomplished by silylation (Scheme 2). Alternatively, the effect can be achieved by heating with
hexamethyldisilazane (HMDS), by action of N,O-bis(trimethylsilyl)acetamide (BSA), or in the presence
of chlorotrimethylsilane (TMSCl) and a tertiary amine [21,25–30]. After addition to an acrylate, the
silylated adduct is decomposed with an alcohol or water.
Transformation of N-protected α-amino-H-phosphinic acid into its ester provides another
opportunity for activation. This reaction involves the action of a strong base, e.g., sodium methoxide
or potassium t-butoxide, to shift the equilibrium from the P(V) tautomer to a more nucleophilic P(III)
species (Scheme 2) [21,31–34].
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As mentioned above, this method for obtaining a phosphinic dipeptide backbone is not problematic
for alkyl, aryl or alkylaryl P1 residues that do not contain an additional functionality, and accordingly,
numerous structures have become available in this manner [16,21,35,36]. However, more complex Cα
side-chains that incorporate a certain heteroatom moiety can greatly influence the chemical behavior
of the phosphorus substrate. For example, the neighboring assistance of a carboxylate group (free
or esterified) in the phosphonous analogue of aspartic acid did not permit the Michael addition to
occur [23]. Even though the target phosphinic compound is obtained, further transformations of
this phosphinic compound are frequently altered by the complexity of the protection/deprotection
strategy. Cbz-Lys(Phth)ψ[P(O)(OH)CH2]-Ala-OMe can serve as a representative example [37]. The
attempts to prepare its free carboxylate form (with all other three functionalities blocked), suitable
for peptide coupling, failed. In this case, the issue had to be addressed by the use of alternative
synthetic approaches.
Selected rare examples of phosphinic dipeptide structures that have been prepared by incorporation
of an additionally functionalized α-amino-H-phosphinic acid to an acrylate are listed in Scheme 3.
The first illustration addresses the preparation of P1 methionine derivatives as inhibitors of
metalloproteases [36,38]. To present a less popular version of obtaining the P-H substrate, Liboska
et al. added methanethiol to acrolein (1) and converted the product into the corresponding oxime,
which, in turn, reacted with anhydrous hypophosphorous acid (Scheme 3A) [38]. Boc-protected
H-phosphinic acid was added to acrylates to yield 2 under typical conditions. The second example
(Scheme 3B) shows a molecule of C2 symmetry obtained by Kabudin and Saadati from benzaldehyde
(3). The final modification to aminobisphosphinic acid 4 was performed in a standard way, however,
without any protection of the phosphorus component [39]. Scheme 3C presents the construction of
a pseudodipeptide containing a 5-membered ring of proline (7) starting from hydroxyaldehyde
5 [40]. To perform this transformation, the Michael addition followed cyclative alkylation of
α-amino-ω-bromobutylphosphonous acid (6). The overall yield of the five-step procedure was
only 6%, whereas the strategy proceeding in the opposite direction (C→N, compare Scheme 1 and
chapter 2.3.1) provided the target molecule in 52% yield in three steps [40].
 
Reaction conditions: (a) MeSH, 0 ◦C; (b) NH2OH×HCl, pyridine, rt; (c) H3PO2, MeOH, reflux, (d) Boc2O,
Na2CO3, H2O/dioxane, 0 ◦C→ rt; (e) TMSCl, DIPEA, then ethyl acrylate or methacrylate, rt; (f) NH4OH,
reflux; (g) H3PO2, EtOH; (h) HMDS, 110 ◦C, then methyl acrylate, heating, then EtOH; (i) Ph2CHNH3+
H2PO2·−, dioxane, reflux; (j) 47% HBraq, reflux; (k) N,N-dimethyldodecylamine, n-Bu4NOH, CH2Cl2,
H2O; (l) CbzCl, Na2CO3, H2O, 0 ◦C→ rt; (m) HMDS, 110 ◦C, then ethyl α-benzylacrylate, heating,
then EtOH.
Scheme 3. Selected examples of preparation of additionally functionalized α-amino-H-phosphinic
acids and their application in addition reactions to acrylates.
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In contrast to the limited tolerance of a P1 functionality, the addition of the P-H moiety to the
activated double bond leads to an extensive choice of structurally variable acrylates (Figure 2). Cyclic
compounds [41], as well as compounds containing a carboxyl group [42–44], a phosphonate [31], a
hydroxyl group [35,45], a thiol [31,35] or an amino function [46] in the side chain (typically, suitably
protected) and residues of an unsaturated character [47,48] allow an effective reaction. Some of
the unsaturated ester substrates are obvious precursors of proteinogenic P1’ fragments that ensure
specificity of the products in biological studies. Other acrylates are designed to introduce a structural
fragment that can be subjected to a further diversification to the phosphinic scaffold.
Figure 2. A selection of additionally functionalized α-substituted acrylate derivatives that were found
to be compatible with phospha-Michael addition chemistry.
Obtaining the acrylates may present individual synthetic challenges (selected examples are shown
in Scheme 4). Preparing the appropriate acrylate usually involves a Knoevenagel condensation of
appropriately substituted malonate monoester with formaldehyde [49]. The key malonate substrate
(e.g., 10, Scheme 4A) can be prepared by condensation of an aldehyde (such as 8) with subsequent
reduction of the product 9 [45] or by a standard alkylation (e.g., 15, Scheme 4B) with alkyl halides (such
as imidazole derivative 13) [50]. The total yield of the product (here, 11 and 16) varies significantly
and depends on the structure of the substituent. Other methods have been developed exclusively
for particular target derivatives [21,35,36]. For example, β-alkoxy or β-alkylthio derivatives (18,
Scheme 4C) are prepared efficiently by alkylation of sodium alkoxides or thiolates with α-bromomethyl
acrylate [35].
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Reaction conditions: (a) piperidine, benzoic acid, benzene (-H2O); (b) NaBH4, MeOH, 0 ◦C; (c) KOH,
MeOH or EtOH, then HClaq; (d) (CHO)n, piperidine, pyridine; (e) SOCl2, benzene, reflux; (f) EtONa,
EtOH, 50 ◦C; (g) TrCl, DIPEA, DMF, rt; (h) Et2O, 15 ◦C→ rt.
Scheme 4. Selected synthetic procedures leading to additionally functionalized α-substituted
acrylate derivatives.
Multistep preparations of the phosphinic dipeptide from acrylates andα-aminophosphonous acids
that converge the substrates in the phospha-Michael addition are reproducible and show reasonable
yields. Consequently, these preparations have generally been employed for the construction of
pseudodipeptides corresponding to both natural and non-natural amino acid sequences. Certain
limitations, mostly concerning the P1 substituent structure, were proposed for the multicomponent
approaches (see below). Several attempts to modify the original N→C Michael addition have also been
undertaken. Most of the attempts at modification involved simplification of the protection/deprotection
procedure and merging both P-C bond formation processes in a one-pot manner that reduced the
number of the synthetic steps [33,34,51,52]. Typically, an appropriate ester of hypophosphorous acid is
treated consecutively with an imine (or triazine) and then by an acrylate. Because these modifications
were scarcely noticed in the scientific community, a single and arbitrarily selected case is presented here.
In the course of studies on the reactivity of trimethylsilylated compounds, including (Me3SiO)2P-H
(20), Prishchenko et al. discovered several reaction variants that led to phosphinic compounds [53–
55]. Among others, N-(methoxymethyl)bis(trimethylsilyl)amine (19) reacted with bis(trimethylsilyl)
phosphonite in the presence of ZnCl2 to yield the GlyPH analogue 21, which was subsequently added
to trimethylsilyl acrylate (22) [53]. Free Glyψ[P(O)(OH)CH2]-Gly (23) was obtained after methanolysis
with a total yield of 44% (Scheme 5).
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Reaction conditions: (a) ZnCl2, TMSCl, 120–140 ◦C; (b) pyridine, CH2Cl2, rt→ 100 ◦C; (c) MeOH, Et2O,
rt→ reflux.
Scheme 5. Glyψ[P(O)(OH)CH2]-Gly preparation from silylated substrates.
An interesting possibility of tandem P-C and C-C bond formation on a phosphinic dipeptide
scaffold was recognized in a preliminary way in the Yiotakis group [56]. The tandem bond
formation involved phospha-Michael addition of a P-H substrate to allyl acrylate (25) followed
by a Claisen-type rearrangement (Scheme 6). Unexpectedly, the product of the addition of optically
active α-N-benzyloxycarbonylaminoalkylphosphonous acid [(R)-24] rearranged to a lesser extent than
structurally less complex phenylphosphinic acid. The ratio of the final product 26 to un-rearranged
allyl ester 27 was 55:45, compared to 91:9 for phenylphosphinic acid. An incompletely understood role
for the amide N-H in intramolecular proton transfer in the silylated intermediate was suggested as a
possible reason. Indeed, bis-N-protection of the α-aminoalkyl-H-phosphinic acid substrate increased
the preparative yield of the target product from 52% to 84%, comparable to the yield obtained for
phenylphosphinic acid. The reaction can be carried out conveniently in a three-component variant
using acryloyl chloride (or other α-substituted analogues) and various allyl and propargyl alcohols.
 
Reaction conditions: (a) DIPEA, CH2Cl2, then TMSCl, −78 ◦C→ rt; (b) H+.
Scheme 6. Phospha-Michael addition of α-N-benzyloxycarbonylaminoalkyl-H-phosphinic acid to allyl
acrylate followed by the Ireland-Claisen rearrangement of the product.
Phospha-Michael Addition on Solid Phase
Formation of the phosphinic bond could also occur on a solid support. Dorff et al. modified Wang
resin with acrylic or metacrylic acid (28, R2 = H or Me) under Mitsunobu conditions (Scheme 7A) [57].
Subsequently, FmocGlyPH (29, R1 = H, PG = Fmoc), activated by BSA, was added to the immobilized
double bond of 30 to give product 31. After esterification of the phosphinate with diazomethane and
Fmoc removal, the N-terminus could easily be modified, e.g., by acyl chlorides or isocyanates [57].
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Reaction conditions: (a) Ph3P, DEAD, THF; (b) Et3N, DMAP; CH2Cl2; (c) BSA, CH2Cl2 or CH2ClCH2Cl,
then MeOH.
Scheme 7. Phospha-Michael addition of N-protected α-aminoalkyl-H-phosphinic acid to acrylates
immobilized on a solid phase.
In a similar approach, Buchardt and Meldal acylated a polyethylene glycol/polystyrene resin with
acryloyl chloride (32), followed by addition of AllocAlaPH (29, R1 =Me, PG = Alloc, Scheme 7B) [58].
The procedure was then validated in a solid-phase synthesis of an undecapeptide containing an internal
Alaψ[P(O)(OH)CH2]-Gly unit. Although these methodologies could provide an interesting alternative
for the preparation of longer sequences in an automatic manner, the methodologies failed to attract
further attention. Introduction of a pre-synthesized pseudodipeptidic building block to the classical
SPPS appeared to be appreciated, for the most part.
2.3. C→ N Strategy
Acrylates are also indispensable starting materials in an alternative strategy for phosphinic
α,α’-dipeptide synthesis. Similarly to N→C strategy, this approach involves incorporation of structural
fragments to the central phosphorus core, but an acrylate, which determines the P1’ portion, is added
first to the activated silyl ester of hypophosphorous acid (Scheme 8) [29,30]. The reaction, starting from
ammonium hypophosphate under the same conditions as described above for α-aminophosphonous
acids (see Scheme 2), is carried out and yields a β-substituted β-alkoxycarboxyl-H-phosphinic
acid. Subsequently, the product is used in a condensation reaction with carbonyl and amine/amide
components to build the N-terminal fragment of the molecule.
 
Typical reaction conditions: (a) HMDS, heating or TMSCl, Et3N, CH2Cl2, 0 ◦C→ rt, then acrylate; (b)
MeOH or EtOH (for HMDS), or HClaq (for TMSCl).
Scheme 8. A general scheme for the synthesis of β-substituted β-alkoxycarboxyl-phosphonous acids,
precursors of the P1’ fragment of phosphinic dipeptides.
2.3.1. Amidoalkylation
Obtaining phosphinic pseudodipeptides in a three-component condensation of carbamate, an
aldehyde and a β-alkoxycarboxylphosphonous acid was initially suggested by Chen and Coward
(Scheme 9) [59].
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Reaction conditions: (a) AcCl, 0 ◦C→ rt.
Scheme 9. Synthesis of phosphinic dipeptides in a three-component condensation of an aldehyde,
benzyl carbamate and 2-ethoxycarbonylethylphosphinic acid.
This reaction was an analogy to the previous applications of less complex phosphorus components
(phosphites) as a method to synthesize α-aminophosphonic acid derivatives [60]. Similarly, aliphatic
and aromatic aldehydes (33, R = Me, Et, p-MeO-C6H4) reacted with benzyl carbamate (34) and
2-ethoxycarbonylethylphosphonous acid (35) in the presence of acetyl chloride. Conversion proceeded
with a good yield (48–75%) to produce the final products 37 after an aqueous workup. The precise role
of acetyl chloride as a dehydration (acetylation) solvent/reagent remained ambiguous.
Matziari and Yiotakis used the corresponding approach to obtain pseudodipeptides that were
directly suitable for solid-phase peptide synthesis [61]. The modification demanded the use of
FmocNH2 (38) instead of CbzNH2 and a carboxylic phosphonous acid 39 (R2 = H, Me, i-Bu, Bzl),
instead of an ester to react with different aldehydes 33 in AcCl/AcOH (Scheme 10). N-Fmoc protected
C-terminal free compounds 40 were isolated with a yield comparable to the yield obtained in the
original report of Chen and Coward. The products incorporated P1’ residues of glycine, alanine,
valine, leucine, isoleucine, phenylglycine and histidine, but also the appropriately protected glutamic
acid and serine. Their utility in solid phase preparation of elongated peptide sequences was also
confirmed. An EDC/HOBt coupling ensured lack of byproducts despite the presence of a non-protected
phosphinate moiety.
 
Reaction conditions: (a) AcCl/AcOH (5:1), 0 ◦C→ rt.
Scheme 10. Synthesis of phosphinic dipeptide building blocks suitable for solid phase peptide synthesis
in a three-component condensation of an aldehyde, 9-fluorenylmethyl carbamate and 2-substituted
2-carboxyethyl-H-phosphinic acid.
A similar amidoalkylation reaction performed in an intramolecular manner was employed to
obtain P1 constrained peptidomimetics 42 (Scheme 11) [62]. Azacyclic compounds of a 5-, 6- and
7-membered ring were readily synthesized from α,ω-carbamoylaldehydes 41 and phosphinic acid
39 (R = Bzl). Formation of rings of these specific sizes was strongly favored. Attempts to obtain
azetidine derivatives were not successful. The cyclization was apparently the driving force for the
condensation. No concurrent open-chain products of intermolecular reactions were indicated in
competitive experiments.
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Reaction conditions: (a) AcCl, rt, dilution of substrates to concentration of 1.4 M.
Scheme 11. Synthesis of constrained phosphinic dipeptides in an intramolecular
three-functional two-component condensation of a 9-fluorenylmethyl carbamate-derived aldehyde and
2-carboxy-3-phenylpropyl-H-phosphinic acid.
Based on the same general methodology, Rozhko and Ragulin synthesized fully deprotected
analogues in a two-step procedure [63]. The condensation of benzaldehyde (3), acetamide (43), and
a phosphonous acid 44 (R = H, i-Bu, CH2COOEt) in acetic anhydride was simply followed by acid
hydrolysis (Scheme 12). Phosphinic compounds 45 were isolated with a low yield (29–37%) using ion
exchange chromatography.
 
Reaction conditions: (a) Ac2O, reflux; (b) 6–8 M HClaq, reflux, then column chromatography on Dowex
50 W (H+).
Scheme 12. Synthesis of deprotected phosphinic dipeptides in a three-component condensation of
benzaldehyde, acetamide, and 2-substituted 2-ethoxycarbonylethyl-H-phosphinic acid.
As mentioned, the precise role of active carboxyl compounds (in the majority of cases, AcCl)
as a driving force for the condensation remained incompletely clear. Recently, this aspect has been
studied in detail by Dmitriev and Ragulin [64–66]. Although acetyl chloride was proven to give the
highest yield (approximately 70% yield in the reaction of benzaldehyde, an alkyl carbamate and an
alkyl acrylate or methacrylate-derived phosphorus component), other systems were almost equally
efficient. These systems included acetic anhydride alone or with the addition of trifluoroacetic or
p-toluenesulfonic acid, which gave rise to 55-65% effectiveness of the condensation [64,65]. More
importantly, careful inspection of the byproducts allowed the isolation of a biscarbamate 46 (Scheme 13)
and suggest its structure as the key intermediate of the process [65].
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Reaction conditions: (a) TFAA (1 eq.), rt, ambient solvent; (b) H2O.
Scheme 13. Synthesis of phosphinic dipeptides in the reaction of benzyl biscarbamate and a
2-ethoxycarbonylethyl-H-phosphinic acid in the presence of trifluoroacetic anhydride (TFAA) and a
suggested mechanism for substrate activation.
Indeed, pre-synthesized biscarbamates reacted with phosphorous species 44 to the same extent as
both substrates separately under analogous conditions [66]. To this end, an Arbuzov-type reaction
was postulated as an amidoalkylation mechanism responsible for the novel P-C bond formation in
47 (Scheme 13). According to the suggestion, formation of a reactive nucleophilic phosphite and
electrophilic acyliminium ion species from the corresponding substrates is mediated by carboxylic acid
chloride or anhydride (here, trifluoroacetic anhydride) [66].
Currently, the amidoalkylation approach to phosphinic pseudodipeptides seems to be considered
advantageous over the phospha-Michael reaction. First of all, the scope of the amidoalkylation is
broader, in particular with respect to the structural complexity of the P1 substituent (Scheme 14).
Typical reaction conditions: (a) an aldehyde, FmocNH2 (or 50 in panel C), β-substituted
β-alkoxycarbonyl-ethyl-H-phosphinic acid, AcCl (AcOH), rt.
Scheme 14. Examples of preparation of multifunctional phosphinic dipeptide analogues in the
amidalkylation approach. Further modification points are highlighted.
P1 functionalities are well tolerated, as can be illustrated by effective preparation of a phosphinic
compound bearing a glutamyl residue (48, Scheme 14A). Previous attempts to use phosphorus substrates
incorporating additional carboxylate in an N→ C silylation-activated process failed [23]. Alternative
acetyl chloride-mediated amidoalkylation allowed the target molecule 48 to be obtained starting from
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complex substrates in one step and with a reasonable yield (48%) [50]. After incorporation into the
target peptide structure (the analogue of thyrotropin-releasing hormone, cycloGlu-His-Pro-NH2),
cyclization to the pseudoglutamyl residue occurred easily. Similarly, Huber et al. constructed a
dipeptide that holds an unsaturated P1 side-chain (49, Scheme 14B, yield 64%) [67]. The properly
protected building block was subsequently introduced into an octapeptide sequence. Ring closing
metathesis involving another homoallylglycine residue produced a cyclic constrained inhibitor of
β-secretase (BACE) with improved serum stability. Finally, a highly functionalized building block 51,
the precursor of P1 constrained peptidomimetics, is also shown. This building block was obtained
in a cyclative manner from a suitably protected amino acid derivative bearing a distal side-chain
aldehyde function 50 (Scheme 14C) [62]. Three points of reactivity of the product are designated for
elongation of the structure in standard amide chemistry. The terminal alkyne group in the P1’ position
is a dipolarophilic site that offers further expansion to the heteroaromatic fragments.
2.3.2. Phospha-Mannich and Kabachnik-Fields Reaction
A related three-component condensation (phospha-Mannich reaction) was used by Hermann
and co-workers to produce multifunctional complexing agents that hold a phosphinic
glycyl-glycine unit. Starting from 2-carboxyethylphosphonous acid 39 (R = H) and a secondary
polyamine, 1,4,7,10-tetraazacyclododecane-1,4,7-triacetate (52) or 1,4,7-trazacyclononane (53),
phosphinate-functionalized products (54 and 55) were obtained (Scheme 15) [68,69]. As the
condensation mechanism involves addition of the P-H function to the imminium ion formed in
situ from the secondary amine and the carbonyl component, the process can be also considered as a
variant of the Kabachnik-Fields reaction.
 
Reaction conditions: (a) HClaq, heating.
Scheme 15. Synthesis of Glyψ[P(O)(OH)CH2]-Gly-substituted polyamines in a phospha-Mannich
condensation with H-phosphinic acid and formaldehyde.
The reaction proceeded with acidic catalysis and, although the reaction gave a moderate yield,
this reaction was found to be simple and inexpensive. New ligands 54 and 55 are suitable for
labeling biomolecules with transition metal radioisotopes in nuclear medicine [68–72]. For example,
1,4,7-trazacyclononane-based phosphinate has recently been described as an exceptionally convenient
platform to develop gadolinium 68Ga(III) complexes as radiopharmaceuticals for positron emission
tomography [72].
A similar idea was earlier employed by Ragulin to obtain phosphinic dipeptides bearing glycine
as the P1 fragment (58, Scheme 16) [63,73]. The whole synthesis was performed in a convenient manner
involving a one-pot two-step sequential reaction of unsaturated compounds, first an acrylate 56, then
N-trityl formimine (57), with the silyl ester of hypophosphorous acid (20). The methodology for
subsequent modification of the phosphorus component is complementary with one-pot modifications
of the C→ N approach (compare chapter 2.2), but the order of P-C bond formation is just reversed.
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Reaction conditions: (a) acrylate, 40 ◦C; (b) imine, toluene, reflux; (c) 6–8 M HClaq, reflux, then column
chromatography on Dowex 50W(H+).
Scheme 16. Synthesis of Glyψ[P(O)(OH)CH2]-Aa derivatives in subsequent addition reactions of an
acrylate and N-trityl formimine to bis(trimethylsilyl) phosphonite.
The overall yield of the reaction was diminished by 10–15% because of
bis(2-carboxyethyl)-phosphinic acid formation. Appearance of the symmetrical byproduct
can be suppressed entirely when at least a 5-fold excess of 20 to acrylate is used [29,30]. However, in
such a case, an additional workup after the first stage would be demanded.
3. Modifications Following the C-P-C Formation
Formation of the Cbz-Aa1ψ[P(O)(OH)CH2]-Aa2-OAlk scaffold assembles a fundamental
phosphinic structure that can rarely be used directly for further studies. At a minimum, the products
of the synthesis need to be deprotected, which is achieved under standard conditions (for carbamates
and esters). Alternatively, subsequent multidirectional transformations can be envisaged. These
transformations typically concern two categories of changes: sequence propagation by amide bond
formation at the N- and/or C-termini and/or structural modification of the R1/R2 substituent. Diverse
chemistry has been applied for the latter purpose, including redox processes and synthesis of novel
carbon-carbon and carbon-heteroatom bonds. All these reactions need careful orthogonal protection
for at least three functionalities present in the molecule. Providing this protection is not an obvious
task because these groups can behave unusually in this particular arrangement. The neighboring
participation in the reactivity is best recognized for the pair phosphinate-β-carboxylate [74,75]. In the
presence of the free carboxyl group, phosphinate protection is particularly labile, both under basic and
acidic conditions. Such a hydrolysis is mediated by presumptive formation of a five-member cyclic
phosphorus species (Scheme 17).
Scheme 17. Suggested mechanism for a facilitated hydrolysis of a phosphinate ester under basic
conditions. The reaction proceeds via a five-membered cyclic intermediate with neighboring-group
assistance of β-carboxylate.
Other examples of cooperative effects were also reported [45,56,76]. One such example is
cyclization of terminal groups. A free amino moiety and a methyl ester form the phosphinic analogue
of diketopiperazine under basic conditions [45]. In this context, proper manipulations on these
groups can be quite demanding. Achievement in this field is adequately illustrated by preparation of
phosphinic dipeptides for solid-phase peptide synthesis.
3.1. Building Blocks for Solid-Phase Peptide Synthesis
Application of phosphinic dipeptides as building blocks for peptide synthesis on a solid phase
demanded the development of a convenient orthogonal protective group for the phosphinic moiety.
After extensive studies in the Yiotakis group, the 1-adamantyl (Ad) group was found to be fully
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compatible with Fmoc methodology [16]. The blocking group was conveniently introduced in a silver
oxide-mediated reaction (Scheme 18).
 
Reaction conditions: (a) AdBr, Ag2O, CH3Cl, reflux; (b) NaOH, H2O/EtOH; (c) HCOONH4, 10% Pd-C,
MeOH; (d) FmocCl, Na2CO3, H2O/dioxane.
Scheme 18. Preparation of phosphinic dipeptides as building blocks suitable for SPPS—the
original procedure.
Typically, the whole procedure of Fmoc-Aa1ψ[P(O)(OAd)CH2]-Aa2-OH (62) preparation is a
four-step protection/deprotection reaction sequence starting from Cbz-Aa1ψ[P(O)(OH)CH2]-Aa2-OR
(59). The sequence consists of: (a) phosphinate adamantylation to obtain 60; (b) C-terminal hydrolysis
leading to acid 61; (c and d) replacement of Cbz by Fmoc at the N-terminus. Cbz hydrogenolysis
had to be carried out under particularly mild conditions to avoid cleaving the adamantyl group, so
ammonium formate was applied as a hydrogen donor for a short-term catalytic process [16].
Since then, some modifications of the original approach have been developed. For example, the
Fmoc protecting group is not sensitive to mild conditions of phosphinic acid activation (TMSCl/tertiary
amine). Accordingly, Fmoc-AaPH could be applied in the Michael addition to synthesize 63 [77]. This
reaction saved two manipulations at the N-terminus in the last stages of the procedure outlined in
Scheme 18. However, to avoid basic conditions of alkyl carboxylate hydrolysis (also causing Fmoc
cleavage), acrylate benzyl esters had to be applied (Scheme 19). Target compounds 62 were obtained
with an excellent yield after adamantylation and hydrogenation.
Reaction conditions: (a) AdBr, Ag2O, CH3Cl, reflux; (b) H2, 10% Pd-C.
Scheme 19. Final stages of phosphinic dipeptide preparation starting from
N-Fmoc-α-amino-H-phosphinic substrates.
To avoid problems in a large scale and expensive silver-mediated adamantylation, Buchardt et
al. suggested a two-step esterification that proceeded via the appropriate phosphinochloridate, and
Buchardt et al. validated this approach for the Gly-Leu analogue (Scheme 20) [78]. Phosphinochloridate
65, prepared quantitatively by oxalyl chloride reaction with substrate 64, spontaneously reacted
with sodium 1-adamantyl oxide to yield the P-protected compound 66. N-Terminus protection and
deprotection leading from 61 to 62 (R1 = H, R2 = i-Bu) were coalesced into one step by hydrogenolysis
performed in the presence of the FmocOSu acylation agent.
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Reaction conditions: (a) (COCl)2, DMF, THF, 0 ◦C; (b) AdONa; (c) NaOH, H2O/EtOH; (d) H2, 5% Pd-C,
FmocOSu, NaHCO3, AcOEt/MeOH/H2O.
Scheme 20. Modification of Fmoc-Aa1ψ[P(O)(OAd)CH2]-Aa2-OH preparation, performed for
Gly-Leu analogue.
Finally, all specific improvements were combined. Following the preparation of adamantylated
products 67 (via the corresponding phosphinochloridates), all three remaining manipulations (tandem
C-benzyl and N-Cbz removal together with simultaneous N-Fmoc introduction) proceeded in a single
reduction step to give 62 (R1 = H, R2 = i-Pr or i-Bu, Scheme 21) [79].
Reaction conditions: (a) H2, 5% Pd-C, FmocOSu, MeOH.
Scheme 21. Transformation of Cbz-Glyψ[P(O)(OAd)CH2]-Aa2-OBzl into
Fmoc-Glyψ[P(O)(OAd)CH2]-Aa2-OH in a single synthetic step.
N-Fmoc-protected phosphinic pseudodipeptides 40 with both acidic functionalities free are
easily accessible using a three-component condensation (compare Scheme 10) [61]. Having these
pseudopeptides in hand, a unique chemoselective protection strategy was envisaged by Yiotakis and
co-workers (Scheme 22) [76]. The phenacyl (Pac) group was installed on both the phosphinate and
carboxylate of 68 under common reaction conditions. However, the action of a mild acid caused fully
selective removal only from the hydroxyphosphinyl moiety (69). Such susceptibility to hydrolysis
was tentatively explained by the assistance of the carbamate neighboring group, which might also
participate in the formation of a five-membered reactive intermediate [76]. Two subsequent steps
consisting of a typical adamantyl ester formation and Pac cleavage from the C-terminus completed the
reaction sequence.
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Reaction conditions: (a) PacBr, Et3N, AcOEt, 0 ◦C→ rt; (b) TFA/CH2Cl2 (4:1), 50 ◦C; (c) AdBr, Ag2O,
CH3Cl, reflux; (d) Mg, AcOH, MeOH/DMF (4:1), rt.
Scheme 22. Chemoselective protection of a phosphinic dipeptide.
Fmoc-Aa1ψ[P(O)(OAd)CH2]-Aa2-OH building blocks (62) are commonly used in standard,
automated Fmoc/benzotriazole solid-phase and combinatorial peptide synthesis [16,21,80–83].
Nevertheless, several reports consider P-protection unnecessary when particular short sequences
are being targeted. The phosphinate functionality is poorly activated by standard coupling agents.
The carboxylate can therefore be chemoselectively converted into the corresponding amide in the
presence of the free phosphinic acid moiety, both in solution and on the solid phase by means of DCC
(EDC)/HOBt, BOP, PyBOP, i-butyl chloroformate or other activators [32,36,61,84,85].
3.2. Side-Chain Substituents Modifications and Parallel Diversification
Post-synthetic modifications of the phosphinate scaffold substituents concern mainly the
C-terminal fragment of the molecule. One of the rare examples of the P1 transformation is an
oxidative conversion of the phenyl ring of 70 into a carboxylate group. Mild conditions of oxidation
allowed Georgiadis et al. to obtained Asp and Glu acidic residues in the Aa1ψ[P(O)(O)CH2]-Ala
sequence (71) in moderate yield (Scheme 23) [23]. This problematic sequence is difficult to obtain in a
typical phospha-Michael approach.
 
Reaction conditions: (a) RuCl3, NaIO4, MeCN, H2O.
Scheme 23. An oxidative approach to Aspψ[P(O)(O)CH2]-Ala and Gluψ[P(O)(O)CH2]-Ala
phosphinic dipeptides.
Among chemical entities implemented in multidirectional and parallel P1’ diversification chemistry,
active methylene phosphinic synthons have been found to be one of the most interesting options
(Scheme 24).
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Scheme 24. A general scheme of multidirectional modifications that have been envisaged starting from
P1’ active methylene phosphinic compounds.
Such synthons are easily prepared by addition of an alkyl methylidenemalonate or
α-phosphonoacrylate to an α-amino-H-phosphinate. The Cα’ proton acidity of the adduct can
subsequently be utilized in several different ways. Two main routes involve alkylation of the malonate
followed by decarboxylation of the product and a Wittig-Horner type of olefination (or, alternatively,
Knoevenagel condensation) to introduce a double bond that can optionally be reduced or added with
a nucleophile. Both methods have served to introduce a specific side-chain substituent to P1’ portion
of the molecule.
The alkylation strategy was used, for example, in the Ebetino group to prepare a precursor for
the phosphinic Phe-Arg dipeptide isostere (74, Scheme 25) [44]. Di-t-butyl malonate-substituted
pseudodipeptide 73, obtained from 24 and malonate 72, allowed effective alkylation with
1-azido-3-iodopropan (yield 88%). The building block was incorporated into the target peptide
sequence and then subjected to one-pot modifications. The azido group was reduced to the amino
group that finally was guanidinated in situ.
Reaction conditions: (a) TMSCl, DIPEA, CH2Cl2, 0 ◦C; (b) i-PrOH, EDC, CH2Cl2; (c) t-BuOK, I(CH2)3N3,
DME; (d) TFA, CH2Cl2; (e) toluene, reflux.
Scheme 25. Construction of phosphinic dipeptide precursor of Pheψ[P(O)(OH)CH2]-Arg.
Similarly, Matziari et al. introduced bulky arylmethyl P1’ substituents to 75 using appropriate
bromides and an alkylation approach (Scheme 26) [86]. The overall yield of products 76 was roughly
50%, outscoring the standard Michael-type addition that had previously been applied to provide the
same 2-naphthyl compound (6.5%).
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Reaction conditions: (a) NaH, RCH2Br, THF, 0 ◦C→ rt; (b) TFA, CH2Cl2; (c) LiOH, MeOH.
Scheme 26. Alkylation of a malonate-derived phosphinic dipeptide.
As an early example of the second variant (double bond formation and subsequent
reduction, compare Scheme 24), Parsons et al. performed a stereoselective synthesis of
D-Alaψ[P(O)(OH)CH2]-D-Ala inhibitor (80) of D-Ala-D-Ala ligase [31], a bacterial enzyme involved in
cell wall biosynthesis. After addition of trimethyl phosphonoacrylate (78) to the H-phosphinic ester 77
and reaction with formaldehyde, stereoselective reduction of the pseudodehydroalanine compound 79
was employed (Scheme 27).
 
Reaction conditions: (a) MeONa, methanol, 0 ◦C; (b) CH2O, 0 ◦C → rt; (c) LiI, THF; (d) H2,
[(COD)RhCl]2, (−)-DIOP ((−)-O-isopropylidene-2,3-dihydroxy-1,4-bis(diphenylphosphino)butane)
then recrystallization from acetic acid.
Scheme 27. Synthesis of D-Alaψ[P(O)(OH)CH2]-D-Ala by a stereoselective reduction
of dehydroalanine.
More recently, an analogous approach was utilized to synthesize phosphinic dehydro analogues
of cyclohexylalanine 81-based inhibitors of renal dipeptidase (Scheme 28) [87,88]. After olefination
of the phosphonoacetate with cyclohexylaldehyde or structurally diversified benzaldehydes, Z and
E diastereoisomeric products 82 and 83 were separated chromatographically. Z isomers slightly
predominated, typically in a 40%:30% ratio. Deprotected compounds, tested against the target
peptidase, revealed the enzyme preference for the Z configuration (IC50 of a low nanomolar value).
 
Reaction conditions: (a) trimethyl-2-phosphonoacrylate, MeONa, MeOH, 0 ◦C; (b) cyclohexylaldehyde
or ArCHO, rt, then chromatographic separation; (c) TFA, CH2Cl2, rt, then HClaq, 50 ◦C.
Scheme 28. Synthesis of P1’ dehydro phosphinic dipeptide inhibitors of renal dipeptidase.
To obtain P1’ dehydroamino acid residues 85, Matziari et al. employed a Knoevenagel-type
condensation (Scheme 29) [86]. Different aldehydes reacted with phosphinic dipeptide-derived malonic
acid (S)-84 with a good yield and a preference for the E diastereoisomer up to 100%. The attempts at
asymmetric reduction with rhodium catalysts and chiral ligands gave poor de.
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Reaction conditions: (a) RCHO, piperidine, pyridine, reflux.
Scheme 29. Synthesis of phosphinic pseudodipeptides containing P1’ dehydroamino acid fragments
by a Knoevenagel condensation.
A mild, one-step and high-yielding conversion of P-H substrates, such as 24, to P1’ dehydroalanine
phosphinic analogues 87 was also proposed in the Yiotakis group [89]. This conversion involved
reaction of α-(bromomethyl)acrylic ester (86) with the trimethylsilylated phosphinate via a tandem
Arbuzov reaction followed by allylic rearrangement (Scheme 30). The same results were obtained
in the reaction of the unsaturated substrate with the acetoxy (instead of bromo) leaving group. A
diversification potential for the dehydroalanine fragment was used to develop novel inhibitors of
matrix metalloproteases (see below).
Reaction conditions: (a) TMSCl, DIPEA, CH2Cl2, 0 ◦C→ rt or HMDS, 110 ◦C; then acrylate, 0 ◦C→ rt
(for TMSCl variant) or 110 ◦C (for HMDS variant), then EtOH.
Scheme 30. Reaction of α-amino-H-phosphinic acid with α-(bromomethyl)acrylates leading to
dehydroalanine phosphinic dipeptides.
The tandem Arbuzov reaction (employing the acetoxy derivative 88), combined with double bond
reduction, was used to introduce the constrained P1’ fragment of proline to the phosphinic dipeptide
scaffold 89 (Scheme 31) [90]. Incorporated as a building block into a tripeptide sequence, it allowed to
establish structural determinants of highly potent and selective inhibitors of the C-terminal domain of
angiotensin-converting enzyme.
Reaction conditions: (a) HMDS, 110 ◦C, then acrylate, 90 ◦C, then EtOH; (b) NaBH4, NiCl2, MeOH, −30◦C.
Scheme 31. Preparation of a phosphinic dipeptide bearing the pseudoproline P1’ fragment.
Dehydroalanine synthon 87 can undergo a variety of subsequent transformations. As indicated,
nitrogen, carbon and sulfur nucleophiles can easily be added to the activated double bond to
yield products 90–93 (Scheme 32) [89]. The reactions were carried out under mild conditions and
without the necessity of phosphinate group protection. The potential of P1’ diversification in
this manner was best recognized in the addition of thiols to acrylate implemented in a tripeptide
sequence. The products were studied as inhibitors of matrix metalloproteases with particular
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attention to MMP-11 [91]. As a result, a diversity of tripeptide analogues of a general structure
Cbz-(L)-Pheψ[P(O)(OH)CH2]-Cys(R)-(L)-Trp-NH2 were obtained and tested for complementarity to
the S1’ pocket of MMP-11. Remarkable selectivity of two orders of magnitude versus other members of
MMP family was found for particular R substituents, for example, o-bromo or o-methoxyphenyl [91].
 
Reaction conditions: (a) piperidine, CH2Cl2, rt; (b) sodium diethylmalonate, EtOH, rt; (c) n-BuLi, CuI,
TMSCl, Et2O/THF, −20 ◦C; (d) BzlSH, Et3N, CH2Cl2, rt.
Scheme 32. Addition of various nucleophiles (Nu) to P1’ dehydroalanine phosphinic dipeptide.
Other unsaturated groups present in the Cα’ side-chain substituent of the phosphinic dipeptides
can also be used for specific transformations. In particular, terminal alkenes and alkynes have
been recognized in “click” chemistry to produce heterocyclic systems (Scheme 33) [40,47,48].
Both unsaturated systems (94 and 96) were successfully subjected to 1,3-dipolar cycloaddition as
dipolarophilic substrates. The unsaturated systems reacted with nitrile oxides generated in situ from
aryl oximes by oxidative chlorination. As a result, aryl-substituted isoxazoles or isoxazolines (95 and
97) were obtained with a good yield. The transformations were found to be equally effective in a
dipeptidic building block and in an elongated peptide structure. Similarly to the previous example, the
products were utilized to explore the specificity of the S1’ binding pocket of selected metalloproteases,
e.g., matrix metalloproteases, angiotensin- and endothelin-converting enzymes [40,47,48].
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Reaction conditions: (a) ArCH=NOH, NCS, pyridine, CHCl3, 45 ◦C, then an alkene or alkyne, Et3N, 45◦C.
Scheme 33. Synthesis of P1’ isoxazole and isoxazoline derivatives of phosphinic peptide in
1,3-dipolar cycloaddition.
An expected anti-aminopeptidase inhibitory activity inspired elaboration of a phosphinic dipeptide
building block containing a β’ amino group that was suitable for parallel substitution [46]. According
to the molecular modeling results, this group should be close to the position of the nitrogen atom in the
transition state of the cleaved amide bond and, thus, favorably bound at the enzyme active site. The
appropriate synthons were obtained by addition of the H-phosphinic analogue of homophenylalanine
(98) to a dehydroalanine derivative 99 (Scheme 34).
 
Reaction conditions: (a) HMDS, 110 ◦C, then dehydroalanine, 90 ◦C; (b) AdBr, Ag2O, CHCl3, reflux; (c)
NaOH, MeOH, rt, then H2, 10% Pd/BaSO4, MeOH (for X =H) or H2, 10% Pd/BaSO4, MeOH (for X =
Me); (d) ArI, CuI, K2CO3, 65 ◦C (for X =H, n = 0) or ArCH2Br, Cs2CO3, DMF, 45 ◦C (for X =Me, n =
1), (e) TFA, CH2Cl2, rt, then HPLC (for X = H) or NaOH, MeOH, rt, then TFA, CH2Cl2, rt, then HPLC
(for X =Me). When necessary, the additional substituents R of the substrate halides were suitably
protected.
Scheme 34. Parallel modification of phosphinic peptides containing a β’ amino group in cross-coupling
and alkylation reactions.
After typical protection/deprotection manipulations of the protecting group, two building blocks
(100, X = H, n = 0 or X = Me, n = 1) were constructed and subjected to an cross-coupling with
corresponding aryl iodides or an alkylation reaction with benzyl bromides [46]. Because of the
structural complexity (namely, the presence of multiple functionality groups in both substrates), the
yield of the cross-coupling reaction was rather low. The final products 101 needed to be purified on
HPLC, which, in turn, allowed separation of diastereoisomers in the majority of cases.
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4. Stereoselective Approaches
Enantiomerically pure α-amino-H-phosphinic acids are relatively readily available.
N-Benzyloxycarbonyl-protected compounds form diastereomeric salts with commercially available
chiral amines, e.g., 1-phenylethylamine. The salts crystallize smoothly to yield the required
enantiomer [22]. The resolved phosphonous acids are not susceptible to racemization and tolerate
diverse reaction conditions. Accordingly, optically pure α-amino-H-phosphinic acids are commonly
used as the substrates in the phospha-Michael addition to produce P1 stereo-defined phosphinic
pseudodipeptides. Even though the enantiomeric phosphonous acids rarely cause a significant
induction of the newly appearing asymmetric center (Cα’ atom), diastereomeric products can be
separated simply by crystallization or chromatography [21,47]. The resolution is particularly effective
when pseudodipeptides are included in a stereo-defined sequence of elongated peptides. In those
cases, differentiation of even four diastereoisomers (epimeric on both Cα and Cα’ atoms) on HPLC is
not problematic [35,36]. Similarly, an astonishing difference in solubility in common solvents allowed
separation of the four diastereoisomers of a phosphinic tripeptide by simple recrystallization [92]. With
the aid of quantum mechanical calculations and molecular dynamics simulation these distinguishing
physicochemical properties were attributed to the conformationally-specific pattern of inter- and
intramolecular interactions among solute and solvent molecules. In accordance with this argument,
stereoselective synthesis of phosphinic dipeptide analogues is not popular in the literature and concerns
basically the P1’ induction. Evans oxazolidinone-type auxiliaries were applied by the Ebetino group to
induce the stereochemistry of the P1’ position of Phe-Phe phosphinic dipeptide 104 (Scheme 35) [93].
 
Reaction conditions: (a) TMSCl, DIPEA, CH2Cl2, 0 ◦C→ rt, then acrylate addition; (b) EtOH, −10 ◦C.
Scheme 35. Diastereoselective addition of chiral oxazolidinone-derived acrylamides to
α-amino-β-phenylethyl-H-phosphinic acid.
To prepare chiral substrates 103, α-benzylacrylic acid was coupled with the lithium salt of an
oxazolidinone. Low-temperature trimethylsilyl-mediated addition of 102 to the acrylamides was found
to produce an optimal induction. Quite naturally, top results of the de were achieved for the most
crowded 4-diphenylmethyl-substituded oxazolidinone. Semiempirical AM1 energy calculation for the
presumed enol ether intermediates pointed out that the R isomer is the favored product.
A double diastereoselective approach to phosphinic dipeptide formation in a Michael addition
followed by a Cα’ alkylation was presented by Yamagishi et al. (Scheme 36) [94]. Using enantiomerically
(R1 =H) or diastereomerically (R1 = i-Bu, Bn) pure P-chiral α-aminoalkyl-H-phosphinic acid esters
(105) as substrates, the authors carried out addition of t-butyl acrylate (106) without a loss of the
phosphorus chirality. The reaction, catalyzed efficiently by magnesium alkoxide, produced a single
isomer 107 with an excellent chemical yield (Scheme 36A). The stereochemistry was controlled by the
phosphorus atom configuration to give the complete retention for various P1 side chain substituents
and N-protection groups.
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Reaction conditions: (a) t-BuOMgBr, 0 ◦C; (b) LiHMDS, R2X, −78 ◦C.
Scheme 36. Diastereoselective phospha-Michael addition and Cα’ alkylation of the resulting
phosphinate dipeptide controlled by the defined phosphorus atom configuration.
Contrarily, the subsequent lithium-mediated alkylation step depended strongly on the steric
parameters of the N-terminus. Excellent diastereoselectivity was observed for the most hindered
Trs sulfonate protection (107, PG = Trs, R1 = Bzl), whereas induction was markedly poorer for
other blocking groups [94]. Bulkiness of the side chain on the Cα position was not critical. Several
different residues (alkyl, benzyl, alkenyl and alkynyl) were introduced in this way to the phosphinate
dipeptide backbone as novel P1’ substituents with a good yield (compounds 108, Scheme 36B). Difficult
N-deprotection can be considered as the single disadvantage of the method. The deprotection is a
moderately effective three-step procedure including additional Cbz carbamoylation, Trs removal by
SmI2 treatment and final Cbz hydrogenolysis [94].
The addition of cyclopentenyl carboxylate to TrsLeuPH ethyl ester (105, R = i-Bu, PG = Trs)
proceeded with difficulty. The methodology failed to prepare a Leuψ[P(O)(OH)CH2]-Pro derivative
in the same manner. To overcome this drawback, a cross-coupling of the phosphorus substrate
with the appropriate triflate 109 was envisaged (Scheme 37) [95]. After careful optimization of
conditions, a palladium-catalyzed reaction carried out in the presence of K2CO3 as a base and DPEphos
((oxydi-2,1-phenylene)bis(diphenylphosphine)) as a chiral ligand yielded the unsaturated dipeptide
110 with a very good yield and an excellent de. Quite naturally, the subsequent reduction gave
predominantly the cis-cyclopentane diastereoisomer 111 that could be isolated in a pure form after
recrystallization or preparative TLC. Epimerization, occurring spontaneously to some extent during
the hydrogenolysis, was preparatively induced by increase the temperature of reduction to yield the
trans-cyclopentane configuration (112) [95].
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Reaction conditions: (a) K2CO3, Pd2(dba)3, DPEphos, triflate (2 eq.), toluene, 80 ◦C; (b) H2 (3.5 atm),
PtO2, EtOH, rt; (c) H2, PtO2, EtOH, 80 ◦C; (d) H2, PtO2, EtOH, rt then 80 ◦C.
Scheme 37. Diastereoselective cross-coupling and subsequent reduction leading to
Leuψ[P(O)(OH)CH2]-Pro derivatives of the controlled pseudoproline configuration.
Diastereoselective Michael-type addition of 2H-2-oxo-1,4,2-oxazaphosphinane 113 to olefins,
including α,β-unsaturated esters (114, R =Me or Bzl, Scheme 38), was investigated by Monbrun et
al. [96]. The reactions catalyzed by potassium t-butoxide proceeded with an excellent chemical yield
and with complete retention of configuration of the phosphorus atom.
Reaction conditions: (a) CH2Cl2, t-BuOK, −5 ◦C→ rt.
Scheme 38. Diastereoselective addition of 2H-2-oxo-1,4,2-oxazaphosphinanes to acrylates.
The chiral induction of the newly formed stereogenic center in 115 depended strongly on
the structure of the unsaturated substrates. For acrylates, the results were rather poor (~30%).
More impressive data were indicated for substituents located closer to the sterically crowded
heteroatom system.
In addition to the synthetic methods, stereoselective instrumental techniques were also applied
to differentiate/resolve enantiomeric phosphinic dipeptide analogues. For example, an anion
exchange chiral stationary phase based on cinchona alkaloids allowed resolution of dipeptide
analogues in the reversed-phase HPLC mode [97]. The most effective O-9-(t-butylcarbamoyl)quinidine
selector immobilized on a solid support was successfully utilized in chiral chromatography or
electrochromatography separation of four stereoisomers of hPheψ[P(O)(OH)CH2]-Phe, a nanomolar
inhibitor of leucine aminopeptidase [98,99].
5. Applications and Conclusions
The main field of application of phosphinic pseudopeptides concerns fundamental and practical
aspects of inhibition of selected enzymes. This field of application mostly means representatives of
two classes of catalytic proteins: ligases and hydrolases, in particular metallo-dependent proteases.
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Among others, these enzymes can catalyze, respectively, formation or cleavage of an amide bond
in a metal ion-mediated process that proceeds via a tetrahedral transition state. C-P-C dipeptides
comprise fundamental structural features of advantageous transition state analogue inhibitors. First,
the dipeptides contain P1 and P1’ fragments dedicated to explore the specificity of the corresponding
S1 and S1’ enzyme binding pockets. Second, the central phosphinate group is tetrahedrally-shaped
and mimics the geometry and electron distribution of a diolate intermediate in the hydrolysis process.
Third, phosphinic acid can be complexed to the central metal ion and block its catalytic function.
Accordingly, phosphinic dipeptide isosters are broadly recognized as reversible, competitive inhibitors
of many enzymatic targets [5–7,21].
Regulation of D-Ala-D-Ala ligase activity by D-Alaψ[P(O)(OH)CH2]-D-Ala (115) is one of the
most prominent examples of ligase inhibition. The enzyme catalyzes condensation of two alanine
molecules with ATP participation to form the terminal peptide of a peptidoglycan monomer. As
the process is specific for bacteria, D-Ala-D-Ala ligase is an attractive antimicrobial target. The
phosphinic analogue of the product of the reaction was found to be a micromolar inhibitor of the
enzyme [31,100]. Interestingly, careful inspection of the mechanism of its action revealed that the
phosphinate is not a typical transition state analogue. The phosphinate binds to the ligase in the
phosphorylated form (116, Scheme 39A). Thus, the pseudodipeptide can be considered as a suicide
substrate [100,101]. Identical phosphorylation of D-Alaψ[P(O)(OH)CH2]-D-Ala was discovered
upon binding with VanA, a ligase responsible for natural resistance of vancomycin [102,103]. Other
bacterial ligases involved in peptidoglycan biosynthesis have also been exploited as targets for
antibacterial drug design using phosphinate dipeptide inhibitors [42,104–106]. Representative examples
of UDP-N-acetylmuramoyl-L-alanyl:D-glutamate ligase (MurD) inhibitors (117 and 118) are shown
in Scheme 39B. Recently, the L-Alaψ[P(O)(OH)CH2]-L-Phe ligand was also used for structural
characterization of an L-amino acid ligase from Bacillus subtilis [107].
 
Scheme 39. (A) The mode of action of D-Alaψ[P(O)(OH)CH2]-D-Ala, a phosphinic dipeptide inhibitor
of D-Ala-D-Ala ligase; (B) Phosphinic dipeptide-derived inhibitors of MurD, another ligase involved in
peptidoglycan biosynthesis.
As far as metalloprotease targets are concerned, inhibition of leucine and alanyl aminopeptidases
(LAP and APN) seems to be the most recognized example of biological activity of phosphinic
dipeptide analogues [45,46,99,108–111]. LAP and APN are multifunctional broad-band specificity
aminopeptidases involved in biological functions in both eukaryotic and prokaryotic cells.
42
Molecules 2012, 17, 13530-13568
hPheψ[P(O)(OH)CH2]-Phe (119) and hPheψ[P(O)(OH)CH2]-Tyr (120), phosphinic compounds of an
optimized structure, exhibited nanomolar activity towards mammalian (porcine kidney) [45], protozoan
(recombinant Plasmodium falciparum) [112,113] and bacterial (recombinant Neisseria meningitides) [114]
enzymes (Figure 3).
 
Figure 3. The structure and activity of hPheψ[P(O)(OH)CH2]-Phe and hPheψ[P(O)(OH)CH2]-Tyr
phosphinic dipeptide inhibitors of leucine and alanyl aminopeptidases.
In the most advanced studies, the phosphinates efficiently controlled the growth of P. falciparum
cell lines and infection of a malaria model in vivo [112,113]. The structural basis of their activity
was established by resolution of the crystal structures of the enzyme-ligand for both protozoan
aminopeptidases complexed with the hPhe-Phe analogue [115,116]. The data altogether validated P.
falciparum aminopeptidases as promising targets to treat malaria [113].
Plasma procarboxypeptidase B (thrombin-activatable fibrinolysis inhibitor, TAFIa) is a zinc-based
exopeptidase proteolytically activated by thrombin into the active enzyme (carboxypeptidase B, CPB)
that down-regulates fibrinolysis by removing the C-terminal lysine from fibrin fiber. Altering the
action of CPB is a new way to target thrombosis-related diseases [117]. Phosphinic dipeptide analogues
that comprise a lysine mimetic in the P1’ position (121 and 122) were found to be excellent tools for
this purpose. Compounds known in the literature as EF6265 and BX 528 (Figure 4) inhibited CPB with
high affinity and excellent selectivity versus other carboxypeptidases and are prospective drugs for
fibrinolytic therapy [118–121].
 
Figure 4. The structure and activity of phosphinic dipeptide inhibitors of TAFIa/carboxypeptidase B.
Other hydrolases, mostly zinc-containing, probed with phosphinic pseudodipeptide tools are
listed below:
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• angiotensin-converting enzyme 2, a mono-zinc carboxypeptidase, the first known human
homologue of ACE [40];
• aminopeptidase A (glutamyl aminopeptidase) [122];
• NAALADase (N-acetylated-α-linked acidic dipeptidase), a metallo-dependent
neuropeptidase [43];
• human renal dipeptidase and its bacterial homologue [87,88,123];
• M18 aspartyl aminopeptidase of Plasmodium falciparum [124];
• dinuclear zinc aminopeptidase PepV from Lactobacillus delbrueckii [125];
• D-Ala-D-Ala dipeptidase VanX, required for vancomycin resistance [126];
• chymotrypsin, cathepsin G and neutrophil elastase, serine proteases [127].
These examples do not complete the wide scope of phosphinic dipeptide utility. The majority
of the currently-studied phosphinic compounds have used the fundamental building blocks for
subsequent evolution into more complex systems. With respect to biological activity, the developed
optimized sequences possess a refined potency/affinity to their targets that is also associated with an
improved selectivity. Phosphinic fragments included in extended structures also acquire interesting
metal complexing properties that have only occasionally been mentioned along the text. To conclude,
phosphinic dipeptide preparation and diversification seem to be fundamental elements in a much
broader and multifaceted area of phosphorus chemistry and biology.
Acknowledgments: The work was financed by a statutory activity subsidy from the Polish Ministry of Science
and Higher Education for the Faculty of Chemistry of Wrocław University of Technology. The work is dedicated
to Vincent Dive and Athanasios Yiotakis who introduced the author to phosphinic peptide chemistry.
References
1. Matthews, B.W. Structural basis of the action of thermolysin and related zinc peptidases. Acc. Chem. Res.
1988, 21, 333–340. [CrossRef]
2. Schechter, I.; Berger, A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun.
1967, 27, 157–162. [CrossRef]
3. Pauling, L. Chemical achievement and hope for the future. Am. Sci. 1948, 36, 51–58. [PubMed]
4. Wolfenden, R. Transition state analogues for enzyme catalysis. Nature 1969, 223, 704–705. [CrossRef]
[PubMed]
5. Kafarski, L.; Lejczak, B. The biological activity of phosphono- and phosphinopeptides. In Aminophosphonic
and Aminophosphinic Acids. Chemistry and Biological Activity; Kukhar, V.P., Hudson, H.R., Eds.; John Wiley &
Sons: Chichester, UK, 2000; pp. 407–442.
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norleucine-derived phosphinopeptides. Tetrahedron Lett. 2008, 49, 5629–5631. [CrossRef]
39. Kaboudin, B.; Saadati, F. A simple, novel and convenient method for the synthesis of 1-aminophosphinic
acids: synthesis of a novel C2-symmetric phosphinic acid pseudodipeptide. Tetrahedron Lett. 2009, 50,
1450–1452. [CrossRef]
40. Mores, A.; Matziari, M.; Beau, F.; Cuniasse, P.; Yiotakis, A.; Dive, V. Development of potent and selective
phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J. Med. Chem. 2008, 51, 2216–2226.
[CrossRef]
41. Demange, L.; Dugave, C. Synthesis of phosphinic alanyl-proline surrogates Alaψ(PO2R-CH)Pro as potential
inhibitors of the human cyclophilin hCyp-18. Tetrahedron Lett. 2001, 42, 6295–6297. [CrossRef]
42. Tanner, M.E.; Vaganay, S.; van Heijenoort, J.; Blanot, D. Phosphinate inhibitors of the D-glutamic acid-adding
enzyme of peptidoglycan biosynthesis. J. Org. Chem. 1996, 61, 1756–1760. [CrossRef] [PubMed]
43. Jackson, P.F.; Tays, K.L.; Maclin, K.M.; Ko, Y.-S.; Li, W.; Vitharana, D.; Tsukamoto, T.; Stoermer, D.; Lu, X.-C.M.;
Wozniak, K.; Slusher, B.S. Design and pharmacological activity of phosphinic acid based NAALADase
inhibitors. J. Med. Chem. 2001, 44, 4170–4175. [CrossRef] [PubMed]
44. Kende, A.S.; Dong, H.-Q.; Liu, X.; Ebetino, F.H. A useful synthesis of the Phe-Arg phosphinic dipeptide
isostere. Tetrahedron Lett. 2002, 43, 4973–4976. [CrossRef]
45. Grembecka, J.; Mucha, A.; Cierpicki, T.; Kafarski, P. The most potent organophosphorus inhibitors of
leucine aminopeptidase. Structure-based design, chemistry, and activity. J. Med. Chem. 2003, 46, 2641–2655.
[CrossRef] [PubMed]
46. Vassiliou, S.; Xeilari, M.; Yiotakis, A.; Grembecka, J.; Pawełczak, M.; Kafarski, P.; Mucha, A. A synthetic
method for diversification of the P1’ substituent in phosphinic dipeptides as a tool for exploration of the
specificity of the S1’ binding pockets of leucine aminopeptidases. Bioorg. Med. Chem. 2007, 15, 3187–3200.
[CrossRef]
47. Makaritis, A.; Georgiadis, D.; Dive, V.; Yiotakis, A. Diastereoselective solution and multipin-based
combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors. Chem.
Eur. J. 2003, 9, 2079–2094. [CrossRef]
48. Jullien, N.; Makritis, A.; Georgiadis, D.; Beau, F.; Yiotakis, A.; Dive, V. Phosphinic tripeptides as dual
angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors. J. Med. Chem.
2010, 53, 208–220. [CrossRef]
49. Stetter, H.; Kuhlmann, H. Eine einfache Herstellung von α-Alkylacrylsäure-estern. Synthesis 1979, 29–30.
[CrossRef]
50. Matziari, M.; Bauer, K.; Dive, V.; Yiotakis, A. Synthesis of the phosphinic analogue of thyrotropin releasing
hormone. J. Org. Chem. 2008, 73, 8591–8593. [CrossRef]
51. Borloo, M.; Jiao, X.-Y.; Wójtowicz, H.; Rajan, P.; Verbruggen, C.; Augustyns, K.; Haemers, A. A convenient
one-pot preparation of disubstituted phosphinic acids derived from simple amino acids and proline. Synthesis
1995, 1074–1076. [CrossRef]
52. Fougère, C.; Guénin, E.; Hardouin, J.; Lecouvey, M. Rapid and efficient synthesis of unsymmetrical phosphinic
acids R’P(O)OHR”. Eur. J. Org. Chem. 2009, 6048–6054. [CrossRef]
46
Molecules 2012, 17, 13530-13568
53. Prishchenko, A.A.; Livantsov, M.V.; Novikova, O.P.; Livantsova, L.I.; Petrosyan, V.S. Synthesis of new
organophosphorus-substituted mono- and bis(trimethylsilyl)amines with PCH2N fragments and their
derivatives. Heteroatom Chem. 2010, 21, 71–77. [CrossRef]
54. Prishchenko, A.A.; Livantsov, M.V.; Novikova, O.P.; Livantsova, L.I.; Petrosyan, V.S. Synthesis of new
organophosphorus-substituted derivatives of functionalized propionates and their analogues. Heteroatom
Chem. 2008, 19, 418–428. [CrossRef]
55. Livantsov, M.V.; Prishchenko, A.A.; Novikova, O.P.; Livantsova, L.I.; Grigor’ev, E.V. Synthesis of
phosphorus-substituted derivatives of methylsuccinic acid. Russ. J. Gen. Chem. 2003, 73, 659–660.
[CrossRef]
56. Rogakos, V.; Georgiadis, D.; Dive, V.; Yiotakis, A. A modular rearrangement approach toward medicinally
relevant phosphinic structures. Org. Lett. 2009, 11, 4696–4699. [CrossRef]
57. Dorff, P.H.; Chiu, G.; Goldstein, S.W.; Morgan, B.P. Solid phase synthesis of phosphinopeptoids as transition
state analog inhibitors. Tetrahedron Lett. 1998, 39, 3375–3378. [CrossRef]
58. Buchardt, J.; Meldal, M. Novel methodology for the solid-phase synthesis of phosphinic peptides. J. Chem.
Soc. Perkin Trans. 1 2000, 3306–3310. [CrossRef]
59. Chen, S.; Coward, J.K. A general method for the synthesis of N-protected α-aminophosphinic acids.
Tetrahedron Lett. 1996, 37, 4335–4338. [CrossRef]
60. Yuan, C.; Wang, G.; Chen, S. Studies on organophosphorus compounds; XLVI. A facile and
direct route to dialkyl 1-(benzyloxycarbonylamino)alkylphosphonates and dialkyl or diphenyl
α-(benzyloxycarbonylamino)benzylphosphonates. Synthesis 1990, 522–524. [CrossRef]
61. Matziari, M.; Yiotakis, A. Shortcut to Fmoc-protected phosphinic pseudodipeptidic blocks. Org. Lett. 2005, 7,
4049–4052. [CrossRef]
62. Nasopoulou, M.; Georgiadis, D.; Matziari, M.; Dive, V.; Yiotakis, A. A versatile annulation protocol toward
novel constrained phosphinic peptidomimetics. J. Org. Chem. 2007, 72, 7222–7228. [CrossRef]
63. Rozhko, L.F.; Ragulin, V.V. Method for the synthesis of phosphinic acids from hypophosphites V. The
synthesis of pseudo-α,α-dipeptides. Amino Acids 2005, 29, 139–143. [CrossRef]
64. Dmitriev, M.E.; Ragulin, V.V. New opinions on the amidoalkylation of hydrophosphorylic compounds.
Tetrahedron Lett. 2010, 51, 2613–2616. [CrossRef]
65. Dmitriev, M.E.; Rossinets, E.A.; Ragulin, V.V. Amidoalkylation of hydrophosphoryl compounds. Russ. J. Gen.
Chem. 2011, 81, 1092–1104. [CrossRef]
66. Dmitriev, M.E.; Ragulin, V.V. Arbuzov-type reaction of acylphosphonites and N-alkoxycarbonylimine cations
generated in situ with trifluoroacetic anhydride. Tetrahedron Lett. 2012, 53, 1634–1636. [CrossRef]
67. Huber, T.; Manzenrieder, F.; Kuttruff, C.A.; Dorner-Ciossek, C.; Kessler, H. Prolonged stability by cyclization:
Macrocyclic phosphino dipeptide isostere inhibitors of β-secretase (BACE1). Bioorg. Med. Chem. Lett. 2009,
19, 4427–4431. [CrossRef]
68. Foersterova, M.; Svobodova, I.; Lubal, P.; Taborsky, P.; Kotek, J.; Hermann, P.; Lukes, I. Thermodynamic study
of lanthanide(III) complexes with bifunctional monophosphinic acid analogues of H4dota and comparative
kinetic study of yttrium(III) complexes. J. Chem. Soc. Dalton Trans. 2007, 535–549. [CrossRef]
69. Notni, J.; Hermann, P.; Havlickova, J.; Kotek, J.; Kubicek, V.; Plutnar, J.; Loktionova, N.; Riss, P.J.; Roesch, F.;
Lukes, I. A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga
tracers for positron emission tomography. Chem. Eur. J. 2010, 16, 7174–7185. [CrossRef]
70. Foersterova, M.; Petrik, M.; Laznickova, A.; Laznicek, M.; Hermann, P.; Lukes, I.; Melichar, F. Complexation
and biodistribution study of 111In and 90Y complexes of bifunctional phosphinic acid analogs of H4dota.
Appl. Radiat. Isotopes 2009, 67, 21–29. [CrossRef]
71. Lacerda, S.; Marques, F.; Campello, P.; Gano, L.; Kubicek, V.; Hermann, P.; Santos, I. Chemical,
radiochemical and biological studies of Sm and Ho complexes of H4dota analogues containing one
methylphosphonic/phosphinic acid pendant arm. J. Labelled Comp. Radiopharm. 2010, 53, 36–43. [CrossRef]
72. Notni, J.; Simecek, J.; Hermann, P.; Wester, H.-J. TRAP, a powerful and versatile framework for gallium-68
radiopharmaceuticals. Chem. Eur. J. 2011, 17, 14718–14722. [CrossRef]
73. Ragulin, V.V. One-pot synthesis of α-amino phosphinic acids. Russ. J. Gen. Chem. 2004, 74, 142–143.
[CrossRef]
47
Molecules 2012, 17, 13530-13568
74. Georgiadis, D.; Dive, V.; Yiotakis, A. Synthesis and comparative study on the reactivity of peptidyl-type
phosphinic esters. Intramolecular effects in the alkaline and acidic cleavage of methyl β-carboxyphosphinates.
J. Org. Chem. 2001, 66, 6604–6610. [CrossRef] [PubMed]
75. Reiter, L.A.; Jones, B.P. Amide-assisted hydrolysis of β-carboxamido-substituted phosphinic acid esters. J.
Org. Chem. 1997, 62, 2808–2812. [CrossRef]
76. Nasopoulou, M.; Matziari, M.; Dive, V.; Yiotakis, A. Chemoselective protection of solid-phase compatible
Fmoc-phosphinic building blocks. J. Org. Chem. 2006, 71, 9525–9527. [CrossRef]
77. Georgiadis, D.; Matziari, M.; Yiotakis, A. A highly efficient method for the preparation of phosphinic
pseudodipeptidic blocks suitably protected for solid-phase peptide synthesis. Tetrahedron 2001, 57, 3471–3478.
[CrossRef]
78. Buchardt, J.; Ferreras, M.; Krog-Jensen, C.; Delaissé, J.-M.; Foged, N.T.; Meldal, M. Phosphinic peptide matrix
metalloproteinase-9 inhibitors by solid-phase synthesis using a building block approach. Chem. Eur. J. 1999,
5, 2877–2884. [CrossRef]
79. Bhowmick, M.; Sappidi, R.R.; Fields, G.B.; Lepore, S.D. Efficient synthesis of Fmoc-protected phosphinic
pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors. Biopolymers 2011,
96, 1–3. [CrossRef]
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Abstract: Dendrimers are multifunctional, hyperbranched and perfectly defined macromolecules,
synthesized layer after layer in an iterative manner. Besides the nature of the terminal groups
responsible for most of the properties, the nature of the internal structure, and more precisely of the
branching points, is also of crucial importance. For more than 15 years, we have demonstrated that the
presence of phosphorus atom(s) at each branching point of the dendrimeric structure is particularly
important and highly valuable for three main reasons: (i) the versatility of phosphorus chemistry
that allows diversified organochemistry for the synthesis of dendrimers; (ii) the use of 31P-NMR,
which is a highly valuable tool for the characterization of dendrimers; (iii) some properties (in the
fields of catalysis, materials, and especially biology), that are directly connected to the nature of the
internal structure and of the branching points. This review will give an overview of the methods of
synthesis of phosphorus-containing dendrimers, as well on the ways to graft phosphorus derivatives
as terminal groups, with emphasis on the various roles played by the chemistry of phosphorus.
Keywords: dendrimers; phosphorus; hydrazone; phosphine; phosphonate
1. Introduction
Dendrimers [1] have an aesthetic structure constituted of branching units emanating radially from
a central core. They are synthesized step-by-step in an iterative fashion. Each time the number of
terminal groups is multiplied, a new generation is created. Due to this highly controlled synthesis,
dendrimers offer a perfect modularity of size (a few nanometers), functionality, and solubility, mainly
depending on the type of their terminal groups. Scheme 1 displays the principles of the divergent
process, most generally used for the synthesis of dendrimers.
 
Scheme 1. The principle of the divergent synthesis of dendrimers.
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Among all types of dendrimers [2], phosphorus-containing dendrimers [3] that have one
phosphorus atom at each branching point, play an important role, with applications ranging from
catalysis [4], materials [5], and even biology/nanomedicine [6]. This review will focus on our work,
emphasizing the role of phosphorus [7]. It will be organized depending on the type of reactions that will
occur on phosphorus atoms, whatever their location. All the other reactions of phosphorus-containing
dendrimers, but not occurring on the P atoms will not be displayed, except if they are a necessary
pathway towards the chemistry of phosphorus, or for the grafting of phosphorus entities.
2. Substitution Reactions on P-Cl Functions for the Synthesis and Functionalization of
Dendrimers
Our first and main method of synthesis of phosphorus dendrimers [8] consists in the
repetition of two quantitative reactions, the first step being the nucleophilic substitution of Cl
by 4-hydroxybenzaldehyde in basic conditions. The second step is the condensation of the aldehydes
with the dichlorophosphothiohydrazide. This compound is also issued from the organic chemistry of
phosphorus (substitution of one Cl of P(S)Cl3 with methylhydrazine, at low temperature). This second
step generates P-Cl2 functions suitable to perform again substitutions with HOC6H4CHO (Scheme 2).
 
Scheme 2. The most important method of synthesis of phosphorus dendrimers.
This method is very powerful and has been carried out up to generation 8 starting from
N3P3Cl6 [9], and to generation 12 (the highest generation ever synthesized for any type of dendrimers)
from P(S)Cl3 [10]. The substitution reaction of P-Cl by phenols is quantitative in most cases, using <5%
excess of reagents. It is particularly powerful for the functionalization of the surface of dendrimers,
with variously functionalized phenols depending on the desired properties. Several examples are
displayed in Figure 1. One can cite in particular the aldehyde (for the elaboration of DNA chips) [11],
various ferrocenes (for studying electrochemical properties [12], evolution of chirality [13], and for
catalysis [14]), various ligands suitable for catalysis such as derivatives of triphenylphosphine [15] (also
precursors of phosphoniums [16]), thiazolylphosphines [17], iminophosphines [18], diphosphines [19],
diketones [20], or azabis-oxazolines [21], dithioesters for thioacylation reactions (R =Me) [22] or as
precursors of star polymers (R = CH2Ph) [23]. Several fluorophores such as maleimide derivatives [24],
dansyl derivatives [25] and also dabsyl dyes and protected tyramine [26], or fluorophores having
two-photon absorption (TPA) properties [27], with eventually interchromophoric activities [28], or third
order non-linear properties [29], have been grafted thanks to the reactivity of phenols, as well as D-xylose
derivatives [30], phosphonates as precursors of anti-HIV derivatives [31], and azabisphosphonates
(and isosteric carboxylic esters analogues [32]) precursors of symmetrical [33] or non-symmetrical [34]
azabisphosphonic salts having important biological properties. In all cases, 31P-NMR is a precious tool
for characterizing these dendrimers and the achievement of the reactions [35].
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Figure 1. Functionalized phenols that have been grafted to dendrimers ended by P(S)Cl2 functions.
The substitution reactions with phenols are also usable for varying the internal structure of
dendrimers, by replacing 4-hydroxybenzaldehyde by other phenol aldehydes (Figure 2). Among them,
one can cite the possibility to have various ferrocenes [12,36,37], longer branches [38], fluorophores [39],
azobenzenes [40], or dialdehydes [41] for multiplying rapidly the number of terminal functions.
 
Figure 2. Some phenol aldehydes used instead of HOC6H4CHO for the synthesis of dendrimers.
We have also attempted to use the substitution reactions of hydrazines for the synthesis of
dendrimers [42,43]. The most recent example is shown on Scheme 3 [44]. However, none of them give
perfectly quantitative yields, and they have been carried out only up to the first generation.
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Scheme 3. Synthesis of a small dendrimer via substitutions with methylhydrazine.
On the contrary, the substitution reactions with amines are very powerful for functionalizing
the surface of dendrimers, starting from P(S)Cl2 end groups (Figure 3). Among them, one can cite in
particular allyl and propargyl amines [45], and also diethylethylenediamine, which affords in a single
step water-soluble dendrimers; HCl generated by the substitution reaction is trapped by the tertiary
amine [46]. Water-soluble dendrimers [47] have important biological properties [48], but those ones
possess interesting properties both in the fields of materials (for the elaboration of nano-tubes [49]
and micro-capsules [50], of highly sensitive DNA chips [51]), and biology (transfection agents [46],
anti-prion agents [52], anti-aggregation agent of Alzheimer peptides [53]). Other types of diamines,
such as morpholine or piperidine derivatives have also been used [54]. In another example, both Cl
linked to the same P react with a single diamine, creating a diazaphospholane cycle. This cycle can
be obtained from various macrocycles [55], or can be linked to a macrocycle that is able to complex
Pd0 [56] or Pt0 [57], to create nanoparticles of these metals, and even to organize them in dendritic
networks [58].
 
Figure 3. Functionalization of the surface of dendrimers by amino derivatives (only one function is
shown, representative of all the terminal groups).
The reactions with amines are also suitable to perform clean monosubstitutions on each P(X)Cl2
(X = S, O) end group. The reaction is regiospecific, but not enantioselective. The monosubstitution
with amines leads to dendrimers with two, three, and even four unique functional groups on each
chain end [59]. The second substitution can be performed with another amine, but also with phenols,
in particular HOC6H4CHO, leading to dendrimers having functions in the internal structure [60]
(Figure 4).
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Figure 4. Multifunctionalization of the surface of dendrimers, and of the internal structure.
3. Diverse Ways for Grafting Phosphorus Entities as Terminal Groups
Diverse reactions have been performed to graft phosphorus derivatives as terminal groups of
dendrimers. They can be divided into two types: those occurring on phosphorus, and those occurring
on a function linked to phosphorus. In the first case, two different types of reactions have been
performed: the addition of P-H onto unsaturated bonds such as aldehydes and imines [61], and the
substitution reactions of P-Cl with N-H functions, from hydrazones [62] or amines [63] (Scheme 4).
 
Scheme 4. Functionalization of terminal groups by direct reaction of phosphorus derivatives.
Various phosphorus derivatives, in particular phosphines and phosphonates or phosphates,
have been grafted to the terminal groups of dendrimers essentially through condensation reactions,
addition reactions and “click” reactions. The condensation reaction of hydrazones with aldehydes
has afforded phosphites, phosphates or aminophosphates as terminal groups [61], whereas the
condensation with Ph2PCH2OH on chiral amines (or hydrazone [64]) has led to chiral phosphines [65].
Addition reactions of amino groups onto unsaturated bonds have led to the grafting of ylides [61], or
gem-bisphosphonates [66]. Alkylation of one nitrogen of PTA (phosphatriazaadamantane) has led to
the grafting of one [67] or two [68] PTA per terminal function. Finally, the “click” reaction (azides with
alkynes) has led to the grafting of azabisphosphonate groups [69] (Scheme 5).
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Scheme 5. Other types of reactions for the grafting of phosphorus derivatives as terminal groups.
4. Staudinger Reactions and Subsequent Reactions
The Staudinger reaction of phosphines with azides creates P=N functions; which are generally
sensitive to hydrolysis. However, if the P=N function is conjugated, its stability is largely increased.
Thus, instead of using organic azides, we have used thiophosphoryl azides, to generate P=N-P=S
functions (or eventually P=N-P=N functions when using azides linked to the cyclotriphosphazene, as
shown in the following scheme). We have synthesized several types of monomers to use alternatively
the condensation reaction (aldehyde with hydrazine) and the Staudinger reaction. These monomers
comprise either phosphines and hydrazine, or aldehydes and azide, in a 2/1 [70] or 5/1 ratio [71],
eventually in combination [72]. Using these monomers allows a rapid multiplication of the number of
terminal groups, and creates a new generation at each step and not every two steps as usual. This
method of synthesis is also compatible with the first one mentioned in Scheme 2 (Scheme 6) [73].
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Scheme 6. Two methods of synthesis of dendrimers by Staudinger reactions.
The compatibility of the Staudinger reaction with the condensation reaction allows having
P=N-P=S linkages selectively at one or two layers. The P=S groups linked to a P=N group have
distinguishable properties compared to the other P=S groups, due to a delocalized form +P-N=P-S−,
with a negative charge on S, which renders it sensitive to alkylation reactions [74] using various
triflates [75] whereas the other P=S groups do not react. It is also suitable for the complexation of
gold [76]. The alkylation induces a weakening of the PS bond, which can be cleaved using a nucleophilic
phosphine such as P(NMe2)3. This reaction generates tricoordinated phosphorus atoms (PIII) at specific
layers of the internal structure, that can be used for alkylation reactions, and can undergo Staudinger
reactions creating P=N-P=N-P=S linkages [77]. The presence of aldehydes inside the dendrimers allows
either the step-by-step growing of new branches [78] (Scheme 7), or the grafting of dendrons, leading
to highly sophisticated dendrimeric structures [79], still unprecedented for any type of dendrimers,
but also the grafting of new functions such as fluorescent groups [80], or zwitter-ions [81].
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Scheme 7. Reactivity of the P=N-P=S linkages and growing of new branches inside the dendrimer.
The P=N-P=S linkage is also able to activate vinyl groups linked to the phosphazene, and used as
core of dendrons (dendritic wedges). Different types of amines were used for Michael-type additions,
suitable for grafting together by their core two dendrons which differ by their terminal functions such as
nitrile, amine or phosphine [82] but also amine and carboxylate [83], leading to “Janus” dendrimers [84]
(Scheme 8).
 
Scheme 8. Example of synthesis of a Janus dendrimer, thanks to the presence of P=N-P=S linkages.
5. Wittig and Horner-Wadsworth-Emmons Reactions
We have used this classical phosphorus reaction for the functionalization of the terminal groups
of dendrimers, starting from the aldehyde functions. The Wittig reaction was used in particular for
the grafting of ketone and nitrile [45], or tetrathiafulvalene (TTF) derivatives, including one with a
macrocyclic substituent, suitable for the electrochemical sensing of Ba2+ [85]. The Wittig reaction was
also applied when only half of the terminal groups were aldehydes [59], or ylides [61] (Scheme 9).
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Scheme 9. Use of the Wittig reaction for the functionalization of the surface of dendrimers.
The Horner-Wadsworth-Emmons reaction has been applied to the aldehyde terminal functions,
affording predominantly the E isomers, in particular for the grafting of aminoacids [86] (Scheme 10).
 
Scheme 10. Horner-Wadsworth-Emmons reaction for the grafting of aminoacids.
6. Cleavage of P-OR Bonds
In the course of our studies about the physico-chemical properties of phosphorus dendrimers, we
have studied their thermal stability, and discovered that in many cases the first mass loss corresponds to
the peeling of the surface, thus to the cleavage of the P-OR terminal groups at high temperature (above
200 ◦C for the least stable, but generally above 350 ◦C) [87]. Such cleavage has been also observed in the
case of diketone terminal groups used for the complexation of copper, then for catalyzing diarylether
formation at 120 ◦C. The efficiency of the catalysis was found independent of the generation of the
dendrimer, and no reuse was possible, contrarily to what we had observed in all previous examples
of catalysis [88]. Studying in details the reaction media after catalysis, we found a large amount of
the monomer, resulting from the cleavage of the surface of the dendrimers. It must be noted that the
cleavage is due to the catalysis, since the dendrimer is recovered intact in the same conditions, but in
the absence of metal (Scheme 11) [17].
 
Scheme 11. Cleavage of P-OR bonds in catalysis conditions.
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The dendrimers ended by azabisphosphonate groups are not easily soluble in water, thus we tried
to obtain phosphonic acid instead of phosphonate terminal groups. For this purpose, the first step is
the reaction with bromotrimethylsilane, which generates P-O-SiMe3 groups, subsequently hydrolyzed.
The last step is the reaction with NaOH (Scheme 12), affording water-soluble dendrimers [89], which
possess very important biological properties [90], in particular towards the human immune system [91],
as anti-inflammatory drug [92], and against rheumatoid arthritis [93].
 
Scheme 12. Cleavage of P-OMe bonds while preserving P-OAr bonds.
7. Conclusions
A large panel of organophosphorus reactions has been used for the synthesis of
phosphorus-containing dendrimers. Besides the efficiency of these reactions, the simplicity of
characterization of these large compounds by 31P-NMR has to be emphasized. Indeed, even highly
sophisticated structures can be totally analyzed by 31P-NMR [78]. It must be emphasized also that
the presence of phosphorus leads to unprecedented properties, particularly in the fields of catalysis,
materials, and biology.
Besides our work, which has been largely displayed in this review, a few other groups have
reported the synthesis of phosphorus-containing dendrimers. We have to mention in particular the
pioneering work made by R. Engel (polyphosphonium dendrimers) [94], M. J. Damha (nucleic acid
dendrimers) [95], and D. L. DuBois (small polyphosphines) [96]. Later on, large polyphosphine
dendrimers have been proposed by A. K. Kakkar [97], and also thiophosphate dendrimers by G. M.
Salamonczyk [98] based on the use of phosphoramidite reagents. Taken all together, these researches
demonstrate the rich diversity of the chemistry of phosphorus, even when applied to nano-objects
such as dendrimers.
Acknowledgments: Thanks are due to the CNRS for financial support, and to the ANR DENDSWITCH.
References
1. Caminade, A.M.; Turrin, C.O.; Laurent, R.; Ouali, A.; Delavaux-Nicot, B. (Eds.) Dendrimers. Towards Catalytic,
Material and Biomedical Uses; John Wiley & Sons: Chichester, UK, 2011; pp. 1–528.
2. Astruc, D.; Boisselier, E.; Ornelas, C. Dendrimers Designed for Functions: From Physical, Photophysical,
and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and
Nanomedicine. Chem. Rev. 2010, 110, 1857–1959. [CrossRef]
3. Majoral, J.P.; Caminade, A.M. Dendrimers containing heteroatoms (Si, P, B, Ge, or Bi). Chem. Rev. 1999, 99,
845–880. [CrossRef]
4. Caminade, A.M.; Servin, P.; Laurent, R.; Majoral, J.P. Dendrimeric phosphines in asymmetric catalysis. Chem.
Soc. Rev. 2008, 37, 56–67. [CrossRef]
5. Knoll, W.; Caminade, A.M.; Char, K.; Duran, H.; Feng, C.L.; Gitsas, A.; Kim, D.H.; Lau, A.; Lazzara, T.D.;
Majoral, J.P.; et al. Nanostructuring Polymeric Materials by Templating Strategies. Small 2011, 7, 1384–1391.
[CrossRef]
6. Caminade, A.M.; Turrin, C.O.; Majoral, J.P. Biological properties of phosphorus dendrimers. New J. Chem.
2010, 34, 1512–1524. [CrossRef]
60
Molecules 2012, 17, 13605-13621
7. Majoral, J.P.; Caminade, A.M.; Maraval, V. The specific contribution of phosphorus in dendrimer chemistry.
Chem. Commun. 2002, 2929–2942. [CrossRef]
8. Launay, N.; Caminade, A.M.; Lahana, R.; Majoral, J.P. A General Synthetic Strategy for Neutral
Phosphorus-Containing Dendrimers. Angew. Chem. Int. Ed. Engl. 1994, 1589–1592. [CrossRef]
9. Launay, N.; Caminade, A.M.; Majoral, J.P. Synthesis of bowl-shaped dendrimers from generation 1 to
generation 8. J. Organomet. Chem. 1997, 529, 51–58. [CrossRef]
10. Lartigue, M.L.; Donnadieu, B.; Galliot, C.; Caminade, A.M.; Majoral, J.P.; Fayet, J.P. Large dipole moments of
phosphorus-containing dendrimers. Macromolecules 1997, 30, 7335–7337. [CrossRef]
11. Trevisiol, E.; Le Berre-Anton, V.; Leclaire, J.; Pratviel, G.; Caminade, A.M.; Majoral, J.P.; Francois, J.M.;
Meunier, B. Dendrislides, dendrichips: A simple chemical functionalization of glass slides with phosphorus
dendrimers as an effective means for the preparation of biochips. New J. Chem. 2003, 27, 1713–1719. [CrossRef]
12. Turrin, C.O.; Chiffre, J.; de Montauzon, D.; Daran, J.C.; Caminade, A.M.; Manoury, E.; Balavoine, G.;
Majoral, J.P. Phosphorus-containing dendrimers with ferrocenyl units at the core, within the branches, and
on the periphery. Macromolecules 2000, 33, 7328–7336. [CrossRef]
13. Turrin, C.O.; Chiffre, J.; Daran, J.C.; de Montauzon, D.; Caminade, A.M.; Manoury, E.; Balavoine, G.;
Majoral, J.P. New chiral phosphorus-containing dendrimers with ferrocenes on the periphery. Tetrahedron
2001, 57, 2521–2536. [CrossRef]
14. Routaboul, L.; Vincendeau, S.; Turrin, C.O.; Caminade, A.M.; Majoral, J.P.; Daran, J.C.; Manoury, E. New
phosphorus dendrimers with chiral ferrocenyl phosphine-thioether ligands on the periphery for asymmetric
catalysis. J. Organomet. Chem. 2007, 692, 1064–1073. [CrossRef]
15. Merino, S.; Brauge, L.; Caminade, A.M.; Majoral, J.P.; Taton, D.; Gnanou, Y. Synthesis and characterization of
linear, hyperbranched, and dendrimer-like polymers constituted of the same repeating unit. Chem. Eur. J.
2001, 7, 3095–3105. [CrossRef]
16. Lacour, M.A.; Zablocka, M.; Caminade, A.M.; Taillefer, M.; Majoral, J.P. Design of phosphonium ended
dendrimers bearing functionalized amines. Tetrahedron Lett. 2009, 50, 4870–4873. [CrossRef]
17. Keller, M.; Hameau, A.; Spataro, G.; Ladeira, S.; Caminade, A.M.; Majoral, J.P.; Ouali, A. An efficient and
recyclable dendritic catalyst able to dramatically reduce palladium leaching in Suzuki couplings. Green
Chem. 2012, 14, 2807–2815. [CrossRef]
18. Koprowski, M.; Sebastian, R.M.; Maraval, V.; Zablocka, M.; Cadierno, V.; Donnadieu, B.; Igau, A.;
Caminade, A.M.; Majoral, J.P. Iminophosphine palladium complexes in catalytic Stille coupling reactions:
From monomers to dendrimers. Organometallics 2002, 21, 4680–4687. [CrossRef]
19. Servin, P.; Laurent, R.; Romerosa, A.; Peruzzini, M.; Majoral, J.P.; Caminade, A.M. Synthesis of dendrimers
terminated by bis(diphenylphosphinomethyl)amino ligands and use of their palladium complexes for
catalyzing C-C cross-coupling reactions. Organometallics 2008, 27, 2066–2073. [CrossRef]
20. Keller, M.; Ianchuk, M.; Ladeira, S.; Taillefer, M.; Caminade, A.M.; Majoral, J.P.; Ouali, A. Synthesis of
Dendritic beta-Diketones and Their Application in Copper-Catalyzed Diaryl Ether Formation. Eur. J. Org.
Chem. 2012, 1056–1062. [CrossRef]
21. Gissibl, A.; Padie, C.; Hager, M.; Jaroschik, F.; Rasappan, R.; Cuevas-Yanez, E.; Turrin, C.O.; Caminade, A.M.;
Majoral, J.P.; Reiser, O. Synthesis and application of phosphorus dendrimer immobilized azabis(oxazolines).
Org. Lett. 2007, 9, 2895–2898. [CrossRef]
22. Marchand, P.; Griffe, L.; Caminade, A.M.; Majoral, J.P.; Destarac, M.; Leising, F. Thioacylation reactions for
the surface functionalization of phosphorus-containing dendrimers. Org. Lett. 2004, 6, 1309–1312. [CrossRef]
23. Darcos, V.; Dureault, A.; Taton, D.; Gnanou, Y.; Marchand, P.; Caminade, A.M.; Majoral, J.P.; Destarac, M.;
Leising, F. Synthesis of hybrid dendrimer-star polymers by the RAFT process. Chem. Commun. 2004,
2110–2111. [CrossRef] [PubMed]
24. Franc, G.; Mazeres, S.; Turrin, C.O.; Vendier, L.; Duhayon, C.; Caminade, A.M.; Majoral, J.P. Synthesis and
properties of dendrimers possessing the same fluorophore(s) located either peripherally or off-center. J. Org.
Chem. 2007, 72, 8707–8715. [CrossRef] [PubMed]
25. Fuchs, S.; Pla-Quintana, A.; Mazeres, S.; Caminade, A.M.; Majoral, J.P. Cationic and Fluorescent “Janus”
Dendrimers. Org. Lett. 2008, 10, 4751–4754. [CrossRef] [PubMed]
26. Hameau, A.; Fuchs, S.; Laurent, R.; Majoral, J.P.; Caminade, A.M. Synthesis of dye/fluorescent functionalized
dendrons based on cyclotriphosphazene. Beilstein J. Org. Chem. 2011, 7, 1577–1583. [CrossRef] [PubMed]
61
Molecules 2012, 17, 13605-13621
27. Mongin, O.; Krishna, T.R.; Werts, M.H.V.; Caminade, A.M.; Majoral, J.P.; Blanchard-Desce, M. A modular
approach to two-photon absorbing organic nanodots: Brilliant dendrimers as an alternative to semiconductor
quantum dots? Chem. Commun. 2006, 915–917. [CrossRef] [PubMed]
28. Terenziani, F.; Parthasarathy, V.; Pla-Quintana, A.; Maishal, T.; Caminade, A.M.; Majoral, J.P.;
Blanchard-Desce, M. Cooperative Two-Photon Absorption Enhancement by Through-Space Interactions in
Multichromophoric Compounds. Angew. Chem. Int. Ed. 2009, 48, 8691–8694. [CrossRef]
29. Fuks-Janczarek, I.; Nunzi, J.M.; Sahraoui, B.; Kityk, I.V.; Berdowski, J.; Caminade, A.M.; Majoral, J.P.;
Martineau, A.C.; Frere, P.; Roncali, J. Third-order nonlinear optical properties and two-photon absorption in
branched oligothienylenevinylenes. Opt. Commun. 2002, 209, 461–466. [CrossRef]
30. Hadad, C.; Majoral, J.P.; Muzart, J.; Caminade, A.M.; Bouquillon, S. First phosphorous D-xylose-derived
glycodendrimers. Tetrahedron Lett. 2009, 50, 1902–1905. [CrossRef]
31. Perez-Anes, A.; Spataro, G.; Coppel, Y.; Moog, C.; Blanzat, M.; Turrin, C.O.; Caminade, A.M.; Rico-Lattes, I.;
Majoral, J.P. Phosphonate terminated PPH dendrimers: Influence of pendant alkyl chains on the in vitro
anti-HIV-1 properties. Org. Biomol. Chem. 2009, 7, 3491–3498. [CrossRef]
32. Rolland, O.; Turrin, C.O.; Bacquet, G.; Poupot, R.; Poupot, M.; Caminade, A.M.; Majoral, J.P. Efficient
synthesis of phosphorus-containing dendrimers capped with isosteric functions of amino-bismethylene
phosphonic acids. Tetrahedron Lett. 2009, 50, 2078–2082. [CrossRef]
33. Poupot, M.; Griffe, L.; Marchand, P.; Maraval, A.; Rolland, O.; Martinet, L.; L’Faqihi-Olive, F.E.; Turrin, C.O.;
Caminade, A.M.; Fournié, J.J.; et al. Design of phosphorylated dendritic architectures to promote human
monocyte activation. FASEB J. 2006, 20, 2339–2351. [CrossRef] [PubMed]
34. Marchand, P.; Griffe, L.; Poupot, M.; Turrin, C.O.; Bacquet, G.; Fournie, J.J.; Majoral, J.P.; Poupot, R.;
Caminade, A.M. Dendrimers ended by non-symmetrical azadiphosphonate groups: Synthesis and
immunological properties. Bioorg. Med. Chem. Lett. 2009, 19, 3963–3966. [CrossRef]
35. Caminade, A.M.; Laurent, R.; Turrin, C.O.; Rebout, C.; Delavaux-Nicot, B.; Ouali, A.; Zablocka, M.; Majoral, J.P.
Phosphorus dendrimers as viewed by P-31 NMR spectroscopy; synthesis and characterization. C. R. Chim.
2010, 13, 1006–1027. [CrossRef]
36. Turrin, C.O.; Chiffre, J.; Daran, J.C.; de Montauzon, D.; Balavoine, G.; Manoury, E.; Caminade, A.M.;
Majoral, J.P. New phosphorus-containing dendrimers with ferrocenyl units in each layer. C. R. Chim. 2002, 5,
309–318. [CrossRef]
37. Turrin, C.O.; Chiffre, J.; de Montauzon, D.; Balavoine, G.; Manoury, E.; Caminade, A.M.; Majoral, J.P. Behavior
of an optically active ferrocene chiral shell located within phosphorus-containing dendrimers. Organometallics
2002, 21, 1891–1897. [CrossRef]
38. Magro, G.; Marchand, P.; Sebastian, R.M.; Guyard-Duhayon, C.; Caminade, A.M.; Majoral, J.P. Synthesis and
characterization of phosphorus dendrimers containing long, conjugated branches. Eur. J. Org. Chem. 2005,
1340–1347. [CrossRef]
39. Mongin, O.; Rouxel, C.; Vabre, J.M.; Mir, Y.; Pla-Quintana, A.; Wei, Y.Q.; Caminade, A.M.; Majoral, J.P.;
Blanchard-Desce, M. Customized multiphotonics nanotools for bioapplications: Soft organic nanodots as an
eco-friendly alternative to quantum dots. In Nanobiosystems: Processing, Characterization, and Applications
II Book Series, Proceedings of SPIE-International Society Optical Engineering: San Diego, CA, USA, 2009;
Kobayashi, N., Ouchen, F., Rau, I., Eds.; SPIE- International Society Optical Engineering: Bellingham, WA,
USA, 2009; Volume 7403, pp. 740303:1–740303:12.
40. Sebastian, R.M.; Blais, J.C.; Caminade, A.M.; Majoral, J.P. Synthesis and photochemical behavior of phosphorus
dendrimers containing azobenzene units within the branches and/or on the surface. Chem. Eur. J. 2002, 8,
2172–2183. [CrossRef]
41. Servin, P.; Rebout, C.; Laurent, R.; Peruzzini, M.; Caminade, A.M.; Majoral, J.P. Reduced number of steps for
the synthesis of dense and highly functionalized dendrimers. Tetrahedron Lett. 2007, 48, 579–583. [CrossRef]
42. Launay, N.; Galliot, C.; Caminade, A.M.; Majoral, J.P. Synthesis of small phosphorus dendrimers from
(S)P[N(Me)-NH2]3. Bull. Soc. Chim. Fr. 1995, 132, 1149–1155.
43. Kraemer, R.; Galliot, C.; Mitjaville, J.; Caminade, A.M.; Majoral, J.P.
Hexamethylhydrazino-cyclotriphosphazene N3P3(NMeNH2)6: Starting reagent for the synthesis
of multifunctionalized species, macrocycles and small dendrimers. Heteroat. Chem. 1996, 7, 149–154.
[CrossRef]
62
Molecules 2012, 17, 13605-13621
44. Katir, N.; Majoral, J.P.; El Kadib, A.; Caminade, A.M.; Bousmina, M. Molecular and Macromolecular
Engineering with Viologens as Building Blocks: Rational Design of Phosphorus-Viologen Dendritic Structures.
Eur. J. Org. Chem. 2012, 269–273. [CrossRef]
45. Launay, N.; Slany, M.; Caminade, A.M.; Majoral, J.P. Phosphorus-containing dendrimers. Easy access to new
multi-difunctionalized macromolecules. J. Org. Chem. 1996, 61, 3799–3805. [CrossRef] [PubMed]
46. Loup, C.; Zanta, M.A.; Caminade, A.M.; Majoral, J.P.; Meunier, B. Preparation of water-soluble cationic
phosphorus-containing dendrimers as DNA transfecting agents. Chem. Eur. J. 1999, 5, 3644–3650. [CrossRef]
47. Caminade, A.M.; Majoral, J.P. Water-soluble phosphorus-containing dendrimers. Prog. Polym. Sci. 2005, 30,
491–505. [CrossRef]
48. Rolland, O.; Turrin, C.O.; Caminade, A.M.; Majoral, J.P. Dendrimers and nanomedicine: Multivalency in
action. New J. Chem. 2009, 33, 1809–1824. [CrossRef]
49. Feng, C.L.; Zhong, X.H.; Steinhart, M.; Caminade, A.M.; Majoral, J.P.; Knoll, W. Functional
quantum-dot/dendrimer nanotubes for sensitive detection of DNA hybridization. Small 2008, 4, 566–571.
[CrossRef]
50. Kim, B.S.; Lebedeva, O.V.; Kim, D.H.; Caminade, A.M.; Majoral, J.P.; Knoll, W.; Vinogradova, O.I. Assembly
and mechanical properties of phosphorus dendrimer/polyelectrolyte multilayer microcapsules. Langmuir
2005, 21, 7200–7206. [CrossRef]
51. Feng, C.L.; Yin, M.Z.; Zhang, D.; Zhu, S.M.; Caminade, A.M.; Majoral, J.P.; Mullen, K. Fluorescent
Core-Shell Star Polymers Based Bioassays for Ultrasensitive DNA Detection by Surface Plasmon Fluorescence
Spectroscopy. Macromol. Rapid Commun. 2011, 32, 679–683. [CrossRef]
52. Solassol, J.; Crozet, C.; Perrier, V.; Leclaire, J.; Beranger, F.; Caminade, A.M.; Meunier, B.; Dormont, D.;
Majoral, J.P.; Lehmann, S. Cationic phosphorus-containing dendrimers reduce prion replication both in cell
culture and in mice infected with scrapie. J. Gen. Virol. 2004, 85, 1791–1799. [CrossRef]
53. Wasiak, T.; Ionov, M.; Nieznanski, K.; Nieznanska, H.; Klementieva, O.; Granell, M.; Cladera, J.; Majoral, J.P.;
Caminade, A.M.; Klajnert, B. Phosphorus Dendrimers Affect Alzheimer’s (A beta(1-28)) Peptide and
MAP-Tau Protein Aggregation. Mol. Pharm. 2012, 9, 458–469. [CrossRef] [PubMed]
54. Padie, C.; Maszewska, M.; Majchrzak, K.; Nawrot, B.; Caminade, A.M.; Majoral, J.P. Polycationic phosphorus
dendrimers: Synthesis, characterization, study of cytotoxicity, complexation of DNA, and transfection
experiments. New J. Chem. 2009, 33, 318–326. [CrossRef]
55. Prevote, D.; Donnadieu, B.; Moreno-Manas, M.; Caminade, A.M.; Majoral, J.P. Grafting of tetraazamacrocycles
on the surface of phosphorus-containing dendrimers. Eur. J. Org. Chem. 1999, 1701–1708. [CrossRef]
56. Badetti, E.; Caminade, A.M.; Majoral, J.P.; Moreno-Manas, M.; Sebastian, R.M. Palladium(0) nanoparticles
stabilized by phosphorus dendrimers containing coordinating 15-membered triolefinic macrocycles in
periphery. Langmuir 2008, 24, 2090–2101. [CrossRef] [PubMed]
57. Franc, G.; Badetti, E.; Duhayon, C.; Coppel, Y.; Turrin, C.O.; Majoral, J.P.; Sebastian, R.M.; Caminade, A.M.
An efficient synthesis combining phosphorus dendrimers and 15-membered triolefinic azamacrocycles:
Towards the stabilization of platinum nanoparticles. New J. Chem. 2010, 34, 547–555. [CrossRef]
58. Franc, G.; Badetti, E.; Colliere, V.; Majoral, J.P.; Sebastian, R.M.; Caminade, A.M. Dendritic structures within
dendritic structures: Dendrimer-induced formation and self-assembly of nanoparticle networks. Nanoscale
2009, 1, 233–237. [CrossRef]
59. Lartigue, M.L.; Slany, M.; Caminade, A.M.; Majoral, J.P. Phosphorus-containing dendrimers: Synthesis of
macromolecules with multiple tri- and tetrafunctionalization. Chem. Eur. J. 1996, 2, 1417–1426. [CrossRef]
60. Severac, M.; Leclaire, J.; Sutra, P.; Caminade, A.M.; Majoral, J.P. A new way for the internal functionalization
of dendrimers. Tetrahedron Lett. 2004, 45, 3019–3022. [CrossRef]
61. Prevote, D.; Caminade, A.M.; Majoral, J.P. Phosphate-, phosphite-, ylide-, and phosphonate-terminated
dendrimers. J. Org. Chem. 1997, 62, 4834–4841. [CrossRef]
62. Galliot, C.; Prevote, D.; Caminade, A.M.; Majoral, J.P. Polyaminophosphines Containing Dendrimers -
Syntheses and Characterizations. J. Am. Chem. Soc. 1995, 117, 5470–5476. [CrossRef]
63. Garcia, L.; Roglans, A.; Laurent, R.; Majoral, J.P.; Pla-Quintana, A.; Caminade, A.M. Dendritic
phosphoramidite ligands for Rh-catalyzed [2+2+2] cycloaddition reactions: Unprecedented enhancement of
enantiodiscrimination. Chem. Commun. 2012, 48, 9248–9250. [CrossRef] [PubMed]
64. Slany, M.; Bardaji, M.; Caminade, A.M.; Chaudret, B.; Majoral, J.P. Versatile complexation ability of very
large phosphino-terminated dendrimers. Inorg. Chem. 1997, 36, 1939–1945. [CrossRef] [PubMed]
63
Molecules 2012, 17, 13605-13621
65. Lartigue, M.L.; Caminade, A.M.; Majoral, J.P. Chiroptical properties of dendrimers with stereogenic end
groups. Tetrahedron: Asymmetry 1997, 8, 2697–2708. [CrossRef]
66. Franc, G.; Turrin, C.O.; Cavero, E.; Costes, J.P.; Duhayon, C.; Caminade, A.M.; Majoral, J.P.
Gem-Bisphosphonate-Ended Group Dendrimers: Design and Gadolinium Complexing Properties. Eur. J.
Org. Chem. 2009, 4290–4299. [CrossRef]
67. Servin, P.; Laurent, R.; Gonsalvi, L.; Tristany, M.; Peruzzini, M.; Majoral, J.P.; Caminade, A.M. Grafting of
water-soluble phosphines to dendrimers and their use in catalysis: Positive dendritic effects in aqueous
media. Dalton Trans. 2009, 4432–4434. [CrossRef]
68. Servin, P.; Laurent, R.; Dib, H.; Gonsalvi, L.; Peruzzini, M.; Majoral, J.P.; Caminade, A.M. Number of terminal
groups versus generation of the dendrimer, which criteria influence the catalytic properties? Tetrahedron Lett.
2012, 53, 3876–3879. [CrossRef]
69. Cavero, E.; Zablocka, M.; Caminade, A.M.; Majoral, J.P. Design of Bisphosphonate-Terminated Dendrimers.
Eur. J. Org. Chem. 2010, 2759–2767. [CrossRef]
70. Brauge, L.; Magro, G.; Caminade, A.M.; Majoral, J.P. First divergent strategy using two AB2 unprotected
monomers for the rapid synthesis of dendrimers. J. Am. Chem. Soc. 2001, 123, 6698–6699. [CrossRef]
71. Maraval, V.; Caminade, A.M.; Majoral, J.P.; Blais, J.C. Dendrimer design: How to circumvent the dilemma
of a reduction of steps or an increase of function multiplicity? Angew. Chem. Int. Ed. 2003, 42, 1822–1826.
[CrossRef]
72. Maraval, V.; Pyzowski, J.; Caminade, A.M.; Majoral, J.P. “Lego” chemistry for the straightforward synthesis
of dendrimers. J. Org. Chem. 2003, 68, 6043–6046. [CrossRef]
73. Sebastian, R.M.; Magro, G.; Caminade, A.M.; Majoral, J.P. Dendrimers with N,N-disubstituted hydrazines
as end groups, useful precursors for the synthesis of water-soluble dendrimers capped with carbohydrate,
carboxylic or boronic acid derivatives. Tetrahedron 2000, 56, 6269–6277. [CrossRef]
74. Larre, C.; Caminade, A.M.; Majoral, J.P. Chemoselective polyalkylations of phosphorus-containing
dendrimers. Angew. Chem. Int. Ed. Engl. 1997, 36, 596–599. [CrossRef]
75. Larre, C.; Donnadieu, B.; Caminade, A.M.; Majoral, J.P. Phosphorus-containing dendrimers: Chemoselective
functionalization of internal layers. J. Am. Chem. Soc. 1998, 120, 4029–4030. [CrossRef]
76. Larre, C.; Donnadieu, B.; Caminade, A.M.; Majoral, J.P. Regioselective gold complexation within the cascade
structure of phosphorus-containing dendrimers. Chem. Eur. J. 1998, 4, 2031–2036. [CrossRef]
77. Larre, C.; Bressolles, D.; Turrin, C.; Donnadieu, B.; Caminade, A.M.; Majoral, J.P. Chemistry within
megamolecules: Regiospecific functionalization after construction of phosphorus dendrimers. J. Am. Chem.
Soc. 1998, 120, 13070–13082. [CrossRef]
78. Galliot, C.; Larre, C.; Caminade, A.M.; Majoral, J.P. Regioselective stepwise growth of dendrimer units in the
internal voids of a main dendrimer. Science 1997, 277, 1981–1984. [CrossRef]
79. Maraval, V.; Laurent, R.; Donnadieu, B.; Mauzac, M.; Caminade, A.M.; Majoral, J.P. Rapid synthesis of
phosphorus-containing dendrimers with controlled molecular architectures: First example of surface-block,
layer-block, and segment-block dendrimers issued from the same dendron. J. Am. Chem. Soc. 2000, 122,
2499–2511. [CrossRef]
80. Brauge, L.; Caminade, A.M.; Majoral, J.P.; Slomkowski, S.; Wolszczak, M. Segmental mobility in
phosphorus-containing dendrimers. Studies by fluorescent spectroscopy. Macromolecules 2001, 34, 5599–5606.
[CrossRef]
81. Cadierno, V.; Igau, A.; Donnadieu, B.; Caminade, A.M.; Majoral, J.P. Dendrimers containing zwitterionic
[phosphonium anionic zirconocene(IV)] complexes. Organometallics 1999, 18, 1580–1582. [CrossRef]
82. Maraval, V.; Laurent, R.; Merino, S.; Caminade, A.M.; Majoral, J.P. Michael-type addition of amines to the
vinyl core of dendrons - Application to the synthesis of multidendritic systems. Eur. J. Org. Chem. 2000,
3555–3568. [CrossRef]
83. Maraval, V.; Maraval, A.; Spataro, G.; Caminade, A.M.; Majoral, J.P.; Kim, D.H.; Knoll, W. Design of tailored
multi-charged phosphorus surface-block dendrimers. New J. Chem. 2006, 30, 1731–1736. [CrossRef]
84. Caminade, A.M.; Laurent, R.; Delavaux-Nicot, B.; Majoral, J.P. “Janus” dendrimers: Syntheses and properties.
New J. Chem. 2012, 36, 217–226. [CrossRef]
85. Le Derf, F.; Levillain, E.; Trippe, G.; Gorgues, A.; Salle, M.; Sebastian, R.M.; Caminade, A.M.; Majoral, J.P.
Immobilization of redox-active ligands on an electrode: The dendrimer route. Angew. Chem. Int. Ed. 2001,
40, 224–227. [CrossRef]
64
Molecules 2012, 17, 13605-13621
86. Prevote, D.; LeRoyGourvennec, S.; Caminade, A.M.; Masson, S.; Majoral, J.P. Application of the
Horner-Wadsworth-Emmons reaction to the functionalization of dendrimers: Synthesis of amino acid
terminated dendrimers. Synthesis-Stuttgart 1997, 1199–1207. [CrossRef]
87. Turrin, C.O.; Maraval, V.; Leclaire, J.; Dantras, E.; Lacabanne, C.; Caminade, A.M.; Majoral, J.P. Surface,
core, and structure modifications of phosphorus-containing dendrimers. Influence on the thermal stability.
Tetrahedron 2003, 59, 3965–3973. [CrossRef]
88. Majoral, J.P.; Caminade, A.M.; Laurent, R. Metallo groups linked to the surface of phosphorus-containing
dendrimers. In Metal-Containing and Metallosupramolecular Polymers and Materials; Schubert, U.S.,
Newkome, G.R., Manners, I., Eds.; American Chemical Society: Washington, DC, USA, 2006; Volume
928, pp. 230–243.
89. Rolland, O.; Griffe, L.; Poupot, M.; Maraval, A.; Ouali, A.; Coppel, Y.; Fournie, J.J.; Bacquet, G.; Turrin, C.O.;
Caminade, A.M.; et al. Tailored control and optimisation of the number of phosphonic acid termini on
phosphorus-containing dendrimers for the ex-vivo activation of human monocytes. Chem. Eur. J. 2008, 14,
4836–4850. [CrossRef]
90. Griffe, L.; Poupot, M.; Marchand, P.; Maraval, A.; Turrin, C.O.; Rolland, O.; Metivier, P.; Bacquet, G.;
Fournie, J.J.; Caminade, A.M.; et al. Multiplication of human natural killer cells by nanosized
phosphonate-capped dendrimers. Angew. Chem. Int. Ed. 2007, 46, 2523–2526. [CrossRef]
91. Portevin, D.; Poupot, M.; Rolland, O.; Turrin, C.O.; Fournie, J.J.; Majoral, J.P.; Caminade, A.M.; Poupot, R.
Regulatory activity of azabisphosphonate-capped dendrimers on human CD4(+) T cell proliferation enhances
ex-vivo expansion of NK cells from PBMCs for immunotherapy. J. Transl. Med. 2009, 7, 13. [CrossRef]
92. Fruchon, S.; Poupot, M.; Martinet, L.; Turrin, C.O.; Majoral, J.P.; Fournie, J.J.; Caminade, A.M.; Poupot, R.
Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer. J.
Leuk. Biol. 2009, 85, 553–562. [CrossRef]
93. Hayder, M.; Poupot, M.; Baron, M.; Nigon, D.; Turrin, C.O.; Caminade, A.M.; Majoral, J.P.; Eisenberg, R.A.;
Fournie, J.J.; Cantagrel, A.; et al. A Phosphorus-Based Dendrimer Targets Inflammation and
Osteoclastogenesis in Experimental Arthritis. Sci. Transl. Med. 2011, 3, 11. [CrossRef]
94. Rengan, K.; Engel, R. Phosphonium Cascade Molecules. J. Chem. Soc. Chem. Commun. 1990, 1084–1085.
[CrossRef]
95. Hudson, R.H.E.; Damha, M.J. Nucleic-Acid Dendrimers—Novel Biopolymer Structures. J. Am. Chem. Soc.
1993, 115, 2119–2124. [CrossRef]
96. Miedaner, A.; Curtis, C.J.; Barkley, R.M.; Dubois, D.L. Electrochemical Reduction of Co2 Catalyzed by Small
Organophosphine Dendrimers Containing Palladium. Inorg. Chem. 1994, 33, 5482–5490. [CrossRef]
97. Petrucci-Samija, M.; Guillemette, V.; Dasgupta, M.; Kakkar, A.K. A new divergent route to the synthesis of
organophosphine and metallodendrimers via simple acid-base hydrolytic chemistry. J. Am. Chem. Soc. 1999,
121, 3248–3248. [CrossRef]
98. Salamonczyk, G.M.; Kuznikowski, M.; Skowronska, A. A divergent synthesis of thiophosphate-based
dendrimers. Tetrahedron Lett. 2000, 41, 1643–1645. [CrossRef]
© 2012 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution





Stoichiometric and Catalytic Synthesis
of Alkynylphosphines
Elise Bernoud, Romain Veillard, Carole Alayrac * and Annie-Claude Gaumont *
Laboratoire de Chimie Moléculaire et Thioorganique, UMR CNRS 6507, INC3M FR3038, ENSICAEN &
Université de Caen Basse-Normandie, 14050 Caen, France; e.bernoud@gmail.com (E.B.);
romain.veillard@ensicaen.fr (R.V.)
* Correspondence: carole.witulski-alayrac@ensicaen.fr (C.A.); annie-claude.gaumont@ensicaen.fr (A.-C.G.);
Tel.: +33-2-31-45-28-86 (C.A.); +33-2-31-45-28-73 (A.-C.G.); Fax: +33-2-31-45-28-77
Received: 23 November 2012; Accepted: 5 December 2012; Published: 7 December 2012
	

Abstract: Alkynylphosphines or their borane complexes are available either through C–P bond
forming reactions or through modification of the phosphorus or the alkynyl function of various
alkynyl phosphorus derivatives. The latter strategy, and in particular the one involving phosphoryl
reduction by alanes or silanes, is the method of choice for preparing primary and secondary
alkynylphosphines, while the former strategy is usually employed for the synthesis of tertiary
alkynylphosphines or their borane complexes. The classical C–P bond forming methods rely on the
reaction between halophosphines or their borane complexes with terminal acetylenes in the presence
of a stoichiometric amount of organometallic bases, which precludes the access to alkynylphosphines
bearing sensitive functional groups. In less than a decade, efficient catalytic procedures, mostly
involving copper complexes and either an electrophilic or a nucleophilic phosphorus reagent, have
emerged. By proceeding under mild conditions, these new methods have allowed a significant
broadening of the substituent scope and structure complexity.
Keywords: organophosphorus chemistry; phosphines; phosphine-boranes; homogeneous catalysis
1. Introduction
Alkynylphosphines are relevant versatile compounds due to the presence of two important
functions, a phosphorus atom—a key-atom in metal coordination [1]—and an alkynyl moiety, which
can also coordinate to metals and is known to display a rich and diverse chemistry [2].
In the past, these phosphines were mainly used in coordination chemistry for the assembly
of various mono- or bi-metallic complexes and clusters [3], by taking advantage of their diverse
coordination modes to transition metals, via the phosphorus atom and/or the triple bond. It is
noteworthy that the range of alkynylphosphines involved in those complexes and clusters is almost
exclusively covered by diphenylphosphino-phenylacetylene and bis(diphenylphosphino)acetylene.
It is only recently that the high potential of alkynylphosphines as ligands for homogeneous
catalysis has emerged through a few relevant catalytic applications [4]. Notably P-stereogenic
alkynylphosphines were shown to induce excellent enantioselectivity in several asymmetric transition
metal-catalyzed reactions [5]. Moreover the easy transformation of alkynylphosphines into valuable
functionalized alkenyl mono- or di-phosphines through addition reactions on the triple bond was
recently demonstrated [6]. These new applications as ligands for homogeneous catalysis and building
blocks for organophosphorus chemistry have aroused the need for new general synthetic methods
allowing the access to a broad substitution pattern.
The classical method for preparing alkynylphosphines is based on the nucleophilic substitution
reaction at the phosphorus atom of a halophosphine by a metal (lithium, magnesium, titanium or zinc)
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acetylide at low temperature (Scheme 1, path A). This methodology was recently successfully applied
to the synthesis of a few enantioenriched P-stereogenic alkynylphosphine-boranes. The reaction
however suffers from severe limitations due to the weak configurational stability of halophosphines.
 
Scheme 1. Strategies A–F for the synthesis of alkynylphosphines and/or their borane complexes.
Catalytic variants of this reaction have been recently described as useful alternative approaches
when sensitive functional groups are present (Scheme 1, path B). They rely on the cross-coupling
reactions of terminal alkynes with chlorophosphines in the presence of a catalytic amount of nickel,
palladium or copper complexes. Both stoichiometric and catalytic methods are mainly based
on an electrophilic phosphorus derivative—a halophosphine—as starting material. The use of a
nucleophilic phosphorus derivative has been only little explored so far. In the stoichiometric series,
attempts involving treatment of alkynylphosphonium chlorides with a base failed to afford the
expected tertiary alkynylphosphines because their oxidation could not be avoided under the reaction
conditions [7]. On the other hand the catalytic synthesis of tertiary alkynylphosphine-boranes
based on the copper(I)-catalyzed cross-coupling reaction between secondary phosphine-boranes
and bromoalkynes was shown to proceed readily (Scheme 1, path C). A further strategy towards
alkynylphosphines relies on the transformation of alkynylphosphorus derivatives through modification
of the alkyne (Scheme 1, path D) or the phosphorus function (Scheme 1, paths E and F). Notably
the reduction of the phosphoryl moiety of alkynylphosphorus derivatives (Scheme 1, path F) is
highly relevant for the synthesis of primary and secondary alkynylphosphines, which are air- and
heat-sensitive compounds.
The scope of this review encompasses the synthesis of alkynylphosphines and their borane
complexes [8]. The stoichiometric methods for C–P bond formation will be first surveyed followed
by the catalytic procedures. Finally the methods based on the transformation of alkynylphosphorus
derivatives will be detailed.
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2. Nucleophilic Substitution at P-atom of Halophosphines
Tertiary alkynylphosphines are classically prepared through the reaction of chlorophosphines
and metal acetylides. For secondary alkynylphosphines, only those bearing sterically encumbered
substituents are available through this procedure.
2.1. Synthesis of Secondary Alkynylphosphines
Märkl and Reitinger reported the synthesis of a set of secondary alkynylphosphines based on the
reaction of the bulky secondary chlorophosphine 1 with various alkyne Grignard reagents in diethyl




Scheme 2. Synthesis of secondary alkynylphosphines via nucleophilic substitution.
The analogous reactions of chlorophosphine 1 with lithium acetylides in THF did not afford
alkynylphosphines but their 3H-phosphaallene tautomers, because of the stronger basicity of lithium
acetylides in comparison to the related Grignard reagents. One exception was found with lithium
trimethylsilylacetylide, which led to the alkynyl product under the same conditions. The reaction of
secondary chlorophosphine 1 with metal acetylides proved to be not only metal- and substrate- but
also solvent-dependent, probably because of the importance of the acetylide solvation. For example
the reaction of 1 with lithium tert-butylacetylide led to the alkynyl product in diethyl ether and to the
allenyl product in THF (Scheme 3).
 
Scheme 3. Solvent-effect on the outcome of the reaction of lithium acetylides with a
secondary chlorophosphine.
2.2. Synthesis of Tertiary Alkynylphosphines
2.2.1. Version with Achiral Reagents
The oldest methods for the preparation of tertiary alkynylphosphines are based on the nucleophilic
substitution reaction at the phosphorus atom of halophosphines by lithium [10] or magnesium [11]
acetylides. For example, Cadiot and Chodkiewicz described the synthesis of a set of alkynylphosphines
in good to excellent yields (50%–93%) through the reaction of Grignard reagents and dialkyl- or
diarylchlorophosphines in THF at −30 ◦C to 40 ◦C (Scheme 4).
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Scheme 4. Reaction of magnesium acetylides with chlorophosphines towards alkynylphosphines.
These procedures involving magnesium or lithium acetylides are still commonly used
nowadays. For example Montchamp [12] described the synthesis of several alkynylphosphines
using sec-butyllithium to generate in situ the lithium acetylide reagent. Subsequent treatment with






Scheme 5. Synthesis of alkynylphosphine-borane complexes from lithium acetylides.
Besides magnesium and lithium reagents, copper- [13], tin- [14], or silver- [15] acetylides have
been involved in a few examples. In view of their high reactivity, magnesium and lithium acetylides
are suitable for the formation of alkynylphosphines which do not bear functional groups sensitive to
nucleophilic attack such as esters. To prevent the occurrence of side reactions, the use of more selective
organometallic reagents like zinc [16] and titanium [17] acetylides was explored. Knochel demonstrated
that zinc organometallics were effective for the synthesis of polyfunctionalized phosphines and
described one example in the alkynyl series, but on a simple substrate. The alkynylzinc bromide
reagent resulting from the transmetalation of 1-hexynyllithium with zinc bromide reacted with
chlorodiphenylphosphine to provide the corresponding alkynylphosphine-borane in 80% yield after









Scheme 6. Synthesis of alkynylphosphines using a zinc acetylide.
Periasamy [17] reported the synthesis of alkynylphosphines using alkynyl titanium reagents. The
latter were not obtained by transmetalation of alkynyllithium reagents [18], but were generated in situ
by direct metalation of 1-alkynes with the combination of titanium tetrachloride and triethylamine
in dichloromethane (Scheme 7, Equation 1). Alkyne dimerisation may occur as a side reaction. For
example, the reaction of phenyl acetylene with diphenylchlorophosphine afforded the corresponding
alkynylphosphine in 54% yield, together with 2% of the diyne. Not only diphenylchlorophosphine
but also triethylphosphite could serve as an electrophile. The substitution of all ethoxy groups was
observed leading to tris(phenylethynyl)phosphine in 59% yield (Scheme 7, Equation 2).
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Scheme 7. Synthesis of alkynylphosphines using titanium acetylides.
2.2.2. Asymmetric Version
The single example relating the synthesis of a set of enantiopure P-stereogenic alkynylphosphines
was described by Imamoto [5] (Scheme 8). The procedure relies on the in situ generation of
a P-stereogenic bromophosphine-borane from an enantiopure secondary phosphine-borane via
deprotonation by n-butyllithium in diethyl ether at −78 ◦C and subsequent halogenation of the
resulting lithium phosphido-borane by treatment with dibromoethane. The bromophosphine-borane
was not isolated because of its tendency to racemize at room temperature, but was treated in situ with
a set of alkynyl lithium reagents. The nucleophilic substitution reaction was shown to occur with clean








Scheme 8. Synthesis of enantioenriched P-stereogenic alkynylphosphine-boranes.
The procedure is up to now only applicable to enantiopure
tert-butylmethylbromophosphine-borane, which displays a sufficient configurational stability
at low temperature. This successful example is probably difficult to extend to a wide variety of
phosphines due to the weak configurational stability of halophosphine-boranes.
3. Catalytic C-P bond Forming Reactions
Within the last ten years a few catalytic approaches towards alkynylphosphines have emerged.
They rely on the use of either (i) electrophilic phosphorus derivatives, using nickel, palladium or copper
complexes as catalytic system, or (ii) nucleophilic phosphorus derivatives using a copper(I) complex.
3.1. Electrophilic Phosphorus Reagent
As previously mentioned, alkynylphosphines are classically available through the reaction of
chlorophosphines with terminal alkynes in the presence of stoichiometric amounts of organometallic
bases. The Beletskaya group reported in 2003 [19] a catalytic variant, which was based on the use
of nickel or palladium complexes in the presence of an excess of triethylamine. Nickel complexes
were shown to display a higher activity than the palladium ones, the best catalysts being Ni(cod)2
and Ni(acac)2. The reaction with aryl or alkyl acetylenes readily proceeded in toluene at 80 ◦C for
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10 to 30 min or at room temperature for 6 to 10 h (Scheme 9). It is noteworthy that the selective






Scheme 9. Nickel-catalyzed cross-coupling of terminal alkynes with chlorophosphines.
The simplified postulated mechanism first involves the insertion of the metal into the P–Cl bond
of the chlorophosphine. The resulting metal phosphido complex undergoes transmetalation with the
in situ formed acetylide ion, followed by reductive elimination (Scheme 10).
 
Scheme 10. Simplified postulated mechanism of nickel- or palladium-catalyzed cross-coupling between
terminal alkynes and chlorophosphines.
The procedure was applied to the synthesis of a set of functionalized alkynylphosphines bearing
carbonyl groups, which would have been difficult to access via the stoichiometric method (Figure 1).
However in the case of aliphatic alkynes, a full conversion could not be reached and poor yields
(around 30%) were obtained [20].
Figure 1. Functionalized alkynylphosphines synthesized via the nickel-catalyzed procedure.
Another limitation of this nickel-catalyzed procedure was its lack of efficiency with substrates
bearing an alkoxy or amino group. To overcome these limitations a more versatile catalytic method
was developed by the same authors. The method is based on the use of copper salts [21] and proceeds
under mild conditions. Copper(I) iodide was used as the copper source in the presence of an excess
of triethylamine in toluene at room temperature (Scheme 11). The reaction scope is broad and
encompasses alkyl and (het)aryl acetylenes. Regarding the phosphorus coupling partner, aryl and
alkyl chlorophosphines are suitable substrates.
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Scheme 11. Copper-catalyzed cross-coupling of terminal alkynes with chlorophosphines.
The postulated mechanism does not rely on P–Cl bond activation by the metal, as proposed in the
case of Ni or Pd catalysis, but copper π-complexation of the terminal alkyne, followed by nucleophilic
substitution at the phosphorus atom of the chlorophosphine in the presence of triethylamine, as
outlined on Scheme 12. This hypothesis was supported by the isolation of the tetrahedral complex
(Ph2PCl)3CuI, which is the first active species involved in the suggested catalytic cycle.
Scheme 12. Postulated mechanism of copper-catalyzed cross-coupling between terminal alkynes
and chlorophosphines.
This general and mild procedure was successfully applied to the synthesis of bulky













Scheme 13. Copper(I)-catalyzed synthesis of functionalized triethynylphosphines.
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3.2. Nucleophilic Phosphorus Reagent
The Gaumont group reported the only example of a catalytic synthesis of alkynylphosphines,
relying on nucleophilic phosphorus reagents [24]. The alkynylphosphines were obtained as their
borane complexes. The methodology is based on the copper-catalyzed cross-coupling of secondary
phosphine-boranes with alkyl or aryl 1-bromoalkynes using CuI/1,10-phenanthroline as catalytic source
(Scheme 14). The reaction proceeds in toluene under mild conditions (20 to 60 ◦C, weak base).
−−
Scheme 14. Copper(I)-catalyzed reaction of secondary phosphine-boranes with 1-bromoalkynes
towards alkynylphosphine-boranes.
Preliminary mechanistic studies are consistent with the involvement of a copper(I)
phosphido-borane complex as the reactive species. Indeed neutral copper phosphido-boranes
[R2PHCuPPh2BH3phen], which could be isolated for the first time and fully characterized via
experimental and computational methods [25], were shown to serve as pre-catalysts in the




Scheme 15. P-alkynylation of secondary phosphine-boranes catalyzed by well-defined copper(I)
phosphido-borane complexes.
The putative mechanism of the reaction involves oxidative addition of the copper(I)
phosphido-borane complex to the 1-bromoalkyne, followed by reductive elimination, leading to
the cross-coupling product and allowing the release of the copper(I) catalyst (Scheme 16).
Scheme 16. Putative mechanistic cycle for the copper(I)-catalyzed P-alkynylation of
secondary phosphine-boranes.
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4. Transformation of Alkynylphosphorus Derivatives
Regarding the synthesis of tertiary alkynylphosphines, modification of the alkynyl or the
phosphorus function of alkynyl phosphorus derivatives is a less commonly used method in comparison
to C–P bond formation. On the other hand, in the case of secondary and primary alkynylphosphines,
the reduction of the phosphoryl moiety of phosphine oxides and phosphonates respectively, is the
method of choice for their preparation.
4.1. Functionalization of the Triple bond Moiety
Classical alkyne chemistry has been applied in the functionalization of alkynylphosphines through
their metalation and subsequent reaction with an electrophile. With the aim of preparing dendrimers,
Caminade and Majoral [26] generated the Grignard reagent of ethynylphosphine as building block for
the synthesis of mono-, di-, tri-, and tetra-phosphines (Scheme 17). It is noteworthy that the lithium
acetylide of ethynylphosphine was not suitable for these transformations, complex mixtures being
formed in this case.
−
−
Scheme 17. Metalation and functionalization of ethynylphosphine.
The Imamoto group [5] described a 4-step reaction sequence allowing the synthesis of an alkynyl
variant of BisP* ligands, analogous to DIPAMP [27], from an enantiopure silyl alkynylphosphine-borane
(Scheme 18). The first step was a dimerization reaction through copper(II)-catalyzed oxidative
coupling leading to the bis-alkynylphosphine-borane 2. The next step was the silyl deprotection
by treatment with TBAF. It was followed by deprotonation with sec-BuLi and methylation of the
resulting lithium derivative with methyl iodide. Finally borane removal by treatment with DABCO
(1,4-diazabicyclo[2.2.2]octane) afforded the bis-alkynylphosphine.
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Scheme 18. Synthesis of an alkynyl analogue of DIPAMP.
4.2. Nucleophilic Substitution at Phosphorus Atom
The nucleophilic substitution at the phosphorus atom of alkynylchlorophosphines by Grignard
reagents has been used for the building of complex structures. As an example, the Yoshifuji group [28]
described the synthesis of the dialkynyldiphosphine 4 from alkynyldichlorophosphine 3 (Scheme 19).
i
−
Scheme 19. Synthesis of alkynylphosphines from alkynyl-chlorophosphines.
Besides chlorophosphines, phosphonites can serve as precursors of alkynylphosphines. The
Aguiar group [29] reported the synthesis of a set of alkynylphosphines through the reaction of the in
situ generated diethyl alkynyl-1-phosphonite 5 and Grignard reagents (Scheme 20).
−−
Scheme 20. Synthesis of alkynylphosphines from in situ generated alkynylphosphonites.
4.3. Reduction of the Phosphoryl Moiety
As described in the Section 2.1, a few secondary alkynylphosphines were prepared via the reaction
of chlorophosphines and metal acetylides. However it concerned specific substrates stabilized by the
presence of bulky substituents on the phosphorus atom.
A more straightforward and general access to unstabilized primary and secondary
alkynylphosphines relies on the reduction of phosphoryl derivatives by alanes or silanes [30]. Guillemin
and Denis [31] developed the chemoselective reduction of alkynylphosphonates using AlHCl2 as
reducing agent. The best yields were obtained when the reaction was performed at low temperature in
diethyl ether or THF (Scheme 21, Equation 1). The same alane reducing agent was less suitable for the
preparation of secondary alkynylphosphines from alkynylphosphinates. Indeed C–P bond cleavage
occurred as a side-reaction [32], thus lowering the yields (Scheme 21, Equation 2).
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− −
Scheme 21. Synthesis of primary and secondary alkynylphosphines via phosphoryl reduction by alanes.
A mild and practical synthesis of secondary alkynylphosphines was reported by Gaumont and
Denis [33]. It is based on the reduction of secondary alkynylphosphine oxides in the presence of silane
derivatives. The starting phosphine oxides were available through acidic cleavage of aminophosphine
precursors. The appropriate silane reducing agent depended on the substituents at the phosphorus
atom. Phenylsilane was used as reducing agent in the case of P-alkyl derivatives (Scheme 22, Equation
1) while the reduction of P-phenyl derivatives was only partial under these conditions. It was finally
achieved with the combination of phenylsilane and trichlorophenylsilane in a 3:1 ratio (Scheme 22,
Equation 2). The active reducing agent is believed to be the in situ generated PhSiHCl2. The presence
of chlorine atoms on silicon, by increasing the oxophilic properties of the silane reagent, would explain
its higher reactivity.
−
Scheme 22. Synthesis of secondary alkynylphosphines via phosphoryl reduction by silanes.
5. Conclusions
The synthetic pathways towards alkynylphosphines used to be restricted to stoichiometric
procedures involving the use of organometallic bases, which limited the scope of the substitution
pattern to robust functional groups. Since less than a decade, benefiting from the renaissance of copper
catalysis for C–C and C–Heteroatom bond forming reactions, catalytic procedures have emerged,
which involve either an electrophilic or a nucleophilic phosphorus derivative. By proceeding under
mild conditions, these new catalytic methods have broadened the substituent scope and have been
successfully applied to the synthesis of functionalized complex phosphine structures.
Future developments comprise catalytic procedures avoiding the use of halogen-containing
derivatives, such as oxidative cross-couplings, which have proven their efficiency for the synthesis of
alkynylphosphonates [34], but whose application to the synthesis of alkynylphosphines is challenging
because of the high sensitivity of phosphines towards oxidation. Another challenge is the extension to
the asymmetric series through the use of chiral ligands associated with the metal catalyst.
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Abstract: The development of nanotechnology is responsible for an increase in the achievements
in medical diagnostics and in the preparation of new therapeutic vehicles. In particular, magnetic
nanoparticles with a modified surface are a very attractive alternative to deliver therapeutic agents.
We describe the modification of the surface of the iron oxide nanoparticles with aminophosphonic
acids by applying the classic hydrophosphonylation approach.
Keywords: magnetic nanoparticles; aminophosphonates; surface modification
1. Introduction
The dynamic development of nanotechnology (including nanoparticle technology) and molecular
biology is the cause of a rapid increase in the achievements in medical diagnostics and in the preparation
of new therapeutic substances [1–3]. Nanoparticles with a suitably chemically modified surface may be
used for many applications, such as magnetic resonance imaging contrast enhancement, immunoassay,
detoxification of biological fluids, drug delivery devices, and in cell separation [4,5]. Magnetic
nanovehicles are especially very attractive for the delivery of therapeutic agents. They can be targeted
to specific locations in the body through the application of an external magnetic field gradient, as has
been documented by a number of promising animal and clinical trials [6–8].
In this paper we describe the usefulness of hydro-phosphonylation of the C=N bond for the
modification of the surface of the iron oxide nanoparticles with aminophosphonic acids. Such
aminophosphonate nanoparticles should act as interesting, surfactant-like species because depending
on the pH of the solution, they may appear as negatively (because of the presence of phosphonate groups
in their structure), positively (because of the presence of ammonium groups) or zwitterionic species,
thus being able to exhibit non-typical properties, similar to those of recently obtained gold-supported
negatively charged surfactant-like nanoparticles [9]. This property should facilitate their ability to
bind organic compounds, proteins and metal ions.
The combination of the biological properties of aminophosphonates [10,11] and the potential of
the magnetic nanoparticles for effective targeted delivery using an external magnetic force, should
lead to magnetic bio-conjugates for selective targeting of physiologically active aminophosphonates
to organs which require their activity. The nanoparticles covered with aminophosphonates may also
be used as the supports for the immobilization of other drugs (especially anticancer ones) or for the
immobilization of enzymes. Additionally, they can be considered as a system for the removal of metal
ions from environmental and body fluids [12]. This could be achieved because aminophosphonic acids
are bifunctional molecules and possess two reactive moieties—amino and phosphonate groups. Thus,
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when present at the surface of nanoparticles they could be used to bind other substances (including
proteins) either covalently or by adsorption. This property should facilitate their ability to bind
organic compounds, proteins and metal ions. In this paper we describe our preliminary studies on the
modification of superparamagnetic iron oxide nanoparticles with aminophosphonic acids.
2. Results and Discussion
2.1. Preparation of Modified Nanoparticles
Iron oxide nanoparticles obtained by the standard co-precipitation method from iron(II) and
iron(III) chlorides in the presence of ammonium hydroxide solution [13], were coated with tetraethyl
orthosilicate and their surface was further functionalized with (3-aminopropyl)triethoxysilane
(APTMS) [14].
Magnetic iron oxide nanoparticles coated with structurally variable aminophosphonates have
been obtained by hydrophosphonylation of Schiff bases. We have applied its reacted version
commonly used in aminophosphonate synthesis [15]. The direct application of this procedure when
(3-aminopropyl)-triethoxysilane functionalized nanoparticles were used gave unsatisfactory results,
because of strong aggregation of the resulting nanoparticles. This might be due to the high density
of amino groups on the nanoparticles’ surface and their simultaneous low flexibility. Therefore, we
decided to apply the double-functionalization approach using aminopyridine or diaminopyrimidine as
linkers. The synthetic procedure, schematically shown in Figure 1, provided two series of nanoparticles
1a–j and 2d and 2g. Finally, one phosphonate moiety was hydrolyzed with sodium iodide in
acetone followed by acidification with 1M hydrochloric acid, a reaction which provided nanoparticles
functionalized with aminophosphonate esters. Finally, one phosphonate moiety was desterilized
with sodium iodide in acetone followed by acidification with 1M hydrochloric acid, a reaction which
provided nanoparticles functionalized with aminophosphonate esters. Hydrolysis to monoester is
of strategic importance—in further studies, the resulting compound library will be used to further
immobilization, including enzymes.
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Figure 1. Synthetic scheme leading to aminophosphonate-functionalized magnetic nanoparticles.
2.2. Characterization of Nanoparticles
The formation of functionalized nanoparticles is accompanied by the sharpening of the IR spectra,
which is in good accordance with the literature [16,17]. The infrared spectra of unmodified and
aminophosphonate-modified iron oxide nanoparticles are shown in Figure 2. The IR spectrum of
pure iron oxide nanoparticle shows a strong and wide band around 580 cm−1, characteristic for the
Fe–O stretching vibrations related to the magnetic core [Figure 2a]. A broad peak at around 1078 cm−1
corresponds to the Si-O and Si-C antisymmetric out of plane stretching bands, which are overlapping
[Figure 2b]. Binding of aminophosphonate results in significant changes in the spectra [Figure 2c].
They are similar to those which are expected for aminophosphonates. The presence of P=O results
in the stretching band at 1,230 cm−1, whereas the peak at 1,030 cm−1 corresponds to both P-O-C and
Ar-O-C vibrations (the latter one in the particular cases of particles 1g and 1j). The peak at 1,600 cm−1
most likely corresponds to the N-H bending scissoring vibrations, while C-N bond stretching is seen at
1,480 cm−1.
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Figure 2. IR spectra of (a) iron oxide nanoparticle; (b) nanoparticle coated with silica and functionalized
with APTMS; (c) aminophosphonate-functionalized nanoparticle 1g.
In order to determine if there is a phosphorus atom present at the surface of the obtained
nanoparticles we have applied energy-dispersive X-ray spectroscopy (SEM-EDX), which gave expected
results (Figure 3). During sample scanning the obtained bands clearly showed the presence of the
following atoms: Fe (6.5 and 0.8 KeV), Si (1.9 KeV), P (2.0KeV), O (0.5KeV) and C (0.1 KeV). Intensified
signals at 0.1, 0.3, 2.5 are derived from elements contained in the matrix: C (0.1 KeV) and Cl (0.3 KeV,
2.5 KeV).
Figure 3. EDX spectrum of 1g nanoparticles.
Due to the magnetic properties of iron oxide nanoparticles we could not apply 31P-NMR, a
technique typically used for the determination of the presence of carbon-to-phosphorus bonds.
Therefore we have decided to obtain pure silica oxide nanoparticles and functionalize their surface
with representative aminophosphonates in a manner identical to the magnetic ones. We expected that
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the infrared spectra of these nanoparticles were going to be similar to those obtained for functionalized
magnetic nanoparticles showing only the lack of the band corresponding to the Fe-O vibrations.
On the other hand, the fact that this system is not magnetic allows us to perform 31P-NMR
measurements. The silica nanoparticles, lacking the iron oxide magnetic core, were synthesized
from tetraethylortosilicate following the procedure described in the literature. In the next step we
modified their surfaces with (3-aminopropyl)-trimethoxysilane and then with aminophosphonates
following the procedure elaborated in this work. The IR spectra received for these particles, lacking
the magnetic core, were identical to those obtained for magnetic ones. The 31P-NMR spectra obtained
for the nanoparticles clearly indicated the presence of a phosphonate moiety appearing at about 20
ppm, which corresponded to the expected products (Figure 4). This finding unequivocally confirms
that the procedure described in this paper results in iron oxide nanoparticles surface covered with
aminophosphonates. Between 5 and 10 ppm additional peaks corresponding to diethyl and monoethyl
phosphites could be observed. Their appearance results from the fact that we had not purified the
functionalized silica.
Figure 4. (a) 31P-NMR spectrum of nanoparticle 1g lacking magnetic core (b) Comparison of IR
spectrum with magnetic core (blue line) and without (red line) of nanoparticles modified with
2,6-diamino-4-chloropyrimidine.
2.3. Nanoparticles Size and Dispersion
The size and distribution of oxide nanoparticles have been measured using dynamic light
scattering. The size distribution of non-functionalized iron oxide nanoparticles, is between 15–50 nm,
with a maximum value at 32 nm (Figure 5). The size distribution of functionalized particles clearly
shows that they have a strong tendency to agglomerate. This is clearly seen from the transmission
electron microscopy measurements (TEM), which support both the nearly uniformly sized uncoated
iron oxide and the wide distribution of the size of the functionalized ones results from aggregation.
The degree of aggregation is dependent on the structure of nanoparticle coating (presence or absence
of linker), the structure of the aminophosphonate side chain and on the solvent used (measurements
were done in water, methanol, toluene and acetone). The measurements indicated that the average
diameter of the obtained nanoparticles appeared to be the smallest in methanol, with compounds 1a
(hydrodynamic size 144 nm), 1c (72 nm), 1f (70 nm), 1i (65 nm) and 1j (139nm) being representative
examples. The respective acids 1a, 1c, 1d, 4d and 4g also exhibit low size of dispersion of 50–200 nm.
85
Molecules 2013, 18, 8473-8484
Figure 5. DLS measurements of iron oxide nanoparticles (red line) and with silica core (blue line).
The measurements in acetone also gave satisfactory results—some nanoparticles (1f, 1c and
5b) exhibit a low range of size dispersion, whereas others yielded quite large aggregates, while in
toluene mostly highly aggregated particles were observed. It is also worth noting that nanoparticles
after hydrolysis 3a–j gave the best results in acetone. It is not possible to draw any meaningful
size-dispersion—structure relationship for these species from these results. In Table 1 all DLS results in
four solvents are summarized.
Table 1. DLS results in four solvents.
No
Hydrodynamic Size [nm] (Fraction %)
Water Methanol Acetone Toluene
1a
168 (79%), 954
(21%) 144 (100%) 85 (100%) Above 1 μm
1b 710 (100%) 184 (100%) 399 (100%) 507 (10%)
1c 485 (100%) 72 (100%) 39 (49%), 81 (51%) 194 (36%), 808(38%)
1d 74 (47%), 259 (53%) 180 (100%) 96 (100%) 280 (23%), 870(77%)
1e 180 (91%), 840 (8%) 170 (100%) 121 (100%) 697 (100%)
1f 820 (100%) 70 (40%), 337 (60%) 73 (40%), 280 (60%) 560 (40%)
1g
402 (25%), 930
(75%) 159 (100%) 294 (100%) Above 1 μm
1i 296 (100%) 65 (100%) 114 (100%) 495 (100%)
1j 519 (100%) 139 (100%) 294 (100%) Above 1 μm
2d 177 (28%) 202 (100%) Powyżej 1 μm Above 1 μm
2g 36 (15%), 116 (85%) 178 (100%) 95 (100%) Above 1 μm
3a 105 (100%) 120 (78%) 86 (100%) Above 1 μm
3c
100 (39%), 319
(61%) 130 (100%) 82 (100%) 349 (100%)
3d 93 (38%), 277 (62%) 109 (100%) 77 (100%) Above 1 μm
3e
158 (15%), 406
(85%) 82 (22%), 125 (78%) 96 (100%)
377 (58%), 840
(42%)
3j 630 (100%) 209 (100%) 86 (100%) 635 (100%)
4d 602 (100%) 196 (100%) 80 (100%) 249 (46%),748(54%)
4g
128 (52%), 380
(48%) 150 (100%) 198 (100%) 175 (100%)
5b
490 (30%), 770
(70%) 71 (100%) 86 (100%)
215 (25%), 743
(75%)
5g 123 (100%) 130 (18%), 346(82%) 93 (100%) Above 1 μm
5h 105 (100%) 118 (100%) 160 (100%) 222 (100%)
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The particles obtained without the application of linker are characterized by an enormous
dispersion of size in water and therefore we decided to modify their structure by the application of
linkers. The latter structures (a representative one is shown in Figure 6) contain multiple protonation
sites, which means that they also tend to aggregate in a pH-dependent manner. They may be considered
as polyionic surfactant-like species.
No
Hydrodynamic Size [nm] (Fraction %)
Water Methanol Acetone Toluene
1a
168 (79%), 954
(21%) 144 (100%) 85 (100%) Above 1 μm
1b 710 (100%) 184 (100%) 399 (100%) 507 (10%)
1c 485 (100%) 72 (100%) 39 (49%), 81 (51%) 194 (36%), 808(38%)
1d 74 (47%), 259 (53%) 180 (100%) 96 (100%) 280 (23%), 870(77%)
1e 180 (91%), 840 (8%) 170 (100%) 121 (100%) 697 (100%)
1f 820 (100%) 70 (40%), 337 (60%) 73 (40%), 280 (60%) 560 (40%)
1g
402 (25%), 930
(75%) 159 (100%) 294 (100%) Above 1 μm
1i 296 (100%) 65 (100%) 114 (100%) 495 (100%)
1j 519 (100%) 139 (100%) 294 (100%) Above 1 μm
2d 177 (28%) 202 (100%) Powyżej 1 μm Above 1 μm
2g 36 (15%), 116 (85%) 178 (100%) 95 (100%) Above 1 μm
3a 105 (100%) 120 (78%) 86 (100%) Above 1 μm
3c
100 (39%), 319
(61%) 130 (100%) 82 (100%) 349 (100%)
3d 93 (38%), 277 (62%) 109 (100%) 77 (100%) Above 1 μm
3e
158 (15%), 406
(85%) 82 (22%), 125 (78%) 96 (100%)
377 (58%), 840
(42%)
3j 630 (100%) 209 (100%) 86 (100%) 635 (100%)
4d 602 (100%) 196 (100%) 80 (100%) 249 (46%),748(54%)
4g
128 (52%), 380
(48%) 150 (100%) 198 (100%) 175 (100%)
5b
490 (30%), 770
(70%) 71 (100%) 86 (100%)
215 (25%), 743
(75%)
5g 123 (100%) 130 (18%), 346(82%) 93 (100%) Above 1 μm
5h 105 (100%) 118 (100%) 160 (100%) 222 (100%)
Figure 6. Representative structure of nanoparticle—arrows indicate protonation sites.
Nanoparticles (both esters and acids) gave satisfactory size-dispersion when directly suspended in
water, being usually in the range of 100 nm. The average sizes of the obtained particles were, however,
usually higher that those obtained in methanol. Therefore we had measured their dependence on
the pH of the aqueous solution by applying pH of 2, 6.8 and 12. At neutral pH, a strong tendency to
aggregation was observed. A representative example obtained is shown in Figure 7. As expected, a
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significant reduction of the average size and size dispersion was obtained in strongly basic (pH 12)
solutions, where all the residues are unprotonated. Also no aggregation was observed at this pH. More
complex, and dependent on the chemical structure of aminophosphonate side chain, is the influence
of acidic pH. In the cases when the aminophosphonate side chain is hydrophobic it usually has a
positive influence on nanoparticle dispersion. Also in this case it is difficult to draw any reasonable
structure-behavior relationship.
Figure 7. Size distribution of nanoparticles 2g in different pH values.
The stability of nanoparticles dispersions correlates well with the ζ—potential measurements. It
is generally accepted that the potential higher than 30 meV or lower than −30 meV characterizes stable
systems. This is also the case in these studies.
3. Experimental
3.1. General
All solvents and reagents were purchased from commercial suppliers (Aldrich, Sigma, Merck,
POCh), were of analytical grade and were used without further purification. Infrared spectra were
measured on a 1600 FT-IR Perkin-Elmer spectrometer. The size of the nanoparticles was determined by
dynamic light scattering using a Malvern Zetasizer Nano ZS in Laboratory of Biomedical Chemistry,
Department of Experimental Oncology, Institute of Immunology and Experimental Therapy, PAS,
Wroclaw. NMR experiments were performed on a Bruker DRX AVANCE TM 300MHz spectrometer.
SEM-EDX and TEM analyses were performed in the Microscopy and Analysis Suite, University of Bath,
on a JEOL JSM6480LV with an Oxford INCA X-ray analyzer and an OEL JEM 1200EXII, respectively.
3.2. The Synthesis of Iron Oxide Nanoparticles Coated with Silica
To a one-litre three neck flask of water (188 mL) and 23% aqueous solution of ammonia (10
mL) was added. The solution was stirred under a nitrogen atmosphere. At the same time a mixture
of FeCl3·6H2O and FeCl2·4H2O (in a molar ratio of 1:2) was dissolved in water (10 mL) containing
36% HCl solution (0.125 mL). This solution of chloride salts was very slowly added dropwise to the
solution of NH4OH with vigorous stirring. A black precipitate of iron oxide nanoparticles was formed
and isolated through magnetic decantation. Magnetic nanoparticles were washed several times with
distilled water and finally with 0.1 M solution of tetramethylammoniun hydroxide (TMAOH, 100 mL).
This mixture was sonicated for 1 h, and the nanoparticles were isolated through magnetic decantation
and dried.
Iron oxide nanoparticles (0.1 g) were placed in distilled water (100 mL) and sonicated for 1
h. Then 2-propanol (100 mL) was added and the mixture sonicated for an additional 3 h. After
that 23% aqueous solution of ammonia (1 mL) was added. The mixture was vigorously stirred and
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tetraethylortosilicate (0.2 mL) was added. After 2 h of stirring the nanoparticles were separated through
magnetic decantation, washed with water and dried.
3.3. The Functionalization of Silica Coated Nanoparticles with (3-aminopropyl)trimethoxysilane
Freshly coated iron oxide nanoparticles (0.5 g), water (25 mL) and methanol (25 mL) were placed
in a flask and sonicated for 1 h. After this time (3-aminepropyl)trimethoxylsilane (0.75 mL) was added
in one portion and the mixture stirred at 80 ◦C for 5 h. The brown precipitate was isolated through
magnetic decantation, washed with water and dried.
3.4. The General Procedure Followed for the Synthesis of Aminophosphonate-Functionalized Magnetic
Nanoparticles
Nanoparticles functionalized surfacially with amino-groups (0.5 g) were mixed with
2-amino-5-chloropyridine (0.5 g) or 2,6-diamino-4-chloropyrimidine (0.5 g) in toluene and refluxed
for 8h. After this time, the solvent was evaporated, the precipitate washed with fresh toluene and
magnetically decanted. The synthesised nanoparticles were then used as amine reagent for the
synthesis of aminophosphonates. Thus, the appropriate amount of nanoparticles (0.5 g) and aldehyde
(1 g) were mixed in toluene and refluxed until the amount of collected water remained unchanged in
the Dean-Stark trap. The solvent was evaporated and the crude nanoparticle Schiff base was used in
the next step without purification. It was suspended in a new portion of toluene and the equivalent
of diethyl phosphite (in 1:1 molar ratio to aldehyde) was added followed by refluxing for 4 h. The
solvent was then evaporated, the residue washed with toluene, and water and isolated through
magnetic decantation.
1a: IR (KBr, cm−1): 570 (m, Fe-O), 1049 (s, P-O-C), 1093 (s, Si-O), 1176 (s, Si-C), 1218 (s, P=O), 1479
(s, N-H), 1596 (s, CAr-NAr), 2919, 2990 (m, C-H), 3326 (m, Ar-O-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9
(Si), 2.0 (P), 6.7 (Fe).
1b: IR (KBr, cm−1): 569.8 (m, Fe-O), 1037 (s, P-O-C), 1060 (s, Si-O), 1172 (s, Si-C), 1284 (m, P=O),
1479 (s, N-H), 1596 (s, CAr-NAr), 2919 (m, C-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7
(Fe).
1c: IR (KBr, cm−1): 541 (m, Fe-O), 1020 (s, P-O-C), 1048 (s, Si-O), 1230 (s, P=O), 1478 (s, N-H), 1598
(s, CAr-NAr), 2899, (m, C-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe).
1d: IR (KBr, cm−1): 567 (m, Fe-O), 1029 (s, P-O-C), 1054 (s, Si-O), 1230 (s, P=O), 1247 (s, Si-C), 1484
(s, N-H), 1598 (s, CAr-NAr), 2865 (m, C-H), 3285,14 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si),
2.0 (P), 6.7 (Fe).
1e: IR: (KBr, cm−1): 577 (m, Fe-O), 1022 (s, P-O-C), 1053 (s, Si-O), 1475 (s, N-H), 1598 (s, CAr-NAr),
2906 (m, C-H), 3294 (m, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe).
1f: IR: (KBr, cm−1): 533 (m, Fe-O), 1036 (s, P-O-C), 1224 (s, P-O), 1288 (m, Si-C), 1481 (s, N-H),
1596 (s, CAr-NAr), 2901, 2979 (m, C-H), 3283 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P),
6.7 (Fe).
1g: IR (KBr, cm−1): 583 (m, Fe-O), 1032 (s, P-O-C), 1052 (m, Si-C), 1238 (s, P=O), 1369 (m, N-O),
1481 (m, N-H), 1533 (m, CAr-NAr), 2976 (m, C-H), 3307 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9
(Si), 2.0 (P), 6.7 (Fe).
1h: IR (KBr, cm−1): 583 (m, Fe-O), 1028 (s, P-O-C), 1028 (m, Si-C), 1238 (s, P=O), 1354 (m, N-O),
1499 (m, N-H), 1533 (m, CAr-NAr), 2986 (m, C-H), 3419 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9
(Si), 2.0 (P), 6.7 (Fe).
1i: IR (KBr, cm−1): 568 (m, Fe-O), 1045 (s, P-O-C), 1162 (m, Si-O), 1224 (m, P=O), 1336 (m, N-O),
1439 (m, N-H), 1508 (m, CAr-NAr), 2982 (m, C-H), 3413 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9
(Si), 2.0 (P), 6.7 (Fe).
1j: IR (KBr, cm−1): 571 (m, Fe-O), 1096 (s, P-O-C), 1148 (s, Si-O), 1213 (s, P-O), 1246 (s, Si-C), 1459
(m, N-H), 2832, 2938 (m, C-H), 3187 (m, Ar-O-H), 3240 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9
(Si), 2.0 (P), 6.7 (Fe).
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2d: IR (KBr, cm−1): 560 (m, Fe-O), 1051 (s, P-O-C), 1162 (s, Si-O), 1495 (m, N-H), 1579 (s, CAr-NAr),
2931, 2982, (m, C-H), 3399 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe).
2g: IR (KBr, cm−1): 546 (m, Fe-O), 1049 (s, P-O-C), 1162 (m, Si-O, Si-C), 1296 (m, Ar-O-C), 1467 (s,
N-H), 1579 (s, CAr-NAr), 2980 (m, C-H), 3100 (m, Ar-O-H), 3303 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5
(O), 1.9 (Si), 2.0 (P), 6.7 (Fe).
3.5. The General Synthesis of Monoesters
The nanoparticle diester (0.5 g) and the sodium iodide (0.5 g) were placed in acetone and refluxed
for 3 h. The sodium salt of the monoester was isolated through magnetic decantation, washed with
acetone and converted into acid form by washing with 1 M HCl. The obtained nanoparticles were
washed with water and dried.
3a: R (KBr, cm−1): 577 (m, Fe-O), 1050 (s, P-O-C), 1068 (s, Si-O), 1189 (s, Si-C), 1223 (m, P=O), 1607
(s, N-H), 1656 (s, CAr-NAr), 2737 (m, C-H), 3257 (m, AO-H), 3417 (s, N-H).
3b: IR (KBr, cm−1): 570 (m, Fe-O), 1037 (s, P-O-C), 1060 (s, Si-O), 1173 (s, Si-C), 1284 (m, P=O),
1479 (s, N-H), 1596 (s, CAr-NAr), 2919, 3228 (m, C-H).
3c: IR (KBr, cm−1): 541 (m, Fe-O), 1012 (s, P-O-C), 1044 (s, Si-O), 1212 (s, P=O), 1473 (s, N-H), 2849,
2917 (s, C-H), 3429 (m, O-H).
3d: IR (KBr, cm−1): 569 (m, Fe-O), 1095 (s, P-O-C), 1228 (s, P=O), 1482 (s, N-H), 1598 (s, CAr-NAr),
3469 (s, O-H).
3e: IR (KBr, cm−1): 611 (m, Fe-O), 1027 (m, P-O-C), 1054 (m, Si-O), 1479 (m, N-H), 1598 (m,
CAr-NAr), 3416 (s, O-H).
3f: IR: (KBr, cm−1): 536 (m, Fe-O), 1026 (s, P-O-C), 1052 (s, Si-O), 1228 (m, P=O), 1478 (s, N-H),
1597 (s, CAr-NAr), 2984, (m, C-H), 3468 (s, O-H).
3g: IR (KBr, cm−1): 546 (m, Fe-O), 1024 (m, P-O-C), 1431 (w, N-H), 1605 (m, CAr-NAr), 3398 (s,
O-H).
3h: IR (KBr, cm−1): 611 (m, Fe-O), 1044 (m, P-O-C), 1162 (M, Si-O, Si-C), 1239 (m, P=O), 1355 (m,
N-O), 1499 (w, N-H), 3416 (s, N-H), 3468 (s, O-H).
3i: R (KBr, cm−1): 570 (m, Fe-O), 1047 (m, P-O-C), 1162 (m, Si-O), 1227 (m, P=O), 1336 (m, N-O),
1440 (w, N-H), 1510 (m, CAr-NAr), 3415 (s, N-H), 3471 (s, O-H).
3j: IR (KBr, cm−1): 571 (m, Fe-O), 1096 (s, P-O-C), 1148 (s, Si-O), 1213 (s, P=O), 1460 (m, N-H),
1625 (s, CAr-NAr), 2832, 2938 (m, C-H), 3187 (m, Ar-O-H), 3240 (m, N-H), 3412 (m, O-H).
4. Conclusions
Hydrophosphonylation surfacial Schiff bases obtained from iron oxide magnetic nanoparticles
functionalized with amino groups appeared to be an effective method for preparation of
aminophosphonate-functionalized nanoparticles. By being surfacially charged (both negative and
positive) these particles behave as micelles.
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Abstract: This research determined the adsorption performance of Florisil® impregnated with
trihexyl(tetradecyl)phosphonium chloride (Cyphos IL-101) in the process of Cs+ removal from
aqueous solutions. The obtained Florisil® impregnated with the studied ionic liquid was characterized
through energy dispersive X-ray analysis and Fourier transform infrared spectroscopy in order to
verify that the impregnation with the ionic liquid had occurred. The adsorption process has been
investigated as a function of pH, solid:liquid ratio, adsorbate concentration, contact time and
temperature. The isotherm data was well described by a Langmuir isotherm model. The maximum
adsorption capacities of the Florisil® impregnated with the studied ionic liquid was found to be 3.086
mg Cs+/g of adsorbent. The results indicated that the adsorption fitted well with the pseudo-second
order kinetic model.
Keywords: Cs+ adsorption; trihexyl(tetradecyl)phosphonium chloride; Florisil®
1. Introduction
In the last decades the attention of researchers was focused on the problem of environmental
pollution with radioactive contaminants. Among all radioactive components Cs+ is an important
radionuclide from several reasons: relatively long-live, high solubility/mobility and strong γ emitting
radiation. Furthermore, it can be easily incorporated into terrestrial and aquatic organisms because
of its chemical similarity to potassium [1–3]. Therefore it should be removed from waste radioactive
solutions. One of the most studied methods of radionuclide removal from waste waters is the
liquid-liquid extraction using various solvents [4–8]. In recent years ionic liquids (ILs) have gained
considerable attention and were investigated as substitutes for the organic solvents normally used in this
application due to their advantages: high-thermal stability, non-inflamability and non-volatility [8–11].
Based on literature survey was observed that the phosphonium ionic liquids, compared to their
imidazolium- or pyridinium-based counterparts, present some advantages: improved thermal and
chemical stability, unique miscibility behaviour and solvating properties [10–12]. Even so they have
not been studied so intensely, and were not used for Cs+ removal. Trihexyl(tetradecyl)phosphonium
bis-2,4,4-trimethylpentylphosphinate has been used in lactic acid separation [13] and metal ions
separation [11,14–17]. Trihexyl(tetradecyl)phosphonium chloride (Cyphos IL-101) has been used as
effective extractant for the removal of bismuth, zinc or platinum [18–21]. We have also focused on the
phosphonium-based ionic liquid, because was observed that from the studied ion exchanges those
based on phosphonium (like ammonium molybdophosphate) have been intensively investigated and
found to be effective for the removal of caesium, but from acidic liquids [22,23]. Therefore in this
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paper a fairly cheap IL—trihexyl(tetradecyl)phosphonium chloride (Cyphos IL-101)—was used as the
separation medium for Cs+ removal from aqueous solutions. Due to its commercial availability and low
price, Cyphos IL-101 is a favourable extractant for Cs+ removal. In the liquid-liquid extraction some
drawbacks may arise like the large amount of ionic liquid used, high viscosity leading unfavourably to
dissolution and diffusion, difficulties of separation and recovery and low interface area [24–26]. In
order to overcome these shortcomings and to enhance the separation capacities of the studied IL this
was impregnated onto a solid support. Doing this is combined the advantages of the IL with those
of the heterogeneous support materials [11,14,17–20,24–31]. As a support material an inorganic one
(Florisil®) was used because of its crystalline and well-ordered periodic pore structure which will
develop higher resistance to chemical, thermal and radiation degradation and also its well known
remarkable selectivity [14,28,31]. In order to determine the adsorption performance of the Florisil®
impregnated with Cyphos IL-101 in the process of Cs+ removal from aqueous solutions, equilibrium
and kinetic studies were used.
2. Results and Discussion
2.1. Characterization of the Florisil® Impregnated with IL
In order to obtain an impregnated solid support with a higher adsorption capacity in the process of
Cs+ removal from aqueous solutions, the optimum quantity of the studied IL which can be impregnated
onto the Florisil® support was determined in the first step. The experimental data regarding the




















Figure 1. The dependence of the Cs+ uptake versus of IL:SS ratio (Ci = 10 mg/L, V = 25 mL, t = 2 h, pH
= 8, m = 0.1 g).
Without impregnation with the studied IL the Florisil® support didn’t present any adsorption
capacity in the process of Cs+ removal from aqueous solutions. It can be observed that by increasing
the quantity of the IL impregnated onto the Florisil® support the Cs+ ions uptake increases, but for
a quantity of IL impregnated onto the solid support higher than 0.1 g the trend is reversed. This
happened because at higher quantities of IL, instead of the impregnation of the Florisil® the surface
becomes clogged, which leads to the agglomeration of the Florisil® particles, decreasing in this way
the surface contact between the adsorbent and adsorbate. The conglomeration of the Florisil® particles
impregnated with a higher quantity of IL is visible with the naked eye. The optimum IL:SS ratio used
in the further studies is 0.1:1.
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The Florisil® impregnated with the optimum quantity of IL was characterized through energy
dispersive X-ray analysis (EDX) in order to demonstrate that the impregnation with IL had occurred.
The SEM images of the Florisil® support before and after impregnation with the studied IL are
presented elsewhere [32]. The EDX spectrum of the impregnated Florisil® is presented in Figure 2 and
in it the characteristic peaks of P and Cl which are components of the ionic liquid can be observed. This
analysis thus proved that the impregnation of the Florisil® solid support with the studied IL occurred.
Figure 2. The EDX spectrum of the Florisil® impregnated with IL.
The Florisil® impregnated with IL and used in the process of Cs+ removal from aqueous solutions
was also characterized by Fourier transform infrared spectroscopy (FTIR). The FTIR spectrum of the
Florisil® impregnated with IL after adsorption of Cs+ from aqueous solutions is presented in Figure 3
and can be observed that the spectrum is in good agreement with those from the literature [32–35].
Table 1 shows the characteristic IR bands in [cm−1] for the Florisil® impregnated with IL after adsorption
of Cs+ and the corresponding assignments. The impregnation of the Florisil® with the studied IL is
confirmed by the IR peaks around 2,957 cm−1, 2,933 cm−1, 2,858 cm−1 and 1,395 cm−1 corresponding to
the CH3 and CH2 stretching vibrations of Cyphos IL 101. The bands at 1,100 cm−1, 1,050 cm−1 and
800 cm−1 are attributed to the group of νa (C-C) + ν (M-O) + P-C stretching vibrations [33–36]. The
IR spectrum shows an intense and broad band with a maximum at 3,455 cm−1, due to the ν(Cs-OH,
Cs-OH2) vibration, also confirming the retention of Cs+.
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Figure 3. FTIR spectrum of the studied material.
Table 1. Assignments of the IR vibrations of the studied material [33–35].
Wavenumber [cm−1] Assignments
3455 (s,b) νOH bonded ν(Cs-OH, Cs-OH2)
2957 (w) νa (CH3)
2933 (w) νa (CH2)
2858 (w) νs (CH3)
1395 (m) P-C stretching νs (CH2)
1100 (vs) P-C stretching νa (C-C)
1050 (vs) P-C stretching ν (M-O)
800 (w) P-C deformation (out of the plane) ν (M-O)
670 (w) ν (Si-O)
465 (s) ν (M-O)
s-strong; v-very; b-broad; m-medium; w-weak; (M = Si, Mg).
2.2. pH Influence on the Cs+ Adsorption Process
The experimental data regarding the dependence of the Cs+ uptake versus the pH of the solution,
using an aqueous solution with a Cs+ concentration of 10 mg/L and a S:L ratio 0.1 g:0.025 L, under
a stirring time of 2 h, was studied. This behaviour is in agreement with other research from the
literature [3,4,36]. This is explained by the fact that Cs+ is stabilized with the increasing pH (6–8) with
the formation of hydroxo complexes ([Cs(OH)2(OH2)2....4]−). This is also in agreement with the results
obtained at the FTIR analysis. In accord with the experimental data we supposed that Cs+ was retained
from aqueous solutions through the attraction of the formed negative hydroxo complex of Cs+ by
the positive phosphonium ions from the IL impregnated onto the Florisil®. Therefore for the further
experiments we use Cs+ solution with an initial pH around value 8.
2.3. Influence of the Amount of Impregnated Florisil® on the Cs+ Adsorption Process
The experimental data regarding the dependence of the Cs+ uptake versus the amount of the
impregnated Florisil® used in 0.025 L of Cs+ solution, are presented in Figure 4.
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Figure 4. The dependence of the Cs+ uptake versus the amount of the impregnated Florisil® (Ci = 10
mg/L, V = 25 mL, t = 2 h, pH = 8).
From Figure 4 can be observed that an increase in the amount of the impregnated Florisil® used
in the process of Cs+ removal from aqueous solutions lead to a decrease of the Cs+ uptake, because the
adsorption capacity is related to the amount of the adsorbent used in the removal process. The optimum
S:L ratio used for the further experiments is 0.1 g of impregnated Florisil® for 0.025 L of aqueous Cs+
solutions. This parameter is important for the scale up of the studies from the laboratory scale.
2.4. Adsorption Isotherm
The aim of the adsorption isotherm are: (1) to express the affinity of the impregnated Florisil®
with the studied IL as a function of its surface properties; (2) to obtain the maximum adsorption
capacity of the Florisil® impregnated with the IL in the process of Cs+ removal from aqueous solutions
and to compare it with other sorbents used in the literature; (3) the obtained results can be used to
upscale laboratory batch experiments to a pilot or industrial scale. The equilibrium data were fitted
with the Langmuir and Freundlich equations. The isotherms are presented in Figure 5 and the obtained























Figure 5. The adsorption isotherms of Cs+ onto the impregnated Florisil® with the studied IL (t = 2 h,
V = 25 mL, pH = 8, m = 0.1 g, Ci = 5–50 mg/L).
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Table 2. Parameters of Langmuir and Freundlich isotherms for Cs+ ion adsorption onto Florisil®
impregnated with the studied IL.
Langmuir isotherm Freundlich isotherm
qm, exp mg/g KL L/mg qm, calc mg/g R2 KF mg/g 1/n R2
2.6 0.123 3.086 0.9907 0.5658 0.4299 0.9863
The constant KF can be defined as an adsorption coefficient which represents the quantity of
adsorbed metal ions for a unit equilibrium concentration. The slope 1/n is a measure of the adsorption
intensity or surface heterogeneity. For 1/n = 1, the partition between the two phases is independent
on the concentration. The situation 1/n < 1 is the most common and correspond to a normal L-type
Langmuir isotherm, whilst 1/n > 1 is indicative of a cooperative adsorption which involves strong
interactions between the molecules of adsorbate. Values of 1/n < 1 show favourable adsorption of
Cs+ ions onto the Florisil® impregnated with IL. Both models showed good correlation coefficients,
but those obtained in case of the Langmuir model is more closed to unity, and also the maximum
adsorption capacity of the impregnated Florisil® with IL obtained from the Langmuir plot is very close
to that obtained experimentally, therefore the experimental data are best described by the Langmuir
isotherm suggesting that the adsorption of Cs+ from aqueous solution take place onto the homogenous
surfaces of the Florisil® impregnated with IL, forming a monolayer on the adsorption surface [1,19].
The adsorption capacities (qm) of different adsorbents for adsorption of Cs+ ions are compared in
Table 3. It may be seen that the Florisil® impregnated with Cyphos IL 101 exhibits a good adsorption
capacity in the process of Cs+ removal from aqueous solutions, compared with other studied materials.
Table 3. Adsorption capacity of various adsorbents in the process of Cs+ removal from
aqueous solutions.
Adsorbent qm, mg/g Reference
Nano-zirconium vanadate 9.1 [3]
Resorcinol-formaldehyde RF 5.56 [37]





2.5. The Influence of Contact Time and Temperature on the Cs+ Adsorption Process and Adsorption Kinetics
The experimental data regarding the dependence of the Cs+ uptake versus the contact time, at
three temperatures (298, 308 and 318 K) using a Cs+ solution having a concentration of 10 mg/L, are
presented in Figure 6. From the experimental data can be observed that the equilibrium between Cs+
and Florisil® impregnated with IL is achieved after 120 min of contact for all the studied temperatures.
This is a very good time comparing with other results from the literature where the equilibrium is
achieved in up to 10 days [38]. The increase of the temperature leads to an increase of the quantity
of Cs+ uptake by the studied adsorbent, but this increase is not significant after the equilibrium is
achieved, therefore from the economic point of view is not recommended to increase the temperature.
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Figure 6. The dependence of the Cs+ uptake versus the contact time (Ci = 10 mg/L, V = 25 mL, pH = 8,
m = 0.1 g).
The kinetics of the adsorption describing the rate of the removal of Cs+ is one of the important
characteristics that defines the efficiency of adsorption. In order to evaluate the kinetic mechanism
that controls the adsorption process, the pseudo-first-order and pseudo-second-order models were
tested to interpret the experimental data. Because of the poor regression coefficient (R2) values of the
Lagergren pseudo-first-order model the results are not included in the text.
The pseudo second-order rate constant k2 and qe were calculated from the slope and intercept of
the plots of t/qt versus t (Figure 7) [1]. The experimental and calculated qe values, pseudo-second-order
rate constants, R2 values are presented in Table 4. The calculated qe values are in agreement with
the experimental qe values and the plots show good linearity, with R2 higher than 0.99 for all three
studied temperatures. Hence, this study suggested that the pseudo-second-order kinetic model better















Figure 7. Pseudo-second-order kinetics plots for Cs+ adsorption onto Florisil® impregnated with IL.
99
Molecules 2013, 18, 12845-12856
Table 4. Pseudo-second-order parameters for Cs+ adsorption onto Florisil® impregnated with IL.
Temperature, K
Parameter
qe, exp, mg/g qe, calc, mg/g k2, g/(min·mg) R2
298 1.15 1.27 0.0304 0.9926
308 1.15 1.16 0.144 0.9999
318 1.18 1.20 0.146 1
3. Experimental
3.1. Materials
The trihexyl(tetradecyl)phosphonium chloride (Cyphos IL-101) was purchased from
Sigma-Aldrich (Oakville, ON, Canada), and the Florisil® support was supplied by Merck (Darmstadt,
Germany). The Cs+ aqueous solutions were prepared by adequate dilution of stock solution of 1000
mg/L (Merck standard solution). In all experiments distilled water was used.
3.2. Preparation and Characterization of the Florisil® Impregnated with IL
The IL was dissolved in acetone (analytical reagent provided by SC Chemical Company SA
(Bucuresti, Romania) in a ratio of 0.1 g of IL in 5 mL of acetone. The Florisil® was impregnated with
the desired quantity of IL via the dry impregnation method [40]. The EDX analysis of the Florisil®
impregnated with IL was investigated by Scanning Electron Microscopy (SEM) using a Quanta FEG
250 instrument (EDAX Inc., Mahwah, NJ, USA), equipped with an Energy Dispersive X-ray quantifier
(EDAX ZAF) (EDAX Inc., Mahwah, NJ, USA). The FTIR spectra (KBr pellets) of the studied materials
were recorded on a Shimadzu Prestige-21 FTIR spectrophotometer (SHIMADEZU, Tokio, Japan) in the
range 4000–400 cm-1.
3.3. Adsorption Experiments
The Cs+ adsorption from aqueous solutions onto Florisil® impregnated with IL was realised using
batch studies. For the batch studies a Julabo SW23 shaker (JULABO Labortechnik GmbH, Sellbach,
Germany) with a constant shaking rate was used. To determine the optimum pH the initial pH of the
Cs+ solutions was adjusted in the 2–12 range using 0.1 N NaOH or 0.1 N HCl, using a S:L ratio of 0.1 g
in 0.025 L Cs+ solution, keeping the samples under stirring for 2 h. Adsorption isotherms were studied
by mixing a known amount of Florisil® impregnated with IL with various intial Cs+ concentrations
ranging from 5 to 50 mg/L at 298 K and pH = 8. The experimental data obtained were tested with
Langmuir and Freundlich isotherms. The effect of contact time was studied varying the time from 30
to 240 min at three temperatures (298 K, 308 K and 318 K). Cs+ concentration was determined through
atomic emission spectrometry using a Varian SpectrAA 280 type atomic absorption spectrometer
(Varian medical systems, Inc., Melbourne, Australia) using an air/acetylene flame. The Cs+ uptake was
determined using the corresponding mass balance.
4. Conclusions
In this work the adsorption properties of Florisil® impregnated with Cyphos Il-101 in the
process of Cs+ removal from aqueous solutions have been studied. The experiments showed that
the adsorption depended on the pH, the maximum desorption capacity being achieved at an initial
solution pH of 8. This conclusion is in accordance with the results obtained from the FTIR analysis
where was observed that the Cs+ ions was retained as hydroxo complexes, which are stable at neutral
pH values. The equilibrium data were fitted with the Langmuir and Freundlich isotherm, the best
correlaion being obtained by the Langmuir one. The maximum sorption capacity obtained with
the Florisil®impregnated with Cyphos IL-101 is 3.086 mg Cs+/g of adsorbent. The kinetic studies
revealed that the process of Cs+ adsorption onto Florisil® impregnated with the studied IL followed the
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pseudo-second order kinetic model, suggesting the chemisorptions profile of the adsorption process.
The proposed method for Cs+ removal from aqueous solutions, by using as adsorbent the Florisil®
impregnated with Cyphos IL-101, is an efficient one, because it combines the advantages of the ionic
liquids with those of the solid support. In this way a smaller amount of the ionic liquid is used for
the removal of Cs+ from aqueous solutions than in the case of liquid-liquid extraction techniques and
there is no risk of loss of the extractant in the aqueous phase. The combined results showed that the
obtained new impregnated material represents an efficient adsorbent in the process of Cs+ ion removal
from aqueous solutions compared with other materials studied in the literature. The experimental
results can be easily used to scale up the studies from the laboratory scale.
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Abstract: The chemical synthesis of DNA and RNA is universally carried out using nucleoside
phosphoramidites or H-phosphonates as synthons. This review focuses on the phosphorus chemistry
behind these synthons and how it has been developed to generate procedures whereby yields per
condensation approach 100% with very few side products. Additionally the synthesis and properties
of certain DNA and RNA analogs that are modified at phosphorus will also be discussed. These
analogs include boranephosphonates, metallophosphonates, and alkylboranephosphines.
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1. Introduction
The ability to chemically synthesize 2’-deoxyoligonucleotides and oligoribonucleotides
(oligonucleotides) in high yield and purity has revolutionized biochemical research as well as enabled
a large number of other technologies such as DNA/RNA based therapeutics, DNA forensics, and
high-throughput sequencing. The chemical structure of DNA/RNA consists of purines and pyrimidines
attached to 2’-deoxyribose or ribose sugars. These 2’-deoxyribonucleosides or ribonucleosides are
then joined via phosphodiester linkages. Thus phosphorus chemistry is central to the development of
synthetic methods for preparing these important biological molecules and for achieving the high yield,
high-throughput synthesis of oligonucleotides.
In this review we will focus on one aspect of organophosphorus chemistry, namely the reactivity
of P (III) centers that enables the synthesis of DNA/RNA. We will describe these developments by first
reviewing the work of Robert Letsinger and co-workers as their research led to the phosphoramidite
approach in our laboratory. We will also discuss the H-phosphonate methodology that is an alternative
P (III) chemistry for the synthesis of oligonucleotides. Both approaches have been used to prepare a
plethora of nucleic acid analogs modified at phosphorus. This is a vast field of research in itself and a
comprehensive description of all the different derivatives is outside the scope of this review. We will
instead discuss a recent and promising class of analogs in which a P (III) center is bonded to a Lewis
acid such as borane and forms stable internucleotide linkages.
2. Synthesis of DNA Using Chlorophosphites and Tetrazoylphosphites
Development of the phosphoramidite method of DNA synthesis was based upon two observations.
One was that chloro- and dichlorophosphites react rapidly with the 3’-hydroxyl group of a
2’-deoxynucleoside, whereas the corresponding phosphorochloridates require several hours at room
temperature [1]. Yields were also much higher with chloro and dichlorophosphites. Thus the possibility
existed that DNA could be prepared rapidly and in high yield from activated phosphites. The other
observation was that Robert Letsinger’s laboratory had used dichlorophosphites to synthesize a
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2’-deoxythymidine pentanucleotide. Stepwise yields for addition of each mononucleotide were
69–82%. Most encouraging was the observation that reaction times were only 5 min in comparison to
hours for earlier approaches.
These observations led us to explore the use of 2’-deoxynucleoside P (III) derivatives for
synthesizing 2’-deoxyoligonucleotides on polymeric supports [2,3]. For several reasons, our research
was predicated on the use of HPLC-grade silica (also known as controlled pore glass (CPG)) as a
support. One was that all previous research utilizing organic polymers, such as polystyrene, to
synthesize DNA [4] had failed in part because organic supports readily adsorbed the synthons and
other reagents. Thus removal of these materials after each condensation step was difficult. This
problem, when coupled with the knowledge that HPLC-grade silica had been designed for efficient
mass transfer, dictated its investigation. Our expectation was that both solvents and reagents could be
removed rapidly and completely from the matrix. This was observed in our early work. Silica was
also expected to be chemically inert towards all the reagents we contemplated using and was a rigid,
non-swelling matrix in common organic solvents. Therefore, it could be packed into a column and
reactants merely pumped through the column.
The initial approach we developed is outlined in Scheme 1. The first step was activating the
silica matrix by attaching (3-aminopropyl)triethoxysilane to silica and then treating the product
of this reaction with succinic anhydride in order to generate 1. The next step was condensing
5’-dimethoxytrityl-2’-deoxythymidine to the support using dicyclohexylcarbodiimide (DCC) to activate
the carboxylic acid. After removal of the 5’-dimethoxytrityl group with ZnBr2 to yield 2, condensation
with a 2’-deoxynucleoside 3’-phosphite 3 was carried out. Of the synthons we examined, the most
reactive while generating the fewest side-products, were the 5’-dimethoxytrityl 3’-methyltetrazoyl
phosphites. Using these synthons, 95% yields per condensation were observed during synthesis. After
oxidation of the phosphite to phosphate with aqueous iodine, capping with diethoxytriazolephosphine
to remove any unreacted intermediates, and removal of the dimethoxytrityl group with ZnBr2, the
product 4 of this reaction sequence could be extended by repetitive use of this cycle in order to generate
a 2’-deoxyoligonucleotide. Finally after completion of oligonucleotide synthesis, methyl groups were
removed from phosphates using thiophenol. This oligomer was then cleaved from the support and
base protecting groups (N-isobutyrylguanine, N-benzoylcytosine and N-benzoyladenine) removed
with ammonium hydroxide. By measuring the amount of dimethoxytrityl cation released following
synthesis of a 12 mer, the overall yield was determined to be 55%, which was unprecedented at that
time in the nucleic acid field.
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Scheme 1. DNA Synthesis on HPLC Silica.
During the course of this work, we also developed a semiautomatic machine where one cycle of
synthesis on a silica column, including the use of all reagents and solvents, could be programmed
and completed automatically. The operator then just added the next appropriately protected
2’-deoxy-nucleoside-3’-phosphite to the column and initiated another synthesis cycle. Although
more successful than any previous method, it was still far from acceptable. The main problem was
that the 2’-deoxy-nucleoside 3’-tetrazoylphosphites had to be prepared at −78 ◦C and preferably used
the same day. The most significant outcome from this research that continues to the present, was the
successful development of silica as a matrix for DNA synthesis.
3. The Phosphoramidite Approach for Synthesis of DNA and RNA
Our discovery of phosphoramidites as synthons was initiated with a study aimed at
activating aminophosphines. The strategy was to activate 5’-dimethoxytrityl 2’-deoxynucleoside
3’-amino-phosphines via insertion of CO2, CS2 or COS to form mixed anhydrides [5,6]
that we posited would condense with a 2’-deoxynucleoside. In our hands, this strategy
was not successful. However during the attempted synthesis of the aminophosphines by
reacting 5’-O-dimethoxytrityl-2’-deoxythymidine with N,N-dimethylaminomethoxychlorophosphine
in pyridine, we observed the appearance of a new dimethoxytrityl positive spot on TLC (thin-layer
chromatography) that moved similar to a dinucleotide. Based upon the previous literature on the
acid activation of aminophosphines [7], we reasoned that the initial product, 5’-dimethoxytrityl
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2’-deoxythymidine 3’-N,N-dimethylamino-methoxyphosphine (a phosphoramidite), was activated by
pyridine hydrochloride that was produced in situ during the reaction. The protonated 5’-dimethoxytrityl
2’-deoxythymidine 3’-O-methoxy-N,N-dimethylammonium phosphine would then react with the
free 3’-hydroxyl of excess 5’-dimethoxytrityl 2’-deoxythymidine present in the reaction mixture to
form bis(5’-dimethoxytrityl 2’-deoxythymidine 3’-O) methylphosphite. Subsequently by repeating this
reaction in the presence of a stronger base (Hunig’s base) in the reaction mixture in order to remove
the acid produced, we were able to isolate the desired phosphoramidites. This allowed us to confirm
that phosphoramidites could indeed be activated with ease towards nucleophilic substitution using a
number of weak acids. We then proceeded to combine this discovery with the use of CPG as a solid
support to develop a high yielding method for oligonucleotide synthesis that has remained essentially
unmodified since our original report [8].
The synthesis of DNA and RNA using the phosphoramidite approach is depicted in
Scheme 2. The synthetic cycle begins with the removal of 5’-DMTr from 5 by treatment
with a solution of 3% trichloroacetic acid in dichloromethane to yield 2. Condensation of a
5’-dimethoxytrityl-2’-deoxynucleoside 3’-phosphoramidite 6 with 2 is then completed using tetrazole
as an activator to produce the phosphite triester 7. The most commonly used phosphoramidites
contain a diisopropyl-amino group. The steric bulk of this group was found to provide an ideal balance
between stability during preparation of these synthons and ease of activation [9]. Although many
activators have been proposed, tetrazole remains a popular choice as it can be obtained as a solid by
sublimation and kept stably as an anhydrous solution on the DNA synthesis machine for long periods
of time.
 
Scheme 2. The Phosphoramidite Approach for Oligonucleotide Synthesis.
The next step is capping of unreacted 5’-hydroxyl groups using acetic anhydride activated by
N-methylimidazole in pyridine (Step C). This is important as it prevents any unreacted oligonucleotides
from continuing to grow. Failing to do this leads to a final product mixture whereby the major
oligonucleotide impurities are hard to remove because they are shorter by only a few nucleotides. For
the synthesis of DNA (≥150 mers) on glass chips using inkjet printers, the capping step was found
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to be unnecessary [10]. This likely resulted from surface effects that allow even better condensation
yields than possible with traditional CPG supports. The final step is oxidation of the phosphite
triester to phosphate 9 using aqueous iodine. The entire sequence can then be repeated iteratively
to obtain the desired oligomer. For the synthesis of various analogs such as phosphorothioates and
phosphoramidates, oxidation can alternatively be carried out using a sulfurizing agent or iodine and
amines respectively.
At this stage, the oligomer can be hydrolyzed from the support using an aqueous solution of
ammonia which also removes the amide groups used to protect the exocylic amines of cytosine, guanine
and adenine as well as the cyanoethyl protection [11] on phosphate. The oligomers can then be purified
by reverse phase HPLC or gel electrophoresis.
During an exploration of various phosphorus protecting groups, we observed that o-methylbenzyl
was removed during the iodine oxidation step [12]. Moreover a deoxyoligonucleotide 20 in length,
as prepared with this protecting group, gave a very high yield of a homogeneous product. At the
same time, van Boom and co-workers published similar results with the 2-cyano-1,1-dimethylethyl
phosphorus protecting group [13]. These observations led us to propose that alkyl deoxynucleoside
phosphites (10a–c, Scheme 3), having alkyl groups that stabilize the SN1 character of the second stage
of an Arbuzov reaction, upon reaction with most electrophiles, would lead to elimination of the
alkyl protecting group with concomitant formation of the phosphoryl bond. Thus upon oxidation
with iodine (the electrophile), the tertiary alkyl protecting group would be eliminated and generate
the phosphoroiodate. Nucleophilic substitution of iodine would yield various desired compounds.
For example if the reaction were performed in aqueous iodine, the product would be the natural,
internucleotide phosphate diester linkage (compound 13, R6 = H). If however oxidation were to take
place under anhydrous conditions in the presence of amines, azides or alcohols then the appropriate
phosphoramidates 11, phosphoroazoamidates 12, or phosphate triesters 13 (R6 = alkyl or aryl) would be
the final products. In contrast if these phosphites were oxidized with tert-butylhydroperoxide or sulfur,
the product was the dinucleotide phosphate triester or thiophosphate triester respectively. Removal of
the 2-cyano-1,1-dimethylethyl protecting group with base would then generate the phosphate diester
or phosphorothioate diester. Thus this approach, depending upon oxidation conditions for each
synthesis cycle, can be used to introduce different analogs selectively throughout an oligonucleotide.
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Scheme 3. (a–c): R1 = 4,4’-dimethoxytrityl, R2 = 3’-acetylthymidylyl; a: R3 = 2-cyano-1,1-dimethylethyl,
R4 = n-butyl; b: R2 = 3’-acetylthymidylyl, R5 = 3-(N-ethylcarbazoyl), R3 = o-methylbenzyl; c: R2 =
methyl, R3 = 2-cyano-1,1-dimethylethyl, R6 = H, alkyl, or aryl.
4. The H-Phosphonate Approach for Synthesis of DNA and RNA
H-Phosphonates are a distinct category of tervalent P (III) compounds that contain a phosphoryl
group (P=O) and a hydrogen atom bonded to the phosphorous center (e.g., 18). H-Phosphonates have
a tetrahedral geometry that is similar to P (V) compounds. The phosphorus atom in H-phosphonates
is electrophillic and lacks a lone pair of electrons. Therefore it is much more resistant towards
oxidation under ambient conditions than most P (III) compounds. At the same time, upon activation,
H-Phosphonate monoesters can be induced to undergo nucleophillic substitutions efficiently. This
combination of properties has made them attractive synthons for preparing oligonucleotides.
H-Phosphonates were first used in nucleotide chemistry by Sir Alexander Todd [14,15].
They demonstrated that treatment of benzyl H-phosphonate monoester 16 with diphenyl
phosphorochloridate (Scheme 4) led to the putative formation of the corresponding activated mixed
anhydride 17. This compound was reacted in situ with the 5’-hydroxyl of a 2’,3’-isopropylidine
nucleoside to produce the H-phosphonate diester 18 that was in turn oxidized by N-chlorosuccinimide
to the phosphorochloridate diester 19. They later adapted this methodology for the first chemical
synthesis of a natural 5’-3’ linked dinucleotide [16]. Ogilvie and Nemer in 1980 [17] as well as
Kume et al. in 1984 [18] next demonstrated the synthesis of dinucleotides containing H-phosphonate
internucleotide linkages. However the use of H-phosphonates as synthons for oligonucleotide
synthesis was not developed till three decades after Todd’s initial reports, when Garegg et al. [19]
and later Froehler and Matteucci [20] described the synthesis of 2’-deoxynucleoside H-phosphonate
diesters by activating 2’-deoxynucleoside H-phosphonate monoesters with several reagents such as
2,4,6-tri- isopropylbenzenesulfonylchloride, N,N-bis(2-oxo-3-oxazolidinyl)-phosphorodiamide chloride,
diphenyl-chlorophosphate and pivaloyl chloride.
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Scheme 4. Mixed Anhydride Activation of H-Phosphonates.
Froehler et al. [21] and Garegg et al. [22,23] next demonstrated the use of this method for the solid
phase synthesis of oligonucleotides using 2’-deoxy and ribonucleoside H-phosphonate monoesters
as synthons. The general method is shown in Scheme 5A. Following acid-mediated removal of the
5’-dimethoxytrityl protecting group, condensation is carried out by addition of an appropriately
protected 2’-deoxy or ribonucleoside H-phosphonate monoester 20 and an activating agent—typically
pivaloyl chloride or adamantoyl chloride. Reaction of the acid chloride with the H-phosphonate
monoester produces the corresponding mixed phosphonocarboxylic anhydride. This mixed anhydride
undergoes a nucleophilic attack at the phosphorous by the 5’- hydroxyl of the nucleoside joined to a
polymer support. The product of this reaction is the H-phosphonate diester 21. Unlike the phosphite
triester 7, this linkage is stable to the acidic conditions (3% trichloroacetic acid in dichloromethane)
required for removal of the 5’-dimethoxytrityl group. Thus it is unnecessary to carry out oxidation
at every cycle. Chain elongation therefore consists of two steps. Oxidation to the phosphodiester
with aqueous iodine is completed following oligonucleotide synthesis. Alternatively oxidation can be
carried out under non-aqueous conditions using various reagents which has enabled the synthesis of a
number of modified oligonucleotides such as phosphoramidates [24], phosphorothioates [25], and
phosphoro-selenoates [26]. After the oxidation step, aqueous ammonia is used to remove nucleobase
amide protecting groups and to cleave the oligonucleotide from the support.
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Scheme 5. The H-Phosphonate Approach to DNA/RNA Synthesis.
The H-phosphonate method is particularly well suited for RNA synthesis as some of the
problems associated with this approach, such as double activation and phosphorus acylation, are
ameliorated when using ribonucleosides having a 2’-protecting group [27]. Coupling of ribonucleoside
H-phosphonates on a solid support when compared to coupling ribonucleoside phosphoramidites is
less sensitive to steric effects that arise due to the 2’-protecting group. RNA molecules up to 50 to 60
nucleotides in length can be made in high yields by this method.
An additional attraction of this chemistry for synthesis of certain DNA or RNA derivatives stems
from the fact that the H-phosphonate diester exists in equilibrium with its phosphite form (Scheme 5B).
Ordinarily the H-phosphonate is more stable and the predominant species. However silylation can be
used to trap the phosphite triester form 23, which creates a nucleophilic phosphorus center having a
lone pair of electrons. This phosphite triester can then be treated with electrophiles to allow synthesis of
various phosphorus analogs. As the silylation procedure can be performed at the end of the synthetic
cycles, repetitive exposure of the desired derivative to the acidic deprotection solution is avoided.
This is an important advantage when preparing acid sensitive analogs. However a limitation of this
protocol is that only uniformly modified oligomers can be produced. H-Phosphonate diesters also
have stable stereochemical configurations and undergo oxidation or conversion to phosphite triesters
(as in Scheme 5B) in a stereospecific manner [28]. This has been exploited as a method for the synthesis
of stereodefined DNA derivatives.
H-Phosphonates offer a useful alternative to the phosphoramidite method particularly for the
synthesis of RNA and acid labile oligonucleotide analogs. Although phosphoramidites continue to be
much more widely adopted because of higher stepwise yields and fewer side-products, it should be
noted that at present H-phosphonates are the only other commercially available DNA/RNA synthons.
It is expected that H-phosphonate chemistry will continue to be useful for the preparation of certain
novel DNA derivatives.
5. DNA Containing Stable Complexes of P (III) with Lewis Acids
The presence of a lone pair of electrons on the phosphorous atom in P (III) compounds allows it
to form stable complexes with Lewis acids. Such complexation stabilizes the phosphorous towards
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oxidation or attack by electrophiles. Barbara Ramsay Shaw and co-workers were the first to exploit this
bonding scheme in their synthesis of 2’-deoxythymidylyl-(3’-5’)-2’-deoxythymidine which contained
a hydrolytically stable boranephosphonate (also referred to as boranophosphate in the literature)
linkage 24 (Figure 1) [29,30]. These compounds are conventionally described as having one of the
non-bridging phosphate oxygens replaced by borane (compound 24a). This depiction emphasizes
that the stability of these compounds is similar to phosphate diesters. On the other hand this linkage
can also be described as a P (III) compound complexed with a borane group (compound 24b). This
representation ties these analogs to a wider category of similar compounds and helps to illustrate
the fact that bonding of this type can be a general approach to creating varied backbone structures
with engineered properties. For example we have reported that methyphosphine diesters complexed
with borane (compound 25) [31] yield a stable structure that is neutral as opposed to the negatively
charged boranephosphonate. Oligomers containing these neutral linkages demonstrate enhanced
cellular uptake. This approach can be extended to include a number of substituents including amines
(compound 26) and acetate (vide infra) with each having unique and tailored properties. In addition to
borane, other Lewis acids can also be used as demonstrated by the synthesis of dinucleotides containing
a P (III) center complexed to pentacarbonyltungstate(-1) and pentacarbonyl-molybdate(-1) (27) [32,33].
These metallophosphonate derivatives should prove to be useful molecules for the construction of
DNA based circuits and metallic nanostructures. Because extensive research on the chemical and
biochemical properties of boranephosphonate DNA and RNA (bpDNA or bpRNA) has already been
completed, the primary emphasis in the following section is on bpDNA with only brief mention of the
synthetic methods used to prepare the other analogs shown in Figure 1.
 
Figure 1. Lewis Acid—Phosphorous Analogs of DNA.
Although the first report of dithymidine having a boranephosphonate diester linkage was
published more than twenty years ago, the lack of high yielding chemical methods till recently has
severely limited the applicability of these molecules. However in the interim, the Ramsay-Shaw
laboratory developed an elegant enzymatic method for synthesizing bpDNA and bpRNA. Their
procedure used 2’-deoxynucleoside or ribonucleoside triphosphates that contained a borane moiety
at the α phosphorous. When these triphosphates were used with certain polymerases and an
appropriate primer/template, bpDNA or bpRNA could readily be prepared [34–37]. Enzymatically
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synthesized bpDNA (or bpRNA) enabled early studies that were important in demonstrating the
biochemical potential of boranephosphonate oligonucleotides. Unfortunately enzymatic synthesis
was not only expensive and low yielding but, because only one of the dNTPs could be replaced
by its corresponding borane derivative during any one synthesis, the flexibility of positioning and
density of boranephosphonate linkages within an oligomer was severely restricted. However it should
be noted that an advantage of enzymatic synthesis was that polymerases recognize only one of the
two enantiomers of α-P-borano dNTPs. Thus diastereomerically pure oligomers were produced by
enzymatic synthesis whereas chemical methods generate mixtures of diastereomers.
Conceptually, the chemical synthesis of boranephosphonates simply requires substituting
oxidation in the synthesis cycle with boronation. Chemically this means that a BH3 group is
exchanged between a labile borane complex (such as THF-borane) and the phosphite triester (e.g.,
7, Scheme 2). However in practice two problems must be addressed. First, BH3 reduces the amide
protecting groups that are conventionally used with the exocylic amines of cytosine, adenine and
guanine. The resulting alkyl amines cannot be removed and therefore represent an undesirable DNA
modification. Additionally the trityl cation, which is generated during deprotection of the 5’-hydroxyl,
reacts with the phosphite-borane linkage and causes degradation.
The earliest chemical synthesis of boranephosphonate oligomers yielded 2’-deoxyoligothymidines
via the H-phosphonate approach (Scheme 6) [38–40]. Following synthesis of an oligonucleotide,
the H-phosphonate linkages were silylated and the resulting phosphite triesters were boronated to
obtain the phosphite triester-borane linkage. The silyl groups were then removed with NH3 which
generated boranephosphonate-linked 2’-deoxyoligothymidines 28. Using this approach, 10–14 mers
were successfully prepared in high yields. As this approach has the advantage of not exposing the P
(III)-Lewis Acid complex to multiple rounds of strong acids, it was found to be well suited for preparing
metallo phosphonate dinucleotides as well (compound 29) [33]. In place of borane the silyltriester was
treated with pentacarbonyltungstate or pentacarbonylmolybdate.
 
Scheme 6. H-Phosphonate method for synthesis of boranephosphonate DNA and metallophosphonate
DNA. (Reagents: (i). N,O-bistrimethylsilylacetamide/DMF, (iia). BH3.THF or BH3.SMe2, (iib).
M(CO)5.THF, (iii). aq. NH3.)
In order to prepare boranephosphonate linked oligomers containing all four
nucleobases, Wada has developed the phosphotriester approach [41,42]. In this
method a pre-boronated phosphitylating agent (triethylammonium bis(2-cyanoethyl)
boranophosphate) was coupled to a 5’-dimethoxytrityl-2’-deoxynucleoside to yield
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5’-dimethoxytrityl-3’-boranephosphonate-2’-deoxynucleoside diester. Coupling of this synthon to a
2’-deoxynucleoside attached to a support through the 3’-hydroxyl was carried out using 3-nitro-1, 2,
4-triazol-1-yl-tris(pyrrolidin-1-yl)phosphonium hexafluorophosphate as an activator. Triethylsilane
was added during acid deprotection in order to scavenge trityl cations. The low step-wise coupling
yields however limited the utility of this approach.
We have reported an alternative method, adapted from RNA synthesis, that uses
5’-O-silyl 2’-deoxynucleosides 3’-phosphoramidites containing N-trimethoxytrityl (TMTr)-protected
nucleobases [43]. These protecting groups were found to be stable toward reduction by borane. Thus
boronation could be performed after each coupling step to obtain the phosphite triester-borane linkage.
Removal of the TMTr groups at the end of the synthesis using aqueous acetic acid did not lead to trityl
cation induced degradation of the boranephosphite triester linkages. Mixed base 14mer oligonucleotides
containing phosphodiester and boranephosphonate diester linkages could be synthesized in good
yields. The same strategy was also useful for the preparation of oligomers containing up to
six methylphosphineborane modifications within a 16-mer 2’-deoxyoligonucleotide [31]. For
borane-phosphonates as well as methylphosphineboranes, attempts to synthesize longer oligomers
however led to many degradation products. These results were perhaps due to the instability of these
linkages towards iterative treatment with basic fluoride solutions that were required for removal of
5’-silyl protection. In addition DNA synthesizers had to be equipped to handle basic fluoride. This
component of the synthesis procedure therefore limited the broad adoption of the methodology.
To circumvent these obstacles we have recently developed N-silyl protected
5’-dimethoxytrityl-2’-deoxynucleoside 3’-phosphoramidites (30a–c; Scheme 7) [44]. This silyl
group (di-tert-butylisobutylsilyl) is stable towards boronation as well as all other reagents used in
DNA synthesis. These synthons in conjunction with the use of a more efficient trityl scavenger
(trimethylphosphite borane; TMPB) allowed us to prepare 24–30 mer bpDNA oligomers in yields
similar to those obtained for standard phosphate linked DNA. Moreover these conditions allow
synthesis of bpDNA essentially using the same cycle as described in Figure 2 for standard DNA
synthesis. The only modification involves replacement of the iodine oxidation reaction with boronation
(Step 3). This leads to conversion of the phosphite triester 31 to a trialkylphosphite-borane derivative
33. If desired, oxidation of 31 with tert-butylhydroperoxide can be performed in order to produce
the phosphate triester 32. Thus oligonucleotides having any desired combination of phosphate and
boranephosphonate linkages can be synthesized by this procedure.
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Scheme 7. N-Silyl Protected Phosphoramidites as Synthons for bpDNA.
A future goal is to prepare stereoregular bpDNA and bpRNA oligomers using chemical methods.
Such oligomers as demonstrated by the Ramsay-Shaw lab using enzymatically synthesized bpDNA
or bpRNA have superior biochemical properties when compared to the diastereomeric mixtures that
are currently obtained through chemical synthesis. In this respect a noteworthy report by Iwamoto et
al. [45] achieved the stereoregular synthesis of boranephosphonate 2’-deoxyoligothymidines using
3’-O-oxazaphospholidine derivatives of 2’-deoxythymidine. A pure stereoisomer of this synthon
(compound 34), when activated, generates stereodefined phosphite triesters 35 that can be converted
to boranephosphonates 37 or 38 in a stereospecific manner via an H-phosphonate intermediate 36
(Scheme 8). Taken together these advances raise the possibility of mixed based, stereoregular synthesis
of boranephosphonate linked DNA.
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Scheme 8. Synthesis of stereodefined boranephosphonate linked DNA. (Reagents and Conditions: (i).
1% Trifluoroacetic acid in CH2Cl2. (ii). BH3.SMe2/N,O-bistrimethylsilylacetamide/DMF (1:1:8, v/v/v),
RT, 15 min; then sat. NH3/CH3OH, RT, 1 h.).
Boranephosphonate diesters posses many properties that are intermediate between P (III) and P
(V) compounds. For example they have a 31P-NMR chemical shift of 94 ppm, which lies between 140
ppm for phosphite triesters and 0 ppm for phosphates. These compounds are stable to mild acids (pH >
2) and oxidizing agents (e.g., tert-butylhydroperoxide) but react with stronger acids or oxidizers such as
iodine [46]. The significantly greater stability of borane-P (III) complexes, relative to analogous nitrogen
complexes, stems from the fact that, in addition to donation of the lone pair from the P atom, back
donation from the σ obital of the BH3 group to empty orbitals on the P atom also occurs. The reduced
hydridic character of BH3 is indirect evidence for this explanation. Substituents on phosphorous also
affect the strength of the backbonding interaction [47] and thus the overall stability of the P-B bond.
Unpublished experiments from our laboratory demonstrate that replacement of the non-bridging
oxygen in boranephosphonate diesters by the less electronegative methyl group significantly increases
the hydridic properties of the BH3 group. Systematic evaluation of such factors in the future has the
potential to create new DNA derivatives with desired chemical and biochemical properties.
The biochemical properties of boranephosphonate linked nucleic acid oligomers have been
investigated. They are stable towards hydrolysis by nucleases [36], are effective substrates for RNaseH
and siRNA [48], and are more lipophilic than unmodified DNA. Current work in our laboratory has
also revealed that these oligomers can be transfected into HeLa cells in the absence of lipid.
We have recently reported that bpDNA reacts with metal ions that possess a high reduction
potential (Ag+, Au3+ and Pt2+) [49]. The products of these reductions are metallic nanoparticles.
Investigations of this reaction further revealed that the boranephosphonate linkage is converted into a
phosphate diester when carried out in water or to a phosphate triester in simple alcohols. We have
taken advantage of this combination of reducing properties and an ability to undergo Watson-Crick
base pairing to incorporate bpDNA at specific locations within DNA assemblies. This in turn allowed
us to carry out deposition of metal nanoparticles onto these assemblies with high spatial resolution [44].
6. Conclusions
Chemical methods that allow synthesis of DNA/RNA and various derivatives have had tremendous
effects on a large number of disciplines. At the heart of all these developments are fundamental
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discoveries in the chemistry of phosphorous. In particular the reactivity of P (III) compounds led to
phosphoramidites as extremely stable, but easily activated synthons for condensation with various
nucleophiles to generate DNA or RNA in very high yields. This discovery was a significant milestone,
initially in the nucleic acids field, but more recently in other research areas as well. Chemists have
also taken advantage of the versatility of phosphorous chemistry in order to create a large number of
oligonucleotide derivatives. The majority of these analogs have been developed for use as therapeutics
and several such candidates are in advanced clinical trials. In addition DNA derivatives that can
combine the binding properties of oligonucleotides with chemically useful functionality are beginning
to find applications in new research areas such as nanotechnology and data storage.
The ability to chemically synthesize DNA that is several hundred nucleotides in length is another
challenge that awaits chemists. While current methods lead to the synthesis of DNA 20–30 nucleotides
in length and more recently to oligomers 150 in length [10] in very high yields and purity, extension to
ultra long regimes raises many issues. Thus the field is ripe once again for fresh developments in the
chemistry of phosphorous that will allow realization of these goals.
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Abstract: The underinvestigated derivatives of unstable phosphorylated formaldehyde
acetals and some of the structurally related compounds, such as thioacetals, aminonitriles,
aminomethylphosphinoyl compounds, are considered. Separately considered are halogen aminals of
phosphorylated formaldehyde, acetals of phosphorylated formaldehyde of H-phosphinate-type and
a phosphorylated gem-diol of formaldehyde. Synthetic methods, chemical properties and examples
of practical applications are given.
Keywords: phosphorylated acetals; -thioacetals; -aminonitriles; -aminomethylphosphinoyl
compounds; -chloro(or bromo)aminals; -gem-dioles; -ketene acetale; H-phosphinate
1. Introduction
Among organophosphorus compounds, α-phosphorylated carbonyl compounds stand out by
the capacity of cleavage of phosphorus–carbon bond under mild conditions when reacted with
nucleophiles [1–5]. The cleavage of phosphorus–carbon bond may proceed spontaneously as well.
At the same time, α-oxoalkylphosphinoyl compounds also retain properties inherent in carbonyl
compounds, for example, they undergo cross aldol condensation.
The least stable compounds among them are phosphorylated formaldehyde derivatives, dialkyl
formylphosphonates (1) [6–11] and N,N,N′,N′-tetraalkyl formylphosphondiamides (2) [12] (Figure 1),
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Figure 1. Structures of dialkyl formylphosphonates (1) and N,N,N′,N′-tetraalkyl
formylphosphondiamides (2).
However, the first synthesis of 1 by reaction of sodium derivatives of dialkyl phosphites with
acetic formic anhydride was described in 1974 [15]. Compounds 1 were shown to be unstable and
prone to spontaneous degradation [9,10,16,17]; thus, diethyl formylphosphonate (3) prepared by the
reaction of triethyl phosphite (4) with acetic formic anhydride (5) at low temperature begins to undergo
decarbonylation even at −10 ◦C [9,10] to give diethyl phosphite (6) (Scheme 1).
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Scheme 1. Syntheses and destruction of diethyl formylphosphonate (3).
N,N,N′,N′-Tetraisopropylformylphosphondiamide (7) obtained by saponification of N,N,N′,N′-
tetraisopropyl[(N”,N”-diisopropylamino)methylydeniminium]phosphondiamide dichlorophosphate
(8) with potassium hydroxide in tetrahydrofuran at 20 ◦C proved to be slightly more stable; it
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Scheme 2. Syntheses and destruction of N,N,N′,N′-tetraisopropyl formylphosphondiamide (7).
The stability of the formylphosphondiamide 7 allowed the study some of its chemical
properties. It was shown that in its reactions with methylene(triphenyl)phosphorane (Ph3P=CH2) and
2,4-dinitrophenylhydrazine (NH2NH-DNP) 7 behaves as a typical aldehyde, yielding the corresponding






















H THF, 20 oCTHF, 20oC
710 11  
THF, 20 °C THF, 20 °C 
Scheme 3. Reactions N,N,N′,N′-tetraisopropylformylphosphondiamide (7) as an aldehyde (DNP
means a 2,4-dinitrophenyl moiety).
However, many authors showed that formylphosphinoyl compounds are also stable in the
form of formylphosphonic acid (12) [12,14,15], its disodium salt [15], aldehyde group derivatives
such as acetals 13 [18–20] and structurally related compounds. These compounds are thioacetals
14 [21–23], aminonitriles 15 [24–26], diphosphinoyl (N,N-dialkylaminomethyl)methanes 16 [27–29],
chloro(or bromo)aminals 17 [30–34], mixed S,O-thioacetals 18 [35–37], aminals 19 [30,38], aminoacetals
20 [31,32,38,39], aminothioacetals 21 [32], chloroacetals 22 [40,41], chloro- (or bromo-) thioacetals
23 [40,42,43], α-chlorosulfinyl derivatives 24 [44,45], α-alkoxynitriles 25 [46–48], α-thionitriles 26 [46],
α-dihalo derivatives 27 [49–51], α-alkoxydiphosphoryl compounds 28 [41], α-mercaptodiphosphoryl
compounds 29 [40,52,53], α-alkoxysilyl derivatives 30 [54], α-aminosilyl derivatives 31 [29,55], or








Figure 2. Molecular structure of phosphorylated formaldehyde acetals (13) and related compounds
(14–32), where R = OAlk, Alk2N, Ph; X, Y are the combinations of OAlk, Alk2N, CN, (AlkO)2P(O),
S(Alk, Ar), S(O)(Alk, Ar), N(H)C(O)Alk, C(O)Ar, N(H)S(O)2Alk, S(O)2Ar, Hal, Me3Si [18–56].
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Among these compounds, phosphorylated acetals 13, thioacetals 14, α-dimethylaminonitriles 15,
aminodiphosphinoyl compounds 16 and chloro- (or bromo-) aminals 17 are used in contemporary
organic synthesis. Nonetheless, the phosphorylated acetals of formaldehyde and structurally
related compounds remain poorly studied types of organophosphorus compounds until now.
The chemical properties of this type of compounds were most studied on an example of
dialkyl(dialkoxymethyl)phosphonates 33. The properties of other compounds 18–32 have been
studied in much less detail, and the majority of them are examined in one-sided manner, only as
precursors for the synthesis of ketene acetals and similar compounds by the Horner reaction.
To date, it is known that—except for formylphosphonic acid (12), phosphorylated acetals
13, and similar compounds 14–32—the phosphorylated formaldehyde derivatives are stable in
the form of H-phosphinate acetals: alkyl (diethoxymethyl)phosphinate 34 [57–59], and geminal













34       35
R = OEt, Ph  
Figure 3. Molecular structure of alkyl (diethoxymethyl)phosphinate 34 and phosphorylated
formaldehyde hydrates 35.
Noteworthy are nitrogen-containing analogs of phosphorylated formaldehyde: N-substituted
imines (36) [16,63,64], N-alkylnitrones 37 [8,65,66], phosphorylated diazomethane (38 [67–69] and
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Figure 4. Molecular structures of formylphosphonates of N-substituted imines 36, N-alkylnitrones 37,
phosphorylated diazomethane 38 and alkylated oximes 39.
However, the properties of compounds 36–39 differ significantly from those of compounds 13–32.
Therefore, compounds 36–39 will be considered in a separate publication.
2. Chemistry of Phosphorylated Formaldehyde Derivatives
2.1. Syntheses and Chemical Properties of Formylphosphonic Acid (12)
Formylphosphonic acid (12), which shows distinct antiviral activity [71] was obtained for the first
time in 1974 [14] as a byproduct of the electrolysis of an aqueous solution of nitrilotrimethylphosphonic
acid (40) (Scheme 4). Later it was shown that 12 might be also obtained in high yields by the catalytic
oxidation of nitrilotrimethylphosphonic acid (40) with hydrogen peroxide in the presence of vanadyl
sulfate or potassium tungstate (88–93% yield) [17] or activated carbon (up to 82% yield) [72]. Compound
12 can be also prepared by the oxidation of hydroxymethylphosphonic acid (41) in aqueous solution
123
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Scheme 4. Possible routes of syntheses of formylphosphonic acid (12).
In a third method of synthesis, 12 was obtained via a two-stage synthesis starting
from dimethyl (dimethoxymethyl)phosphonate (42), which was converted by treatment with
bromotrimethylsilane (43) into bis(trimethylsilyl)(dimethoxymethyl)phosphonate (44). Hydrolysis of
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Scheme 5. Synthesis of formylphosphonic acid (12) from dimethyl (dimethoxymethyl)phosphonate
(42).
However, the chemical properties of formylphosphonic acid (12) have been poorly studied until
now. It is known that heating 12 in acidic medium leads to the cleavage of the P–C bond to form
phosphoric and formic acids 45 and 46. In the presence of bases 12 undergoes disproportionation
(Cannizzaro reaction) to give hydroxymethylphosphonic 41 and carboxyphosphonic acids 47. Acid 47
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Scheme 6. Degradation of formylphosphonic acid (12) to form phosphoric 45 and formic acids 46 and
disproportionation of 12 in aqueous solutions.
2.2. Chemistry of Phosphorylated Formaldehyde Acetals 13
Chemistry of phosphorylated formaldehyde acetals 13 started as a chemistry
of dialkyl (dialkoxymethyl)phosphonates 33 due to their more ready availability as
compared with the analogs—N,N,N′,N′-tetraalkyl(dialkoxymethyl)phosphondiamides 48, dialkyl
(dialkoxymethyl)-phosphine oxides 49 or diphenyl(dialkoxymethyl)phosphine oxide 50. Many types
of acetals are known to date, but their chemical properties are still insufficiently studied, although they
are more studied than the other derivatives of phosphorylated formaldehyde.
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2.2.1. Methods of Synthesis of Phosphorylated Formaldehyde Acetals 13
First phosphorylated formaldehyde acetals 13 were obtained by the reaction of hydrophosphinoyl
compounds 51–53 with orthoformate esters 54 on heating. The reaction with dialkyl phosphites
51 [19,75] is conducted by heating to 182 ◦C [76,77] or at 60 ◦C in the presence of BF3·Et2O as
catalyst (without the catalyst the yields decrease from 69–90% to 25% [75]). In the case of sec-phosphine
oxides—dialkylphosphine oxides 52 [77] and diphenylphosphine oxide 53 [77,78], the reaction proceeds





















Scheme 7. Synthesis of phosphorylated formaldehyde acetals 33, 49, 50 from dialkyl phosphites 51 or
sec-phosphine oxides 52, 53 by means of orthoformate esters 54.
A variant of this method consists in the reaction of phosphoric acid (H3PO3, 45) or
phosphoric anhydride (55) with triethyl orthoformate (56) in 1:3 ratio that results in diethyl
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Scheme 8. Synthesis of diethyl (diethoxymethyl)phosphonate (57) from phosphoric acid (45) or
phosphorous anhydride (55).
Compounds 33 can be also prepared by the reaction of trialkyl phosphites 58 with orthoformate
esters 54. It was shown that phosphites 58 do not react directly with 54 even on heating [19]. However,
as in the case of dialkyl phosphites 51, orthoformates 54 react with trialkyl phosphites 58 and their
analogs (AlkO)2POX 59, where X =Me3Si, (AlkO)2P, (AlkO2)P(O) on heating in the presence of catalytic
amounts of boron trifluoride etherate BF3·Et2O [19]. The reaction of 58 with orthoformate esters
54 is also possible in the presence of phosphorus trichloride (PCl3, 60) or diethoxychloromethane
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Scheme 9. Synthesis of dialkyl (dialkoxymethyl)phosphonates 33 from orthoformate esters 54, trialkyl
phosphites 58 and their analogs (AlkO)2POX 59.
It was reported that the reaction of trialkyl phosphites 58 with acetoxy(diethoxy)methane
(61), which is more reactive derivative than orthoformate esters 54 [19,82], results in dialkyl
(diethoxymethyl)phosphonates 62 (Scheme 10).
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Scheme 10. Synthesis of dialkyl (diethoxymethyl)phosphonates 62 from orthoformate esters 54 and
acetoxy(diethoxy)methane (61).
The most general method of synthesis of phosphorylated formaldehyde acetals 13 is the reaction of
phosphorus trichloride derivatives 60 with orthoformate esters 54. Excess of 54 reacts on heating with
60 [79,81,83–85] and mono- and dialkyl AlkPCl2 63, Alk2PCl 64, alkoxy (AlkO)PCl2 65, (AlkO)2PCl 66,
and phenyl PhPCl2 67, Ph2PCl 68 [80,84,86–89] derivatives of 60 (Scheme 11), to form symmetrical
and unsymmetrical acetals 33, 49, 50 and 69, 70, respectively. It was noted that the reaction of
2-chloro-1,2,3-dioxaphospholanes 71 with 54 leads to the opening of the dioxaphospholane ring to
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Scheme 11. Syntheses of phosphorylated formaldehyde acetals 33, 49, 50, 69, 70 from phosphorus
trichloride derivatives 63–68 with orthoformate esters 54. See the text above.
The reaction of N,N,N′,N′-tetraalkyl(chloro)phosphindiamides 73 with orthoformates 54
proceeds with a partial exchange of dialkylamino groups at phosphorus atom of 73 to give
both N,N,N′,N′-tetraalkyl (dialkoxymethyl)phosphondiamides 48 and mixed phosphonamidates
74 [19,91,92]. In the case of N,N-dialkyl(dichloro)phosphinamides 75, a total exchange of
dialkylamino groups at the phosphorus atom for alkoxy groups takes place to yield dialkyl























(Alk'2N)2PCl (73) Alk''2NPCl2 (75)
 
Scheme 12. Interaction of N,N,N′,N′-tetraalkyl(chloro)phosphindiamides 73 and
N,N-dialkyl(dichloro)phosphinamides 75 with orthoformates 54.
Quaternary ammonium salts of dimethylformamide acetals can be used instead of orthoformates
54 [18,93]. The method only allows preparation of cyclic phosphorylated formaldehyde dialkyl acetals
76 since the quaternary ammonium salts of dialkylformamide acetals of linear structure are unstable
and undergo fast degradation [93] (Scheme 13).
126














Scheme 13. Synthesis of cyclic acetals 76 by interaction of trialkyl phosphites 58 with the quaternary
ammonium salts of dimethylformamide acetals.
Nonetheless, linear compounds 33 can be obtained by this method in low yield (15–25%) using a
one-pot method from methyl iodide, dialkylformamide acetals 77, and trialkyl phosphites 58 [18].
The reaction of phosphorus trichloride (60) with dimethylformamide dimethylacetal (78) also
leads to the formation of dimethyl (dimethoxymethyl)phosphonate (42) (along with a certain amount
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Scheme 14. Syntheses of dimethyl (dimethoxymethyl)phosphonate (42) from phosphorus trichloride
(60) and dimethylformamide dimethylacetal (78).
Dialkyl acetals 33 can be also prepared by the reaction of alcohols with tetraalkyl
bis(dialkoxymethyl)pyrophosphonates 80. The method provides a possibility to obtain formaldehyde
dialkyl acetals with different alkoxy substituents at phosphorus atom 81 [89] that are difficult to prepare
from trivalent phosphorus derivatives and orthoformates 54 or their derivatives because of competitive
exchange of substituents at phosphorus atom [19,89] (Scheme 15). Alkyl (dialkoxymethyl)phosphonic

























8180 82  
Scheme 15. Preparation of acetals 81 with different alkoxy substituents at phosphorus atom by means
of alcoholysis of tetraalkyl bis(dialkoxymethyl)pyrophosphonates 80.
Alkyl alkyl(dialkoxymethyl)phosphinates 83 unsymmetrically substituted at the phosphorus
atom were synthesized by the Arbuzov reaction of dialkyl (dialkoxymethyl)phosphonites 84 with alkyl














+    MeI
8384  
Scheme 16. Example synthesis of acetals with different substitutients at phosphorus atom by the
Arbuzov reaction. See also Scheme 11, Scheme 15, Scheme 17, Schemes 21–23 and 111–114.
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8685 87  
CH3CN, 60 °C 
Scheme 17. Synthesis of ethyl aryl(diethoxymethyl)phosphinates 85 and ethyl aryl
(diethoxymethyl)phosphonates 87 from ethyl (diethoxymethyl)phosphinate (86), R are Alk or Hal.
The catalytic synthesis of ethyl aryl(diethoxymethyl)phosphinates 85 by the reaction of
ethyl (diethoxymethyl)phosphinate (86) with ortho-substituted aryl bromides in the presence of
tetrakis(triphenylphosphine)palladium(0) Pd(Ph3P)4 in 75–90% yields was reported in 1995 [94]. The
Todd-Atherton reaction of 86 with ortho-substituted phenols in the presence of triethylamine at 0–23
◦C leads to ethyl aryl (diethoxymethyl)phosphonates 87 [94] (Scheme 17).
The attempted preparations of novel acetales 33 by the transesterification of phosphorus
ester groups failed because they gave rise to intractable mixtures of compounds [95].
Ethoxyphosphoryl groups in acetal 57 were replaced by butoxyphosphoryl groups only under
cathode electrolysis conditions. As a result, butyl ethyl (diethoxymethyl)phosphonate (88) and


















0.5 M Et4NClO4, 
CH3CN, 20
 oC
+   BuOH
electrolysis
57 88 89  
CH3CN, 20 °C 
Scheme 18. Synthesis of acetales 88 and 89 by transesterification under the conditions of electrolysis.
However, the heating of 57 with 1,3-dimethylpropanediols in the presence of a catalytic amount
of benzenesulfonic acid (PhSO3H) results in the replacement of ethoxy groups of the acetal fragment to















57 90  
Scheme 19. Preparation of cyclic diethyl (5-dimethyl-[1,3]-dioxan-2-yl)phosphonates 90 by the
transesterification under acid catalysis.
2.2.2. Chemical Properties of Phosphorylated Formaldehyde Acetals 13
The chemistry of phosphorylated formaldehyde acetals 13 was initially developed for the most
part as a chemistry of available dialkyl (dialkoxymethyl)phosphonates 33. Therefore the properties of
acetals as a separate type of organophosphorus compounds were studied mainly by the examples of
compounds 33 whose reactivity is affected by the presence of both phosphorus ester and acetal groups.
Hydrolysis of acetals 33 was studied by the example of compound 57 and a compound with
aromatic substituents in the acetal group, diethyl (5,6-dichloro-1,3-benzodioxomethyl)phosphonate
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(91). However, the attempted acid hydrolysis of acetal 57 on heating lead to the cleavage of
phosphorus–carbon bond [77,95,98]. Compound 91 underwent acid hydrolysis on heating to give
(5,6-dichloro-1,3-benzodioxomethyl)phosphonic acid (92) (Scheme 20). See also the section “Cleavage















 HCl (HBr) conc., 
     heat, 3-4 h.
91 92  
Scheme 20. Acid hydrolysis of diethyl (5,6-dichloro-1,3-benzodioxomethyl)phosphonate (91).
The heating of a solution of diethyl (dialkoxymethyl)phosphonate 93 in absolute ethanol
with sodium ethoxide (NaOEt) leads to dealkylation of one of the ethoxy groups by phosphorus
atom to form ethyl sodium (dialkoxymethyl)phosphonate 94, which produces the free acid 95 on
acidification [95]. Heating of 93 with sodium iodide NaI leads to the same result [93]. The reaction of
ethyl sodium (diethoxymethyl)phosphonate (96) with electrophilic reagents brings about the formation


































Scheme 21. Acetals 93 dealkylation at their interaction with sodium ethoxide or sodium iodide.
Synthesis of acetals 97 with different substituents at phosphorus atom, where R = Alk, Ac, Me3Si,
MeOCH2, ArOCH2.
Acids 95 show typical properties of hydroxy compounds. Using as example ethyl
(diethoxymethyl)phosphonic acid (98) it is shown that they react with diazomethane and thionyl
chloride. The reaction products are ethyl methyl (diethoxymethyl)phosphonate (99) and ethyl
(diethoxymethyl)phosphonic chloride (100) [95], which reacts with phenylmagnesium bromide in




























Scheme 22. Ethyl (diethoxymethyl)phosphonic acid (98) transformations.
Unsymmetrical ethyl aryl (diethoxymethyl)phosphonates 87 containing aryloxy substituents
at the phosphorus atom [94] undergo rearrangement in the presence of equimolar amount of
129
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lithium diisopropylamide LDA in tetrahydrofuran at −70 ◦C to yield ethyl (2-hydroxyaryl)-










OEt1) LDA, THF, -78 oC
           2) H+
87 102  
1) LDA, THF, −78 °C 
Scheme 23. Rearrangement of compounds 87, R = Alk, Hal.
Heating of diethyl (diethoxymethyl)phosphonate (57) with a catalytic amount of BF3·Et2O gives











57 103  
Scheme 24. Formation of tetraethyl (ethoxymethyl)diphosphonate (103) from acetal 57 under a catalysis
by BF3·Et2O.
The acetal group of compounds 13 is rather stable to the action of co-reactants. Nonetheless, a
series of transformations of phosphorylated formaldehyde acetals (33) that involves dialkoxyacetal
group is described.
The halogenation of compounds 33 with N-bromosuccinimide leads to
alcoxycarbonylphosphonates 104. Five-membered cyclic acetals 76 by halogenation with
N-chlorosuccinimide and azodiisobutyro-nitrile mix produce β-haloethoxycarbonylphosphonates









































+    Alk'
76
105  
Scheme 25. Interaction of compounds 33 and 76 with N-bromosuccinimide or N-chlorosuccinimide.
The reaction of 57 with o-aminophenol in oxygen flow at 160 ◦C results in diethyl
(2-benzoxazolyl)phosphonate (106) [100] (Scheme 26).
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57 106  
O2, 160 °C 
Scheme 26. The reaction of diethyl (diethoxymethyl)phosphonate (57) with o-aminophenol.
When compound 33 reacted with thiols in a 1:1 mixture of acetic and hydrochloric acid at 0 ◦C,












      Alk''SH
33 107  
Scheme 27. Transformation of compounds 33 into dialkyl (dialkylthiomethyl)phosphonates 107.
Diethyl (diethoxymethyl)phosphonate (57) reacts with titanium tetrachloride TiCl4 or tetrabromide
TiBr4 in diethyl ether to give diethyl [(ethoxy)chloromethyl]phosphonate (108) or diethyl












109, X=Br  
Scheme 28. Syntheses of phosphorylated halogenacetals 108, 109 from diethyl
(diethoxymethyl)phosphonate (57).
Cyclic diisopropyl [(4-bromomethyl-[1,3]-dioxolan)-2-yl]phosphonates 110 were used in the
synthesis of analogs of natural purine and pyrimidine nucleotides [101]. Guanine analog 111 was









































ZnCl2/0–20 °C DMF, Cs2CO3/60 °C 
Scheme 29. Synthesis of [1,3]-dioxolane analog guanine nucleotide 111.
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The corresponding uracil analog was obtained in a similar manner. Both compounds showed
moderate activity in vitro toward human cytomegalovirus [101]. See also Scheme 16, Scheme 18,
Scheme 19, Schemes 54, 57, 58, 60, 62, 86–88 and 90–92.
2.3. Phosphorylated Formaldehyde Thioacetals 14
The first syntheses of compounds 14, linear dialkyl (dialkylthiomethyl)phosphonates 107 or dialkyl
(diphenylthiomethyl)phosphonates 112 [21,22], cyclic dialkyl ([1,3]-dithiolan-2-yl)phosphonates 113,
dialkyl ([1,3]-dithian-2-yl)phosphonates 114 [102] and dialkyl (1,3-benzodithiolylmethyl)phosphonates























Figure 5. First representatives of the phosphorylated formaldehyde thioacetals 107, 112–115.
2.3.1. Methods of Synthesis of Phosphorylated Formaldehyde Thioacetals 14
The first syntheses of linear and cyclic dialkyl (dialkylthiomethyl)phosphonates 107, 112–114
were performed by the analogy with the syntheses of dialkyl (dialkoxymethyl)phosphonates
33 (Schemes 9 and 13), namely, by the Arbuzov reaction of trialkyl phosphites 58 with
linear (dialkylthio)chloromethanes 116 or (diphenylthio)chloromethane (117) [21,22], and cyclic
2-chloro-1,3-dithiolane [22,102] (118) or 2-chloro-1,3-dithiane (119) with 93–95% yields (or quaternary




























Scheme 30. The first syntheses of linear 107, 112 and cyclic 113, 114 phosphorylated
formaldehyde thioacetals.
At present, the method is used for the synthesis of cyclic dialkyl (dialkylthiomethyl)phosphonates
113, 114, because initial 2-chloro-1,3-dithiolane (118) and 2-chloro-1,3-dithiane (119) are readily prepared
by the reaction of 1,3-dithiolane and 1,3-dithiane with N-chlorosuccinimide [102,104–106]. The method
allows one to obtain in good yields both cyclic dialkyl (dialkylthiomethyl)phosphonates 113, 114
(55–96%), [102,104,106]) and diphenyl(dialkylthiomethyl)phosphine oxides 121, 122 (57–85%), [56,104,
105]) (Scheme 31).
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113,  n=1; R=OAlk;
114,  n=2; R=OAlk;
121,  n=1; R=Ph;






Scheme 31. Syntheses of cyclic dialkyl (dialkylthiomethyl)phosphonates 113, 114 and
diphenyl(dialkylthiomethyl)phosphine oxides 121, 122.
However, the poor availability of linear dialkylthiochloromethanes [21] confined the use of this
method of synthesis of phosphorylated thioacetals 14 and stimulated the search for alternative methods
for their synthesis.
In 1979, a new two-step method was proposed for the synthesis of unsymmetrical diethyl
(dialkylthiomethyl)phosphonates 123 starting from diethyl (methylthiomethyl)phosphonate (124).
After one-pot treatment with butyllithium and elemental sulfur (sulfenylation) followed by aqueous
treatment, 124 was converted into diethyl [(methylthio)mercaptomethyl]phosphonate (125), which
under phase transfer catalysis conditions was further alkylated to give final unsymmetrical thioacetals
123 [107] (Scheme 32). In further work, alkyl halides (AlkHal) were introduced in the reaction





















3) HCl aq.  78%
1) 6% NaOH/benzene
2) AlkBr  70%-72%
125 123124  
 i, THF/−78 °C, 
Scheme 32. The synthesis of unsymmetrical diethyl (dialkylthiomethyl)phosphonates (123).
Diphenyl(diphenylthiomethyl)phosphine oxide (126) [109] was previously obtained in similar












1) BuLi, THF, -78 oC
2) PhSSPh
126127  
1) uLi, THF, −78 °C, 
Scheme 33. Syntheses of diphenyl(diphenylthiomethyl)phosphine oxide (126) from
diphenyl(phenylthiomethyl)phosphine oxide (127).
It was shown later that diethyl (diphenylthiomethyl)phosphonate (128) can be prepared from
dialkyl methylphosphonate (129) [108] by a one-pot technique in 84% yield (Scheme 34).
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1) BuLi, THF, -78 oC, 
2) PhSSPh
3) BuLi, THF, -78 oC, 
4) PhSSPh 128129  
i, THF, −78 °C, 
) i, THF, −78 °C, 
Scheme 34. Syntheses of diethyl (diphenylthiomethyl)phosphonate (128) from dialkyl
methylphosphonate (129) by a one-pot technique.
Diethyl [(methylthio)(trimethylsilyl)methyl]phosphonate (130) undergoes a similar transformation












1) BuLi, THF, -78 oC,
2) AlkSSAlk
130 131  
1) BuLi, THF, −78 °C, 
Scheme 35. Interaction of diethyl [(methylthio)(trimethylsilyl)methyl]phosphonate (130)
with diethyldisulfide.
This method [107] and its variations [108–110] provide a possibility to synthesize linear dialkyl
(dialkylthiomethyl)phosphonates 107 containing different substituents in the thioacetal group.
The reduction of phosphonodithioformates 132 with sodium borohydride (NaBH4) or
borane–dimethyl sulfide adduct BH3·SMe2 [111] followed by alkylation of the resulted
dialkyl [(methylthio)mercaptomethyl]phosphonates 133 finally results in unsymmetrical dialkyl
















AlkO O1) BuLi, THF, 20 oC,




20 °C, CH3CN, 90%-95% 
1) BuLi, THF, 20 °C, 
Scheme 36. Transformation of phosphonodithioformates 132 into dialkyl
[(methylthio)(alkylthio)methyl]phosphonates 134.
It was shown later that dialkyl and diaryl disulfides in the presence of catalysts (Cat.)
like BF3·Et2O, rhodium(II) tetraacetate Rh2(OAc)4, or copper(II) sulfate CuSO4, can react with
diazomethanephosphonates 38, where R=OAlk. Phosphorylated carbenes produced in the reaction
undergo insertion into S–S bond to afford dialkyl (dialkylthiomethyl)phosphonates 107 or dialkyl
(diarylthiomethyl)phosphonates 135 in 42–93% yields [56,112]. Reactions proceed by the carbene
mechanism (Scheme 37) [112].
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 Cat., 25 oC,
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Cat., 25 °C, 
Scheme 37. Diazomethanephosphonates 38 reaction with organic disulfides with formation of dialkyl
(dialkylthiomethyl)phosphonates 107 or dialkyl (diarylthiomethyl)-phosphonates 135.
A method of synthesis of substituted diphenyl([1,3]-dithian-2-yl)phosphine oxides 136 (yields
34–85%) starting from substituted 1,3-dithianes and chlorodiphenylphosphine (68) was also
suggested [104,113,114]. Initially formed diphenyl([1,3]-dithian-2-yl)phosphines 137 undergo further
oxidation with molecular oxygen to final 136 (Scheme 38). Diphenyl([1,3]-dithian-2-yl)phosphine
sulfides 138 or selenides 139 can be obtained by this method when elemental sulfur or selenium are



















O2 or S or Se
136 (X=O)
138 (X=S)
139 (X=Se)  
Scheme 38. Obtaining of substituted diphenyl([1,3]-dithian-2-yl)phosphine oxides 136 and
corresponding phosphine sulfides 138 and phosphine selenides 139 from dithianes.
The attempted preparation of 107 and 114 in one step from dialkylthiomethanes
or 1,3-dithianes and dialkyl chlorophosphate in the presence of strong bases failed, as
evidenced by the negligible yield of final products [21,115]. The syntheses of 107 by the
interaction of thioles with dialkyl [(N,N-dimethylamino)alkoxymethyl]phosphonates 140 or dialkyl
[(alkylthio)chloromethyl]phosphonates 141 also failed [21].
Hovewer a method of synthesis of linear phosphorylated formaldehyde thioacetals 14 by the
reaction of dialkyl [(arylthio)chloromethyl]phosphonates 142 with thiols at 0 ◦C in the presence of
equimolar amount of tin(IV) tetrachloride SnCl4 was succesful. This route provided a preparation of












 oC+     AlkSH
142 143  
SnCl4, CH2Cl2, 0 °C 
Scheme 39. Obtaining of dialkyl [(alkylthio)(arylthio)methyl]phosphonates 143 by the reaction of
dialkyl [(arylthio)chloromethyl]phosphonates 142 with thiols.
Dialkyl (dialkylthiomethyl)phosphonates 107 were also obtained by the reaction of dialkyl
(dialkoxymethyl)phosphonates 33 with thiols in the presence of acids [21] (see Scheme 27).
135
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Dialkyl (1,3-benzodithiolylmethyl)phosphonates 115 were prepared for the first time by the
reaction of 1,3-benzodithiolyl tetrafluoroborate with 58 in the presence of NaI [103]. The method is












      20 oC
11558  
20 °C 
Scheme 40. The synthesis of dialkyl (1,3-benzodithiolylmethyl)phosphonates 115 from
1,3-benzodithiolyl tetrafluoroborate.
2.3.2. Chemical Properties of Phosphorylated Formaldehyde Thioacetals 14
The chemical properties of phosphorylated formaldehyde thioacetals 14 have been studied in
much less detail compared with the corresponding acetals 13. Their properties are determined by
the presence of sulfur atoms and a disubstituted phosphoryl group. Both sulfur atoms are oxidized
when diethyl ([1,3]-dithian-2-yl)phosphonate (144) is treated with sodium periodate NaIO4 in aqueous














144 145  
Scheme 41. Diethyl ([1,3]-dithian-2-yl)phosphonate (144) oxidation by periodate.
The heating of diphenyl([1,3]-dithiolan-2-yl)phosphine oxides 121 [115] and diphenyl([1,
3]-dithian-2-yl)phosphine oxides 122 [56,104] with phosphorus pentasulfide P2S5 in benzene or
N,N-diethylaniline PhNMe2 leads to the replacement of phosphinoyl oxygen by sulfur to yield
diphenyl([1,3]-dithiolan-2-yl)phosphine sulfide (146) and diphenyl([1,3]-dithian-2-yl)phosphine sulfide,































Scheme 42. Transformation of phosphorylated cyclic thioacetals 122, 123 into corresponding phosphines
148, 149, phosphine sulfides 146, 147 and phosphine selenides 151, 152.
The sequential treatment of the prepared phosphine sulfides 146 and 147 with
trifluoromethylsulfonate CF3SO3Me and tris(dimethylamino)phosphite (Me2N)3P finally affords
diphenyl([1,3]-dithiolan-2-yl)phosphine (148) [105] and diphenyl([1,3]-dithian-2-yl)phosphines 149 [56,
104]. The reaction of diphenyl(5-tert-butyl-[1,3]-dithian-2-yl)phosphine sulfide (150) with trichlorosilane
leads to the same result [56]. The obtained phosphines 146, 147 combine with elemental selenium to yield
diphenyl([1,3]-dithiolan-2-yl)phosphine selenide (151) [105] and diphenyl([1,3]-dithian-2-yl)phosphine
selenide (152) [56,104]. See also Schemes 59, 60, 64, 65, 74–81.
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2.4. (N,N-dialkylamino)cyanomethyl Derivatives of Phosphorylated Formaldehyde (α-dialkylamino-nitriles) 15
For 1982 till now, only two derivatives of this type of organophosphorus compounds of
phosphonate series were obtained, diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153) [24]
and diethyl [(N-morpholino)cyanomethyl]phosphonate (154) [26].
2.4.1. Methods of Synthesis of Diethyl [(N,N-Dialkylamino)cyanomethyl]phosphonates 15
Diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153) was obtained for the first time by
a reaction similar to the preparation of phosphorylated acetals 13 (Scheme 7) from diethyl phosphite















6 153  
90 °C 
Scheme 43. Syntheses of diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153).
Diethyl [(N-morpholino)cyanomethyl]phosphonate (154) was prepared by the second method
from diethyl chlorophosphate (155) and (N-cyanomethyl)morpholine [26] (Scheme 44) and was used


















THF, −78 °C 
Scheme 44. Syntheses of diethyl [(N-morpholino)cyanomethyl]phosphonate (154) from diethyl
chlorophosphate (155).
2.4.2. Chemical Properties of Diethyl [(N,N-Dialkylamino)cyanomethyl]phosphonates 15
The chemical properties of this type of compounds have been studied almost completely
using the example of diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153). The
treatment of 153 with methyl iodide (MeI) or dimethyl sulfate Me2SO4 [117,118] gives rise
to methylation of nitrogen atom (quaternization) of the dimethylamino group and formation
of diethyl [(N,N,N-trimethylammonio)cyanomethyl]phosphonate cation (156), whose α proton
shows enhanced acidity and breaks off under the action of aqueous potassium carbonate
solution K2CO3. The resultant diethoxy [(N,N,N-trimethylammonio)cyanomethylidium]phosphonate
(157) can react with electrophiles—MeI and molecular chlorine Cl2 [117], to give
diethyl [(1-(N,N,N-trimethylammonio))(1-cyano)ethan-1-yl]phosphonate cation (158) and diethyl
[chloro(1-N,N,N-trimethylammonio)cyanomethyl]phosphonate cation (159), respectively (Scheme 45).
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Scheme 45. Transformation of diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153).
Under phase transfer catalysis conditions—50% KOH solution, [Et3NCH2Ph]+Cl− (TEBAC) [24]
phosphonate 153 combines with nitrosobenzene PhN=O similarly to the Horner reaction to afford
[(N,N-dimethyl)(N′-phenyl)amidinoyl]oxalnitrile (160) in 58% yield (Scheme 46). See also Schemes 55,









+ 50% KOH, CH2Cl2
       TEBAC
160153  
Scheme 46. Horner—analog reaction of phosphonate 153 with nitrosobenzene.
2.5. Diphosphinoyl N,N-Dialkylaminomethanes 16
2.5.1. Methods of Synthesis of Diphosphinoyl N,N-Dialkylaminomethanes 16
The first report on the synthesis of tetraethyl (N,N-dimethylaminomethyl)diphosphonate
(161) was published in 1968. Compound 161 was obtained in 62% yield by heating a 2:1
mixture of diethyl phosphite (6) and dimethylformamide dimethylacetal (78) [27]. Dialkyl
phosphites 51, dialkyl- and diphenylphosphine oxides 52, 53 can be also involved in this
reaction [31,32,119]. Intermediate dialkyl [(N,N-dimethylamino)methoxymethyl]phosphonates (162)
or dialkyl[(N,N-dimethylamino)-methoxymethyl]phosphine oxides 163 may be isolated in many
cases [32,119]. This allows preparation of symmetrical 164 and unsymmetrical diphosphinoyl






















78 162,163 164,165  
Scheme 47. Synthesis of diphosphinoyl N,N-dimethylaminomethanes 164 and 165 from
dimethylformamide dimethylacetal (78), where R, R′ = OAlk, Alk, Ph. See text above.
Other methods of synthesis of symmetrical tetraalkyl (N,N-dimethylaminomethyl)diphosphonates
166 were proposed later. Since trialkyl phosphites 58 do not react with dimethylformamide
dimethylacetal (78) [18], mixed dialkyl trimethylsilyl phosphites (EtO)2PSiMe3 were successfully
employed in the reaction. The reaction proceeds spontaneously at 20 ◦C [121] in 36–66% yield or upon
heating in the presence of zinc chloride in 72–77% yield [122,123] (Scheme 48).
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Scheme 48. Use mixed dialkyl trimethylsilyl phosphites for the syntheses of tetraalkyl diphosphonates
166 from dimethylformamide dimethylacetal (78).
A convenient method of synthesis of unsymmetrical tetraalkyl (N,N-dialkylaminomethyl)-
diphosphonates 167 by the reaction of trialkyl phosphites (58) with
N,N-dialkylhalo-methylideneiminium halides [HalC(H)=NAlk2]+Hal−, where Hal = Cl (compounds
168) [28,31,32,120] or Br (compounds 169) [29] in 2:1 ratio was proposed in 1969.
It was shown that the reaction of trialkyl phosphites 58 with N,N-dimethylchloro-
methylideneiminium chloride (170) proceeds via intermediate formation of
dialkyl [(N,N-dimethylamino)chloromethyl]phosphonate 171 [31,32], specially
prepared dimethyl [(N,N-dimethylamino)chloromethyl]phosphonate (172) and diethyl
[(N,N-dimethylamino)chloromethyl]- phosphonate (173) may be also involved in the
reaction [30,31,124]. This method enables preparation of symmetrical and unsymmetrical

















P(OAlk)3 (58) P(OAlk') (58)
-40 oC, CH2Cl2 -40
 oC, CH2Cl2
170 171 174  
−40 °C, CH2CL2 −40 °C, CH2CL2 
Scheme 49. Method of synthesis of symmetrical and unsymmetrical dialkyl
(N,N-dimethylaminochloromethyl)phosphonates 174 from N,N-dimethylchloromethylideneiminium
chloride (170) and trialkyl phosphites (58).
Dialkyl phosphites 51, dialkylphosphine oxides 52 and diphenylphosphine oxide (53) also react
with N,N-dialkylchloromethylideneiminium chlorides 168 [31,120] and their analogs 175 obtained from
N,N-dialkylformamides and phosphorus oxychloride [28] (Scheme 50). The reaction also proceeds via
intermediate compounds 176, where X=Cl or Cl2PO2. This allows also the preparation of symmetrical

















P(OAlk)3 (58) P(OAlk') (58)
-40 oC, CH2Cl2 -40
 oC, CH2Cl2
170 171 174  
−40 °C, CH2CL2 −40 °C, CH2CL2 
Scheme 50. Synthesis of diphosphinoyl N,N-dialkylaminomethanes 177 and 178 from
N,N-dimethylchloromethylideneiminium chloride (170) and hydrophosphorylic compounds 51, 52, 53.
See text above.
See also Scheme 14.
2.5.2. Chemical Properties of Diphosphinoyl N,N-Dialkylaminomethanes 16
The chemical properties of this type of organophosphorus compounds are studied insufficiently
and almost exclusively by the example of tetraethyl (N,N-dimethylaminomethyl)diphosphonate
(161). Their properties are attributable to the presence of both an amino group and disubstituted
phosphoryl groups.
139
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Hydrolysis of tetraalkyl (N,N-dimethylaminomethyl)diphosphonates 174 was studied using the
example of compound 161. Boiling diphosphonate 161 with concentrated hydrochloric acid leads to






















53 (R=Ph)  
−40 °C
Scheme 51. Acid hydrolysis of tetraethyl (N,N-dimethylaminomethyl)diphosphonate (161).
The amino group of diphosphonate 161 undergoes methylation (quaternization) when
reacted with methyl iodide (MeI) or dimethyl sulfate (Me2SO4) to give tetraethyl
(N,N,N-trimethylammoniomethyl)diphosphonate cation (180) in 76 and 85% yields, respectively [118,
125]. The α-proton of the latter shows enhanced acidity and undergoes elimination
under the action of aqueous solution of potassium carbonate (K2CO3) to afford tetraethyl

















O161 180 181  
Scheme 52. Transformation of tetraethyl (N,N-dimethylaminomethyl)diphosphonate (161) into
methylidiumdiphosphonate 181, where X = I, MeSO3.
Ylide 181 exhibits an enhanced stability: it can be stored for a long time in air, it is thermally
stable and does not react with methyl iodide [126]. However, ylide 181, like cyanomethylide 154, reacts
with molecular chlorine to yield tetraethyl [(N,N,N-trimethylammonio)chloromethyl)diphosphonate
chloride (182) that undergoes fast dealkylation on storage to afford the corresponding betaine 183 in
























182 183  
Scheme 53. Interaction of methylidiumdiphosphonate 181 with chlorine with the subsequent formation
of betaine 183.
See also Schemes 60, 68 and 72–74.
3. General Chemical Properties of Phosphorylated Formaldehyde Acetals 13 and Structurally
Related Compounds 14–16
3.1. Phosphorus–Carbon Bond Cleavage
3.1.1. Cleavage of Phosphorus–Carbon Bond under the Action of Acids and Acidic Reagents
The general property of phosphorylated formaldehyde acetals 13 and structurally related
compounds 14–16 is the possibility of phosphorus–carbon bond cleavage under the action of acids and
acidic reagents [24,77,95,98], organic reagents [19,119], and bases [37,127,128].
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The cleavage of phosphorus–carbon bond under acidic conditions compounds 33 is studied
on examples of diethyl (diethoxymethyl)phosphonate (57). Phosphonate 57 was shown to undergo
cleavage of the phosphorus–carbon bond on heating with 5% hydrochloric acid [77,98] to form diethyl
phosphites (6), ethyl formate (184) and ethanol. Similar degradation of compound 57 occurs in a flow
of hydrogen chloride at 20 ◦C [95] (ethyl chloride is formed as a byproduct) (Scheme 54). Unlike 57,
interaction of diethyl (diphenoxymethyl)phosphonate (185) with dry hydrogen chloride does not lead
to the cleavage of phosphorus–carbon bond, but leads to the dealkylation of one ethoxy substituent at














EtOH 5% HCl,  heat;
 or HCl (gas)/CCl4,
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Scheme 54. Interaction of acetals 57 and 185 with hydrochloric acid (only for 57) and hydrogen chloride.
It was shown that acid hydrolysis of diethyl (diethylthiomethyl)phosphonates (187) is accompanied
by a partial cleavage of the phosphorus–carbon bond [98]. Prolonged refluxing of diethyl
[(N,N-dimethylamino)cyanomethyl]phosphonate (153) in concentrated hydrochloric acid leads to











conc. HCl,  heat
153 188  
Scheme 55. Obtaining N,N-dimethylaminoacetic acid (188) by acid hydrolysis of
cyanomethylphosphonate 153.
It was shown in [95] that the attempted transesterification of ethoxy substituents at the phosphorus





















57 1846  
Scheme 56. Destruction of acetales 57 at its interaction with catechol.
The cleavage of phosphorus–carbon bond may also occur when diethyl
(dialkoxymethyl)phosphonates 93 are exposed to phosphorus pentachloride [95].
3.1.2. The Cleavage of Phosphorus–Carbon Bond in Reactions with Organic Coreactants
The reactions of 57 with dichloromethoxymethane Cl2C(H)OMe or acetyl bromide MeC(O)Br
was shown to be accompanied by the cleavage of phosphorus–carbon bond [19] to form
diethoxychlorophosphine (189) and diethyl acethylphosphonate (190) (Scheme 57).
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Scheme 57. Acetales 57 interaction with Cl2C(H)OMe and MeC(O)Br leading to the cleavage of
phosphorus–carbon bond.
The reaction of diethyl phosphite (6) with dipropyl [(N,N-dimethylamino)ethoxymethyl]phosphonate
(191) is also accompanied by the partial cleavage of the phosphorus–carbon bond [119].
3.1.3. Phosphorus–Carbon Bond Cleavage under the Action of Bases
The reaction of the lithium derivatives of diphenyl(dialkoxymethyl)phosphine oxides 50 with
n-octanal and p-isopropylbenzaldehyde leads to α-phosphorylated alcohols 192, the products of
addition of diphenylphosphinite anion (193) to the carbonyl group (Abramov reaction) [127,128],
rather than ketene O,O-acetals 194 as expected products of the Horner reaction [9,10] (Scheme 58).
The reason of this course is the instability of diphenyl (dialkoxymethyl)phosphine oxide anion (195)
that compound 50 decomposes after long exposition under the reaction conditions to form anion 193,






















































THF, −110 °C 
Scheme 58. Cleavage of phosphorus–carbon bond of acetal 57 and O,S-acetal 196 leading to the
formation of α-phosphorylated alcohols 192 and 198.
Like phosphine oxides 50, the reaction of diethyl [(acetoxy)methylthiomethyl]phosphonate
(196) with benzaldehyde PhC(H)O under phase transfer catalysis conditions gives rise to diethyl
[(hydroxy)phenylmethyl]phosphonate (197), the Abramov reaction product, instead of the expected
ketene O,S-acetal 198 resulting from the Horner reaction [37] (Scheme 58).
Lithiated anions 199 of diethyl [(methylthio)(alkylthio)methyl]phosphonates 123 react quickly
with molecular oxygen with the cleavage of phosphorus–carbon bond and formation of dialkyl
dithiocarbonates 200 (yields 71–72%) [129] (Scheme 59).
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123 199 200  
−78 °C 
Scheme 59. Destruction of thioacetal 123 in the presence of oxygen, leading to formation of
dithiocarbonates 200.
See also Schemes 63, 96, 103, 104, 113–117 and 120.
3.2. Synthesis of Formacetalphosphonic Acids
Attempted preparations of formacetalphosphonic acids 201, 202 and 203 from the corresponding
phosphorylated acetal 57, thioacetal 187 and aminonitrile 153 by acid hydrolysis lead to cleavage of
the phosphorus–carbon bond, but in the case of compound 91 with a aromatic substituent in the acetal
group, it undergoes acid hydrolysis to give the expected phosphonic acid 92 (Scheme 20). See also
Section 3.1.1. “Cleavage of phosphorus–carbon bond under the action of acids and acidic reagents”.
However, the target formacetalphosphonic acids 201–203 may be successfully
prepared by the reaction of acetals 33, diethyl (diethylthiomethyl)phosphonate
(187), diethyl [(N,N-dimethyl-amino)cyanomethyl]phosphonate (153), and
tetraethyl(N,N-dimethylaminomethyl)diphosphonate (161) with trimethylsilyl bromide (Me3SiBr)
in acetonitrile. Alkyl groups at the phosphorus atom are eliminated as alkyl halides to afford
the corresponding intermediate bis(trimethylsilyl) phosphonates 204 (or tetrakis(trimethylsilyl)
phosphonate (205) from diphosphonate 161), which are further readily hydrolyzed by water treatment
to give:
- (dialkoxymethyl)phosphonic acids 201 in 93–100% yield from 33 [19,98]. It was shown that the
reaction 33 with an equimolar mixture of trimethylsilyl chloride Me3SiCl and NaBr or LiBr [130] in
acetonitrile of trimethylsilyl chloride and NaI in methylene chloride [131] leads to the same result,
- (diethylthiomethyl)phosphonic acid (202) from 187 in 58% yield [98],
- (1-dimethylamino-1-cyanomethyl)phosphonic acid (203) from 153 in 55% yield [24],














































Scheme 60. Syntheses of formacetalphosphonic acids 201–203 and 179 from compounds 57, 187, 153,
161 by means of Me3SiBr or Me3SiI. See text above.
See also Schemes 15, 20–22, 29 and 54.
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3.3. Alkylation (Acylation) of the Formacetal Carbon Atom
Dialkyl (dialkoxymethyl)phosphonates 33 produce no stable phosphorylated carbanion 206 when
reacted with bases (no metallation occurs, even under the action of tert-butyllithium (t-BuLi), which











33 206  
Scheme 61. Phosphorylated acetals 33 do not produce carbanions 206.
This fact was explained by insufficient stabilization of the negative charge of carbanion on the
two oxygen atoms in the α-position [23]. However, it was shown in 1983 [133] that, in contrast to
phosphonates 33, diphenyl(dialkoxymethyl)phosphine oxides 50 produce phosphorylated anions 195
at −110 ◦C that undergo metallation. The reason for the stability of the lithium derivatives of phosphine
oxides 50 is the ability of diphenylphosphinoyl group to delocalize the negative charge of carbanion
195 [20,134] (Scheme 58). By the example of anion 207 of diphenyl(dimethoxy-methyl)phosphine oxide
(208), it was shown that it is rather stable to subsequent alkylation with alkyl halides and acylation with
benzoyl chloride [20]. The reactions afford diphenyl[(dimethoxy)alkylmethyl]phosphine oxides 209, in
































THF, −110 °C 
Scheme 62. Alkylation and acylation of carbanion 207.
In acidic medium at 20 ◦C, phosphine oxides 209 are readily decomposed with cleavage of the
phosphorus–carbon bond. The resultant methyl carboxylates 211 are homologous to the initial alkyl



















Scheme 63. Hydrolysis of phosphine oxide 209 leads to phosphorus–carbon bond cleavage.
Similarly, according to 1H-NMR spectroscopy, the methanolysis of
diphenyl[(1,1-dialkoxy)nonan-1-yl)phosphine oxide (212) in the presence of trifluoroacetic
acid leads to 1,1,1-trimethoxynonane (213) in 65% yield [20].
Nonetheless, the storage of a solution of lithiated anion 207 for two hours even at −110 ◦C causes
the cleavage of phosphorus–carbon bond (see Scheme 58).
Distinct from acetals 33 [23,132], the two sulfur atoms of thioacetals 113, 114 stabilize well the
neighboring carbanion [23], therefore the α-hydrogen atom in the thioacetal group is readily removed
under the action of strong bases [23,132] in both dialkyl (dialkythiomethyl)phosphonates 113, 114 [135]
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and diphenyl(dialkythiomethyl)phosphine oxides 121, 122 [113]. Further, the carbanions are readily
alkylated with alkyl halides [113,135]. For example, dialkyl ([1,3]-dithian-2-yl)phosphonates 114
in this reaction produce dialkyl [(2-alkyl-[1,3]-dithian)-2-yl]phosphonates 214, and their oxidative
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1) i-Pr2NLi, THF, −78 °C 
Scheme 64. Thioacetals 114 alkylation with the subsequent transformation of thioketals 214 into
α-phosphorylated carbonyl compounds 215.
The possibility to alkylate diethyl ([1,3]-dithian-2-yl)phosphonate (144) was used for the elongation
of the hydrocarbon chain in the synthesis of 3-deoxy-D-manno-octulosonic acid (216), through

























2) BuLi, THF,  -78 oC
1) (144)
217  
2) BuLi, THF, −78 °C 
Scheme 65. Synthesis of 3-deoxy-d-manno-octulosonic acid (216) by the alkylation of thioacetal 144.
In contrast to dialkyl (dialkoxymethyl)phosphonates 33 and similarly to phosphorylated
formaldehyde thioacetals 14, diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153) is readily
deprotonated under the action of sodium hydride in dioxane or dimethyl sulfoxide or 50% KOH
solution under phase transfer catalysis conditions [24] as well as with butyllithium BuLi in THF [25].
Lithium derivative 218 of diethyl [(N,N-dimethylamino)cyanomethyl]phosphonate (153) proved to be













153 218  
Scheme 66. Synthesis of stable lithium derivative 218 of diethyl [(N,N-dimethylamino)-
cyanomethyl]phosphonate (153).
The anion of 218 undergoes alkylation at the carbon atom when treated with methyl iodide
MeI [24,25,117], dimethyl sulfate Me2SO4 [117] or benzyl chloride PhCH2Cl [24] to give α-alkylated
derivatives 219 and 220. Benzyl derivative 220 prepared by this method eliminates hydrogen cyanide
on heating to give α-phosphorylated enamine 221 [24] (Scheme 67).
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Scheme 67. Anion 218 alkylation.
Similarly to diphenyl(dialkoxymethyl)phosphine oxides (50), cyclic dialkyl (dialkylthiomethyl)-
phosphonates 113, 114, cyclic diphenyl(dialkylthiomethyl)phosphine oxides 121, 122, and diethyl
[(N,N-dimethylamino)cyanomethyl]phosphonate (153), and tetraethyl (N,N-dimethylaminomethyl)-
diphosphonate (161) under the action of strong bases readily eliminate a proton from the acetal carbon
atom to give anion 222. This provides an opportunity for its further alkylation (compounds 223) [28],
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AlkHal
161 222 223
Hal = Cl, Br
 
−78 °C 
Scheme 68. Alkylation of methyldiphosphonate 161, (Hal = Cl, Br).
3.4. Horner Reaction
In 1958 and 1959 L. Horner and co-authors reported their discovery of a new reaction [137,
138] that they named as “P=O-activated olefination”. The authors showed that the reaction of
alkyl(diphenyl)phosphine oxides 224 and dialkyl alkylphosphonates 225 with aldehydes and ketones
in the presence of strong bases produce olefins 226 (Scheme 69). Key reaction intermediates—lithium
derivatives of carbanion of the initial phosphinoyl compounds 227 and β-phosphorylated hydroxy
derivatives 228 were identified on the example reaction of benzyl(diphenyl)phosphine oxide (229)





















224, 225 227 228 226
R''(R''')C=O
 
Scheme 69. Syntheses of olefins 226 from aldehydes and ketones by means of Horner’s reaction, R =
OAlk, Ph; R’ = Alk; R”, R”’ = H, Alk, Ar.
The reaction has a number of advantages in comparison with similar reaction of phosphorus ylides
previously described by L. Wittig [139] where ketones are difficult to react, whereas both aldehydes and
ketones undergo the Horner reaction. It was further shown that Horner reaction has a larger synthetic
potential and is applicable for the synthesis of other types of organic compounds, for example, allenes,
cyclopropanes, terminal [140] and disubstituted alkynes [132]. The involvement of phosphonates
functionalized at the α-position with dialkylamino, alkoxy or alkylthio groups in the reaction leads
146
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to enamines, vinyl ethers [132,141–143] and vinyl thioethers [141,143]. Their subsequent hydrolysis
affords aldehydes and ketones with elongated hydrocarbon chain in high yields (homologation).
The Horner reaction also provides the possibility to prepare carboxylic acids homologized by
one carbon atom via the shortest route starting from phosphinoyl compounds functionalized at the
α-position with two heteroatoms, namely, phosphorylated formaldehyde acetals and structurally
related compounds [132,141]. In this case, carbanions 230 of phosphorylated formaldehyde acetals
and structurally related compounds 13–16, 18–32 behave as a masked form of triply functionalized
carbanions 231 that may be considered as a synthetic equivalent or carrier of reversed-polarity formate
















13-16, 17-32 230 232231  
Scheme 70. Compounds 13–16, 18–32 as hidden form of reversed-polarity formate carbanion 232,
where R = OAlk, Ph; X, Y = AlkO, AlkS, Alk2N, CN, R2P(O), Hal, AlkS(O).
Carbanions 230, prepared by the deprotonation of the initial phosphoryl compound, react with
carbonyl compounds to afford β-phosphorylated alcohols 233, which can be isolated. The subsequent
treatment of alcohols 233 with strong bases, usually potassium tert-butoxide, leads to ketene acetals and
structurally related compounds 234 that are valuable precursors in the synthesis of organic compounds
of different kinds [23,24,132,133,143]. Further acid hydrolysis of compounds 234 produces carboxylic
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R'(R'')C=O
 
Scheme 71. Syntheses of carboxylic acids 235 by means of Horner’s reaction, R′,R” = H, Alk, Ar.
However, the simplest and most available phosphorylated formaldehyde acetals, dialkyl
(dialkoxymethyl)phosphonates 33, do not form stable carbanions [23,132], therefore the attempted
synthesis of carboxylic acids and their derivatives by Horner reaction failed for a long time. Among
acetals of phosphonate type compounds, only diethyl (5,6-dichloro-1,3-benzodioxomethyl)phosphonate
(91) participated in the reaction with ketones at 90 ◦C in dioxane in the presence of sodium hydride
NaH to give ketene acetals in 19–32% yields [23]. See also Section 3.3 “Alkylation of formacetal carbon
atom”.
Carboxylic acids were obtained for the first time by Horner reaction in 75–90% yields in
1968 by reacting tetraethyl (N,N-dimethylaminomethyl)diphosphonate (161) with aliphatic and
aromatic aldehydes [27]. After formation of the carbanion 222, the reaction proceeds through the
sequential formation of 1-dimethylaminoalkenylphosphonates—α-phosphorylated enamines 236, then
α-phosphinoylacyl derivatives 237, and finally yields free linear acids 238 (Scheme 72).
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Scheme 72. Synthesis of carboxylic acids 238 by reacting tetraethyl
(N,N-dimethylaminomethyl)diphosphonate (161) with aliphatic and aromatic aldehydes.
Since phosphorylated enamines 236 (synthesized from aliphatic aldehydes only) contain an
anion-stabilizing diethoxyphosphinoyl group in the α-position, the methylene group in the γ-position
is readily deprotonated under the action of strong bases. The resulting phosphorylated aminoallyl
anions 239 react with alkyl halides and finally form carboxylic acids 240 branched at the β-position via
the phosphorylated enamines 241. The reaction of anions 239 with aldehydes gives rise to hydroxy
compounds (242) and then to β,γ-disubstituted γ-butyrolactones 243 over unisolated γ-hydroxy





































Scheme 73. Syntheses of carboxylic acids 240 and γ-butyrolactones 243 from phosphorylated enamines
236.
Because only aldehydes react with compound 161 [27,132], this method of synthesis of carboxylic
acids is not widely used. However, compound 161 is employed for the preparation of substituted acetic
acids as intermediate stages in the synthesis of potential pharmaceuticals [124,145] and pesticides [28],























161 244  
Scheme 74. Synthesis of 2-benzothienylacetic acid 244 by Horner’s reaction.
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The successful homologation of aldehydes with the use of diphosphonate 161 stimulated further
search for the synthetic equivalents of formate carbanion 232 among organophosphorus compounds. In
1976–1977, linear (107) and cyclic dialkyl (dialkythiomethyl)phosphonates 113, 114 were proposed [21,
146]. These compounds can form a stable carbanion 245, and react with both aldehydes and ketones to
form ketene thioacetals 246 and further under subsequent hydrolysis (over thioesters 237) produce
homologous carboxylic acids 235 (Scheme 75), see also section “Alkylation of formacetal carbon
atom”. Ketene thioacetals 246 were obtained from ketones and aldehydes [102,146], including those






















Scheme 75. Syntheses of carboxylic acids 235 by reacting thiomethylphosphonates 107, 113, 114 with
aldehydes and ketones.
The reaction is observed also for diphenyl([1,3]-dithian-2-yl)phosphine oxide (122) [123,124]
and diethyl (1,3-benzodithiolylmethyl)phosphonate (247) [113,147]. Phosphonate 247 produces
benzo-analogs of ketene thioacetals, 1,4-benzodithiafulvenes 248, in 92–98% yields when reacted with













1) BuLi, THF, −78 °C 
Scheme 76. Syntheses 1,4-benzodithiafulvenes 248 from diphenyl([1,3]-dithian-2-yl)phosphine oxide
(122) by the reaction with carbonyl compounds.
Phosphorylated thioacetals 107, 113, 114 and thioacetals produced from its ketene 246, 248 have a
synthetic importance because, along with carboxylic acid synthesis, they undergo numerous reactions
to afford various products [23]. For example, aldehydes 250, branched out in α-position are formed
in the reduction of 1,4-benzodithiafulvenes 248 followed by hydrolysis (over the stage of reduced
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248 250249  
Scheme 77. Obtaining branched aldehydes 250 from 1,4-benzodithiafulvenes 248.
Methyl esters 251 result from thioacetal 252 methanolysis [149] (Scheme 78).
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2) BuLi, THF, −78 °C, 73% 65 °C, 85% 
Scheme 78. Synthesis of methyl esters 251 by methanolysis of thioacetal 252.
Dimethyl (dimethylthiomethyl)phosphonate 253 is used in the practice of contemporary organic
chemistry, for example, in the intermediate stages of synthesis of biologically active dipeptide mimetics
254 [149] (Scheme 79), the antibiotic thienamycin (255) [150] (Scheme 80), and “organic metals”
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BuLi, THF, −78 °C, 
Scheme 81. Example of synthesis of “organic metals” 256.
However, the long duration of the two-stage conversion of ketene thioacetals 246 into acids 235,
often in the presence of mercury Hg2+ [141] or copper Cu2+ salts [149] and the necessity of working
with mercaptans [23,141,154] limits the application of phosphorylated formaldehyde thioacetals 14 in
the Horner reaction.
Therefore, the search for efficient precursors for the synthesis of carboxylic acids 235 from carbonyl
compounds by the Horner reaction has continued. From the mid-1970s to the early 1980s, many
acetal-like derivatives of diethyl formylphosphonates 13–32 [18,19,21–56], where the negative charge
of the carbanion was stabilized by two heteroatoms of the “acetal” group, were obtained [54]. See
also Figure 2, where R = OEt. In the case of X =Me3Si, Peterson olefination prevails over the Horner
reaction [54–56,110] and trimethylsyloxy fragment is a leaving group.
Because the majority of compounds 18–32 have no substantial advantages over the phosphorylated
formaldehyde thioacetals 14, the study of Horner reaction with their participation was confined mainly
to academic interest. More detailed studies of reactivity of the majority of these compounds were
not conducted.
150
Molecules 2014, 19, 12949-13009
Among the compounds synthesized over this period, diethyl [(N,N-dialkylamino)cyano-
methyl]phosphonate (153) and diphenyl(dialkoxymethyl)phosphine oxides 50 were involved in
the practice of organic synthesis.
Compound 153 proposed in 1982 [24] reacts like dialkyl (dialkylthiomethyl)phosphonates 107
with aldehydes, in 50–69% yields, and acetophenone as ketone example, in 24% yield [24,132]. The
products of Horner reaction in this case are cyanoenamines 257, whose acid hydrolysis produces linear
























  -78 oC
153 218
257 238  
−78 °C 
Scheme 82. Carboxylic acids 238 synthesis by means of diethyl
[(N,N-dialkylamino)cyanomethyl]phosphonates 153, where R = Alk, Ph.
Like phosphorylated enamines 236 (Scheme 73), compound 257 contains an anion-stabilizing
CN-group in the α-position. Resulting cyanoaminoallyl anions 258 combine with alkyl halides to
form carboxylic acids 240 through cyanoenamines 259, while the reaction with aldehydes leads to
γ-hydroxy acids that undergo cyclization to give β,γ-disubstituted γ-butyrolactones 243 through cyano


































Scheme 83. Enamines 257 alkylation by means of alkyl halides or aldehydes leads to obtaining branched
acids 240 or butyrolactones 243.
Diethyl [(N-morpholino)cyanomethyl]phosphonate (154) was used in the synthesis of the
colerofragarone fragment—terminator of fungi Collerotrichum fragariac [155] (Scheme 84, compound
261).
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1) (254)
261  
THF, −78 °C, 71% 
Scheme 84. Synthesis of colerofragarone fragment 262 using diethyl
[(N-morpholino)cyanomethyl]phosphonate (154).
It was shown that compound 153 can react also with cyclic semiacetal 262, which was used in one
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2) BuLi, THF, 65 °C 
Scheme 85. Synthesis of 263, a semi-product of synthesis of the analog of cloprosterol PGF2 from cyclic
semiacetal 262 by means of phosphonate 153.
However, compound 153 was not widely used because of the low yields in its reactions
with ketones [25] and formation of hydrogen cyanide on hydrolysis of cyanoenamines. Almost
simultaneously with 153, a successful synthesis of ketene acetal at −110 ◦C starting from
diphenyl(dialkoxymethyl)phosphine oxides 50, over carbanion 195 and both aldehydes and ketones
was reported in 1983 [133]. Intermediate β-hydroxydiphenylphosphinoyl derivatives 264 were isolated
in almost quantitative yield that further react with potassium tert-butoxide (t-BuOK) to give ketene





























THF, −110 °C 
Scheme 86. Synthesis of ketene acetals 265 from diphenyl(dialkoxymethyl)phosphine oxides 50 through
conpounds 264 as intermediates.
This publication attracted no attention for a long time, although in 1993 it was shown that the
reaction of diphenyl(diethoxymethyl)phosphine oxide (266) with substituted cyclohexadienone in the
presence of lithium diisopropylamide leads to the formation of carboxylic acid 267 through the stages
of ketene acetal 268 and ethyl ester 269 formation [20,157] (Scheme 87).
152















  THF, -98 oC, 61%
1)   HCl aq.
     94%
1) NaOH·EtOH
2) HCl aq.
    88%
(266)
268 269 267  
THF, −  ° ,  
Scheme 87. Synthesis of carboxylic acid 267 from (diethoxymethyl)phosphine oxide (266) through
ketene acetal 268 and ethyl ester 269.
It was found in 2002, however, that the reaction of diphenyl(dimethoxymethyl)phosphine
oxide (209) with aliphatic aldehydes, in contrast to other phosphorylated equivalents of
formate anion—compounds 107, 112–115, 153 (154), 161 (166), may also result in derivatives
of α-hydroxycarboxylic acids 270 [140,158,159]. Initially formed β-hydroxydiphenylphosphinoyl
derivatives 271 in wet acidified dichloromethane readily decompose with the cleavage of the P–C
bond to afford methyl esters of α-hydroxycarboxylic acids 272 in 41–89% yield and diphenylphosphine




































Scheme 88. Synthesis and decomposition of β-hydroxydiphenylphosphinoyl compounds 271 lead to
methyl esters of α-hydroxycarboxylic acids 272.
It was further shown that ketene acetals 273 resulting from aldehydes and phosphine oxide
266 may be successfully oxidized [20,128,160] in the Sharpless asymmetric dihydroxylation—AD
reaction [161]. As a result, the esters of chiral α-hydroxycarboxylic acids 274, 275 were obtained in













AD mix a AD mix b
274 273 275  
Scheme 89. Using of Sharpless asymmetric dihydroxylation (AD reaction) for synthesis of chiral
α-hydroxycarboxylic acids 274, 275 from ketene acetals 273.
It should be noted that ketene thioacetals 246 do not undergo the AD reaction. Mixed O,S-acetal
18 reacts but yields and enantiomeric excess of α-hydroxycarboxylic acids do not exceed 7–37% and
80%, correspondingly [127,128]. The combination of Horner and AD reactions was successfully used
on one of stages of synthesis of the diterpenoid tonantzitlolone ( 276) [162] (Scheme 90).
153
































 THF, -110 oC-82 oC
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THF, −110 °C–82 °C 
1) t-BuOK, THF, 0 °C 
Scheme 90. Using of combination of Horner and AD reactions to obtain compound 276—intermediate
stage of synthesis of the diterpenoid tonantzitlolone.
The involvement of chiral α-alkylaminoaldehydes in the Horner reaction, correspondingly, leads




































THF, −110 °C 
Scheme 91. Synthesis of chiral β-amino acids 277 by the Horner reaction.
Sharpless asymmetric dihydroxylation followed of Horner reaction also provides an opportunity




































THF, −110 °C 
Scheme 92. Using of combination of Horner and AD reactions to form α-hydroxy-β-amino acid
diastereomers 278, 279 (R = t-BuOC(O)).
4. Phosphorylated Formaldehyde Halogenoaminals (Phosphorylated Vilsmeier–Haak Reagents)
17
At present, four types of phosphorus compounds are known that can
be related to phosphorylated Vilsmeier–Haak reagents: N,N,N′,N′-tetraisopropyl
[(N”,N”-diisopropylamino)methylydeniminium] phosphondiamide dichlorophosphate
(8) [12], dialkyl [(N,N-dimethylamino)chloromethyl]phosphonates 171 [31,32],
diphenyl[(N,N-dialkylamino)chloromethyl]phosphine oxides 280 [163], and structurally related to
the phosphorylated Vilsmeier–Haak reagents, diethyl [(N-acylamino)bromomethyl]phosphonates
281 [164] (Figure 6).
154



























Figure 6. Representatives of phosphorylated Vilsmeier–Haak reagents 8, 171, 280, 281 synthesized
to date.
No general methods of synthesis have been found for the compounds of this type 8, 171, 280, 281.
Their chemical properties also differ significantly from each other.
4.1. Synthesis of N,N,N′,N′-Tetraisopropyl [(N”,N”-Diisopropylamino)methylydeniminium] Phosphondiamide
Dichlorophosphate (8)
A sole paper was published in 1999 [12] on the synthesis of
N,N,N′,N′-tetraisopropyl [(N”,N”-diisopropylamino)methylydeniminium]phosphondiamide
dichlorophosphate (8) by the oxidation of N,N,N′,N′-tetraisopropyl
[(N”,N”-diisopropylamino)methylydeniminium]phosphindiamide dichlorophosphate (282)
with dimethyl sulfoxide DMSO (Scheme 93). However, the chemical properties of 8 are insufficiently




















282 8  
60 °C 
Scheme 93. Phosphindiamide dichlorophosphate 282 oxidation by means of DMSO leads to the
formation of phosphondiamide dichlorophosphate 8.
4.2. Synthesis and Chemical Properties of Dialkyl [(N,N-Dimethylamino)chloromethyl]phosphonates 171
The first compounds of this type, dimethyl [(N,N-dimethylamino)chloromethyl] phosphonate
(172) and diethyl [(N,N-dimethylamino)chloromethyl]phosphonate (173) were synthesized in
1969 [31,32]. For the first time, these compounds were obtained as intermediates in
the synthesis of tetraalkyl (N,N-dimethylaminomethyl)diphosphonates 174 by reaction of
N,N-dimethyl(chloromethylideneiminium) chloride (171) with trialkyl phosphites 58 [32]—see
Scheme 49, section “Diphosphinoyl N,N-dialkylaminomethanes”.
Preparative amounts of these compounds were prepared by a two-step scheme [30,31]. First,
the reaction of dimethylformamide dimethylacetal (78) with dialkyl phosphites 51 resulted in dialkyl
[(N,N-dimethylamino)methoxymethyl]phosphonates 162, which were further reacted with thionyl



























78 162 172 (Alk=Me)
173 (Alk=Et)  
20 °C 
0 °C, Et2O 
Scheme 94. Reaction dialkyl phosphites 51 and dimethylformamide dimethylacetal (78) leads to
phosphorilated halogenoaminals 172 (Alk =Me), 173 (Alk = Et).
This scheme is currently used [33,165]; phosphorus trichloride can be used instead
of thionyl chloride [83]. Dimethyl [(N,N-dimethylamino)chloromethyl]phosphonate (172)
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was found to undergo spontaneous dealkylation on storage [31], therefore only diethyl
[(N,N-dimethylamino)chloromethyl]phosphonate (173) is used in organic synthesis. Phosphonate
173, as a phosphorylated Vilsmeier–Haak reagent where one chlorine atom is substituted by a
diethoxyphosphoryl group, show electrophilic properties [166] inherent in compounds of such kind
and readily reacts with nucleophiles. Thus, compound 173 reacts vigorously with secondary amines,
carbazole, alcohols, thiols, and hydrophosphinoyl compounds 51, 53 in the presence of equimolar
amount of triethylamine. The reaction of α-phosphono-α-aminomethylation leads to the corresponding
diethoxyphosphinoylformaldehyde derivatives: asymmetric aminals 283, 284, aminoacetals 285,
aminothioacetals 286, and diphosphorylated N,N-dimethylaminomethanes 164 [30], including
unsymmetrical 165 [165] (Scheme 95). The reaction with aromatic and aliphatic amides RC(O)NH2, urea
and thiourea (NH2)2C=X [30] proceeds in a similar manner. Products of reactions are phosphorylated
amidoaminals 287, 288 and symmetrically disubstituted derivatives of urea and thiourea 289, 290


























































285 (X=O), 286 (X=S)
283
284 287 (R=Alk), 288 (R=Ar)
289 (X=O), 290 (X=S)
        164, 165;
173
 
Scheme 95. Reactions of diethyl [(N,N-dimethylamino)chloromethyl]phosphonate (173) with
nucleophilic co-reagents.
Diethyl [(N,N-dimethylamino)chloromethyl]phosphonate (173) reacts with arylsulfonamides to
lead to the cleavage of the phosphorus–carbon bond and give N-sulfonyl-substituted derivatives
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Scheme 96. Cleavage of phosphorus–carbon bond by means of the reaction of compound 173
with arylsulfonamides.
Compound 173 reacts with methyl aryl ketones [30] and dialkyl or aryl alkyl ketones [33] to give
diethyl [(N,N-dimethylamino)(aroyl(or alkanoyl)alkylmethyl)methyl]phosphonates 292 and 293 [30,33],
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phosphorylated analogs of natural α-amino acids potentially possessing biological activity [33]





























Scheme 97. Reaction of compound 173 with ketones leads to diethyl [(N,N-dimethylamino)(aroyl(or
alkanoyl)alkylmethyl)methyl]phosphonates 292 and 293.
Like ketones, the reaction of 173 proceeds also with aldehydes branched at the α-position to the
carbonyl group to give phosphorylated aminoaldehydes 294 and 295 (Scheme 98), but the reaction is




















Scheme 98. Reaction of compound 173 with aldehydes leads to phosphorylated aminoaldehydes 294
and 295.
The involvement of enamines instead of ketones as their synthetic equivalents in the reaction
with phosphonate 173 provides stereoselective synthesis of diethyl (α-methylamino-α-aroyl(or




























 oCR = Ar or Alk
173 292 296  
CH2Cl2, 20 °C 
Scheme 99. Synthesis of diethyl (α-methylamino-α-aroyl(or alkanoyl))methylphosphonates 292 and
phosphorylated vinyl ketones 296.
Diethyl [(N,N-dimethylamino)(aroyl(or alkanoyl)alkylmethyl)methyl]phosphonates 292, 293
(Schemes 101–103) are obtained as hydrochlorides in the above-stated syntheses. They are unstable
and on storage undergo spontaneous β-elimination of dimethylamino group as dimethylammonium
chloride—with conversion up to 40% over 24 h [30] to form the corresponding phosphorylated vinyl
ketones 296. The same result was achieved on the heating of hydrochlorides of compounds 292 and
293 to 100 ◦C over 45 min [30] or stirring their solutions in methylene chloride with silica gel at 20 ◦C
for 15 h [33]. The reaction of amino group elimination with the use of silica gel is also stereoselective:
the anti stereoisomers 292 produce only E isomers of vinyl compounds 297 [33] (Scheme 99).
The reaction of β-enaminonitriles 298 with compound 173 was used in the synthesis of substituted
nitriles of nicotinic acid 299 [167] (Scheme 100).
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Scheme 100. The reaction of compound 173 with β-enaminonitriles 298 leads to nitriles of nicotinic
acid 299.
As a phosphorylated Vilsmeier–Haak reagent, phosphonate 173 undergoes typical reactions with
activated aromatic compounds: N,N-dimethylaniline, triethylammonium salts of β-naphthol and
p-cresol, and heteroaromatic compounds: N-methylindole, N-methylpyrrole, α-methylfuran. The
synthesis of aromatic α-aminomethylphosphonates 300 is regiospecific: only one addition product












173 300  
Scheme 101. Interactions of phosphonate 173 with aromatic compounds (Ar =
4-dimethylaminophenyl; 2-hydroxynaphthyl-1; 2-hydroxy(5-methyl)phenyl; 1-methylaminoindol-3-yl;
1,5-dimethylaminopyrrol-2-yl; 5-methylfur-2-yl).
4.3. Syntheses and Chemical Properties of Diphenyl[(N,N-dialkylamino)chloromethyl]phosphine Oxides 280
Diphenyl[(N,N-dialkylamino)chloromethyl]phosphine oxides 280 are the diphenylphosphinoyl
analogs of dialkyl [((N,N-dialkylamino)chloromethyl]phosphonates. They are obtained by
the reaction of chlorodiphenylphosphine (68) with N,N-dialkylformamides in the presence of
10–20% of N,N-dialkylchloromethyleniminium chloride [Alk2N=C(H)Cl]+Cl− (168)—Vilsmeier–Haak



















Scheme 102. Synthesis of diphenyl[(N,N-dialkylamino)chloromethyl]phosphine oxides 280.
Although phosphine oxides 280 are the formal analogs of dialkyl
[(N,N-dialkylamino)chloromethyl]phosphonates 171, they differ substantially in reactivity. It
was shown by the example of diphenyl[(N,N-dimethylamino)chloromethyl]phosphine oxide (301)
that compounds 280 can dissociate in solutions with the cleavage of C–Cl and C–P bonds. See
also section “Cleavage of phosphorus–carbon bond”. The dissociation in solution results in the
formation of both diphenyl[(N,N-dimethylamino)chloromethyliden]phosphine oxide cation (302) and
diphenylphosphinite anion (193) [170] (Scheme 103).
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Scheme 103. Diphenyl[(N,N-dimethylamino)chloromethyl]phosphine oxide (301) dissociation in
solutions with a cleavage as bond C-Cl and bond C-P.
Therefore there are two kinds of reactivity for 301 (and accordingly 280) [163,170]:
electrophilic diphenyl[(N,N-dimethylamino)chloromethylidene]phosphine oxide cation (302) reacts
with nucleophiles such as hydrophosphinoyl compounds 6, 53, mixed diethyl trimethylsilyl
phosphite (EtO)2POSiMe3 and N,N-dimethylamino aniline PhNMe2, to give symmetrical 303,
R=Ph and unsymmetrical 304, R=OEt diphosphorylated N,N-dimethylaminomethanes and
diphenyl[(bis(4-N,N-dimethylamino)phenyl)methyl] phosphine oxide (305), the product of substitution
of both chloro and amino groups at the carbon atom of 301. However, nucleophilic diphenylphosphinite
anion (193) reacts with electrophiles: acetic aldehyde MeC(O)H, acetone Me2C(O), phenyl
isocyanate PhNCO, triethyl orthoformate (EtO)3CH, dimethylformamide dimethylacetal (79), and
bis(diethylamino)methane (Et2N)2CH2 to form addition or substitution products, α-phosphorylated





















































































Scheme 104. Reactions of diphenyl[(N,N-dimethylamino)chloromethyl]phosphine oxide (280) with
nucleophilic and electrophilic coreagents.
4.4. Synthesis and Chemical Properties of Diethyl [(N-Acylamino)bromomethyl]phosphonates 281
Diethyl [(N-acylamino)bromomethyl]phosphonates 281 were prepared in high yields by the
bromination of diethyl (N-acylamino)methylphosphonates 312 with N-bromosuccinimide (NBS) in
carbon tetrachloride [164,171] (Scheme 105).
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Scheme 105. Synthesis of diethyl [(N-acylamino)bromomethyl]phosphonates 281 where R = AlkC(O),
ArC(O), AlkS(O)2, ArS(O)2.
To date diethyl [(N-acylamino)bromomethyl]phosphonates 281 remain poorly studied, and
their chemical properties are insufficiently studied. Nonetheless, compounds 281, structurally
related to the phosphorylated Vilsmeier–Haak reagents, behave as electrophiles similarly to
dialkyl [(N,N-dimethylamino)chloromethyl]phosphonates 171 [166]. They react readily with such
nucleophiles as primary aliphatic and aromatic amines and secondary cyclic amines in the presence
of ethyldiisopropylamine—Hünig’s base as well as triethylamine (Scheme 106). Reaction products
are diethyl [(N-acylamino)aminomethyl]phosphonates 313, unsymmetrical amidoaminals of diethyl














Scheme 106. Transformation of bromomethylphosphonates 281 into unsymmetrical amidoaminals
313, where HNR′R” are morpholine, piperidine, pyrrole, 2-aminomethyltetrahydrofuran,
N-methylbenzylamine, and aniline.
The reaction of compounds 282 with sodium azide leads to diethyl
[(N-acylamino)azidomethyl]-phosphonates 314, valuable precursors in the synthesis
of phosphinoyl-substituted 1,2,3-triazoles, the products of 1,3-dipolar addition to
disubstituted alkynes [173,174]. A mixture of the resultant two regioisomers
of diethyl [(N-acylamino)(1-(1,2,3-triazolyl))methyl]phosphonates (315) and diethyl
[(N-acylamino)(2-(1,2,3-triazolyl))methyl]phosphonates (316) can be separated by chromatography on
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Scheme 107. Synthesis of (triazolylmethyl)phosphonates 315 and 316 from bromomethylphosphonates
281, where R′, R” = AlkC(O), ArC(O), AlkS(O)2, ArS(O)2.
Prolonged heating of acetonitrile solutions of 315 leads to migration of
[(N-acylamino)(diethylphosphinoyl)]methyl group from the first to the second nitrogen atom
(N1–N2 migration) of 1,2,3-triazole group to give 316. In the presence of nucleophiles, azide ion or
160
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imidazole, the triazole fragment is displaced to yield diethyl [(N-acylamino)azidomethyl]phosphonates




































Scheme 108. Reaction replacement of 1,2,3-triazole group of compound 315 with nucleophiles to give
compounds 314 and 317 and isomerisation of 315 into compound 316.
The treatment of phosphonates 281 with Hünig’s base i-Pr2NEt [164] or triethylamine Et3N [171]
in tetrahydrofuran at −78 ◦C was shown to result in diethyl [(N-acyl)iminomethyl]phosphonates 318
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THF, −78 °C 
Scheme 109. Synthesis of diethyl [(N-acyl)iminomethyl]phosphonates (318) from phosphonates 281.
5. Alkyl (dialkoxymethyl)phosphinates—H-Phosphinates 34. Syntheses and Chemical Properties
The synthesis of alkyl (dialkoxymethyl)phosphinates—H-phosphinates 34 in yields up to 96% by
the reaction of hypophosphorous acid (319) with orthoformates 54 in the presence of catalytic amounts
amounts of p-toluenesulfonic acid (p-TolSO3H) [57,175] or trifluoroacetic acid (CF3SO3H) [58] was











p-TolSO3H or CF3SO3H 
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HO O
H
319 54 34  
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Scheme 110. Synthesis of alkyl (dialkoxymethyl)phosphinates 34.
The chemical properties of phosphinates 34 were studied almost exclusively by the example of
ethyl (diethoxymethyl)phosphinate (86). Ethyl (diethoxymethyl)phosphinate (86) retains properties
typical for both phosphorus esters and hydrophosphoryl compounds and retains the general ability of
phosphorylated formaldehyde acetals to undergo the cleavage of the phosphorus–carbon bond.
Phosphinate 86 is readily alkylated under the action of alkyl halides in the presence of bases:
Na, NaH, BuLi (B−) (via anion 320) to give ethyl alkyl(diethoxymethyl)phosphinates 321 [58,176]
(Scheme 111).
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Scheme 111. Phosphinate 86 alkylation with alkylhalydes.
Compound 86 also readily undergoes addition to activated double bonds, or it can transform into
three-coordinated phosphorus compounds [59,176,177], for example, in Scheme 112, compounds 322
























Scheme 112. Transformations of compound 86 into phosphinate 322 and a three-coordinated
phosphorus compound (phosphinite 323).
It also undergoes Todd–Atherton reaction with phenols and cross-coupling reactions with
aryl bromides [106] in the presence of tetrakis(triphenylphosphine)palladium(0), Pd(Ph3P)4, see
Scheme 17. In 86, one of two P–H bonds of initial hypophosphorous acid 319 is protected by a
diethoxymethyl group and can be restored in subsequent stages after deprotection [58,176]. When
treated with two equivalents of organomagnesium or organolithium compounds, phosphinate 86
produces secondary phosphine oxides 324 [178], a hidden form of unstable primary phosphine oxides
325 apt to disproportionation [179], that can be easily obtained by subsequent acid hydrolysis. Further
alkylation of secondary phosphine oxides 324 in the presence of a base leads to unsymmetrical tertiary
phosphine oxides 326, which in turn are the hidden form of unsymmetrical secondary phosphine oxides
328. Similarly to primary phosphine oxides 325, compounds 327 can be also obtained by subsequent
acid hydrolysis of tertiary phosphine oxides 326. Further oxidation leads to the corresponding
phosphonic 328 and unsymmetrical phosphinic acids 329. Unsymmetrical tertiary phosphine oxides
330 can be obtained by the following alkylation of secondary phosphine oxides 327 (Scheme 113).
162





















































86 324 325 327
326 328 329
330  
Scheme 113. Using phosphinate 86 for the synthesis of phosphine oxides 325, 328, 330, phosphonic
328 and unsymmetrical phosphinic acids 329.
Phosphonic and unsymmetrical phosphinic acids 328 and 329 can also be obtained by the scheme
that begins with the alkylation reaction by introducing 86 in the reaction of one or sequentially both P–H
bonds, thus solving the problem of selectivity [58,59,176,178], over phosphinates 331 and H-phosphinic
acids 332, respectively. The scheme allows one to avoid the use of highly toxic hypophosphorous acid





























Scheme 114. Phosphonic 328, H-phosphinic 332 and unsymmetrical phosphinic acids 329 syntheses
starting with the reaction of 86 with electrophiles, where E = RHal or olefins with the activated
double bond.
Due to the unique combination of chemical properties, phosphinate 86 is used in modern
organic synthesis and synthesis of biologically active compounds. H-phosphinic analogs of natural
α-amino acids 333 were obtained with >95% enantiomeric excess by the reaction of 86 with chiral
(S)-N-tert-butylsulfinylketimines (334) [180] (Scheme 115).
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Scheme 115. Synthesis of H-phosphinic analogs of natural α-amino acids 333 by means of the reaction
of phosphinate 86 with chiral (S)-N-tert-butylsulfinylketimines 334.
3-Amino-2-fluoropropyl-H-phosphinic acid (335), a γ-aminobutyric acid (GABA) analog, a
potential pharmaceutical for the treatment of central nervous system diseases, was prepared from
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Scheme 116. Silylated compound 323 used for the synthesis of γ-aminobutyric acid analog 335.
Disubstituted 3-aminopropyl-4-pyridylphosphinic acid (336), a potential neurotropic
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Scheme 117. Synthesis of potential neurotropic pharmaceutical, GABA antagonist 336.
6. Phosphorylated Formaldehyde Hydrates—Geminal Diols 35. Syntheses and Chemical
Properties
The chemistry of phosphorylated formaldehyde hydrates 35 began to develop since the mid
1990s when diethyl (dihydroxymethyl)phosphonate (337) was obtained in quantitative yield by the
164
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reaction of diethyl (diazomethyl)phosphonate (338) with 3,3-dimethyldioxirane—acetone peroxide at
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Scheme 118. Synthesis of diethyl (dihydroxymethyl)phosphonate (337) by the reaction of
diazomethylphosphonate (338) with 3,3-dimethyldioxirane.
It was shown that 337 exists in an equilibrium with the hydrated form of diethyl formylphosphonate
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Scheme 119. Equilibrium between diethyl (dihydroxymethyl)phosphonate (337) and the hydrated
form of diethyl formylphosphonate 3.
The chemical properties of phosphonate 337 provide the possibility of considering it as a hidden
form of phosphorylated formaldehyde. Compound 337 reacts with secondary amines R′2NH with
the cleavage of the phosphorus–carbon bond and formation of the corresponding N,N-disubstituted
formamides and diethyl phosphite (6) [60,61] (it behaves as a source of formyl group [C(O)H]+ cation,
synthon type a1 [183,184].
Compound 337 also shows properties of a typical aldehyde when reacted with primary
amines RNH2, trimethylsilyl cyanide Me3SiCN, and hydroxylamine NH2OH to give phosphorylated








































Scheme 120. Reactions of compound 337 with some coreagents, where R= t-Bu or Ph.
As a hidden form of diethyl (formyl)phosphonate (3), phosphonate 337 in the presence of silver
trifluoroacetate AgOTf as a catalyst undergoes a Mannich reaction with anisidine and terminal alkyl-
165
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or aryl-substituted alkynes. Reaction products, α-aminopropargylphosphonates 342, are valuable
precursors in the synthesis of α-aminophosphonic acids showing high biological activity as α-amino
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Scheme 121. Catalytical synthesis of α-aminopropargylphosphonates 342 by a Mannich reaction.
In the presence l-proline amide (343) as a catalyst, 337 undergoes an asymmetrical cross aldol
condensation with aliphatic ketones. Diastereomerically pure α-hydroxyphosphonates 344, precursors
of α-hydroxyphosphonic acids, result from chirality induction with diastereomeric excesses greater
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Scheme 122. Synthesis of diastereomeric α-hydroxyphosphonates 344 by asymmetrical
cross-aldol condensation.
Like α-aminophosphonic acids, α-hydroxyphosphonic acids are also α-amino acid mimetics and
exhibit high biological activity [185]. Similar results were obtained in the aldol condensation of ketones
with racemic ethyl phenyl(dihydroxymethyl)phosphinate (345). In this case, the final products are
α-hydroxyphosphinic acids 346 [62].
7. Conclusions
Phosphorylated formaldehyde derivatives, i.e., acetals and related compounds, are a group of
largely underinvestigated species. The experimental data accumulated since the early 1960s confirm
that these compounds can be used in a wide variety of syntheses that have not been fully realized
to date. For this reason, the growth of interest to these compounds will allow investigating their
chemical properties in more detail and potentially enrich organic and organoelement chemistry with
new synthetic methods.
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Abstract: The aim of this work was to synthesize selected thiophene-derived aminophosphonic
systems and evaluate the phytotoxicity of newly obtained products according to the OECD 208
Guideline. Seven new thiophene-derived N-substituted dimethyl aminomethylphosphonic acid esters
2a–h were synthesized by the addition of an appropriate phosphite to azomethine bond of starting
Schiff bases 1a–h, and NMR spectroscopic properties of aminophosphonates were investigated.
These eight compounds were analyzed in regard to their phytotoxicity towards two plants, radish
(Raphanus sativus) and oat (Avena sativa). On the basis of the obtained results, it was found that
tested aminophosphonates 2a–h showed an ecotoxicological impact against selected plants, albeit to
various degrees.
Keywords: thiophene-derived aminophosphonates; phytotoxicity; growth inhibition; environmental
protection; ecotoxicology; OECD standard
1. Introduction
Nowadays, since production of food in agricultural areas is in the phase of intensive growth, the
use of herbicides is absolutely necessary to manipulate or control undesirable vegetation of plants.
Herbicides are used in landscapes throughout all over the world and are generally accepted as a
moderately safe compounds. However, widespread use or overdosage of herbicides over long periods
of time can result in residues in crops, soil, and land waters and, as a consequence, may lead to health
and environmental risks [1–4]. Permanent applications of a given herbicide can result in resistance
of a weed to the agent. Consequently, the weeds, while becoming resistant will not respond to the
herbicide’s active properties [5,6]. With this respect, there is a necessity of designing new compounds
with potential herbicidal properties.
Sulfur-containing compounds, which have been developed as agrochemicals for plant protection,
are currently being reviewed from the standpoint of their use and biological properties in each field of
fungicides, insecticides, or herbicides [7–9].
Sulfur-containing herbicides are successfully and widely used as a foliar (applied to weed foliage)
and a soil-applied herbicide absorbed by the root or shoot of emerging seedlings.
Biodegradability, photodegradation, persistence, soil mobility, and the accumulation in living
organisms of sulfur-containing herbicides are currently in extensive research phases [10–14].
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Designing new sulfur-containing compounds with potential herbicidal activity in soil, their
persistence in soil must be taken into consideration. On the one side, herbicides, which are applied
to the soil, typically affect seed emergence or the growth of weed seedlings and must remain in the
soil to be effective. Unfortunately, on the other side, some herbicides like thifensulfuron-methyl can
persist in the environment for a long time, becoming harmful agents for the surrounding environment.
Therefore, planning the synthesis, it is difficult to strike a balance between the activity of a compound
and its biodegradability in soil [15].
Biological properties of thiophene-deriving aminophosphonates have been largely studied [16–20].
Scientists found several of them to be promising plant protection agents [16] or to have rather strong
antimicrobial [17], cytotoxic [18], antifungal [19,20], or even antiviral [20] properties. Therefore,
working on new variations of methods for synthesis of aminophosphonic systems, chemists include
derivatives bearing thiophene moiety as examples [17,21–26]. It is to stress that all those methodologies
are mostly based on the Kabachnik–Fields reaction [27–29].
Working on our large project aimed at the search of a new class of herbicidal agents, we feel
obliged to perform tests of phytotoxicity of newly synthesized compounds, especially when these
compounds are aminophosphonic derivatives, which are known generally to have moderate-to-strong
phytotoxic action on higher plants [30–33].
Our previous investigation provided results demonstrating that aminophosphonic acids
bearing furfuryl moiety (derivatives of C-furfurylphosphonoglycine) are compounds of moderate
phytotoxicity being able to kill both monocotyledonous oat (Avena sativa) and dicotyledonous radish
(Raphanus sativus) with an amount of 100–200 mg in 1 kg of soil [34].
The presented research is concerned with a screening test of a synthesized series of
variously N-substituted dimethyl amino(2-thienyl)methylphosphonates (2a–g) and dibenzyl
N-furfurylamino(2-thienyl)methylphosphonate (2h) with respect to their phytotoxic properties. Our
assumption was that the potential hazard of thiophene-derived aminophosphonates is important
enough in the light of their possible applications and therefore should be investigated.
Apart from that, we performed the preliminary evaluation of aminophosphonates 2a–h as
potential soil-applied herbicides for agricultural/horticultural purposes. The potential effects of
herbicides strongly results from their mechanism of action and the way they are applied. Since
some types of herbicides are non-selective, which means the chemicals kill all classes of plants,
not only unwanted weeds, for the proposed experiment, but also two types of plants (mono- and
dicotyledonous) have been chosen as experimental objects.
2. Results and Discussion
2.1. Chemistry
Schiff bases 1a–h were synthesized following the published and commonly known procedure of
simple mixing thiophene-2-carboxaldehyde with appropriate amine in methanol and stirring them
at room temperature for 24 h [35]. This procedure produced imines 1a–h, which were isolated and
used for further conversions without any purification. 1H-NMR spectra were made only to verify
the identity, based on the 1H-NMR diagnostic singlet of a proton of the azomethine group (–CH=N–)
above 8 ppm [31,32].
Aminophosphonates 2a–h were synthesized basing on the aza-Pudovik reaction—a slightly
modified procedure of a dimethyl or dibenzyl phosphite addition to the azomethine bond of
corresponding Schiff bases 1a–h in boiling toluene for 5 h. After the workup described in Section 3,
the resulting aminophosphonates 2a–h were obtained in 60%–70% yields (Scheme 1).
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Scheme 1. Synthesis of thiophene-derived aminophosphonates 2a–h.
2.2. Evaluation of Phytotoxicity of Aminophosphonates 2a–h
The rate of growth and development of plants as well as their quality, including increased number
and size of leaves and stems, is strongly dependent (as commonly known) on the ground composition.
Since plants have a high amount of water, its level depends on the contents of water in its environment,
so taking dry mass as a measure of plant growth seems to be more credible.
Water content is given as a percentage of the dry or fresh weight. To assess the phytotoxicity of the
analyzed compounds, the emergence and weight (dry and green) of control plant seedlings, with the
emergence and mass (dry and green) of plant seedlings growing on the soil with a given admixture of
the examined substances 2a–h, were determined and compared. Dry weight changes of tested plants
are shown in Figure 1. The visual assessment of any damage of tested plants concerns mainly the
degree of plant growth inhibition, which is evaluated by visible or other signs of necrosis of chlorosis.
Necrosis is the symptom of the death of plant tissues or organs caused by infection. Leaf and/or
stem deformation may also be observed, while chlorosis is an inhibition of chlorophyll biosynthesis,















Concentration of compound (mg/kg  of soil d.w.)
2a 2b 2c 2a 2b 2c
Figure 1. Changes of dry weight of treated plants expressed as percent to the value in untreated plants
(control plants = 100% of dry weight). Solid lines represent changes of oat dry weight. Dotted lines
represent changes of radish dry weight.
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Preliminary tests for aminophosphonates 2a–c for both oat and radish have shown inhibitive
effects for plants. The dicotyledonous radish was noticed as the more sensitive plant when compared
to sprouts of oat. Comparing results of toxicity of aminophosphonates 2a–c for both types of tested
plants, it was noticed that Compounds 2a and 2b are more toxic as compared with 2c (Tables 1 and 2
Figures 1–4).
Table 1. Average changes (mean of three replicates) in basic parameters of the plant growth test for oat
(Avena sativa) treated with 2a–c. Least significant difference for samples (LSDS) and concentration
(LSDC) is given for each tested parameter. %F.M. refers to plant biomass (fresh weight) expressed as
percent of untreated control.
Sample Concentration in Soil








0 20 100 2.780 100
1 19 97 2.682 96
10 19 95 2.654 95
100 19 97 2.919 105
200 19 95 2.644 95
400 19 95 2.715 98
800 18 88 2.100 76
1000 18 90 1.847 66
0 20 100 2.780 100
1 19 95 2.740 99
10 19 97 2.663 96
100 19 97 2.729 98
200 19 97 2.651 95
400 20 98 2.661 96
800 18 92 2.021 73
1000 18 92 1.659 60
0 20 100 2.780 100
1 19 97 2.759 99
10 20 98 2.704 97
100 20 98 2.801 101
200 19 97 2.862 103
400 20 98 2.762 99
800 19 95 2.643 95
1000 19 95 2.253 81
LSDS = 1 LSDS = 0.401
LSDC = 1 LSDC = 0.245
All the other results, to avoid confusion concerned with a large amount of data, have been placed in
Supplementary Materials. To describe results, moreover, the demonstrated values of no observed effect
concentration (NOEC) and lowest observed effect concentration (LOEC), changes in the fresh mass of plants were
expressed as % inhibition compared to control and presented as EC50 (Figure 2). Effective concentration EC50
was calculated using GraphPad Prism software (Version 7, GraphPad Software, Inc., La Jolla, CA 92037, USA).
Table 2. Average changes (mean of three replicates) in basic parameters of the plant growth test for
radish (Raphanus sativus) treated with 2a–c.
Sample Concentration in Soil








0 20 100 4.951 100
1 20 100 4.908 99
10 19 97 4.831 98
100 19 98 4.728 95
200 18 93 3.928 79
400 16 83 1.752 35
800 18 90 1.136 23
1000 15 75 0.772 16
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Table 2. Cont.
Sample Concentration in Soil








0 20 100 4.951 100
1 20 100 4.803 97
10 19 95 4.843 98
100 19 97 4.728 95
200 19 97 3.928 79
400 17 86 2.142 43
800 17 88 1.546 31
1000 15 78 1.106 22
0 20 100 4.951 100
1 19 98 4.914 99
10 19 98 4.798 97
100 19 98 4.873 98
200 19 97 4.787 97
400 18 93 3.934 79
800 18 93 3.328 67
1000 17 86 2.733 55
LSDS = 1 LSDS = 0.435
LSDC = 1 LSDC = 0.267
Least significant difference for samples (LSDS) and concentration (LSDC) is given for each tested parameter.





































Figure 2. The EC50 values of fresh weight inhibition following exposure to tested compounds.
Figure 3. Cont.
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Figure 3. Digital photographs of oat treated with 2a–c (concentration in mg/kg of soil dry weight) on
the 14th day of growth.
Figure 4. Digital photographs of radish treated with 2a–c (concentration in mg/kg of soil dry weight)
on the 14th day of growth.
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N-methylphenyl aminophosphonates with ortho and meta substituted phenyl ring (2a, 2b)
have a significantly stronger influence on the inhibition of plant growth as compared with
N-para-methylphenyl aminophosphonate (2c). In a case of oat, the values of NOEC and LOEC
for Compounds 2a and 2b were 400 and 800 mg/kg of soil dry weight, respectively. These values
for Compound 2c were higher (NOEC and LOEC 800 and 1000 mg/kg d.w. of soil), indicating lower
toxicity and subsequently higher tolerance of oat against this substance (Figure 3).
At the highest concentration (1000 mg), a ca. 40% decrease in fresh matter of oat sprouts for
Compounds 2a and 2b when compared to control plants is observed (Table 1).
To make the description of the obtained results more readable and user-friendly, we only present
selected tables and figures to the main text here (Tables 1 and 2, Figures 1–4).
Tested substances were much more toxic for the seedlings of radish, resulting in a decrease in
NOEC and LOEC values. The first observed negative symptoms of tested 2a–c compounds against
radish were observed for the concentrations of 200 mg/kg of dry weight of soil (Samples 2a, 2b) and
of 400 mg/kg of dry weight of soil for Compound 2c (Figure 4). A very high drop of fresh weight of
radish seedling was noticed for all compounds (2a–c), but aminophosphonates 2a and 2b were more
toxic. At the concentration of 1000 mg/kg of dry weight of soil, a decrease in radish fresh weight,
resulting from the action of Compounds 2a–c, was 16%, 22%, and 55%, respectively. High values
of dry matter at higher concentrations of the tested substances in pots correspond with a stronger
inhibition of water uptake through the root system of plants (Figure 1). The increase in values of oat
dry matter when compared to control plants is not as high as in the case of radish, which indicates
better tolerance of oat roots against tested substances and moderately observed disturbances in the
water uptake process.
The number of emerged seedlings at higher concentrations of tested compounds also decreased
and was more visible for radish.
A plant growth test conducted for aminophosphonates bearing methoxy groups substituted in
position meta (2d) and para (2e) in a phenyl ring have proved their toxic impact against both types of
plants. Contrary to Compounds 2b–c substituted with meta-methyl and para-methylphenyl groups,
respectively, the examined N-m-methoxyphenyl derivative 2d was less toxic for both radish and oat
as compared with N-p-methoxyphenyl derivative 2e (Tables S1 and S2, Figures S1–S3). The NOEC
and LOEC values in the oat growth test for Compounds 2d were much higher (800 and 1000 mg
respectively) when compared to 2e (100 and 200 mg respectively). The same values of NOEC and
LOEC of Sample 2e were revealed for radish. Again, as in the case of Compounds 2a–c, the much
more sensitive plant was radish. In comparison, the yield of the fresh matter of oat at the highest
concentration (1000 mg) of 2d and 2e was 19% and 31% (respectively) lower compared to non-treated
plants. The yield of the fresh weight of radish at the highest concentration did not exceed 29% (for 2d)
and 13% (for 2e) of fresh matter of control plants. The high increase in dry matter values point out the
dysfunction of roots (Figure S1).
Comparing the phytotoxicity results of aminophosphonates 2f, 2g, and 2h, Compound 2h was the
most toxic agent for both plants. NOEC and LOEC values of Compound 2h were the same for radish
and oat—40 and 80 mg/kg of dry matter, respectively. Among Compounds 2f and 2g, the former
had a higher negative impact on treated radish and oat. It was shown again that the more sensitive
specimen of plant was radish. A very low yield of fresh matter for radish at the highest concentration
(1000 mg) when compared to non-treated plants with simultaneously very high dry matter of plants
indicates a strong inhibition of plant growth (both sprouts and roots) (Tables S3–S5, Figures S4–S8)
It is worth comparing the plant growth of Samples 2a–c with 2f, the non-aromatic amine
derivative bearing the non-substituted phenyl ring. Sample 2f is much more toxic against oat
when compared to 2a–c. In the case of radish, results are comparable to those obtained for
Samples 2a,b (the same values of NOEC and LOEC). Samples 2a and 2b, as well as N-benzyl
derivative 2f, in the highest applied concentration (1000 mg/kg), harmfully influenced radish
seeds especially, while for oat, at the same concentration, Sample 2f (without substituted phenyl
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ring with methyl group) caused almost total inhibition of sprout germination. As a result,
contrary to dimethyl N-benzylamino(2-thienyl)methylphosphonate (2f), which kills both plants
in a non-selective way, dimethyl N-(2-methylphenyl)amino(2-thienyl)methylphosphonate (2a) and
dimethyl N-(3-methylphenyl)amino(2-thienyl)methylphosphonate (2b) were found to be selectively
toxic towards radish, slightly harming oat.
3. Materials and Methods
3.1. Chemistry
All solvents (POCh, Gliwice, Poland) were routinely distilled and dried prior to use. Amines,
dimethyl and dibenzyl phosphites, as well as 2-thiophenecarboxaldehyde (Aldrich, Poznań, Poland)
were used as received. Melting points were measured on a MelTemp II apparatus (Bibby Scientific
Limited, Staffordshire, UK) and were not corrected. NMR spectra were recorded on a Bruker Avance III
600 MHz (Billerica, MA, USA) operating at 600 MHz (1H-NMR), 150 MHz (13C-NMR), and 243 MHz
(31P-NMR). TMS was used as the internal standard for 1H- and 13C-NMR, and phosphoric acid was
used as the external standard for 31P-NMR. The following abbreviations were used for listing NMR
signals: s—singlet, d—doublet, dd—doublet of doublets, ddd—doublet of doublet of doublets, and
m—multiplet. Elemental analyses were carried out at the Centre for Molecular and Macromolecular
Science of the Polish Academy of Science in Łódź, Poland.
General Procedures of Preparaing Amino(2-thienyl)methylphosphonates 2a–h
2-Thiophenecarboxaldehyde (1.12 g, 10 mmol) was dissolved in methanol (15 mL), and a solution
of an appropriate amine (10 mmol) in methanol (15 mL) was added. The obtained solution was stirred
at room temperature for 24 h. Then, a small portion of anhydrous potassium carbonate was added,
the mixture stirred for additional 15 min. Then, the inorganic salt was filtered off, and the filtrate was
evaporated to achieve imines in quantitative yields, which were used for the further reaction without
any purification.
Thus, the obtained imine (10 mmol) was dissolved in acetonitrile (15 mL), and an appropriate
phosphite (10 mmol) in acetonitrile (15 mL) was added. The mixture was refluxed during the day and
stirred at room temperature during the night. Total time of the reaction was 72 h. Then, the solvent
was evaporated, and the crude product was isolated and purified using various procedures.
Dimethyl aminophosphonates 2a–g were isolated as follows: crude products were dissolved
in DCM (30 mL), and the solution was washed 5 times with saturated aqueous sodium hydrogen
carbonate. After the usual workup, DCM was evaporated, and the product was purified by column
chromatography on silica gel using ethyl acetate-hexane in a 4:1 ratio.
Product 2h was chromatographed after evaporating acetonitrile, eluted using ethyl
acetate—hexane in a 3:2 ratio.
Dimethyl N-(2-methylphenyl)amino(2-thienyl)methylphosphonate (2a): Yield = 83% (2.58 g) yellow oil.
1H-NMR (CDCl3, 600 MHz): δ 7.27–7.25 (m, H5thioph, 1H), 7.21–7.19 (m, H3thioph, 1H), 7.11 (d,
3JHH = 7.4 Hz, o-C6H4, 1H), 7.07 (ddd, 3J(1)HH = 3J(2)HH = 7.4 Hz and 4JHH = 1.7 Hz, o-C6H4, 1H), 7.01
(ddd, 3JHH = 5.0 and 4.2 Hz and 4JHH = 0.7 Hz, H4thioph, 1H), 6.74 (ddd, 3J(1)HH = 3J(2)HH = 7.4 Hz and
4JHH = 1.0 Hz, o-C6H4, 1H), 6.65 (d, 3JHH = 7.4 Hz, o-C6H4, 1H), 5.16 (d, 2JPH = 23.7 Hz, CHP, 1H), 3.82
(d, 3JPH = 10.6 Hz, POCH3, 3H), 3.67 (d, 3JPH = 10.6 Hz, POCH3, 3H), 2.28 (s, CH3, 3H). 13C-NMR
(CDCl3, 150 MHz): δ 143.98 (d, 2JCP = 12.3 Hz, C2thioph), 139.81 (Carom), 130.41 (Carom), 127.19 (d,
J = 2.5 Hz, Cthioph), 127.03 (Carom), 126.19 (d, J = 7.2 Hz, Cthioph), 125.43 (d, J = 3.4 Hz, Cthioph), 123.39
(Carom), 118.86 (Carom), 111.48 (Carom), 54.17 (d, 2JCP = 7.0 Hz, POC), 53.88 (d, 2JCP = 7.3 Hz, POC),
51.84 (d, 1JCP = 157.8 Hz, PC), 17.47 (ArC). 31P-NMR (243 MHz, CDCl3): δ 23.33. Elem. Anal. Calcd.
for C14H18NO3PS: C, 54.01, H, 5.83, N, 4.50. Found: C, 54.18, H, 5.97, N, 4.59.
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Dimethyl N-(3-methylphenyl)amino(2-thienyl)methylphosphonate (2b): Yield = 94% (2.92 g) yellow crystals,
m.p.: 81–83 ˝C. 1H-NMR (CDCl3, 600 MHz): δ 7.26–7.25 (m, H5thioph, 1H), 7.21–7.20 (m, H3thioph,
1H), 7.07 (dd, 3JHH = 7.2 and 7.0 Hz, m-C6H4, 1H), 7.01 (m, H4thioph, 1H), 6.62 (d, 3JHH = 7.0 Hz,
m-C6H4, 1H), 6.55 (s, m-C6H4, 1H), 6.52 (dd, 3JHH = 7.2 Hz and 4JHH = 1.9 Hz, m-C6H4, 1H), 5.11 (d,
2JPH = 24.4 Hz, CHP, 1H), 3.82 (d, 3JPH = 10.4 Hz, POCH3, 3H), 3.65 (d, 3JPH = 10.8 Hz, POCH3, 3H),
2.28 (s, CH3, 3H). 13C-NMR (CDCl3, 150 MHz): δ 145.94 (d, 2JCP = 13.1 Hz, C2thioph), 139.68 (Carom),
139.10 (Carom), 129.15 (Carom), 127.17 (d, J = 3.1 Hz, Cthioph), 126.25 (d, J = 7.3 Hz, Cthioph), 125.41 (d,
J = 4.0 Hz, Cthioph), 120.09 (Carom), 114.94 (Carom), 111.01 (Carom), 54.13 (d, 2JCP = 6.7 Hz, POC), 53.83
(d, 2JCP = 7.4 Hz, POC), 51.73 (d, 1JCP = 158.4 Hz, PC), 21.54 (ArC). 31P-NMR (243 MHz, CDCl3): δ
23.20. Elem. Anal. Calcd. for C14H18NO3PS: C, 54.01, H, 5.83, N, 4.50. Found: C, 54.17, H, 5.79, N, 4.51.
Dimethyl N-(4-methylphenyl)amino(2-thienyl)methylphosphonate (2c): Yield = 54% (1.68 g) yellow crystals,
m.p.: 98–100 ˝C. 1H-NMR (CDCl3, 600 MHz): δ 7.25–7.24 (m, H5thioph, 1H), 7.20–7.19 (m, H3thioph,
1H), 7.05–6.98 (m, H5thioph, p-C6H4, 3H), 6.64 (part of AA’XX’ system, 3JHH = 9.0 and 4JHH = 1.2
and 1.1 Hz, p-C6H4, 2H), 5.09 (d, 2JPH = 24.0 Hz, CHP, 1H), 3.82 (d, 3JPH = 10.8 Hz, POCH3, 3H),
3.65 (d, 3JPH = 10.8 Hz, POCH3, 3H), 2.24 (s, CH3, 3H). 13C-NMR (CDCl3, 150 MHz): δ 143.63 (d,
2JCP = 13.4 Hz, C2thioph), 139.77 (Carom), 129.79 (Carom), 128.40 (Carom), 127.15 (d, J = 2.4 Hz, Cthioph),
126.26 (d, J = 7.4 Hz, Cthioph), 125.41 (d, J = 3.4 Hz, Cthioph), 114.25 (Carom), 54.13 (d, 2JCP = 7.1 Hz,
POC), 53.81 (d, 2JCP = 7.1 Hz, POC), 52.12 (d, 1JCP = 157.9 Hz, PC), 20.40 (ArC). 31P-NMR (243 MHz,
CDCl3): δ 23.27. Elem. Anal. Calcd. for C14H18NO3PS: C, 54.01, H, 5.83, N, 4.50. Found: C, 54.13, H,
5.88, N, 4.63.
Dimethyl N-(3-methoxyphenyl)amino(2-thienyl)methylphosphonate (2d): Yield = 72% (2.35 g) yellow oil
1H-NMR (CDCl3, 600 MHz): δ 7.26–7.25 (m, H5thioph, 1H), 7.20–7.19 (m, H3thioph, 1H), 7.08 (dd, J1 = J2
= 7.8 Hz, m-C6H4, 1H), 7.01–6.99 (m, H4thioph, 1H), 6.35–6.34 (m, m-C6H4, 1H), 6.33–6.31 (m, m-C6H4,
1H), 6.28–6.26 (m, m-C6H4, 1H), 5.10 (d, 2JPH = 24.0 Hz, CHP, 1H), 3.81 (d, 3JPH = 10.8 Hz, POCH3,
3H), 3.74 (s, OCH3, 3H), 3.65 (d, 3JPH = 10.8 Hz, POCH3, 3H). 13C-NMR (CDCl3, 150 MHz): δ 160.77
(Carom), 147.34 (d, 2JCP = 13.5 Hz, C2thioph), 139.46 (Carom), 130.12 (Carom), 127.2 (d, J = 3.0 Hz, Cthioph),
126.3 (d, J = 6.9 Hz, Cthioph), 125.5 (d, J = 3.5 Hz, Cthioph), 106.91 (Carom), 104.38 (Carom), 100.23 (Carom),
55.08 (ArOC), 54.12 (d, 2JCP = 6.7 Hz, POC), 53.90 (d, 2JCP = 6.7 Hz, POC), 51.69 (d, 1JCP = 158.4 Hz,
PC).31P-NMR (243 MHz, CDCl3: δ 23.06. Elem. Anal. Calcd. for C14H18NO4PS ˆ 1/5 C6H14: C, 52.98,
H, 6.08, N, 4.06. Found: C, 52.97, H, 5.96, N, 4.38.
Dimethyl N-(4-methoxyphenyl)amino(2-thienyl)methylphosphonate (2e): Yield = 80% (2.62 g) yellow oil.
1H-NMR (CDCl3, 600 MHz): δ 7.25–7.23 (m, H5thioph, 1H), 7.18–7.16 (m, H3thioph, 1H), 6.99–6.98 (m,
H4thioph, 1H), 6.75 and 6.66 (AA’XX’ system, 3JHH = 9.0 and 4JHH = 1.2 and 1.1 Hz, p-C6H4, 4H), 4.94
(d, 2JPH = 23.4 Hz, CHP, 1H), 4.54 (d, J = 8.4 Hz, NH, 1H), 3.81 (d, 3JPH = 10.8 Hz, POCH3, 3H), 3.72
(s, OCH3, 3H), 3.64 (d, 3JPH = 10.8 Hz, POCH3, 3H). 13C-NMR (CDCl3, 150 MHz): δ 153.26 (Carom),
139.91 (d, 2JCP = 14.1 Hz, C2thioph), 139.73 (Carom), 127.1 (d, J = 2.8 Hz, Cthioph), 126.3 (d, J = 6.9 Hz,
Cthioph), 125.4 (d, J = 4.0 Hz, Cthioph), 115.69 (Carom), 114.83 (Carom), 55.63 (ArOC), 54.13 (d, 2JCP = 6.7 Hz,
POC), 53.81 (d, 2JCP = 6.7 Hz, POC), 52.85 (d, 1JCP = 158.4 Hz, PC). 31P-NMR (243 MHz, CDCl3): δ
23.33. Elem. Anal. Calcd. for C14H18NO4PS ˆ 1/6 C7H8: C, 53.16, H, 5.69, N, 4.09. Found: C, 53.21, H,
5.78, N, 4.26.
Dimethyl N-benzylamino(2-thienyl)methylphosphonate (2f): Yield = 57% (1.77 g) yellow oil. 1H-NMR
(CDCl3, 600 MHz): 7.26–7.20 (m, PhH, H5thioph, 5H), 7.18–7.15 (m, PhH, 1H), 7.02–7.01 (m, H3thioph, 1H),
6.93 (dd, 3JHH = 4.8 and 3.6 Hz, H4thioph, 1H), 4.24 (d, 2JPH = 23.8 Hz, CHP, 1H), 3.82 (d, 2JHH = 13.8 Hz,
CH2Ph, 1H), 3.68 (d, 3JPH = 10.2 Hz, POCH3, 3H), 3.57 (d, 2JHH = 13.8 Hz, CH2Ph, 1H), 3.55 (d,
3JPH = 10.2 Hz, POCH3, 3H). 13C-NMR (CDCl3, 150 MHz): δ 139.30 (d, 2JCP = 4.3 Hz, C2thioph), 138.99
(Carom), 128.47 (d, J = 7.5 Hz, Cthioph), 128.38 (Carom), 128.23 (Carom), 127.28 (Carom), 126.97 (d, J = 3.5 Hz,
Cthioph), 125.68 (d, J = 3.3 Hz, Cthioph), 54.74 (d, 1JCP = 159.7 Hz, PC), 53.94 (d, 2JCP = 6.8 Hz, POC),
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53.63 (d, 2JCP = 6.8 Hz, POC), 51.24 (d, 3JCP = 15.6 Hz, PCC). 31P-NMR (243 MHz, CDCl3): δ 23.98.
Elem. Anal. Calcd. for C14H18NO3PS: C, 54.01, H, 5.83, N, 4.50. Found: C, 53.77, H, 5.67, N, 4.46.
Dimethyl N-benzhydrylamino(2-thienyl)methylphosphonate (2g): Yield = 41% (1.59 g) yellow oil. 1H-NMR
(CDCl3, 600 MHz): 7.44–7.34 (m, PhH, H5thioph, 6H), 7.32–7.22 (m, PhH, 5H), 7.07–7.06 (m, H3thioph,
H4thioph, 2H), 4.91 (s, CH, 1H), 4.29 (d, 2JPH = 22.8 Hz, CHP, 1H), 3.91 (d, 3JPH = 10.8 Hz, POCH3, 3H),
3.64 (d, 3JPH = 10.8 Hz, POCH3, 3H), 2.57–2.48 (bs, NH, 1H). 13C-NMR (CDCl3, 150 MHz): δ 139.36
(d, 2JCP = 6.4 Hz, C2thioph), 139.73 (Carom), 128.75 (Carom), 128.56 (Carom), 127.89 (Carom), 127.17 (d,
J = 7.9 Hz, Cthioph), 127.07 (d, J = 2.3 Hz, Cthioph), 125.72 (d, J = 3.4 Hz, Cthioph), 63.81 (d, 3JCP = 16.0 Hz,
PCC), 54.12 (d, 2JCP = 6.7 Hz, POC), 53.53 (d, 2JCP = 6.7 Hz, POC), 53.19 (d, 1JCP = 161.5 Hz, PC).
31P-NMR (243 MHz, CDCl3): δ 24.32. Elem. Anal. Calcd. for C20H22NO3PS ˆ 1/5 C7H8: C, 63.33, H,
5.86, N, 3.45. Found: C, 63.54, H, 5.69, N, 3.75.
Dibenzyl N-furfurylamino(2-thienyl)methylphosphonate (2h): Yield = 62% (2.81 g) yellow oil. 1H-NMR
(CDCl3, 600 MHz): δ 7.36–7.32 (m, PhH, 10H), 7.25–7.23 (m, H5thioph, H5fur, 1H), 7.11–7.09 (m, H3thioph,
1H), 7.03–7.02 (m, H4thioph, 1H), 6.33–6.31 (m, H3fur, 1H), 6.15–6.14 (m, H4fur, 1H), 5.10–5.02 (Part AB
of ABX system, 3JPH = 7.5 and 8.8 Hz, 2JHH = 11.7 Hz, POCH2Ph, CHP, 2H), 5.00 (Part A of AMX
system, 3JPH = 7.2 and 2JHH = 11.8 Hz, POCH2Ph, 1H), 4.90 (Part M of AMX system, 3JPH = 8.2 and
2JHH = 11.8 Hz, POCH2Ph, 1H), 4.43 (d, 2JPH = 19.3 Hz, CHP, 1H), 3.92 and 3.69 (2d, 2JHH = 14.6 Hz,
CH2Fur, 3H). 13C-NMR (150 MHz, CDCl3): δ 152.60 (Carom), 142.12 (Carom), 138.67 (d, J = 4.8 Hz,
Carom), 136.32 (d, 3JCP = 6.0 Hz, Carom), 136.19 (d, 3JCP = 6.3 Hz, Carom), 128.48 (d, J = 6.5 Hz, Carom),
128.34 (Carom), 128.28 (Carom), 128.00 (Carom), 127.84 (Carom), 127.36 (Carom), 127.30 (Carom), 126.92 (d,
J = 2.4 Hz, Carom), 125.82 (d, J = 3.5 Hz, Carom), 110.14 (Carom), 107.92 (Carom), 68.58 and 68.18 (2d,
2JCP = 40.6 Hz, POC), 55.11 (d, 1JCP = 159.8 Hz, PC), 43.72 (d, 3JCP = 16.4 Hz, NC). 31P-NMR (243 MHz,
CDCl3): δ 22.19. Elem. Anal. Calcd. for C24H24NO4PS ˆ 1/10 CH2Cl2: C, 62.66, H, 5.28, .N, 3.03. Found:
C, 62.77, H, 5.03, N, 3.05.
3.2. Plant Growth Test of New Synthesized Compounds
The plant growth test of thiophene-derived aminophosphonates 2a–h was performed in
laboratory conditions following the OECD 208 Guideline Terrestrial Plants Growth Test for oat
(Avena sativa) as a monocotyledonous plant and radish (Raphanus sativus L. subvar. radicula Pers.),
a dicotyledonous plant.
According to the mentioned OECD 208 standard, the plant growth test of Compounds 2a–h was
carried out in sandy soil having the following parameters: granulometric composition of soil—77%
sand, 14% dust and loam, organic carbon content of approx. 1.2%, pH (KCl) equal to 6.3.
Tests were carried out in polypropylene pots (diameter of 90 mm and capacity of 300 cm3), which
were filled with the control soil or with the soil mixed with the tested Compounds 2a–h added at a
specific concentration. Twenty identical seeds of each of the selected plant species were sown into
the soil. Seeds originated from the same source. Plants were grown for 14 days under controlled
conditions: a constant humidity content at the level required for the plants (70% field water capacity),
light intensity (7000 lux), and temperature (20 ˘ 2 ˝C) were maintained. Then, seedlings were counted,
and the dry as well as fresh weight of the plants was determined. The parts of plants above the soil
surface were analyzed.
The performed plant growth was evaluated using a preliminary test; subsequently, the final test
was conducted afterward based on the obtained screening results. Preliminary tests were performed
to determine the range of concentrations of compounds affecting the soil quality; therefore, the used
concentrations of Samples 2a–h were as follows: 0 mg (control), 1 mg, 10 mg, 100 mg, and 1000 mg/kg
of soil dry weight.
184
Molecules 2016, 21, 694
As already mentioned, based on the obtained results from preliminary test, the final, more precise
test to find values of the no observed effect concentration (NOEC) and the lowest observed effect
concentration (LOEC) of the compounds under study 2a–h was performed.
The evaluation of phytotoxicity of the studied aminophosphonates 2a–h at applied concentrations
was made by comparing the germination and (dry and fresh) weight of control plant sprouts (seedlings)
with germination and of (dry and fresh) plants sprouts grown in the soil with an admixture of given
amounts of the tested compounds.
The dry weights of tested plants were measured after drying at 75 ˝C until the constant weight.
The visual evaluation of phytotoxicity of aminophosphonates 2a–h at applied concentrations was
performed by digital photography. Obtained pictures were analyzed in terms of any type of damage
to tested plants, such as their growth inhibition, chlorosis, and necrosis. Tests were carried out three
times for each sample.
The significance of the obtained results was evaluated using the analysis of variance (ANOVA).
The least significant difference (LSD) values at a confidence level of 95% were computed using the
Tukey test.
4. Conclusions
To conclude, the toxicity of N-methylphenyl aminophosphonates 2a–c was diagnosed to be
promising as a potential soil-applied herbicide, especially for their selectivity—they are evidently toxic
for dicotyledonous radish and not so harmful for monocotyledonous oat. Moreover, their herbicidal
efficiency is stronger for the N-methylphenyl aminophosphonates substituted with methyl group at
position ortho (2a) and meta (2b) in the phenyl ring.
Dimethyl N-benzylamino(2-thienyl)methylphosphonate (2f) exhibited non-selective, harmful
effects against both tested plants.
Among N-methoxyphenyl aminophosphonates 2d and 2e, the latter showed an inhibitive
effect especially against dicotyldenous plants. Its impact, however, was significantly weaker than
impact of 2a,b. This is to point out that the sole structural difference between N-methoxyphenyl
aminophosphonates 2d,e and N-methylphenyl aminophosphonates 2a–c is the substituent of the
phenyl moiety, i.e., the methoxy and methyl group, respectively, which indicates that the type and
position of those groups in the phenyl ring play a key role in the toxicity effect against tested plants.
Among all tested samples, dibenzyl N-furfurylamino(2-thienyl)methylphosphonate (2h) was
found to be the most toxic for radish and oat but without significant selectivity. The investigation of
Compounds 2a,b, 2f, and 2h, such as their potential applications and mechanistic approaches, will
be continued.
Some thiophene-derived aminophosphonic derivatives were found to have various biological
properties (vide supra); therefore, important microbiological, herbicidal, and cytotoxic properties of
the studied aminophosphonic systems bearing thiophene moiety 2a–h cannot be excluded. If so, the
synthesis of such compounds for potential agrochemical or pharmacological application must be
taken into consideration from the environmental protection point of view. Our results call attention to
the necessity of further phytotoxicological investigation of any new synthesized aminophosphonic
derivatives bearing thiophene moiety.
Supplementary Materials: Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/
21/6/694/s1.
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Abstract: Four diphenyl pyrene-derived aminophosphonates were synthesized. Attempts were
made to synthesize diphenyl N-(R)-α-methylbenzylamino(pyren-1-yl)methylphosphonate (3e) in
order to obtain the chiral aminophosphonate bearing a pyrene moiety. Because these attempts
failed, dimethyl and dibenzyl N-(R)-α-methylbenzyl substituted aminophosphonates 4 and 5 were
synthesized and the predominant diastereoisomer of dimethyl aminophosphonate 4 was isolated. The
resolution of the diastereomeric mixture of 5 failed. Aminophosphonates 3a–d and the predominant
diastereoisomer of 4 were investigated in terms of their ecotoxicity using tests performed on the
ostracode Heterocypris incongruens and the fluorescent bacterium Vibrio fisheri. The tests confirmed the
moderate-to-high ecotoxicity of aminophosphonates 3a–d and 4, but no evident correlation between
the structure and toxicity has been found.
Keywords: pyrene-1-carboxaldehyde; aminophosphonates; ecotoxicity; ostracode test; Vibrio fisheri test
1. Introduction
Aminophosphonic derivatives are well known for their biological activity. They are described
as effective inhibitors of various enzymes and, therefore they find applications as crop protective [1],
antibacterial [2] or anticancer [3] agents. Analogues of C-phenylphosphonoglycine, have been
demonstrated to show activity in various fields as herbicides and plant growth regulators [4],
agrochemical fungicides [5,6] and glutamate receptor agonists and antagonists [7].
In a sort of logical consequence, a lot of compounds from this group have been synthesized,
including those bearing benzene and its polycyclic aromatic analogues [8], five- and six-membered
heteroaromatic rings [9,10], and even the ferrocene [11] moiety. Their syntheses are generally based on
the Kabachnik-Fields and the aza-Pudovik reactions [12–14].
In contrast, aminophosphonic derivatives of 1-pyrene, i.e., amino(1-pyrene)methylphosphonic
compounds have been described only twice in the chemical literature. Hudson et al. [15] reported
the synthesis of diethyl N-benzhydrylamino(1-pyrene)methyl phosphonate, and Jayaprakash and
co-workers [16] described the synthesis of a series of N-aryl substituted, diethyl amino(1-pyrene)methyl
phosphonates and results of preliminary studies on their fluorescence properties.
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We have tried to fill this void and very recently have published results of our studies on the
synthesis, photophysical properties and cytotoxic action of a series of α-aminophosphonates bearing
pyren-1-yl moieties [17]. They demonstrated moderate-to-satisfactory cytotoxicities against two colon
cancer cell lines. Such interesting biological properties may result in potential future applications and
their biological hazards should be evaluated using typical biotoxicological tests.
Herein, we wish to report the synthesis of a new series of N-substituted-C-(pyren-1-yl)-
phosphonoglycine derivatives and their ecotoxicological properties evaluated using ostracode
(Heterocypris incongruens) and fluorescence bacteria Vibrio fisheri tests.
Nowadays, ecotoxicology faces the challenge of evaluating and predicting the effects of a variety
of chemicals on aquatic species and ecosystems. Since a chemical pollutant may follow various routes
from a source to the target, there is an urgent need to follow their potential ecotoxicological impact
using different biotests [18–21].
Toxkit microbiotests are presently used in many countries worldwide for biomonitoring of
contaminated waters and soils. These small-scale bioassays are becoming more and more popular
in laboratories all over the world because of their various useful advantages, such as high degree
of standardization and precision, simple testing procedures which are very clearly documented
down to the last detail, operation with small sample volumes, the repeatability as well as giving
comparable results to equivalent ISO and OECD full-scale tests. However, the major advantage of
Toxkit microbiotests in comparison to conventional bioassays is that the tested microorganisms are
incorporated in the kits in a dormant or immobilized form, from which they can be hatched or activated
“on demand” prior to carrying out the toxicity tests [22].
The Microtox® system test with the luminescent bacterium Vibrio fischeri and the crustacean
Heterocypris incongruens, when used as bioindicator allows one to monitor potential toxicity of
soil or water contaminants in a rapid, simple and inexpensive way. This bioanalytical technique
allows one to overcome some disadvantages of the traditional physicochemical methods such as
concentration of toxic substances below analytical limits or potential chemical interactions leading
to additive, synergistic or antagonistic effect which cannot be identified using the abovementioned
methods. The Vibrio fischeri bioassay can be applied in all types of water, including surface and ground
water, wastewater, drilling sump fluids and many other aqueous solutions [23]. Both Vibrio fischeri
and Heterocypris incongruens bioassay tests have been already successfully used for ecotoxicity
determination of various pharmaceuticals, pesticides, ionic liquids, detergents, heavy metals, road dust,
eluates and organic extracts of wastes, etc. [24–30].
As it was mentioned above, the aim of the study was the preliminary evaluation of the potential
toxicity of newly synthesized aminophosphonates 3a–d and 4, if introduced to the environment.
In order to perform it, the Microtox® test using the bioluminescent bacterium Vibrio fischeri
was employed to examine the acute toxicity of sediment eluates loaded with tested compounds.
Due to the cost effective, simple operation and time-savings, the biotest based on the bioluminescence
inhibition of Vibrio fischeri is probably the most widely applied bacterial test used for environmental
pollution monitoring.
However, due to fact that the obtained substances are almost insoluble in water, the Microtox®
solid phase test (MSPT), as a one of the most popular tests for sediment toxicity assessments due to its
simplicity, reproducibility, ecological relevance and sensitivity, has been used [26,31–33].
Additionally, the standardized crustacean biotest with Heterocypris incongruens was selected
as a representative benthic invertebrate species for screening the toxicity of sediments containing
the tested substances. Crustaceans are promising representative species of the benthic environment
as they spend their lives swimming in water and in direct contact with the sediment. Therefore,
the Ostracodtoxkit® test has been used for toxicity evaluation. The toxicity test using mentioned
freshwater ostracodes is a sub-chronic static test that exposes individuals to whole sediments over a
period of 6 days, the endpoints being mortality and growth changes [34].
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2. Results and Discussion
2.1. Synthesis of Aminophosphonic Derivatives 3a–e, 4 and 5 Bearing 1-Pyrene Moieties
Schiff bases 1a–e were synthesized following the published and commonly known procedure by
simple mixing pyrene-1-carboxaldehyde with an appropriate amine in hexane (in a case of p-anisidine,
p-toluidine and aniline) or methanol (for benzylamine and (R)-α-methylbenzylamine) and stirring
them at room temperature for 24 h; the reaction with p-anisidine required 48 h [14]. This procedure
gave imines 1a–e, which were isolated and used for further conversions without any purification.
1H-NMR spectra were recorded only to verify the identity, based on the diagnostic 1H-NMR singlet
corresponding to the proton of the azomethine group (–CH=N–) above 8 ppm [17].
Aminophosphonates 3a–d, 4 and 5 were synthesized basing on the aza-Pudovik reaction,
i.e., the addition of diphenyl phosphite to imines 1a–d. However, important modifications were
necessary to be introduced, whereby reactions were carried out in a small amount of dichloromethane
and diphenyl phosphite was used in three-fold excess. The reaction mixtures were heated for
5 min then stirred for 24 h at room temperature. After workup as described in the Experimental
Section, the resulting aminophosphonates 3a–d were obtained in 60%–70% yields (Scheme 1).
They were purified by column chromatography on neutral aluminum oxide, because diphenyl



















a: R = C6H5
b: R = 4-(CH3O)C6H4
c: R = 4-CH3C6H4
d: R = CH2C6H5
e: R = (R)-CH(CH3)C6H5
2B, 4:   R' = CH3




Scheme 1. Synthesis of N-substituted amino(1-pyrene)methylphosphonates 3a–e, 4 and 5.
The identity of synthesized compounds was verified by means of 1H-, 31P- and 13C-NMR as well
as by FT-IR spectroscopy. The proton NMR spectra of diphenyl pyrene-derived aminophosphonates
3a–d showed the characteristic signals of all compounds, i.e., the doublet corresponding to the proton
from the CH-P bond and the system of signals attributable to the pyrene ring protons. The 13C-NMR
spectra revealed the presence of two doublets at around 150 ppm with a coupling constant close
to 10 Hz, which are attributed to the phenyl ring carbons from the P-O-C groups. Doublets in the
50–55 ppm range with coupling constants between 150 and 160 Hz are easily recognizable as C-P bond
signals. IR bands at around 1250 cm´1 correspond to the bending vibrations of P=O bonds, while
the presence of aromatic carbon-carbon bonds was confirmed by characteristic bands at around 1600,
1570, 1500 and 1450 cm´1. Scans of NMR spectra are collected in the Supplementary Materials as
Figures S1–S7.
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In order to obtain the chiral, non-racemic diphenyl ester of a phosphonoglycine derivative
bearing a pyren-1-yl moiety, the synthesis of diphenyl N-(R)-α-methylbenzylamino(pyren-1-yl)-
methylphosphonate (3e) was performed using the method described above. The resulting mixture
contained two diastereomers in a 100:15 ratio, but all attempts to purify the product by column
chromatography on neutral aluminum oxide caused extensive decomposition of the product. From
among available adsorbents, silica gel was totally inconvenient (vide supra), and chromatography on
microcrystalline cellulose with chloroform allowed us to get rid of impurities only roughly, i.e., crude
diphenyl N-(R)-α-methylbenzylamino(pyren-1-yl)methylphosphonate (3e) was obtained.
Thus, in order to investigate the stereochemistry of phosphite addition to the azomethine
bond of pyrene-1-carboxaldimine 1e, addition of dimethyl and dibenzylphosphites has been
performed. Dimethyl N-(R)-α-methylbenzylamino(pyren-1-yl)methylphosphonate (4) was obtained as
a mixture of two diastereoisomers in a 100:13 ratio. We succeeded in separation of the predominant
diastereoisomer using column chromatography on silica gel. Its absolute configuration however could
not be determined, because the predominant isomer of aminophosphonate 4 is a dense oily liquid,
thus an X-ray study could not be performed. Isolation of the minor diastereoisomer of 4 failed, it was
always obtained in a mixture with the major one.
Dibenzyl N-(R)-α-methylbenzylamino(pyren-1-yl)methylphosphonate (5) was obtained as
a mixture of two diastereoisomers in a 100:26 ratio. Unfortunately, the obtained mixture of
diastereoisomers was not separable by column chromatography, as all applied solvent systems led to
mixtures with different ratios of isomers. However, the crude diastereomeric mixture of 5 was purified
by column chromatography on silica gel to give satisfactory elemental analysis results.
Thus the obtained diphenyl aminophosphonates 3a–d and the isolated predominant
diastereoisomer of 4 were tested in terms of their ecotoxicity using two popular ecotoxicological
tests, the ostracode Heterocypris incongruens and fluorescence bacteria Vibrio fisheri.
2.2. Ecotoxicological Properties of Aminophosphonates 3a–d and 4
2.2.1. Microtox Toxicity Assay
Bioassays are the complementary tool for characterizing the biological effects and hazards of
contaminated sediments or soils. During the solid phase Microtox® assay the bioluminescent bacteria
are exposed to a sediment suspension and their response reflects totally the action of toxic agents along
with synergists and antagonists present in a given sample. The effects on light emission are evaluated
in the liquid phase that remains after removal of the sediments by filtration. Effective concentration
(EC50) values (Table 1) were calculated from the concentration–response curves (Figure 1).
Obtained EC50 values ranged between 92 and 533 mg/kg of dry weight of soil, depending
on the tested compound. Among the compounds 3a–c with aromatic substituents on the amine
groups, diphenyl N-(4-methoxyphenyl)amino(pyren-1-yl)methylphosphonate (3b) was found to
be the most toxic, with the lowest EC50 value (92.63 mg/kg). Much less harmful action against
Vibrio fischeri was found for the N-(4-methylphenyl) derivative 3c (EC50 = 214.5 mg/kg), while diphenyl
N-phenylamino(pyren-1-yl)methylphosphonate (3a) demonstrated nearly a lack of toxicity. Thus,
the presence of a substituent at the phenyl group linked to nitrogen seems to be crucial in terms of
toxicological properties of the studied compounds 3a–c. The results also showed that a methoxy
substituent increases the toxicity of the compound 3b in comparison with the methyl substituted
aminophosphonate 3c.
Among the aminophosphonates 3d and 4 having the amino groups substituted with non-aromatic
groups, results were indeed surprising. Diphenyl N-benzylamino(pyren-1-yl)methylphosphonate
(3d) with a N-benzyl substituent demonstrated five times higher toxicity (EC50 = 102.7 mg/kg) as
compared to the N-(R)-α-methylbenzylamino derivative 4 (EC50 = 533.1 mg/kg). Therefore we can
conclude that the presence of a methyl substituent in the benzyl moiety dramatically decreases the
toxicity of compound 4.
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Table 1. Microtox® EC50 values (mg/kg of soil dry weight) of exposure of the luminescent marine
bacteria Vibrio fischeri to tested aminophosphonates 3a–d and 4, with respective 95% confidence limits
(in brackets) obtained in the fit of the data.
Compounds EC50 (Lower Limit; Upper Limit) Coefficient of Determination (R
2)
3a 495.9 (203.4; 1209) 0.7632
3b 92.63 (65.27; 131.4) 0.8912
3c 214.5 (165.0; 279.0) 0.9452
3d 102.7 (81.83; 128.9) 0.9571
4 533.1 (439.4; 646.8) 0.9516
Figure 1. The EC50 graded dose-response curves for the five tested compounds 3a–d and 4. Overlapped
curves are plotted by the Microtox® Analyzer 500 software. Error bars represent standard deviation
error (SD, n = 3 determinations).
2.2.2. Ostracod Test Kit
Ostracodtoxkit FTM is the very first sediment-contact microbiotest with a crustacean test species
for the assessment of the total toxicity of sediments, hence covering the toxic hazards of both dissolved
and not dissolved pollutants. Considering the very low solubility of synthesized aminophosphonates
3a–d and 4, it seemed justified to evaluate reliably their potential toxicity.
The first criterion of the effect on tested crustaceans is the percent of mortality. Toxicity
was expressed in % of mortality, i.e., the lethal effect of the sample on the number of ostracods
compared with the control plate. As it was expected, the mortality of ostracodes increased with
growing concentration of tested substance in soil (Figure 2). The concentration 500 mg/kg of soil
was found to be lethal for all samples. However, among all tested compounds, N-benzylamino
(pyren-1-yl)methylphosphonate (3d) demonstrated the highest toxicity at every concentration when
compared to other samples (with the sole exception of aminophosphonate 4 at a concentration of
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100 mg/kg of soil). Even at a concentration of 10 mg/kg of dry weight of soil, compound 3d caused
10% mortality of crustaceans, while other samples at this concentration did not show any mortal effect.
Figure 2. The mortality (%) of Heterocypris incongruens living in soil contaminated with pyrene-derived
aminophosphonates 3a–d and 4 at concentrations: 10, 50, 100 and 500 mg/kg of soil dry weight.
Error bars represent standard deviation error (SD, n = 6 determinations).
Growth inhibition is the second criterion of the toxic effect indicated by the Ostracodtoxkit F™
microbiotest. This criterion allows one to evaluate the sub-lethal toxicity of sediments. The growth
inhibition is determined by comparing the size of surviving ostracods living in the test sediment
with the size of ostracods living in the reference sediment at the end of the test. Determination of
the sub-lethal impact of sediment toxicants is justified only for sediments which do not cause a high
ostracod mortality. It is advised that the growth inhibition should only be determined for sediments
which mortality was found to be less than 30%. Therefore, the growth inhibition was chosen as
a criterion of sub-lethal effects to determine toxicity not inducing substantial mortality in the test
organisms. Consequently, measurements of lengths were only performed when the mortality was less
than 30%. In this respect, the growth inhibition rates have not been measured for aminophosphonates
3c, 3d and 4 at concentrations of 100, 250 and 500 mg per kg of soil dry weight. Crustaceans were more
resistant against compounds 3a and 3b and their growth inhibition reached ca. 20% for a concentration
of 100 mg/kg of soil, nevertheless it was not measured at 250 and 500 mg per kg of soil dry weight.
Values of growth inhibition for compounds 3c, 3d and 4 at 50 mg/kg of soil concentration varied
between 16% and 23% (Figure 3).
Figure 3. Growth inhibition (%) of Heterocypris incongruens living in soil contaminated with
pyrene-derived aminophosphonates 3a–d and 4 at concentrations of 10, 50, 100 and 500 mg/kg of soil
dry weight. Error bars represent standard deviation error (SD, n = 6 determinations).
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Comparison of results of luminescence inhibition for Vibrio fischeri tests with growth inhibition
of crustaceans for all concentration of compounds did not show any reasonable relationship.
Only diphenyl N-benzylamino(pyren-1-yl)methylphosphonate (3d), which was strongly toxic for
Vibrio fischeri (EC50 ~103 mg/kg of soil) also revealed the highest mortality of ostracods even at a
concentration of 10 mg/kg of soil.
However, diphenyl N-(4-methoxyphenyl)amino(pyren-1-yl) methylphosphonate (3b) that
induced a very strong luminescence inhibition in V. fischeri was only moderately toxic for crustaceans
considering both the mortality and the growth inhibition index. On the other hand, diphenyl
N-phenylamino(pyren-1-yl)methylphosphonate (3a), being nearly non-toxic for V. fischeri (EC50 close
to 500 mg/kg of soil) is also very weakly toxic for ostracods (with respect to both criteria, the mortality
and the growth inhibition).
Thus, based on the obtained results, Vibrio fischeri bacteria were very sensitive to
aminophosphonates 3b and 3d, since relatively low effective concentration (EC50) values were
determined, while for ostracods, the highest negative impact considering both mortality and inhibition
growth have been found for diphenyl N-benzylamino(pyren-1-yl)methylphosphonate (3d). Therefore,
being the most toxic against both tested organisms, the aminophosphonate 3d should be considered as
a potentially hazardous compound for environment, which may be toxic against many other living
species. Its high toxicity may be related with its N-benzyl group, which is more flexible than other
substituents and may bind more easily to enzymes or receptors of the tested organisms. Nevertheless,
this is only a very preliminary hypothesis, which requires further verification.
The usefulness of bioassays for the assessment of areas affected by phosphate industry wastes
has already been reported and discussed [35,36]. Authors performing risk assessments in such
contaminated areas have proven that the development of sensitive and observable organisms as
bio-indicators for monitoring and management of the environmental pollution is a very useful tool
to complement chemical analyses. Biological analysis allows one to reflect the harmful effects of
contaminants on organisms and provides data to reveal the mechanisms of the toxic effects including
formation, development and removal of contaminants.
Since the soil is generally the reservoir for agrochemical residues, the evaluation of any xenobiotics
including pesticides using a simple battery of assay tests is strongly needed to control level and fate
of their residues. In a successful study focused on the ecotoxicological evaluation of select pesticides
(chlorpyrifos, glyphosate, vinclozolin, endosulfan) present in agricultural soils, Antunes et al have
reported the use of standard aquatic bioassays for testing of soil eluates [30].
Our obtained effective concentration values are very close to the inhibition concentration (IC50)
values for herbicides examined by Joly et al. [28]. Toxicity values of the pesticides S-metolachlor,
nicosulfuron and benoxacor were 178.4, 167.8 and 93.3 mg/L, respectively. In this respect, the toxicity
of the first two herbicides are close to that of the tested aminophosphonate 3c, while the last IC50 value
matches the values of compounds 3b and 3d. Nevertheless, the action of aminophosphonates 3a–d
and 4 against V. fischeri demonstrated much lower toxicity when compared to the herbicides tested by
the mentioned authors.
Ostracodtoxit tests using Heterocypris incongruens are also a very useful tool for environmental
toxicity determination. Results related to mortality and growth inhibition of ostracods correlated with
various types of polycyclic aromatic hydrocarbons (PAHs) have been reported by Cvancarova et al. [37].
They found that H. incongruens was strongly sensitive to bioavailable PAHs, while luminescence
inhibition of V. fischeri varied widely between ca. 15%–90% depending on the type of soil examined.
Oleszczuk and Hollert [38], in their studies devoted to determination of the influence of different
soils on sewage sludge toxicity, have found that the mortality values of Heterocypris incongruens ranged
from 0.26% to 11.5% depending on the sludge tested [39]. Growth inhibition values ranged from 10.7%
to 36.2% depending on the type of sludge. Płaza et al. [39] applied Microtox®, Ostracodtoxkit F™,
to assay bioremediation processes in soils heavily contaminated with petroleum. The test species
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demonstrated varying sensitivity to soils and the effects on test organisms exposed to tested soils
correlated with the soil contaminants’ concentrations [39].
Results of toxicity against H. incongruens obtained for the studied aminophosphonates 3a–d
and 4 were at a similar level. The mortality varied from ca. 5% until 70% for the concentration
range 10–100 mg per kg of soil. At higher concentrations, the tested compounds were practically
lethal for crustaceans. The growth inhibition varied from 16% up to 23% for a concentration of
50 mg per kg of soil. All the data presented above lead us to stress the necessity of handling
pyrene-derived aminophosphonic derivatives with special care, as they may be potentially hazardous
for the environment.
3. Materials and Methods
3.1. Chemistry
All solvents (POCh, Gliwice, Poland) were applied routinely and dried prior to use. Commercial
reagents (Aldrich, Poznań, Poland) were generally used as received. NMR spectra were recorded
on an Avance III 600 MHz apparatus (Bruker, Billerica, MA, USA) operating at 600 MHz (1H-NMR),
150 MHz (13C-NMR) and 243 MHz (31P-NMR). IR spectra were recorded on a Nexus FT-IR
spectrometer (Thermo Nicolet, Waltham, MA, USA). Rotations were measured using a 241 MC
polarimeter (Perkin-Elmer, Waltham, MA, USA). Melting points were measured using a MelTemp
II apparatus (Bibby Scientific Limited, Staffordshire, UK), in a capillary and were not corrected.
Elemental analyses were performed in the Laboratory of Microanalysis, the Center of Molecular and
Macromolecular Studies PAS in Łódź and the Laboratory of Molecular Spectroscopy at the Faculty of
Chemistry, University of Łódź.
3.1.1. General Procedure for Synthesis of Phosphonates 3a–d, 4 and 5
Equimolar quantities of 1-pyrenecarboxaldehyde and amine (2 mmol each) were dissolved in
hexane (1a–c) or methanol (1d–e) (20 mL) and stirred at reflux for 24 h (1b–c, 1d–e) or 48 h (1a).
The reaction was monitored by 1H-NMR and after the completion, the solvent was removed under
reduced pressure, and obtained products were used directly for further conversion. Imine (1 mmol)
and the appropriate phosphite 2A–C (3 mmol or 5–6 mmol in a case of dimethyl phosphite due to the
low solubility of the imine in it) were placed in a 25 mL round-bottom flask, which was heated with
stirring on a water bath for 5 min until all of the imine was dissolved in the phosphite. In the case
of derivatives 3a–d, dichloromethane (2 mL) was added in order to improve the solubility. Then the
mixture was stirred at room temperature for 24 h. The crude aminophosphonates were purified by
column chromatography on neutral aluminum oxide using chloroform as eluent.
Diphenyl N-phenylamino(pyren-1-yl)methylphosphonate (3a). Y = 0.41 g (76%), yellow solid, m.p.
184–185 ˝C. 1H-NMR (CDCl3): δ 8.38 (d, 3JHH = 9.3 Hz, Hpyr, 1H); 8.28 (dd, 3JHH = 8.0 and
4JHH = 2.6 Hz, Hpyr, 1H); 8.20 (t, Hpyr, 3JHH = 8.0 Hz, 2H); 8.12 (d, 3JHH = 8.0 Hz, Hpyr, 1H);
8.10 (d, 3JHH = 9.2 Hz, Hpyr, 1H); 8.07–8.06 (m, Hpyr, 1H); 8.04–8.01 (m, Hpyr, 2H); 7.30–7.29
(m, HPh, 5H); 6.94 (t, 3JHH = 7.4 Hz, HPh, 1H); 6.84 (dd, 3JHH(1) = 3JHH(2) = 7.8 Hz, HPh, 2H); 6.79
(app. d, 3JHH = 8.5 Hz, p-C6H4, 2H); 6.67 (d, 3JHH = 7.4 Hz, HPh, 2H); 6.46 (app. d, 3JHH = 8.5 Hz,
p-C6H4, 2H); 5.92 (d, 2JPH = 24.1 Hz, CHP, 1H); 5.10–5.08 (m, POCH2, 2H); 4.65 and 4.22 (Part of
AMX system, 2JHH = 11.6 Hz and 3JPH = 7.8 and 8.5 Hz, POCH2, 2H). 13C-NMR (CDCl3): δ 150.7
(d, 2JCP = 9.9 Hz, CPOC); 150.3 (d, 2JCP = 9.5 Hz, CPOC); 146.1 (d, 3JCP = 15.27 Hz, CPh); 131.6 (Cpyr);
131.5 (d, 4JCP = 3.1 Hz, Cpyr); 130.8 (Cpyr); 130.2 (Cpyr) 130.0 (CPh); 129.6 (Cpyr); 129.5 (d, 4JCP = 2.0 Hz,
CPh); 128.7 (Cpyr); 128.6 (d, 4JCP = 2.1 Hz, Cpyr); 127.9 (Cpyr); 127.7 (Cpyr); 127.4 (Cpyr); 127.0 (Cpyr);
126.8 (Cpyr); 126.3 (Cpyr); 125.8 (CPh); 125.7 (CPh); 125.6 (d, 4JCP = 3.4 Hz, Cpyr); 125.5 (Cpyr); 125.2
(Cpyr); 125.0 (Cpyr); 122.1 (Cpyr); 120.9 (d, 3JCP = 4.0 Hz, CPh); 119.9 (d, 3JCP = 4.4 Hz, CPh); 119.1
(CPh); 114.2 (CPh); 52.2 (d, 1JCP = 154.6 Hz, PC). 31P-NMR (CDCl3): δ 16.16. IR (KBr): 3313 (νCH);
3037; 2923 (CH3); 1600, 1581; 1524, 1483 (C=C); 1249 (P=O); 1214; 1185; 1062; 1021 (P-O); 941; 853;
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824; 622.Elemental analysis: Calcd. for C35H26NO3P: C, 77.91; H, 4.86; N, 2.60. Found: C, 77.76, H,
4.86, N, 2.79.
Diphenyl N-(4-methoxyphenyl)amino(pyren-1-yl)methylphosphonate (3b). Y = 0.3 g (52%), yellow solid, m.p.
161 ˝C. 1H-NMR (CDCl3): δ 8.49 (d, 3JHH = 9.2 Hz, Hpyr, 1H); 8.34 (dd, 3JHH = 7.7 and 4JHH = 1.9 Hz,
Hpyr, 1H); 8.24-8.21 (m, Hpyr, 3H); 8.14 (d, Hpyr, 3JHH = 8.1 Hz, 1H); 8.08 (d, 3JHH = 8.9 Hz, Hpyr, 1H);
8.04 (d, 3JHH = 7.7 Hz, Hpyr, 1H); 8.02–8.01 (m, Hpyr, 2H); 7.31–7.28 (m, HPh, 2H); 7.19–7.16 (m, HPh, 3H);
6.95–6.92 (m, HPh, 2H); 6.89–6.87 (m, HPh, 1H); 6.62–6.58 (m, HPh, p-C6H4, 6H); 6.23 (d, 2JPH = 24.4 Hz,
CHP, 1H); 3.61 (s, CH3, 3H). 13C-NMR (CDCl3): δ 153.2 (d, 2JCP = 5.4 Hz, Cpara); 150.7 (d, 2JCP = 9.9 Hz,
CPOC); 150.3 (d, 2JCP = 9.7 Hz, CPOC); 131.5 (Cpyr); 131.2 (d, 4JCP = 3.2 Hz, Cpyr); 130.8 (Cpyr); 130.0 (CPh);
129.7 (Cpyr); 129.6 (d, 3JCP = 7.2 Hz, Cpyr); 129.5 (CPh); 128.8 (Cpyr); 128.6 (Cpyr); 127.9 (Cpyr); 127.7
(Cpyr); 126.3 (CPh); 125.8 (CPh); 125.6 (Cpyr); 125.6 (Cpyr); 125.5 (Cpyr); 125.2 (d, 4JCP = 1.8 Hz, Cpyr);
125.0 (Cpyr); 124.9 (Cpyr); 122.2 (Cpyr); 121.0 (d, 3JCP = 4.2 Hz, CPh); 120.0 (d, 4JCP = 4.4 Hz, CPh); 115.7
(d, 4JCP = 9.7 Hz, CPh); 115.1 (Cpara); 55.7 (CAr-OC); 53.0 (d, 1JCP = 154.3 Hz, PC). 31P-NMR (CDCl3):
δ 16.32. IR (KBr): 3383 (νNH); 3294 (νCH); 3037; 2958 (CH3); 1591, 1511, 1486; 1451 (C=C); 1245 (P=O);
1211; 1068; 1024 (P-O); 941; 834; 815; 618. Elemental analysis: Calcd. for C36H28NO4P: C, 75.91; H, 4.95;
N, 2.46. Found: C, 75.76, H, 5.06, N, 2.54.
Diphenyl N-(4-methylphenyl)amino(pyren-1-yl)methylphosphonate (3c). Y = 0.44 g (79%), yellow solid,
m.p. 181–182 ˝C. 1H-NMR (CDCl3): δ 8.51 (d, 3JHH = 9.3 Hz, Hpyr, 1H); 8.34 (dd, 3JHH = 8.2
and 4JHH = 2.5 Hz, Hpyr, 1H); 8.25-8.21 (m, Hpyr, 3H); 8.13 (d, Hpyr, 3JHH = 8.2 Hz, 1H); 8.08
(d, 3JHH = 8.9 Hz, Hpyr, 1H); 8.04 (t, 3JHH = 7.6 Hz, Hpyr, 1H); 8.01 (d, 3JHH = 8.8 Hz, Hpyr, 2H);
7.31–7.29 (m, HPh, 2H); 7.20–7.15 (m, HPh, 3H); 7.05–7.02 (m, HPh, 2H); 6.94–6.91 (m, HPh, 2H); 6.88-6.86
(m, HPh, 1H); 6.68-6.64 (m, HPh, 3H); 6.58–6.57 (m, HPh, 2H); 6.31 (d, 2JPH = 24.6 Hz, CHP, 1H). 13C-NMR
(CDCl3): δ 150.7 (d, 2JCP = 9.8 Hz, CPOC); 150.3 (d, 2JCP = 9.7 Hz, CPOC); 143.7 (d, 2JCP = 15.9 Hz, Cpara);
131.6 (Cpyr); 131.2 (d, 4JCP = 3.2 Hz, Cpyr); 130.8 (Cpyr); 130.0 (CPh); 129.8 (Cpyr); 129.6 (d, 3JCP = 7.3 Hz,
Cpyr); 129.5 (Cpara); 128.8 (d, 4JCP = 2.1 Hz, Cpyr); 128.6 (Cpyr); 128.3 (Cpyr); 127.8 (Cpara); 127.7
(d, 4JCP = 1.6 Hz, Cpyr); 126.3 (Cpyr); 125.8 (Cpyr); 125.6 (CPh); 125.5 (d, 4JCP = 2.3 Hz, Cpyr); 125.5 (CPh);
125.2 (d, 4JCP = 1.9 Hz, Cpyr); 125.0 (Cpyr); 124.9 (Cpyr); 122.2 (Cpyr); 121.0 (d, 3JCP = 4.0 Hz, CPh); 120.0
(d, 3JCP = 4.4 Hz, CPh); 114.3 (Cpara); 52.5 (d, 1JCP = 155.1 Hz, PC); 20.5 (CAr-OC). 31P-NMR (CDCl3):
δ 15.23. IR (KBr): 3303 (νCH); 2923 (CH3); 1591, 1489, 1458 (C=C); 1268 (P=O); 1024 (P-O); 926, 840;
770; 688. Elemental analysis: Calcd. for C36H28NO3P: C, 78.11; H, 5.10; N, 2.53. Found: C, 77.86;
H, 5.31; N, 2.47.
Diphenyl N-benzylamino(pyren-1-yl)methylphosphonate (3d). Y = 0.43 g (77%), yellow solid, m.p.
118–119 ˝C. 1H-NMR (CDCl3): δ 8.51–8.49 (m, Hpyr, 1H); 8.26 (d, 3JHH = 8.0 Hz, Hpyr, 1H); 8.24–8.21
(m, Hpyr, 3H); 8.13–8.09 (m, Hpyr, 3H); 8.04 (t, 3JHH = 7.6 Hz, Hpyr, 1H); 7.29–7.25 (m, HPh, 5H);
7.20–7.19 (m, HPh, 2H); 7.15–7.13 (m, HPh, 3H); 7.02–7.00 (m, HPh, 2H); 6.93 (app. t, 3JHH = 7.4 Hz,
HPh, 1H); 6.73 (app. d, 3JHH = 8.2 Hz, HPh, 2H); 5.58 (d, 2JPH = 20.8 Hz, CHP, 1H); 3.93
(d, 3JHH = 13.3 Hz, NCH2, 1H); 3.66 (d, 3JHH = 13.3 Hz, NCH2, 1H). 13C-NMR (CDCl3): δ 151.0
(d, 2JCP = 9.9 Hz, CPOC); 150.5 (d, 2JCP = 9.7 Hz, CPOC); 139.1 (CPh); 131.6 (Cpyr); 131.4 (d, 4JCP = 3.0 Hz,
Cpyr); 130.8 (Cpyr); 130.4 (Cpyr); 130.3 (Cpyr) 130.0 (Cpyr); 129.9 (Cpyr); 129.8 (CPh); 129.5 (CPh); 128.8
(CPh); 128.6 (CPh); 128.2 (Cpyr); 128.0 (Cpyr); 127.7 (d, 4JCP = 1.5 Hz, Cpyr); 127.5 (Cpyr); 126.3 (Cpyr);
125.7 (CPh); 125.5 (d, 4JCP = 2.8 Hz, Cpyr); 125.4 (CPh); 125.2 (Cpyr); 125.0 (Cpyr); 122.7 (Cpyr); 120.8
(d, 3JCP = 4.3 Hz, CPh); 120.3 (d, 3JCP = 4.3 Hz, CPh); 51.6 (d, 3JCP = 17.8 Hz, PCNC). 31P-NMR (CDCl3):
δ 16.22. IR (KBr): 3386 (νNH); 3041, 2917 (CH3); 1616, 1587, 1518, 1451 (C=C); 1245 (P=O); 1066; 1024
(P-O); 941, 843; 777; 618. Elemental analysis: Calcd. for C36H28NO3P: C, 78.11; H, 5.10; N, 2.53. Found:
C, 77.81; H, 5.24; N, 2.40.
3.1.2. Dimethyl N-(R)-α-Methylbenzylamino(pyren-1-yl)methylphosphonate (4)
The reaction was carried out as it is described above, but the post-reaction mixture was dissolved
in dichloromethane and washed three times with a saturated aqueous sodium bicarbonate solution. The
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organic layer was dried, the solvent was removed in vacuo and the residual oil was purified by column
chromatography on silica gel with chloroform as eluent. The procedure gave 440 mg of 4 as a dense
yellow oil. Isolated predominant diastereomer: Y = 0.4 g (92%, after column chromatography), dense yellow
oil.
“
αs20D = ´48.3˝ (c = 0.1, CHCl3). 1H-NMR (CDCl3): δ 8.29–8.27 (m, Hpyr, 1H); 8.22 (d, 3JHH = 8.0 Hz,
Hpyr, 1H); 8.21–8.18 (m, Hpyr, 3H); 8.10–8.06 (m, Hpyr, 3H); 8.02 (t, 3JHH = 7.6 Hz, Hpyr, 1H); 7.25–7.23
(m, PhH, 2H); 7.22–7.20 (m, PhH, 2H); 7.19–7,16 (m, PhH, 1H); 5.33 (d, 2JPH = 21.1 Hz, CHP, 1H);
3.91 (q, 3JHH = 6.5 Hz, CHPh, 1H); 3.86 (d, 3JPH = 10.5 Hz, POCH3, 3H); 3.26 (d, 3JPH = 10.5 Hz,
POCH3, 3H); 1.39 (d, 3JHH = 6.5 Hz, CHCH3, 3H). 13C-NMR (CDCl3): δ 145.2 (CPh); 131.6 (Cpyr);
131.1 (d, 4JCP = 2.3 Hz, Cpyr); 130.8 (Cpyr); 130.3 (Cpyr); 129.4 (d, 3JCP = 7.7 Hz, Cpyr); 128.6 (CPh); 128.2
(Cpyr); 127.8 (Cpyr); 127.7 (Cpyr); 127.3 (CPh); 127.0 (CPh); 126.2 (Cpyr); 126.1 (Cpyr); 125.6 (Cpyr); 125.4
(d, 4JCP = 2.8 Hz, Cpyr); 125.3 (Cpyr); 125.1 (Cpyr); 125.0 (Cpyr); 55.8 (d, 3JCP = 11.9 Hz, PCNC); 54.0
(d, 2JCP = 7.4 Hz, POC); 53.6 (d, 2JCP = 7.2 Hz, POC); 29.9 (Caliph); 27.8 (Caliph). 31P-NMR (CDCl3):
δ 26.70. IR (KBr): 3440 (νNH); 3309 (νCH); 2949 (CH2); 1600, 1584, 1511, 1454 (C=C); 1242 (P=O);
1055; 1027 (P-O); 846; 815; 761; 609. Elemental analysis: Calcd. for C27H26NO3P: C, 73.12; H, 5.91;
N, 3.16. Found: C, 73.15, H, 5.72, N, 2.96. Mixture of diastereomers—the minor diastereomer is denoted
with an asterisk. 1H-NMR (CDCl3): δ 8.29–8.28 (m, Hpyr, 1H); 8.23–8.22 (m, Hpyr, 1H); 8.21–8.17
(m, Hpyr, 3H); 8.17–8.16* (m, Hpyr, 1H); 8.10–8.06 (m, Hpyr, 3H); 8.03–8.00 (m, Hpyr, 1H); 7.95–7.94*
(m, Hpyr, 1H); 7.30–7.26* (m, PhH); 7.24–7.22 (m, PhH, 2H); 7.22–7.20 (m, PhH, 2H); 7.19–7.16 (m, PhH,
1H); 7.12–7.10 (m, PhH); 5.33 (d, 2JPH = 21.0 Hz, CHP, 1H); 4.98* (d, 2JPH = 21.7 Hz, CHP, 1H); 3.91
(q, 3JHH = 6.5 Hz, CHPh, 1H); 3.86 (d, 3JPH = 10.6 Hz, POCH3, 3H); 3.83* (d, 3JPH = 10.5 Hz, POCH3,
3H); 3.50* (q, 3JHH = 6.6Hz, CHPh, 1H); 3.26 (d, 3JPH = 10.4 Hz, POCH3, 3H); 3.23* (d, 3JPH = 10.4 Hz,
POCH3, 3H); 1.39 (d, 3JHH = 6.5 Hz, CHCH3, 3H); 1.34* (d, 3JHH = 6.6 Hz, CHCH3, 3H). 31P-NMR
(CDCl3): δ 26.70 and 26.18* (10:4). Elemental analysis: Calctd for C27H26NO3P: C, 73.12; H, 5.91; N,
3.16. Found: C, 73.17, H, 5.85, N, 3.10.
3.1.3. Dibenzyl N-(R)-α-Methylbenzylamino(pyren-1-yl)methylphosphonate (5)
The procedure was identical as in a case of aminophosphonate 4. Mixture of diastereoisomers—the
predominant diastereoisomer is denoted with an asterisk (13C-NMR data are quoted with two decimal
digits due to the large number of signals situated very close one to another). Y = 0.12 g, (20%, after
column chromatography), dense yellow oil (mixture). 1H-NMR (CDCl3): δ 8.21–8.20 (m, Hpyr, 2H);
8.16* (d, 3JHH = 7.5 Hz, Hpyr, 1H); 8.15–8.12 (m, Hpyr); 8.10–8.06 (m, Hpyr, 4H); 8.03–8.01 (m, Hpyr,
1H); 7.98* (d, 3JHH = 9.3 Hz, Hpyr, 1H); 7.38–7.36 (m, PhH, 2H); 7.34–7.32 (m, PhH, 3H); 7.22–7.17
(m, PhH, 5H); 6.97–6.94* (m, PhH, 2H); 6.92–6.90 (m, PhH); 6.89–6.86* (m, PhH, 2H); 6.83–6.81
(m, PhH); 6.76–6.74 (m, PhH, 2H); 6.68–6.66 (m, PhH); 5.38* (d, 2JPH = 21.0 Hz, CHP, 1H); 5.26* and
5.10* (Part of ABX system, 2JHH = 11.8 and 3JPH = 8.6 and 7.0 Hz, OCH2Ph, 2H); 5.24–5.22 (m, CHP);
5.13–5.03 (m, OCH2Ph); 4.72* and 4.39* (part of AMX system, 2JHH = 11.8 and 3JPH = 8.4 and 7.3 Hz,
OCH2Ph, 2H); 4.67-4.64 (m, OCH2Ph); 4.40–4.35 (m, OCH2Ph); 3.93* (q, 3JHH = 6.4 Hz, CHPh, 1H); 1.33*
(d, 3JHH = 6.4 Hz, CHCH3, 3H); 1.30–1.29 (m, CHCH3). 13C-NMR (CDCl3): δ 145.21 (CAr); 144.28 (CAr);
136.83 (CAr); 136.79 (CAr); 136.01 and 135.98 (CAr); 131.58 (CAr); 131.06 and 131.05 (CAr); 130.87 (CAr);
130.41 (CAr); 129.57 and 129.52 (CAr); 128.67 and 128.66 (CAr); 128.63 (CAr); 128.45 (CAr); 128.41 (CAr);
128.12 (CAr); 128.03 (CAr); 127.98 (CAr); 127.85 (CAr); 127.75, 127.74, 127.71 and 127.70 (CAr); 127.49 and
127.48 (CAr); 127.43 (CAr); 127.29 (CAr); 126.98 (CAr); 126.13 (CAr); 125.49 (CAr); 125.40 (CAr); 125.32 and
125.30 (CAr); 125.19 (CAr); 125.16 (CAr); 125.09 (CAr); 125.00 (CAr); 124.97 (CAr); 68.79 and 68.75 (POC);
68.64 and 68.60 (POC); 68.34 and 68.30 (POC); 68.10 and 68.06 (POC); 55.94 (Caliph); 55.86 (Caliph); 55.58
(Caliph); 55.46 (Caliph); 24.92 (Caliph); 22.85 (Caliph). 31P-NMR (CDCl3): δ 25.31*; 24.64 (4:1).Elemental
analysis: Calcd. for C39H34NO3P: C, 78.64; H, 5.75; N, 2.35. Found: C, 78.48, H, 5.96, N, 2.16.
3.1.4. Diphenyl N-(R)-α-Methylbenzylamino(pyren-1-yl)methylphosphonate (3e)
To a solution of the imine 1e (1mmol) and diphenyl phosphite (1 mmol) in dichloromethane
(ca. 2 mL) was slowly added BF3¨ OEt2 (24 mg, 0.67 mmol) via syringe. The mixture was stirred at
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room temperature for 24 h while monitoring the course of the reaction using 31P-NMR spectroscopy
or TLC. The solvent was removed in vacuo and the residual oil was roughly purified by column
chromatography on microcrystalline cellulose with chloroform as eluent to give 3e as a brown oil in
0.9 g (72%) yield of a crude product. Further attempts to purify and to analyze the product resulted in
its decomposition.
3.2. Toxicity Tests
3.2.1. Microtox® Toxicity Assay
The method is based on the analysis of light emission reduction of luminescent bacteria
(Vibrio fischeri) under toxic stress. The tests were carried out in a Microtox® M500 analyzer according
to the 1992 Microtox® Manual. The Microtox® Solid-Phase Test (MSPT) was adopted to report of
Doe et al. [31]. The MSPT procedure allows the test organisms to come direct contact with the solid
sample in an aqueous suspension of the test sample. Thus it is possible to detect toxicity which is due
to the insoluble solids that are not in the solution.
All materials and reagents were purchased from MODERNWATER (New Castle, DE, USA).
Toxicity was determined by using the marine luminescent bacterium, Vibrio fischeri, naturally adapted
to a saline environment. Briefly, bacteria were regenerated with 1 mL of Reconstitution Solution
(0.01%) and placed in the reagent well of the Microtox®. A suspension of 7 g of the sediment was
prepared in 35 mL of a Solid Phase Diluent (3.5% NaCl) and was magnetically stirred for 10 min. Then
a series of dilutions were made and bacteria (approx. 1 ˆ 106 cell¨ mL´1 per assay) were exposed to
these dilutions and to a blank (3.5% NaCl solution) for 20 min. Next, after filtration, the light output
of supernatants containing exposed bacteria was measured after 5 min with a Microtox® Analyzer
500. Inhibition was calculated as the concentration of compound loaded to sediment (mg/L) that
caused a 50% reduction in the light emitted by the bacteria, and EC50 along with 95% confidence limit
determined by the software provided with the Analyzer.
3.2.2. Ostracod Test Kit
Ecotoxicity evaluation of synthesized compounds was performed in a short term contact test
using Ostracodtoxkit F™ provided by MicroBiotests Inc. (Gent, Belgium). This direct sediment contact
bioassay was performed in multiwell test plates using neonates of the benthic ostracod crustacean
Heterocypris incongruens hatched from cysts [35]. After 6 days of contact with the sediment (or soil) the
percentage mortality and the growth of the crustaceans were determined and compared to the results
obtained in a non-treated reference sediment (soil).
Briefly, according to manual of Ostracodtoxkit test, the cysts (Heterocypris incongruens) were
transferred into a Petri dish filled with 10 mL standard fresh water (reconstituted water) and were
incubated at 25 ˝C for 52 h under continuous illumination (approx. 3000–4000 lux).
After 48 h of cysts incubation, pre-feeding of the freshly hatched ostracods was performed
with algae (spirulina-powder) provided in the test kit. Next, after hatching, before feeding with
algal food suspension, the length measurements of ostracod neonates has been done. Algae
(Selenastrum capricornutum) used as feed in the test plate were reconstituted according to the
manufacturer’s procedure. Each well of a test plate was filled in the following order: 2 mL standard
freshwater, 2 ˆ 500 μL of sediment (soil) treated and non-treated for comparison (blank), 2 mL already
prepared algal suspension, 10 ostracods. The test plates were covered with Parafilm® and closed by a
lid. Then multiwall plates were incubated at 25 ˝C in darkness for 6 days. After 6 days of exposure, the
ostracods have been recovered from the multiwells to determine the percentage mortality. To calculate
the growth inhibition of survived organisms, their length measurements have been also done. Mortality
of test organisms was determined in six replicates. The measurement of length was carried out by
means of a micrometric strip placed on the bottom of a glass microscope plate. Growth inhibition (GI)
of H. incongruens in the test sediment was calculated as follows:
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% growth inhibition “ 100 ´ rpgrowth in test sed.{growth in ref. sed.q ˆ 100s (1)
Statistical differences between variables were analyzed with ANOVA.
4. Conclusions
To conclude, a series of diphenyl pyrene-derived aminophosphonates 3a–d, 4 and 5 has
been prepared. Our previous study [17] revealed that pyrene-derived aminophosphonates have
interesting cytotoxic properties against colon cancer cell lines, therefore, the ecotoxicity of the
newly synthesized compounds has been evaluated using the crustacean Heterocypris incongruens
and bacterium Vibrio fischeri biotests. The evaluation demonstrated clearly that all compounds
3a–d and 4 are toxic in a moderate to high degree and that diphenyl N-benzylamino(pyren-1-yl)
methylphosphonate (3d) shows the highest degree of ecotoxicity. It has been also revealed that a weak
correlation between the toxicity against H. incongruens and against V. fischeri has been found and the
structure-toxicity correlation is rather problematic.
Although no evident correlations between the structure of the tested compounds and their toxicity
have been observed, the combination of the different bioassays—the Microtox® and Ostracodtoxkit F™
tests—has been proved to be a very useful tool for determining and comparing the potential toxicities
of examined substances 3a–d and 4 as well as for the assessment of their toxicity interactions.
Supplementary Materials: The following are available online at: http://www.mdpi.com/1420-3049/21/7/936/s1,
scans of 1H, 13C and 31P NMR of compounds 3a–d, 4 and 5.
Acknowledgments: We thank the Polish National Centre of Science (NCN) for funding the work in the framework
of the grant no. 2014/13/B/NZ9/02418. Within the framework of this grant, funds for covering the costs to
publish in open access were scheduled.
Author Contributions: Jarosław Lewkowski and Piotr Rychter conceived and designed the experiments;
Maria Rodriguez Moya and Marta Chmielak performed the chemical experiments; Diana Rogacz and Kamila
Lewicka performed the ecotoxicological experiments; Jarosław Lewkowski and Piotr Rychter analyzed the
data (Jarosław Lewkowski chemistry, Piotr Rychter. ecotoxicity); Jarosław Lewkowski and Piotr Rychter wrote
the paper.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Kafarski, P.; Lejczak, B.; Tyka, R.; Koba, L.; Pliszczak, E.; Wieczorek, P. Herbicidal activity of phosphonic,
phosphinic, and phosphonous acid analogues of phenylglycine and phenylalanine. J. Plant Growth Regul.
1995, 14, 199–203. [CrossRef]
2. Kafarski, P.; Lejczak, B. Biological Activity of Aminophosphonic Acids. Phosphorus Sulfur Silicon Relat. Elem.
1991, 63, 193–215. [CrossRef]
3. Kafarski, P.; Lejczak, B. Aminophosphonic Acids of Potential Medical Importance. Curr. Med. Chem.
Anti-Cancer Agents 2001, 1, 301–312. [CrossRef] [PubMed]
4. Hudson, H.R. Aminophosphonic and Aminophosphinic Acids and their Derivatives as Agrochemicals.
In Aminophosphonic and Aminophosphinic Acids: Chemistry and Biological Activity; Kukhar, V.P., Hudson, H.R.,
Eds.; Wiley and Sons: Chichester, UK, 2000.
5. Maier, L.; Diel, P.J. Organic Phosphorus Compounds 94. Preparation, Physical and Biological Properties
of Aminoarylmethylphosphonic- and -Phosphonous Acids. Phosphorus Sulfur Silicon Relat. Elem. 1991, 57,
57–64. [CrossRef]
6. Hudson, H.R. Phosphorus-Containing Fungicides: A Review of Current Research and Prospects.
Phosphorus Sulfur Silicon Relat. Elem. 1999, 144–146, 441–444. [CrossRef]
7. Jane, D.E. Neuroactive aminophosphonic and aminophosphinic acid derivatives. In Aminophosphonic and
Aminophosphinic Acids: Chemistry and Biological Activity; Kukhar, V.P., Hudson, H.R., Eds.; Wiley and Sons:
Chichester, UK, 2000.
200
Molecules 2016, 21, 936
8. Mohd-Pahmi, S.H.; Hussein, W.M.; Schenk, G.; McGeary, R.P. Synthesis, modelling and kinetic assays of
potent inhibitors of purple acid phosphatase. Bioorg. Med. Chem. Lett. 2011, 21, 3092–3094. [CrossRef]
[PubMed]
9. Klimczak, A.A.; Kuropatwa, A.; Lewkowski, J.; Szemraj, J. Synthesis of new N-arylamino(2- furyl)
methylphosphonic acid diesters, and in vitro evaluation of their cytotoxicity against esophageal cancer
cells. Med. Chem. Res. 2013, 22, 852–860. [CrossRef]
10. Boduszek, B. The Acidic Cleavage of Pyridylmethyl(amino)phosphonates. Formation of the Corresponding
Amines. Tetrahedron 1996, 52, 12483–12494. [CrossRef]
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Abstract: The syntheses of hydroxymethylenebisphosphonic acid derivatives (dronic acid derivatives)
starting from the corresponding substituted acetic acids and P-reagents, mainly phosphorus
trichloride and phosphorous acid are surveyed according to the solvents applied. The nature of the
solvent is a critical point due to the heterogeneity of the reaction mixtures. This review sheds light on
the optimum choice and ratio of the P-reactants, and on the optimum conditions.
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1. Introduction
The hydroxymethylenebisphosphonic acid derivatives (dronic acid derivatives) form an important
group within organophosphorus pharmaceutics. It is known that the two phosphonic functions are
capable of forming complex with calcium ions, hence, the resorption of these ions is prevented.
Bisphosphonic derivatives are used in the treatment of osteoporosis, Paget disease and tumor-induced
hypercalcaemia, but they also show direct antitumor and antiparasitic activity [1–6].
Although the synthesis of dronic acid derivatives is widely discussed in the literature, it can be
considered a sort of “black box”. They were prepared in many solvents, but the optimum circumstances,
and the molar ratios of the P-reagents were not explored. The role of the reagents and the reaction
mechanism were not clarified. In most cases, the purity of the products was not reported, or when crude
products were prepared, unrealistically high, and hence misleading yields were claimed. We wish to
summarize the preparation of the most important hydroxymethylenebisphosphonic acid derivatives
according to solvents, hoping to make the syntheses more transparent. The most important therapeutic
agents discussed in this review are listed in Table 1.
Table 1. The dronic acid derivatives discussed in this review.
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According to the general scheme for the preparation of hydroxymethylenebisphosphonic acid
derivatives, the corresponding carboxylic acid, or its chloride, ester and anhydride derivative was
used as the starting material, and reacted with phosphorus trichloride and/or phosphorous acid,
phosphoric acid or phosphoryl chloride in a wide variety of solvents, for example methanesulfonic
acid (MSA), sulfolane, chlorobenzene, toluene, xylene, n-octane, methyl cyclohexane, 1,4-dioxane,
acetonitrile, phenol and its derivatives, alkyl carbonates, phosphates, silicon or sunflower oil, ionic







Y= alkyl, aryl, heteroaryl










Scheme 1. General scheme for the preparation of hydroxymethylenebisphosphonic acids.
In many publications, water was applied as the solvent, and phosphorus trichloride as the reagent,
which is absolutely pointless, as the water reacts fast with the P-reagent to provide phosphorous
acid [7–11]. The concept of generating phosphorous acid “in situ” may be questioned, as this approach
is expensive, pollutes the environment, and rather dangerous on the industrial scale. We did not deal
with this not too practical method.
2. Reactions in Methanesulfonic Acid (MSA)
MSA may be considered the best solvent during the synthesis of dronic acid derivatives, as it
helps to overcome the problems of heterogeneity during the reaction. However, the MSA is likely
to participate in the reactions themselves. It can activate the carboxylic acid to form a carboxylic
acid-MSA mixed anhydride, which may be formed in two ways, as shown in Scheme 2 [12].
 
Scheme 2. Possible formation of carboxylic acid-MSA mixed anhydride as an intermediate.
MSA may also react with phosphorus trichloride to provide a more reactive P-species (Scheme 3).
Scheme 3. Activation of phosphorus trichloride by reaction with MSA.
In all syntheses of pamidronate described, β-alanine was applied as the starting material in MSA
(Scheme 1, Y = −CH2CH2NH2, Z = −OH, solvent: MSA). Szűcs, Vepsäläinen and his co-workers
used 2 equivalents of phosphorus trichloride and 1 equivalent of phosphoric acid as the P-reagents
(Table 2/Entries 1 and 2) [13,14]. Shinkai et al. applied phosphorus trichloride and phosphorous acid
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in ratio of 2.1:1 (Table 2/Entry 3) [15]. In the lack of purification, no purities were provided. The best
result was achieved by Keglevich et al. who proved that the phosphorous acid did not participate in
the reaction under discussion due its low nucleophilicity. For this, only 3.2 equivalents of phosphorus
trichloride were measured in. The yield of pamidronic acid monosodium salt trihydrate was 57%, and
the purity was 99% (Scheme 4) (Table 2/Entry 4) [16].
Table 2. Synthesis of pamidronate from β-alanine in MSA.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO4 (2:1) 65 16 Na - 55 1 [13]
2 PCl3:H3PO4 (2:1) 65 18 Na - 22 1 [14]
3 PCl3:H3PO3 (2.1:1) 65 16–20 Na - 57 1 [15]
4 PCl3 (3.2) 75 24 Na·2H2O 99 2 57 [16]
1 For the crude product; 2 On the basis of acid-base titration.
Scheme 4. Preparation of pamidronate in MSA by an optimized method [16].
The preparations of alendronic acid derivatives were also studied in details using MSA. In most
cases γ-aminobutyric acid (GABA) was treated with the P-reagents (Table 3/Entries 1–9) [14,15,17–23].
In one instance, 2-pyrrolidone was the starting material (Table 3/Entry 10) [24].
Table 3. Synthesis of alendronic acid derivatives in MSA.
Entry Starting Material Reagent (Equiv.) T (◦C) t (h) Product form Purity (%) Yield (%) Ref.
1 GABA PCl3:H3PO3 (2:1) 65 18 Na - 91 1 [19]
2 GABA PCl3:H3PO3 (2.4:1.5) 65 20 Na·3H2O 99.7 2 90 1 [23]
3 GABA PCl3:H3PO3 (2.1:1) 65 16–20 Na·3H2O 99.7 2 89 1 [15]
4 GABA PCl3:H3PO4 (2:1) 65 18 acid - 85 1 [14]
5 GABA PCl3:H3PO3 (2:1) 65 18 - - 82 1 [18]
6 GABA PCl3:H3PO3 (2.1:1) 65 18 - - 82 1 [20]
7 GABA PCl3 (3.2) 75 12 Na·3H2O 93 2 58 [21]
8 GABA POCl3:H3PO3 (2:3 or 3:3 ) 75 12 Na·3H2O 97 2 60 [22]
9 GABA P2O5:H3PO3 (1:2) 70 24 Na·3H2O >99.9 3 48 [17]
10 2-Pyrrolidone PCl3 (3.4) 100–105 6 Na·3H2O - 81 1 [24]
1 For the crude product; 2 On the basis of acid-base or complexometric titration; 3 On the basis of HPLC.
The majority of the researchers applied phosphorus trichloride and phosphorous acid as reagents
in a ratio of ca. 2:1 (Scheme 1, Y = −CH2(CH2)2NH2, Z = −OH, solvent: MSA) (Table 3/Entries 1–3, 5
and 6) [15,18–20,23]. Yields around 80%–90% were claimed. As in the case of pamidronate, Vepsäläinen
and his co-workers used 2 equivalents of phosphorus trichloride and 1 equivalent of phosphoric acid
(Table 3/Entry 4) [14]. The best reproducible results were reported by Keglevich et al., furnishing
alendronate in a yield of 58% (Scheme 5) (Table 3/Entry 7) [21]. It was clarified that phosphorous acid
is unnecessary, when phosphorus trichloride is the P-reagent and MSA is the solvent.
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Scheme 5. Preparation of alendronate in MSA by an optimized method [21].
Typically, the yields were higher than 80% for the crude product (Table 3/Entries 1–6 and
10) [14,15,18–20,23,24]. In only two cases were the purities reported, however, the values of 99.7% seem
to be excessive (Table 3/Entries 2 and 3) [15,23]. Our experience is that a crude product may never be
pure, and such high values are not realistic.
In a special combination, phosphoryl chloride and phosphorous acid were used in a proportion of
2:3 or 3:3 in MSA (Table 3/Entry 8) [22]. In one case, 2 equivalents of phosphorous acid and 1 equivalent
of phosphorus pentoxide were the P-reactants, and the target dronate was obtained in a yield of 48%
(Table 3/Entry 9) [17]. Using 2-pyrrolidone as the starting material together with 3.4 equivalents of
phosphorus trichloride, the crude alendronate was isolated in a yield of 81% (Table 3/Entry 10) [24].
The synthesis of ibandronate in MSA was discussed in only a few publications. In these
preparations, N-Methyl-N-pentyl-β-alanine (MPA) was treated with phosphorus trichloride and
phosphorous acid under different conditions (Scheme 1, Y = −CH2CH2N(Me)(Pen), Z = −OH, solvent:
MSA). Soni et al. applied 5 equivalents of phosphorus trichloride together with 2 equivalents of
phosphorous acid. According to their description, pure alendronate was isolated in a yield of 86%
(Table 4/Entry 1) [25]. The use of phosphorus trichloride is completely unnecessary. Applying
2.5 equivalents of phosphorus trichloride, and the same amount of phosphorous acid in the mixture
of MSA and chlorobenzene, the yield was 60% (Table 4/Entry 2) [26]. The optimum case was, when
3.2 equivalents of phosphorus trichloride were used. The realistic and reproducible yield was 46%


















Scheme 6. Preparation of ibandronate in MSA by an optimized method [21].
Table 4. Synthesis of ibandronate from MPA in MSA.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (5:2) 65–67 24 Na·H2O 99.6 1 86 [25]
2 PCl3:H3PO3 2 (2.5:2) 96 3 Na·H2O 99.8 1 60 [26]
3 PCl3 (3.2) 75 12 Na 99 3 46 [21]
1 On the basis of HPLC; 2 in the mixture of MSA and PhCl; 3 On the basis of acid-base titration.
For risedronic acid derivatives, yields of 38%–74% were reported. In the basic syntheses,
3-pyridylacetic acid (PAA) was reacted with phosphorus trichloride and phosphorous acid in MSA
(Scheme 1, Y = 3-pyridylmethylene-, Z = −OH, solvent: MSA).
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A yield of 73% was obtained, when 3-3 equivalents of phosphorus trichloride and phosphorous
acid were used in the mixture of MSA and diethyl carbonate (Table 5/Entry 1) [27]. Another
combination, a 2.1:1 ratio of the P-reagents led to the dronic acid in a yield of 38%. No purity
was reported (Table 5/Entry 2) [15]. When the mixture of 3 equivalents of phosphorous acid and
2 equivalents of phosphoryl chloride, or 2 equivalents of phosphorous acid and 1 equivalent of
phosphorus pentoxide were reacted with the corresponding carboxylic acid, yields of ca. 55% were
reported (Table 5/Entries 3 and 4) [17,22]. The application of phosphorus trichloride (3.1 equivalents)
alone led to the highest yield (74%), and the unnecessity of phosphorous acid was again proved
(Scheme 7) (Table 5/Entry 5) [28,29].
Scheme 7. Preparation of risedronic acid in MSA by an optimized method [28,29].
Table 5. Synthesis of risedronic acid derivatives from PAA in MSA.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 1 (3:3) 70–72 5 Na·2.5H2O 99.9 2 73 [27]
2 PCl3:H3PO3 (2.1:1) 65 16–20 acid - 38 3 [15]
3 POCl3:H3PO3 (2:3) 75 12 acid 98 4 55 [22]
4 P2O5:H3PO3 (1:2) 80–100 72 acid·H2O 99.9 2 54 [17]
5 PCl3 (3.1) 75 12 acid 92 4 (100 2) 74 3 [28,29]
1 in the mixture of MSA and diethyl carbonate; 2 On the basis of HPLC; 3 For the crude product; 4 On the basis
of acid-base titration.
During the preparation of zoledronic acid in MSA, imidazol-1-yl-acetic acid (IAA) was treated
with only phosphorus trichloride, or with the mixture of this reagent and phosphorous acid
(Scheme 1, Y = 1-imidazolylmethylene-, Z = −OH, solvent: MSA). Kieczykowski and co-workers
applied phosphorus trichloride and phosphorous acid in a quantity of 2.1:1 equivalents. The yield of
the target dronic acid was 31% (Table 6/Entry 1) [15]. Using phosphorus trichloride as the reactant in
amounts of 3.1 or 3.2, yields of 53% and 46%, respectively, were reported by the Keglevich group in
comparable purity (Scheme 8) (Table 6/Entries 2 and 3) [28,29].
Table 6. Synthesis of zoledronic acid from IAA in MSA.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (2.1:1) 65 16–20 acid - 31 1 [15]
2 PCl3 (3.1) 80 3 acid 99 2 53 [29]
3 PCl3 (3.2) 80 3 acid 98 2 46 [28]
1 For the crude product; 2 On the basis of acid-base titration.
Scheme 8. Preparation of zoledronic acid in MSA by an optimized method [28,29].
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In overall, it can be said that the lower yields of the Keglevich group are better, than the higher
ones published for the crude products neglecting the purity. The reliable yields were obtained after
purifying the products and analyzing the purity by potentiometric titration.
3. Synthesis of Dronic Acid Derivatives in Chlorobenzene
The second frequently used solvent is chlorobenzene. Chlorobenzene has a few advantages in
comparison with MSA. It has a lower viscosity, can be removed by distillation, and can be reused. The
real problem with MSA is that during the pH adjustment sodium methanesulfonate may be formed
from MSA, which is difficult to remove. In the procedures reported, the corresponding carboxylic
acids were reacted with phosphorus trichloride and phosphorous acid/phosphoric acid. None of
the reactions were performed with solely phosphorus trichloride, as, in this case, it is unreactive
without another P-containing partner (Scheme 9). In most reports no data on the purity of dronic acid
derivatives was provided, for this, the yields are not reliable.
Scheme 9. General scheme for the preparation of dronic acid derivatives in chlorobenzene.
Reacting β-alanine or GABA with 1.5 equivalents of phosphorus trichloride and 1.5 equivalents
of phosphorous acid at 100 ◦C for 3 h, the yields were in the range of 45%–59% (Table 7/Entries 1
and 3–5) [30–32]. Starting from β-alanine or GABA, and measuring in phosphorus trichloride and
phosphoric acid in molar equivalents of 2.4:1.5 or 2:3, respectively, the pamidronic acid or alendronic
acid was obtained in a yield of 53% and 18%, respectively (Table 7/Entries 2 and 6) [33,34].
Table 7. Synthesis of pamidronic acid and alendronic acid in chlorobenzene.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PD β-alanine PCl3:H3PO3 (1.5:1.5) 100 3 acid - 59 1 [30]
2 PD β-alanine PCl3:H3PO4 (2.4:1.5) 105–110 2 acid - 53 [33]
3 PD β-alanine PCl3:H3PO3 (1.5:1.5) 100 3 acid - 51 [31]
4 AD GABA PCl3:H3PO3 (1.5:1.5) 100 3 acid - 46 [31]
5 AD GABA PCl3:H3PO3 (1.5:1.5) 100 3 acid - 45 [32]
6 AD GABA PCl3:H3PO4 (2:3) 100–110 3 acid - 18 1 [34]
1 For the crude product.
In two variations for the syntheses of ibandronate, a yield of 60% was reached. Phosphorus
trichloride and phosphorous acid were applied in a 1.5:1.5 or 2.5:2 molar equivalent quantity (in a
mixture of MSA and chlorobenzene) (Table 8/Entries 1 and 2) [26,35]. Using phosphorus trichloride and
phosphoric acid in amounts of 3:3 and 2:3, the yield was 37% and 6%, respectively (Table 8/Entries 3
and 4) [34,36]. In one instance, the proportion of phosphorous acid was not provided, and a peripheral
result (a yield of 3%) was reported (Table 8/Entry 5) [26].
Table 8. Synthesis of ibandronic acid derivatives from MPA in chlorobenzene.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (1.5:1.5) 80 4 Na·H2O - 60 [35]
2 PCl3:H3PO3 1 (2.5:2) 96 3 Na·H2O 99.8 2 60 [26]
3 PCl3:H3PO4 (3:3) 110 11 Na - 37 3 [36]
4 PCl3:H3PO4 (2:3) 100–110 3 acid - 6 1 [34]
5 PCl3 4:H3PO3 85–90 4–5 acid 95 2 3 [26]
1 in the mixture of MSA and PhCl; 2 On the basis of HPLC; 3 For the crude product; 4 Two and a half equivalents.
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The preparation of risedronic acid derivatives in chlorobenzene as the solvent was in all reactions
implemented using phosphorus trichloride and phosphorous acid. An unrealistically high yield of
96% was claimed for risedronic acid using 3.5 equivalents of phosphorus trichloride, and the same
amounts of phosphorous acid without specifying the purity (Table 9/Entry 1) [37]. Applying the
P-reagents in a quantity of 1.5 equivalents, the yield was 68% (Table 9/Entry 2) [35]. The most reliable
result was described by Wadhwa, but the reaction time was not given. The reactants were used in
amount of 2.4 equivalents, and the risedronic acid was obtained in a yield of 58% with a purity of 84%
(Table 9/Entry 3) [38]. Applying phosphorus trichloride and phosphorous acid in a molar ratio of 3:3.5,
the dronate was isolated in a yield of 52%. However, no temperature was reported. A similar yield
(52%) was described, when 2 equivalents of phosphorus trichloride was used with phosphorous acid.
However, the quantity of the latter species was not provided (Table 9/Entries 4 and 5) [39,40].
Table 9. Synthesis of risedronic acid derivatives from PAA in chlorobenzene.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (3.5:3.5) 90–95 2.5 acid - 96 1 [37]
2 PCl3:H3PO3 (1.5:1.5) 80 4 acid - 68 1 [35]
3 PCl3:H3PO3 (2.4:2.4) 85–90 - acid 84 2 58 1 [38]
4 PCl3:H3PO3 (3:3.5) - 2.5 Na·2.5H2O - 52 [39]
5 PCl3 3:H3PO3 100 6 acid - 52 1 [40]
1 For the crude product; 2 On the basis of HPLC; 3 Two equivalents.
For the synthesis of zoledronic acid in chlorobenzene, the purity remains unclear in all cases,
therefore, the yields are not reliable at all. Carrying out the synthesis with 3.7 equivalents of phosphorus
trichloride and with the same amount of phosphorous acid, quantitative yield was claimed that is
entirely unrealistic (Table 10/Entry 1) [41]. In other instances, phosphorus trichloride and phosphoric
acid were applied in different, such as 4.7:2.9, 2:3 and 3:1.9 ratios to lead to yields of 79%, 67% and
41%, respectively (Table 10/Entries 2–4) [34,42,43].
The need for the joint application of phosphorus trichloride and phosphorous acid will be
explained in the next sub-chapter.
Table 10. Synthesis of zoledronic acid from IAA in chlorobenzene.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (3.7:3.7) 100 1 acid - 100 1 [41]
2 PCl3:H3PO4 (4.7:2.9) 80 2–2.5 acid - 79 1 [42]
3 PCl3:H3PO4 (2:3) 100–110 3 acid - 67 1 [34]
4 PCl3:H3PO4 (3:1.9) 100 3 acid - 41 [43]
1 For the crude product.
4. Methods for the Preparation of Dronic Acid Derivatives in Sulfolane
Sulfolane is also a preferred solvent in the preparation of hydroxymethylenebisphosphonic acid
derivatives, but less data were published. In all such cases, phosphorus trichloride and phosphorous
acid were the P-reagents (Scheme 10).
Scheme 10. General scheme for the preparation of dronic acid derivatives in sulfolane.
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Approximately in half of the cases, the purities were not described, therefore the data may be
misleading. The synthesis of a part of the dronic acid derivatives was attempted also under MW
conditions. The synthesis of ibandronic acid derivatives was not attempted in sulfolane.
Applying phosphorus trichloride and phosphorous acid in a molar ratio of 3:3, under conventional
and MW-assisted conditions at 65 ◦C for 3.5 h and 3 min, respectively, yields of 72% and 64%,
respectively, were reported for crude pamidronic acid derivatives (Table 11/Entries 1 and 2) [44].
(The forms of product were not provided.) Alendronate was obtained under similar conditions in
yields of 38% and 41%, respectively (the forms of product were not provided) (Table 11/Entries 7
and 8) [44]. It can be seen that MW irradiation was useful in respect of reaction time in these
reactions. Keglevich et al. used 2-2 equivalents of the P-reagents in reaction with β-alanine to afford
pure pamidronic acid in a yield of 63% (Table 11/Entry 3) [16]. When phosphorus trichloride and
phosphorous acid were used in a ratio of 3.4:1.5, pure sodium pamidronate was obtained in a lower
yield (Table 11/Entry 4) [45]. Applying phosphorus trichloride and phosphorous acid in ratios of
3.4:1.5 and 2.5:3.5, the yield of sodium alendronate was 69% (crude product), and 55% (pure dronate),
respectively (Table 11/Entries 5 and 6) [45,46].
Table 11. Synthesis of pamidronic and alendronic acid derivatives in sulfolane.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PD β-alanine PCl3:H3PO3 (3:3) 65 3.5 - - 72 1 [44]
2 PD β-alanine PCl3:H3PO3 (3:3) 65 2 0.05 - - 64 1 [44]
3 PD β-alanine PCl3:H3PO3 (2:2) 75 12 acid 100 3 63 [16]
4 PD β-alanine PCl3:H3PO3 (3.4:1.5) 63–67 3 2Na·5H2O >99 48 [45]
5 AD GABA PCl3:H3PO3 (3.4:1.5) 63–67 3 Na·3H2O >99 69 1 [45]
6 AD GABA PCl3:H3PO3 (2.5:3.5) 60–65 12 Na·3H2O >99 4 55 [46]
7 AD GABA PCl3:H3PO3 (3:3) 65 2 0.1 - - 41 1 [44]
8 AD GABA PCl3:H3PO3 (3:3) 65 3.5 - - 38 1 [44]
1 For the crude product; 2 MW heating; 3 On the basis of acid-base titration; 4 On the basis of HPLC.
McKenna and his co-workers investigated the synthesis of risedronic and zoledronic acid
derivatives (the forms of product were not provided) also under MW conditions, using 3 equivalents
of both the phosphorus trichloride and phosphorous acid at 65 ◦C for 3 min. The dronic acid
derivatives, risedronic acid and zoledronic acid derivatives were obtained in yields of 74% and
70%, respectively (Table 12/Entries 1 and 3) [44]. In case of conventional heating, the yield of
zoledronic acid derivative was 67% (Table 12/Entry 4) [44]. The reaction of 1 equivalent of PAA
or IAA with 3.4 equivalents of phosphorus trichloride and 1.5 equivalents of phosphorous acid on
conventional heating at around 65 ◦C provided risedronate and zoledronic acid in a yield of 54% and
71%, respectively (Table 12/Entries 2 and 5) [45]. No attempts were made to prepare pure zoledronic
acid derivatives.
Table 12. Synthesis of risedronic and zoledronic acid derivatives in sulfolane.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 RD PAA PCl3:H3PO3 (3:3) 65 1 0.05 acid·H2O - 74 2 [44]
2 RD PAA PCl3:H3PO3 (3.4:1.5) 63–67 3 Na >99 54 [45]
3 ZD IAA PCl3:H3PO3 (3:3) 65 1 0.05 - - 70 2 [44]
4 ZD IAA PCl3:H3PO3 (3:3) 65 3.5 - - 67 2 [44]
5 ZD IAA PCl3:H3PO3 (3.4:1.5) 63–67 3 acid·H2O >99 71 2 [45]
1 Under MW irradiation; 2 For the crude product.
It was shown in Chapter 2 that using MSA as the solvent, there was no need to use phosphorous
acid together with phosphorus trichloride (Tables 2–6) [16,21,28,29]. However, using a solvent other
than MSA, it is necessary to apply phosphorus trichloride and phosphorous acid jointly. A logical
explanation may be that, before phosphorus trichloride would react with the carboxylic acid or its
derivatives, it reacts with 1 or 2 equivalents of phosphorous acid resulting in the formation of activated
P-species, such as (HO)2P-O-PCl2 and/or (HO)2P-O-PCl-O-P(OH)2 (Scheme 11). In the next step, the
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reactive intermediates formed may react with the substituted acetic acid, providing the target dronic
acid derivative after several steps [16].
 
Scheme 11. Formation of the reactive P-species by the condensation of phosphorus trichloride and
phosphorous acid and their reaction with the substituted acetic acids.
5. Synthesis of Dronic Acid Derivatives in Toluene
The preparations of alendronic acid derivatives, ibandronate and risedronic acid have also been
investigated in toluene (Scheme 12).
Scheme 12. General scheme for the preparation of dronic acid derivatives in toluene.
In one approach towards alendronic acid, a mixture of toluene and PEG 400 was used as the
solvent, and 1.6 equivalents of phosphorus trichloride along with 1 equivalent of phosphorous acid as
the P-reagents. The yield was 56% for crude alendronic acid (Table 13/Entry 1) [47]. Using phosphorus
trichloride and methanesulfonic anhydride (Ms2O) in a molar ratio of 3:3 in toluene, a yield of 66%
was reported (Table 13/Entry 2) [48]. The application of 3.7 equivalents of phosphorus trichloride
and 4.2 equivalents of phosphorous acid led to a moderate yield (44%) of sodium ibandronate
(Table 13/Entry 3) [49].
Table 13. Synthesis of alendronic acid derivatives and ibandronate in toluene.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 AD GABA PCl3:H3PO3 1 (1.6:1) 75 4 acid - 56 2 [47]
2 AD GABA PCl3:Ms2O (3:3) 70 9.5 Na·3H2O - 66 [48]
3 ID MPA PCl3:H3PO3 (3.7:4.2) 80–85 7–8 Na - 44 [49]
1 in the mixture of toluene and PEG 400; 2 For the crude product.
Regarding the synthesis of risedronic acid, in most instances unusual reagents for example,
propylphosphonic anhydride (T3P), Ms2O or PCl5 were used together with phosphorous acid, and
purities of >90% were reported according to HPLC (Table 14/Entries 1–6). Unrealistically high yields of
90% and 81% were reported, when 3.1 equivalents phosphorous acid were reacted with 2.5 equivalents
of T3P or 3.1 equivalents of phosphoryl chloride (Table 14/Entries 1 and 2) [50]. In similar reactions,
with ca. 3 equivalents of reactants (phosphorous acid and Ms2O) a lower yield of 34% was obtained
(Table 14/Entry 3) [50]. Other interesting combinations, such as a 3.1:2:1 ratio of H3PO3:Ms2O:POCl3, or
a 3.1:1:1 ratio of H3PO3:Ms2O:PCl5 afforded the risedronic acid in yields of ca. 60% (Table 14/Entries 4
and 5) [50]. The application of 3.2 equivalents of phosphorus trichloride alone led to the lowest yield
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(15%) (Table 14/Entry 6) [12]. It seems to have been confirmed that phosphorus trichloride alone is not
enough if not MSA is the solvent. In the cases discussed, it was necessary to apply an activating agent.
Table 14. Synthesis of risedronic acid from PAA in toluene
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 H3PO3:T3P (3.1:2.5) 95 20.5 acid·H2O 99.6 1 90 2 [50]
2 H3PO3:POCl3 (3.1:3.1) 95 20.5 acid·H2O 98.5 1 81 2 [50]
3 H3PO3:Ms2O (3.1:3) 95 20.5 acid·H2O 95.9 1 34 2 [50]
4 H3PO3:Ms2O:POCl3 (3.1:2:1) 95 20.5 acid·H2O 99.2 1 62 2 [50]
5 H3PO3:Ms2O:PCl5 (3.1:1:1) 95 20.5 acid·H2O 98.3 1 58 2 [50]
6 PCl3 (3.2) 110 6 acid 90.1 3 15 2 [12]
1 On the basis of HPLC; 2 For the crude product; 3 On the basis of acid-base titration.
6. Reactions in the Absence of Solvent
In many publications, the hydroxymethylenebisphosphonic acid derivatives were prepared in
the absence of any solvent. These reactions are more heterogeneous, and in most cases they cannot be
stirred, due to the (almost) solid consistency. Although the yields reported are not wrong, the purities
were provided only in a few instances. For this, the conclusions from the yields may be misleading.
It can be seen that beside phosphorus trichloride or phosphoryl chloride, there was need for another
reactant as well, for example for phosphorous acid or Ms2O.
Reacting β-alanine with an unnecessarily large amount of phosphorus trichloride (5 equivalents)
and phosphorous acid (3 equivalents) under MW conditions, sodium pamidronate was isolated in a
yield of 67% (Table 15/Entry 1) [51]. A rather similar yield (61%) was reported applying the above
P-reagents in a 2:1.5 equivalents quantity (Table 15/Entry 2) [52]. Keglevich et al. obtained pure
pamidronic acid in a yield of 44%, when both phosphorus trichloride and phosphorous acid were used
in a quantity of 2 equivalents [53]. According to our experiences, in most cases it is not possible to
prepare the hydroxymethylenebisphosphonic acid derivatives in the absence of solvents.
Table 15. Synthesis of pamidronic acid derivatives from β-alanine in neat.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (5:3) 80 1 0.05 Na - 67 2 [51]
2 PCl3:H3PO3 (2:1.5) 100 4 acid - 61 2 [52]
3 PCl3:H3PO3 (2:2) 75 3 acid >99 3 44 [53]
1 Under MW conditions; 2 For the crude product; 3 On the basis of acid-base titration.
Alendronic acid derivatives were prepared starting from GABA, N-phthalimido-GABA, or
N-phthalimido-GABA-chloride, but the purities were not reported at all. Using GABA as the
starting material, and phosphorus trichloride along with Ms2O or phosphorous acid as the other
reagent in a molar ratio of 3:3 (PCl3:Ms2O) and 5:3 (PCl3:H3PO3 under MW conditions), or 2:1.5
(PCl3:H3PO3), the yields were 78%, 78% and 59%, respectively (Table 16/Entries 1–3) [48,51,52].
Starting from N-phthalimido-GABA and applying phosphorus trichloride along with phosphorous
acid, or this combined with phosphoric acid, crude alendronic acid was obtained in yields of 38%
and 57% (Table 16/Entries 4–5) [54]. In one instance, N-phthalimido-GABA-chloride was reacted
with 2 equivalents of phosphorous acid alone, leading to the target dronic acid in a poor yield of
19% (Table 16/Entry 6) [54]. According to our earlier results [16,21,29,53], phosphorous acid alone is
completely unreactive in the synthesis of hydroxymethylenebisphosphonic acid derivatives. Therefore,
even the low yield (19%) reported is questionable (Table 16/Entry 6) [54].
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Table 16. Synthesis of alendronic acid derivatives in the absence of solvents.
Entry Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 GABA PCl3:Ms2O (3:3) 70–100 7 Na·3H2O - 78 [48]
2 GABA PCl3:H3PO3 (5:3) 80 1 0.05 Na - 78 2 [51]
3 GABA PCl3:H3PO3 (2:1.5) 100 4 acid - 59 2 [52]
4 N-phthalimido-GABA PCl3:H3PO3 (2:5) 80 3 acid - 38 2 [54]
5 N-phthalimido-GABA PCl3:H3PO3:H3PO4 (2:1.5:4) 80 3 acid - 57 2 [54]
6 N-phthalimido-GABA-chloride H3PO3 (2) 130 4 acid - 19 2 [54]
1 Under MW conditions; 2 For the crude product.
The application of 2.9 equivalents of phosphorus trichloride and 1.5 equivalents of phosphorous
acid under somewhat different conditions (at 60–65 ◦C for 1.5 h or at 70–75 ◦C for 20 h) led to
ibandronate in yields of 89% and 82% (Table 17/Entries 1 and 2) [55,56]. A similar result (82%)
was reported using a larger excess of the P-reagents (4.1 equivalents of phosphorus trichloride
and 2.5 equivalents of phosphorous acid). However, no criterions of purity were provided
(Table 17/Entry 3) [57]. Measuring in, even more reagents (5 equivalents of phosphorus trichloride and
3 equivalents of phosphorous acid), and performing the reaction under MW conditions, a somewhat
lower yield (72%) was obtained (Table 17/Entry 4) [51]. With a not defined quantity of phosphorus
trichloride and 1.3 equivalents of phosphorous acid, sodium ibandronate was prepared in a yield of
68% (Table 17/Entry 5) [58]. The lowest yield of 59% was observed using 3.2 equivalents of phosphoryl
chloride and a large excess (9.7 equivalents) of phosphorous acid (Table 17/Entry 6) [59]. The use of
this large excess is completely needless, even makes the purification more difficult.
Table 17. Synthesis of ibandronic acid derivatives from MPA in the absence of any solvent.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (2.9:1.5) 60–65 1.5 Na - 89 [55]
2 PCl3:H3PO3 (2.9:1.5) 70–75 20 Na·H2O - 82 [56]
3 PCl3:H3PO3 (4.1:2.5) 75 5 Na - 82 1 [57]
4 PCl3:H3PO3 (5:3) 80 2 0.05 Na - 72 1 [51]
5 PCl3:H3PO3 3 75 6 Na·H2O - 68 1 [58]
6 POCl3:H3PO3 (3.2:9.7) 60–70 24 acid - 59 1 [59]
1 For the crude product; 2 Under MW conditions; 3 1.3 equivalents of phosphorous acid were used.
Risedronic acid derivatives were synthesized from PAA. Using phosphorus trichloride and
phosphorous acid in a molar ratio of 5:3, the yield was 86% (Table 18/Entry 1) [51]. In one case,
morpholine was also added to the reaction mixture beside the P-reagents, and the crude risedronic
acid was prepared in a yield of 78% (Table 18/Entry 2) [60]. Yields around 66% were claimed
using ca. 2 equivalents of both phosphorus trichloride and phosphorous acid at a temperature
of 70–100 ◦C (Table 18/Entries 3 and 4) [52,61]. Carrying out the reaction applying 3.2 equivalents
of phosphoryl chloride and a large excess (9.7 equivalents) of phosphorous acid, the yield was 60%
(Table 18/Entry 5) [59].
Table 18. Synthesis of risedronic acid derivatives from PAA in the absence of solvent.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (5:3) 80 1 0.05 Na - 86 2 [51]
2 PCl3:H3PO3:morpholine (2:5:1) 68–75 2.5–4 acid - 78 2 [60]
3 PCl3:H3PO3 (2:1.5) 100 4 acid - 67 2 [52]
4 PCl3:H3PO3 (2.5:2.2) 70–75 8 Na·2.5H2O 99.9 3 65 [61]
5 POCl3:H3PO3 (3.2:9.7) 60–70 24 acid - 60 2 [59]
1 Under MW conditions; 2 For the crude product; 3 On the basis of HPLC.
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Reacting IAA, phosphorus trichloride and phosphorous acid in a molar ratio of 1:5:3 under MW
conditions, or in a ratio of 1:3:5, zoledronate and zoledronic acid were obtained in a yield of 80% and
61%, respectively. The first yield was related on crude product (Table 19/Entries 1–2) [51,62]. Using
3 equivalents of phosphoryl chloride and 5 equivalents of phosphorous acid, the yield was 79% for the
crude, but pure zoledronic acid (Table 19/Entry 3) [62]. The application of phosphoryl chloride and
phosphorous acid measured in an excessive quantity (reported also for ibandronic and risedronic acid)
led to a yield of 62% (Table 19/Entry 4) [59].
Table 19. Synthesis of zoledronic acid derivatives from IAA under solvent-free conditions.
Entry Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PCl3:H3PO3 (5:3) 80 1 0.05 Na - 80 2 [51]
2 PCl3:H3PO3 (3:5) 75 6 acid 99.9 3 61 [62]
3 POCl3:H3PO3 (3:5) 75 5 acid 99.9 3 79 2 [62]
4 POCl3:H3PO3 (3.2:9.7) 60–70 24 acid - 62 2 [59]
1 Under MW conditions; 2 For the crude product; 3 On the basis of HPLC.
7. Methods in ILs
The ILs are considered green solvents, because of their low vapor pressure, high thermal stability,
and, as they can be recycled and reused. Although their use in organic syntheses is spreading,
























ZDX = H or Na
n = 0, 1 or 3
x n H2O
Scheme 13. General scheme for the preparation of dronic acid derivatives in ILs.
De Ferra and co-workers investigated the preparation of pamidronic and alendronic acid
derivatives (in two cases, the form of the products was not provided), as well as risedronic and
zoledronic acid in tributylmethylammonium chloride ([Bu3NH][Cl]). Reacting the mixture of
2 equivalents of phosphorus trichloride and 1 equivalent of phosphorous acid with the corresponding
carboxylic acid, low yields of the respective dronic acid derivatives were reported (12%–31%)
(Table 20/Entries 2 and 4–6) [63]. The Keglevich group reached better results, when synthesizing
pamidronic acid in the presence of 1-butyl-3-methylimidazolium hexafluorophosphate ([bmim][PF6]).
The IL was not used a solvent, only as an additive. Reacting β-alanine with 2:2 or 3:2 equivalents
of phosphorus trichloride and phosphorous acid, the optimum amount of the IL was found to
be around 0.3–0.6 equivalents. Under such conditions, record yields of 70%–72% were reached
(Table 20/Entry 1) [53]. GABA was reacted with 2 equivalents of phosphorus trichloride and
1.5 equivalents of phosphorous acid, in the presence of 0.5 equivalents of various ILs at 60 ◦C for
about 6 h. Depending on the ILs used, the yield of pure alendronate was 92%–94% (Table 20/Entry
3) [64]. The same research group also prepared zoledronic acid in different ILs. For crude
zoledronic acid, yields of 90%–92% were reported. In the basic syntheses, IAA was reacted with
2.5 equivalents of phosphorus trichloride and 1.7 equivalents of phosphoric acid in 1.6 equivalents
of ILs (Table 20/Entry 7). Carrying out the reaction with the same amount of P-reactants but with
[bmim][BF4], the yield was 60% for sodium zoledronate (Table 20/Entry 8) [65].
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Table 20. Synthesis of hydroxymethylenebisphosphonic acid derivatives in the presence of ILs.












1 PD [bmim][PF6](0.3 or 0.6) β-alanine
PCl3:H3PO3
(2:2 or 3:2) 75 3 acid >99
1 70–72 [53]
2 PD [Bu3NH][Cl] β-alanine
PCl3:H3PO3
(2:1) 60 2 - - 26 [63]




(2:1.5) 60 6 Na·3H2O >99 3 92–94 [64]
4 AD [Bu3NH][Cl] GABA
PCl3:H3PO3
(2:1) 60 2 - - 31 [63]
5 RD [Bu3NH][Cl] PAA
PCl3:H3PO3
(2:1) 80 2 acid - 12 [63]
6 ZD [Bu3NH][Cl] IAA
PCl3:H3PO3
(2:1) 80 2 acid - 26 [63]




(2.5:1.7) 65 4 acid - 90–92
5 [65]
8 ZD [bmim][BF4](1.6) IAA
PCl3:H3PO4
(2.5:1.7) 65 4 Na·H2O 99.8 3 60 [65]
1 On the basis of acid-base titration; 2 [bmim][BF4], [bmim][PF6], 1-hydroxyethyl-2,3-dimethyl-imidazolium
chloride (LOH), 1-propyl-3-carbonitrile-imidazolium chloride (LCN), 1-carboxyethyl-3-methyl-imidazolium
chloride (LOOH); 3 On the basis of HPLC; 4 N-ethylpyridine tetrafluoroborate [EPy][BF4], [bmim][PF6], LOH,
LCN, LOOH; 5 For the crude product.
8. Processes for the Preparation of Hydroxymethylenebisphosphonic Acid Derivatives in
Other Solvents
In a few instances, the synthesis of hydroxymethylenebisphosphonic acid derivatives was
carried out in other solvents, from among p-cresol, acetonitrile and n-octane should be mentioned.
In these cases again the corresponding carboxylic acids were reacted with phosphorus trichloride and
phosphorous acid. In the first series let us see the examples carried out in p-cresol (Scheme 14).
 
Scheme 14. General scheme for the preparation of dronic acid derivatives in p-cresol.
Applying β-alanine or IAA together with phosphorus trichloride and phosphorous acid in a
molar ratio of 3.5:3 and using p-cresol as the solvent, crude pamidronic acid was obtained in a yield of
57%, while crude zoledronic acid in a yield of 80% (Table 21/Entries 1 and 5) [66]. Carrying out the
syntheses from GABA, and using phosphorus trichloride and phosphorous acid in a ratio of 3.2:1.5
or 3.5:2, alendronate was obtained in a yield of ca. 40% (Table 21/Entries 2 and 3) [67,68]. When
PAA was reacted with the mixture of 3.4 equivalents of phosphorus trichloride and 3 equivalents of
phosphorous acid, a yield of 59% was reported for risedronic acid (Table 21/Entry 4) [68].
215
Molecules 2016, 21, 1046
Table 21. Synthesis of hydroxymethylenebisphosphonic acid derivatives in p-cresol.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PD β-alanine PCl3:H3PO3 (3.5:3) 65–70 5 acid - 57 1 [66]
2 AD GABA PCl3:H3PO3 (3.2:1.5) 75 5 Na·3H2O 99.9 2 42 [67]
3 AD GABA PCl3:H3PO3 (3.5:2) 50–55 2 Na·3H2O 99 2 39 [68]
4 RD PAA PCl3:H3PO3 (3.4:3) 65–70 4 acid - 59 1 [68]
5 ZD IAA PCl3:H3PO3 (3.5:3) 65–70 5 acid - 80 1 [66]
1 For the crude product; 2 On the basis of HPLC.
From among the basic hydroxymethylenebisphosphonates, only pamidronate, alendronate and
risedronate was synthesized in acetonitrile (Scheme 15).
 
Scheme 15. General scheme for the preparation of dronic acid derivatives in acetonitrile.
In the synthesis of pamidronate, β-alanine and the usual P-reactants were used in a ratio of
1:2:1.5, and the crude product was obtained in a yield of 60% (Table 22/Entry 1) [69]. Applying both
phosphorus trichloride and phosphorous acid in amount of 2 equivalents in reaction with GABA,
crude alendronate was obtained in a yield of 70% (Table 22/Entry 2) [69]. Risedronic acid was
synthesized in a yield of 85% from PAA using phosphorus trichloride and phosphorous acid in a ratio
of 2.7:2.4 (Table 22/Entry 3) [38]. When the mixture of 2.7 equivalents of phosphorus trichloride and
2.4 equivalents of phosphorous acid, or 2 equivalents of phosphorus trichloride and 1.2 equivalent of
phosphorous acid was reacted with PAA, yields of 77% and 45% were reported for sodium risedronate,
respectively (Table 22/Entries 4 and 5) [38,69].
Table 22. Synthesis of hydroxymethylenebisphosphonates in acetonitrile.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 PD β-alanine PCl3:H3PO3 (2:1.5) 70–75 6–9 Na - 60 1 [69]
2 AD GABA PCl3:H3PO3 (2:2) 70–75 6–9 Na - 70 1 [69]
3 RD PAA PCl3:H3PO3 (2.7:2.4) 82 5 acid 98.6 2 85 1 [38]
4 RD PAA PCl3:H3PO3 (2.7:2.4) 82 5 Na 99.3 2 77 1 [38]
5 RD PAA PCl3:H3PO3 (2:1.2) 70–75 6–9 Na·2.5H2O 99.7 2 45 [69]
1 For the crude product; 2 On the basis of HPLC.
In a few instances, n-octane was also described as the solvent (Scheme 16).
 
Scheme 16. General scheme for the preparation of dronic acid derivatives in n-octane.
Starting from GABA and PAA, and applying phosphorus trichloride and phosphorous acid
in a quantity of ca. 3.5 equivalents, yields of 43% and 96% were reported for alendronic acid and
risedronic acid, respectively (Table 23/Entries 1 and 2) [70]. In another combination, the use of
phosphoryl chloride and phosphorous acid in a ratio of 3:5 led the risedronate in a yield of 64%
(Table 23/Entry 3) [71]. Starting from IAA, and measuring in both phosphorus trichloride and
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phosphorous acid in a 4.6 molar equivalent quantity, zoledronic acid was obtained in a yield of 65%
(Table 23/Entry 4) [70].
Table 23. Synthesis of hydroxymethylenebisphosphonic acid derivatives in n-octane.
Entry BP Starting Material Reagent (Equiv.) T (◦C) t (h) Product Form Purity (%) Yield (%) Ref.
1 AD GABA PCl3:H3PO3 (3.6:3.5) 90–95 - acid - 43 1 [70]
2 RD PAA PCl3:H3PO3 (3.5:3.5) 90–95 - acid - 96 1 [70]
3 RD PAA POCl3:H3PO3 (3:5) 85–90 3–4 Na·2.5H2O 99.9 2 64 [71]
4 ZD IAA PCl3:H3PO3 (4.6:4.6) 90–95 - acid - 65 [70]
1 For the crude product; 2 On the basis of HPLC.
The syntheses of the hydroxymethylenebisphosphonates discussed were studied only sporadically
in other solvents. For the sake of completeness, we list the special cases in Table 24.
Table 24. Synthesis of hydroxymethylenebisphosphonic acid derivatives in other solvents.
Solvent PD AD ID RD ZD











dioxane [77] [70] [70]
diphenyl ether [78] [78] [78]








diethyl carbonate [81–83] [27]
propylene carbonate [84]







sunflower oil [88,89] [80]
olive oil [80]
in the presence of paraffin [80]
silicon oil [90] [41]
9. Conclusions
The methods for the preparation of the most important dronic acid derivatives starting from
the corresponding substituted acetic acids and P-reagents, especially phosphorus trichloride and
phosphorous acid were surveyed according to the solvents applied. Methanesulfonic acid is a special
solvent, as it may enter into reaction also with phosphorus trichloride. The formation of Cl2P-OSO2Me
may mean some kind of activation, and hence there is no need to use phosphorous acid. However, in
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other cases (typically with sulfolane as the solvent), phosphorus trichloride should be applied together
with phosphorous acid to provide more reactive species formed by condensation. The optimum molar
ratios of the P-reactants were pointed out. In general, it was a problem during the evaluation of the
literature cases that not much stress was placed on purity criterions.
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Abstract: In view of the fact that the phosphorus atom in its low co-ordination state (coordination
numbers 1 and 2) has been termed as the carbon copy, there have been attempts to investigate,
theoretically as well as experimentally, the effect of the exchange(s) of CH- moiety with phosphorus
atom(s) (CH/P) on the structural and other aspects of the classical carbocyclic and heterocyclic
systems. Tropylium ion is a well-known non-benzenoid aromatic system and has been studied
extensively for its aromatic character. We have now investigated the effect of mono- and poly-CH/P
exchange(s) on the aromaticity of the tropylium ion. For this purpose, the parameters based on the
geometry and magnetic properties, namely bond equalization, aromatic stabilization energies (ASE),
Nucleus-Independent Chemical Shift (NICS) values, (NICS(0), NICS(1), NICS(1)zz), proton nucleus
magnetic resonance (1H-NMR) chemical shifts, magnetic susceptibility exaltation and magnetic
anisotropic values of mono-, di-, tri- and tetra-phosphatropylium ions have been determined at
the Density Functional Theory (DFT) (B3LYP/6-31+G(d)) level. Geometry optimization reveals
bond length equalization. ASEs range from −46.3 kcal/mol to −6.2 kcal/mol in mono- and
diphospha-analogues which are planar. However, the ions having three and four phosphorus atoms
lose planarity and their ASE values approach the values typical for non-aromatic structures. Of the
three NICS values, the NICS(1)zz is consistently negative showing aromatic character of all the systems
studied. It is also supported by the magnetic susceptibility exaltations and magnetic anisotropic
values. Furthermore, 1H-NMR chemical shifts also fall in the aromatic region. The conclusion that
mono-, di-, tri- and tetra-phosphatropylium ions are aromatic in nature has been further corroborated
by determining the energy gap between the Highest Occupied Molecular Orbital (HOMO) and
Lowest Unoccupied Molecular Orbital (LUMO) (HOMO − LUMO gap), which falls in the range,
ca. 3 × 10−19–9 × 10−19 J. The systems having more than four phosphorus atoms are not able to
sustain their monocyclic structure.
Keywords: phosphatropylium ions; aromaticity; NICS; magnetic susceptibility exaltation;
HOMO − LUMO gap
1. Introduction
The concept of aromaticity is of fundamental importance for explaining the structure, stability
and reactivity of many molecules, due to which it continues to attract attention of many eminent
theoretical chemists and forms the basis of many interesting monographs [1–3], research papers [4–9]
and thematic issues [10–12]. Hückel’s predictions based on the molecular orbital theory that
conjugated monocyclic planar systems containing (4n + 2) π electrons should be aromatic, i.e.,
conjugatively stabilized [13], was modified by Platt [14], who broadened the scope of the postulation
by including neutral as well as charged polycyclic systems in this category. The term “antiaromatic”
was used in substitution of “pseudoaromatic” after 1965 by Breslow for those compounds that
exhibited significant destabilization characteristics and possessed (4n) π conjugated electrons [15]. The
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possibility of verifying theoretical predictions with experimental isolations is limited to aromatic
compounds only. Post-Hückel, there have been many attempts to propose newer and more
reliable indicators to determine aromaticity/antiaromaticity of a particular system or a class of
compounds. Schleyer et al. [16] endeavoured to divide various theoretical parameters into four
categories, each based on a particular property:
Structure—tendency towards bond length equalization and planarity (if applicable).
Energy—enhanced stability.
Reactivity—lowered reactivity, electrophilic aromatic substitution (if applicable).
Magnetic properties—proton nucleus magnetic resonance (1H-NMR) chemical shift, magnetic
susceptibility exaltation and anisotropies, nucleus-independent chemical shift (NICS), ring
current plots.
In a recent review [17], geometry-based various aromaticity indices have been discussed elegantly.
Bond length equalization has been perceived as one of the important manifestations of aromaticity,
but it cannot be used as the sole criterion to characterize it unambiguously, as there are examples
like borazine, which has equalized bond length but is not aromatic. The quantitative indices have
been developed by Francois and Julg [18] and Bird [19], but extension of these indicators to the
heteroaromatic compounds is not straightforward.
The aromatic stabilization energies (ASEs) and the enhanced resonance energies (REs) have been
recognized to be the keystone of aromaticity since long ago. However, these energy estimates vary
significantly, depending strongly on the equations used and on the choice of the reference molecules.
As such, the other effects like hyperconjugative, etc. are also not taken into consideration or are
neglected while calculating the ASEs and REs, and, therefore, in some specific cases, large discrepancy
is noted. Schleyer et al. [20] have reported improved results by calculating isomerization stabilization
energies (ISE) instead of ASEs.
The most reliable and commonly used indicators for validating aromaticity of different systems
including the transition states are the magnetic criteria. The exalted diamagnetic susceptibility has
been used to quantify aromaticity ever since it was proposed by Pascal in 1910 [21]. 1H-NMR chemical
shifts are also used frequently for characterizing aromatic compounds [22]. The effect of the diatropic
ring current induced in an aromatic molecule by an external magnetic field is much stronger inside
the ring in comparison to outside. Schleyer et al. in 1996 proposed another indicator of aromaticity,
namely NICS based on the magnetic shielding at the center of the aromatic ring caused by the induced
diatropic current [23]. Subsequently, it was refined and magnetic shielding 1Å above the center of
the aromatic ring (NICS(1)), the zz component of NICS(1) (NICS(1)zz), and dissected NICS were
considered to be better indicators [16].
An impressive analogy between P=C and C=C double bonds in the molecules having
several PC double bonds was emphasized for the first time by Appel [24] while describing
Cope-rearrangement of several diphospha- and tetraphospa-hexadienes. Thereafter, similar
conjugative ability of the P=C and C=C double bonds was reiterated by analyzing π-ionization
energies and ring-fragmentation/isodesmic energies of a series of heterocyclic conjugated systems
containing σ2,λ3-P atoms [25–28]. The analogy turned out to be so prolific that besides a few research
papers [29–33] on this theme, a monograph with the title, “Phosphorus: The Carbon Copy” [34]
has been published. The effect of the exchange of the CH moiety with phosphorus atom (CH/P
exchange) on the aromaticity of the carbocyclic rings has been discussed in two recent reviews [35,36],
which include detailed experimental and theoretical discussion of the three- to six-membered rings
having one or more phosphorus atoms. It was concluded that due to the small angle at the P atom
(ca. 95 degrees), aromaticity is sustained on CH/P exchange in the small rings, but in large rings,
it results in reduced aromatic character and planarity is disturbed.
On the basis of the recent studies carried out by our research group [37,38], it was demonstrated
that mono- and poly-phospha analogues of carbocyclic cations and anions, namely, cyclopropenium,
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cyclopropenide, cyclopentadienium and cyclopentadienide, display aromatic or antiaromatic character
comparable with that of the respective carbocyclic ion. However, the results are not uniform in the
case of antiaromatic systems.
The aromatic character of the tropylium cation and its monophospha- and other hetero-analogues
has been probed earlier at the hybrid functional level using various structural and magnetic
descriptors [39–41]. The tropylium cation was found to have a planar structure with completely
delocalized 6π-electrons. The CH/P exchange in the tropylium cation was accompanied by lowering
of the aromaticity only marginally.
As no attempt has been made so far to study the effect of more than one CH/P exchanges on
the aromaticity of the tropylium cation, the present study concerns the investigation of the effect of
mono- and poly-CH/P exchange(s) and to compare the results obtained on the basis of geometry,
energetic and magnetic criteria. For this purpose, we computed the optimized geometries and
calculated ASEs, 1H-NMR chemical shifts, NICS(0), NICS(1), NICS(1)zz, magnetic susceptibility
exaltation and magnetic susceptibility anisotropy values and the energy difference of the highest
occupied molecular orbital and lowest unoccupied molecular orbital (HOMO − LUMO energy gap)
for the tropylium ion and its mono-, di-, tri- and tetra-phospha analogues at the Density Functional
Theory (DFT) (B3LYP/6-31+G(d)) level. As discussed later, phosphatropylium ions having five or
more phosphorus atoms do not sustain their monocyclic structures. These results are presented here.
The corresponding anions will be discussed in a separate communication.
2. Results and Discussion
The following model cations (Scheme 1) were computed at the B3LYP/6-31+G(d) level to study
the effect of the CH/P exchange on the aromaticity of the tropylium ion.
















































Scheme 1. Tropylium ion and its mono- and poly-phospha analogues.
2.1. Optimized Geometries
The Julg concept [18] is based on bond length equalization in the aromatic systems. However,
it could not be extended to the heteroaromatic systems. To overcome this difficulty, the Bird index [19]
was developed, but that too involved cumbersome calculations involving several aromaticity indices
as constants. In the present study, our discussion is limited to the equalization or localization of the
bonds without resorting to the calculation of the Julg or Bird indices.
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The geometries of different systems optimized at the B3LYP/6-31+G(d) level along with bond
lengths and Wiberg bond indices are reproduced in Figure 1.
  
 
1 D7h 2 C2v 3 C2v 
   




7 Cs 8 Cs 9 Cs 
  
 
10 C2 11 C1 12 Cs 
  
 
13 Cs 14 C1 15 C1 
Figure 1. Optimized geometries of tropylium ion and its mono- and poly-phosha analogues at the
B3LYP/6-31+G(d) level with bond distances (in Å) and Wiberg bond indices (in parenthesis). For better
visualization, H atoms have been omitted.
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The compounds 1–15 exhibit significant structural delocalization with CC, CP and PP bond
lengths approaching the average of the respective double and single bond lengths of the prototype
systems (Table 1).
Table 1. Average bond lengths (in Å) at the B3LYP/6-31+G(d) level.
Species C-C (1.53 Å) C=C (1.33 Å) P-C (1.87 Å) P=C (1.67 Å) P-P (2.72 Å) P=P (2.04 Å)
1 1.40 1.40 - - - -
2 1.41 1.39 1.75 - - -
3 1.40 1.40 1.75 1.75 2.15 -
4 1.41 1.35 1.75 1.75 - -
5 1.40 1.40 1.75 1.75 - -
6 1.40 1.41 - 1.76 2.13 -
7 1.40 1.40 1.75 1.75 2.17 -
8 - 1.38 1.76 1.74 - -
9 - 1.40 1.76 - 2.13 2.14
10 1.40 1.39 1.75 1.75 - 2.14
11 - 1.38 1.76 1.74 2.14 2.11
12 - 1.40 1.75 1.75 2.14 2.15
13 - - 1.75 1.74 2.17 -
14 - 1.38 1.76 - 2.14 2.11
15 - - 1.75 1.75 2.15 2.13
It is further noted that the planarity of the ring is not disturbed with one and two CH/P
exchange(s) in the tropylium ion. Thus, systems 2–5 are planar with C2v symmetry. It is in accordance
with the earlier results, according to which incorporation of two σ2, λ3-P atoms in the five-membered
ring reduces the ring strain and makes it planar even if a σ3-P atom is also present in the α-position [42].
Likewise, pentaphosphole having a σ3-P atom was found to be planar [43,44]. Experimentally also, the
first aromatic 1H-1,2,4-triphosphole having a fully planar structure could be prepared [45]. Three or
more CH/P exchanges in the tropylium cation, leading to 6, 10, 11, 12, 13, 14 and 15 are accompanied
by loss of planarity, with the exception of 1,2,4- (7) and 1,3,5-triphosphacycloheptatrienyl (9) cations,
though this deviation is not much, as evident from the dihedral angles Dh Ca 30◦.
As mentioned earlier, on making five or more CH/P exchanges in the tropylium ion, monocyclic
structure is no more stable and it changes into bicyclic (7P atoms, 18) or polycyclic (5P atoms, 16;
6P atoms, 17) structures as shown in Figure 2.
 
16 17 18 
Figure 2. 5P (16), 6P (17) and 7P (18) analogues of tropylium ion.
2.2. Frontier Molecular Orbitals
The tropylium cation (1) has doubly degenerate HOMOs, whereas, in the case of mono- and
poly-phosphatropylium cations, the p orbital on the phosphorus atom(s) containing the lone pair
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constitutes the HOMO. As discussed later, the HOMO − LUMO gap in a molecule can be used
as a measure of its aromatic character. In view of this, the frontier molecular orbitals (FMOs) of
the tropylium cation (1) and two representative phosphatropylium cations (2 and 3) along with
their energies are shown in Figure 3. It may be noted that, as compared to the tropylium cation,
the HOMO − LUMO gap in the phosphatropylium cations is smaller.
 
Figure 3. Frontier molecular orbitals (FMOs) of the tropylium cation (1); phosphatropylium cation (2)
and 1,2-diphosphatropylium cation (3).
Further FMO analysis reveals that the HOMO-4 orbital of the species 1, 2, 3, HOMO-5 orbital
of 4, 5, 7, 8 and HOMO-6 orbital of 9 are the delocalized orbitals of the π symmetry as in their
non-phosha analogue i.e., compound 1 (Figure 4). This, in particular, indicates that the aromatic
behaviour of these ions is comparable to that of the tropylium ion. However, in the case of the
compounds 6, 10, 11, 12, 13, 14 and 15, loss of planarity of the ring reduces the interaction between
some of the π orbitals, resulting in diminished delocalization of the π electrons.
 
 
1 HOMO-4 2 HOMO-4 3 HOMO-4 4 HOMO-5 
  
5 HOMO-5 6 HOMO-5 7 HOMO-5 8 HOMO-5 
Figure 4. Cont.
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Figure 4. HOMOs of π-symmetry of the tropylium ion and its mono- and poly-phospha analogues at
the density functional theory (DFT) (B3LYP/6-31+G(d)) level.
2.3. HOMO − LUMO Energy Gap
The correlation of the HOMO − LUMO energy gap with kinetic stability and chemical reactivity
has been well established [46–54]. It can therefore be an important parameter to determine or explain
aromaticity in molecules. A large HOMO − LUMO gap means high kinetic stability and low chemical
reactivity associated with the aromatic behaviour. It can be well understood on the basis of the fact
that it is energetically unfavourable to add electrons to a high-lying LUMO and to extract electrons
from a low-lying HOMO to form the activated complex in a potential reaction [46].
This concept was for the first time used to rationalize aromatic character of the polycyclic aromatic
hydrocarbons [55]. We extended application of this concept to the present study and have attempted
to explain the aromatic behaviour of the tropylium cation and its phospha analogues on the basis
of the HOMO − LUMO energy separation and chemical hardness. The chemical hardness has been
calculated using Pearson formula (Equation (1)) [56,57]:
η = (εLUMO – εHOMO) / 2 (1)
The values of the HOMO − LUMO energy gap (Δε) and chemical hardness (η) are given
in Table 2.
Table 2. Frontier molecular orbital energies and hardness of the tropylium ion and its mono- and
poly-phospha analogues.
Species HOMO (a.u.) LUMO (a.u.) LUMO − HOMO (a.u.) Δε (×10−19 J) η (×10−19 J)
1 −0.4951 −0.2872 0.2078 9.05 4.53
2 −0.4719 −0.3067 0.1652 7.19 3.60
3 −0.4459 −0.3160 0.1299 5.65 2.83
4 −0.4485 −0.3179 0.1306 5.65 2.84
5 −0.4650 −0.3176 0.1474 6.52 3.20
6 −0.4376 −0.3287 0.1089 4.74 2.37
7 −0.4372 −0.3259 0.1113 4.85 2.43
8 −0.4431 −0.3264 0.1167 5.09 2.55
9 −0.4384 −0.3258 0.1126 4.90 2.45
10 −0.4284 −0.3328 0.0956 4.16 2.08
11 −0.4332 −0.3341 0.0991 4.32 2.16
12 −0.4357 −0.3335 0.1022 4.45 2.27
13 −0.4331 −0.3261 0.1070 4.66 2.33
14 −0.4271 −0.3412 0.0859 3.75 1.87
15 −0.4272 −0.3394 0.0878 3.83 1.91
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A low HOMO − LUMO energy gap (<2.08 × 10−19 J) was associated with the antiaromatic
character of the dianions of the polycyclic hydrocarbons [58]. From these results, it was extrapolated
that the aromatic systems would have a large HOMO - LUMO energy gap. It may be noted that the
value of the HOMO − LUMO energy gap for 1 to 15 lies in the range of 3.75 × 10−19–9.05 × 10−19 J,
which indicates aromatic character of these systems. The decrease in HOMO − LUMO energy gap in
the case of 6 and 10–15 can be attributed to the loss of planarity in these compounds.
It has been shown earlier that an excellent correlation exists between absolute hardness and
aromaticity, both increasing almost parallel to each other [56]. In the present case, chemical hardness

















Figure 5. Variation of ΔHOMO–LUMO and chemical hardness in tropylium cation and its mono- and
poly-phospha analogues.
2.4. ASE
The ASEs of different systems were computed using the following homodesmotic reactions
(Scheme 2).
The ASEs of the tropylium ion (1) and phosphatropylium ion (2) are in conformity with their
aromatic character. However, on further CH/P exchange(s), the systems lose planarity as a result of
which, ASEs do not change consistently. It is obvious that for the phosphatropylium ions having two
or more phosphorus atoms, ASE is no more a reliable indicator of the aromaticity.
2.5. Magnetic Criteria
It is well known that a diatropic current is induced in an aromatic system when it is placed in
an external magnetic field. This generates a secondary magnetic field causing a deshielding effect
at the periphery and a shielding effect inside the ring. Based on this effect, three indicators, namely
1H-NMR chemicals shifts [22], NICS [23] and magnetic susceptibility exaltation [59,60] have been used
extensively to understand aromaticity. A closely related parameter, magnetic susceptibility anisotropy
has also been used to validate aromatic character of different compounds. The aromatic character of
the species 1–15 is discussed on the basis of all these criteria.
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Scheme 2. Homodesmotic reactions for aromatic stabilization energy (ASE) determination.
2.5.1. 1H-NMR Chemical Shifts
The most common measure of the ring current is the 1H-NMR chemical shift, although
Schleyer et al. reminded the chemical community of the limitations of proton shifts in the measurement
of a ring current [16]. The chemical shift of a proton is the difference of the magnetic shielding of a
reference (Tetramethylsilane in the present case) and the proton in question calculated at the same
level of theory (Equation (2)):
δ1H = σTMS − σ1H ppm (2)
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The 1H-NMR chemical shift values of different species calculated are given in Table 3. It is noted
that 1H-NMR chemical shifts of protons in all of the species 1–15, fall in the aromatic region, confirming
their aromatic character. In tropylium ion (1), all protons are equivalent and the calculated chemical
shift value is δ 9.3. It is noteworthy that on successive CH/P exchanges, the NMR shift values of the
protons adjacent to the phosphorus atom(s) appear further downfield, which may be attributed to the
stronger electron-acceptor character of the P=C- moiety.
Table 3. 1H-NMR chemical shifts, nucleus-independent chemical shift (NICS), magnetic susceptibility
exaltation, magnetic anisotropy and aromatic stabilization energy ASE values of tropylium ion and its
phospha analogues.
Species 1H-NMR Chem. Shift (δ) NICS(0) NICS(1) NICS(1)zz Λ χanis ASE (×10−19J)
1





































































H7 11.06 −7.83 −9.79 −22.83 −54.31 −107.81 93.69
H6 10.12
15
H3 12.63 −3.25 −7.54 −19.96 −42.88 −105.24 173.95
H7 11.54
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2.5.2. NICS Values
Among the widely used magnetic criteria for aromaticity and anti-aromaticity, NICS proposed
by Schleyer and co-workers in 1996 is a simple efficient probe [23]. Subsequently, there have been
many refinements and at present NICS(1)zz value is considered to be the most reliable indicator of
aromaticity [61]. NICS(0) is defined as the negative value of the absolute shielding computed at the
ring centre determined by the average of the heavy atoms coordinates in the ring. NICS(1) is the
negative value of the absolute shielding measured 1 Å above the center of the ring, while NICS(1)zz
is the out-of-plane component of the absolute shielding estimated in the same position as NICS(1).
Rings with highly negative values of NICS are qualified as aromatic by definition, whereas those with
positive values are anti-aromatic.
The calculated NICS(0), NICS(1) and NICS(1)zz tensor component values for all species are given
in Table 3.
It is noteworthy that these values are negative ranging from −17.54 to −26.42, confirming the
aromatic character of the species 1 to 15.
2.5.3. Magnetic Susceptibility Exaltation
The magnetic susceptibility exaltation (Λ) evaluates the effect of a ring current by comparing the
bulk magnetic susceptibility (χ) to the susceptibility of a localized ring system [59,60].
The magnetic susceptibility exaltation with CSGT (continuous set gauge transformations) method
values is determined by subtracting the sum of the magnetic susceptibilities of the fragments of cyclic
electron delocalization from the values of the respective species (Equation (3)):
Λ = χM − χM′ (3)
The Λ values calculated for different species are given in Table 3. As expected, the exaltation values
(Λ) of all these compounds are negative ranging from −20.7 to −54.3 revealing their aromatic character.
2.5.4. Magnetic Anisotropy
Magnetic anisotropy is defined as the difference between out-of-plane and the average in-plane
diamagnetic susceptibilities for a ring lying in the (xy) plane [62,63] (Equation (4)):
Δχ = χzz – (1/2) [χxx + χyy] (4)
The values of magnetic anisotropies so calculated are given in Table 3. It may be noted that these
values are negative confirming aromatic character of the species.
3. Computational Method and Models
All calculations were carried out using a Gaussian 03 suite of programmes [64]. A diffuse function
was added to the heavy atoms and geometry optimization of all the systems was done in the gas
phase at the B3LYP/6-31+G(d) level of theory. Frequency calculations were done at the same level to
determine zero-point energies and to characterize the energy minima.
1H-NMR chemical shifts were calculated at the GIAO-B3LYP/6-311++G(d,p)//B3LYP/6-31+G(d)
level. NICS values were calculated at the (3,+1) ring critical point of the electron density topology
as defined by Bader [65] at the GIAO-B3LYP/6-311++G(d,p)//B3LYP/6-31+G(d) level. Magnetic
susceptibilities were calculated at the csgt-B3LYP/6-31+G(d)//B3LYP/6-31+G(d) level and exaltation
values were determined by subtracting the sum of the magnetic susceptibilities of the fragments
(as explained in the supporting information) calculated at the same level from the value of the
respective species.
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4. Conclusions
On CH/P- exchange in the tropylium ion, aromaticity is sustained up to four carbon atoms.
However, with further exchange(s), the system does not remain monocyclic, and it changes to
bicyclic and polycyclic systems. Of the various indicators for the aromaticity, the ones based on the
magnetic field effect, namely 1H-NMR chemical shifts, NICS(1)zz, magnetic susceptibility exaltation
and magnetic anisotropies are more consistent and confirm the aromatic character of these species.
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Abstract: α-Amino-C-phosphinic acids and derivatives are an important group of compounds of
synthetic and medicinal interest and particular attention has been dedicated to their stereoselective
synthesis in recent years. Among these, phosphinic pseudopeptides have acquired pharmacological
importance in influencing physiologic and pathologic processes, primarily acting as inhibitors
for proteolytic enzymes where molecular stereochemistry has proven to be critical. This review
summarizes the latest developments in the asymmetric synthesis of acyclic and phosphacyclic
α-amino-C-phosphinic acids and derivatives, following in the first case an order according to the
strategy used, whereas for cyclic compounds the nitrogen embedding in the heterocyclic core is
considered. In addition selected examples of pharmacological implications of title compounds are
also disclosed.
Keywords: α-amino-C-phosphinic acids; α-amino-C-phosphinates; α-amino acids; stereoselective
synthesis; biological activity
1. Introduction
Optically active α-aminoalkylphosphonic acids 1 are probably the most important analogues of
the α-amino acids 2, obtained by isosteric substitution of the planar and less bulky carboxylic acid
(CO2H) by a tetrahedral phosphonic acid functionality (PO3H2). These classes of compounds are
currently attracting great interest in organic and medicinal chemistry, as well as in agriculture, due to
their important biological and pharmacological properties [1–5]. The great importance of this type
of compounds has prompted organic chemists to report numerous procedures for their racemic or
stereoselective synthesis [6–11]. On the other hand, the optically active α-amino-C-phosphinic acids
3 are also considered as analogues of α-amino acids 2 where now the carboxylic group (CO2H) is
replaced by a tetrahedral and sterically more demanding phosphinic acid functionality (PO2HR′).
As part of peptides, α-amino-C-phosphinic acids 3 are much closer analogues to natural α-amino acids
2 than their α-aminophosphonic counterparts 1, due to their mono acidic character, and the higher
stability of the P-C bond of 3 compared to the P-O bond of 1 (Figure 1) [12].
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Figure 1. General structure for α-amino acids (2) and their phosphonic (1) and C-phosphinic
(3) analogues.
Phosphinic, phosphonic and carboxylic acids differ in several characteristics. The carboxylic
group is planar at carbon while their phosphorus analogues are tetrahedral and considerably larger in
size (the phosphorus atom has a much larger atomic radius than carbon). Phosphinic and phosphonic
acids exist mainly in their tetracoordinate form, and they are considered as mono- and diacids,
respectively. The phosphinic acids (pKa ~1.0) are slightly stronger than the corresponding phosphonic
acids (pKa ~0.5–1.5) and both more acidic than the carboxylic acid equivalent (pKa ~2.0–3.0); the former
are mono acids and no evidence for the second acidity due to the P-H bond is reported, while for
phosphonic acids, it is well-known that the second acidity is about 5 pK units higher than the first P-OH
acidity. Similar to α-amino acids, the aminophosphonic and aminophosphinic acids have a zwitterionic
form due to the internal hydrogen transfer between the P-OH and amino groups [13,14]. In addition,
a characteristic feature of tetracoordinated phosphorus (III) compounds such as H-phosphonate
and H-phosphinate derivatives, is the configurational stability of the phosphorus center at room
temperature, and their tautomeric equilibria with trivalent species that occurs without epimerization
at the phosphorus center. This is the basis for synthetic applications of these compounds as
chiral precursors in several stereospecific transformations [15]. Although, different structures of
phosphonic and phosphinic groups compared with the carboxylic function could a priori disrupt
enzyme-ligand interactions, they frequently are recognized by enzymes or receptors as inhibitors or
false substrates [16,17].
Phosphinopeptides containing C-terminal α-aminophosphinic acids have been prepared by
similar methods to those used with their phosphonic analogues, for example the coupling of
N-protected amino acids or their active esters with α-aminophosphinates [18], or with free
α-aminophosphinic acids in organic or aqueous-organic media has been reported [19]. Additionally,
the synthesis of phosphinopeptides via the Mannich-type condensation of N-Cbz protected
alkanamides/peptide amides, aldehydes and aryldichlorophosphines, followed by hydrolysis, has also
been reported [20]. Therefore, the α-amino-C-phosphinic acids are currently attracting interest
in medicinal chemistry due to their relevance mainly as pseudopeptides, which have acquired
pharmacological importance in influencing physiologic and pathologic processes, primarily acting
as inhibitors for proteolytic enzymes. The success of these compounds is based on the resemblance
of phosphinic acids to the sp3 transition state of the hydrolysis of peptide bonds. Considering that
lengths of O-P and C-P bonds are significantly longer than the corresponding O-C and C-C bonds,
the phosphinic fragment might be considered as an extended tetrahedral intermediate and thus
can be treated similar to the transition state of the hydrolysis (Figure 2) [21]. Moreover, they can
act as simple analogues of amino acids replacing the carboxylic group by the phosphinic moiety,
as non-hydrolysable phosphate analogues or as chelating agents of metal ions present in the active
site of the enzymes [22]. A number of excellent reviews on various aspects of their activity in natural
systems have been published [16,17].
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Figure 2. Similarity between the transition state of peptide hydrolysis and the α-amino-C-phosphinic
motif. The additional interaction with the metal ion in the metalloproteases active site is included.
Simple pseudopeptides containing α-amino-C-phosphinate moieties replacing the scissile peptide
bonds, rank among most potent inhibitors of metalloproteinases, where their tumorigenesis and
invasion-related functions makes these enzymes molecular targets for the development of potential
anticancer drugs [23]. The role of neutral aminopeptidase in the pathogenesis of hypertension
provides an opportunity for regulating arterial blood pressure through its inhibition with this
class of compounds [24]. Furthermore, these pseudopeptides appear to be excellent inhibitors to
Plasmodium falciparum aminopeptidases, promising targets for a novel treatment of malaria [25,26].
α-Amino-C-phosphinic pseudopeptides have also revealed their potential activity in the regulation of
matrix metalloproteinases (MMPs), whose overexpression or inadequate levels leads to pathological
states such as osteoarthritis, rheumatoid arthritis and inflammation, but also it is associated with
tumor growth, invasion and metastasis [27,28]. Additionally, is noteworthy that in these derivatives
the stereochemistry affects their biological activity, hence the importance of the synthesis of these
compounds in enantiomerically pure form [29,30].
In view of the broad biological applications of the optically active α-amino-C-phosphinic acids and
their peptidic derivatives, in the last years the development of suitable synthetic methodologies for their
preparation in optically pure form has been a topic of great interest in several research groups [31,32].
In this context, now we would like to report herein a summary of the stereoselective synthesis of
α-amino-C-phosphinic acids and their derivatives covering the last 20 years. In this review article,
the compounds have been classified in acyclic and phosphacyclic α-amino-C-phosphinic derivatives.
In the first case an order is established according to the strategy used, in this way all procedures
can be classified into C-P bond formation using a Pudovik or Kabachnik-Fields like reaction, C-H
bond formation derived from catalytic asymmetric hydrogenation of α,β-dehydroaminophosphinates,
resolution methodologies, preparation from chiral α-amino-phosphonates and also P-C bond formation
from chiral α-amino-H-phosphinic derivatives is included (Scheme 1). Otherwise, in the second case
involving the phosphacyclic derivatives, the classification will be based in the presence or lack of the
nitrogen atom in the heterocycle.
 
Scheme 1. General overview of the synthetic strategies leading to α-amino-C-phosphinic acids.
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2. Stereoselective Synthesis of Acyclic α-Amino-C-phosphinic Acids and Derivatives
2.1. Stereoselective C-P Bond Formation (Addition of Phosphorus Compounds to Imines)
A strategy widely used for the stereoselective synthesis of α-amino-C-phosphinic acids is the
addition of a nucleophile HX (X = CN, PO2R, PO2RR′) to a preformed N-substituted chiral imine
in the presence or absence of a chiral catalyst [33], leading to optically active α-amino carboxylic,
α-aminophosphonic and α-aminophosphinic acids precursors, respectively. The extent of asymmetric
induction at the Cα depends on the nature of the substituents (steric or hydrophobic interactions) and
nucleophile–substrate interactions, which are favored in organocatalytic processes [34].
Indeed, the nucleophilic addition of phosphorus compounds (alkyl or aryl phosphinates)
to imines, a Pudovik-like reaction [35], is an appropriate procedure for the preparation of
α-amino-C-phosphinates. Generally, the high diastereoselective ratio can be explained on the basis of
the most stable conformation of the Schiff bases, in which the C-H bond of the imine is eclipsed with the
N–C–H fragment, as would be expected from the 1,3-allylic strain model [36,37], and the nucleophilic
attack of the alkyl or aryl phosphinate takes place on the less hindered side (in the example below,
R’ is bulkier than the methyl group) (Scheme 2).
 
Scheme 2. Model to explain the high diastereoselectivity in the nucleophilic addition to chiral
imine compounds.
Contrary to the phosphonate synthesis, the addition of H-phosphinates to imines results in
the generation of two new stereogenic centers due to the attack of the chiral phosphinates at the
prochiral C=N bond [38]; however, the phosphorus chirality is lost during the hydrolysis through the
delocalization of P=O bond due to d-p π bond (Scheme 3) [28].
Scheme 3. Structure of α-amino-C-phosphinates and α-amino-C-phosphinic acids.
2.1.1. Chiral Imine Compounds
Petneházy et al. [39] reported the first enantioselective synthesis of α-amino-C-phosphinic
acids by the addition of phosphinates to chiral imines in the absence of a catalyst. In this regard,
the (S)-α-methylbenzylamine and (S)-α-methoxymethylbenzylamine derived imines 4a–g were reacted
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with ethyl phenylphosphinate in toluene at 70 ◦C, to obtain the α-amino-C-phosphinates 5a–g in
40%–84% yield and moderate diastereoisomeric ratio. The hydrolysis of the phosphinate moiety in
5a–g using concd. HCl or HBr/AcOH, followed by treatment with propylene oxide and hydrogenolysis
using Pd/C in MeOH, provided the optically active α-amino-C-phosphinic acids 6a–d in 20%–60%
yield and with an enantiomeric ratio of good to excellent (Scheme 4).
 
Scheme 4. First enantioselective synthesis of α-amino-C-phosphinic acids 6a–d.
Recently, Zhao et al. [40] described the synthesis of a P-chiral compound, whose RP
chirality, was fully confirmed by X-ray analysis. In this context, the hydrophosphinylation of the
N-(R)-α-methylbenzyl Schiff base (R)-4g with the (RP)-O-(−)-menthyl phenylphosphinate at 80 ◦C,
gave after crystallization the optically pure O-menthyl phosphinate (R,S,R)-7 (Scheme 5).
 
Scheme 5. Synthesis of the P-chiral O-menthyl phosphinate (R,S,R)-7.
Rossi et al. [41] carried out the nucleophilic addition of the racemic ethyl phenylphosphinate onto
the chiral imines 8a,b in chloroform at 60–70 ◦C, to obtain the α-amino-C-phosphinates 9a,b in 96%
and 80% yield, respectively, and good diastereoselectivities (Scheme 6).
Scheme 6. Nucleophilic addition of ethyl phenylphosphinate onto the chiral imines 8a,b.
The (S)-configuration at Cα of the major diastereoisomers 9a resulted from the preferred addition
of ethyl phenylphosphinate onto the si face of the imine 8a, which adopts the most stable conformation
according to the 1,3-allylic strain model [37], as shown in the Scheme 7 [41].
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Scheme 7. Preferential addition of ethylphenylphosphinate onto the si face of the imine 8a.
The reaction of (R,S)-9a with aqueous AgNO3/HNO3 in methanol at 50 ◦C, produced the
α-amino-C-phosphinate 10a in 63% yield and with 78:22 diastereoisomeric ratio, which by treatment
with HBr/AcOH, afforded the enantiomerically pure (S)-α-aminobenzyl phenylphosphinic acid 6d
(Scheme 8) [41].
Scheme 8. Synthesis of the (S)-α-aminobenzyl phenylphosphinic acid 6d.
Carbohydrate derivatives are efficient auxiliaries in many stereoselective chiral syntheses [42–44].
For example, Chen et al. [45] achieved the nucleophilic addition of ethyl phenylphosphinate
to N-galactosylaldimines 11a–g in the presence of catalytic amounts of SnCl4 in THF at room
temperature to obtain the N-galactosyl α-aminoalkyl-C-phosphinates 12a–g in good yield and
moderate diastereoselectivity (Scheme 9). Diastereoisomerically pure compounds 12a–c,e,g were
obtained by recrystallization.
Scheme 9. Nucleophilic addition of ethyl phenylphosphinate to N-galactosylaldimines 11a–g.
The (S)-configuration at the α-carbon of the major diastereoisomers 12a–g can be explained by
the attack of ethyl phenylphosphinate from si face of (E)-imines 11a–g. The imine-SnCl4 complex and
simultaneous chelation with the auxiliary’s pivaloyl group inhibits free rotation along the N-anomeric
carbon bond. According to this rationalization, the attack of the phosphinate in its PIII phosphonous
tautomeric form proceeds from the back face of the imine 11a–g, as shown in Scheme 10 [45].
242
Molecules 2016, 21, 1141
Scheme 10. Plausible reaction mechanism for the addition of ethyl phenylphosphinate to 11a–g.
With the aim to assign the configuration, the reaction of N-galactosyl α-aminoalkyl-C-
phosphinates 12a–g with 1 M HCl/MeOH at room temperature produced the α-amino-C-phosphinate
hydrochlorides 13a–g in 78%–95% yield, which by hydrolysis with 1.5 M HCl under reflux followed
by treatment with propylene oxide in ethanol at reflux, afforded the α-amino-C-phosphinic acids 6d
and 14a–f in 82%–93% yield and with 73%–97% enantiomeric excess (Scheme 11) [45].
Scheme 11. Synthesis of the α-amino-C-phosphinic acids 6d and 14a–f.
Readily available enantiopure sulfinylimines also constitute valuable molecules in asymmetric
synthesis [46]. Indeed, Petneházy et al. [47] reported the synthesis of optically enriched α-amino-C-
phosphinic acids using ethyl phenylphosphinate and chiral N-sulfinylaldimines. In this context,
the nucleophilic addition of ethyl phenylphosphinate to the chiral imines (S)-15a–c in toluene at
70 ◦C, furnished the α-amino-C-phosphinates (RC,SS)-16a–c in 19%–35% yield, which by simultaneous
removal of the N-sulfinyl auxiliary and hydrolysis of the ethyl phosphinate with concentrated HCl
at reflux, gave the α-amino-C-phosphinic acids (R)-6a,d and (R)-17a in 48%–58% yield and 20%–40%
enantiomeric excesses (Scheme 12).
Scheme 12. Synthesis of α-amino-C-phosphinic acids from chiral N-sulfinylaldimines (S)-15a–c.
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2.1.2. Chiral Catalyst
The stereoselective hydrophosphinylation of aldimines under organocatalytic conditions is
emerging as a suitable method for the synthesis of optically active α-amino-C-phosphinates, in this
regard the guanidines and guanidinium salts have shown to be highly efficient catalysts for
enantioselective reactions [48]. For example, following the principle of activation of imines through
hydrogen bonding, Tan et al. [49] carried out the hydrophosphinylation reaction of the N-tosyl
imines 18a–g with arylphosphinates and alkylphosphinates in the presence of catalytic amounts of the
guanidinium salt 19·HBArF4 in a CH2Cl2:toluene mixture and K2CO3 as a base at −40 ◦C, obtaining the
α-amino-C-phosphinates 20a–k in 71%–93% yield and 3:1–16:1 diastereoisomeric ratio, with preference
for the diastereoisomers (RC,SP)-20a–k with 82%–94% enantiomeric excess (Scheme 13).
Scheme 13. Hydrophosphinylation of aldimines 18a–g under organocatalytic conditions.
2.2. Stereoselective C-P Bond Formation (One-Pot Three-Component Reaction)
2.2.1. Chiral Amino Compounds
Possibly the simplest experimental proposal to prepare optically active α-amino-C-phosphinates
is the “one-pot” three-component reaction, where the reactants are placed all together with or without
solvent and catalyst, which is identical to the Kabachnik-Fields reaction widely studied in the synthesis
of α-aminophosphonates [50–52].
Meng and Xu [19] reported a direct synthetic route for the preparation of phosphinopeptides
containing C-terminal α-aminoalkyl-C-phosphinic acids, valuable peptide mimics. Thus, the “one-pot”
three-component reaction of N-Cbz-aminoalkanamides (S)-21a–c obtained from N-protected amino
acids, with benzaldehyde and phenyldichlorophosphine in dry acetonitrile at 80 ◦C followed by
hydrolysis, produced the phosphinopeptides 22a–c in 65%–75% yield and low degree of asymmetric
induction, obtaining the (S,S)-22a–c diastereoisomers as major products (Scheme 14).
According to the authors, the reaction of the N-Cbz-aminoalkanamide, benzaldehyde and
phenyldichlorophosphine produce the N-acylimine 23b and phenylchlorophosphonous acid, which
attacks to the imine favorably from the si face because the amino acid substituent blocks the
opposite re face. Finally, a proton transfer affords the intermediate aminoalkylphosphinic chloride,
which undergoes hydrolysis gave the (S,S)-phosphinopeptide 22b as major product (Scheme 15) [19].
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Scheme 14. Preparation of phosphinopeptides (S,S)-22a–c.
 
Scheme 15. Mechanism for the formation of diastereoisomeric phosphinopeptide (S,S)-22b.
Similarly, a series of phosphinodepsipeptides were synthesized via a pseudo-four-component
condensation reaction, in a convergent and atom economic synthetic strategy [53]. In this context,
the “one-pot” reaction of N-Cbz-amino amides derived from amino acids with different aldehydes and
aryldichlorophosphines in dry acetonitrile at 80 ◦C followed by alcoholysis with α-hydroxy esters or
ethanol, produced the phosphinodepsipeptides 24a–k in 50%–66% yield and low diastereo selectivities,
where the (RC*,RP*)-products were assumed as major diastereoisomers (Scheme 16).
Scheme 16. Synthesis of phosphinodepsipeptides (RC*,RP*)-24a–k.
In a similar way, Meng et al. [54] reported the preparation of hybrid sulfonophosphinopeptides
incorporating α-aminoalkyl-C-phosphinic acids. The compounds of interest were synthesized
by reaction of the N-Cbz protected aminoalkanesulfonamides, benzaldehyde and phenyldichloro
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phosphine in dry acetonitrile at 45 ◦C and subsequent hydrolysis at room temperature, obtaining the
sulfonophosphinodipeptides 26a–d in good yield, but low diastereoselectivity. The diastereo isomers
(S,S)-26a–d were assumed as the major products (Scheme 17).
Scheme 17. Synthesis of the sulfonophosphinodipeptides 26a–d.
2.3. Stereoselective C-H Bond Formation
2.3.1. Reduction of C=C Bond in α,β-Dehydroaminophosphinates
Catalytic asymmetric hydrogenation of α,β-dehydroaminophosphinates is another nice method
for the synthesis of optically pure α-amino-C-phosphinic acids and its derivatives. For example,
Drauz et al. [55] described for the first time the catalytic asymmetric hydrogenations of the
α,β-dehydroaminophosphinates 27a–e [56] using the rhodium complex 28 in methanol at room
temperature and 0.1 MPa H2-pressure, obtaining the α-amino-C-phosphinates 29a–e in quantitative
yield and 81%–87% enantiomeric excesses (Scheme 18).
Scheme 18. Catalytic asymmetric hydrogenation of the α,β-dehydroaminophosphinates 27a–e.
Additionally, Oehme et al. [57] conducted a comprehensive study on the hydrogenation of
α,β-dehydroaminophosphinates evaluating different chiral rhodium complexes, substrate-catalyst
ratio, temperatures, hydrogen pressures, modified substrates and both organic and aqueous
solvents. Thus, under optimized conditions, they carried out the catalytic hydrogenation
of the α,β-dehydroaminophosphinates 27a–g [56] in the presence of catalytic amounts of
[Rh(cod)(S,S)-bppm]BF4 28 in aqueous micellar media at room temperature and 1 bar H2-pressure,
obtaining the α-amino-C-phosphinates 29a–g in 66%–100% yield and with 53%–97% enantiomeric
excess (Scheme 19).
Furthermore, Darses et al. [58] reported an alternative approach for the synthesis of α-amino-C-
phosphinates through the asymmetric rhodium-catalyzed addition of organoboron derivatives to
α,β-dehydroaminophosphinates. Indeed, the addition of potassium phenyltrifluoroborate to the
α,β-dehydroaminophosphinate 30 [59] in the presence of NaHCO3, [RhCl(CH2CH2)2]2 as catalyst
precursor and (S)-DifluorPhos 31 as chiral ligand in isopropyl alcohol at 90 ◦C, afforded the
diastereoisomeric α-amino-C-phosphinates 32 and 33 in moderate yield and with 94% and 92%
enantiomeric excesses, respectively (Scheme 20).
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Scheme 19. Optimized conditions for the catalytic hydrogenation of 27a–g.
Scheme 20. Asymmetric rhodium-catalyzed addition of phenyltrifluoroborate to 30.
2.4. Resolution Methodologies
The resolution strategies of racemic compounds have also demonstrated its usefulness for the
preparation of optically enriched α-amino-C-phosphinic acids. For example, Lämmerhofer et al. [60]
carried out the chiral HPLC separation of N-Cbz phosphinic pseudopeptide esters 34a–d as well
as their free C-terminal carboxylic derivatives 34e–h using a set of cinchona alkaloid-derived
chiral anion-exchangers 35,36 (Scheme 21). Semi-preparative scale chromatography supplied single
enantiomers in 100 mg quantities allowing the biological activity assays.
Scheme 21. Chiral HPLC separation of N-Cbz phosphinic pseudopeptides 34a–h.
In a related work, Lämmerhofer et al. [61] developed a capillary electrochromatography (CEC)
method for the separation of the stereoisomers of N-Cbz phosphinic pseudodipeptide methyl ester
37a and 38a and its N-DNP derivative with free C-terminal carboxylic group 37b and 38b, using a
monolithic silica capillary column modified with a cinchona alkaloid-derived anion-exchange-type
chiral selector 39 (Scheme 22). This method proved superiority compared to the HPLC separation,
which was attributed to significantly enhanced plate numbers.
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Scheme 22. Capillary electrochromatography (CEC) method for the separation of (±)-37a,b
and (±)-38a,b.
Taking into account that phosphinic dipeptides, although tested as stereoisomeric mixtures,
are considered amongst the most potent inhibitors of bizinc cytosolic leucine aminopeptidase
(LAP) [62], Mucha, et al. [63] carried out the chiral HPLC separation of all stereoisomers of phosphinic
dipeptide homophenylalanyl-phenylalanine derivative 40 and 41 on a quinidine carbamate modified
silica stationary phase 42 (Scheme 23). Significant differences in inhibition of the unprotected
derivatives 43 and 44 show the importance of the molecular stereochemistry in spatial interaction with
the enzyme active site.
Scheme 23. Chiral HPLC separation of phosphinic dipeptide derivatives 40 and 41 and activities of
unprotected derivatives 43 and 44 as inhibitors of leucine aminopeptidase (LAP).
In another example, Ragulun and Rozhko [64] reported the preparation of the optically pure
α-aminobenzyl hydroxymethyl phosphinic acid (R)- and (S)-45, where the key step was a biocatalytic
resolution. Thus, the racemic α-aminobenzyl hydroxymethyl phosphinic acid (±)-45, obtained from
the hydroxymethyl phosphinic acid, was acylated with phenylacetyl chloride and KOH in water to
obtain the N-phenylacetyl derivative 46 in 63% yield, which by hydrolysis using penicillin amidase
(PcAm) as the biocatalyst, afforded the enantiomerically pure (R)-46 in 62% yield and the deacylated
product (S)-45 in 57% yield. Finally, hydrolysis of compounds (R)-46 with 6 N HCl at reflux followed
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by treatment with propylene oxide, provided the α-amino-C-phosphinic acid (R)-45 in 84% yield
(Scheme 24).
Scheme 24. Synthesis of optically pure α-aminobenzyl hydroxymethyl phosphinic acid (R)- and (S)-45.
2.5. Conversion from Chiral α-Aminophosphonates
Undoubtedly, a useful but not as explored strategy for the synthesis of optically enriched
α-amino-C-phosphinic acids is their conversion from the corresponding enantiomerically pure
α-aminophosphonic counterparts [8]. Considering this possibility, Pyun et al. [65,66] carried
out the transformation of chiral phosphonate (1S,2S)-47 into C-phosphinates (1S,2S)-50a–l. Thus,
the reaction of the optically pure diethyl (1S,2S)-1-amino-2-vinylcyclopropanephosphonate 47 [67]
with benzyl chloroformate and NaHCO3 followed by treatment with NaI in pyridine at reflux, gave
the phosphonate monoester (1S,2S)-48 in 88% yield. The reaction of (1S,2S)-48 with oxalyl chloride and
DMF in MeCN, afforded the phosphonomonochloridate (1S,2S)-49, that without additional purification
was reacted with different organolithium or Grignard reagents, to obtain the α-amino-C-phosphinates
(1S,2S)-50a–d in 37%–56% yield, which have been used in the design and synthesis of new enzyme
inhibitors (Scheme 25).
Scheme 25. Transformation of chiral phosphonate (1S,2S)-47 into C-phosphinates (1S,2S)-50a–d.
On the other hand, the reduction of the phosphonomonochloridate (1S,2S)-49 with LiAlH(Ot-Bu)3
in THF at −78 ◦C, produced the H-phosphinate (1S,2S)-51 in 78% yield, which by alkylation either
by activation with chlorotrimethylsilane (TMSCl) and diisopropyl ethylamine (DIPEA) followed by
addition of an alkyl halide (method A), or using NaHMDS and subsequent addition of an alkyl
halide (method B), furnished the P-alkylated α-amino-C-phosphinates (1S,2S)-50e–l in 27%–63% yield
(Scheme 26) [65,66].
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Scheme 26. Transformation of chiral phosphonate (1S,2S)-47 into C-phosphinates (1S,2S)-50e–l.
Additionally, the reaction of (1S,2S)-50a–l with iodotrimethylsilane in MeCN produced
the simultaneous deprotection of both the Cbz group and the ethyl ester, to obtain the
α-amino-C-phosphinic acids (1S,2S)-52a–l. On the other hand, cleavage of N-Cbz bond in (1S,2S)-50a–l
with TFA-SMe2 [68] gave the α-amino-C-phosphinates (1S,2S)-53a–l. Both, the α-amino-C-phosphinic
acids (1S,2S)-52a–l and C-phosphinates (1S,2S)-53a–l were used in the synthesis of the acyclic 54a–l
and cyclic 55a–l C-phosphinate analogs of BI-2061 [66], respectively, and their inhibition of the HCV
NS3 protease was tested (Scheme 27).
Scheme 27. Synthesis of the acyclic 54a–l and cyclic 55a–l C-phosphinate analogs of BI-2061.
The acyclic C-phosphinate analog 54a showed an IC50 of 6 nM, whereas the carboxylic 56 and
phosphonic 57 derivatives were found to have an IC50 of 3 and 0.9 nM, respectively. The lower
inhibition of the C-phosphinic compared to its phosphonic analog was attributed to the loss of
H-bonding interaction (Figure 3) [66].
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Figure 3. Carboxylic 56, phosphonic 57 and C-phosphinic 54a analogs of BI-2061 and activities as
inhibitors of the HCV NS3 protease.
Recently, Hammerschmidt et al. [69] reported the s-BuLi or LiTMP induced phosphonate-
phosphinate rearrangement of N-Boc α-aminophosphonates through deprotonation- metallation at the
methoxy group. In this context, the treatment of enantiomerically pure N-Boc α-aminophosphonate 58
with 2.5 equiv of LiTMP in dry THF at −78 ◦C followed by acidic workup, provided the C-phosphinates
(R,SP)-64 and (R,RP)-65 in 12% yield and with 22:78 diastereoisomeric ratio, via the metallated
phosphonates (RC,SP)-60 and (RC,RP)-61 and the ensuing rearrangement to C-phosphinates (RC,SP)-62
and (RC,RP)-63, respectively (Scheme 28).
Scheme 28. LiTMP induced phosphonate-phosphinate rearrangement of the α-aminophosphonate (R)-58.
2.6. P-C Bond Formation from Chiral α-Amino-H-phosphinic Derivatives
There is a continuously growing interest in phosphorus-carbon bond formation due to the great
applications of organophosphorus compounds in synthetic organic and bioorganic chemistry [5,70].
In this context, the chiral α-amino-H-phosphinates have also proved efficiency as P-nucleophiles in
Michael additions. In this regard, Yiotakis et al. [27,71] reported the synthesis of dehydroalaninyl
phosphinic dipeptide analogues, which were tested as zinc-metalloproteases MMP-8 inhibitors. For this
purpose, the optically pure α-amino-H-phosphinic acid (R)-66a [72] was reacted with TMSCl/DIPEA
in CH2Cl2 followed by addition of tert-butyl 2-(bromomethyl)acrylate, obtaining the dehydroalanine
derivative (R)-67 in 94% yield, presumably via an allylic rearrangement. Cleavage of the O-tert-butyl
bond in (R)-67 with trifluoroacetic acid (TFA) and coupling with L-tryptophanyl-amide, gave the
pseudotripeptide (R,S)-68 in 69% yield. Finally, the Michael-type addition of benzyl thiols to (R,S)-68,
produced the cysteine analogues 69a–c in good yield (Scheme 29).
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Scheme 29. Synthesis of phosphinic pseudotripeptides 69a–c and their activities toward MMP-8
(human neutrophile collagenase, HNC).
On the other hand, McKittrick et al. [73] reported the synthesis of the phosphinic pseudotripeptide
(R,S)-71, which not only inhibits the metalloprotease endothelin converting enzyme (ECE), but also the
angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) with IC50 values <100 nM.
Thus, the hydroxyphosphinyl group in enantiopure Cbz-protected phenylalanine phosphinic analogue
(R)-66a [72] was reacted with diazomethane, followed by treatment with LDA in THF at −78 ◦C and
subsequent addition of the triflate, to afford the P-alkylated α-amino-C-phosphinate (R)-70 in 43%
yield, which was further transformed into pseudotripeptide (R,S)-71 (Scheme 30).
 
Scheme 30. Synthesis of the phosphinic pseudotripeptide (R,S)-71 and its activities as inhibitor
of endothelin converting enzyme (ECE), angiotensin converting enzyme (ACE) and neutral
endopeptidase (NEP).
Hamilton et al. [74] reported the synthesis of phenyl phosphinate derivatives 73a,b from
Cbz-protected phenylalanine and valine phosphinic analogues [72] and their inhibitory properties
against human neutrophile elastase (HNE) (valine analogue) and chymotrypsin (phenylalanine
analogue) were evaluated, determining specific inhibitory activity for analogues having (R)
configuration at α-carbon. Thus, the reaction of the α-amino-H-phosphinic acids (R)-66a,b with
TMSCl and Et3N in CH2Cl2 at 0 ◦C followed by the addition of ethyl acrylate, produced the Michael
adducts (R)-72a,b, which by reaction with thionyl chloride (SOCl2) in CH2Cl2 followed by addition
of phenol, provided the phenyl C-phosphinates (R)-73a,b with 91:9 and 89:11 diastereoisomeric ratio,
respectively (Scheme 31).
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Scheme 31. Synthesis of phenyl phosphinate derivatives 73a,b and second-order rate constants
[A = k/Ki] of inhibition of chymotrypsin and human neutrophile elastase (HNE).
Additionally, Lloyd et al. [75] synthesized the C-phosphinic acid 75 and tested its effect on
ECE inhibition. In this context, the reaction of α-amino-H-phosphinic acid (R)-66a obtained by
resolution [72], with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) followed by the Michael
addition to ethyl 2-benzylacrylate and subsequent basic hydrolysis of the ethoxycarbonyl group,
produced the C-phosphinic acid 74. Finally, the reaction of 74 with oxalyl chloride, followed by
coupling with (S)-Trp-OMe and subsequent saponification with LiOH, afforded the phosphinic
pseudopeptide 75 as a 4:1 diastereoisomeric mixture (Scheme 32).
 
Scheme 32. Synthesis of the C-phosphinic acid 75 and its activities as inhibitor of endothelin converting
enzyme (ECE) and neutral endopeptidase (NEP).
Roques et al. [76] reported the synthesis of the iodinated tripeptide (R,S,S)-78 analogue of a highly
efficient aminopeptidase N inhibitor, as a tool for complete characterization of the biochemical and
pharmacological properties of this enzyme. The Michael addition of N-Cbz alanine H-phosphinic
analogue (R)-66c obtained by resolution [72], to the methyl benzylacrylate in the presence of
N,O-bistrimethylsilylacetamide (BSA), followed by alkaline hydrolysis and subsequent coupling
with the L-tyrosine benzyl ester, produced the tripeptide 76 in 57% yield as a diastereoisomeric mixture,
which by saponification of benzyl ester and Cbz removal under acidic conditions, gave the (R,S,S)-77
diastereoisomer in 47% yield after HPLC separation. Finally, the radioiodination of (R,S,S)-77 was
performed by using Na125I in sodium hydroxide solution and chloramine-T, providing the radiolabeled
compound (R,S,S)-78 (Scheme 33).
In a similar way, Roques et al. [77] reported the synthesis of the phosphinic pseudopeptide
(R,S,S)-81, which proved to be a potent dual inhibitor of the zinc metallopeptidases neprilysin and
aminopeptidase N. For this purpose, the Michael addition of N-Cbz alanine H-phosphinic acid (R)-66c
obtained by resolution [72], to ethyl p-bromobenzylacrylate followed by a Suzuki coupling using
phenylboronic acid and subsequent alkaline hydrolysis of the ethyl ester, gave the C-phosphinic acid
derivative 79 in 75% yield, which by the coupling with (S)-alanine methyl ester afforded the tripeptide
80 in 59% yield. Finally, the saponification of the methyl ester followed by the cleavage of the N-Cbz
bond with BBr3 and the semipreparative HPLC purification, provided the enantiomerically pure
phosphinic pseudopeptide (R,S,S)-81 in 92% yield (Scheme 34).
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Scheme 33. Synthesis of the iodinated tripeptide (R,S,S)-78 and its activity as inhibitor of
aminopeptidase N.
Scheme 34. Synthesis of the phosphinic pseudopeptide (R,S,S)-81 and its activities as inhibitor of
aminopeptidase N (APN), neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE).
In a related work, Samios et al. [78] developed an efficient synthetic methodology for
the preparation of the phosphinic pseudotripeptide known as RXP03, which has been widely
studied as MMPs inhibitor [79,80]. Initially, reaction of the N-Cbz H-phosphinic acid analogue of
phenylalanine (R)-66a [72] with bis(trimethylsilyl)amine (HMDS) followed by the addition of ethyl
phenylpropyl-acrylate and subsequent hydrolysis of the ethyl ester group, gave C-phosphinate 82 in
90% yield, which by coupling with (S)-TrpNH2, afforded the phosphinic pseudotripeptides (R,S,S)-83
and (R,R,S)-84 in 77% yield, which were separated in 99% purity by preferential precipitation in EtOH
(Scheme 35). This methodology allows the separation of the diastereoisomers based in their solubility
differences, which was explained by conformational and solvation theoretical studies in terms of their
intra- and intermolecular structure.
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Scheme 35. Synthesis of the phosphinic pseudotripeptides (R,S,S)-83 and (R,R,S)-84 and its activities
of the most potent diastereoisomer of RXP03 [(R,S,S)-83] as inhibitor of matrix metalloproteinases.
Similarly, the phosphinic pseudotripeptides (S,S,S)-85 and (S,R,S)-86 were obtained from the
enantiomeric pure N-Cbz H-phosphinic acid analogue of phenylalanine (S)-66a in 64% yield. As in the
previous example, each diastereoisomer showed different solubility properties in ethyl ether allowing
their complete separation (Scheme 36) [78].
Scheme 36. Synthesis of the phosphinic pseudotripeptides (S,S,S)-85 and (S,R,S)-86.
Considering that phosphinic peptides are well recognized as peptide isosters and powerful
inhibitors of many classes of enzymes, mainly zinc proteases, Yiotakis et al. [81,82] reported the
synthesis of phosphinopeptidic building blocks incorporating a triple bond, which through 1,3-dipolar
cycloaddition process, gives access to novel class of isoxazole-containing phosphinic peptides. Thus,
the reaction of N-Cbz H-phosphinic acid analogue of phenylalanine (R)-66a [72] with TMSCl/DIPEA
followed by the addition of ethyl α-propargylic acrylate and saponification of the ethyl ester, gave the
C-phosphinates 87 in 96% yield and 3.5:1 diastereoisomeric ratio. Coupling of 87 with (S)-TrpNH2
afforded the tripeptide 88 as a diastereoisomeric mixture, from which the diastereoisomer (R,S,S)-88
was isolated by means of simple crystallization. Finally, the 1,3-dipolar cycloaddition reaction of
(R,S,S)-88 with different nitrile oxides generated in situ from the chlorination of the corresponding
oxime, furnished the isoxazoles (R,S,S)-89a–d in good yields (Scheme 37).
On the other hand, the 1,3-dipolar cycloaddition reaction of propargylic C-phosphinic acid 87
(1:1 diastereoisomeric mixture) [81] with benzonitrile oxide, gave the isoxazole-phosphinate 90 in
83% yield, which by coupling with di-tert-butyl protected (S)-tyrosine followed by the cleavage of
the tert-butyl group and semipreparative RP-HPLC isolation, provided the pure diastereoisomeric
phosphinic tripeptide (R,R,S)-91 in 90% yield (Scheme 38) [83]. These compounds were administered
intravenously and lowered mean arterial blood pressure in spontaneously hypertensive rats.
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Scheme 37. Preparation of a novel class of isoxazole-containing phosphinic peptides 89a–d and its
activities as inhibitors of matrix metalloproteinases MMP-13 and MMP-14.
 
Scheme 38. Synthesis of the phosphinic tripeptide (R,R,S)-91 and its activities as inhibitor of angiotensin
converting enzyme (ACE), neutral endopeptidase (NEP) and endothelin converting enzyme (ECE).
In a similar way, Stratikos et al. [84] reported the synthesis of the phosphinic tripeptide (R,S,S)-94,
which was tested in the inhibition of the endoplasmic reticulum aminopeptidases 1 and 2 (ERAP1
and ERAP2), involved in regulation of cytotoxic cellular responses. Thus, the reaction of N-Boc
H-phosphinic acid analogue of homophenylalanine (R)-92 [72] with HMDS followed by the addition
of ethyl isobutylacrylate and saponification of the ethyl ester, gave the C-phosphinate 93 in 72% yield,
which by coupling with (S)-TrpNH2, deprotection and HPLC separation, afforded the phosphinic
tripeptide (R,S,S)-94 in 87% (Scheme 39) [78].
Scheme 39. Synthesis of the phosphinic tripeptide (R,S,S)-94 and its activities as inhibitor of
intracellular aminopeptidases endoplasmic reticulum aminopeptidases 1 and 2 (ERAP 1 and ERAP 2).
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In order to functionalize the phosphinic pseudopeptide framework, Yiotakis et al. [85] developed
a simple and efficient method for P1′ diversification obtaining a variety of dehydrophosphinic peptides.
According to this strategy, the treatment of N-Cbz phenylalanine H-phosphinic analogue (S)-66a [72]
with TMSCl/DIPEA followed by addition of diethyl 2-methylenemalonate and subsequent alkaline
hydrolysis, afforded the phosphinic pseudodipeptide (S)-95 in 67% yield, which was subjected to a
Knoevenagel-type condensation with several aldehydes, to give the dehydrophosphinic peptides 96a–i
in good yields (Scheme 40).
Scheme 40. Synthesis of the dehydrophosphinic peptides 96a–i.
Gegnas et al. [86] described the synthesis of the phosphinic pseudopeptide 99, which proved to
be an inhibitor of the D-glutamic acid-adding enzyme (MurD) of bacterial peptidoglycan biosynthesis.
The nucleophilic addition of compound (R)-97 [72] to 2-methylene pentanedioate in the presence of
sodium methoxide provided the dipeptide isostere as a mixture of four diastereoisomers, which under
hydrogenolysis over Pd/C catalyst in methanol provided the derivative 98 with the free amino group
in 56% yield. Compound 98 was further transformed into the target pseudopeptide 99 in 2% overall
yield through a six steps sequence, whose biological activity lied below the sensitivity of the enzyme
assay used (<1 nM) (Scheme 41).
Scheme 41. Synthesis of the phosphinic pseudopeptide 99 and its activity as inhibitor of the D-glutamic
acid-adding enzyme (MurD) isolated from E. coli.
Additionally, Yiotakis et al. [87] developed an Ireland-Claisen rearrangement triggered by
the phospha-Michael addition of silyl phosphonites to allyl acrylates, as a new strategy to access
pharmacologically relevant C-phosphinic derivatives. In this context, the reaction of Cbz-protected
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phenylalanine H-phosphinic analogue (R)-66a [72] with the acrylate in the presence of DIPEA in
CH2Cl2 followed by addition of TMSCl at −78 ◦C, provided the P-alkylated α-amino-C-phosphinic
acid (R)-100 in 52% yield with retention of configuration at phosphorus atom (Scheme 42).
Scheme 42. Synthesis of the α-amino-C-phosphinic acid (R)-100.
On the other hand, the diastereoselective synthesis of Pro-Phe phosphinyl dipeptide isosteres was
accomplished from optically active prolinephosphinate derivative (R,RP)-101 [88], which was obtained
in 13 steps from 1,1-diethoxyethyl(hydroxymethyl)phosphinate via a lipase-catalyzed acylation [89].
Thus, the Michael addition of the H-phosphinate (R,RP)-101 to t-butyl acrylate in the presence of
t-BuOMgBr in THF at 0 ◦C, provided the C-phosphinate (R,RP)-102 in 95% yield, which by treatment
with LiHMDS followed by the addition of benzyl bromide in THF at −78 ◦C, produced the Pro-Phe
phosphinyl dipeptide (R,RP,R)-103 in 81% yield and 4.8:1 diastereoisomeric ratio (Scheme 43).
Scheme 43. Synthesis of the Pro-Phe phosphinyl dipeptide (R,RP,R)-103.
3. Synthesis of Phosphacyclic α-Amino-C-phosphinates
Several strategies for the preparation of P-heterocycles have been described over the last years,
and excellent reviews have been published [90–93]. In the past 20 years, significant effort has been
devoted to synthetic and reactivity studies of this particular class of compounds, here we only report
the stereoselective methods recently reported in the literature where the α-amino-C-phosphinate motif
is incorporated.
3.1. 1,4,2-Oxazaphosphacycles
The strategies described for the stereoselective synthesis of 1,4,2-oxazaphosphacycles typically
involve the diastereoselective nucleophilic addition-cyclization reaction from hypophosphorous acid
(H3PO2) or methyl hypophosphite (H2PO2Me) and chiral imino alcohols (Scheme 44).
Scheme 44. Retrosynthetic analysis of the 1,4,2-oxazaphosphacycle scaffold.
With previously acquired knowledge in the preparation and reactivity of oxazaphosphinanes,
Pirat et al. [94] addressed the enantioselective synthesis of phosphinic analogues of 2-aryl-morpholinols,
which have shown strong activity on the noradrenergic systems [95] and therefore constitute new
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therapeutic means for depression treatment. Thus, the palladium catalyzed coupling of (2R,3R,5R)-104
with aryl halides and catalytic amounts of tetrakis(triphenylphosphine) palladium and Et3N in PhMe
at reflux, afforded the 2-aryl-1,4,2-oxazaphosphinanes (2R,3R,5R)-105a–e in 68%–74% yield as single
diastereoisomers (Scheme 45). The retention of configuration at phosphorus atom was confirmed
through X-ray analysis of final products.
Scheme 45. Palladium catalyzed coupling of (2R,3R,5R)-104 with aryl halides.
Treatment of (2R,3R,5R)-105a with 12 M HCl at 70 ◦C and subsequent addition of propylene
oxide, produced the (2S,3R,5R)-2,3,5-triphenyl-1,4,2-oxazaphosphinane (−)-106a in 80% yield through
a selective inversion of configuration at phosphorus center (Scheme 46) [94].
Scheme 46. Inversion of configuration at the phosphorus of (2R,3R,5R)-105a.
In a complementary work, Pirat et al. [96] evaluated the diastereoselectivity in the Michael
addition of the enantiomerically pure oxazaphosphinane (2S,3S,5S,6R)-107 to methyl cinnamate. Thus,
reaction of (2S,3S,5S,6R)-107 with catalytic amounts of potassium tert-butoxide in CH2Cl2 at room
temperature followed by the addition of methyl cinnamate, gave the cyclic α-amino-C-phosphinate
(2S,3S,5S,6R)-108 in 92% yield and with 70% diastereoisomeric excess (Scheme 47).
Scheme 47. Michael addition of the oxazaphosphinane (2S,3S,5S,6R)-107 to methyl cinnamate.
On the other hand, Ordóñez et al. [97] carried out the stereoselective synthesis of novel
1,4,2-oxazaphosphepines from chiral 1,3-benzoxazines. For this purpose, the reaction of the chiral
1,3-benzoxazines 109a–d with dichlorophenylphosphine in the presence of Et3N in CH2Cl2 at room
temperature, gave the 1,4,2-oxazaphosphepines 110a–d in 50:50 to 100:0 diastereoisomeric ratio.
In a similar way, the reaction of 111a,b, afforded the 1,4,2-oxazaphosphepines 112a,b in 74:26 and
84:16 diastereoisomeric ratio, respectively (Scheme 48). The configuration assignment was stablished
by X-ray analysis of final products.
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Scheme 48. Synthesis of novel 1,4,2-oxazaphosphepines from chiral 1,3-benzoxazines.
3.2. 1,2-Oxaphosphacycles
The stereoselective synthesis of 1,2-oxaphosphacycles with an exocyclic amino group has been
performed, mainly through two pathways: (a) diastereoselective nucleophilic addition-cyclization
reaction from arylphosphinates and chiral cyclic hemiaminals; or (b) substitution with N-nucleophiles
on derivatized chiral 3-hydroxy-1,2-oxaphosphinanes (Scheme 49).
Scheme 49. Retrosynthetic analysis of the 1,2-oxaphosphacycle scaffold.
For example, the reaction of tris(benzyloxy)-D-arabinofuranose 113 with ethyl phenylphosphinate
in the presence of catalytic amounts of potassium tert-butoxide followed by preparative reverse
phase HPLC separation, led to the cyclic α-amino-C-phosphinate (2S,3R,4S,5S,6R)-114 in 17% yield.
The reaction of (2S,3R,4S,5S,6R)-114 with triflic anhydride in the presence of pyridine in CH2Cl2 at 0 ◦C,
produced the triflate, which without additional purification it was reacted with trimethylsilylazide in
the presence of TBAF in THF at 65 ◦C, obtaining the azido derivative (2S,3S,4S,5S,6R)-115 in 28% yield.
Finally, reduction of azide group in the compound 115 with Ph3P/THF/H2O, furnished the glucose
like oxaphosphinane (2S,3S,4S,5S,6R)-116 in 42% yield, which was tested for their antiproliferative
activity in the search for new therapeutic agents against glioblastoma (Scheme 50) [98].
 
Scheme 50. Synthesis of (2S,3S,4S,5S,6R)-116 and its antiproliferative activity on glioblastoma cell
line C6.
Additionally, the reaction of tris(benzyloxy)-D-arabinofuranose 113 with allylamine or
benzylamine in the presence of MgSO4 in EtOH at reflux, provided the cyclic hemiaminal ethers 117a,b
in 70% yield, which by nucleophilic addition of ethyl phenylphosphinate and cyclization in the presence
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of catalytic amounts of potassium tert-butoxide, afforded the 3-alkylamino-1,2-oxaphosphinanes 118a,b
in 12% and 7% yield, respectively (Scheme 51) [98].
Scheme 51. Synthesis of 118a,b and its antiproliferative activities against glioblastoma cell line C6.
Finally, Bakalara et al. [99] carried out the synthesis of 3-amino-1,2-oxaphosphinanes as
C-glycoside mimetics and new pharmacological agents against glioma stem cell proliferation, migration
and invasion. In this respect, the condensation of the 2,3,5,6-di-O-isopropylidene-α-D-manno-furanose
(3S,4S,5R)-119 with different amines in the presence of MgSO4 in EtOH at reflux, afforded the
cyclic hemiaminal ethers (3S,4S,5R)-120a–d in 58%–90% yield, which by reaction with ethyl
phenylphosphinate and cyclization in the presence of catalytic amounts of potassium tert-butoxide,
produced the 3-aryl or 3-alkylamino-1,2-oxaphosphinanes (2S,3S,4S,5R,6R)-121a–d in 53%–73% yield
(Scheme 52).
Scheme 52. Synthesis of the 3-aryl or 3-alkylamino-1,2-oxaphosphinanes (2S,3S,4S,5R,6R)-121a–d and
its antiproliferative activities toward glioblastoma cell line C6.
4. Conclusions
In this review, we have covered recent progress in the development of stereoselective
methodologies for the synthesis of both acyclic and cyclic α-amino-C-phosphinic acids and derivatives.
As we have shown, a number of optically active α-amino-C-phosphinic derivatives are now accessible
through different strategies; however, there is still a long way to be covered, considering the poor
availability of stereoselective methods for the preparation of pure stereoisomers of phosphinic peptides,
taking into account that diastereoisomers with a particular three dimensional structure are able to
interact efficiently with the receptor binding site, while other configurations are discriminated. Authors
believe that much effort must be made in this direction and further advances in the search and
improvement of synthetic procedures, new chemical applications and biological activities of these
interesting compounds will be a very rewarding task in coming years.
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endothelin converting enzyme; EDC: 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide; ERAP1: endoplasmic
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MPa: megapascal; MurD: D-glutamic acid-adding enzyme; NaHMDS: sodium hexamethyl-disilazide; n-Bu:
n-butyl; NCS: N-chlorosuccinimide; NEP: neutral endopeptidase; nM: nanomolar; PcAm: penicillin amidase; Ph:
phenyl; Phth: phthaloyl; Py: pyridine; r.t.: room temperature; RP-HPLC: reversed phase high performance
liquid chromato-graphy; SDS: sodium dodecyl sulfate; sec-Bu: sec-butyl; TBAF: tetra-n-butyl-ammonium
fluoride; t-Bu: tert-butyl; Tf: trifluoromethanesulfonate; TFA: trifluoroacetic acid; THF: tetrahydrofuran; TMEDA:
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Abstract: We report here a practical and efficient synthesis of α-aminophosphonic acid incorporated
into 1,2,3,4-tetrahydroquinoline and 1,2,3,4-tetrahydroisoquinoline heterocycles, which could be
considered to be conformationally constrained analogues of pipecolic acid. The principal contribution
of this synthesis is the introduction of the phosphonate group in the N-acyliminium ion intermediates,
obtained from activation of the quinoline and isoquinoline heterocycles or from the appropriate
δ-lactam with benzyl chloroformate. Finally, the hydrolysis of phosphonate moiety with simultaneous
cleavage of the carbamate afforded the target compounds.
Keywords: α-aminophosphonic acids; N-acyliminium ions; conformationally constrained
1. Introduction
There is a continuously growing interest in the development of new peptidomimetics, compounds
that mimic the bioactive conformation and action of therapeutic peptides while possessing greater
bioavailability and stability and less undesirable effects. In this regard, the incorporation of
rigid unusual secondary α-amino acids, where the nitrogen is involved in a ring, may result
in significant consequences for the conformation of peptidomimetics as synthetic tools for drug
discovery [1,2]. Some of the most important molecules are the 1,2,3,4-tetrahydroquinoline-2-carboxylic
acid 1 [3,4] and 1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid 2 [5,6], which are conformationally
constrained analogues of unnatural pipecolic acid, and 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(Tic) 3 [7,8], which is considered a conformationally constrained analogue of phenylalanine (Phe).
These compounds are important unnatural α-amino acids, and they are used as key intermediates in
organic synthesis for the preparation of biologically active compounds. Therefore, much effort has
been dedicated to the preparation of these compounds.
On the other hand, the α-aminoalkylphosphonic acids are probably the most important
analogues of the α-amino acids, obtained by isosteric substitution of the planar and less bulky
carboxylic acid (CO2H) by a tetrahedral phosphonic acid functionality (PO3H2). This class of
compounds is currently attracting interest in organic and medicinal chemistry, due to their
important biological and pharmacological properties [9–12]. The great importance of this type
of compound has prompted organic chemists to report numerous procedures for their racemic
or stereoselective synthesis [13–18], principally using the diastereoselective and enantioselective
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Pudovik [19,20] and Kabachnik–Fields [21–25] reactions for acyclic α-aminoalkylphosphonates,
and through N-acyl iminium ions for the synthesis of cyclic derivatives [26–34]. However, to
the best of our knowledge, the synthesis of 1,2,3,4-tetrahydroquinoline-2-phosphonic acid 4 and
1,2,3,4-tetrahydroisoquinoline-1-phosphonic acid 5 analogues [35–38] has not yet been described in
the literature, whereas the synthesis of 1,2,3,4-tetrahydroisoquinoline-3-phosphonic acid 6 has been
recently described by our research group [39,40] (Figure 1).
Figure 1. α-Amino acids characterized by a tetrahydroquinoline or tetrahydroisoquinoline heterocyles
and their α-amino phosphonic analogues.
Considering the high value of these non-coded compounds in connection with our current research
interest in the synthesis of novel conformationally restricted α-aminophosphonic acids [26–28,41–43],
we now report herein the practical and efficient synthesis of α-aminophosphonic acids incorporating
1,2,3,4-tetrahydroquinoline 4, and 1,2,3,4-tetrahydroisoquinoline rings 5 and 6, which could be
considered to be conformationally constrained analogues of pipecolic acid. The principal contribution
of this work is the regioselective introduction of the phosphonate group in the N-acyliminium ions
derivatives obtained from activation of the quinoline and isoquinoline nucleous or from the appropriate
δ-lactams with benzyl chloroformate.
2. Results and Discussion
For the synthesis of 1,2,3,4-tetrahydroquinoline-2-phosphonic acid 4, we proposed the
N-acyliminium ions as suitable precursors, considering that the well-known reduction of the
carbonyl group of lactams such as the 3,4-dihydro-2(1H)-quinolinone 7, and their subsequent
transformation into a N-acyliminium ion, is one of the methods that allows the incorporation of
the phosphonate functionality into the α position of the nitrogen atom such as we have previously
described [26–28]. These proposals prompted us to explore further application of the N-acyliminium
strategy for the synthesis of the target compound. In this context, the commercially available
3,4-dihydro-2(1H)-quinolinone 7 was reacted with lithium bis(trimethylsilyl)amide (LiHMDS) as
a base and benzyl chloroformate in THF at −78 ◦C, to obtain the N-Cbz-3,4-dihydro-2(1H)-quinolinone
8 in 91% yield. Reduction of the carbonyl group in 8 with diisobutylaluminium hydride (DIBAL-H) and
subsequent reaction with methanol and catalytic amounts of pyridinium p-toluenesulfonate (PPTS),
gave the methoxyaminal 9, which was treated immediately with trimethyl phosphite in the presence of
BF3·OEt2, obtaining the dimethyl N-Cbz-1,2,3,4-tetrahydroquinoline-2-phosphonate 11 in 62% via the
N-acyliminium ion 10 in 62% yield from 8. Treatment of this N-Cbz-protected phosphonate with a 33%
solution of hydrogen bromide in acetic acid, afforded the 1,2,3,4-tetrahydroquinoline-2-phosphonic
acid 4 as hydrobromide in quantitative yield (Scheme 1).
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Scheme 1. Synthesis of 1,2,3,4-tetrahydroquinoline-2-phosphonic acid 4 from lactam 7.
The literature has described the hydrophosphonylation of quinoline derivatives to obtain the
1,2-dihydroquinolin-2-ylphosphonate and 2,4-diphosphono-1,2,3,4-tetrahydroquinoline derivatives
using activating agents [44–48]. These reactions proceed via quinolinium ions that can be viewed
as counterparts of the above-mentioned iminium species. Thus, the addition of an acyl chloride
to quinoline can be considered as a way to generate the iminium ion necessary for subsequent
regioselective incorporation of the phosphonate functionality α to the nitrogen atom.
Based on this precedent, we decided to compare the efficiency of the N-acylquinolinium salts as
intermediates in the synthesis of α-aminophosphonic acid 4. For this purpose, benzyl chloroformate
was added to quinoline and the N-Cbz-quinolinium chloride formed 12 was reacted with trimethyl
phosphite in acetonitrile at 50 ◦C, obtaining the dimethyl N-Cbz-1,2-dihydroquinoline-2-phosphonate
derivative 13 in 74% yield from quinolone. The diphosphonylation products at the 2- and 4-positions
of the quinoline ring were not detected. The regioselectivity observed in the addition of trimethyl
phosphite to the N-acylquinolinium ion 12 may be attributed to the electron-withdrawing character
of the benzyloxycarbonyl group, which increases the electrophilic nature of the carbon adjacent to
the nitrogen atom. Additionally, the benzyloxycarbonyl group was selected for its easy incorporation
and removal under mild conditions. Thus, the catalytic hydrogenation resulted in simultaneous
removal of the Cbz group and reduction of the double bond at positions 3,4 to afford the
α-aminophosphonate 14, which, by treatment with hydrogen bromide in acetic acid, gave the
1,2,3,4-tetrahydroquinoline-2-phosphonic acid 4 as hydrobromide. The latter two steps proceeded

































Scheme 2. Synthesis of 1,2,3,4-tetrahydroquinoline-2-phosphonic acid 4 from quinoline.
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The 1,2,3,4-tetrahydroquinoline-2-phosphonic acid 4 was obtained in 74% overall yield from
quinoline following the synthetic strategy in Scheme 2, which compares favorably with the 56% global
yield achieved in Scheme 1, when starting from quinolinone 1. Accordingly, the superior global yield,
together with the much lower price of quinoline in comparison with 3,4-dihydro-2(1H)-quinolinone 7,
makes the methodology in Scheme 2 more advantageous than the lactam-based one for the preparation
of α-aminophosphonic acid 4. From an operational viewpoint, both routes required few purification
steps—by column chromatography—of intermediate compounds.
We next addressed the preparation of 1,2,3,4-tetrahydroisoquinoline-1-phosphonic acid 5.
Similarly to that described above for the quinoline counterpart, the preparation of N-substituted-1,2-
dihydroisoquinoline-1-phosphonates through the isoquinolinium salts formed by reaction of isoquinoline
with acyl chlorides and subsequent addition of trialkyl phosphites has been described [49,50]. Thus,
the synthesis of dimethyl N-Cbz-1,2-dihydroisoquinoline-1-phosphonate should be straightforward,
as shown above for the preparation of dimethyl N-Cbz-1,2-dihydroquinoline-2-phosphonate 13.
On the other hand, the lactam to be used as a starting product for the preparation of the target
amino acid 5 is not easily available from commercial sources in this case. This fact together with
the advantageous preparation of amino acid 4 via the formation of quinolinium salt prompted us to
undertake the synthesis of 1,2,3,4-tetrahydroisoquinoline-1-phosphonic acid following an analogous
synthetic route.
Thus, using the reaction conditions described above, the isoquinoline was reacted with benzyl
chloroformate followed by the addition of trimethyl phosphite in acetonitrile at 50 ◦C. However,
under these reaction conditions, the desired compound 16 was not obtained. It is noteworthy that
during the addition of benzyl chloroformate to isoquinoline, a yellow solid was formed, which was
later identified as the isoquinolinium salt 15. This compound remained unaltered upon addition of
trimethyl phosphite so that the formation of the expected 1,2-dihydroisoquinoline-1-phosphonate 16
did not take place. We reasoned that if the trimethyl phosphite was present in the reaction medium
before benzyl chloroformate was added, the isoquinolinium ion formed 16 would immediately
react with it, thus preventing precipitation. To our delight, when the order of addition of these
reagents was exchanged (that is, trimethyl phosphite prior to benzyl chloroformate), the dimethyl
N-Cbz-1,2-dihydroisoquinoline-1-phosphonate 16 was obtained at 92% yield. In the next step, we
carried out the catalytic hydrogenation of the double bond in 16 under an atmospheric pressure of
hydrogen gas and using Pd/C as a catalyst, to generate the tetrahydroisoquinoline moiety. However,
the Cbz group in 16 was readily eliminated at room temperature, whereas the double bond at positions
3,4 was only partially hydrogenated even after long reaction times. As a consequence, mixtures of
the desired tetrahydroisoquinoline derivative 17 and the analogous dihydroisoquinoline 18 were
obtained. Attempts to improve this result by changing the solvent as well as by increasing the reaction
temperature or hydrogen gas pressure proved unsuccessful and a mixture of 17 and 18 was always
obtained (Scheme 3).
 
Scheme 3. First attempt to synthetize 1,2,3,4-tetrahydroisoquinoline-1-phosphonic acids derivatives.
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To circumvent this problem, we synthesized the compound analogous to 16 that bears the
less acid-sensitive diethyl phosphonate group 19. A procedure identical to that established for the
dimethyl derivative but using triethyl phosphite as the phosphorus source provided the desired diethyl
N-Cbz-1,2-dihydroisoquinoline-1-phosphonate 19 in 98% yield from isoquinoline. Taking into account
the fact that compound 19 can be considered not only as an N-acyl-α-aminophosphonate, but also
as an enamide, we decided to perform the reduction of the double bond using trifluoroacetic acid
and triethylsilane as the reducing agent, following the conditions described by Jacobsen et al. [51]
for cyclic enamides. In this case, the diethyl N-Cbz-1,2,3,4-tetrahydroisoquinoline-1-phosphonate
20 was readily obtained in quantitative yield by reaction with triethylsilane and trifluoroacetic acid.
Subsequent cleavage of the protecting groups in 20 by treatment with hydrogen bromide in acetic acid,
afforded the 1,2,3,4-tetrahydroisoquinoline-1-phosphonic acid 5 as hydrobromide in quantitative yield.
This compound was isolated in 97% overall yield from isoquinoline (Scheme 4).
Scheme 4. Synthesis of 1,2,3,4-tetrahydroisoquinoline-1-phosphonic acid 5 from isoquinoline.
Finally, we focused on the preparation of 1,2,3,4-tetrahydroisoquinoline-3-phosphonic acid 6,
that is, the phosphonic analogue of Tic (TicP). This compound exhibits a tetrahydroisoquinoline
core, as does the aminophosphonic acid 5. However, in the case of TicP, the phosphonate group
is at the 3-position. However, the isoquinoline selectively provides the phosphonate group at the
1-position of the ring. Therefore, we believe that the generation of a suitable iminium ion for the
introduction of the phosphonate moiety at the desired 3-position, the lactam precursor was the only
route to consider in this case. It should be noted that, following this strategy, the position of the
carbonyl group in the starting lactam determines with complete regiocontrol the introduction of the
phosphonate substituent, which is a distinctive advantage of this methodology. The adequate lactam 21
used in the synthesis of the target amino acid was easily prepared following reported procedures that
involved reaction of 2-phenylacetyl chloride with aqueous ammonia to give 2-phenylacetamide [52]
and subsequent condensation with formaldehyde [53]. Lactam 21 was readily transformed into
1,2,3,4-tetrahydroisoquinoline-3-phosphonic acid (TicP, 6) following the synthetic route strictly similar
to that reported above for the preparation of the α-aminophosphonic acid 4 from lactam 7 (Scheme 1).
The 1,2,3,4-tetrahydroisoquinoline-3-phosphonic acid 6 was thus obtained as hydrobromide in 52%
global yield from the starting substrate 21, with isolation and purification of only two synthetic
intermediates 22, 25 (Scheme 5).
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Scheme 5. Synthesis of 1,2,3,4-tetrahydroisoquinoline-3-phosphonic acid, TicP 6.
The results obtained show the successful use of the lactam 21 to generate the key intermediate
N-acyliminium ion, which by phosphonylation, afforded the desired diethyl N-Cbz-1,2,3,4-
tetrahydroisoquinoline-3-phosphonate 25, demonstrating thus the versatility of this methodology in
the preparation of α-aminophosphonic acids structurally related to pipecolic acid.
3. Materials and Methods
3.1. General
All reagents were used as received from commercial suppliers (Sigma-Aldrich Chemie GmbH,
Buchs, Switzerland) without further purification. Thin-layer chromatography (TLC) was performed
on Macherey-Nagel Polygram® SIL G/UV254 (Macherey-Nagel, Duren, Germany) precoated silica gel
polyester plates. The products were visualized by exposure to UV light (254 nm), iodine vapour or
ethanolic solution of phosphomolybdic acid. Column chromatography was performed using 60 M
(0.04–0.063 mm) silica gel from Macherey-Nagel. Melting points were determined on a Gallenkamp
apparatus (Weiss Gallenkamp, Loughborough, UK). IR spectra were registered on a Nicolet Avatar
360 FTIR spectrophotometer (Thermo Electron Corporation, Madison, WI, USA); νmax is given for
the main absorption bands. 1H-, 13C- and 31P-NMR spectra were recorded on Bruker AV-400 or
AV-300 instruments (Bruker BioSpin GmbH, Rheinstetten, Germany) at room temperature, unless
otherwise indicated, using the residual solvent signal as the internal standard; chemical shifts (δ) are
expressed in ppm and coupling constants (J) in Hertz. High-resolution mass spectra were obtained on
a Bruker Microtof-Q spectrometer. Compound 22 was prepared by reaction of 2-phenylacetamide [52]
with formaldehyde [53]. 1H-, 13C- and 31P- NMR spectra of all final compounds are showed in the
supplementary material (Figures S1–S34).
3.2. Synthesis of N-Benzyloxycarbonyl-3,4-dihydro-2-quinolinone 8
A 1 M solution of lithium bis(trimethylsilyl)amide in tetrahydrofuran (2.80 mL, 2.80 mmol) was
slowly added to a solution of 3,4-dihydro-2(1H)-quinolinone 7 (400 mg, 2.72 mmol) in anhydrous
tetrahydrofuran (10 mL) kept at −78 ◦C under argon. After 30 min, benzyl chloroformate (0.39 mL,
464 mg, 2.72 mmol) was added dropwise and stirring was continued for additional 3 h. The reaction
mixture was then treated with saturated aqueous ammonium chloride (10 mL) and allowed to warm
to room temperature. The two layers were separated and the aqueous phase was extracted with
dichloromethane (2 × 20 mL). The combined organic extracts were dried, filtered, and concentrated.
Purification by column chromatography (eluent:hexanes/ethyl acetate 4:1) afforded 8 as a colourless
oil (694 mg, 2.47 mmol, 91% yield). IR (neat) νmax 1773, 1699 cm−1. 1H-NMR (400 MHz, CDCl3):
δ = 7.48–7.33 (m, 5H, Ar), 7.20–7.13 (m, 2H, Ar), 7.10–7.04 (m, 1H, Ar), 6.92–6.88 (m, 1H, Ar), 5.41
(s, 2H, CH2Ph), 2.98–2.92 (m, 2H, H-4), 2.72–2.67 (m, 2H, H-3) ppm. 13C-NMR (100 MHz, CDCl3):
δ = 169.90 (CO), 153.46 (COO), 136.94 (Ar), 134.52 (Ar), 128.85 (Ar), 128.76 (Ar), 128.75 (Ar), 127.95 (Ar),
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127.39 (Ar), 126.95 (Ar), 124.78 (Ar), 118.65 (Ar), 70.05 (CH2Ph), 33.05 (C-3), 25.55 (C-4) ppm. HRMS
(ESI): calcd. for C17H15NNaO3 [M + Na]+ 304.0944; found 304.0947.
3.3. Synthesis of Dimethyl N-benzyloxycarbonyl-1,2,3,4-tetrahydroquinoline-2-phosphonate 11
A 1 M solution of diisobutylaluminium hydride in hexanes (2.40 mL, 2.40 mmol) was slowly
added to a solution of 8 (448 mg, 1.59 mmol) in anhydrous tetrahydrofuran (8 mL) kept at −78 ◦C
under argon. After stirring at this temperature for 2 h, the reaction was treated with saturated aqueous
sodium acetate (5 mL) and warmed to room temperature. A 3:1 mixture of diethyl ether and saturated
aqueous ammonium chloride (16 mL) was then added and the resulting mixture was stirred at room
temperature until a suspension was formed. The solid was filtered off under reduced pressure and
washed with diethyl ether (2 × 10 mL). The organic layer was separated and the aqueous phase was
extracted with diethyl ether (2 × 20 mL). The combined organic extracts were washed with brine
(20 mL), dried, filtered, and evaporated to provide the hemiaminal as an oil. It was dissolved in
methanol (6 mL) and treated with pyridinium p-toluenesulfonate (40 mg, 0.16 mmol). After stirring
at room temperature for 2 h, triethylamine (0.10 mL, 74 mg, 0.73 mmol) was added. The solvent
was evaporated and the crude methoxyaminal 9 thus obtained was dissolved in anhydrous
dichloromethane (7 mL) and kept under argon. Trimethyl phosphite (0.19 mL, 198 mg, 1.59 mmol)
was added and the resulting solution was cooled to −20 ◦C. Boron trifluoride-diethyl ether
(0.20 mL, 226 mg, 1.59 mmol) was added dropwise and the reaction mixture was slowly warmed
to room temperature and stirred for 12 h. After quenching with water (2 mL), the two layers were
separated and the aqueous phase was extracted with dichloromethane (2 × 10 mL). The combined
organic extracts were dried, filtered, and concentrated. Purification by column chromatography
(eluent:ethyl acetate/hexanes 4:1) afforded 11 as a colourless oil (372 mg, 0.99 mmol, 62% yield). IR
(neat) νmax 1702, 1279, 1029 cm−1. 1H-NMR (400 MHz, CDCl3): δ = 7.53–7.46 (m, 1H, Ar), 7.37–7.28
(m, 5H, Ar), 7.22–7.16 (m, 1H, Ar), 7.14–7.06 (m, 2H, Ar), 5.31 (d, J = 12.5 Hz, 1H, CH2Ph), 5.16
(d, J = 12.5 Hz, 1H, CH2Ph), 5.04 (ddd, J = 13.4, 8.7, 7.3 Hz, 1H, H-2), 3.63 (d, J = 10.6 Hz, 3H, OMe),
3.51 (d, J = 10.6 Hz, 3H, OMe), 2.85–2.75 (m, 1H, H-4), 2.67–2.57 (m, 1H, H-4′), 2.54–2.40 (m, 1H, H-3),
2.17–2.03 (m, 1H, H-3′) ppm. 13C-NMR (100 MHz, CDCl3): δ = 154.68 (CO), 136.84 (Ar), 136.08 (Ar),
132.78 (Ar), 128.54 (Ar), 128.16 (Ar), 127.88 (Ar), 127.56 (Ar), 126.36 (Ar), 125.97 (Ar), 125.22 (Ar), 68.11
(CH2Ph), 53.07 (d, J = 6.2 Hz, OMe), 52.82 (d, J = 7.2 Hz, OMe), 49.33 (d, J = 158.2 Hz, C-2), 25.75 (C-3),
25.66 (C-4) ppm. 31P-NMR (162 MHz, CDCl3): δ = 26.39 ppm. HRMS (ESI): calcd. for C19H22NNaO5P
[M + Na]+ 398.1128; found 398.1145.
3.4. Synthesis of Dimethyl N-Benzyloxycarbonyl-1,2-dihydroquinoline-2-phosphonate 13
Benzyl chloroformate (0.61 mL, 726 mg, 4.26 mmol) was added dropwise to a solution of quinoline
(0.46 mL, 500 mg, 3.87 mmol) in anhydrous acetonitrile (6 mL) kept at 0 ◦C under argon. After stirring
at this temperature for 10 min, trimethyl phosphite (0.50 mL, 528 mg, 4.26 mmol) was slowly added
followed by sodium iodide (853 mg, 5.69 mmol). The mixture was heated at 50 ◦C for 10 min.
The solvent was evaporated and the crude product was partitioned between dichloromethane (15 mL)
and saturated aqueous sodium bicarbonate (15 mL). The organic phase was separated and the aqueous
layer was further extracted with dichloromethane (3 × 15 mL). The combined organic extracts were
washed with brine (10 mL), dried, filtered, and concentrated. Purification by column chromatography
(eluent:ethyl acetate/hexanes 4:1) afforded 13 as a colourless oil (1.07 g, 2.87 mmol, 74% yield).
IR (neat) νmax 1706, 1653, 1603, 1263, 1125, 1026 cm−1. 1H-NMR (400 MHz, DMSO-d6, 80 ◦C):
δ = 7.58–7.52 (m, 1H, Ar), 7.44–7.30 (m, 5H, Ar), 7.25–7.07 (m, 3H, Ar), 6.71–6.65 (m, 1H, H-4), 6.07
(ddd, J = 9.5, 6.3, 4.5 Hz, 1H, H-3), 5.61 (ddd, J = 21.4, 6.3, 1.2 Hz, 1H, H-2), 5.27 (s, 2H, CH2Ph), 3.47
(d, J = 10.6 Hz, 6H, OMe) ppm. 13C-NMR (100 MHz, DMSO-d6, 80 ◦C): δ = 152.90 (d, J = 4.7 Hz, CO),
135.68 (Ar), 134.66 (Ar), 128.05 (Ar), 127.70 (Ar), 127.40 (Ar), 127.35 (Ar), 127.01 (d, J = 9.7 Hz, C-4),
126.77 (d, J = 4.0 Hz, Ar), 126.06 (d, J = 1.5 Hz, Ar), 124.35 (Ar), 123.66 (Ar), 122.55 (d, J = 3.0 Hz, C-3),
67.44 (CH2Ph), 52.70 (d, J = 7.0 Hz, OMe), 52.39 (d, J = 6.6 Hz, OMe), 50.84 (d, J = 151.5 Hz, C-2) ppm.
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31P-NMR (162 MHz, DMSO-d6, 80 ◦C): δ = 20.41 ppm. HRMS (ESI): calcd. for C19H20NNaO5P
[M + Na]+ 396.0971; found 396.0991.
3.5. Synthesis of Dimethyl 1,2,3,4-Tetrahydroquinoline-2-phosphonate 14
A mixture of 13 (200 mg, 0.54 mmol) and 10% Pd/C (20 mg) in ethyl acetate (10 mL) was stirred
at room temperature under an atmospheric pressure of hydrogen gas for 12 h. Filtration of the catalyst
and evaporation of the solvent provided pure 14 as a colourless oil (130 mg, 0.54 mmol, 100% yield).
IR (neat) νmax 3316, 1231, 1057, 1029 cm−1. 1H-NMR (400 MHz, CDCl3): δ = 7.02–6.93 (m, 2H, Ar),
6.70–6.63 (m, 1H, Ar), 6.58–6.53 (m, 1H, Ar), 4.16 (br s, 1H, NH), 3.82 (d, J = 10.3 Hz, 3H, OMe), 3.81
(d, J = 10.5 Hz, 3H, OMe), 3.71 (ddd, J = 10.1, 6.7, 3.4 Hz, 1H, H-2), 2.88–2.75 (m, 2H, H-4), 2.29–2.19
(m, 1H, H-3), 2.12–1.98 (m, 1H, H-3′) ppm. 13C-NMR (100 MHz, CDCl3): δ = 143.08 (d, J = 10.9 Hz, Ar),
129.40 (Ar), 127.11 (Ar), 121.05 (Ar), 118.26 (Ar), 114.97 (Ar), 53.83 (d, J = 6.7 Hz, OMe), 53.08
(d, J = 7.3 Hz, OMe), 49.05 (d, J = 161.5 Hz, C-2), 26.09 (d, J = 13.7 Hz, C-4), 22.39 (d, J = 5.2 Hz,
C-3) ppm. 31P-NMR (162 MHz, CDCl3): δ = 27.39 ppm. HRMS (ESI): calcd. for C11H16NNaO3P
[M + Na]+ 264.0760; found 264.0752.
3.6. Synthesis of 1,2,3,4-Tetrahydroquinoline-2-phosphonic Acid Hydrobromide 4
From 11: A 33% solution of hydrogen bromide in acetic acid (2 mL) was added to compound 11
(110 mg, 0.29 mmol) and the reaction mixture was stirred at room temperature for 3 h. The solvent
was evaporated and the residue was taken up in water and lyophilised to afford 4 as a white solid
(86 mg, 0.29 mmol, 100% yield). M.p. 94–96 ◦C (dec.). IR (nujol) νmax 3381, 1171, 1077, 1057 cm−1.
1H-NMR (400 MHz, CD3OD): δ = 7.40–7.28 (m, 4H, Ar), 3.78 (ddd, J = 13.1, 12.1, 2.5 Hz, 1H, H-2),
3.08–3.01 (m, 2H, H-4), 2.52–2.43 (m, 1H, H-3), 2.19–2.06 (m, 1H, H-3′) ppm. 13C-NMR (100 MHz,
CD3OD): δ = 132.21 (d, J = 0.7 Hz, Ar), 131.87 (Ar), 131.78 (Ar), 130.25 (Ar), 128.64 (Ar), 124.49 (Ar),
52.52 (d, J = 153.2 Hz, C-2), 25.94 (d, J = 12.4 Hz, C-4), 22.37 (d, J = 2.2 Hz, C-3) ppm. 31P-NMR
(162 MHz, CD3OD): δ = 14.61 ppm. HRMS (ESI): calcd. for C9H13NO3P [M − Br]+ 214.0628;
found 214.0632.
From 14: A 33% solution of hydrogen bromide in acetic acid (2 mL) was added to compound 14
(130 mg, 0.54 mmol) and the reaction mixture was stirred at room temperature for 3 h. The solvent
was evaporated and the residue was taken up in water and lyophilised to afford 4 as a white solid
(158 mg, 0.54 mmol, 100% yield). Spectroscopic data were identical to those described above.
3.7. Synthesis of Dimethyl N-Benzyloxycarbonyl-1,2-dihydroisoquinoline-1-phosphonate 16
Benzyl chloroformate (0.61 mL, 726 mg, 4.26 mmol) was added dropwise to a solution of
isoquinoline (500 mg, 3.87 mmol) and trimethyl phosphite (0.50 mL, 528 mg, 4.26 mmol) in anhydrous
acetonitrile (6 mL) kept at 0 ◦C under argon. Sodium iodide (853 mg, 5.69 mmol) was slowly added
and the mixture was heated at 50 ◦C for 10 min. The solvent was evaporated and the crude product
was partitioned between dichloromethane (15 mL) and saturated aqueous sodium bicarbonate (15 mL).
The organic phase was separated and the aqueous layer was further extracted with dichloromethane
(3 × 15 mL). The combined organic extracts were washed with brine (10 mL), dried, filtered, and
concentrated. Purification by column chromatography (eluent: ethyl acetate/hexanes 4:1) afforded
16 as a colourless oil (1.33 g, 3.56 mmol, 92% yield). IR (neat) νmax 1715, 1342, 1295, 1238, 1121,
1028 cm−1. 1H-NMR (300 MHz, DMSO-d6, 50 ◦C): δ = 7.51–7.11 (m, 9H, Ar), 6.91 (d, J = 7.7 Hz, 1H,
H-3), 6.08–5.94 (m, 1H, H-4), 5.83 (d, J = 15.8 Hz, 1H, H-1), 5.27 (s, 2H, CH2Ph), 3.57–3.38 (m, 6H, OMe)
ppm. 13C-NMR (100 MHz, DMSO-d6): δ = (duplicate signals are observed for some carbons; asterisks
indicate those corresponding to the minor rotamer) 152.37* (CO), 151.88 (CO), 136.01 (Ar), 135.91* (Ar),
131.03* (d, J = 3.6 Hz, Ar), 130.84 (d, J = 3.6 Hz, Ar), 128.75* (d J = 3.0 Hz, Ar), 128.68 (d, J = 3.1 Hz,
Ar), 128.54 (Ar), 128.47* (Ar), 128.26 (Ar), 128.11* (Ar), 127.92 (Ar), 127.55 (d, J = 5.2 Hz, Ar), 127.30
(d, J = 2.3 Hz, Ar), 127.18 (d, J = 2.0 Hz, Ar), 125.43 (Ar), 125.35 (Ar), 124.86 (d, J = 2.9 Hz, C-3), 124.79*
(C-3), 109.86 (C-4), 67.86* (CH2Ph), 67.77 (CH2Ph), 53.40* (d, J = 148.4 Hz, C-1), 53.16* (d, J = 6.1 Hz,
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OMe), 53.12 (d, J = 7.0 Hz, OMe), 52.64 (d, J = 149.6 Hz, C-1) ppm. 31P-NMR (122 MHz, DMSO-d6,
50 ◦C): δ = 21.34 ppm. HRMS (ESI): calcd. for C19H20NNaO5P [M + Na]+ 396.0971; found 396.0982.
3.8. Synthesis of Diethyl N-Benzyloxycarbonyl-1,2-dihydroisoquinoline-1-phosphonate 19
Benzyl chloroformate (0.61 mL, 726 mg, 4.26 mmol) was added dropwise to a solution of
isoquinoline (500 mg, 3.87 mmol) and triethyl phosphite (0.73 mL, 708 mg, 4.26 mmol) in anhydrous
acetonitrile (6 mL) kept at 0 ◦C under argon. Sodium iodide (853 mg, 5.69 mmol) was slowly added
and the mixture was heated at 50 ◦C for 10 min. The solvent was evaporated and the crude product
was partitioned between dichloromethane (15 mL) and saturated aqueous sodium bicarbonate (15 mL).
The organic phase was separated and the aqueous layer was further extracted with dichloromethane
(3 × 15 mL). The combined organic extracts were washed with brine (10 mL), dried, filtered, and
concentrated. Purification by column chromatography (eluent:ethyl acetate/hexanes 3:2) afforded
19 as a colourless oil (1.52 g, 3.79 mmol, 98% yield). IR (neat) νmax 1715, 1294, 1253, 1120, 1023 cm−1.
1H-NMR (300 MHz, DMSO-d6, 70 ◦C): δ = 7.50–7.10 (m, 9H, Ar), 6.91 (d, J = 7.8 Hz, 1H, H-3), 5.98
(d, J = 7.8 Hz, 1H, H-4), 5.77 (d, J = 15.9 Hz, 1H, H-1), 5.26 (s, 2H, CH2Ph), 3.95–3.69 (m, 4H, OCH2), 1.08
(t, J = 7.0 Hz, 3H, Me), 1.07 (t, J = 7.0 Hz, 3H, Me) ppm. 13C-NMR (100 MHz, DMSO-d6): δ = (duplicate
signals are observed for some carbons; asterisks indicate those corresponding to the minor rotamer)
152.48* (CO), 151.91 (CO), 136.05 (Ar), 135.88* (Ar), 131.15* (d, J = 3.6 Hz, Ar), 130.98 (d, J = 3.7 Hz,
Ar), 128.69* (d, J = 3.3 Hz, Ar), 128.61 (d, J = 3.3 Hz, Ar), 128.56 (Ar), 128.47* (Ar), 128.28 (Ar),
128.25* (Ar), 128.13* (Ar), 127.97 (Ar), 127.53 (d, J = 5.2 Hz, Ar), 127.22 (d, J = 2.6 Hz, Ar), 127.11* (d,
J = 2.7 Hz, Ar), 125.59 (d, J = 1.8 Hz, Ar), 125.56* (d, J = 2.4 Hz, Ar), 125.42 (Ar), 124.84* (C-3), 124.81
(C-3), 109.95 (C-4), 67.84* (CH2Ph), 67.71 (CH2Ph), 62.54 (d, J = 7.1 Hz, OCH2), 62.42* (d, J = 6.6 Hz,
OCH2), 62.38* (d, J = 7.1 Hz, OCH2), 53.97* (d, J = 148.9 Hz, C-1), 53.15 (d, J = 150.2 Hz, C-1), 16.17
(d, J = 5.3 Hz, Me), 16.15* (d, J = 5.7 Hz, Me) ppm. 31P-NMR (122 MHz, DMSO-d6, 70 ◦C): δ = 18.77 ppm.
HRMS (ESI): calcd. for C21H25NO5P [M + H]+ 402.1465; found 402.1466.
3.9. Synthesis of Diethyl N-Benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinoline-1-phosphonate 20
Triethylsilane (1.0 mL, 730 mg, 6.28 mmol) and trifluoroacetic acid (0.48 mL, 716 mg, 6.28 mmol)
were added to a solution of 19 (300 mg, 0.75 mmol) in anhydrous dichloromethane (15 mL) kept at 0 ◦C
under argon. The solution was allowed to warm to room temperature and stirred for 18 h. Evaporation
of the solvent followed by column chromatography (eluent:hexanes/ethyl acetate 1:1) afforded 20 as a
colourless oil (298 mg, 0.74 mmol, 99% yield). IR (neat) νmax 1701, 1294, 1249, 1230, 1051, 1022 cm−1.
1H-NMR (300 MHz, DMSO-d6, 70 ◦C): δ = 7.44–7.16 (m, 9H, Ar), 5.53 (d, J = 20.4 Hz, 1H, H-1), 5.17
(s, 2H, CH2Ph), 4.14–3.77 (m, 5H, H-3, OCH2), 3.72–3.52 (m, 1H, H-3′), 2.98–2.78 (m, 2H, H-4), 1.17
(t, J = 7.0 Hz, 3H, Me), 1.08 (t, J = 6.9 Hz, 3H, Me) ppm. 13C-NMR (100 MHz, DMSO-d6):
δ = (duplicate signals are observed for some carbons; asterisks indicate those corresponding to
the minor rotamer) 154.60 (d, J = 3.9 Hz, CO), 154.18* (d, J = 2.4 Hz, CO), 136.66 (Ar), 136.46* (Ar),
134.73 (d, J = 5.6 Hz, Ar), 134.63* (d, J = 5.6 Hz, Ar), 129.22 (Ar), 129.13* (d, J = 2.2 Hz, Ar), 128.95
(d, J = 2.3 Hz, Ar), 128.85 (Ar), 128.38 (Ar), 128.33* (Ar), 127.94* (Ar), 127.91 (Ar), 127.86* (Ar), 127.67
(d, J = 4.0 Hz, Ar), 127.58 (Ar), 127.38 (Ar), 125.88 (d, J = 2.8 Hz, Ar), 125.83* (d, J = 2.8 Hz, Ar),
66.92* (CH2Ph), 66.82 (CH2Ph), 62.58 (d, J = 7.2 Hz, OCH2), 62.19 (d, J = 7.1 Hz, OCH2), 52.76*
(d, J = 149.9 Hz, C-1), 52.34 (d, J = 152.0 Hz, C-1), 39.05* (C-3), 38.84 (C-3), 27.43 (C-4), 27.15* (C-4),
16.08* (d, J = 5.6 Hz, Me), 16.05 (d, J = 5.3 Hz, Me). 31P-NMR (122 MHz, DMSO-d6, 70 ◦C): δ = 20.75.
HRMS (ESI): calcd. for C21H27NO5P [M + H]+ 404.1621; found 404.1611.
3.10. Synthesis of 1,2,3,4-Tetrahydroisoquinoline-1-phosphonic Acid Hydrobromide 5
A 33% solution of hydrogen bromide in acetic acid (2 mL) was added to 20 (160 mg, 0.40 mmol)
and the reaction mixture was stirred at room temperature for 3 h. The solvent was evaporated and
the residue was taken up in water and lyophilised to afford 5 as a white solid (117 mg, 0.40 mmol,
100% yield). M.p. 85–87 ◦C (dec.). IR (nujol) νmax 3421, 1212, 1118, 1019 cm−1. 1H-NMR (400 MHz,
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D2O): δ = 7.45–7.41 (m, 1H, Ar), 7.37–7.27 (m, 3H, Ar), 4.70 (d, J = 17.6 Hz, 1H, H-1), 3.78 (ddd, J = 12.7,
9.2, 6.5 Hz, 1H, H-3), 3.58–3.51 (m, 1H, H-3′), 3.18–3.12 (m, 2H, H-4) ppm. 13C-NMR (100 MHz,
CD3OD): δ = 132.88 (d, J = 5.4 Hz, Ar), 130.40 (d, J = 2.2 Hz, Ar), 129.47 (d, J = 2.7 Hz, Ar), 128.94 (d,
J = 3.6 Hz, Ar), 127.92 (d, J = 2.6 Hz, Ar), 127.40 (d, J = 5.1 Hz, Ar), 54.00 (d, J = 147.3 Hz, C-1), 41.15 (d,
J = 2.1 Hz, C-3), 25.88 (C-4) ppm. 31P-NMR (162 MHz, D2O): δ = 10.02 ppm. HRMS (ESI): calcd. for
C9H13NO3P [M − Br]+ 214.0628; found 214.0633.
3.11. Synthesis of N-Benzyloxycarbonyl-1,4-dihydro-3-isoquinolinone 22
A 1 M solution of lithium bis(trimethylsilyl)amide in tetrahydrofuran (0.83 mL, 0.83 mmol)
was slowly added to a solution of 1,4-dihydro-3(2H)-isoquinolinone 21 (122 mg, 0.83 mmol) in
anhydrous tetrahydrofuran (5 mL) kept at −78 ◦C under argon. After 30 min, benzyl chloroformate
(0.12 mL, 142 mg, 0.83 mmol) was added dropwise and stirring was continued for additional 3 h.
The reaction was then treated with saturated aqueous ammonium chloride (10 mL) and allowed to
warm to room temperature. The two layers were separated and the aqueous phase was extracted with
dichloromethane (2 × 10 mL). The combined organic extracts were dried, filtered, and concentrated.
Purification by column chromatography (eluent:hexanes/ethyl acetate 7:3) afforded 22 as a white
solid (172 mg, 0.61 mmol, 73% yield). M.p. 63–65 ◦C. IR (nujol) νmax 1692 cm−1. 1H-NMR (400 MHz,
CDCl3): δ = 7.49–7.44 (m, 2H, Ar), 7.40–7.25 (m, 6H, Ar), 7.23–7.19 (m, 1H, Ar), 5.34 (s, 2H, CH2Ph),
4.92 (s, 2H, H-1), 3.73 (s, 2H, H-4) ppm. 13C-NMR (100 MHz, CDCl3): δ = 169.43 (CO), 153.62 (COO),
135.38 (Ar), 132.25 (Ar), 132.13 (Ar), 128.74 (Ar), 128.50 (Ar), 128.46 (Ar), 128.22 (Ar), 127.35 (Ar), 126.99
(Ar), 125.81 (Ar), 68.97 (CH2Ph), 48.75 (C-1), 41.53 (C-4) ppm. HRMS (ESI): calcd. for C17H15NNaO3
[M + Na]+ 304.0944; found 304.0943.
3.12. Synthesis of Dimethyl N-Benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinoline-3-phosphonate 25
A 1 M solution of diisobutylaluminium hydride in hexanes (0.78 mL, 0.78 mmol) was slowly
added to a solution of 22 (146 mg, 0.52 mmol) in anhydrous tetrahydrofuran (5 mL) kept at −78 ◦C
under argon. After stirring at this temperature for 2 h, the reaction was treated with saturated aqueous
sodium acetate (10 mL) and allowed to warm to room temperature. A 3:1 mixture of diethyl ether
and saturated aqueous ammonium chloride (16 mL) was then added and the resulting mixture was
stirred at room temperature until a suspension was formed. The solid was filtered off under reduced
pressure and washed with diethyl ether (2 × 10 mL). The organic layer was separated and the aqueous
phase was extracted with diethyl ether (2 × 10 mL). The combined organic extracts were washed with
brine (10 mL), dried, filtered, and evaporated to provide the hemiaminal as an oil. It was dissolved in
methanol (5 mL) and treated with pyridinium p-toluenesulfonate (13 mg, 0.05 mmol). After stirring
at room temperature for 2 h, triethylamine (31 μL, 22 mg, 0.22 mmol) was added. The solvent was
evaporated and the crude methoxyaminal obtained 23 was dissolved in anhydrous dichloromethane
(5 mL) and kept under argon. Trimethyl phosphite (61 μL, 65 mg, 0.52 mmol) was added and the
resulting solution was cooled to −20 ◦C. Boron trifluoride-diethyl ether (65 μL, 74 mg, 0.52 mmol)
was added and the reaction mixture was slowly warmed to room temperature and stirred for 12 h.
After quenching with water (10 mL), the two layers were separated and the aqueous phase was
extracted with dichloromethane (2 × 10 mL). The combined organic extracts were dried, filtered, and
concentrated. Purification by column chromatography (eluent:ethyl acetate/hexanes 9:1) afforded 25
as a colourless oil (138 mg, 0.37 mmol, 71% yield). IR (neat) νmax 1703, 1410, 1246, 1055, 1031 cm−1.
1H-NMR (400 MHz, CDCl3): δ = (duplicate signals are observed for some protons; asterisks indicate
those corresponding to the minor rotamer) 7.42–7.30 (m, 5H, Ar), 7.23–7.04 (m, 4H, Ar), 5.31–5.12
(m, 2H, CH2Ph), 5.11–5.03 (m, 1H, H-3), 5.00–4.86 (m, 1H, H-1) overlapped with 4.97*–4.89*
(m, 1H, H-3), 4.52 (d, J = 16.6 Hz, 1H, H-1′), 4.45* (d, J = 16.6 Hz, 1H, H-1′), 3.65 (d, J = 10.7 Hz,
3H, OMe), 3.51* (d, J = 10.7 Hz, 3H, OMe), 3.35 (d, J = 10.7 Hz, 3H, OMe), 3.33–3.16 (m, 2H, H-4)
overlapped with 3.24* (d, J = 10.7 Hz, 3H, OMe) ppm. 13C-NMR (100 MHz, CDCl3): δ = (duplicate
signals are observed for some carbons; asterisks indicate those corresponding to the minor rotamer)
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155.72 (CO), 155.05* (CO), 136.37 (Ar), 136.18* (Ar), 132.61* (Ar), 132.46 (Ar), 131.41 (Ar), 131.00* (Ar),
128.64 (Ar), 128.53 (Ar), 128.45* (Ar), 128.24 (Ar), 128.17* (Ar), 127.95 (Ar), 126.70 (Ar), 126.64* (Ar),
126.60 (Ar), 126.09* (Ar), 125.86 (Ar), 67.79 (CH2Ph), 52.74 (d, J = 6.4 Hz, OMe), 52.58 (d, J = 6.6 Hz,
OMe), 52.34* (d, J = 6.9 Hz, OMe), 47.07* (d, J = 154.2 Hz, C-3), 46.29 (d, J = 154.1 Hz, C-3), 44.37
(C-1), 28.56* (C-4), 28.32 (C-4) ppm. 31P-NMR (162 MHz, CDCl3): δ = (a duplicate signal is observed;
an asterisk indicates that corresponding to the minor rotamer) 27.67, 27.07* ppm. HRMS (ESI): calcd.
for C19H22NNaO5P [M + Na]+ 398.1128; found 398.1144.
3.13. Synthesis of 1,2,3,4-Tetrahydroisoquinoline-3-phosphonic Acid Hydrobromide 6
A 33% solution of hydrogen bromide in acetic acid (2 mL) was added to 25 (100 mg, 0.27 mmol)
and the reaction mixture was stirred at room temperature for 3 h. The solvent was evaporated and
the residue was taken up in water and lyophilised to afford 6 as a white solid (79 mg, 0.27 mmol,
100% yield). M.p. 102–103 ◦C (dec.). IR (nujol) νmax 3404, 1232, 1010 cm−1. 1H-NMR (400 MHz,
CD3OD): δ = 7.35–7.22 (m, 4H, Ar), 4.52 (d, J = 15.7 Hz, 1H, H-1), 4.42 (dd, J = 15.7, 3.1 Hz, 1H,
H-1′), 3.94–3.83 (m, 1H, H-3), 3.34–3.25 (m, 2H, H-4) ppm. 13C-NMR (100 MHz, CD3OD): δ = 131.71
(d, J = 12.2 Hz, Ar), 129.97 (Ar), 129.27 (Ar), 128.69 (Ar), 128.32 (Ar), 127.77 (Ar), 51.34 (d, J = 153.1 Hz,
C-3), 47.01 (d, J = 7.7 Hz, C-1), 27.44 (C-4) ppm. 31P-NMR (162 MHz, CD3OD): δ = 14.06 ppm.
HRMS (ESI): calcd. for C9H13NO3P [M − Br]+ 214.0628; found 214.0631.
4. Conclusions
The synthesis of α-aminophosphonic acids characterized by a tetrahydroquinoline or
tetrahydroisoquinoline heterocycles is described. Specifically, 1,2,3,4-tetrahydroquinoline-2-phosphonic
acid 4, 1,2,3,4-tetrahydroisoquinoline-1-phosphonic acid 5, and 1,2,3,4-tetrahydro-isoquinoline-3-
phosphonic acid 6 have been prepared in high overall yields using efficient methods that make use
of easily available substrates. The compounds obtained can be viewed as higher homologues of
phosphopipecolic acid that bear a benzene ring fused at different positions of the six-membered
piperidine cycle. In particular, the latter is the phosphonic surrogate of Tic, an amino acid of
extraordinary value in the design of pharmacologically useful peptides. The synthetic routes developed
rely on the addition of trialkyl phosphites to iminium ions generated from quinoline/isoquinoline or
from the appropriate δ-lactam bearing a fused benzene ring. Thus, lactams have proven to be versatile
starting materials for the efficient and selective synthesis of α-aminophosphonic acids containing
an azacyclic skeleton. The presence of the carbonyl group in the starting lactam determines, with
full regiocontrol, the position at which the phosphonate substituent is incorporated. Formation of
the intermediate N-acyliminium ion with the adequate regiochemistry has allowed the synthesis of
the phosphonic counterpart of Tic (TicP). Importantly, this α-aminophosphonic acid is not accessible
through other methodologies traditionally used to generate iminium ions.
Supplementary Materials: 1H-, 13C-, and 31P- (when applicable) NMR spectra of the final compounds and all
key intermediates are available online at http://www.mdpi.com/1420-3049/21/9/1140/s1.
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Abstract: The Pd-catalyzed direct alkylation of H-phosphinic acids and hypophosphorous acid with
allylic/benzylic alcohols has been described previously. Here, the extension of this methodology to
H-phosphinate esters is presented. The new reaction appears general, although its scope is narrower
than with the acids, and its mechanism is likely different. Various alcohols are examined in their
reaction with phosphinylidene compounds R1R2P(O)H.
Keywords: palladium; cross-coupling; alcohols; H-phosphinate esters; allylation; benzylation
1. Introduction
In the classic Pd-catalyzed Tsuji-Trost reaction, the allylic electrophile is an alcohol derivative
(most often the acetate) and numerous nucleophiles can be employed easily [1]. More recently,
the use of allylic alcohols has emerged [1,2]. Using alcohols for the direct allylation of nucleophiles is
desirable because water is the only byproduct. In the context of carbon-phosphorus bond-formation,
we disclosed 10 years ago the reaction between hypophosphorous acid (HPA) and allylic alcohols
catalyzed by Pd to directly afford the corresponding allylic H-phosphinic acids (Scheme 1a) [3].
The reaction was subsequently extended to include H-phosphinic acids instead of HPA to form
disubstituted phosphinic acids under slightly more forcing conditions (Scheme 1b) [4]. Around the
same time, we also described the benzylation of HPA and H-phosphinic acids with benzylic alcohols
under similar conditions (Scheme 1c) [5]. These reactions were discovered based on mechanistic
reasoning that was supported by model studies [6]. It was thought that the reaction required a PO2H
motif for Fisher esterification and tautomerization. More recently, we decided to reexamine this type
of reaction, but using H-phosphinic esters as starting materials, and were surprised to observe a
successful allylation, suggesting that a different mechanism could be operative. This manuscript
describes these findings (Scheme 1d).
2. Results and Discussion
Based on our prior work in this area, we selected cinnamyl alcohol and butyl
phenyl-H-phosphinate in equimolar amounts as the reacting partners for the initial investigation
(Table 1). Cinnamyl alcohol was identified previously as a very reactive partner in our Pd-catalyzed
allylation [3–6]. Additionally, based on our prior findings, t-amyl alcohol was selected as
the solvent for the azeotropic removal of the water byproduct (reflux, Dean-Stark trap) [4,5].
Using palladium acetate as the catalyst, and without added ligand, the reaction failed to
produce any detectable amount of product (entry 1). As we had found in our other couplings,
Xantphos (4,5-bis(diphenylphosphino)-9,9-dimethylxanthene) performed superbly affording the
desired product in nearly quantitative isolated yield (entry 2). Switching the solvent to toluene (still
with a Dean-Stark trap) gave a satisfactory yield, albeit lower (entry 3). This was not entirely unexpected
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as t-amyl alcohol was initially identified for its ability to promote P(V) to P(III) tautomerization through
hydrogen-bonding. Changing the salt from palladium acetate to palladium chloride resulted in a
slightly lower yield (entry 4 vs. 2). On the other hand, tris(dibenzylideneacetone)dipalladium(0)
(Pd2(dba)3) (as we had done in most of our prior work on allylation/benzylation) also gave a nearly
quantitative yield of product (entry 5). Using 1,1’-bis(diphenylphosphino)ferrocene (Dppf) as the
ligand did afford the desired product, but in significantly lower yield (entry 6). Thus, the results
shown in Table 1 confirmed the catalyst system we had identified earlier for the cross-coupling of
phosphinic acids.
 
Scheme 1. Carbon-phosphorus bond formation by allylation/benzylation with alcohols. Xantphos,
4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; MS, molecular sieves; t-AmOH, t-amyl alcohol.
Table 1. Test reaction between butyl phenyl-H-phosphinate and cinnamyl alcohol.
Entry Solvent a Temp. (◦C) a Pd Salt (mol %) Ligand (mol %) Yield (%) b
1 t-AmOH 102 Pd(OAc)2 (2) None (-) 0 c
2 t-AmOH 102 Pd(OAc)2 (2) Xantphos (2) d 99
3 toluene 111 Pd(OAc)2 (2) Xantphos (2) d 88
4 t-AmOH 102 PdCl2 (2) Xantphos (2) d 90
5 t-AmOH 102 Pd2(dba)3 (1) e Xantphos (2) d 99
6 t-AmOH 102 Pd2(dba)3 (1) e Dppf (2) f 67
a Reflux, Dean-Stark trap; b Isolated yield after column chromatography over silica gel (Note: the 31P-NMR
yield of the crude before purification is comparable); c No product in the 31P-NMR spectrum; d Xantphos,
4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; e Pd2(dba)3, tris(dibenzylideneacetone)dipalladium(0); dba,
dibenzylideneacetone; f Dppf, 1,1’-bis(diphenylphosphino)ferrocene.
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Next, the scope of the allylation with cinnamyl alcohol was investigated with a variety of
phosphinylidene compounds (Table 2). Not surprisingly, changing the ester group from n-butyl
to cyclohexyl gave a good result (entry 2), while a benzyl ester gave a lower yield (entry 3), presumably
because of competing transesterification. The less reactive cyclohexyl-octyl-H-phosphinate [7]
reacted uneventfully (entry 4), while butyl cinnamyl-H-phosphinate afforded a quantitative yield
of butyl bis(cinnamyl)phosphinate (entry 5). Other functionalized H-phosphinate esters were
tested (entries 6–9) giving generally good results. However, the Ciba-Geigy reagent (entry 10)
was unsatisfactory. The acetal moiety is acid sensitive and this result may point out to the
presence of acidic species along the reaction coordinates. The rather special H-phosphinate DOPO
(6H-dibenzo[c,e][1,2λ5]oxaphosphinine 6-oxide) [7] gave an excellent yield of product (entry 11).
Other types of phosphinylidene were tested: diethyl H-phosphonate and diphenyl phosphine oxide
both afforded the desired products in excellent yields (entries 12–13).
Table 2. Allylation of various phosphinylidene compounds with cinnamyl alcohol.
Entry R1 R2 Isolated Yield (%) a
1 Ph OBu 99
2 Ph OCy 91
3 Ph OBn 77
4 Oct OCy 87
5 PhCH=CHCH2 (Cin) OBu 100
6 4-MeOC6H4CH2CH2 OBu 70
7 PhtNCH2CH2 OBu 100
8 AcOCH2 OBu 77
9 HOCH2 OMen b,c 91
10 MeC(OEt)2 OEt 47 d,e
11 DOPO f 96
12 OEt OEt 94
13 Ph Ph 92
a Isolated yield after column chromatography over silica gel. Unless otherwise noted, the palladium salt is
Pd2(dba)3 (1 mol %); b Men, (−)-menthyl; c 50:50 diastereoisomeric mixture; d Pd(OAc)2 (2 mol %) was used;
e 31P-NMR yield; f DOPO, 6H-dibenzo[c,e][1,2λ5]oxaphosphinine 6-oxide.
Whereas the cinnamyl moiety is a versatile functional group and its introduction appears quite
general (Table 2), we next examined other allylic alcohols as well as benzylic alcohols. The results are
gathered in Table 3.
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Reactions with the simple allyl alcohol (2 equiv.) gave excellent results (>90% isolated
yield) as shown in entries 1–3. The 2-methyl substituted version of cinnamyl alcohol,
2-methyl-3-phenyl-2-propen-1-ol (1 equiv.) also gave satisfactory results (entries 4–5). Methallyl
alcohol, on the other hand, gave only a moderate yield of product (entry 6), but this result was
not unexpected, as this alcohol also had given poor results with HPA [3]. Myrtenol also reacted
successfully (entry 7). Next, the benzylation was investigated (entries 8–11) and products were
obtained in moderate to good yields. Unfortunately, some other combinations of reactants did not
afford the desired product in acceptable yields (for example: entries 12–14), thereby showing some
limitations in scope. Electron-rich furfuryl alcohol (entry 12) may lead to slow oxidative-addition
and an overall inefficient transformation. Acid sensitivity may become an issue: while this alcohol
was successful with hypophosphorous acid [5], the more difficult the desired reaction, the more side
reactions will be competing. Perhaps for a similar reason, none of the secondary allylic alcohols we
tried reacted successfully. In entry 13, transesterification of the benzyl ester is a greater problem than it
was in entry 8 because the reaction is slower than with cinnamyl alcohol (Table 2, entry 4). Similarly,
diethyl H-phosphonate, which reacted satisfactorily with cinnamyl alcohol (Table 2, entry 12) also gave
little product with benzyl alcohol (entry 14). Thus, marginal results are obtained when the reaction
is slowed due to any of the following parameters (or combinations): less reactive allylic/benzylic
electrophile (aromatics, of course, being much less reactive than alkenes), unfavorable tautomerization
profile [7], transesterification of the phosphorus ester, or acid sensitivity of a reactant.
Although the scope of this reaction seems more limited than the corresponding reaction
of phosphinic acids, it can offer significant synthetic advantages. Since disubstituted phosphinic
acids cannot be esterified easily through Fischer-like reactions with azeotropic water-removal [8,9],
formation of their esters requires prior activation of the acid (P(O)OH to P(O)LVG + ROH, P(O)OH to
P(O)(OAg) + RX, where LVG is a leaving group and RX an alkyl halide) or a diazoalkane. Therefore,
the intermediacy of disubstituted phosphinic acids implies atom-wasteful procedures (Scheme 2).
On the other hand, H-phosphinic acids can be esterified easily with an alcohol and, therefore,
the resulting synthetic sequence is more convenient and environmentally friendly (Scheme 2).
 
Scheme 2. H-phosphinic acids versus H-phosphinic esters.1 SOCl2 then ROH; carbodiimide + ROH;
RCHN2; R1COCl then ROH; Ag2O then alkyl halide (RX), etc.
An illustrative example is shown in Scheme 3 for the preparation of 3-phospholenic esters.
The “classic” approach is illustrated by Miokowski’s work (Scheme 3a) [10]. The double allylation of
bis-(trimethylsiloxy)phosphine afforded the symmetrical phosphinic acid. Subsequent esterification via
P(O)Cl then provided the benzyl ester, which was converted to the phospholene ester by ring-closing
metathesis (RCM). It should be noted that the attempted RCM reaction of diallylphosphinic acid failed
completely. The overall sequence produced the phospholene in 31% isolated yield.
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Scheme 3. Comparison of methods for the synthesis of 3-phospholenic esters. HMDS:
hexamethyldisilazane; IMes: 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene.
Next, our allylation methodology was used to produce bis(cinnamyl)phosphinic acid in
quantitative yield [4]. Silver-promoted esterification gave the corresponding benzyl ester in 77%
yield. Ring-closing metathesis afforded the desired heterocycle in 51% isolated yield. The moderate
yield of this reaction may be attributed to the fact that both alkenes are substituted. In spite of this,
the overall sequence gave the phospholene derivative in 39% yield.
Cinnamyl-H-phosphinic acid is easily synthesized, as we reported [11]. Low loading of Pd
(0.5 mol %) can be employed to still deliver a very high 95% yield (Scheme 2c) [3]. Esterification with
n-butanol under Dean-Stark conditions proceeded in 96% yield. The present allylation reaction (Table 3,
entry 3) gave the disubstituted ester in 91% yield (Scheme 2c, in box). Subsequent RCM afforded the
phospholene in 85% yield. Overall, the sequence in Scheme 3c produced the phospholene derivative
in four steps and 70% overall yield, through catalytic reactions and with only water as the byproduct.
An alternative using our silicate esterification [9] directly gives butyl cinnamyl-H-phosphinate from
cinnamyl alcohol in 98% isolated yield [6]. Using this sequence, the phospholenic acid is still produced
inexpensively in an outstanding 76% overall yield.
In addition to the advantages of Dean-Stark processes over the use of wasteful stoichiometric
reagents, the present allylation of H-phosphinate esters can offer unique opportunities. For example
(Scheme 4), the cinnamylation of optically-active menthyl hydroxymethyl-H-phosphinate proceeds
with complete stereoselectivity in a nearly quantitative isolated yield [12].
Scheme 4. Stereospecific cinnamylation. Men: (−)-menthyl.
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Mechanistically, the present reaction must proceed through a pathway different from the one we
have proposed for the allylation of phosphinic acids [6]. Scheme 5 shows a proposed mechanism for
the Pd-catalyzed allylation/benzylation of H-phosphinate esters.
 
Scheme 5. Proposed Mechanisms for the allylation of H-phosphinate esters (top) and phosphinic
acids (bottom).
The key difference between the two mechanisms (Scheme 5) is in the order of tautomerization
and esterification. H-phosphinic esters are not esterified to the P(III) phosphonite under Dean-Stark
conditions. Furthermore, while transesterification is possible in principle, this reaction is inefficient
(in the absence of catalysts, particularly bases) and very difficult on esters like cyclohexyl. This would
also result in the formation of disubstituted phosphinic acids. The fact that the reaction takes place
with Pd(0) complexes but not with Pd(II) (Table 1) also points to a mechanism in which Lewis acidity
is not key. Given those facts and some of the limitations in the scope discussed earlier, we propose the
following (Scheme 5, top): the H-phosphinate ester must tautomerize to the P(III) form, which can then
act as a ligand to the Pd(0) catalyst. The resulting putative intermediate would be sufficiently acidic to
undergo Fischer-like esterification (with water being removed azeotropically). The esterification of the
phosphinite-Pd complex would be a key step. The resulting Pd complex of the mixed phosphonite
ester would then undergo oxidative addition (allylO to allylPd migration) to produce the classic Pd(II)
intermediate in the Tsuji-Trost reaction. Subsequent formation of a π-allyl complex and attack of the
phosphorus nucleophile would afford the allylated product with concomitant reductive elimination to
regenerate the Pd(0) catalyst.
In the case of phosphinic acids (HPA or H-phosphinic, Scheme 5, bottom), first esterification
to produce the allyl ester takes place in a well-established process. Tautomerization of the
allyl-H-phosphinate ester leads to a phosphonite, which then complexes the Pd(0). Oxidative addition
in this complex produces the same type of Pd(II) intermediate (R = H). The mechanism of phosphinic
acid allylation (Scheme 5, bottom) is fully consistent with all our prior results [6]. Overall, the success
or failure of the allylation depends on various parameters, like the tautomeric equilibrium of the
phosphinylidene species, the nucleophilicity of the P(III) tautomer to complex the Pd, and the reactivity
of the allylic/benzylic moiety towards oxidative addition.
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3. Materials and Methods
3.1. General Procedure for the Allylation/Benzylation of H-Phosphinates and Related Compounds
To a solution of the appropriate H-phosphinate ester (1 equiv.) in t-amyl alcohol (10 mL),
tris(dibenzylideneacetone)dipalladium(0) Pd2(dba)3 (1 mol %), Xantphos (2 mol %), and the
corresponding alcohol (1 equiv.) were added. The reaction mixture was stirred at reflux for 24 h
under N2 in a flask equipped with a Dean-Stark trap. After cooling down the reaction to room
temperature (rt), the solvent was removed under vacuum and the residue obtained was purified by
column chromatography on silica gel using a mixture of hexane/ethyl acetate to afford the different
products. The NMR spectra of the products can be found in the Supplementary Materials.
Butyl cinnamyl phenylphosphinate (Table 2, Entry 1) [13]. General procedure was used with cinnamyl
alcohol (0.13 mL, 1 mmol, 1 equiv.) and butyl phenyl-H-phosphinate (198 mg, 1 mmol, 1 equiv.).
The crude obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to
afford the product as a yellow oil (310 mg, 99%). 31P-NMR (CDCl3, 162 MHz) δ = 39.1 (s); 1H-NMR
(CDCl3, 400 MHz) δ = 7.73–7.80 (m, 2H), 7.47–7.54 (m, 1H), 7.40–7.46 (m, 2H), 7.21–7.27 (m, 4H),
7.14–7.20 (m, 1H), 6.33 (dd, J = 5.0 and 15.8 Hz, 1H), 6.04–6.15 (m, 1H), 3.93 (dm, J = 95 Hz, 2H), 2.89
(dd, J = 7.6 and 18.5 Hz, 2H), 1.63 (quint., J = 6.8 Hz, 2H), 1.37 (dsextuplet, J = 1.7 and 7.5 Hz, 2H), 0.87
(t, J = 7.4 Hz, 3H).
Cyclohexyl cinnamyl phenylphosphinate (Table 2, Entry 2). General procedure was used with cinnamyl
alcohol (0.13 mL, 1 mmol, 1 equiv.) and cyclohexyl phenyl-H-phosphinate (224 mg, 1 mmol, 1 equiv.).
The crude obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to
afford the product as a yellow oil (311 mg, 91%). 31P-NMR (CDCl3, 162 MHz) δ = 37.7 (s); 1H-NMR
(CDCl3, 400 MHz) δ = 7.76–7.84 (m, 2H), 7.49–7.55 (m, 1H), 7.41–7.47 (m, 2H), 7.23–7.30 (m, 4H),
7.16–7.22 (m, 1H), 6.35 (dd, J = 5.0 and 15.8 Hz, 1H), 6.06–6.17 (m, 1H), 4.30–4.41 (m, 1H), 2.89
(ddd, J = 1.0, 7.6 and 18.4 Hz, 2H), 1.97–2.07 (m, 1H), 1.57–1.79 (m, 4H), 1.39–1.52 (m, 2H), 1.15–1.36
(m, 3H); 13C-NMR (101 MHz, CDCl3): δ = 137.0 (d, JPCCCC = 3.3 Hz), 134.9 (d, JPCC = 13.2 Hz),
132.2 (d, JPCCCC = 2.7 Hz), 131.7 (d, JPCCC = 9.6 Hz, 2C), 131.5 (d, JPC = 128 Hz), 128.5 (2C), 128.4
(d, JPCC = 12.5 Hz, 2C), 127.4, 126.1, 126.1, 118.9 (d, JPCCC = 10.3 Hz), 74.7 (d, JPOC = 6.9 Hz), 35.9
(d, JPC = 97.3 Hz), 34.2 (d, JPOCC = 2.9 Hz), 33.7 (d, JPOC = 4.1 Hz), 25.1, 23.6, 23.6; HRMS (EI+) m/z
calcd for C21H26O2P ([M + H]+) 341.1665, found 341.1675.
Benzyl cinnamyl phenylphosphinate (Table 2, Entry 3). General procedure was used with cinnamyl alcohol
(0.13 mL, 1 mmol, 1 equiv.) and benzyl phenyl-H-phosphinate (232 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford the
product as an orange oil (248 mg, 71%). 31P-NMR (CDCl3, 162 MHz) δ = 41.4 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.80–7.87 (m, 2H), 7.54–7.60 (m, 1H), 7.45–7.52 (m, 2H), 7.31–7.40 (m, 5H), 7.26–7.31
(m, 4H), 7.20–7.25 (m, 1H), 6.38 (dd, J = 5.2 and 15.9 Hz, 1H), 6.08–6.19 (m, 1H), 5.18 (dd, J = 7.3 and
11.8 Hz, 1H), 4.88 (dd, J = 7.2 and 11.8 Hz, 1H), 2.99 (dd, J = 7.6 and 18.7 Hz, 2H); 13C-NMR (101 MHz,
CDCl3): δ = 136.9 (d, JPCCCC = 3.5 Hz), 136.4 (d, JPOCC = 6.8 Hz), 135.3 (d, JPCC = 13.3 Hz), 132.6
(d, JPCCCC = 2.5 Hz), 131.9 (d, JPCCC = 9.7 Hz, 2C), 130.1 (d, JPC = 125 Hz), 128.7 (d, JPCC = 12.3 Hz,
2C), 128.6 (2C), 128.5 (2C), 128.4, 127.9 (2C), 127.6, 126.3, 126.2, 118.4 (d, JPCCC = 10.4 Hz), 66.3
(d, JPOC = 6.4 Hz), 35.3 (d, JPC = 96.3 Hz); HRMS (EI+) m/z calcd for C22H22O2P ([M + H]+) 349.1357,
found 349.1379.
Cyclohexyl cinnamyl octylphosphinate (Table 2, Entry 4). General procedure was used with cinnamyl
alcohol (0.13 mL, 1 mmol, 1 equiv.) and cyclohexyl octyl-H-phosphinate (260 mg, 1 mmol, 1 equiv.).
The crude obtained was purified by column chromatography (hexane/ethyl acetate 50:50 to 0:100) to
afford the product as an orange oil (328 mg, 87%). 31P-NMR (CDCl3, 162 MHz) δ = 51.6 (s); 1H-NMR
(CDCl3, 400 MHz) δ = 7.24–7.35 (m, 4H), 7.16–7.22 (m, 1H), 6.47 (dd, J = 4.5 and 15.8 Hz, 1H), 6.10–6.22
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(m, 1H), 4.34–4.46 (m, 1H), 2.71 (dd, J = 7.7 and 17.3 Hz, 2H), 1.83–1.94 (m, 2H), 1.42–1.75 (m, 8H),
1.15–1.37 (m, 14 H), 0.84 (t, J = 6.8 Hz, 3 H); 13C-NMR (101 MHz, CDCl3): δ = 136.8 (d, JPCCCC = 3.0 Hz),
134.4 (d, JPCC = 12.6 Hz), 128.5 (2C), 127.5, 126.1, 126.1, 119.7 (d, JPCCC = 9.4 Hz), 73.7 (d, JPOC = 7.0 Hz),
34.6 (d, JPC = 82.2 Hz), 34.2 (d, JPOCC = 5.6 Hz), 34.1, 31.8, 30.8 (d, JPCC = 15.1 Hz), 29.0, 29.0, 28.3 (d,
JPC = 93.1 Hz), 25.2, 23.7 (2C), 22.6, 21.6 (d, JPCCC = 4.2 Hz), 14.1; HRMS (EI+) m/z calcd for C23H38O2P
([M + H]+) 377.2609, found 377.2531.
Butyl bis cinnamylphosphinate (Table 2, Entry 5). General procedure was used with cinnamyl alcohol
(0.13 mL, 1 mmol, 1 equiv.) and butyl cinnamyl-H-phosphinate (238 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 50:50 to 0:100) to afford the
product as an orange oil (354 mg, 100%). 31P-NMR (CDCl3, 162 MHz) δ = 49.9 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.21–7.33 (m, 8H), 7.14–7.20 (m, 2H), 6.45 (dd, J = 4.6 and 15.8 Hz, 2H), 6.11–6.22 (m,
2H), 4.02 (dt, J = 6.8 and 7.0 Hz, 2H), 2.73 (dd, J = 7.6 and 17.5 Hz, 4H), 1.61 (quint., J = 7.2 Hz, 2H),
1.36 (sextuplet, J = 7.5 Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 136.7 (d,
JPCCCC = 3.0 Hz, 2C), 135.0 (d, JPCC = 13.1 Hz, 2C), 128.6 (4C), 127.7 (2C), 126.2 (2C), 126.2 (2C), 118.9
(d, JPCCC = 9.6 Hz, 2C), 64.6 (d, JPOC = 7.2 Hz), 33.3 (d, JPC = 88.7 Hz, 2C), 32.8 (d, JPOCC = 5.6 Hz), 18.8,
13.7; HRMS (EI+) m/z calcd for C22H28O2P ([M + H]+) 355.1827, found 355.1831.
Butyl 2-[(4-methoxyphenyl)ethyl] cinnamylphosphinate (Table 2, Entry 6). General procedure was used with
cinnamyl alcohol (0.13 mL, 1 mmol, 1 equiv.) and butyl 2-[4-methoxyphenyl)ethyl]-H-phosphinate
(256 mg, 1 mmol, 1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl
acetate 100:0 to 0:100) to afford the product as an orange oil (261 mg, 70%). 31P-NMR (CDCl3, 162 MHz)
δ = 52.3 (s); 1H-NMR (CDCl3, 400 MHz) δ = 7.29–7.38 (m, 4H), 7.22–7.28 (m, 1H), 7.10–7.15 (m, 2H),
6.81–6.87 (m, 2H), 6.45 (dd, J = 4.6 and 15.8 Hz, 1H), 6.11–6.22 (m, 1H), 4.06 (dt, J = 6.6 and 6.7 Hz, 2H),
3.78 (s, 3H), 2.83–2.99 (m, 2H), 2.73 (ddd, J = 0.7, 7.2 and 16.8 Hz, 2H), 2.01–2.12 (m, 2H), 1.68 (quint.,
J = 7.5 Hz, 2H), 1.43 (sextuplet, J = 7.5 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3):
δ = 158.2, 136.7 (d, JPCCCC = 3.2 Hz), 134.8 (d, JPCCC = 12.9 Hz), 133.0 (d, JPCC = 14.6 Hz), 129.1 (2C),
128.6 (2C), 127.7, 126.2, 126.2, 119.1 (d, JPCCC = 9.4 Hz, 2C), 114.0 (2C), 64.4 (d, JPOC = 7.0 Hz), 55.3, 34.0
(d, JPC = 86.0 Hz), 32.8 (d, JPOCC = 5.7 Hz), 29.7 (d, JPC = 90.4 Hz), 27.0 (d, JPCC = 3.5 Hz), 18.9, 13.7;
HRMS (EI+) m/z calcd for C22H29O3P ([M + H]+) 373.1933, found 373.1855.
Butyl (2-ethylphthalimide) cinnamylphosphinate (Table 2, Entry 7). General procedure was used with
cinnamyl alcohol (1.7 mL, 12.94 mmol, 1 equiv.) and butyl (2-ethylphthalimide)-H-phosphinate
(3.3 g, 12.94 mmol, 1 equiv.). The crude obtained was purified by column chromatography
(dichloromethane/acetone 100:0 to 90:10) to afford the product as an orange oil (4.87 g, 100%).
31P-NMR (CDCl3, 162 MHz) δ = 49.1 (s); 1H-NMR (CDCl3, 400 MHz) δ = 7.82–7.90 (m, 2H), 7.68–7.75
(m, 2H), 7.20–7.44 (m, 5H), 6.62 (dd, J = 4.7 and 15.8 Hz, 1H), 6.16–6.27 (m, 1H), 3.95–4.12 (m, 4H),
2.88 (dd, J = 7.5 and 17.5 Hz, 2H), 2.17–2.34 (m, 2H), 1.58 (quint., J = 7.1 Hz, 2H), 1.35 (sextuplet,
J = 7.4 Hz, 2H), 0.89 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 167.8 (2C), 136.6 (d,
JPCCCC = 3.2 Hz), 135.3 (d, JPCC = 13.1 Hz), 134.1 (2C), 132.0 (2C), 128.6 (2C), 127.7, 126.3, 126.3, 123.4
(2C), 118.5 (d, JPCCC = 9.6 Hz), 64.6 (d, JPOC = 7.0 Hz), 33.7 (d, JPC = 88.4 Hz), 32.6 (d, JPCC = 5.9 Hz),
31.7, 26.5 (d, JPC = 89.7 Hz), 18.8, 13.6; HRMS (EI+) m/z calcd for C23H27NO4P ([M + H]+) 412.1678,
found 412.1676.
Butyl (acetoxymethyl) cinnamylphosphinate (Table 2, Entry 8). General procedure was used with cinnamyl
alcohol (0.13 mL, 1 mmol, 1 equiv.) and butyl (acetoxymethyl)-H-phosphinate (194 mg, 1 mmol,
1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to
0:100) to afford the product as an orange oil (239 mg, 77%). 31P-NMR (CDCl3, 162 MHz) δ = 43.6 (s);
1H-NMR (CDCl3, 400 MHz) δ = 7.27–7.32 (m, 2H), 7.21–7.27 (m, 2H), 7.14–7.20 (m, 1H), 6.50 (dd, J = 5.0
and 15.9 Hz, 1H), 6.06–6.17 (m, 1H), 4.43 (dd, J = 7.8 and 14.5 Hz, 1H), 4.27 (dd, J = 4.2 and 14.5 Hz, 1H),
4.03 (dm, J = 39.6 Hz, 2H), 2.79 (ddd, J = 1.0, 7.7 and 18.5 Hz, 2H), 2.03 (s, 3H), 1.60 (quint., J = 7.5 Hz,
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2H), 1.34 (sextuplet, J = 7.5 Hz, 2H), 0.86 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 170.0
(d, JPCOC = 6.8 Hz), 136.5 (d, JPCCCC = 3.5 Hz), 135.5 (d, JPCC = 13.3 Hz), 128.6 (2C), 127.8, 126.3, 126.2,
117.5 (d, JPCCC = 10.2 Hz), 65.2 (d, JPOC = 6.9 Hz), 57.9 (d, JPC = 108 Hz), 32.6 (d, JPOCC = 5.8 Hz), 32.5 (d,
JPC = 93.1 Hz), 20.5 (d, JPOCCC = 8.8 Hz), 18.7, 13.6; HRMS (EI+) m/z calcd for C16H24O4P ([M + H]+)
311.1407, found 311.1401.
(Rp)/(Sp)-Menthyl cinnamyl(hydroxymethyl)phosphinate (Table 2, Entry 9) [14]. To a solution of
(Rp)/(Sp)-menthyl (hydroxymethyl)-H-phosphinate (2.34 g, 10 mmol, 1 equiv, 56:44 diastereoisomeric
ratio) in t-amyl alcohol (30 mL), Pd2(dba)3 (92 mg, 0.1 mmol, 1 mol %), Xantphos (116 mg, 0.2 mmol,
2 mol %), and cinnamyl alcohol (1.3 mL, 10 mmol, 1 equiv.) were added. The reaction mixture was
stirred at reflux for 20 h under N2 in a flask equipped with a Dean-Stark trap. After cooling down
the reaction to rt, the solvent was removed under vacuum and the residue obtained was purified by
column chromatography (dichloromethane/acetone 100:0 to 90:10) to afford the product as a white
solid (3.19 g, 91%, 56:44 diastereoisomeric ratio). 31P-NMR (162 MHz, CDCl3): δ = 48.4 (s, 56%) and
48.1 (s, 44%).
6-(Cinnamyl)-6H-dibenzo[c,e][1,2λ5]oxaphosphinine-6-oxide (Table 2, Entry 11). General procedure was
used with cinnamyl alcohol (0.13 mL, 1 mmol, 1 equiv.) and DOPO (216 mg, 1 mmol, 1 equiv.).
The crude obtained was purified by column chromatography (hexane/ethyl acetate 50:50 to 0:100) to
afford the product as a yellow solid (318 mg, 96%). 31P-NMR (CDCl3, 162 MHz) δ = 27.4 (s); 1H-NMR
(CDCl3, 400 MHz) δ = 7.89–7.99 (m, 2H), 7.68–7.74 (m, 1H), 7.49–7.55 (m, 1H), 7.36–7.42 (m, 1H),
7.22–7.30 (m, 6H), 7.16–7.21 (m, 2H), 6.35 (dd, J = 5.3 and 15.8 Hz, 1H), 6.02–6.13 (m, 1H), 3.08 (ddt,
J = 1.3, 7.6 and 18.2 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ = 149.6 (d, JPOC = 8.2 Hz), 136.5 (d,
JPCCCC = 3.6 Hz), 135.9 (d, JPCCC = 6.1 Hz), 135.8 (d, JPCC = 13.8 Hz), 133.4 (d, JPCCCC = 2.3 Hz), 130.7,
130.5 (d, JPCCC = 10.2 Hz), 128.5 (2C), 128.4 (d, JPCC = 13.0 Hz), 127.7 (d, JPCCCC = 2.2 Hz), 126.2, 126.2,
125.2, 124.6, 124.2 (d, JPC = 120 Hz), 123.8 (d, JPCCC = 9.6 Hz), 122.3 (d, JPCCC = 10.5 Hz), 120.4 (d,
JPCCC = 6.3 Hz), 117.2 (d, JPCC = 11.0 Hz), 34.5 (d, JPC = 93.8 Hz); HRMS (EI+) m/z calcd for C21H18O2P
([M + H]+) 333.1039, found 333.1048.
Diethyl cinnamylphosphonate (Table 2, Entry 12) [15]. General procedure was used with cinnamyl alcohol
(0.13 mL, 1 mmol, 1 equiv.) and diethylphosphite (138 mg, 1 mmol, 1 equiv.). The crude obtained
was purified by column chromatography (hexane/ethyl acetate 50:50 to 0:100) to afford the product
as an orange oil (240 mg, 94%). 31P-NMR (CDCl3, 162 MHz) δ = 34.8 (s); 1H-NMR (CDCl3, 400 MHz)
δ = 7.34–7.40 (m, 2H), 7.28–7.34 (m, 2H), 7.21–7.26 (m, 1H), 6.53 (dd, J = 5.1 and 15.8 Hz, 1H), 6.12–6.23
(m, 1H), 4.08–4.18 (m, 4H), 2.76 (dd, J = 7.6 and 22.2 Hz, 2H), 1.32 (t, J = 6.1 Hz, 6H).
Cinnamyl diphenylphosphine oxide (Table 2, Entry 13) [16]. General procedure was used with cinnamyl
alcohol (0.13 mL, 1 mmol, 1 equiv.) and diphenyl phosphine oxide (202 mg, 1 mmol, 1 equiv.).
The crude obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to
afford the product as a yellow oil (292 mg, 92%). 31P-NMR (CDCl3, 162 MHz) δ = 28.9 (s); 1H-NMR
(CDCl3, 400 MHz) δ = 7.75–7.82 (m, 4H), 7.46–7.58 (m, 6H), 7.18–7.29 (m, 5H), 6.44 (dd, J = 4.5 and
15.8 Hz, 1H), 6.14–6.25 (m, 1H), 3.31 (ddd, J = 1.2, 7.5 and 15.0 Hz, 2H).
Butyl allyl phenylphosphinate (Table 3, Entry 1) [17]. General procedure was used with allyl alcohol
(0.13 mL, 2 mmol, 2 equiv.) and butyl phenyl-H-phosphinate (198 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford the
product as a yellow oil (234 mg, 98%). 31P-NMR (CDCl3, 162 MHz) δ = 35.1 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.66–7.75 (m, 2H), 7.45–7.51 (m, 1H), 7.36–7.43 (m, 2H), 5.61–5.75 (m, 1H), 4.95–5.09 (m,
1H), 3.93–4.03 (m, 1H), 3.69–3.80 (m, 1H), 3.31 (dd, J = 7.0 and 18.5 Hz, 2H), 1.58 (quint., J = 7.1 Hz, 2H),
1.32 (sextuplet, J = 1.9 and 7.4 Hz, 2H), 0.83 (t, J = 7.4 Hz, 3H).
292
Molecules 2016, 21, 1295
Cyclohexyl allyl phenylphosphinate (Table 3, Entry 2). General procedure was used with allyl alcohol
(0.13 mL, 2 mmol, 2 equiv.) and cyclohexyl phenyl-H-phosphinate (224 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford
the product as an orange oil (247 mg, 94%). 31P-NMR (CDCl3, 162 MHz) δ = 37.7 (s); 1H-NMR
(CDCl3, 400 MHz) δ = 7.70–7.79 (m, 2H), 7.46–7.52 (m, 1H), 7.38–7.45 (m, 2H), 5.64–5.78 (m, 1H),
4.97–5.11 (m, 2H), 4.22–4.33 (m, 1H), 2.65–2.76 (m, 2H), 1.92–2.02 (m, 1H), 1.51–1.75 (m, 4H), 1.34–1.47
(m, 2H), 1.12–1.32 (m, 3H); 13C-NMR (101 MHz, CDCl3): δ = 132.1 (d, JPCCCC = 2.7 Hz), 131.7 (d,
JPCCC = 9.6 Hz, 2C), 131.4 (d, JPC = 126 Hz), 128.3 (d, JPCC = 12.5 Hz, 2C), 127.4 (d, JPCCC = 9.2 Hz),
120.1 (d, JPCC = 13.0 Hz), 74.6 (d, JPOC = 6.9 Hz), 36.6 (d, JPC = 97.5 Hz), 34.2 (d, JPOCC = 3.1 Hz),
33.7 (d, JPOCC = 4.3 Hz), 25.1, 23.6, 23.6; HRMS (EI+) m/z calcd for C15H22O2P ([M + H]+) 265.1352,
found 265.1359.
Butyl allyl cinnamylphosphinate (Table 3, Entry 3) [6]. General procedure was used with allyl alcohol
(0.15 mL, 2 mmol, 2 equiv.) and butyl cinnamyl-H-phosphinate (238 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford the
product as an orange oil (254 mg, 91%). 31P-NMR (CDCl3, 162 MHz) δ = 48.0 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.23–7.34 (m, 4H), 7.15–7.21 (m, 1H), 6.46 (dd, J = 4.7 and 15.8 Hz, 1H), 6.08–6.19 (m,
1H), 5.72–5.86 (m, 1H), 5.14–5.23 (m, 2H), 4.00 (dt, J = 6.8 and 6.9 Hz, 2H), 2.72 (ddd, J = 0.7, 7.6 and
17.6 Hz, 2H), 2.60 (dd, J = 7.5 and 17.2 Hz, 2H), 1.60 (quint., J = 7.1 Hz, 2H), 1.35 (sextuplet, J = 7.5 Hz,
2H), 0.88 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 136.7 (d, JPCCCC = 3.3 Hz), 135.0 (d,
JPCC = 12.9 Hz), 128.6 (2C), 127.7 (d, JPCCC = 8.0 Hz), 127.6, 126.2, 126.1, 120.3 (d, JPCC = 12.6 Hz), 118.8
(d, JPCCC = 9.6 Hz), 64.5 (d, JPOC = 7.2 Hz), 33.8 (d, JPC = 88.7 Hz), 32.9 (d, JPC = 89.0 Hz), 32.7 (d,
JPOCC = 5.7 Hz), 18.8, 13.6.
Cyclohexyl 3-[(2-methyl-2-propene)phenyl] phenylphosphinate (Table 3, Entry 4). General procedure
was used with trans-2-methyl-3-phenyl-2-propen-1-ol (0.15 mL, 1 mmol, 1 equiv.) and cyclohexyl
phenyl-H-phosphinate (224 mg, 1 mmol, 1 equiv.). The crude obtained was purified by column
chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford the product as an orange oil (330 mg,
93%). 31P-NMR (CDCl3, 162 MHz) δ = 39.5 (s); 1H-NMR (CDCl3, 400 MHz) δ = 7.77–7.85 (m, 2H),
7.48–7.54 (m, 1H), 7.40–7.47 (m, 2H), 7.22–7.29 (m, 2H), 7.11–7.17 (m, 1H), 7.03–7.09 (m, 2H), 6.09 (d,
J = 5.5 Hz, 1H), 4.29–4.40 (m, 1H), 2.76–2.91 (m, 2H), 1.98–2.07 (m, 1H), 1.92 (dd, J = 1.3 and 3.5 Hz,
3H), 1.59–1.79 (m, 4H), 1.39–1.49 (m, 2H), 1.17–1.36 (m, 3H); 13C-NMR (101 MHz, CDCl3): δ = 137.8 (d,
JPCCCC = 3.7 Hz), 132.1 (d, JPCCCC = 2.7 Hz), 131.9 (d, JPCCC = 9.5 Hz, 2C), 131.6 (d, JPC = 125 Hz), 130.0
(d, JPCC = 11.5 Hz), 129.3 (d, JPCCC = 10.3 Hz), 128.7 (d, JPCCCCC = 2.9 Hz, 2C), 128.3 (d, JPCC = 12.4 Hz,
2C), 128.0 (2C), 126.3, 74.7 (d, JPOC = 7.0 Hz), 42.8 (d, JPC = 95.2 Hz), 34.3 (d, JPOCC = 2.9 Hz), 33.7
(d, JPOCC = 4.3 Hz), 25.2, 23.6 (2C), 19.5 (d, JCCC = 2.1 Hz); HRMS (EI+) m/z calcd for C22H28O2P
([M + H]+) 355.1827, found 355.1849.
Butyl 3-[(2-methyl-2-propene)phenyl] cinnamylphosphinate (Table 3, Entry 5). General procedure
was used with trans-2-methyl-3-phenyl-2-propen-1-ol (0.15 mL, 1 mmol, 1 equiv.) and butyl
cinnamyl-H-phosphinate (238 mg, 1 mmol, 1 equiv.). The crude obtained was purified by column
chromatography (hexane/ethyl acetate 50:50 to 0:100) to afford the product as an orange oil (283 mg,
77%). 31P-NMR (CDCl3, 162 MHz) δ = 48.2 (s); 1H-NMR (CDCl3, 400 MHz) δ = 7.19–7.38 (m, 10H),
6.54 (dd, J = 4.4 and 15.8 Hz, 1H), 6.43 (d, J = 4.8 Hz, 1H), 6.19–6.30 (m, 1H), 4.10 (dt, J = 6.7 and
6.8 Hz, 2H), 2.84 (dd, J = 7.6 and 17.1 Hz, 2H), 2.77 (d, J = 17.3 Hz, 2H), 2.07 (d, J = 3.1 Hz, 3H), 1.68
(quint., J = 7.4 Hz, 2H), 1.42 (sextuplet, J = 7.5 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz,
CDCl3): δ = 137.5 (d, JPCCCC = 3.5 Hz), 136.8 (d, JPCCCC = 3.1 Hz), 135.0 (d, JPCC = 12.7 Hz), 129.9 (d,
JPCCC = 11.7 Hz), 129.8 (d, JPCC = 10.0 Hz), 128.9, 128.8, 128.6 (2C), 128.2 (2C), 127.7, 126.6, 126.2, 126.2,
119.2 (d, JPCCC = 9.9 Hz), 64.6 (d, JPOC = 7.2 Hz), 40.6 (d, JPC = 86.7 Hz), 33.5 (d, JPC = 88.0 Hz), 32.9 (d,
JPOCC = 5.7 Hz), 19.6 (d, JPCCC = 1.9 Hz), 18.9, 13.7; HRMS (EI+) m/z calcd for C23H30O2P ([M + H]+)
369.1983, found 369.1906.
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Butyl (2-methylprop-2-ene) cinnamylphosphinate (Table 3, Entry 6). General procedure was used with
methylallyl alcohol (0.154 mL, 1 mmol, 1 equiv.) and butyl cinnamyl-H-phosphinate (238 mg, 1 mmol,
1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl acetate 100:0
to 0:100) to afford the product as an orange oil (148 mg, 51%). 31P-NMR (CDCl3, 162 MHz) δ = 47.4
(s); 1H-NMR (CDCl3, 400 MHz) δ = 7.30–7.39 (m, 4H), 7.22–7.28 (m, 1H), 6.52 (dd, J = 4.6 and 15.8 Hz,
1H), 6.14–6.25 (m, 1H), 4.97–5.01 (m, 1H), 4.95 (d, J = 4.5 Hz, 1H), 4.06 (dt, J = 6.8 Hz, 2H), 2.81 (dd,
J = 7.6 and 17.3 Hz, 2H), 2.62 (d, J = 17.4 Hz, 2H), 1.92 (t, J = 1.2 Hz, 3H), 1.66 (quint., J = 7.5 Hz, 2H),
1.41 (sextuplet, J = 7.6 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 136.8 (d,
JPCCCC = 3.3 Hz), 136.7 (d, JPCCC = 9.0 Hz), 134.9 (d, JPCC = 13.1 Hz), 128.6 (2C), 127.6, 126.2, 126.2,
119.2 (d, JPCCC = 9.7 Hz), 115.7 (d, JPCC = 10.9 Hz), 64.6 (d, JPOC = 7.2 Hz), 37.6 (d, JPC = 87.4 Hz), 33.1
(d, JPC = 88.3 Hz), 32.8 (d, JPOCC = 5.8 Hz), 24.1 (d, JPCCC = 2.2 Hz), 18.8, 13.7; HRMS (EI+) m/z calcd
for C17H26O2P ([M + H]+) 293.1670, found 293.1693.
Butyl myrtenyl phenylphosphinate (Table 3, Entry 7). General procedure was used with myrtenol (0.17 mL,
1 mmol, 1 equiv.) and butyl phenyl-H-phosphinate (198 mg, 1 mmol, 1 equiv.). The crude obtained
was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford the product
as an orange oil (246 mg, 74%). 31P-NMR (CDCl3, 162 MHz) δ = 40.3 (s); 1H-NMR (CDCl3, 400 MHz)
δ = 7.64–7.72 (m, 2H), 7.41–7.47 (m, 1H), 7.33–7.40 (m, 2H), 5.15–5.21 (m, 1H), 3.88–3.97 (m, 1H),
3.61–3.71 (m, 1H), 2.52–2.76 (m, 2H), 2.17–2.26 (m, 1H), 2.00–2.12 (m, 3H), 1.87–1.96 (m, 1H), 1.53
(quint., J = 7.2 Hz, 2H), 1.30 (sextuplet, J = 7.5 Hz, 2H), 1.14 (d, J = 10.4 Hz, 3H), 0.99 (dd, J = 8.7
and 20.1 Hz, 1H), 0.81 (t, J = 7.6 Hz, 3H), 0.72 (d, J = 4.0 Hz, 3H); 13C-NMR (101 MHz, CDCl3):
δ = 137.8 (d, JPCC = 10.4 Hz), 132.0 (d, JPCCCC = 2.8 Hz, 0.5C), 132.0 (d, JPCCCC = 2.8 Hz, 0.5C), 131.8
(d, JPCCC = 9.7 Hz), 131.8 (d, JPCCC = 9.8 Hz), 131.0 (d, JPC = 123 Hz), 131.0 (d, JPC = 123 Hz), 128.2
(d, JPCC = 12.3 Hz, 2C), 122.2 (d, JPCCC = 12.6 Hz, 0.5C), 122.2 (d, JPCCC = 12.6 Hz, 0.5C), 64.1 (d,
JPOC = 7.0 Hz, 0.5C), 64.0 (d, JPOC = 7.0 Hz, 0.5C), 46.9 (d, JPOCC = 2.8 Hz, 0.5C), 46.7 (d, JPOCC = 2.4 Hz,
0.5C), 40.1 (0.5C), 40.1 (0.5C), 38.7 (d, JPC = 97.6 Hz), 37.9 (d, JPCCCC = 2.2 Hz, 0.5C), 37.9 (d,
JPOCC = 2.2 Hz, 0.5C), 32.5 (0.5C), 32.5 (0.5C), 31.6 (d, JPCCCC = 2.4 Hz, 0.5C), 31.5 (d, JPCCCC = 2.0 Hz,
0.5C), 26.1 (0.5C), 26.1 (0.5C), 21.0 (0.5C), 20.9 (0.5C), 18.7, 13.6; HRMS (EI+) m/z calcd for C20H30O2P
([M + H]+) 333.1983, found 333.1906.
Cyclohexyl benzyl octylphosphinate (Table 3, Entry 8) [1]. General procedure was used with benzyl alcohol
(0.11 mL, 1 mmol, 1 equiv.) and cyclohexyl octyl-H-phosphinate (260 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 50:50 to 0:100) to afford the
product as an orange oil (226 mg, 65%). 31P-NMR (CDCl3, 162 MHz) δ = 52.1 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.22–7.37 (m, 5H), 4.30–4.42 (m, 1H), 3.13 (d, J = 16.7 Hz, 2H), 1.86–1.95 (m, 2H), 1.40–1.84
(m, 10H), 1.17–1.37 (m, 12H), 0.89 (t, J = 6.9 Hz, 3H).
Butyl benzyl cinnamylphosphinate (Table 3, Entry 9). General procedure was used with benzyl alcohol
(0.11 mL, 1 mmol, 1 equiv.) and butyl cinnamyl-H-phosphinate (238 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford the
product as an orange oil (187 mg, 57%). 31P-NMR (CDCl3, 162 MHz) δ = 48.5 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.21–7.39 (m, 10H), 6.45 (dd, J = 4.2 and 15.8 Hz, 1H), 6.08–6.20 (m, 1H), 3.93–4.07 (m, 2H),
3.20 (d, J = 16.8 Hz, 2H), 2.70 (dd, J = 7.6 and 17.2 Hz, 2H), 2.01–2.12 (m, 2H), 1.62 (quint., J = 7.3 Hz,
2H), 1.37 (sextuplet, J = 7.5 Hz, 2H), 0.91 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 136.8
(d, JPCCCC = 3.1 Hz), 135.1 (d, JPCCC = 13.0 Hz), 131.6 (d, JPCC = 7.3 Hz), 129.9 (d, JPCCC = 5.8 Hz,
2C), 128.7 (d, JPCCCC = 2.6 Hz, 2C), 128.6 (2C), 127.7, 127.0 (d, JPCCCCC = 3.0 Hz), 126.2, 126.2, 118.9
(d, JPCCC = 9.8 Hz), 64.8 (d, JPOC = 7.0 Hz), 36.0 (d, JPC = 87.1 Hz), 33.2 (d, JPC = 88.0 Hz), 32.8 (d,
JPOCC = 5.9 Hz), 27.0 (d, JPCC = 3.5 Hz), 18.8, 13.7; HRMS (EI+) m/z calcd for C20H26O2P ([M + H]+)
329.1665, found 329.1671.
Cyclohexyl 1-(naphthylmethyl) phenylphosphinate (Table 3, Entry 10). General procedure was used with
1-naphthalenemethanol (158 mg, 1 mmol, 1 equiv.) and cyclohexyl phenyl-H-phosphinate (224 mg,
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1 mmol, 1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl acetate
100:0 to 0:100) to afford the product as an orange oil (266 mg, 73%). 31P-NMR (CDCl3, 162 MHz)
δ = 35.5 (s); 1H-NMR (CDCl3, 400 MHz) δ = 7.95–8.02 (m, 1H), 7.77–7.84 (m, 1H), 7.69–7.75 (m, 1H),
7.56–7.65 (m, 2H), 7.39–7.48 (m, 3H), 7.29–7.37 (m, 3H), 7.22–7.28 (m, 1H), 4.22–4.33 (m, 1H), 3.76
(d, J = 17.8 Hz, 2H), 1.77–1.86 (m, 1H), 1.45–1.67 (m, 4H), 1.09–1.44 (m, 5H); 13C-NMR (101 MHz,
CDCl3): δ = 133.8 (d, JPCCCC = 2.1 Hz), 132.2 (d, JPCCCC = 4.3 Hz), 132.1 (d, JPCCCC = 2.2 Hz), 132.0 (d,
JPCCC = 9.5 Hz, 2C), 131.4 (d, JPC = 124 Hz), 128.6 (d, JPCCC = 6.7 Hz), 128.4, 128.4 (d, JPCC = 8.0 Hz),
128.2 (d, JPCC = 12.4 Hz, 2C), 127.5 (d, JPCCCC = 3.8 Hz), 125.7, 125.5, 125.2 (d, JPCCCC = 3.6 Hz), 124.6,
74.9 (d, JPOC = 6.8 Hz), 35.9 (d, JPC = 96.1 Hz), 34.0 (d, JPOCC = 2.6 Hz), 33.5 (d, JPOCC = 4.0 Hz), 25.1,
23.4 (2C); HRMS (EI+) m/z calcd for C22H28O2P ([M + H]+) 355.1827, found 355.1849.
Butyl (1-methylnaphthalene) cinnamylphosphinate (Table 3, Entry 11). General procedure was used with
1-naphthalenemethanol (316 mg, 2 mmol, 2 equiv.) and butyl cinnamyl-H-phosphinate (238 mg,
1 mmol, 1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl acetate
100:0 to 0:100) to afford the product as an orange oil (186 mg, 49%). 31P-NMR (CDCl3, 162 MHz)
δ = 47.5 (s); 1H-NMR (CDCl3, 400 MHz) δ = 8.09–8.14 (m, 1H), 7.85–7.90 (m, 1H), 7.76–7.82 (m, 1H),
7.49–7.58 (m, 2H), 7.42–7.48 (m, 1H), 7.29–7.36 (m, 5H), 7.23–7.29 (m, 1H), 6.40 (dd, J = 4.5 and 15.8 Hz,
1H), 6.09–6.20 (m, 1H), 3.83–4.01 (m, 2H), 3.62–3.78 (m, 2H), 2.75 (dd, J = 7.6 and 16.8 Hz, 2H), 1.51
(quint., J = 7.4 Hz, 2H), 1.27 (sextuplet, J = 7.6 Hz, 2H), 0.85 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz,
CDCl3): δ = 136.7 (d, JPCCCC = 3.1 Hz), 135.0 (d, JPCC = 12.8 Hz), 134.0 (d, JPCCCC = 2.4 Hz), 132.1
(d, JPCCC = 4.6 Hz), 128.8, 128.6 (2C), 128.5 (d, JPCCCC = 6.7 Hz), 128.1 (d, JPCC = 8.2 Hz), 127.9 (d,
JPCCCC = 3.8 Hz), 127.7, 126.2 (3C), 125.9, 125.4 (d, JPCCCC = 3.6 Hz), 124.4 (d, JPCCCCC = 1.2 Hz), 118.9
(d, JPCCC = 9.9 Hz), 64.9 (d, JPOC = 7.3 Hz), 33.7 (d, JPC = 88.2 Hz), 33.2 (d, JPC = 87.7 Hz), 32.7 (d,
JPOCC = 5.9 Hz), 18.7, 13.6; HRMS (EI+) m/z calcd for C24H28O2P ([M + H]+) 379.1827, found 379.1750.
3.2. 1-Butoxy-3-Phospholene 1-Oxide (Scheme 3c) [6]
To a solution of cinnamyl phosphinic acid [13] (3.64 g, 20 mmol, 1 equiv.) in toluene (40 mL),
1-butanol (3.7 mL, 40 mmol, 2 equiv.) was added and the reaction was stirred for 16 h at reflux
in a flask equipped with a Dean-Stark trap. After cooling down the reaction to room temperature,
the solvent was removed under vacuum. The residue obtained was dissolved in ethyl acetate and
the organic layer was washed with an aqueous saturated solution of NaHCO3 and brine, dried over
MgSO4, filtered, and concentrated under vacuum. The residue obtained was purified by column
chromatography (hexane/ethyl acetate 80:0 to 20:80) to afford butyl cinnamyl-H-phosphinate as a
yellow oil (4.59 g, 96%) [1]. 31P-NMR (CDCl3, 162 MHz) δ = 36.2 (dm, J = 543 Hz); 1H-NMR (CDCl3,
400 MHz) δ = 7.31–7.41 (m, 4H), 7.23–7.29 (m, 1H), 7.07 (dt, J = 1.9 and 543 Hz, 1H), 6.57 (dd, J = 6.0
and 15.9 Hz, 1H), 6.06–6.18 (m, 1H), 4.12–4.21 (m, 1H), 4.00–4.09 (m, 1H), 2.83 (dd, J = 7.6 and 16.8 Hz,
2H), 1.71 (quint., J = 7.1 Hz, 2H), 1.43 (sextuplet, J = 7.5 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H).
General procedure was used with allyl alcohol (0.15 mL, 2 mmol, 2 equiv.) and butyl
cinnamyl-H-phosphinate (238 mg, 1 mmol, 1 equiv.). The crude obtained was purified by column
chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford butyl allyl cinnamylphosphinate
as an orange oil (254 mg, 91%) [6]. 31P-NMR (CDCl3, 162 MHz) δ = 48.0 (s); 1H-NMR (CDCl3,
400 MHz) δ = 7.23–7.34 (m, 4H), 7.15–7.21 (m, 1H), 6.46 (dd, J = 4.7 and 15.8 Hz, 1H), 6.08–6.19 (m,
1H), 5.72–5.86 (m, 1H), 5.14–5.23 (m, 2H), 4.00 (dt, J = 6.8 and 6.9 Hz, 2H), 2.72 (ddd, J = 0.7, 7.6 and
17.6 Hz, 2H), 2.60 (dd, J = 7.5 and 17.2 Hz, 2H), 1.60 (quint., J = 7.1 Hz, 2H), 1.35 (sextuplet, J = 7.5 Hz,
2H), 0.88 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 136.7 (d, JPCCCC = 3.3 Hz), 135.0
(d, JPCC = 12.9 Hz), 128.6 (2C), 127.7 (d, JPCCC = 8.0 Hz), 127.6, 126.2, 126.1, 120.3 (d, JPCC = 12.6 Hz),
118.8 (d, JPCCC = 9.6 Hz), 64.5 (d, JPOC = 7.2 Hz), 33.8 (d, JPC = 88.7 Hz), 32.9 (d, JPC = 89.0 Hz), 32.7
(d, JPOCC = 5.7 Hz), 18.8, 13.6.
To a solution of butyl allyl cinnamylphosphinate (92 mg, 0.33 mmol, 1 equiv.) in dichloromethane
(50 mL), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene] dichloro(phenylmethylene)-
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(tricyclohexylphosphine)ruthenium (5.6 mg, 0.0066 mmol, 0.02 equiv.) was added and the mixture was
placed under N2. The reaction was heated at reflux for 12 h and then allowed to cool down to rt and
treated with activated charcoal (0.1 g). The resulting suspension was stirred for 12 h at rt, suction-filtered
through a Celite pad in a Buchner funnel, and concentrated under vacuum. The crude obtained was
purified by column chromatography (hexane/ethyl acetate 100:0 to 0:100) to afford an orange oil (48 mg,
85%). 31P-NMR (CDCl3, 162 MHz) δ = 74.2 (s); 1H-NMR (CDCl3, 400 MHz) δ = 5.91 (d, J = 33.0 Hz,
2H), 4.04 (dt, J = 6.9 and 7.0 Hz, 2H), 2.35–2.50 (m, 4H), 1.67 (quint., J = 7.1 Hz, 2H), 1.40 (sextuplet,
J = 7.5 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 127.0 (d, JPCC = 15.4 Hz, 2C), 64.7
(d, JPOC = 6.7 Hz), 32.6 (d, JPOCC = 6.0 Hz), 29.2 (d, JPC = 91.2 Hz, 2C), 18.8, 13.6.
3.3. (Rp)-Menthyl Cinnamyl(hydroxymethyl)phosphinate (Scheme 4) [14]
To a solution of (Rp)-menthyl (hydroxymethyl)-H-phosphinate (468 mg, 2 mmol, 1 equiv., >99%
diastereoisomeric excess) in t-amyl alcohol (10 mL), Pd2(dba)3 (18.3 mg, 0.02 mmol, 1 mol %), Xantphos
(23.2 mg, 0.04 mmol, 2 mol %) and cinnamyl alcohol (0.26 mL, 2 mmol, 1 equiv.) were added.
The reaction mixture was stirred at reflux for 20 h under N2 in a flask equipped with a Dean-Stark
trap. After cooling down the reaction to rt, the solvent was removed under vacuum and the residue
obtained was purified by column chromatography (dichloromethane/acetone 100:0 to 90:10) to afford
the product as a white solid (681 mg, 97%, >99% diastereoisomeric excess). Mp = 145–146 ◦C; 31P-NMR
(162 MHz, CDCl3): δ = 48.8 (s); 1H-NMR (400 MHz, CDCl3): δ = 7.19–7.39 (m, 5H), 6.55 (dd, J = 4.7
and 15.8 Hz, 1H), 6.12–6.27 (m, 1H), 4.20–4.34 (m, 1H), 3.87 (s, 2H), 3.64 (s, 1H), 2.85 (dd, J = 7.6
and 17.6 Hz, 2H), 2.06–2.22 (m, 2H), 1.60–1.71 (m, 2H), 1.28–1.54 (m, 2H), 1.15 (q, J = 11.7 Hz, 1H),
0.74–1.07 (m, 2H), 0.91 (d, J = 6.4 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H), 0.77 (d, J = 7.0 Hz, 3H); 13C-NMR
(101 MHz, CDCl3): δ = 136.8 (d, JPCCCC = 3.3 Hz), 135.0 (d, JPCC = 12.2 Hz), 128.5 (2C), 127.5, 126.2 (d,
JPCCCCC = 1.7 Hz, 2C), 118.4 (d, JPCCC = 10.5 Hz), 76.7 (d, JPOC = 8.3 Hz), 59.5 (d, JPC = 106 Hz), 48.6 (d,
JPOCC = 5.6 Hz, 2C), 43.5, 34.0, 31.6 (d, JPC = 87.3 Hz), 31.5, 25.5, 22.7, 22.1, 21.0, 15.5; HRMS (EI+) m/z
calcd for C20H31O3P ([M]+) 350.2011, found 350.2012; [α]
24
D −51.6◦ (c 1 g/100 mL, chloroform).
4. Conclusions
We have described the Pd-catalyzed allylation/benzylation of H-phosphinate esters using alcohols
as the electrophilic partner. While the scope of this reaction is somewhat narrower than when
phosphinic acids are used, it still constitutes a useful synthetic methodology for the synthesis of
disubstituted phosphinic acid derivatives. In addition, because H-phosphinate esters can be produced
easily by Dean-Stark esterification of the corresponding acids, it avoids the need for cumbersome
esterification procedures on disubstituted phosphinic acids. Therefore, when the present reaction
is successful, the sequence esterification-allylation/benzylation is superior to the reverse sequence
allylation/benzylation-esterification. A possible mechanism is also proposed.
Supplementary Materials: Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/21/
10/1295/s1.
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Abstract: Results of research into four-membered 2-halo-1,2λ5-oxaphosphetane phosphorus(V)-
heterocycles are presented. The preparation of 2-halo-1,2λ5-oxaphosphetanes by reaction
of P-haloylides with carbonyl compounds is described. The mechanism of asynchronous
[2+2]-cycloaddition of ylides to aldehydes was proposed on the base of low-temperature NMR
investigations. 2-Halo-1,2λ5-oxaphosphetanes were isolated as individual compounds and their
structures were confirmed by 1H-, 13C-, 19F- and 31P-NMR spectra. These compounds are convenient
reagents for preparing of various organic and organophosphorus compounds hardly available by
other methods. Chemical and physical properties of the 2-halo-1,2λ5-oxaphosphetanes are reviewed.
The 2-chloro-1,2λ5-oxaphosphetanes, rearrange with formation of 2-chloroalkyl-phosphonates or
convert into trans-phosphorylated alkenes depending on the substituents at the α-carbon atom.
Prospective synthetic applications of 2-halo-1,2λ5-oxaphosphetanes are analyzed. The 2-halo-
1,2λ5-oxaphosphetanes may be easily converted to various alkenylphosphonates: allyl- or
vinylphosphonates, phosphorus ketenes, thioketenes, ketenimines.
Keywords: 2-halo-1,2λ5-oxaphosphetanes; allylphosphonates; vinylphosphonates; phosphorus ketenes
1. Introduction
One of the most interesting and intriguing classes of organophosphorus compounds are the
1,2-oxaphosphetanes—four-membered heterocycles containing pentacoordinated phosphorus [1–7].
Since 1,2-oxaphosphetanes are well-known intermediates in the Wittig reaction, a number of efforts
have been made for their structural characterization both in solution and the solid state [8–13].
In 1967, Birum and Matthews had already reported the structural characterization (NMR and
X-ray study) of the first isolated 1,2-oxaphosphetane 1. Compound 1 was prepared in 76% yield








1, mp 158 oC
40-50 oC
Scheme 1. First representative of stable 1,2-oxaphosphetanes isolated by Birum and Matthews.
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Vedejs [3,4] succeeded in detecting of 1,2-oxaphosphetanes 2–4 by low temperature NMR
spectroscopy during typical Wittig reactions and observed that these intermediates readily decompose
upon warming to room temperature into alkenes and phosphine oxides (Scheme 2).
Scheme 2. 1,2-oxaphosphetanes 2–4 registered by low temperature NMR spectroscopy.
Schmutzler and co-workers reported several stabilized bis(trifluoromethylated) oxaphosphetanes
5, 6 (Scheme 3) [15] which were characterized by NMR, MS spectra and X-ray analysis. At room
temperature Berry-pseudorotation was fast on the NMR time scale, impeding one from distinguishing
apical and equatorial P-CF3 groups. Decreasing the temperature to −60 ◦C in toluene-d8 allowed
resolving the signals for all CF3 groups of molecule 7 [16].
Scheme 3. Stabilized bis(trifluoromethylated) oxaphosphetanes 5,6.
Kojima [17] reported the interesting anti-apicophilic spirophosphorane 8 bearing an oxaphosphetane
ring. The structure of compounds 8 was confirmed by X-ray diffraction. Crystallization from hexane
gave the pure anti-apicophilic derivative. Stereomutation of compound 8 was observed in the presence
of acids and slowed down when DBU was present, suggesting that the isomerization into 9 is rather
the result of a P–O bond breaking-recombination process. Evidently, this conversion represents
an example of a thermodynamically stable oxaphosphetanes, in which pseudorotation is faster than
alkene formation (Scheme 4).
Scheme 4. Stereomutation of anti-apicophilic oxaphosphetane 8.
Most of the previously reported stable oxaphosphetane structures contain fluorine-bearing
or bicyclic phosphole-type ligands either at the phosphorus position or at the 4 position in
the oxaphosphetane ring 10, 11 [15–20]. Recently, Streubel and coworkers have prepared the
first 1,2-oxaphosphetane complexes 12 formally similar to traditional oxaphosphetanes, using
low-temperature ring expansion of epoxides with a Li/Cl phosphinidenoid complex [18] (Scheme 5).
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Scheme 5. Oxaphosphetanes stabilized by CF3 groups 10,11 and 1,2-oxaphosphetane complex 12.
Gilheany studied oxaphosphetane intermediates in the Wittig reaction by variable-temperature
NMR spectroscopy [9–11]. Compound 13 was obtained by low-temperature acid quenching of the
Wittig reaction of ylide with benzaldehyde, a suitable representative aromatic aldehyde (see Scheme 6).
The major diastereomer was the syn-13 on the basis that the unquenched Wittig reaction gives the
(Z)-alkene as the major product. In this manner, the syn/anti ratio of 13 was 89:11.
Scheme 6. Stereospecific decomposition of oxaphosphetane 13.
Keglevich reported detection of enantiomers of P-stereogenic pentacoordinated phosphorus
compounds [20]. Detailed 31P-NMR investigations of oxaphosphetes in optically active solvents have
clearly shown that the most electronegative substituents (e.g., oxygen) prefers the apical position in
a trigonal bipyramidal structure and that the pentacoordinated phosphorus atom is in a dynamic
condition due to pseudorotation. Berger and coworkers found that 2-furyl groups on the phosphorus
atom increase the thermal stabilities of oxaphosphetanes and succeeded in isolation and determination
of the X-ray structure of tris(2-furyl) substituted oxaphosphetane, the stability of which is attributed to
the electron-withdrawing properties of the 2-furyl group [21].
Among the stable oxaphosphetanes [1–22], 2-halo-1,2λ5-oxaphosphetanes 14, which possess
relatively high stability and diverse reactivity, attract particular interest [23–38] (Scheme 7).
These oxaphosphetanes containing fluorine, chlorine or bromine atoms bonded to phosphorus are
an interesting class of pentacoordinated phosphorus heterocycles possessing peculiar properties.
The chemical properties of 2-halo-1,2λ5-oxaphosphetanes, first of all of P-chloro- and P-fluoroylides,
due to the presence of a labile halogen atom on phosphorus, are very specific and differ
from the properties of triphenylphosphonium ylides. For example, reactions and conversions
of 2-halo-1,2λ5-oxaphosphetanes proceed with preservation of the P-C bond and leads to the
formation of different organophosphorus compounds. In addition, this type of compounds
exhibit also physico-chemical properties uncharacteristic for traditional P,P,P-triorganosubstituted
oxaphosphetanes. For the first time the 2-halo-1,2λ5-oxaphosphetanes were prepared in our laboratory
almost twenty years ago and up to today we and some other authors are still studying their chemistry.
In this article, we summarize the synthesis and properties of this type of organophosphorus compounds.
The chemistry of 2-halo-1,2λ5-oxaphosphetanes was not previously analyzed, generalized or reviewed.
Scheme 7. Examples of stable oxaphosphetanes.
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2. Results and Discussion
2.1. General Description
Since pentacoordinated phosphoranes formally have 10 electrons in the valence shell, they display
a specific bonding model. Therefore pentacoordinated phosphoranes take a trigonal bipyramidal
structure and there are two ligating sites, apical and equatorial sites. The apical bond consists of
three-center four-electron bond using the p orbital of the central phosphorus atom, while the equatorial
bond is a typical s bond using sp2 hybrid orbital of the phosphorus atom. This three-center four-electron
bond forms three molecular orbitals.
It is generally known that pentacoordinated phosphoranes rapidly undergo intramolecular
positional isomerization without bond cleavage. A very rapid non-dissociative intramolecular site
exchange is usually explained by the Berry pseudorotation mechanism [19,22,23].
The 2-halo-1,2λ5-oxaphosphetanes (halogen = chlorine, bromine, fluorine) are the most stable
representatives of this type of compounds. They can be purified by distillation under vacuum and
stored in a refrigerator. At the same time they possess interesting chemical properties and participate
in various chemical transformations [24–28].
The stability of 2-halo-oxaphosphetanes changes in the same sequence of substituents R4 at
the endocyclic carbon atoms at position 4. The most stable are compounds containing strong
electron-accepting groups at C(4), drawing off electron density from the oxygen atom as a result
of which the three-centre apical bond O—P—Hal is strengthened. Chloro-oxaphosphetanes, having
less electron-accepting substituents at C(4), are dissociated to a large extent and correspondingly are
converted into vinylphosphine oxides at room temperature.
2.2. Synthesis of 2-Halo-1,2λ5-oxaphosphetane
Available methods for the synthesis of 2-halo-1,2λ5-oxaphosphetanes can be used for
investigation of the reaction mechanism of phosphorus ylides with carbonyl compounds as well
as for preparing stable oxaphosphetanes that can be used as reactants for organic synthesis.
The 2-halo-1,2λ5-oxaphosphetanes were prepared by reaction of P-fluoro-, chloro- or bromoylides
with carbonyl compounds. P-Chloro- and P-bromoylides react with active ketones, containing
a trifluoromethyl group, with the formation of stable [2+2]-cycloaddition products, 2-chloro- or
2-bromo-1,2λ5-oxaphosphetenes 14 were isolated in yields close to quantitative as crystalline
substances or as liquids distillable in vacuum (Scheme 8, Table 1) [29–42].
Scheme 8. Synthesis of 2-halo-1,2λ5-oxaphosphetanes. Hlg = F, Cl, Br; R1 = Alk, Ph; CR2R3 = CH2,
CHAlk, CAlk2, CHPh, CHSiMe3, CCl2, CBr2; CR4R5 = C=O, CNPh, CHAlk, CAlk2, CHPh, CPh2,
CH2CH = CH2.
The addition of P-halogen-ylides to ketones proceeded stereoselectively and led predominantly
to the formation of one of the possible 2-halo-1,2λ5-oxaphosphetane diastereomers. 2-Halo-1,2λ5-
oxaphosphetanes dissociate at the P-halogen bond in solution with the formation of cyclic
phosphonium salts, as a result of which an equilibrium is established between the forms with five-
and four-coordinate phosphorus atoms. Dissociation of 2-halo-1,2λ5-oxaphosphetanes is enhanced
by reducing the electron-accepting properties of substituents and also by increasing priority solvent.
The 2-halo-1,2λ5-oxaphosphetanes containing electron-accepting groups at C(4) are distinctly stabler
than oxaphosphetanes with alkyl groups in this position [25–27].
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The reaction of P-bromomethylides with fluorinated acetophenone afforded in high yield
oxaphosphetanes 15, which were isolated as crystalline compounds (Scheme 9 and Table 1,
entries 10–13). The compounds 15 exist in solution as cyclic phosphonium salt.
Scheme 9. Ionized form of 2-bromo-1,2λ5-oxaphosphetanes 15.
At the same time the 2-chloro-1,2λ5-oxaphosphetanes 16 exist as mixture of P(IV) and P(V)-forms.
These compounds can be distilled under vacuum and dissolved in non-polar solvents (benzene)
(Scheme 10 and Table 1, entries 1–9). Reaction of P-Fluoroylids with aldehydes and ketones proceeds
in ether or pentane at −40–−20 ◦C and leads to the formation of stable 2-fluoro-1,2λ5-oxaphosphetanes
17 (Scheme 11 and Table 2).
 
Scheme 10. P(IV) and P(V)-forms of 2-chloro-1,2λ5-oxaphosphetane 16.
 
Scheme 11. 2-Fluoro-1,2λ5-oxaphosphetane 17.
The compounds 17 are liquids distilling in vacuo, the structure of which was proved by
means of mass and NMR spectra. The 31P-NMR spectra of 2-fluoro-oxaphosphetanes 17 present
doublets with 800 Hz 1JPF constants in the high magnetic field of a NMR spectrum at −37–−8 ppm.
This corresponds to a pentacoordinate state of compounds 17 [24,26–31]. Tetracoordinated forms of
2-fluoro-oxaphosphetanes 17 were not registered by 19F- and 31P-NMR spectroscopy (Scheme 11).
C-Silyl-P-chloroylides 18 react with carbonyl compounds to afford 2-chloro-1,2λ5-
oxaphosphetanes 19. The oxaphosphetanes 19 bearing an electronegative CF3 substituent at
C-4 are relatively stable and can be isolated and analyzed by NMR (Scheme 12). The NMR spectra
of these compounds reveal signals at 0.2 ppm, singlet (Me3Si), at 2 ppm, doublet, 3JPH 18.0 Hz
(C3H), and at 4.5 ppm (C4H). 13C-NMR signals of C-3 and C-4 carbons were found at 30 and
90 ppm, correspondingly. The 31P-NMR signals of 2-chloro-1,2λ5-oxaphosphetanes 19 at δP +48 ppm
(R1 = i-PrO) and at δP = 60 ppm (R1 = Et2N) correspond to tetracoordinate phosphorus included in
four-membered phosphetane cycle (Table 1) [25,32].
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Scheme 12. Silylated 2-halogene-1,2λ5-oxaphosphetanes 19.
Table 1. 2-Chloro- and 2-bromo-1,2λ5-oxaphosphetanes.
Entry R1 R2 R3 R4 X δP δF References
1 t-Bu t-Bu H C6H4F-4 Cl + 9.0 +7.2 c (CF3); −32.9 (C6H4F) [36,42]
2 i-Pr i-Pr Ph Ph Cl +1.23; +0.53 +1.08; +1.64 [42]
3 t-Bu t-Bu H Ph Cl + 9.94 +1.0 [42]
4 t-Bu t-Bu H An-4 Cl +13.6 +7.35 c [36,42]
5 t-Bu t-Bu H CF3 Cl +0.25 6.0 [36,42]
6 t-Bu t-Bu Me Ph Cl +13.8; +11.65 +6.1 [42]
7 t-Bu Et2N H Ph Cl +5.01; +9.13 +6.06; +6.09 [42]
8 t-Bu t-Bu Me CF3 Cl +2.53 +5.38; [42]
9 t-Bu Et2N H CF3 Cl −2.6 +2.65 q; +2.94 q, 1JFF 8 [42]
10 t-Bu t-Bu H CF3 Br +24.4 +6.25 [42]
11 t-Bu t-Bu H Ph Br +46 +7.35 [42]
12 t-Bu t-Bu H C6H4F-4 Br +46 +5.6 (CF3); −34.2 (C6H4F) [42]
13 t-Bu t-Bu H An-4 Br +60 +6.1 [42]
14 t-Bu t-Bu H Ph OMe −14.6 +1.15 [42]
15 t-Bu t-Bu H Ph OPh −12.8 +2.0 [42]
Sotiropulos and Bertrand [33] reported the addition of phosphacumulene ylides 20 bearing the
diazo group to isocyanates, leading to the formation of products 22. It was proposed that initial
nucleophilic attack of the ylide carbon atom on the carbonyl carbon gives a oxaphosphetane 21, which
depending on the relationship of the oxygen atom (or NR group) to nitrogen or phosphorus rearranges
into products of 1,4- or 1,5-cyclisation 22 (Scheme 13). Benzaldehyde gives the 2-chlorooxaphosphetane
23 with the ylide 20 which readily eliminates hydrogen chloride and a nitrogen molecule being
converted into an acetylene phosphonate 24 (Scheme 14).
Scheme 13. Adduct of phosphacumulene-ylide 20 with isocyanate.
A number of 2-fluoro-1,2λ5-oxaphosphetanes 25 were prepared by reaction of P-fluoroylides
with aldehydes and ketones (Scheme 15, Table 2). The 2-fluoro-1,2λ5-oxaphosphetanes 25 are stable
compounds, which can be isolated and purified by distillation under vacuum or by crystallization
from non-polar solvents. These compounds are much distinguished from unstable adducts of
carbonyl compounds with triphenylphosphonium ylides. Cycloadducts of P-fluoroylides with
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carbonyl compounds, 2-fluoro-1,2λ5-oxaphosphetanes, are also much more stable than 2-chloro- or
2-bromo-1,2λ5-oxaphosphetanes [25–31].
Scheme 14. Reaction of phosphacumulene-ylide 20 with benzaldehyde.
Scheme 15. Synthesis of 2-fluoro-1,2λ5-oxaphosphetanes 25. R1 = Alk, Ph; CR2R3 = CH2, CHAlk,
CAlk2, CHPh, CHSiMe3, CCl2, CBr2; CR4R5 = C=O, CNPh, CHAlk, CAlk2, CHPh, CPh2, CH2CH = CH2.
The stability of 2-fluoro-oxaphosphetanes is explained by the high electronegativity of the
fluorine atom, compared to the electronegativities of chlorine and bromine. The P-F bond in
2-fluoro-1,2λ5-oxaphosphetanes is very strong, and, therefore, these compounds do not dissociate
with formation of cyclic phosphonium salts, what is observed, for example, with 2-chloro-
1,2λ5-oxaphosphetanes. Various stable 2-fluoro-1,2λ5-oxaphosphetanes were synthesized, isolated as
pure specimens, and characterized (Table 2). Typical representatives of such compounds 26–29 are
shown in Schemes 16–18 [26,29].
 
Scheme 16. The simplest representatives of 2-Fluoro-1,2λ5-oxaphosphetanes 26,27.
The 31P-NMR spectra of compounds 25 show a doublet at −6 to −45 ppm with
760–850 Hz PF coupling constants appropriate for axial fluorine atoms. The 31P-NMR spectra
of 2-fluoro-1,2λ5-oxaphosphetanes exhibit a doublet in the range −6 to −45 ppm, belonging to
the five-coordinate phosphorus with corresponding coupling constants on axial fluorine atoms
(760–850 Hz). The 19F-NMR spectra of 2-fluoro-1,2λ5-oxaphosphetanes exhibit doublets with the
same PF coupling constants.
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Scheme 18. 2-Fluoro-1,2λ5-oxaphosphetane 29.
The P,P-difluoroylides 30 react with aldehydes and active ketones to afford the stable
oxaphosphetanes 31 bearing two fluorine atoms at the phosphorus (Scheme 19) [34–36].
The compounds 31 (R=CF3) were distilled under reduced pressure without decomposition and were



















R1=Et2N; Pr2N; R3=H, CF3; R4=CF3, Ph, 4-Tol
31
 
Scheme 19. 2,2-Difluoro-1,2λ5-oxaphosphetanes 31.
The 19F-NMR spectra contain two double doublets at −47 and −65 ppm with expected coupling
constants for the axial and equatorial fluorine atoms: 1JPFa = 915 Hz, 1JPFe = 1025 Hz, and 2JFaFe = 62 Hz.
Apparently [2+2]-cycloaddition of the C=O group to the ylide 15 proceeds with high stereoselectivity,
because the 19F- and 31P-NMR spectra show the signals belonging to the single diastereomer of the
compounds 31. The signals of the second diastereomer, the existence of which one can suppose as
a consequence of the presence of two asymmetric endocyclic C-3 and C-4 carbon atoms are absent.
The 13C-NMR spectra reveal the presence of the signals at 62.5 ppm (1JCP = 150 Hz, 2JCF = 53 Hz) and
75.6 ppm due to the C-3 and C-4 carbon atoms in complete accordance with the assigned structure of
oxaphosphetane (Figures 1 and 2).
P-Fluoroylides add easily isocyanates, carbon dioxide and carbon disulfide with formation of
oxaphosphetanes 32–35. For example, the reaction of P-fluoroylides with phenyl isocyanate resulted
in the formation of 2-fluorooxaphosphetane 34 which was stable during several hours at ambient
temperature. Compound 34 was purified by crystallization in pentane and isolated as colorless
crystalline matter. In IR spectra of compounds was found the strong band at 1730 cm−1 belonging
to the C=O bond in a four-membered cycle. The 31P-NMR spectra disclosed a doublet with constant
1JPF = 780 Hz and a doublet with the same constant in 19F-NMR spectra. The oxaphosphetanes 32–35
convert at room temperature slowly and at heating quickly into phosphorylated heterocumulenes
(ketenes, thioketenes, ketenimines, see Scheme 20) [29,37–39].
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Figure 1. 31P-NMR spectrum of 2-(diethylamino)-2,2-difluoro-4-tolyl-3-propyl-4-(trifluorophenyl-
1,2λ5-oxaphosphetane 31 (See Table 2, entry 15).
 
Figure 2. 19F-NMR spectra of 2-(diethylamino)-2,2-difluoro-4-tolyl-3-propyl-4-(trifluorophenyl-1,2λ5-
oxaphosphetane 31 (see Table 2, entry 15).
Scheme 20. Addition of heterocumulenes (X=C=Y) to P-fluoroylides.
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Table 2. 2-Fluoro-1,2λ5-oxaphosphetanes [26,32,37].
Entry R1 R2 R3 R4 R5 R6 Yield, %
b.p., ◦C
(P, mmHg) δP, ppm. δF, ppm.
1JPF, Hz
1 Et2N Et2N H H H Bu 85 90 (0.06) −42.15 31.30 767
2 Et2N Et2N H H H C6H13 85 100 (0.06) −42.25 31.12 766
3 Et2N Et2N H H Me Me 70 75 (0.02) −47.53 31.04 765
4 Et2N Et2N H H Me Et 85 85 (0.06) −49.20 31.04 765
5 Et2N Et2N H H Me Ph 99 a −44.00 32.00 766
6 Et2N Et2N H H (CH2)5 90 110 (0.06) −44.60 34.90 766
7 Et2N Et2N H Me (CH2)5 99 a −44.00 21.00 853
8 Et2N Et2N H H Ph Ph 99 a −41.60 34.90 766
9 Et2N Et2N H H H Ph 99 a −42.13 31.18 768
10 Et2N Et2N Cl Cl H Pr 90 a −47.00 5.40 853
11 Et2N Et2N Br Br H Pr a −56.03 5.80 842
12 Et2N Et2N H Me CF3 Ph 80 120 (0.06)
−36.39;
−38.27 (7:1) b −0.4 795; 795
13 Ph Ph Ph H CH3 H 95 a −43.50 47.8 670
14 Et2N F H Pr CF3 Ph 85 105 (0.06) −26.7 (99% dr) −46.9,−65 (CF3) 915; 1025
15 Et2N F H Pr CF3 4-Tol 80 108 (0.06) −26.5 (99% dr) −46.6,−65 (CF3) 915; 1025
16 Et2N Et2N H Ph CF3 Ph 85 <20 c −38.96 27 792.6
17 t-Bu t-Bu H Pr CF3 Ph 70 125 (0.06)
−7.73,
−8.79 (9:1) b −1.03 768; 770
18 t-Bu t-Bu H Pr H Ph 75 120 (0.08) −10.1;−9.62 (15:1) b 9.9 762; 762
19 t-Bu t-Bu H H H Ph 70 <20 c −5.9 13 750
20 Et2N Et2N H i-Pr H Ph 70 110 (0.06)
−33.7;
−33.54 (15:1) b 7.2 827; 827
21 t-Bu t-Bu H Pr C=NPh 50 84–86 c −18.85 5.55 820
22 t-Bu t-Bu H Pr C=O a 20.01 −26.23 785
23 Ph Ph Ph SiMe3 Ph H 85 a −43.5 28.76 670





25 t-Bu t-Bu H SiMe3 Ph H 90 a −11.0 - 768

























a Oil; b Diastereomers; c melting point (m.p.).
2.3. Properties of Oxaphosphetanes
The cycloaddition of P-halogenylides to aldehydes and ketones proceeds stereoselectively
and leads predominantly to the formation of one of the possible diastereomers of 2-halo-1,2λ5-
oxaphosphetanes (Tables 1 and 2). P-Haloylides (chloro- and bromo) react stereoselectively with
aldehydes to give predominantly single diastereoisomers of 2-halo-oxaphosphetanes, bearing
asymmetric endocyclic C-3 and C-4 carbon atoms (dr ~7:1–15:1). It was established by NMR
that the ratio of diastereoisomers of 2-halooxaphosphetanes containing asymmetric atoms at C(3)
and C(4) was within the limits ~99:1–90:10. The ratio of diastereomers after completion of the
reaction was approximately 6:4–9:1. However on heating, as a result of permutational changes
in the molecule, the ratio of diastereomers grew in favour of the thermodynamically more stable
diastereomer. 2-Fluoro- and 2-chloroxaphosphetanes containing chiral phosphorus or endocyclic
carbon atoms exist as mixtures of diastereomers whose ratio depends on the nature of the starting
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reagents (Scheme 21). The diastereomeric purity of the compounds, assessed by NMR spectroscopy,
was 80%–96%. The reaction of α,α,α-trifluoroacetophenone with P,P-difluoroylides proceeded
with very high stereo-selectivity to furnish only one diastereomer of compound. At the same
time 2-halo-1,2λ5-oxa-phosphetanes bearing asymmetric phosphorus atom are formed with low
stereoselectivity (dr~3:1).
Scheme 21. Diastereomeric composition of 2-chloro- and 2-fluoro-1,2λ5-oxaphosphetanes.
The reaction of P-halogenylides with aldehydes leads to the formation of an erythro-oxaphosphetanes
with the oxygen in the apical position, because of the tendency of electron-acceptor atoms to occupy this
position [40]. The preferred orientation of the transition state leading to the erythro-oxaphosphetane
is stereoselective approach of the ylide nucleophilic center to the carbonyl group at an angle of
107◦, with the double bonds of both reagents arranged in one plane. This was associated with
the Burgi-Dunitz trajectory concept (Scheme 22) [41]. The first step of reaction stereoselectively
leads to the formation of the betaine B. The conversion of reagents into oxaphosphetane requires
minimum energy when it proceeds with the non-synchronous formation of bonds between the carbonyl
and ylidic carbon atoms. On the second step the betaine converts into oxaphosphetane C with
low stereoselectivity, because of free rotation around of the P-C bond [28,42]. This mechanism of
asynchronous addition of P-haloylides to carbonyl compounds was confirmed by low temperature
NMR investigations. The reaction of di-tert-butylchlorphosphonium methylide with Ph(CF3)C=O
was studied by 31P-NMR at low temperature (−70–0 ◦C) in diethyl ether solution. At −70 ◦C
was found only a decreasing signal of P-chloroylide (+114 ppm) and a growing signal of
2-chloro-1,2λ5-oxaphosphetane (+9.9 ppm). The signal which could be referred to betaine was not
found, probably, because of the high speed of betaine cyclisation into 2-chloroxaphosphetane. However
the reaction of tert-butyl(diethylamino)chlorophosphonium methylide with benzaldehyde began at
−70 ◦C and led to the formation of erythro-betaine which was registered by increasing signal δP
+106 ppm, located in more weaker field than the signal of initial P-chloroylide (+102 ppm) (Figure 3).
The betaine formation was proceeded stereoselectively as in the 31P-(1H-)NMR spectrum only one
diastereomer signal was registered. The rise of temperature to −50 ◦C led to the formation of two
signals of threo and erythro-oxaphosphetane diastereomers δP + 92.6 and +84.6 ppm in the ratio of
2:1. Evidently, the formation of diastereomers proceeded via SN2@P substitution with inversion of
configuration at the phosphorus atom [43]. The formation of isomers indicates on the nucleophilic
substitution at asymmetric tetracoordinate phosphorus atom, proceeding with partial inversion
of configuration. At −50–−40 ◦C the oxaphosphetane was converted into 2-chloralkylphosphine
oxide, which was also formed as two threo- and erythro-diastereomers in the ratio of 2:1 (δP +48.7
and +49.2 ppm). The conversion was completed at −20 ◦C. The threo- and erythro diastereomers
were separated and isolated in pure state by chromatography and crystallization (m.p. 100 and
123 ◦C, see Table 3, entries 13, 14). Although at present many of the puzzling features about the
reaction mechanism of ylides phosphorus with carbonyl compounds have been clarified, it seems
there is no general mechanism, which could explain the progress of the reaction, transition states
and stereochemistry. Nevertheless in case of P-chloroylide addition to aldehydes, on the basis of
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presented above stereochemical researches the asynchronous [2+2]-cycloaddition seems to be the most
likely mechanism.
 
Scheme 22. Mechanism of asynchronous [2+2]-cycloaddition of P-chloroylide to benzaldehyde.
 
Figure 3. 31P-(1H-)NMR monitoring of the reaction of ylide a with PhCHO leading via the formation
of betaine b, and oxaphosphetane c to the formation of β-chloroalkylphosphonates d and d′.
2-Halo-oxaphosphetanes exist in pentacoordinate form, but ionize under certain conditions
with formation of tetracoordinate forms. In the mass spectra of 2-chlorooxaphosphetanes the
peak of molecular ion was observed that indicated the covalent character of the P–Cl bond.
All oxaphosphetanes show methyl carbons with lJPC values characteristic of equatorial placement in
the trigonal bipyramid. The resonances of the methylene carbons of the phosphetane ring system lay
downfield of the methyl carbons and the large measured lJPC values indicate equatorial placement.
The four-membered ring is occupying an apical-equatorial plane where the O-P-C angle is 90◦,
and never a diequatorial plane or a diapical plane where the O-P-C angle would have to be 120
or 180◦, respectively.
In the 1H-NMR spectra of the 2-halooxaphosphetanes possessing asymmetric carbon atom C4 the
magnetic nonequivalence of protons CHaHb in the four-membered ring became apparent because the
geminal spin-spin interaction arose between them. Each of the signals CHa and CHb was the double
doublet with the coupling constant with phosphorus nucleus 2JPH = 20–22 Hz and a constant of geminal
interaction 2JHH = 16–17 Hz. The chemical shifts 31P of 2-halogenoxaphosphetanes depended on the
polarity of the solvent. Thus, in nonpolar solvents (diethyl ether, pentane) the signals of δP are located in
the strong field of the 31P-NMR spectrum (from −3 to 10 ppm) that corresponds to the pentacoordinated
state of the phosphorus atom. In polar solvents and especially in the presence of Lewis acids, like AlCl3,
the values of δP were shifted downfield. For example, for 2-chloro-oxaphosphetanes the chemical
shift of phosphorus, δP was as follows (ppm): 9 (pentane), 22 (CH2C12), 30 (CHC13), 35 (CH3CN), 45
(CHC13 + A1C13 (traces)). With the increase in amount of aluminum chloride up to equimolar level
the value of δP 100 ppm was registered for 2-chlorooxaphosphetanes that was in accordance with the
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values of chemical shifts for the known alkoxyphosphonium salts and apparently indicated complete
ionization of chlorophosphorane with the formation of phosphonium salt. The dependence of the
chemical shift value of phosphorus in 2-chlorooxaphosphetanes on the solvent polarity and on the
presence of Lewis acid is in accordance with the published data showing that chlorophosphoranes
can be ionized with the formation of phosphonium structures. Herewith in the 31P-NMR spectrum
the resultant signal is registered due to fast exchange in the phosphorus coordination 15A 15B.
The value of δP is shifted downfield proportionally to the increase in the phosphonium structure
content, which in its turn depends on the solvent polarity. Substitution of electron withdrawing
CF3 group at C4 atom by hydrogen atom destabilizes the oxaphosphetane cycle and considerably
reinforces the ionization of P-C1 bond. The stability of 2-halogenoxaphosphetanes decreases, and
positive values δP and ionization of P-C1 bond increases in the sequence of substituents at C4 atom:
CF3 > C6H4F-4 >-C6N5 > C6H4OMe > H (Table 4) [25,30,31]. Chemical shifts of phosphorus in
2-bromo-1,2λ5-oxaphosphetanes (δP = +20–+75 ppm) were in the weaker fields relatively to chemical
shifts of chloro-oxaphosphetanes. Evidently high positive values δP of 2-bromoxaphosphetanes
is undoubtedly explained by bigger, than in case of 2-chlorooxaphosphetanes, contribution of
phosphonium forms 15B in the equilibrium 15A 15B.
Table 3. 2-Chloroalkylphosphine oxides 35 (Scheme 23) [36,42].
N R1 R2 R3′ R4 R5 Yield, % m.p./b.p. ◦C δP
1 t-Bu t-Bu H H CF3 60 62 (pentane) 57.8
2 t-Bu t-Bu H Me CF3 60 86 (hexane) 57.0
3 t-Bu t-Bu H Pr CF3 60 88 (hexane) 57.0
4 t-Bu t-Bu H Ph CF3 75 112.5 (benzene) 57.2
5 t-Bu t-Bu H C6H4NO2 CF3 70 139 (hexane) 59
6 t-Bu t-Bu Me C6H4NO2 CF3 70 131 (hexane) 60.1
7 t-Bu t-Bu Pr C6H4NO2 CF3 60 143.5 (hexane) 60.0
8 Me2N Me2N H Pr CF3 60 b.p. 95 (0.06 mmHg) 45.8
9 Et2N Et2N H Ph CF3 40 123 (ether-pentane) 46.0
10 Et2N Et2N H Ph CF3 20 160 (hexane) 46.3
11 i-Pr2N i-Pr2N Me Ph H 50 107–111 34.4
12 t-Bu Ph H Ph H 75 oil 57.9; 58.3 (10:1)
13 t-Bu Et2N H H Ph 20 100 (hexane) 46.3
14 t-Bu Et2N H Ph H 40 123 (ether-pentane) 46.0
Table 4. Effect of solvent on δP of 2-chloro and 2-bromo-1,2λ5-oxaphosphetanes.
R3 CF3 C6H4F C6H5 C6H4OMe
δP (CHCl3), Hlg = C1 +0.25 +9.0 +10.0 +13.6
δP (ether), Hlg = Br +25.0 +60.0 +65.0 +75.0
2-Chloro-1,2λ5-oxaphosphetanes enter into a number of interesting chemical conversions.
Thus, 2-chloro-1,2λ5-oxaphosphetanes as a result of [1,3]-migration of chlorine atom to carbon
atom underwent 2-chlorooxaphosphetane-2-chlorooxyphosphine oxide rearrangement to convert
into the 2-chlorooxyphosphine oxides 35. Thermal stability of 2-chloro-1,2λ5-oxaphosphetanes was
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decreased in case of oxaphosphetanes which not contain at C4 atom strong acceptor substituents,
which rearranged into chloroalkylphosphonates at room temperature (Table 3). At heating
2-chloralkylphosphine oxides yield vinylphosphine oxides 38. Hydrolysis of 2-chloro- and
bromo-oxaphosphetanes led to the formation of 2-hydroxyalkylphosphine oxides 36 (Table 5).
The chlorine atom of 2-chloro-1,2λ5-oxaphosphetanes is easily substituted on methoxy- or phenoxy
groups by reaction with methanol or phenol in the presence of triethylamine with formation of
2-alkoxyoxaphosphetanes 37, which at heating were converted into alkenes (Scheme 23, Table 1,
entries 14, 15) [27,42].
Scheme 23. Chemical reactions of 2-chloro and 2-bromo-1,2λ5-oxaphosphetanes.
The 2-chloro-1,2λ5-oxaphosphetanes not containing electron accepting groups at C-3 are unstable
and rearrange easily into 2-cloroalkylphosphonates at temperature below +20 ◦C. The oxaphophetanes
bearing at C4 electronegative CF3 groups convert into vinylphosphonates with elimination of
hydrogen chloride at heading up to 150–160 ◦C. 2-Bromooxaphosphetanes are less stable than
2-chlorooxaphosphetanes and are converted into vinylphosphine oxides at room temperature.
At heating (160–190 ◦C) 2-chloralkylphosphine oxides eliminate HCl to convert into vinylphosphine
oxides (Scheme 24) [27–29,42].
 
Scheme 24. 2-Chloro-1,2λ5-oxaphosphetane-2-chloroalkylphosphonate rearrangement.
Table 5. 2-Hydroxyalkylphosphine oxides 23 (Scheme 23) [39,42].
 
Entry R1 R2 R3 R4 Yield, % m.p., ◦C δP δF
1 i-Pr i-Pr Ph Ph 90 131–132 +66.0 +5.63
2 t-Bu t-Bu H Ph 90 155–156 +68.25 −1.78
3 t-Bu t-Bu H C6H4F-p 85 132 +68.7 −2.02; −34.5
4 t-Bu t-Bu H An-p 70 140–141 +68.5 +4.12
5 t-Bu t-Bu Me Ph 50 152 +73.4 +3.13
6 t-Bu Et2N Me CF3 50 108 +53.4 +8.1
7 t-Bu Et2N H Ph 65 150 +57.4 −3.06
8 t-Bu Et2N H CF3 90 46–48 +56.6 +6.1
9 t-Bu t-Bu H CF3 90 88-89 +67.5 +6.25
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The oxaphosphetanes bearing a trimethylsilyl group at C-3 atom eliminate the
trimethylchlorosilane moiety and convert into the phosphorylated alkenes 38. The conversion of
oxaphosphetanes into alkenephosphonates proceeds at room temperature slowly, and at heating
faster to give the alkenes 38 in good yields (Scheme 25). The phosphorylated alkenes 38 were
purified by distillation under vacuum and isolated as pure compounds. The reaction of ylides
14 with aldehydes is regioselective. For example, the oxaphosphetanes obtained by reaction of
silylated P-chloroylide 5 with terephthalic aldehyde depending on a ratio of initial reactants led to the
formation of 1,4-bis-vinylphosphonobenzene or phosphonovinylbenzaldehyde, that represent interest
as reactants for organic synthesis (See Table 6, entries 10, 11) [13,18–20].
Scheme 25. Conversions of 2-chloro-1,2λ5-oxaphosphetanes 14.
The 2-fluoro-1,2λ5-oxaphosphetanes enter readily into a number of interesting organophosphorus
compounds proceeding without P—C bond cleavage [26]. Thus, the treatment of 2-fluorooxaphosphetanes
25 with ether solution of HCl led to the formation of 2-chloro-oxaphosphetanes 40, which was isolated
in good yield. At heating the 2-fluorooxaphosphetanes 25, in contrast to triphenyloxaphosphetanes,
convert into phosphorylated alkenes: vinylphosphonates or allylphosphonates. The direction
of reaction depended on substituents R2 and R3 at C-3 and C-4 of oxaphosphetane cycle.
The 2-fluorooxaphosphetanes bearing at C-3 R2 = H, Alk, Ar, and at C-4 R3 = Alkyl eliminated
HF to convert into the allylphosphonates 42 [39,44,45]. The reaction was catalyzed by boron trifluoride
etherate. At the same time the 2-fluorooxaphosphetanes 25 bearing at C-3 substituent R = Me3Si
eliminated Me3SiF and afforded the vinylphosphonates 41 (Scheme 26, Table 7). This reaction represent
a convenient method for the preparation of phosphorylated alkenes that are versatile building blocks
for organic synthesis [45–48]. 2-Fluoro-1,2λ5-oxaphosphetanes containing two alkyl groups at C3 as
well eliminated hydrogen fluoride and afforded the allylphosphonates 42 (Scheme 26, Table 8).




Time, h t ◦C Solvent
1 t-Bu Ph 0.5 150 a 80 [25,32]
2 EtO Ph 2 25–100 ether 80 [25,32]
3 EtO 2-BrC6H4 6–8 25–100 ether 60 [25,32]
4 i-PrO Ph 2 25–100 ether 60 [25,32]
5 Et2N Ph 14 25 ether 80 [25,32]
6 Et2N 2-FC6H4 24 25 ether 60 [25,32]
8 Et2N CH=CHPh 18 25 ether 80 [25,32]
9 Et2N 24 25 THF 70 [25,32]
9 EtO 48 35 THF 65 [25,32]
10 Et2N C6H4CHO-p 25 18 THF 50 [25,32]
11 Et2N R2P(O)CH=CHC6H4 25 24 THF 50 [25,32]
12 i-PrO R2P(O)CH=CHC6H4 25 24 THF 50 [25,32]
a without solvent.
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The reaction occurs by the 1,4-elimination as shown in Scheme 26 [25]. Opposite to
2,2,2-triphenyloxaphosphetanes, upon heating, the decyclization of 2-fluorooxaphosphetanes led
to the formation of phosphorylated alkenes 41, 42.
Scheme 26. Chemical properties of 2-fluoro-1,2λ5-oxaphosphetanes. a = H2O (-HF); b = HCl,
ether (-HF); c = 100–120 ◦C, ~0.5 h (-HF) or BF3·Et2O, +20 ◦C, 168 h; d = 60–80 ◦C (-Me3SiF).
At heating to +100 ◦C the 2-fluoro-3-silyloxaphosphetanes 25, bearing CF3 group at C-4, afforded
a mixture of E- and Z-vinylphosphonates 29, 30 in the ratio 2:1 with elimination of Me3SiF. However
the slow conversion of oxaphosphetane at +20 ◦C during several days provided almost pure
vinylphosphonates E-29, containing only 2%–3% of Z-isomer (Scheme 27) [26]. This effect was
explained by formation of carbocation intermediate and rotation of substituents around the C-C
bond (Scheme 28).
 
Scheme 27. Effect of temperature on the stereoselectivity of 2-fluoro-1,2λ5-oxaphosphetane conversion
into vinylphosphonates.
The conversion of 2-fluoro-1,2λ5-oxaphosphetanes bearing alkyl groups at C-3 into
allylphosphonates 42 represents an interesting example of 1,4-elimination as Scheme 28 and
Table 8 show [45]. The study of the reaction mechanism showed that Lewis and Broensted
acids actively catalyze the conversion of 2-fluorooxaphosphetanes into allylphosphine oxides.
The reaction is autocatalytic because the evolving hydrogen fluoride catalyzes the transition
of 2-fluorooxaphosphetanes into allylphosphine oxides. The decomposition of protonated
2-fluorooxaphosphetanes leads to the formation of oxonium salts and carbocation intermediates
under conditions of EN1 elimination. We suppose that the 2-fluorooxaphosphetanes under condition of
acid catalysis (with HF or BF3) via the formation of an oxonium intermediate F, convert to carbocation
intermediate G which has a planar configuration [46]. The removal of a proton from the carbocation
intermediate G depends on electronic effects of the substituents. Alkyl groups possessing the +I-effect
and the effect of hyperconjugation stabilize the positive charge and reduce the energy of intermediate G
formation. Therefore, the intermediate G′ leading to allylphosphonates is energetically more favorable
than this one that is converted into vinylphosphonates.
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Table 7. Vinylphosphonates 41 (Scheme 26) [26].
δEntry R1 R3 R4 Yield, % a b.p.
◦C (p mmHg)/
m.p. ◦C (Solvent) δP, ppm
1 t-Bu H Ph 50 138 (heptane) 35.0
2 Ph H Ph 40 165 (heptane) 22.0
3 Et2N H Ph 85 103.5 (hexane) 24.7
4 Et2N H Me 80 120 (0.05) 24.7
5 Et2N H Pr 72 120 (0.05) 24.3
6 Et2N H Bu 68 120–123 (0.04) 23.95
7 Et2N H C6H13 80 135 (0.06) 24.1
8 Et2N H C8H17 79 145–150 (0.05) 24.1
9 Et2N H PhCH=CH- 60 170 (0.06) 23.30
10 Et2N H Me2C=CHCH2CH2C(Me)CH=C- 35 160 (0.08) 25.0
11 Et2N CF3 Ph 74 140 (0.03) 17.0; 18.7 b
12 Et2N H -C6H4CHO-4 50 98 (hexane) 23.7
13 Et2N H -C6H4CH=CHP(O)(NEt2)2 50 190 (heptane) 24.8
a yield of the isolated product; b mixture of E/Z-diastereomers in 97:3 ratio.
In addition, even in case when the initial 2-fluorooxaphosphetanes 25 exist as a mixture of threo-
and erythro-diastereomers, they converted into pure E-vinylphosphonates. Probably, this effect can be
explained by rotation of substituents around the C-C bond in carbocation intermediate G. However,
the presence of Me3Si at C-3 in G′′ leads to the elimination of Me3SiF, which has a high energy of
formation, that creates a preference for the formation of vinylphosphonates 45 (Scheme 28) [26,40].
δ
Scheme 28. The mechanism for the 2-fluoro-1,2λ5-oxaphosphetane conversion into allyl- or
vinylphosphonates 44, 45.
The formation of carbocation intermediate G was experimentally confirmed (Scheme 29).
The treatment of 2-hydroxyphosphonate 46 with trifluoracetic acid and refluxing for several hours,
generated the carbocation intermediate, as a result of acid-catalyzed dehydration of alcohol.
After that the carbocation intermediate is converted into allylphosphonate 47, which is identical
to the one obtained from 2-fluorooxaphosphetane 25 [26,40,45].
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Table 8. Allylphosphonates 28.
Entry R1 R2 R3 R4 R5 Yield, %
b.p. ◦C
(P, mmHg) References
1 Et2N H H H Pr 70 120 (0.06) [40,45]
2 Et2N H H H C5H11 70 140 (0.08) [40,45]
3 Et2N H H Me H 55 105 (0.08) [40,45]
4 Et2N H H Me Me 60 95 (0.06) [40,43]
5 Et2N H H Ph H 65 145 (0.08) [40]
6 Et2N H H (CH2)4 85 145 (0.08) [26,45]
7 Et2N H Me (CH2)4 75 110 (0.06) [40,45]
8 Et2N Me Me (CH2)4 70 110 (0.06) [40,45]
Scheme 29. The conversion of hydroxyphosphonate 46 into the allylphosphonate 47.
The reaction of P-fluoroylides with carbonyl compounds is a convenient method for the
synthesis of allylphosphonates having various applications in the synthesis of naturally occurring
compounds (Scheme 30) [45–47]. In this case, the carbonyl compounds can be used twice for the
constructing of diene structures: first in reaction with P-fluoroylide and then in the Wittig reaction
with allylphosphonate. This reaction was used for preparing analogs of the juvenile hormone.
 
Scheme 30. Synthetic application of allylphosphonates.
The cycloadducts of P-fluoroylides with carbon dioxide or with carbon disulfide were isolated as
colorless liquids or crystalline substances. Their structure was confirmed by the NMR spectra. Upon
gentle heating or at room temperature these cycloadducts 32–35 (Table 2, entries 21, 22) are converted to
phosphorylated ketenes or thioketenes 48 (Scheme 31). Stable [2+2]-cycloadducts of 2-fluoroylides with
alkyl and aryl isothiocyanates were also synthesized and converted into phosphorylated ketenimines.
The reaction of P-fluoroylides with carbon disulfide gives unstable cycloadducts that at temperatures
above 0 ◦C converted completely into phosphorylated thioketenes in high yields. Phosphorylated
thioketenes are red liquids distillable in vacuum and susceptible for various transformations [29,36,37].
The same phosphorylated ketenes or thioketenes 29 were prepared by reaction of P-cloroylides
corresponding with CO2 and CS2 (See Scheme 31 and Table 9) [37–39].
 
Scheme 31. Preparation of phosphorylated ketenes, thioketenes, ketenimines 48 (Table 9).
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Table 9. Preparation of phosphorylated ketenes, thioketenes, ketenimines 48 (Scheme 31).
Entry R X Y Z Yield, % b.p. ◦C (mmHg) References
1 H Cl O O 80 a [36,39]
2 Me F O O 70 98 (0.06) [37]
3 Me Cl O O 85 98 (0.06) [36,39]
4 Pr F O O 60 102 (0.06) [37]
5 Pr Cl O O 69 102 (0.06) [36,39]
6 Me F O NPh 45 150 (0.06) [37]
7 Pr F O NPh 45 150 (0.06) [37]
8 Me Cl S S 75 95 (0.06) [38]
9 Pr Cl S S 80 115 (0.06) [38]
10 Pr F S S 70 115–120 (0.06) [37,38]
11 i-Pr Cl S S 80 105 (0.06) [38]
a unstable compound.
3. Conclusions
In conclusion, this review has summarized the achievements in the synthesis and properties
of stable four-membered phosphorus heterocycles-2-chloro-, 2-bromo- and 2-fluoro-1,2λ5-oxa-
phosphetanes. These interesting compounds were obtained by reaction of P-halogenylides
with various carbonyl compounds (aldehydes, ketones, isocyanates, carbon dioxide, and others).
The 2-chloro and 2-bromo-1,2λ5-oxaphosphetanes, depending on the halogen nature and
substituents at the α-carbon atom, underwent the rearrangement into 2-haloalkylphosphonates
or with elimination of hydrogen halides were converted into trans-phosphorylated alkenes.
Hydrolysis of 2-halo-1,2λ5-oxaphosphetanes led to the formation of 2-hydroxyalkylphosphonates.
The 2-fluoro-oxaphosphetanes, bearing alkyl groups at the C-4 atom at heating as a result of
1,4-elimination of hydrogen fluoride are turned to allylphosphonates. Upon heating 3-silyl-2-fluoro-
1,2λ5-oxaphosphetanes easily eliminate the trimethylsilylfluoride to convert into E-vinylphosphonates
in high yields. These reactions provide efficient protocols for the preparation of various phosphorylated
alkenes (vinylphosphonates, allylphosphonates, phosphorus ketenes, ketenimines, thioketenes) and
can be useful for fine organic synthesis.
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Abstract: Growing interest in the biological activity of aminobisphosphonates has stimulated the
development of methods for their synthesis. Although several general procedures were previously
elaborated to reach this goal, aminobisphosphonate chemistry is still developing quite substantially.
Thus, innovative modifications of the existing commonly used reactions, as well as development of
new procedures, are presented in this review, concentrating on recent achievements. Additionally,
selected examples of aminobisphosphonate derivatization illustrate their usefulness for obtaining
new diagnostic and therapeutic agents.
Keywords: bisphosphonates; bisphosphonylation procedures; Vilsmayer-Haack-like reactions;
functionalization of aminoalkylbisphosphonates
1. Introduction
Bisphosphonates are a class of compounds that are currently receiving significant attention.
Over 50 new papers are seen each week when searching the literature with the keyword
“bisphosphonate” via Web of Science. More than 17,000 various bisphosphonate structures have been
synthesized and described in the literature [1]. Most papers concern their important subclass, namely
aminobisphosphonates. This strong interest results from these compounds acting as strong inhibitors
of bone resorption, with several representatives of this class already commercialized as drugs of choice
for the treatment of osteoporosis, skeletal complications of malignancy, Paget’s disease, multiple
myeloma, hypercalcemia and fibrous dysplasia [2–7] Consequently, most of the papers are devoted
to various clinical aspects of the anti-resorptive effects that bisphosphonates exert towards bone
tissues; however, there is also a growing interest in their applications as anticancer and antibacterial
agents [5–7]. Additionally, aminobisphosphonic acids have found important industrial applications,
largely as inhibitors of scale formation and as corrosion inhibitors, actions which result from their
ability to complex metal ions [8–10].
Thus, simple and effective procedures for their synthesis are becoming increasingly important.
However, only a few general reactions leading to these compounds have been described to date and are
only partially reviewed in the literature [11,12]. Novel reports are mostly concentrated on modifications
and improvement of these procedures, and there are only a few papers aiming at new reactions, which
results from the commonly applied procedures being simple, economical and effective.
In this paper, we comprehensively review the recent studies (supplemented by older papers
if necessary) on reactions applied to synthesize the most important class of bisphosphonates—
aminobisphosphonates—and discuss their scope and limitations.
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2. Overview of Synthetic Procedures
There are contradictory reports of the origin of bisphosphonates [13]. Most likely, the first one
was obtained in the 19th century by Nikolay Menschutkin and/or Theodor Saltzer as an impurity in
reactions designed to obtain different compounds. It was further identified by Hans von Baeyer and
Wilhelm Heideprim as 1-hydroxyethanebisphosphonic acid.
There are only a few general methods for the synthesis of aminobisphosphonates. However, there
are many individual procedures described for their preparation [11,12]. In this review, the following
general reactions are presented: (i) starting from carboxylic acids and (ii) their amides; (iii) reactions
using nitriles and (iv) isonitriles as substrates; (v) syntheses based on addition of phosphites to
oxophosphonates; (vi) three-component condensation of amines, trialkyl orthoformates and dialkyl
phosphites; (vii) addition of amines to vinylidenebisphosphonates; and (viii) functionalization of
simple bisphosphonates treated as building blocks for the preparation of more complex structures.
Additionally, some specific and non-conventional procedures that have been elucidated will be
presented in this review.
2.1. Synthesis from Carboxylic Acids
1-Hydroxyethylidene-1,1-bisphosphonic acids are perhaps the oldest group of bisphosphonates.
They are standardly prepared by a large-scale, one-step reaction of carboxylic acids with phosphorus
trichloride and phosphorous or phosphoric acids, followed by hydrolysis with water; the procedure
was optimized by Kieczykowski et al. [14]. The reaction is carried out in selected solvents
(phenylsulphonic acid, various phenols, chlorobenzene, diphenyl ether or ionic liquids) with sulfone
and methanesulphonic acid being preferred choices [11,15–20]. Despite many theories [19,21–23],
the exact mechanism of this reaction is not fully understood; however, the formation of acid chloride as
a first intermediate has been undoubtedly demonstrated (Scheme 1). This intermediate may react with
methanesulphonic acid (when used as a solvent), and the formed mixed anhydride is also considered
a potential intermediate for the next step [24], which is an Arbuzov-like reaction of phosphorus acid
or one of its several derivatives (including anhydrides of variable structure [17]) formed during the
reaction. The formed derivative of ketophosphonate is a substrate for the addition reaction of trivalent
P-OH species, and bisphosphonate is obtained (Scheme 1). It has also been documented that the
use of phosphorous acid could be omitted if water was added to the reaction medium, and thus this
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1  
Scheme 1. Presumable mechanism of the synthesis of 1-hydroxy-1,1-bisphosphonic acids.
This reaction was commonly used for the preparation of a wide variety of anti-osteoporotic
bisphosphonic acids containing free amino groups (so called dronic acids, compound 1). In this case,
free unblocked amino acids are used as substrates, and the final neutralization of reaction mixtures to
a pH of approximately 4 causes precipitation of the desired products, which are formed in satisfactory
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yields and are of good purity [16,23–26]. Because of its technological importance, this reaction is
still quite intensively studied and optimized; however, most of the studies are done in industrial
laboratories, and their results are mostly disseminated as patents. Consequently, it is difficult, if not
impossible, to determine which conditions are optimal for the synthesis of individual drugs. It is
important because, as in the case of any multicomponent reaction, a synthetic course is strongly
dependent on applied conditions and molar ratios of reagents. For example, one of the patents reports
that the omission of phosphorus chloride in the reaction of 4-aminobutyric acid as the substrate
in methanesulphonic acid provides mixtures of anhydrides as final products (compounds 2 and 3,


















Scheme 2. Cyclic products of the reaction between carboxylic acids and phosphorous acid in
methanesulphonic acid.
Among modifications of this procedure are (i) replacement of phosphorus trichloride with thionyl
chloride to generate acid chloride in the first reaction step [11]; (ii) replacement of acid by its chloride
or anhydride [11] or (iii) t-butyl ester [27]; (iv) blocking the amino moiety in the case of α-amino
acids [28]; and (v) application of microwave-assisted procedures [29].
2.2. Synthesis from Amides
Although studies on the biological activity of 1-amino-1,1-bisphosphonic acids are scarce,
a significant number of procedures for their preparation have been described. They have recently
been reviewed by Romanenko and Kukhar [12]. Amides, being highly stable and easily available
compounds, are substrates of choice, and the most commonly applied procedures are simple
modifications of those elaborated for carboxylic acids. The most straightforward are reactions of
N-acylamines and N-formylamines with phosphorus trichloride and phosphorous acid [30–32],
phosphorus tribromide [33], or triphosgene [34], which provide a wide structural variety of
1-amino-1,1-bisphosphonic acids (compound 4, Scheme 3). They are based on modification of the first












R2= alkyl, aryl, heteroaryl, cycloalkyl
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Scheme 3. Bisphosphonylation of amides.
The exact reaction mechanism in this case is also not fully known; however, a Vilsmayer-
Haack-like route via iminium ion is postulated here (Scheme 4).
Another possibility is using trialkyl or trimethylsilyl phosphites in reactions prompted by
phosphoryl chloride [36–39], trifluoromethanesulphonic anhydride (Tf2O) [40], zinc chloride [41]
or trimethylsilyl trifluoromethanesulfonate [42,43]. Unfortunately, primary amides are not suitable
substrates for this reaction [38]. The use of triethyl phosphite and phosphoryl chloride appeared to be
especially useful when lactams were used as substrates, resulting in high yields of aminomethylene-
gem-bisphosphonates (Scheme 5) [36–39]. They were readily hydrolyzed, yielding corresponding
bisphosphonic acids (representative example compound 5). On the other hand, this reaction is not suitable
for the conversion of benzoannulated lactams, and mixtures of the desired bisphosphonates and
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monophosphonates of variable structures were obtained (compounds 6, 7, 8 and 9, Scheme 5). In fact,
monophosphonates are usually major products, and the reaction course is dependent on the size of the
substrate aliphatic ring [44]. Additionally, these bisphosphonates and monophosphonates appeared to
be unstable upon acid hydrolysis and upon storage, and undergo degradation with cleavage of the
carbon-to-phosphorus bond (for example compound 10, Scheme 5). Thus, corresponding acids have






































































Scheme 5. Representative reactions of lactams with triethyl phosphite prompted by phosphoryl chloride.
The formation of a Vilsmayer-Haack-like intermediate is also proposed in this case with the
further addition of a nucleophilic phosphorus reagent. This assumption is additionally supported
by studies on the use of structurally variable imine salts as substrates for synthesis of compounds 11
(Scheme 6) [41–45].
The reaction of dibutoxyphosphine or bis(trimethylsiloxy)phosphine with dimethylformamides
in the presence of trimethylsilyl trifluoromethanesulfonate affords the corresponding
aminomethylenebisphosphonites 12 in high yields (Scheme 7) [41–43]. Similar products were
obtained by reacting diethyl pivaloylphosphonite with dialkylformamides in the presence of excess
ethanol and catalytic amounts of zinc chloride (Scheme 7). Pivaloylphosphonite decomposes in these
reaction conditions, yielding diethoxyphosphine, which is the real substrate of the reaction [41].
N-Octylpyrrolidinone treated with LDA, followed by the addition of diethyl phosphorochloridite
and oxidation of the reaction mixture with 30% hydrogen peroxide resulted in bisphosphonylated
lactam 13 with excellent yield (Scheme 8). This reaction was then applied for the synthesis
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of N-geranylated lactams 14 and 15 and linear amides, potential inhibitors of farnesyl:protein
transferase [46]. In the case of cyclic imides, in which two equivalent positions for enolate formation
are present on the imide rings, and thus two carbon atoms may be phosphonylated, the structure
of the product was dependent on the mode of reaction. If phosphonylation was carried out in one
step, two carbon atoms were phosphonylated and vicinal bisphosphonate was obtained. Step-by-step
reaction resulted in the predomination of the phosphonylation of one carbon atom, and the desired














































R1= R2 = CH3, n-propyl,






















Scheme 7. Reaction of diethoxyphosphine with the acetal of dimethylformamide.
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Scheme 8. Synthesis of bisphosphonate lactams.
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2.3. Synthesis from Nitriles
1-Aminoalkylidene-1,1-bisphosphonic acids could also be prepared from nitriles by applying the
same procedures as in syntheses starting from amides. Despite being readily available substrates, there
is limited literature on their use for that purpose. The most popular route is the reaction of nitriles
with phosphorous acid, in some cases prompted by phosphorus trichloride and phenylsulphonic or
methylsulphonic acids [12,31,47,48]. The conditions of this reaction are sufficiently delicate to use
peptidyl nitriles as substrates, which was demonstrated using cyanoethyl derivatives of dipeptides
















Scheme 9. Representative example of the synthesis of peptidylbisphosphonates from nitriles.
Recently, elegant, mild, and atom economical double phosphonylation of nitriles in the presence
of titanocene has been described. This procedure used induced phosphorus-centered radicals
mediated by titanocene dichloride (Cp2TiCl2) (Scheme 10) and provided a wide structural variety of
aminobisphosphonates 17 [50]. This is a double radical transfer reaction initiated by the reaction of
titanocene with zinc dust and the transfer of the obtained radical to epoxypropane by cleavage of its
oxirane ring, followed by transfer of this radical to diethyl phosphite, which in turn reacts with nitrile
(Scheme 10). The reaction carried out without epoxide, under microwave stimulation, also results in



















R = alkyl, cycloalkyl, halogenoalkyl, aryl, HOOC-CH2-,CH3-CH2CH2-, N
Ph
Ph  
Scheme 10. Radical procedure for the synthesis of bisphosphonates from nitriles.
2.4. Synthesis from Isonitriles
Isonitriles, which are quite common substrates, especially in multicomponent reactions [51], have
been seldom used for the preparation of aminobisphosphonates 18. Their reactions with H-phosphine
oxides carried out in the presence of typical palladium catalysts (Pd2dba3) afforded the product
19 of monophosphonylation, whereas the use of various rhodium catalysts afforded products of
diphosphonylation (Scheme 11) [52].
Far simpler is the addition of diethyl phosphite to isonitriles. This reaction is carried out with
an excess of hydrogen chloride in aprotic solvents. Under these conditions, nitrile is converted to
an onium salt, and after addition of the first phosphite molecule, iminium salt is formed, a substrate
for the addition of a second phosphite molecule (Scheme 12) [53]. Using this procedure, two distinct
libraries of bisphosphonates 20 and 21 have been prepared [54–56].
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R1 = CH3, t-butyl, cyclohexyl, aryl
R2 = CH3, t-butyl, cyclohexyl, aryl
Scheme 11. Addition of H-phosphine oxides to isonitriles catalyzed by metallocatalysts.
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Scheme 12. Addition of phosphites to isonitriles.
2.5. Synthesis via Ketophosphonates
Presumably, the addition of phosphites to ketophosphonates was the first procedure for
preparation of dialkyl 1-hydroxy-1,1-bisphosphonates [16,19,57]. Starting ketophosphonates are
obtained by the Arbuzov reaction of acyl chlorides with trialkyl phosphites and used as substrates in the
next step, namely, the addition of dialkyl phosphite to carbonyl double bonds (a representative example
for preparation of tetramethyl pamidronate 22 is shown in Scheme 13). Since ketophosphonates
are unstable species [58], the desired bisphosphonates are usually obtained via one-pot procedures
applying mixtures of trialkyl- and dialkylphosphonates at elevated temperature [59]. Additionally, in
situ generation of dialkyl- from trialkyl phosphites is possible by the addition of a protic solvent to
the reaction mixture. A useful modification of this procedure is the application of tris(trimethylsilyl)
phosphite, followed by the easy removal of ester groups by methanolysis [23,60,61]. This was used
to prepare a wide variety of 1-hydroxy-1,1-bisphosphonates containing amino groups [19,23,61–63].
Additionally, the use of bis((trimethylsilyl)oxy)phosphine generated from ammonium hypophosphite
was applied to prepare hydroxybisphosphinic acids (also presented in Scheme 13) [64]. Another
modification was the use of acyl phosphonamidates readily prepared from phosphoramidite type
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reagents and a range of acid chlorides, followed by reaction with trimethyl phosphite in the presence



























Scheme 13. Representative syntheses via ketophosphonates.
Recently, a one-pot synthesis was described reacting carboxylic acids with catecholborane,
followed by the treatment of the formed acyloxy-benzodioxaborolane with tris(trimethylsilyl)phosphite
(Scheme 13) [66]. The efficiency of that simple methodology was proved by the syntheses of alendronate
and N-methyl pamidronate (compound 23) without additional steps for the protection/deprotection
of their amine functions.
2.6. Three-Component Condensation of Amines with Triethyl Orthoformate and Diethylphosphite
Simple three-component condensation of stoichiometric ratios of amines, diethyl phosphite
and triethyl orthoformate, first reported in patent literature by Suzuki [67] and further extended
by Maier [68], is perhaps the most common procedure for the preparation of a wide variety of
aminomethylenebisphosphonic acids (Scheme 14). Since this reaction usually gives a complex mixture
of products [56] that are difficult to separate, the resulting esters are not isolated but rather, the crude
reaction mixtures are hydrolyzed, yielding bisphosphonic acids that are isolated after the hydrolytic
step. Some modifications of this classic procedure have also been reported. They include the use of a
solvent-free, microwave-assisted reaction [69–71] and reactions catalyzed by titanium dioxide [72] and
by crown ethers (increasing the selectivity of the process by 10%–20%) [73]. Additionally, a reaction









R =  over 300 structurally variable substituents  
Scheme 14. Condensation of amines with triethyl orthoformate and diethyl phosphite.
The three-component reaction was applied to synthesize a large series of physiologically active
compounds, in some cases of very complex chemical structures, including bone antiresorptive drug
candidates [75–82]; bone imaging [83,84], antiprotozoal [85–88], antibacterial [72,89–92], anti-HIV [93]
and anti-inflammatory [94] agents; herbicides [95–97]; and complex ones for various metals [10,98].
In some cases, this reaction appears to be quite capricious and affords unexpected side-products
along with the expected aminomethylenebisphosphonates (see representative examples in Scheme 15),
the compositions of which are dependent on the applied conditions (molar ratio of substrates,
temperature and reaction time). Most often, alkylation (for example, compounds 24 and 25) or
formylation (compound 26) of amine moieties is observed [71,99], while in selected cases the formation
of aminomethylenebisphosphonic acid (compound 27) is observed. Because this compound was
previously prepared by acid hydrolysis of N-benzhydrylaminomethylenebisphosphonic acid [83,100],
it may be that it is formed upon hydrolysis of N-aryl derivatives.
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Scheme 15. Representative side products of the three-component procedure for the synthesis of
aminomethylenebisphosphonic acids.
The mechanism of this useful reaction had been thoroughly studied by using 31P-NMR and by
isolation of all intermediates [71,72,99] and identifying interrelations between them (Scheme 16) [99].
The mechanism appeared to be quite complex because the intermediates exist in thermodynamic























































Scheme 16. Mechanism of the three-component reaction of amines with orthoformates and phosphites.
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Modification of this procedure and the use of ethyl diethoxymethyl-H-phosphinate instead
of diethyl phosphite allowed obtaining structurally variable bisphosphinates 28 (Scheme 17) [101].
Better results were obtained if the reaction was carried out under nitrogen (air oxidizes substrates and
products). Notably, aromatic amines provided the desired bisphosphinates in high yields (78%–92%),
whereas the reaction yields when using cyclic and aliphatic derivatives were lower. Interestingly, of
many methods for the synthesis of corresponding acids 29, acidolysis of the obtained esters 28 appeared
to be optimal. The use of other conditions, including mild transesterification with trimethylsilyl











































R1 = aryl, cycloalyk, alkyl





Scheme 17. Three-component synthesis of aminobisphosphonates.
2.7. Addition of Amines to Vinylidenebisphosphonates
Tetraethyl vinylidenebisphosphonate 32 is a versatile synthon useful for preparation of a wide
variety of bisphosphonates. Its usefulness is a subject of recent comprehensive review [102]. As an
electron-deficient alkene, it can undergo conjugate addition of strong and mild nucleophiles, with
amines belonging to the latter class. Primary amines undergo smooth Michael addition (Scheme 18),
however, the obtained compounds 33 must be quickly purified and hydrolyzed since they tend to














R = alkyl, cyckloalkyl, heterocycloalkyl, benzyl  
Scheme 18. Michael addition of amines to vinylidenebisphosphonate.
The reactivity of vinylidenebisphosphonates has been used for the synthesis of derivatives
of various analogues of fluoroquinolone antibacterial agents [105,106], heteroaromatics with
potential pharmaceutical applications [107,108], simple antiplasmodial agents [103,104], HIV reverse
transcriptase inhibitors [59,93], potential anti-osteoporotic agents [109,110], and N-alkylated antitumor
pyridines [111]. Some representatives of these compounds (35–39) are shown in Scheme 19.
Another example, albeit far less developed, is the addition of organometallic amines to
vinylidenebisphosphonate 22 (Scheme 20) [112]. Huisgen copper-catalyzed 1,3-dipolar cycloaddition
of this bisphosphonate to azides was used to obtain substrate 40 for a “click reaction”. This reaction
yielded compounds that may be considered aza-analogues 41 of zoledronate (Scheme 20) [113].
Similar substrates could also be obtained by addition of propargylamine to the double bond of
vinylidenebisphosphonate [114].
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39, inhibitor of HIV reverse transcriptase  
Scheme 19. Representatives of useful bisphosphonates obtained via addition of amines to
vinylidenebisphosphonate.










Scheme 20. An example of the synthesis of novel bisphosphonates via “click chemistry”.
2.8. Miscellaneous Procedures
The desire to obtain new aminobisphosphonate scaffolds for biological studies has stimulated
numerous studies on general methods of their synthesis. The methods discussed here are mostly
designed to prepare specific scaffolds or are applicable only to specific, if not unusual, substrates.
Only some of them may be considered as novel, general procedures.
Radical addition of sodium hypophosphite to terminal alkynes in the presence of triethylborane,
which produced 1-alkyl-1,1-bis-H-phosphinates in moderate yields, gives access to a wide
structural variety of bisphosphonates [115]. When using propargylamino acids, the corresponding
bisphosphinates were obtained in satisfactory yields (a representative example is given in Scheme 21 for







Scheme 21. Procedure for the synthesis of bisphosphinates and their conversion into bisphosphonates.
1-(N-acylamino)alkylphosphonates, easily accessible from N-acyl-α-amino acids using a two-step
transformation, underwent electrophilic activation at the α-carbon by electrochemical α-methoxylation
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in methanol in a process mediated by NaCl. Attempts to carry out a Michaelis-Arbuzov-like reaction
of the obtained diethyl 1-(N-acetylamino)-1-methoxy-alkylphosphonates with triethyl phosphite
failed; however, they readily reacted with triphenylphosphine (Scheme 22) [116]. The resulting
diethyl 1-(N-acetylamino)-1-triphenylphosphoniumalkylphosphonate tetrafluoroborates 43 reacted
smoothly with trialkyl phosphites, dialkyl phosphonites or alkyl phosphinites in the presence of
Hünig’s base and methyltriphenylphosphonium iodide as catalysts. This gave bisphosphonates 44,
1-phosphinylalkylphosphonates or 1-phosphinoylalkylphosphonates in good yields. This reaction has

































P(O)R1R2R R = H, CH3R1 = OEt, Ph
R2 = OEt, CH3, Ph




Scheme 22. Transformation of diethyl 1-(N-acetylamino)-1-alkylphosphonates into bisphosphoric acid
esters via the corresponding phosphonium salts.
Alkylation of tetraalkyl methylenebisphosphonate 45, a classical method for synthesizing variable
bisphosphonic acids, has been rarely used for the synthesis of amino derivatives. Thus, its direct
amination with the hydroxylamine ester of diphenylphosphinic acid, followed by its bromoacetylation
(Scheme 23), provided substrate 46 for functionalization into glycopeptide antibiotics, in the hope that
they will find an application as medication for osteomyelitis [117]. Another classical example is the
monoalkylation of tetraisopropyl methylenebisphosphonate with 1,6-dibromohexane, followed by
fluorination with Selectofluor and conversion of the remaining bromide into amine, which resulted in
compound 47 (Scheme 23) [118].




































Scheme 23. Synthesis of aminobisphosphonates via alkylation of tetraalkyl methylenebisphosphonates.
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An unusual procedure is metallacarbenoid insertion of aromatic amines into tetraethyl
diphosphonodiazomethane 48, which yields corresponding aminomethylenebisphosphonates 49











R = H, CH3
R1 = Ph, OCH3 NO2, ,
48 49
Scheme 24. N-H insertion of the reaction of aromatic amines.
A specific and unexpected reaction was the addition of silylated dialkyl phosphites to
4-phosphono-1-aza-1,3-dienes 50, which resulted in γ-phosphono-α–aminobisphosphonates 51
(Scheme 25) [120]. This reaction is interesting in that, depending on the steric demand of the substituent
present on nitrogen, double 1,2-addition or tandem 1,4-1,2-addition with formation of bisphosphonate













Scheme 25. Addition of phosphites to 4-phosphono-1-aza-1,3-dienes.
Additionally, the addition of phosphites to iminophosphonate esters has been studied.
This reaction is limited to specific substrates, and usually the obtained bisphosphonates 53 are unstable,
and phosphoryl C-N transfer to compounds 54 is observed (Scheme 26), which may be considered an















Ar = Ph, 4-Me-C6H4
Scheme 26. Addition of phosphites to iminophosphonates.
Finally, syntheses of rare aminomethyltrisphosphonates are presented in a recent review
by Romanenko and Kukhar devoted to applications of methylidynetrisphosphonates [124].
Two procedures for the synthesis of bis- and trisphosphonates 55 and 56 taken from this review
and described in patent literature are depicted in Scheme 27.
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Scheme 27. Syntheses of aminomethyltrisphosphonates.
3. Functionalization of Aminobisphosphonates
Bisphosphonates are known for their affinity to bone tissue, and thus their conjugation to
various drugs has been quite intensively studied; they are expected to serve as system-targeting
drugs [6]. Because dronic acids are produced at industrial scale and are thus readily available and
inexpensive, they are most frequently used for that purpose. However, their extreme hydrophilic
character means that they are practically insoluble in most organic solvents, which limits the use
of aqueous media or requires their conversion into phosphonate esters prior to functionalization.
Unfortunately, the methods for direct esterification of phosphonate moieties are scarce and usually
give unsatisfactory results; these esters must generally be synthesized independently.
Methods for functionalizing aminobisphosphonic acids with structurally variable molecules
were recently reviewed [12]; therefore, in this review, the methods arbitrarily chosen as the most
representative are reported.
3.1. Direct Acylation of Aminobisphosphonic Acids
Direct acylation of aminobisphosphonic acids is difficult because this reaction is accompanied
by the possible competitive acylation of phosphonic groups [125,126] and hydroxylic groups when
amino-1-hydroxy-1,1-bisphosphonic acids are substrates [126,127]. A representative example of this






























Scheme 28. Direct acylation of alendronic acid with indication of possible side-products.
Acylation of dronic acid salts with acyl chlorides in sodium hydroxide in water or in water/propanol
solutions is the simple Schotten-Baumann variant [127,128]. Acidification of the solution results in the
precipitation of the desired acids or their monosodium salts. To conjugate aminobisphosphonic acids
with molecules bearing carboxylic groups, classical coupling protocols used in peptide synthesis have
also been used. These include the activation of carboxylic groups with N,N’-dicyclohexylcarbodiimide
(DCC) [129,130]; the use of previously prepared succinimidate esters to obtain 21 extremely complex
fluorescent imaging probes (representative examples of a green fluorescent dye 58 and a red fluorescent
dye 59 are shown in Scheme 29) [131]; and N,N’-dicarbonylimidazole, which was used to conjugate
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59, derivative of Rhodamine Red -X
Scheme 29. Representative fluorescent imaging probes obtained via acylation of bisphosphonic acids
(green—carboxyfluoresceine fragment, red—rhodamine Red-X fragment).
Acylation of aminobisphosphonic acids with small acids, such as acrylic acid [133], chloroacetic
acid [134] or succinic acid [135], provided useful substrates for further functionalization of larger
molecules, such as macrocycles devised for lanthanide ion complexation, chitosan, and hyaluronan.
3.2. Direct Acylation of Tetraethyl Aminobisphosphonates
Esters are far more suitable substrates for acylation than free phosphonic acids, with tetraethyl
aminomethylenebisphosphonate being the most popular substrate. It has been used to obtain
structurally variable conjugates with estradiol (compounds 60, 61 and 62 in Scheme 30) using
classical peptide synthesis coupling agents such as DCC and DPPA (diphenylphosphoryl azide) [136].
These conjugates were synthesized as bone-specific estrogens in the hope that they will protect elderly























Scheme 30. Representative structures of bone-specific estrogens.
A derivative of raloxifene, a selective estrogen receptor or modulator, was obtained using
a suitable acid chloride as substrate [137], whereas radioligands, which are selectively bound to
bone tissue, have been synthesized by using DCC/HOBt (hydroxybenzotriazol) activation [138]
and antibacterial bisphosphonated benzoxazinorifamycin prodrugs using EDCl (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide) [139].
In this case, acylation of aminobisphosphonic acids with small acids was also applied as a starting
step to produce antibacterial agents against osteomyelitis [88] and bone imaging macrocycles [81],
using acid chlorides as acylating agents.
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Using DCC as a coupling agent, diethyl 1-(2-aminoethylamino)-1,1-ethylbisphosphonate was
acylated by structurally variable natural acids, such as folic acid [140,141], ursulonic and betulinic
acids [142], and trolox [141,143].
Acylation of pamidronic acid ester 22 by using HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate) was used to prepare a catecholic derivative, which was
then bound to the surface of magnetic iron oxide nanoparticles (Scheme 31) [144]. The particle 63 has

















































Scheme 31. Synthesis of bisphosphonate functionalized magnetic nanoparticles.
3.3. Synthesis of Building Blocks for Polymer Chemistry
Self-etching adhesives are polymeric materials containing phosphonate groups that have become
popular in restorative dentistry because they allow strong bonds between dental hard tissues (enamel
and dentin). One possibility for their preparation is to obtain monomers containing phosphonic
groups [145]. Such methacrylamide monomers 64 and 65 were synthesized by acylation with suitable
acryloylchlorides (Scheme 32) [146]. Studies of their photopolymerization indicated that they may be














Scheme 32. Bisphosphonylated methacrylamide monomers.
A similar monomer, acryloylated pamidronate, has been used to obtain a hyaluronic acid
derivative that is dually polymerized with cross-linkable hydrazide groups and bisphosphonate
ligands. By mixing bisphosphonate polymer with calcium ions and aldehyde-derivatized hyaluronic
acid, a hybrid hydrogel was obtained, which quickly mineralizes [147]. Such a system is of interest as
a mediator for fast bone regeneration.
By dispersion copolymerization of three monomers (methacrylate bisphosphonate 66, N-(3-
aminopropyl) methacrylamide 67, and tetra(ethylene glycol) diacrylate 68) (Scheme 33), polymeric
nanoparticles 69 were obtained [148]. Their size distribution was controlled by changing various
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polymerization parameters. By covalent attachment of a drug and/or a dye to amino groups (such as






































Scheme 33. Synthesis of polymeric nanoparticles as potential dye and drug carriers.
Macromolecular co-conjugates of bisphosphonate and ferrocene were synthesized by means
of Michael addition copolymerization of methylenebisacrylamide (MBA) with primary amines-6-
amino-1-hydroxyhexylidene-1,1-bisphosphonate and 4-ferrocenyl-butamidopropylamine [149].
The mass percentage incorporation of ferrocene analogues was found to be between 4%–5%,
and 10%–12% for bisphosphonate. Such polymers could be selectively bound to bone tissue and
slowly release anticancer ferrocene derivatives at this target site.
3.4. Miscellaneous
Other means to functionalize amino moieties are quite scarce and dispersed. Classical ones
include the formation of Schiff bases, which are then alkylated [150] or reduced [126], and synthesis of
thioureido derivatives as intermediates in the preparation of heterocyclic compounds [151–153].
The functionalization of polysaccharides is the gateway of aminobisphosphonates into
nanoscience. For example, phosphonated cellulose was utilized to obtain nanocellulose with good
thermal stability and potential intumescent properties. It was synthesized from birch pulp via
sequential periodate oxidation and reductive amination using alendronate 57 as a phosphonating
reagent (Scheme 34) [154]. After high-pressure homogenization, bisphosphonate cellulose nanofibers
























Scheme 34. Periodate oxidation of cellulose followed by reductive amination with sodium alendronate.
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Alendronate was also bound to conjugates of pullulan and paclitaxel, which were bound to the
polysaccharide by a cathepsin K-sensitive tetrapeptide spacer. This should ensure release of paclitaxel
in bones. Then, bisphosphonate was covalently conjugated to the sugar chain via a polyethyleneglycol
chain, using a technique similar to that described above (identical to those shown in Scheme 34) [155].
This system exhibited strong antiproliferative action against several cancer cell lines.
4. Conclusions
Aminobisphosphonic acids are gaining significant interest as a class of compounds with promising
physiologic activity, with some representatives already commercialized as bone resorption inhibitors,
and therefore useful drugs against osteoporosis and related bone disorders. This leads to both the
modification of existing and the elaboration of novel procedures for their preparation. There are
several commonly used reactions for this purpose; however, they have also been modified in the last
decade to be tailored to specific biological needs. A few novel procedures have also been developed.
Functionalization of simple aminobisphosphonic acids is a difficult task because of their strongly
polar character. However, successful examples of functionalization of the amino moieties of these
compounds have provided promising diagnostics and novel therapeutic agents.
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Olsen, J.R.; Meints, G.A.; Burzyńska, A.; et al. Activity of Bisphosphonates against Trypanosoma brucei
rhodesiense. J. Med. Chem. 2002, 45, 2904–2914. [CrossRef] [PubMed]
86. Sanders, J.M.; Gomez, A.O.; Mao, J.; Meints, G.A.; van Brussel, E.M.; Burzyńska, A.; Kafarski, P.;
Gonzalez-Pacanowska, D.; Oldfield, E. 3-D QSAR investigations of the inhibition of Leishmania major farnesyl
pyrophosphate synthase by bisphosphonates. J. Med. Chem. 2003, 46, 5171–5183. [CrossRef] [PubMed]
87. Ghosh, S.; Chan, J.M.; Lea, C.R.; Meints, G.A.; Lewis, J.C.; Tovian, Z.S.; Flessner, R.M.; Loftus, T.C.;
Bruchhaus, I.; Kendrick, H.; et al. Effects of bisphosphonates on the growth of Entamoeba histolytica and
Plasmodium species in vitro and in vivo. J. Med. Chem. 2004, 47, 175–187. [CrossRef] [PubMed]
88. Ling, Y.; Sahota, D.; Odeh, S.; Chan, J.M.; Araujo, F.G.; Moreno, S.N.; Oldfield, E. Bisphosphonate inhibitors
of Toxoplasma gondi growth: In vitro, QSAR, and in vivo investigations. J. Med. Chem. 2005, 48, 3130–3140.
[CrossRef] [PubMed]
89. Tanaka, K.S.E.; Houghton, T.J.; Kang, T.; Dietrich, E.; Delorme, D.; Ferreira, S.S.; Caron, L.; Viens, F.;
Arhin, S.S.; Sarmiento, I.; et al. Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the
prevention of osteomyelitis. Bioorg. Med. Chem. 2008, 16, 9217–9229. [CrossRef] [PubMed]
90. Forlani, G.; Petrolino, D.; Fusetti, M.; Romanini, L.; Nocek, B.; Joachimiak, A.; Berlicki, L.; Kafarski, P.
δ1-Pyrroline-5-carboxylate reductase as a new target for therapeutics: Inhibition of the enzyme from
Streptococcus pyogenes and effects in vivo. Amino Acids 2012, 42, 2283–2291. [CrossRef] [PubMed]
91. Brel, V.K. Synthesis of gem-bisphosphonates with (3-aryl-4,5-dihydroxisoxazol-5-yl)methylamino moiety.
Mendeleev Commun. 2015, 25, 234–235. [CrossRef]
92. Kosikowska, P.; Bochno, M.; Macegoniuk, K.; Forlani, G.; Kafarski, P.; Berlicki, Ł. Bisphosphonic acids as
effective inhibitors of Mycobacterium tuberculosis glutamine synthetase. J. Enzyme Inhib. Med. Chem. 2016, 31,
931–938. [CrossRef] [PubMed]
93. Lacbay, C.M.; Mancuso, J.; Lin, Y.-S.; Bennett, N.; Götte, M.; Tsantrizos, Y.S. Modular assembly of purine-like
bisphosphonates as inhibitors of HIV-1 reverse transcriptase. J. Med. Chem. 2014, 57, 7435–7449. [CrossRef]
[PubMed]
342
Molecules 2016, 21, 1474
94. Shaddy, A.A.; Kamel, A.A.; Abdou, W.M. Synthesis, quantitative structure-activity relationship, and
anti-inflammatory profiles of substituted 5- and 6-N-heterocycle bisphosphonate esters. Chem. Commun.
2013, 43, 236–252. [CrossRef]
95. Kafarski, P.; Lejczak, B.; Forlani, G. Herbicidally active aminomethylenebisphosphonic acids. Heteroat. Chem.
2000, 11, 449–453. [CrossRef]
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1. Introduction
The phenomenon of chirality plays a very important role in organic chemistry and biological
processes [1–5]. Therefore an easy access to chiral compounds, especially optically active species,
constitutes a vital challenge in modern synthetic organic chemistry. At least two reasons are responsible
for this fact. Firstly, single stereoisomers are used very often as active components in formulations
which serve as drugs, food additives or substances having the requested flavor or fragrance. The second
reason stems from their application as chiral catalysts in various asymmetric reactions [6,7]. Moreover,
detailed mechanistic description of a number of reactions would not be possible without taking into
account their stereochemical aspects. These can be studied only with the use of optically active species
which allow simultaneous application of kinetic and polarimetric measurements carried out with
the use of the suitably designated model substrates (enantiomerically or diastereomerically pure or
enriched samples) containing an appropriate chirality element [8]. In the organophosphorus chemistry
the phenomenon of chirality is very common among organic derivatives having different valency
and/or coordination number [9,10]. Their optical activity can be related to the presence of the following
elements of chirality:
(a) a stereogenic center (for trivalent, tricoordinated, tetravalent tetracoordinated, pentavalent
tetracoordinated derivatives)
(b) “trigonal bipyramidal chirality”
(c) “tetragonal bipyramidal chirality”
Organophosphorus derivatives in which optical activity results from the presence of a phosphorus
atom at a center of trigonal bipyramid, are commonly named phosphoranes [11,12]. They have the
general formula P(La)2(Le)3, where “a” means an axial position and “e” means an equatorial position
(Figure 1).
Molecules 2016, 21, 1573; doi:10.3390/molecules21111573 www.mdpi.com/journal/molecules347
Molecules 2016, 21, 1573
Figure 1. General formula of a phosphorus-containing trigonal bipyramid.
They constitute the family of hypervalent derivatives, showing “trigonal bipyramidal chirality”
in which the central phosphorus atom has expanded its valence shell from 8 to 10 electrons (the
concept was for the first time proposed by Musher in 1969) [13]. According to general systematic
scheme proposed by Martin and coworkers [14,15] [N-P-L (nAmB) coding system, in which N stands
for the number of valence electrons associated formally with a central phosphorus atom and L shows
the number of ligands (A and B stand for the bonding element)]—this group should be considered
as the family of 10-P-5 derivatives. The definition of hypervalency is also formally fulfilled by the
corresponding phosphonium ylides (in which a phosphorus atom has also expanded its formal valence
shell from 8 to 10 electrons). However, when one considers that the important resonance structures of
these compounds are polarized from phosphorus to carbon it becomes evident that they represent 8-P-4
species (Figure 2). Therefore they do not meet the condition of hypervalency and they are excluded
from this review.
Figure 2. Resonance structure of phosphonium ylides.
The nature of bonding of hypervalent derivatives is presented in details in a few chapters of
“The Chemistry of Hypervalent Compounds” [16,17] and more recently has again been studied using the
topological analysis of the electron localization function (ELF)” [18]. Their structure and reactivity are
dominated by the weak three-center-four-electron (3c-4e) bond. Its weakness results from the fact that
two of the four electrons that participate in the bonding are in a nonbonding molecular orbital.
Phosphoranes, like other compounds having a trigonal bipyramide (TBP) geometry can exist in
an enantiomeric form when the number of different ligands is sufficiently large to induce chirality of
such a structure. For 10-P-5 derivatives having the general structure with five substituents (Figure 1)
bonded to the central phosphorus atom the numbers of achiral and chiral structures are given in
Table 1. According to the Mutterties rule [19] in hypervalent structures the more electronegative
ligands tend to occupy the apical positions whereas the lone electron pair “should be located at the
equatorial position” [19]. Moreover, “five- and six-membered rings, which stabilize the hypervalent
molecules, span both the axial and equatorial positions” [14].
Table 1. Number of chiral and achiral species of 10-P-5 (TBP geometry).




PL13L2L3 2 achiral and 2 pairs of enantiomers
PL12L22L3 2 achiral and 3 pairs of enantiomers
PL12L2L3L4 1 achiral and 6 pairs of enantiomers
PL1L2L3L4L5 10 pairs of enantiomers
It is evident from this table that phosphoranes containing at least three different ligands can be
chiral and for structures PL12L22L3 chirality may appear in the symmetric bicyclic spiro derivatives
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(Figure 3). Therefore, from the synthetic point of view, hypervalent structures exhibiting chirality due to
the presence of one or two bidentate ligands should be more easily available than its acyclic analogues.
Figure 3. Chiral and achiral structure of hypervalent phosphoranes.
In hypervalent phosphoranes 10-P-5 the apical and equatorial ligands can be interchanged with
each other according to the Berry pseudorotation mechanism (BPR) [20–22] (Scheme 1) or by the
“turnstile” rotation mechanism (TR) proposed by Ugi and Ramirez [23–26] (Scheme 2). It should
be noted here that the very recent DFT calculations of the fluxional behavior of experimentally
known pentavalent molecules have suggested the equivalence of the turnstile rotation with the Berry
pseudorotation. This suggestion is based on identification of three principal mechanisms by which the
substituents interchange can be achieved (Berry pseudorotation, threefold cyclic permutation, and
half-twist axial-equatorial interchange) [27].
Scheme 1. Berry pseudorotation mechanism.
Scheme 2. “Turnstile” rotation mechanism (TR).
As early as 1949, Wittig and Rieber [28] reported isolation of pentaphenylphosphorane as
the first example of a pentacoordinated organophosphorus derivative. However, a real opening
in the hypervalent organophosphorus chemistry can be ascribed to a much later finding that the
Ramirez reaction affords oxyphosphoranes by an oxidative addition of α-diketones to trivalent
phosphines [29,30] and Westheimer’s proposal that a pentacoordinate phosphorane (able to
stereomutate by pseudorotation) is involved in the hydrolysis of phosphoric esters [31]. Since that
time, studies devoted to the synthesis, structural determinations, stereochemistry and reactivity of
this group of the organophosphorus derivatives, have been carried out in a number of academic
and industrial laboratories. Their results are regularly published in renowned chemical journals and,
fortunately for those who work on these topics, are regularly presented in the chapters devoted to
penta- and hexacoordinated organophosphorus derivatives included in the subsequent volumes of
RSC monographic series “Organophosphorus Chemistry” [32–43]. In this respect, a very recent review
highlighting methods for the asymmetric synthesis of P-chiral pentacoordinated spirophosphoranes
should also be mentioned [44].
2. Chiral Hypervalent Phosphoranes and Their Anions
2.1. Chiral Phosphoranes as Reactive Intermediates
In most cases the papers describing the involvement of unstable chiral phosphoranes as reactive
intermediates tackle the problem of the mechanism of SN-P reactions. This is connected with the fact
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that a nucleophilic substitution at phosphorus can occur either synchronously according to an SN2-P
mechanism or in a stepwise manner by an addition-elimination mechanism (A-E). The later involves
formation of a phosphorane as an intermediate, by the addition of a nucleophiles (Nu) to a chiral
substrate. It is now generally accepted that diaxial or diequatorial disposal of entering “Nu” and
leaving “L” groups in a trigonal bipyramidal structure of a transient or intermediary phosphorane
should lead to inversion of the configuration at phosphorus while the steric course of axial-equatorial
substitution (which is possible if a phosphorane intermediate undergoes pseudorotation) is predicted
to be a retention (Scheme 3).
 
Scheme 3. Possible mechanism for nucleophilic substitution reaction at phosphorus.
The stereochemical consequences (retention or inversion) of such substitution reactions may be
conveniently discussed with the aid of the Desargues–Levi graph [45], which originally was proposed
by Mislow [46] for stereoisomerization of pentacoordinate phosphoranes.
The participation of such chiral phosphoranes I–V as intermediates and their pseudorotation
was suggested by Juge and coworkers [47] to explain retention of configuration during the
rearrangement of the lithium salts 2a–c derived from the 2-bromophenylphosphinite boranes 1a–c to
the o-hydroxyphenylphosphine boranes 3a–c induced by halogen–metal exchange (Scheme 4) [47].
Scheme 4. The rearrangement of the lithium salts 2a–c derived from the 2-bromophenylphosphinite
boranes 1a–c to the o-hydroxyphenylphosphine boranes 3a–c.
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Earlier the same group proposed that pseudorotation of the intermediate phosphoranes VI, VII
was responsible for predominant retention of configuration during the regiospecific ring opening
reaction of the diastereomerically pure dioxaphospholane borane 4 with organolithium reagents which
afforded phosphinite boranes 7a,b (Scheme 5) [48].
Scheme 5. Stereochemical outcome of the regiospecific ring opening reaction of the diastereomerically
pure dioxaphospholane borane 4 with organolithium reagents.
As another example of such a transformation, hydrolysis of quasiphosphonium salts, cis- and
trans-3-methoxy-2,2,6-trimethyl-3-phenyl-1,3-oxaphosphorinanium tetrafluoroborate salts 8a and 8b
can be presented, by which the corresponding phosphine oxides 9a and 9b were formed with complete
retention of configuration at phosphorus. The detailed NMR and stereochemical studies allow
rationalization of the stereochemical outcome of this reaction in terms of the addition-elimination
mechanism, A-E, involving two hydroxyphosphorane intermediates 10a and 10b (that are able to

















































Scheme 6. The hydrolysis of quasiphosphonium salts 8a and 8b involving two hydroxyphosphorane
intermediates 10a and 10b.
Similarly, the participation of the chiral hydridophosphorane 12 as an intermediate in the
intramolecular transesterification of the 2-hydroxyphenyl phosphite 11 to the 3-hydroxypropyl
phosphite 13 (Scheme 7) was supported by low temperature 31P-NMR measurements [50].
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Scheme 7. The intramolecular transesterification of the 2-hydroxyphenyl phosphite 11.
Earlier, the participation of chiral hydridophosphoranes was proposed in the intermolecular
transesterification of chiral asymmetric phenyl phosphites [51] and in the addition of achiral
alcohols to compounds having a stereogenic tricoordinated phosphorus atom [52] and very recently
in the hydrolysis of a trinucleoside monophosphate by the intramolecular 2α-hydroxy group
neighbouring the scissile phosphodiester linkage [53]. The regioselective formation of chiral
3-hydroxypropylphosphinates 17 from cyclic oxaphospholane 14 and Grignard reagents was explained
by assuming that during the reactions a pentavalent TBP phosphorane intermediate 15 is formed,
which could not undergo pseudorotation to generate another phosphorane 16 due to a high energetic
barrier. Therefore, the endocyclic P–O bond in 15 is cleaved almost exclusively to form the phosphinates
17 in high yields (Scheme 8) [54].
Scheme 8. Reaction of cyclic oxaphospholane 14 and Grignard reagents.
2.2. Chiral Phosphoranes and Their Anions as Isolable Species
As it was mentioned above, from the synthetic point of view, hypervalent structures exhibiting
chirality due to the presence of one or two bidentate ligands should be more easily available than
their acyclic analogues. Therefore, the majority of isolated hypervalent phosphoranes constitute mono-
and especially bicylic derivatives in which a cyclic frame include pentacoordinated phosphorus atom
bonded to a carbon and/or heteroatoms.
2.2.1. Chiral Monocyclic Phosphoranes and Their Anions as Isolable Species
The non-concerted [2 + 2] cycloaddition reaction of P-haloylides 18 with trifluorometyl ketones
led to the stereoselective formation of monocyclic halophosphoranes 19 (Scheme 9) [55].
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Scheme 9. Monocyclic halophosphoranes 19.
The monocyclic vinyl phosphoranes 21 were prepared by the reaction of cyclic phosphite 20 with
dimethyl acetylenedicarboxylate in the presence of the appropriate phenol (Scheme 10) [56].
Scheme 10. Reaction of cyclic phosphite 20 with dimethyl acetylenedicarboxylate.
The formation of monocyclic phosphorane 23 was observed in the reaction of ylide 22 with
hexafluoroacetone (Scheme 11) [57].
Scheme 11. Reaction of ylide 22 with hexafluoroacetone.
A similar reaction of ylide 24 with hexafluoroacetone gave monocyclic phosphorene 25
(Scheme 12) [57].
Scheme 12. Reaction of ylide 24 with hexafluoroacetone.
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The tricoordinate organophosphorus derivatives 26a–c were found to react with hexafluoroacetone
to give chiral monocyclic phosphoranes 27a–c (Scheme 13) in which no ligand exchange processes
were observed at room temperature. However, the chiral phosphonic acid ester 29 was isolated upon
hydrolysis of the chlorophosphorane 27a, which proceeds most probably via hydroxyphosphorane 28
(Scheme 13) [58].
Scheme 13. Reaction of organophosphorus derivatives 26a–c with hexafluoroacetone.
Preparation of monocyclic halophosphoranes 31a,b and 31c was based on the reaction of
the tricoordinate phosphinites 30a,b with benzyl chloride or benzyl bromide. The corresponding
fluorophosphoranes 31d or 31e were isolated upon the chloride-fluoride or bromide-fluoride exchange
reactions when the chloride 31a or bromide 31c were used as a substrate respectively (Scheme 14) [59].
Scheme 14. Preparation of monocyclic halophosphoranes 31a–e.
Monocyclic (ethylthio)fluorophosphorane 34 was isolated in quantitative yield upon fluoride
anion abstraction from BF4 counter anion of phosphonium salt 33 easily generated by the reaction
of cyclic phosphinothionate 32 with triethyloxonium tetrafluoroborate. Defluorination of the
fluorophosphorane 34 with trimethylsilyl trifluoromethanesulfonate gave phosphonium salt 35 [60]
(Scheme 15).
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Scheme 15. Preparation of monocyclic (ethylthio)fluorophosphorane 34.
2.2.2. Chiral Bicyclic Phosphoranes and Their Anions as Isolable Species
A relatively rich number of isolable bicyclic hypervalent phosphoranes have been well
documented in the older and more recent chapters by Hellwinkel [61], Burger [62], Holmes [63],
Husband and McNab [64], Burgada and Setton [65], Akiba [16], and Kawashima [66]. These chapters
mention, more or less extensively, chiral bicyclic phosphoranes, but without deeper comments devoted
to the phenomenon of chirality in such derivatives. Therefore, in this part of our compilation we
are going to present, as comprehensively as possible, isolable hypervalent derivatives in which their
chirality results from the presence of two heterocyclic units forming a P-spiro system. They are divided
in accord with the commonly accepted Martin’s N-P-L (nAmB) coding system, in which N stands for
the number of valence electrons associated formally with a central phosphorus atom and L shows the
number of ligands (A and B stand for the bonding element) [14].
10P-5C Phosphoranes
Hellwinkel as early as 1966 reported on the isolation of the first optically active
pentaarylphosphorane. Initially, hexacoordinate phosphorane potassium salt 37 was synthesized
in good yield in racemic form by the reaction of bis(biphenyl)phosphonium iodide 36 with 2,2′-dilithio-
4-methyl-biphenyl. The optical resolution of the racemic salt 37 was based on its conversion into
two diastereomeric ammonium salts by the treatment with N-methylammonium iodide derived
from brucine. The isolation of the levorotatory diastereoisomer ([α]578 = −1200) was achieved in
moderate yield by recrystallization of a crude crystalline fraction from acetone. The dextrorotatory
diastereoisomer of the ammonium salt was isolated from a mother liquor in poor yield and with
a lower optical purity ([α]578 = +986). The isolated diastereoisomers were reconverted into the
enantiomeric potassium salts upon the treatment with potassium iodide in acetone followed by
repeating crystallizations. Their maximum specific rotation reached values [α]578 = + and −1870.
Acidification of optically active potassium salts of hexacoordinate phosphorus derivatives (+) and
(−)-37 with HCl in methanol/acetone solution provided the mixture of spirophosphoranes from
which enantiomeric spirophosphoranes 38 having [α]578 = + and −94, respectively were isolated by
multiple recrystallization (Scheme 16). Additionally, the structure of 38 as a racemate was confirmed
by the alternative method for its preparation using biphenyl-biphenylyl-2-phosphine 39 as the starting
material (Scheme 17) [67].
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Scheme 16. Preparation of enantiomeric spirophosphoranes 38.
 
Scheme 17. Preparation of 38 using biphenyl-biphenylyl-2-phosphine 39.
More recently the reaction of spirocyclotetraalkylphosphonium salts 41 with a series of
organolithium reagents RLi, was found to give spirobicyclophosphoranes 42a–e in good to low yields
(Scheme 18). Single crystal X-ray analysis of 42a showed a TBP geometry with the axial-equatorial
rings and the methyl group in an equatorial position. Low temperature NMR measurements indicated
that all the pentacoordinate structures 42 show fluxional behaviour in a solution with a very low
pseudorotation barrier [68].
 
Scheme 18. Reaction of spirocyclotetraalkylphosphonium salts 41 with a series of organolithium reagents.
10P-4C-1O Phosphoranes
Oxaphosphetane (OPA) is a widely recognized intermediate formed via an irreversible [2 + 2]
cycloaddition of an aldehyde or ketone with the phosphonium ylide in the Wittig reactions.
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The stereoselectivity of the reaction is decided by the course of the first irreversible step. Then,
the oxaphosphetane undergoes irreversible [2 + 2] syn cycloreversion to give an alkene and
phosphine oxide. In most cases the diastereomeric ratio of the oxaphosphetane (OPA) intermediate
exactly corresponds to the final alkene, except the cases when a stereochemical drift occurs in the
formation of the alkene product. The process “stereochemical drift” refers to the nonstereospecific
decomposition of the oxaphosphetane (OPA) intermediate in reactions of certain alkylides with
certain aldehydes. The particular investigations on the stereochemical drift in the Wittig reactions
(alkylidenephosphonium ylide with aldehydes) under Li-salt-free conditions were undertaken by
D. G. Gilheany et al. [69], and based on Variable-Temperature NMR measurements. A particularly
suitable candidate for the study of stereochemical drift was intermediate 44a formed in the reaction of
biphenylphenylethylidene-phosphonium ylide 43 with 2-bromobenzaldehyde. It is due to its stability
at room temperature (Scheme 19). It undergoes significant stereochemical drift on decomposition
in THF at reflux: A sample containing cis- and trans-44a in a ratio of 94:6 gave alkenes of a (Z)/(E)
ratio 82:18 under reflux conditions. On the other hand, the decomposition conducted at 50 ◦C was
not complete after 6d, but the maximum possible (Z)/(E) ratio that could have been achieved in
this reaction was 88:12, revealing that a smaller amount of the stereochemical drift had occurred.
A very similar experiment supported with VTNMR spectra analysis over the temperature range −20 to
+40 ◦C on 44b (produced in the reaction of biphenylphenylethylidenephosphonium ylide 43 and
benzaldehyde) was performed. Oxaphosphetane intermediate 44b was formed in a diastereomeric
ratio 71:29 (cis/trans). Again, the ratio of OPA, ylide and phosphine oxide was invariant within the
temperature range from −20 to 30 ◦C, which indicates that no decomposition to alkene and phosphine
oxide occurred. On heating the OPA 44b was decomposed to produce the alkene in 53:47 (Z)/(E)
isomeric ratio. In the 31P NMR spectra recorded for 44a and 44b in the presence of an excess aldehyde
additional signals appeared in the pentavalent region (δ = −50 to −80 ppm). The observation was
consistent with that reported earlier by Vedejs et al. [70]. Thus, the apparent interaction between OPA
and aldehyde was expected to have an impact on the occurrence of the stereochemical drift.
Scheme 19. Reaction of biphenylphenylethylidene-phosphonium ylide 43 with benzaldehydes.
10P-3C-1N-1O Phosphoranes
In 1996 Kawashima and Okazaki succeeded in preparing pentacoordinate N-apical
1,2-azaphosphetidines, whose structures were fully characterized. They also investigated their
thermolysis. The first observation on the occurrence of the N-equatorial pseudorotamers was also
reported [71]. The synthetic pathway was as follows: the treatment of 2-(methylphenylphosphinyl)-α,
α-bis(trifluoromethyl)phenylmethanol 45 with n-BuLi led to the generation of methylene carbanion
species, which subsequently underwent nucleophilic addition to a Schiff base providing the
β-aminoethyl derivative 46. 1,2-Azaphosphetidine 47 was formed in 93% yield by intramolecular
cyclization followed by dehydration under the Mitsunobu reaction condition (Scheme 20).
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Scheme 20. Synthesis of 1,2-Azaphosphetidine 47 and 48.
A typical chemical shift in the NMR spectra was observed for compounds with a TBP geometry
in which an apical position was occupied with O or N atom. X-ray single crystal analysis revealed
the distorted TBP geometry with phosphorus as a central core. Hydrolysis of 47 on silica gel resulted
in its cycloreversion to the starting material 46. Finally, 1,2-azaphosphetidine 47 was converted
into the 3-methoxycarbonyl derivative 48, likewise it had been reported, for the corresponding
1,2-λ5-oxaphosphetanes [72,73]. In the 31P-NMR spectrum recorded for the solution of 47 in deuterated
toluene, apart from the appropriate resonance signal (δP = −29.9), another upfielded peak (δP = −50.9),
was observed which was assigned to the N-equatorial pseudorotamer 49 (Scheme 21). A similar
pseudorotamer (δP = −51) was observed also in the case of 48.
Scheme 21. The equilibrium between phosphoranes 47 and 49.
Thermolysis of 47 or 48 proceeded with the quantitative formation of the corresponding alkenes
and iminophosphorane (Scheme 22), which implies that azaphosphetidines should be considered as
aza-Wittig intermediates.
Scheme 22. Thermolysis of 47 or 48.
The reaction of an iminophosphorane, the nitrogen analogue of a phosphonium ylide, with
a reactive alkyne has been intensely studied because it constitutes a useful synthetic pathway for
the corresponding α-iminoalkylidenephosphoranes via a [2 + 2]-cycloadduct. The intermediate had
neither been observed nor isolated until the first stable pentacoordinate l,2-λ5-azaphosphetine 51 was
synthesized by Kawashima et al. [74]. Its preparation was achieved by the cycloaddition reaction of
the Martin ligand-based iminophosphorane 50 with an alkyne (Scheme 23). X-ray crystallography of
51 showed a distorted TBP with N and O atoms at the apical positions. The variable temperature 31P
NMR spectra of 51 in C7D8 or CD3CN showed a shift to a lower field with decreasing temperature
indicating that (51) was in an equilibrium with the corresponding ylide structure 52.
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Scheme 23. Cycloaddition reaction of the iminophosphorane 50 with an alkyne.
The isomerization and thermal decomposition of isolable spiro-1,2-oxaphosphetanes has been
studied in details with the aim to recognize a stereomutation mechanism of spiro-1,2-oxaphosphetanes,
the Wittig intermediate products. Spiro-oxaphosphetanes 54–58, stabilized by the presence of the
o-benzamide moiety, were found to be good candidates for the studies [75]. The OPA’s 54–56 were
obtained according to the previously reported procedure [76] (Scheme 24). The reactions with the
hindered ketone, L-(−)-camphor, gave products 57 and 58 (in a 45:55 ratio) arising from the endo attack
at the CO group of L-camphor.
 
Scheme 24. Synthesis of spiro-oxaphosphetanes 54–58 and their thermal decompositions.
All thermal decompositions of OPAs 54–58 furnished the appropriate alkenes and a phosphinamide,
quantitatively. On the thermolysis of 55–58, partial isomerization to 55a–58a was observed, which
resulted in the inverted configuration at phosphorus atom. It has been found that oxaphosphetane
decomposition took place in a single step via a polar transition state. For the first time the
stereomutation through three possible mechanisms MB2, MB3, and MB4 involving two, three, and four
Berry pseudorotations (at phosphorus atom), respectively, supported by DFT calculations has been
evidenced [75].
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10P-3C-2O Phosphoranes
The first configurationally stable enantiomeric pair of 10-P-3C-2O phosphoranes with well-defined
sole stereogenic centre at phosphorus atom was successfully obtained and characterized by
Akiba et al. [77]. The synthesis of diastereomeric 60-(RP) and 60-(SP) was achieved via a facile
alkylation of the in situ generated phosphoranide anion by (−)-menthyl chloroacetate in 87% yield
(Scheme 25). The diastereomeric mixture could be resolved effectively by fractional crystallization
to furnish 60-(RP) in 25% and 60-(SP) in 22% yield. Thus, the separation and the selection of suitable
crystals allowed for the determination of absolute configurations for both diastereoisomers by X-ray
diffraction. The alkylation of P–H phosphorane derivatives was recognized to proceed with complete
retention of configuration at the phosphorus sterereogenic centre, most probably due to no detectable
racemization at the step of phosphoranide intermediate formation.
Scheme 25. Synthesis of diastereomeric phosphoranes 60 and enantiomeric phosphoranes 61.
The removal of the menthyl unit by treating the diastereoisomers 60-(RP) and 60-(SP) with
an excess of LiAlH4 provided the enantiomerically pure phosphoranes 61-(RP) and 61-(SP), respectively,
with a single chirality center at the pentacoordinated phosphorus atom. In order to verify enantiomeric
purity of the obtained P-chiral 2-hydroxyethylphosphoranes 61, they were converted into the (R)-(+)
Mosher esters 62 using (R)-(+)-2-methoxy-2-(trifluoromethyl)phenylacetic acid chloride ((+)-MTPA-Cl))
(Scheme 26) [78].
Scheme 26. Conversion of phosphoranes 61 to esters 62.
Independently, the H-phosphorane 59 was converted (by the treatment with n-BuLi) into an anion,
which was reacted with CH2I2 affording the alkylating product 63 in 82% yield. Subsequently
α-iodomethyl phosphorane derivative was treated with α-methylbenzylamine to give a diastereomeric
mixture of 64 in 56% yield (Scheme 27). The pure diastereoisomers were isolated by recrystallization
and their absolute configuration was determined by X-ray analysis.
It was also found that deprotonation of the nitrogen-bonded proton in each single diastereomer
64 afforded enantiomeric phosphoroanidates 65-(RP) and 65-(SP) (via imine elimination). They, after
acidification, gave the desired optically active P-H phosphoranes 59-(RP) and 59-(SP) (Scheme 28).
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Scheme 27. Synthesis of diastereomeric phosphoranes 64.
Scheme 28. Conversion of diastereomeric phosphoranes 64 to enantiomeric phosphoranes 59.
Later on, Akiba and co-workers reported the first example of an “anti-apicophilic” (O-cis)
spirophosphoranes 67 [79–81], in which the oxygen atom occupies an equatorial position and the
carbon atom is located in an apical position of a five membered ring, which is in contrast to the general
concept of apicophilicity. According to the procedure shown in Scheme 29 (O-cis) phosphoranes 66
were obtained. The treatment of P–H phosphorane 59 with an excess of alkyl(aryl)lithium resulted
in the formation of a dianionic intermediate which upon treatment with I2, as an oxidizing agent,
afforded P–I equatorial phosphorane. Its cyclization, initiated by the nucleophilic attack of the alkoxide
anion at the phosphorous centre and the simultaneous extrusion of I− produced O-cis-alkyl-or aryl
spirophosphoranes 66.
 
Scheme 29. Synthesis of (O-cis) spirophosphoranes 66 and their stereomutation to (O-trans)
phosphoranes 67.
The effects of substituents in the monodentate aryl ring of O-cis arylphosphoranes on the
stereomutation process, along with a kinetic study on the stereomutation of O-cis 66k–n to O-trans
67k–n were studied in details. The exclusive generation of O-cis 66 could be observed for the
alkyl derivatives 66a–c right after oxidation, however, in the case of the phenyl derivative 66d the
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O-cis isomer was the minor product. The pseudorotation to O-trans 67d isomer was complete in
30 min at room temperature, which could be explained by the higher apicophilicity of aryl groups
in comparison to alkyl groups. For compounds 66e–g, bearing electron donating groups (tBu, OMe,
NMe2, respectively) in the 4-position of the monodentate aryl groups O-cis isomers were the major
products. Finally, the use of bulky aryl organometallic reagents containing two substituents in ortho
positions led to the exclusive formation of the O-cis isomers (66i–n), having the sufficient lifetimes for
characterization. From the relative stability of 66i–n, it is evident that steric effects contributed mainly
to the stabilization against pseudorotation in these isomers that exhibited reversed apicophilicity.
In the case of 66n, pseudorotation was slow enough to allow for its isolation (purification on silica
gel in 71% yield) and the crystal structure determination by X-ray diffraction. The differences in
the reactivity of O-cis-66b and O-trans-67b toward nucleophiles were also indicated (Scheme 30).
The reaction of O-cis-66 with TBAF as a nucleophile afforded the hexacoordinated phosphate 68 with
the newly formed P–F bond while the trans-isomer did not react. Rapid decomposition of 68 caused
by the presence of traces of water was observed. O-Cis 66b likewise was reacted with MeLi to give
product 69, while O-trans-67b treated with organolithium reagent remained unreacted under the same
conditions; however by increasing MeLi molar equivalency and temperature the product 69 was
successfully isolated.
Scheme 30. Reactivity of O-cis-66b and O-trans-67b toward nucleophiles.
A three-component reaction of phosphoranide 70, silane 71, and THF was applied for the
preparation of hypervalent compound 72 containing simultaneously pentacoordinated phosphorus and
silicon atoms (Scheme 31) [82,83]. The 31P-NMR spectrum indicated the presence of two diastereomeric
products in a ratio of 1:1.
Scheme 31. Reaction of phosphoranide 70 with silane 71.
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The synthesis of other phosphoranylalkoxysilicates was achieved by the nucleophilic addition
of phosphoranylalkoxides generated from hydroxy(alkyl)phosphoranes 61 and 73a–c to silane
74 (Scheme 32). Hydroxy(alkyl)phosphoranes 61 and 73a–c were prepared by deprotonation of
hydrophosphorane 59 with DBU and subsequent treatment with an electrophile, such as hydrogen
peroxide, formaldehyde, 2-bromoethanol, and 4-bromobutanol, respectively. Their treatment with
KH in the presence of 18-crown-6 followed by the addition of silane 71 in THF afforded the
appropriate phosphoranyloxysilicate 74a (56%), and phosphoranylalkoxysilicates 74b,c and 72
(53%–96%). Potassium silicates 74a–c were obtained as a mixture of two diastereomers (in ratios
of 66:34 for 74a, 53:47 for 74b, 50:50 for 74c, respectively), as estimated by the integrals in the 31P-NMR
spectra [82,83].
Scheme 32. Reactivity of phosphoranes 59, 61 and 73.
More recently, studies on spirophosphoranes, prepared from a new bulkier analogue of the
Martin ligand containing two decafluoroetyl units, have been carried out by the Yamamoto group.
This new ligand was expected to suppress BPR more efficiently than the Martin ligand [84].
The synthesis of P–H-spirophosphoranes 75a,b was based on a two-step reaction involving
dimetallation of perfluorocumyl alcohol derivatives leading to the corresponding dianion and its
subsequent condensation with PCl3, followed by acidification with 6 molar HCl. The O-equatorial
spirophosphoranes 76a,b were obtained by the reaction of 75a,b with 3 molar equivalents of RLi
followed by the oxidation with I2. Their conversion to the corresponding O-apical stereoisomers 70a,b
proceeded in the solution at high temperatures. The stereomutation of 76a-1 to 77a-1 was found to
proceed with first–order kinetics. The free energy of activation for stereomutation was higher by
3.6 kcal/mol in comparison with the CF3 analogue indicating that steric hindrance of pentafluoroethyl
group is the major factor for freezing pseudorotation. Recently, Jiang and coworkers [85] obtained
a new stable anti-apicophilic phosphorene 76b with four bulky n-C3F7 groups, which was converted
to more stable O-apical phosphorane 77b only by heating, (Scheme 33).
Scheme 33. Synthesis of phosphoranes 76 and 77.
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The same research group elaborated the synthesis of a series of anti-apicophilic phosphoranes
bearing a para-substituted aryl group (–C6H4(p-X); X = H, CF3, F, OMe) or a mesityl group as a more
electronegative monodentate ligand than an alkyl group. The O-equatorial arylphosphoranes 69c–g
were successfully synthesized by the reaction of the P-H spirophosphorane 68a with an excess of
ArLi, followed by treatment with I2 (Scheme 34) [86]. These phosphoranes were found to be stable
at r.t. Their isolation indicates that the steric effect of the C2F5 groups for freezing the isomerization
is remarkable. By heating in an organic solvent the O-equatorial arylphosphoranes 69c–g were
quantitatively converted into the more stable O-apical isomers 70c–g. The effect of a solvent and
a para-substituent on the rate of the isomerization were also investigated in order to provide an insight
into the π → σ* P–O interaction in the O-equatorial arylphosphoranes. The kinetic study showed
a small para-substituent effect on the stereomutations. However, the multi-regression analysis for
the para substituents revealed the 1.3 times greater contribution of the resonance effect on the on
the isomerization rate in C6D6 than the inductive effect suggesting that the π → σ* P–O stabilizing
interaction in the O-equatorial isomer plays some role in the isomerization.
 
Scheme 34. Synthesis of phosphoranes 76 and their interconversion into 77.
In this context it is interesting to note that the O-equatorial methylphosphorane 76a treated
with MeLi was converted to the more stable O-apical isomer 77a, but on the contrary, the O-apical
phosphorane did not react with MeLi at all (Scheme 35) [87].
Scheme 35. Methyllithium induced epimerization of O-equatorial methylphosphorane 76a.
Deprotonation of methylphosphorane 76a at the methyl group using superbase (t-BuOK/n-BuLi)
led to the corresponding α-anion, which upon treatment with electrophilic agents gave new
phosphorane derivatives 78 and/or 79 (Scheme 36). The O-equatorial and O-apical phosphoranes
having a β-hydroxyethyl group were synthesized according to this procedure using paraformaldehyde
and applied as monodentate ligands [87].
Akiba et al. reported the preparation and characterization of an anti-apicophilic spirophosphorane
bearing an oxaphosphetane ring and the Martin ligand [88]. Although the substitution pattern on the
phosphorus atom slightly differs from that of oxaphosphetane in the typical Wittig reaction they can
be considered as a model for the possible reactive intermediate for the Wittig reaction.
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Scheme 36. Synthesis of phosphorane derivatives 78 and/or 79.
The synthesis of isomeric mixture of oxaphosphetane 80a and 80b in 1:1 ratio was achieved by the
oxidation procedure using n-BuLi followed by iodine in ether (Scheme 37). The sole anti-apicophilic 80a
isomer was isolated from the reaction mixture by crystallization upon addition of hexane. Under acidic
conditions 80a underwent complete stereomutation to 80b. A similar conversion took place within
minutes upon dissolution of 80a in anhydrous CDCl3 at room temperature. A 31P-NMR measurement
of the 80b sample heated to 120 ◦C in p-xylene did not show the presence of 80a in equilibrium,
indicating that 80a is thermodynamically much less favorable than its O-apical isomer. Moreover,
heating a solid sample of 80a at 120 ◦C for 5 min. gave only 80b as a result of pseudorotation.
Scheme 37. Synthesis of isomeric mixture of oxaphosphetane 80a and 80b.
The synthesis of pentacoordinate phosphirenes 82a and 82b bearing a phenyl group on the
phosphorus atom was achieved by the reaction of tricoordinate phosphirenes 81a and 81b with
o-chloranil (Scheme 38) [89].
 
Scheme 38. Reaction of phosphirenes 81a and 81b with o-chloranil.
The formation of 82c was evidenced by 31P-NMR spectrum that showed a suitable signal at
δP −92.7. It was converted rapidly to phosphorane 83 bearing two tetrachlorocatecholate ligands.
For relatively more thermally stable phosphirene 82a the crystal structure was determined by X-ray
analysis. It showed that phosphirene 82a has a highly distorted square pyramidal SP arrangement
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at the phosphorus atom as a core. The basal positions are occupied by two oxygen atoms from
the tetrachlorocatecholate ligand and two carbon atoms belonging to the three-membered ring of
phosphirene, when the phenyl group is located at the apical position. No decomposition was observed
for 82a after heating at 60 ◦C for 40 h. On the other hand, phosphirene 82b was thermally less
stable, and decomposed at room temperature to give the o-chloranil derived phenylphosphinite and
phenyl(trimethylsilyl)acetylene. These results indicate that an attachment of a trimethylsilyl group to
the endocyclic carbon lowers the thermal stability of the pentacoordinate phosphirenes.
10P-3C-1O-1Se; 10P-3C-1O-1S; 10P-3C-1O-1F; 10P-3C-1O-1H Phosphoranes
The synthesis of the first 1,2-σ5−selenaphosphirane and 1,2-σ5-thiaphosphirane involving
a pentacoordinate phosphorus atom was based on the reaction of the Martin ligand based phosphorus
ylide with elemental selenium [90], CpTiSe5 [91] or elemental sulfur [92]. Treatment of ylide 84 with 1.6
equiv. of elemental selenium in THF at room temperature or with Cp2TiSe5 under the same conditions
resulted in the formation of selenaphosphirane 85 as a solid in 96% and 85% yield, respectively (Scheme 37).
Although the selenaphosphirane 85 is highly moisture-sensitive, its isolation was successful under an
argon atmosphere and its structure was crystallographically characterized. Both, the solid-state 31P{1H}
NMR spectrum and the 31P{1H} NMR spectrum of the C6D6 solution showed a single peak with chemical
shifts at −26.1 and −26.6, respectively. This was considered as evidence for the pentacoordinate state
of the phosphorus atom of the selenaphosphirane. It is interesting to note that in the 77Se{1H}-NMR
spectrum (the resonance signal at δSe 147.5 in C6D6), the coupling constant between the phosphorus
and the selenium nuclei was not observed. This selenaphosphirane upon treatment with methyl triflate
in CDCl3 afforded the highly air-sensitive α-(methylseleno)-α-methylethyl phosphonium triflate 86
in 76% yield (Scheme 39). The formation of 86 was initiated by the electrophilic attack of methyl
triflate on the negatively charged selenium atom in 85 and proceeded with the subsequent cleavage
of the polarized P–Se bond. In a similar manner the thiaphosphirane 87 was prepared in 68% yield,
by the reaction of the ylide 84 with 0.96 equivalent of elemental sulfur in THF at −30 ◦C for 7 h
(Scheme 39). Thiaphosphirane 87 was found to be air-sensitive and its single crystal was obtained by
recrystallization from hexane under an argon atmosphere. Its X-ray crystallographic analysis showed
that the oxygen and sulfur atom are located at apical positions.
 
Scheme 39. Reactions of monocyclic phosphorus ylide 84.
Thiaphosphirane 87 showed inertness toward triaryl- or trialkylphosphines. This is in a contrast
to tri- and tetracoordinate thiaphosphiranes which underwent desulfurization to form phosphaalkene
derivarives and phosphine sulfides [93]. When the thiaphosphirane 87 was treated with additional
portion of elemental sulfur the corresponding phosphinothionate 88 was isolated in 72% yield.
The independent experiment showed that the phosphorus ylide 84 treated with 2 equiv. of elemental
sulfur provided phosphinothionate 88 in 31% yield.
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10P-2C-2N-1O; 10P-2C-1N-2O Phosphoranes
The reactions of iminophosphorane bearing the Martin ligand and a bulky 2,4,6-triisopropyl-phenyl
group with a ketone, an isothiocyanate and an alkyne has been found to proceed with the
formation of the corresponding cycloadducts as novel heterocycles bearing pentacoordinated
phosphorus atom [94,95]. Cyclic iminophosphinate 89 reacted with carbonyl compounds, phenyl
isothiocyanate and phenylethynyl trifluoromethyl sulfone affording the appropriate cycloadducts:
1,3,2λ5-oxazaphosphetidines 90a–c, 1,3,2λ5-diazaphosphetidine-4-thione 91, 1,2λ5-azaphosphetine
92, respectively. The reaction with hexafluoroacetone proceeded at room temperature yielding
cyclic phosphorane which could be even purified by silica gel chromatography. With dimethyl
acetylenedicarboxylate (DMAD) and water the reaction provided 1,2λ5-oxaphosphol-5(2H)-one 93
instead of the expected 1,2-azaphosphetine (Scheme 40).
Scheme 40. Syntheses of bicyclic phosphoranes 90–93.
Thermolysis of 90c at 140 ◦C in a sealed tube gave the corresponding imine 94 and
cyclic phosphinate 95 (Scheme 41), indicating that 1,3,2λ5-oxazaphosphetidine 90c is regarded as
an intermediate of the aza-Wittig reaction [95].
Scheme 41. Thermolysis of spirophosphorane 90c.
The detailed studies on the formation of 1,2λ5-oxaphosphol-5(2H)-one 93 were conducted on
the basis of 31P-NMR analysis [96]. In the course of the reaction a decrease of the resonance signal
at +25.6 ppm along with an increase of the new one at +47.3 ppm corresponding to 96 was observed.
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The latter was found to be unstable in the presence of moisture which resulted in the slow conversion
to the final product. The proven synthetic pathway was concluded in Scheme 42.
Scheme 42. The mechanism of formation of the bicyclic phosphorane 93 from cyclic iminophosphinate 89.
10P-2C-2O-1Z (Z = N, O, etc.) Phosphoranes
It is already well known that the preparation of pentacoordinate phosphoranes can be accomplished
by the reaction of phosphorus (III) compounds with ylidene derivatives of β-carbonyl compounds.
This approach was exemplified by the reaction of 2-phenyl-1,3,2-benzodioxaphosphorin-4-one 97
with diethyl benzylidenemalonate 98 which occurred along two pathway, yielding pentacoordinate
phosphorane 99 and phosphinate derivative 100 containing tetracoordinate phosphorus atom [97].
When the reaction was allowed to heat for a short time the formation of the seven-membered
phosphonate derivative with relatively high stereoselectivity equal to 50% was observed (Scheme 43).
Scheme 43. Synthesis of pentacoordinate phosphorane 99 and phosphinate derivative 100.
The plausible mechanism involves the nucleophilic attack of the phosphorus atom at the β-carbon
atom in α,β-unsaturated carbonyl compounds to produce an intermediate with delocalized π-electrons
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along three atoms, as is presented by its two resonance structures. In case of synthetic pathway A
the attack of negatively charged oxygen on phosphorus atom occurs with reversible formation of
pentacoordinate phosphorane. The second synthetic pathway (B) assumes nucleophilic substitution
at the carbonyl carbon atom to yield the seven-membered ring, 1,2-benzoxaphosphepine. In further
investigations Akiba et al. [98] succeeded in preparing spirophosphoranes bearing Martin ligand units
and a monodentate primary amino substituent. These O-equatorial isomers were found to be surprisingly
stable, taking into account the fact that the equatorial substituents, which are more electronegative than
carbon, are expected to facilitate pseudorotation. The O-equatorial aminophosphoranes 102 along with
O-apical isomers 103 were obtained from the in-situ generated chlorophosphorane 101 which was allowed
to react with the corresponding amines (Scheme 44). However, when methylamine or aniline were used,









































Scheme 44. Synthesis of aminophosphoranes 102 and 103.
The O-equatorial phosphoranes 102 were stable at room temperature and could still be converted
to their more stable O-apical pseudorotamers 103 when they were heated in a solution, indicating
that the phosphoranes 102 are kinetic products, as in the case of O-equatorial alkylphosphoranes.
The structures of 102c and 102e were determined by single-crystal X-ray analyses to be in the
O-equatorial configuration. The unusual stability of the O-equatorial phosphorane 102 could be
attributed to the stabilizing nN → σ*P-O orbital interaction. More detailed studies on the experimental
determination of the nN → σ*P-O interaction energy of O-equatorial C-apical phosphorane supported
with DFT calculations have been also reported providing an additional proof for this assumption.
Juge et al. described the formation of chiral bicyclic phosphoranes in the Arbuzov-type reaction
of diastereomerically pure cyclic tricoordinated oxaphosphacycloalkanes and very reactive Koshland
reagent I 104 [99]. They found that both enantiomers of 2-phenyl-1.3.2-oxazaphospholidine [(−)-105
derived from (+)-ephedrine or (+)-105 from (−)-ephedrine], treated with 2-hydroxy-5-nitrobenzyl
bromide 104a afforded the stable pentacoordinated phosphoranes [(−)-106 from (−)-105 or
(+)-106 from (+)-105] which were isolated by simple chromatography. The minor isomeric
spirophosphoranes with the opposite configuration at the phosphorus atom were also formed
(Scheme 45). 2-Hydroxy-5-nitrobenzyl halides 104a,b reacted also with five- or six-membered cyclic
tricoordinated phosphorus compounds (−)-107 (derived from (+)-2-methyl-2,3-butanediol) or (−)-110
(derived from (−)-chloramphenicol), yielding spirophosphoranes, 108 and 109 or 110, respectively.
However, these spirophosphoranes were too unstable to be isolated. Their formation was confirmed
only by the 31P-NMR spectra of a crude reaction product.
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Scheme 45. Reactions of cyclic five or six-membered tricoordinated phosphorus compounds with
2-hydroxy-5-nitrobenzyl halides.
10P-1C-1N-3O Phosphoranes
The synthesis of a pentacoordinated phosphorane containing tricyclic system was reported by
Sevenard et al. [100]. 2-Fluoroacetylcycloalkanones 111a,b reacted with diethyl isocyanatophosphite
diastereospecifically leading to phosphoranes 112a,b via intermediate species formed by the addition
of phosphorus to a trifluoromethyl substituted carbonyl atom which subsequently underwent two
additional heterocyclizations (Scheme 46).
Scheme 46. Synthesis of bicyclic aminophosphoranes 112.
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The phosphorane derived from 2-trifluoroacetylcyclopentanone 112b was moisture-sensitive,
unlike the cyclohexane derivative 112a, probably due to the greater ring strains. The proposed
structure was strictly confirmed by means of NMR data on the basis of which it was found that
carbon atom occupies an axial position and two annulated five membered rings are arranged in the
equatorial-axial-equatorial order.
10P-1C-2N-2O Phosphoranes
Pudovik et al. reported the synthesis and crystal structure analysis of spirophosphoranes
derived from benzoxazaphospholidines and/or 2-aminophenol [101]. It has been found that the
condensation reaction of 2-aminophenol with chloromethylphosphonic dichloride proceeded with
the formation of the expected benzoxazaphospholidine-2-oxide 99 along with the unexpected one:
spirophosphorane 100 (Scheme 47).
 
Scheme 47. Synthesis of bicyclic aminophosphorane 114.
As indicated by the authors, the crucial step in a plausible pathway for their synthesis is
an initial phosphorylation of a hydroxy group in 2-aminophenol with phosphonic dichloride leading
to chloromethylphosphonochloridate intermediate (I). Subsequent nucleophilic attack of the amino
group at the phosphorus atom leads to the cyclization product 99. Simultaneously, the second pathway
is realized when chloromethylphosphonochloridate intermediate reacts with the next molecule of the
starting aminophenol to give the OH condensation product, which undergoes cyclization to provide
unstable intermediate (II, III). It is then converted to the spirophosphorane as a result of intramolecular
nucleophilic attack of the amino group at electrophilic phosphorus atom with the elimination of water
(Scheme 48).
Scheme 48. The mechanism for the formation of spirophosphorane 114.
The alkylation of 2-alkoxy-1,3,2-benzoxazaphospholidine with bis(dialkylamino)methanes
afforded N-alkylated product 115 which underwent tautomerization to phosphonimidate 116 and
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further transformation to polycyclic phosphoranes 117 in 30 days [102]. It is worth to mention that
both benzoxazaphospholidine 115 and polycyclic phosphorane 117 were used as phosphorylating
agent for 2-aminophenol yielding spirophosphorane 118 (Scheme 49). The crystal and molecular
structure of the synthesized spirophosphoranes 114 and 118 were determined by single-crystal X-ray
diffraction [101,103,104].
Scheme 49. Syntheses of bicyclic diaminophosphoranes 117 and 118.
Amino alcohol based monocyclic hydrophosphorane 119 was prepared in the reaction of
2-aminophenol with tetraalkylphenylphosphonous diamide and used for the preparation of bicyclic
spirophosphorane 120 [105] based on the oxidation procedure or on heating above its melting point
(Scheme 50).
 
Scheme 50. Synthesis of bicyclic diaminophosphorane 120.
The alternative approach to synthesize bicyclic pentacoordinate spirophosphoranes proposed by
Gholivand et al. [106] is based on the condensation of simple hydrazides (i.e., benzhydrazide 123a and
4-pyridinecarboxylic acid hydrazide 123b) with phosphoryl reagents followed by a dehydration–cyclization
rearrangement of the resulting phosphorylated hydrazides. Such spiro-bicyclophosphorane with a trigonal
bipyramidal structure is formed if phosphoryl reagent contains at least two appropriate leaving groups
such as chlorine atoms (in PhPOCl2 or POCl3). Benzhydrazide reacted with POCl3 in refluxing
acetonitrile to give the P–Cl phosphorane intermediate 121 which treated with the appropriate amine
was converted to the P-N spirophosphorane 122a,b (Scheme 51). The mechanism proposed for the
formation of the intermediate involved β-amidic proton elimination in phosphorylated hydrazides A
upon which the cyclization product with new C=N imine bond B was formed. The intermediate was
finally converted into 121 by dehydration.
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Scheme 51. Syntheses of bicyclic diaminophosphoranes 121 and 122.
Similarly, several pentacoordinate phosphoranes 122c–g were easily prepared in the reaction
of benzhydrazide 123a or 4-pyridinecarboxylic acid hydrazide 123b with PhPOCl2, PhNHPOCl2 or
POCl3 in the presence of triethylamine [106] (Scheme 52).
 
Scheme 52. Synthesis of bicyclic diaminophosphoranes 122.
10P-1C-4O Phosphoranes
The reaction of (E)-bis-(2,4,6-tri-t-butylphenyl)diphosphane 125 with a fourfold excess of
tetrachloro-o-benzoquinone 126 was found to give the chiral perchlorinated spirophosphorane 127.
It was suggested that the reaction, proceeding according to an electron transfer mechanism, occurred
via 128 with a cleavage of the P-P bond and indeed, 127 was isolated in low yield even with two
equivalents of 126 (Scheme 53) [107].
Scheme 53. Synthesis of bicyclic phosphoranes 127.
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Similarly, the reactions of tricoordinated organophosphorus precursors 129–131 with an appropriate
equivalent of ethylene glycol was found to give the spirophosphorane 132. All the three reactions
occurred via the bis-ester 133 formed in a nucleophilic exchange reaction at the tricoordinated



























Scheme 54. Synthesis of bicyclic phosphorane 132.
10P-1C-1N-2O-1H Phosphoranes
The reactions of tricoordinated phosphonous diamides 115a–d with an appropriate equivalent
of aminodiols 120 led to a series of chiral enantiomeric or diastereomeric bicyclic spirophosphoranes
121a–f (Scheme 55) [109].
Scheme 55. Synthesis of bicyclic azaphosphoranes 135.
10P-2N-2O-1H and 10P-2N-3O Phosphoranes
Chiral hydrospirophosphoranes derived from L-amino acids were for the first time obtained
by Koenig et al. as early as 1979 [110]. More recently this approach based on the reaction of
phosphorus trichloride with amino acids was used by Zhao and coworkers for the preparation
of spirophosphoranes from enantiomerically pure valine 136a, isoleucine 136b and phenylalanine
136c. [111–114]. The spirophosphoranes formed as mixtures of diastereoisomers were separated to the
pure stereoisomers 137a–c and 138a–c by reverse-phase HPLC or recrystallization (Scheme 56).
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Scheme 56. Synthesis of hydrospirophosphoranes 137 and 138 derived from L-amino acids.
The pure stereoisomers 137 were used for the preparation of pentacoordinate spirophosphorane
carbamates 139 [115] via the two-steps Atherton–Todd-type reaction (Scheme 57). Initially, the
spirophosphoranes 137 reacted with CCl4 yielding chlorospirophosphoranes 140 (with retention
of configuration at the phosphorus atom). In a second step chlorophosphoranes, upon the reaction
with carbamate anions, (formed in situ from CO2 and secondary amines), afforded the carbamates 139
with inversion of configuration (Scheme 58).
 
Scheme 57. Preparation of pentacoordinate spirophosphorane carbamates 139.
 
Scheme 58. The mechanism of formation spirophosphorane carbamates 139.
Similarly, the spirophosphoranes 137a–e and 138a–e were used as substrates for the synthesis of
pentacoordinate pyrospirophosphoranes containing a P–O–P bond 141–143 under modified Atherton–Todd
conditions [116] (Scheme 59). It was found, upon optimization of the reaction conditions, that the
spirophosphoranes 137a,b gave the pure diasteroisomer of pyrospirophosphoranes 142a,b whereas
a mixture of diastereoisomers 141c–e and 143c–e were isolated if hydrospirophosphoranes 137c–e
were used as substrates.
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Scheme 59. Synthesis of pentacoordinate pyrospirophosphoranes 141–143.
A series of the alkoxy spirophosphoranes 144,145 was also prepared by this approach (Scheme 60)
but unfortunately as a mixture of diastereoisomers (in most cases in 1:1 ratio) [117].
 
Scheme 60. Synthesis of alkoxy spirophosphoranes 144,145.
Bicyclic hydrophosphoranes 147 and 148 were synthesized as a 3:2 mixture of two epimers by the
reaction of tris-(N,N-diethyl)phosphorus amide with isoleucinol 146. On the other hand, the tricyclic
phosphorane 149 was isolated as a single stereoisomer in a similar reaction with the diaminodiole
151 (Scheme 61) [118]. The isolated spirophosphoranes 147–149 were used as chiral ligands in the
Pd-catalyzed alkylation of 1,3-diphenyl allyl acetate with acceptable stereoselectivity (up to 74% ee)
(Scheme 61) [119]. Moreover, these hydrophosphorane derivatives were used to obtain complexes with
[Pt(COD)Cl2], [Rh(CO)2Cl]2 [Rh(THF)2(COD)]+BF4−.
Chiral triquinphosphoranes 152–154 were easily synthesized from chiral enantiopure
diaminodiols with a C2 symmetry axis. It was shown that their structure is best represented by two
trigonal bipyramid structures (TBP) with opposite absolute configurations at the phosphorus atom, RP
and SP, being in a fast equilibrium by a Berry pseudorotation process (Scheme 62) [120]. They reacted
with various activated carbonyl compounds: trifluoroacetophenone, ketopantolactone and aromatic
aldehydes to afford two diastereomeric hydroxyphosphoranes with a de up to 90% depending on the
nature of the electrophile (Scheme 62). Diastereomeric mixture of hydroxyphosphoranes formed by
the addition of ketopantolactone 155–156d–f were quantitatively converted into alkoxyphosphoranes
157 with diastereomeric excesses decreasing from 86% to 8% for R = Me, from 90% to 50% for R = iPr
and from 84% to 2% for R = Bn.
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Scheme 61. Syntheses of bicyclic hydrophosphoranes 147–149 and their use as chiral ligands.
 
Scheme 62. Chiral triquinphosphoranes 152–154 and their reactions with various activated
carbonyl compounds.
Similarly, the parent triquinphosphorane 158 was found to react with methyl, n-butyl,
or t-butyl disulfide to produce the corresponding alkylthiophosphoranes 159a–c, although
t-butylthio-phosphorane 159c was only a minor product and the major one was identified as the
thiophosphoramide 160 (Scheme 63). Under irradiation at −50 ◦C t-butylthiophosphorane 159c was
produced in high yield, however, by increasing the reaction temperature its slow conversion to 160
was observed. The reactivity of the triquinphosphorane 158 with alkyl disulfides was compared
both under irradiation and in the dark at room temperature. The reactivity increased significantly
in the case of n-butyl disulfide and t-butyl disulfide when the reactions were conducted under
irradiation. This observation led to the conclusion that this type of the reaction does involve free
radical species [121].
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Scheme 63. Reaction of chiral hydrido-triquinphosphorane 158 with alkyl disulfides.
10P-1N-3O-1H and 10P-2N-2O-1H Phosphoranes
Three synthetic protocols were applied to the preparation of this type of hydrophosphoranes with
the use of amidooxime derivatives as substrates [122]. The first procedure started with the reaction of
amidooxime 161a–e with PCl3 leading to 5-chloro-1,2,4,5-oxadiazaphospholines 162a–e. Their reactions
with ethylene glycol or ortho-hydroxyphenol afforded the unsymmetrical spirophosphoranes 163 or
164 whereas the treatment with another dose of the amidooxime 161 led to symmetrically substituted
spirophosphoranes 165a–e (Scheme 64).
Scheme 64. Syntheses of bicyclic hydrophosphoranes 163–165.
In the second approach, amidooxime 161a,c,d upon reaction with 2-dimethylamino-
1,3,2-dioxaphospholane 166 provided unsymmetrical spirophosphoranes 163a,c,d and in the reaction
with 2-dimethylamino-(4,5)benzo-1,3,2-dioxaphospholane 167 in acetonitrile yielded unexpected
symmetrically substituted spirophosphoranes 165a–e instead of unsymmetrically substituted
phosphorane 164a–e (Scheme 65).
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Scheme 65. Syntheses of bicyclic hydrophosphoranes 163 and 165.
The third synthetic pathway involved the treatment of amidooximes 161b,d,e with 2-chloro-
(4,5)benzo-1,3,2-dioxaphospholane 168 leading, as it was expected, to the corresponding unsymmetrical
spirophosphoranes 164. The latter were converted into the corresponding unsymmetrical
spirophosphorane 170 by transesterification with pinacol 169 taking place in the presence of
triethylamine (Scheme 66).
Scheme 66. Synthesis of bicyclic hydrophosphoranes 164 and 170.
10P-2N-3O and 10P-1N-4O Phosphoranes
Amidooximes 161d,e were used also as substrates for the preparation of the spirophosphoranes
containing the P–OMe grouping 173, 175. They were isolated upon application of the oxidation
procedure carried out under basic conditions with iodine as an oxidant [122] (Scheme 67).
Scheme 67. Synthesis of bicyclic spirophosphoranes 173 and 175.
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O-Trimethylsilyl derivatives of spirophosphoranes 177 containing an amino acid residue were
formed by the cyclisation of the corresponding cyclic amides 176 [123] (Scheme 68). The resulting
spirophosphoranes 177 were used for the formation of peptides from amino acids such as histidine,
serine, threonine and α-alanine but not β-alanine.
Scheme 68. Synthesis of bicyclic phosphoranes 177.
Later on, spirophosphoranes 177 were also used as substrates in a new method for the solid phase
synthesis of oligopeptides. This approach was based on their rapid reaction with hydroxymethyl
polystyrene resin leading to unstable hydroxyphosphoranes 178 which after mild hydrolysis gave the
phosphate 180 and a solid phase bound amino-acids 179. Coupling of 179 with further phosphorane
177, followed by hydrolysis afforded a solid phase bound dipeptide. The process was repeated to
give oligopeptides. The final oligopeptide was liberated from the resin by treatment with TFA [124]
(Scheme 69).
 
Scheme 69. Synthesis of oligopeptides with the use of spirophosphoranes 177 as substrates.
10P-4O-1H Phosphoranes
The synthesis and reactivity of the hydrophosphorane 181 derived from perfluoropinacol was
described as early as 1983 [125]. It was found that it could be rapidly oxidized by dimethyl sulfoxide
to form the hydroxyphosphorane 182, and then silylated to the derivative 183. Chlorine and bromine
reacted with 181 to give the corresponding halospirophosphoranes 184a,b. In this context it is
interesting to note that the corresponding fluorospirophosphorane 184c was obtained from the
dichlorofluoro-perfluoropinacolophosphorane FCl2P(CH2Ph)[OC(CF3)C(CF3)O] 185 and dilithium
perfluoropinacolate LiOC(CF3)C(CF3)OLi 186. In the presence of triethylamine the hydrophosphorane
181 reacted with benzyl bromide or acetyl chloride to form the phosphoranes 187 or 188. Moreover,
the treatment of the hydrophosphorane 181 with trimethylphosphine gave a thermally unstable
phosphonium salts 189. Hydrophosphorane 181 undergoes fast hydrolysis affording phosphorous
acid and perfluoropinacol [125] (Scheme 70).
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Scheme 70. Interconversions of spirophosphoranes 181 and 182.
10P-4O-1Metal and 10P-3N-1O-1Metal Phosphoranes
Another group of chiral pentacoordinate organophosphorus compounds are metallophosphoranes
192a–e. Nakazawa et al. [126] developed a synthetic method for the preparation of metallophosphoranes
192, which was based on the nucleophilic attack of the, in situ generated, anion 191a–e on the
complexed trivalent phosphorus atom 190a,b (Scheme 71). For example, ferrocenyl complex 190a
reacted with in situ generated anions 191a–e to form chiral metallophosphoranes 192a–e. The valency
of the phosphorus atom increased from III to V without breaking the Fe-P bond and the nature of Fe-P
bond changed from coordinative to covalent.
 
Scheme 71. Preparation of chiral metallophosphoranes 192.
It is worthy to note that treatment of HP(C6H4NH)2-193 with nBuLi led to unexpected
deprotonation on nitrogen atom (giving 194b) instead on phosphorus (to afford 194a). Moreover,
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an amide anion 194b is in an equilibrium with phosphoranide 194a. The reaction of the in situ
generated anion 194a with [Cp(CO)LFeCl] (195a or 195b) gave a P-metallated phosphorane 196a or
196b. On the contrary, the reaction the equilibrated mixture of 194 with [Cp(CO)CoI2]-197 led to
N-metallated compound 198. Interestingly, in the reaction of the phosphoranide 194a with MeI the
P-methylated product 199 was formed. On the other hand, electrophiles such as Me3SiCl, Me3GeCl or
Me3SnCl, provided N-substituted products (200a–c) [127,128] (Scheme 72).
 
Scheme 72. Functionalization of hydrophosphorane 193 leading to phosphoranes 196 and 198–200.
Moreover, it was found that in the presence of a base a migration of pentacoordinate phosphorane
fragment occured from the transition metal in 196 to the carbon atom in the Cp ring in 201 [129]
(Scheme 73).
 
Scheme 73. Alkylation of metallophosphoranes 196.
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10P-5O Phosphoranes
The hydroxyphosphorane 203 was prepared by N2O4 oxidation of the parent hydrophosphorane
202 (Scheme 74). Its single crystal analysis showed an almost perfect trigonal bipyramidal structure
with the unit cell containing two molecules of the same helicity connected by H-bonds between the
P–OH and carbonyl groups [130].
Scheme 74. Oxidation of hydrophosphorane 202.
The triethylammonium salt of the hydroxyspirophosphorane 205 derived from n-butyl tartrate
was prepared on treatment of the very acidic [pKa = 4.4(DMSO)] monocyclic phosphorus ester 204
with triethylamine (Scheme 75) [131].
Scheme 75. Formation of salt 205.
The radical reaction of the bicyclic hydrophosphorane 206 derived from glycol with ethyl vinyl
ether provided the corresponding P–C spirophosphorane 207 along with the monocyclic phosphite
208. The reaction of the hydrospirophosphorane 206 with ethylene glycol and enamine 209 afforded
the pentaoxyspirophosphorane 210 with the simultaneous reduction of the enamine 209 to amine
211 [132] (Scheme 76).
Scheme 76. Synthesis of spirophosphoranes 207 and 210.
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3. Conclusions
Enantiomerically enriched pentavalent phosphoranes constitute an interesting group of
heterocyclic chiral auxiliaries. Their still limited applications in asymmetric synthesis are however
hampered mainly by a limited access to diastereomerically pure and especially enantiomerically pure
(or at least enantiomerically enriched) samples. It is our hope that this review, which describes briefly
the basic procedures used for the preparation of these derivatives, their stereoisomerization mechanisms
and their selected interconversions, will encourage wider interest in the synthesis, structural
determinations and applications of these groups of chiral, hypervalent organophosphorus derivatives.
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Abstract: The alkaline deacylation of a representative series of 1-(acylamino)alkylphosphonic acids
[(AC)-AAP: (AC) = Ac, TFA, Bz; AAP = GlyP, AlaP, ValP, PglP and PheP] in an aqueous solution of
KOH (2M) was investigated. The results suggested a two-stage reaction mechanism with a quick
interaction of the hydroxyl ion on the carbonyl function of the amide R-C(O)-N(H)- group in the first
stage, which leads to instant formation of the intermediary acyl-hydroxyl adducts of R-C(O−)2-N(H)-,
visible in the 31P NMR spectra. In the second stage, these intermediates decompose slowly by splitting
of the RC(O−)2-N(H)- function with the subsequent formation of 1-aminoalkylphosphonate and
carboxylate ions.
Keywords: amino acids; aminophosphonic acids; 1-aminoalkylphosphonic acids; 1-(acylamino)
alkylphosphonic acids; 31P NMR spectra of intermediates; hydrolytic deacylation
1. Introduction
Aminoalkylphosphonic acids (AAP) are structural analogues of amino acids (AAC) [1], some of
which are of natural origin [2]. Due to the structural analogy, they present similar biological properties
to the class and are important inhibitors of enzymes of the amino acids metabolism [1,3] (Table 1).
Table 1. Structures of aminophosphonic acids (AAP)—phosphonic analogs of amino acids (AAC) and
1-(acylamino)alkylphosphonic acids (AC)-AAP and phosphonopeptides AAC-AAP and AAP-AAC [4–14].
AAC ω-AAC AAP ω-AAP AAP–R
Naturally occurring aminophosphonic acids.
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Table 1. Cont.
β-AlaP [4] Aspβ–P [5] IserP [6] TyrP [7] Glu−γ–P(Me) [8]
Representative, biologically active aminophosphonates.






Abbreviation of AAP and (AC)-AAP follow the general rules elaborated by Kudzin et al. [15].
Several papers reflected the complexing abilities of this class of compounds [16–18] and
their pharmacological [19–22], agro-chemical [23] and industrial [11,24,25] applications. Therefore,
the studies on the synthesis [26–30] and physico-chemical properties [31–40] of AAP and their
derivatives constitute an important topic in chemistry and biochemistry also in addition to material
science (e.g., Self-assembled monolayers agents, SAMs [41]).
The 1-(acylamino)alkylphosphonic acids (AC)-AAP belong to the interesting group of compounds
that is of potential pharmacological importance since the corresponding 1-N-aminoacylamino
derivatives of AAC-AAP (mixed P-terminal phosphono-dipeptides, e.g., Alaphosphaline) exhibit
antibacterial activity [1,23] (Table 1).
1-(Acylamino)alkylphosphonic acids [36,37] and esters [42] are easily formed from starting
aminoalkylphosphonic acids, the latter being substrates for selective deacylation to O,O-dialkyl
aminoalkylphosphonates [43]. Both of these groups are substrates for stereoselective enzymatic
hydrolysis [44–48] (Figure 1). 1-(Acylamino)alkylphosphonic acids are also formed in so-called
Engelman-Pikl-Oleksyszyn method synthesis of 1-aminoalkylphosphonic and 1-aminoalkylphosphonic
acids, which starts from appropriate amides and phosphorus chlorides [10,27,49,50] ( Figure 2). As some
secondary 1-aminoalkanephosphonates are unstable in the process of acidic degradation [40], alkaline
hydrolysis can present an alternative method in such procedures.
Figure 1. Transformation of 1-aminoalkylphosphonic acids via N-acyl-derivatives [(1)
R1-C(O)OH/[R1-C(O)]2O [36–38]; (2) R1-C(O)OH/[R1-C(O)]2O/HC(OR2)3 [42]; (3) NaBH4/MeOH [43];
(4) enzymatic hydrolysis of racemic (D,L)-(AC)-AAP and (D,L)-(AC)-AAP(OR)2 [44–48]].
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Figure 2. Scheme of Engelmann-Pikl-Oleksyszyn methods for synthesis of secondary
1-aminoalkylphosphonic (R2=OH) and 1-aminoalkylphosphinic (R2=H, alkyl) acids (1) aldehyde,
R-PCl2/AcOH; and (2) 5M HCl-H2O, Δ8–10 h.
The susceptibility of (AC)-AAP to hydrolysis/solvolysis constitutes an important factor influencing
their biological activity, especially during penetration through cell membranes. Therefore, the detailed
studies on deacylation of these compounds should be helpful in obtaining a deeper understanding of
this phenomenon. To tackle this problem, we have decided to carry out studies devoted to deacylation of
(AC)-AAP under different reaction conditions. Our preliminary results of experiments were carried
out in aqueous media in the pH range of 0–6.5, which occurs namely in an aqueous 2M HCl and
buffer solutions. These are briefly described in a recently published article [51]. As an obvious and
necessary continuation of this topic, this paper presents our results on the deacylation of representative
types of 1-(acylamino)alkylphosphonic acids (AC)-AAP in aqueous 2M KOH solution. These include
1-(acetylamino)alkylphosphonic Ac-AAP, 1-(trifluoroacetylamino)alkylphosphonic acids TFA-AAP and
1-(benzoylamino)alkylphosphonic Bz-AAP, derived from representative 1-aminoalkylphosphonic acids
AAP (GlyP, AlaP, ValP, PglP and PheP).
2. Results and Discussion
It is generally known that amides can be hydrolyzed with either acidic or basic catalysis, with
products being the free acid and the ammonium/substituted ammonium ions or the salts of the acid and
ammonia/amine, respectively. Both the acid- and base-catalyzed hydrolyses are essentially irreversible,
since salts are formed in both cases [52–55]. Water alone is not sufficient to hydrolyze most of amides [56].
The very low rate of amide hydrolysis by water has been measured by Kahne & Still [57].
A kinetic study has been conducted on the alkaline hydrolyses of several types
of amides, including formanilides [58,59], N-methylformanilides and N-acetanilides [60],
1,8-bis(trifluoroacetylamino)-naphthalene [61] also in addition to N-methylacetamide, N-methylbenzamide
and acetanilide [62]. A mild protocol for the alkaline hydrolysis of secondary and tertiary amides in
non-aqueous conditions at room temperature or under reflux has been recently described [63].
The structural analogy of 1-(acylamino)alkylphosphonic acids (AC)-AAP and 1-(acylamino)-alkanoic
acids (AC)-AAC or amides causes the mechanism of hydrolytic scission of the amide linkage R-C(O)-N in
common amides and in 1-(acylamino)alkylphosphonic acids. These should be ruled by similar if not the
same mechanisms.
2.1. Investigations on the Deacylation Course of 1-(acylamino)alkylphosphonic Acids
The (AC)-AAP contain amidic functions, which has a hydrolytic sensitivity that should be
dependent on the structure of their acyl moieties and on the type of applied hydrolytic medium [49].
For conducting an inquiry into the hydrolytic stability of (AC)-AAP, we undertook deacylation
investigations of these compounds in aqueous 2M KOH solutions.
The application of 31P NMR monitoring of the reaction course enabled identification and
quantification of phosphoric components of the reaction mixtures formed. Essentially, monitoring
of the deacylation course of Ac-GlyP in 2M KOH solution reveals the formation of GlyP (Figure 3).
The results of 31P NMR monitoring of the deacylation of the various types of (AC)-AAP (Ac-AAP,
Bz-AAP and TFA-AAP) at a temperature of 25 ◦C and exposition period up to 240 h are presented in
Figure 4 (Ac-AAP), Figure 5 (TFA-AAP) and Figure 6 (TFA-AAP), respectively.
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Figure 3. 31P NMR spectra of Ac-GlyP recorded in 2 M KOH. (A) Immediately after mixing the reaction
mixture, and (B) After 192 h of exposition of the reaction mixture. [Ac-GlyP: 13.4 ppm; GlyP: 19.0 ppm].
Figure 4. A solution of 0.1 M 1-(acetylamino)alkylphosphonic acids Ac-AAP in 2 M KOH reacted at
25 ◦C, which was monitored by 31P NMR [DD (%) vs. time (h)].
Figure 5. A solution of 0.1 M 1-(trifluoroacetylamino)alkylphosphonic acids TFA-AAP in 2 M KOH
reacted at 25 ◦C, which was monitored by 31P NMR [DD (%) vs. time (h)].
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Figure 6. A solution of 0.1 M 1-(benzoylamino)alkylphosphonic acids Bz-AAP in 2 M KOH reacted at
25 ◦C, which was monitored by 31P NMR [DD (%) vs. time (h)]. Thus, the presented graphs illustrate
much higher stability of benzoyl-derivatives Bz-AAP (Bz-GlyP: DD200h ~30%; for Bz-AlaP and Bz-PglP:
DD200h < 3%) in comparison with acetyl-derivatives Ac-AAP (Ac-GlyP: DD200h ~70%; for Ac-AlaP:
DD200h ~20%; and Ac-PglP: DD200h < 7%).
The comparison of hydrolytic stability of TFA-GlyP, Ac-GlyP and Bz-GlyP in 2M KOH is presented
in Figure 7.
Figure 7. A solution of 0.1 M 1-(acylamino)methylphosphonic acids (AC)-GlyP (AC: Ac, TFA, Bz) in
2M KOH reacted at 25 ◦C, which was monitored by 31P NMR [DD (%) vs. time (h)]. Points on the plots
corresponds to GlyP released from the parent (AC)-GlyP, which means GlyP from Ac-GlyP, GlyP from
Bz-GlyP and GlyP from TFA-GlyP.
Since no products of the scission of the C-P bond in all investigated cases were observed,
the deacylation mechanism of (AC)-AAP in alkaline solutions can be illustrated by an analogy to the
corresponding basic deacylation of 1-(acylamino)alkanoic acids (Scheme 1) [54,62,63].
Scheme 1. Hypothetical mechanism of deacylation of (AC)-AAP in 2 M KOH solution.
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This includes the prior interaction of hydroxyl ion on the carbonyl carbon of 1, which occurs
with the formation of the tetrahedral intermediate state 2 (Scheme 1). These intermediates were
observed on 31P NMR spectra as signals down-shifted in comparison with the parent signals of
AC-AAP (e.g., Figure 2). The 31P NMR chemical shifts of (AC)-AAP (1) and the corresponding adduct
compounds AC(OH)-AAP (2) formed are listed in Table 2.
Table 2. 31P NMR chemical shifts of (AC)-AAP and the corresponding adduct compounds
(AC)(OH)-AAP formed immediately after mixing the reaction mixture. (A) 31P NMR chemical shifts of
Ac-AAP and the corresponding adduct compounds Ac(OH)-AAP formed. (B) 31P NMR chemical shifts
of (AC)-GlyP and the corresponding adduct compounds [AC(OH)]-GlyP formed.
These compounds [AC(OH)]-AAP] slowly disappeared during the deacylation progress (Figure 8).
Figure 8. Ac-GlyP hydrolysis in 2M KOH [DD (%) vs. time (h)].
The rehybridization (sp3→sp2) of the carbonyl carbon in 2 enforces the splitting of the amide
bond R-C(O)-N and the subsequent formation of the aminophosphonate 3.
The comparison of (AC)-AAP stability in aqueous 2M KOH and 2M HCl solutions is given in Figure 9.
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Figure 9. (AC)-GlyP(Ac-GlyP, TFA-GlyP, TFA-GlyP) hydrolysis in aqueous solutions of 2M KOH and
2M HCl [DD (%) vs. time (h)].
2.2. Quantum Chemical Calculations for Deacylation of (AC)-AAP in Basic Conditions
The reaction illustrated in Scheme 1 was divided into two stages (reactions 1.1 and 1.2,
respectively), which were studied separately. Stage 1.1 concerns the addition of hydroxide to
amidophosphonate anion 1 with the formation of trianion 2 (the example structure of the addition
product 2 for Ac-AlaP (R=R1=Me) is given in Figure 10). Stage 1.2 involves dissociation of the trianion
2 into aminophosphonate dianion 3 and carboxylate anion 4. We assumed that the transfer of proton
from OH to the amide nitrogen in 2 proceeds simultaneously with dissociation. The thermodynamics
of this two-stage process was studied by density functional theory (DFT) methods in the gas phase and
in aqueous solution. Gas phase calculations were performed only for comparison with the aqueous
system, which was the real reaction system to illustrate the essential role of the solvation effect.
Figure 10. The structure of the addition product 2 (R=R1=Me, Ac(OH)-AlaP) with intramolecular
hydrogen bond between OH and phosphoryl group (orange—phosphorus, blue—nitrogen,
red—oxygen).
Stage 1: Hydroxide anion attack on the carbonyl moiety of (AC)-AAP dianion 1 (Scheme 1, r. 1.1).
This reaction stage presumably proceeds by the attack of a lone pair of negatively charged oxygen
atoms on sp2 carbon in the carbonyl group. This process is highly unfavorable since it involves the
reaction of two anions with the formation of the molecule with a total charge of −3. The energy of this
reaction in the gas phase is very high, so this process seems to be thermodynamically very unlikely
(Table 3).
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Table 3. Gibbs free energies ΔG (298 K) for reaction 1.1 in gas phase (kcal/mol).
However, when carried out in aqueous solutions, this reaction is much less unfavorable due to
the stabilization of ionic structures by the polar solvent (Table 2). Similarly, this reaction should also
be facilitated by counterions, although these were omitted in order to keep the model system simple.
The values of the Gibbs free energy ΔG298 (kcal/mol) for reaction 1.1 in gas phase and in aqueous
phase are listed in Tables 3 and 4, respectively.
Table 4. Gibbs free energies ΔG (298 K) for reaction 1.1 in aqueous phase (kcal/mol).
The free energy barriers, ΔG‡ (298 K), calculated for reaction 1.1 in a water solution are shown
in Table 5. The lowest energy barriers for OH− addition (Scheme 1, r. 1.1) occur when R1 = CF3,
which results from stabilization of the negative charge by the electron-withdrawing CF3 group.
Table 5. Free energy barriers (ΔG‡ (298 K), kcal/mol) for OH− addition (reaction 1.1) in water.
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Stage 2: Dissociation of trianion 2 into aminophosphonate dianion 3 and carboxylate anion 4 (Scheme 1,
reaction 1.2).
This reaction stage presumably involves the proton transfer from the geminal hydroxyl group to
nitrogen with dissociation of the C-N bond. This hypothesis is supported by the transition structures
found for this reaction. The example of this structure for the proton transfer/dissociation of the C-N
bond in Ac-AlaP(3−) is shown in Figure 11. Vibrational analysis indicates that the imaginary vibration
is associated with proton transfer from OH to NH. In the structure of the transition state shown in
Figure 11, the geminal C-O bond distance is 1.284 Å, which corresponds well to C=O double bond.
Furthermore, the C-N distance is 1.802 Å compared to 1.503 Å in the starting amide, which indicates
that the bond breaking in the transition state is significantly advanced.
Figure 11. The transition state for proton transfer/dissociation of the C-N bond in Ac(OH)-AlaP(3−).
The Gibbs free energies for the dissociation reaction 1.2 in the gas phase and in water are presented
in Tables 6 and 7, respectively.
Table 6. Gibbs free energy ΔG (298 K) for the reaction 1.2 in gas phase (kcal/mol).
Table 7. Gibbs free energy ΔG (298 K) for the reaction 1.2 in an aqueous phase (kcal/mol).
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Comparing the thermodynamic quantities in Tables 3 and 6, it is evident that the total free energy
of the reaction 1 is negative in all cases by approximately −30 kcal/mol and thus, the entire process 1
is thermodynamically feasible. However, the very high energy barrier for the first step of reaction 1.1
(Table 3) prevents this reaction from proceeding in the gas phase.
Analogously, the reaction 1 in water is equally thermodynamically favorable (ΔG = −20 to
−30 kcal/mol, Tables 4 and 7), but the energy barrier associated with the first step 1.1 is much lower in this
case (Table 4). Table 8 presents the results of free energy barrier calculations for reaction 1.2 in water.
Table 8. Free energy barriers (ΔG‡ (298 K), kcal/mol) for proton transfer/dissociation of the C-N bond
in water (reaction 1.2).
The total Gibbs free energy profiles of entire process 1 for two selected pairs of
1-(acylamino)alkylphosphonic acids [Ac-AlaP(2−), TFA-AlaP(2−) , Bz-PglP(2−) and TFA-PglP(2−)] in
water solution are shown in Figure 12.
Figure 12. Free energy profiles ΔG298 (kcal/mol) for the reaction of Ac-AlaP(2−) (blue), TFA-AlaP(2−) (red),
Bz-PglP(2−) (green), and TFA-PglP(2−) (purple) with hydroxyl ions in water solution (the general reaction
scheme is given above).
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The total Gibbs free energies and reaction barriers for the entire process 1 are shown in Table 9.
Moreover, Figure 12 reveals that the energy profiles for both TFA-substituted phosphonic acids are
essentially identical and all stationary points are significantly lower in energy than Ac-substituted
phosphonic acids.
Table 9. Total Gibbs free energiesΔG298(1.1) + ΔG298(1.2) for the overall deacylation process in the
aqueous phase and total Gibbs free energy barriers (ΔG298(1.1) + ΔG‡(1.2), in parentheses) (kcal/mol).
Therefore, the presence of a TFA group is the only factor determining the free energy barrier of the
reaction. From the energy profile, it is obvious that the overall energy barrier in water ΔG‡ is G298[TS
(1.2)] − (G298(1) + G298(OH−)), while the net Gibbs energy effect for the reaction in water solution can
be calculated as ΔGr298 = G298(3) + G298(4) −[(G298(1) + G298(OH−)] = ΔG298(1.1) + ΔG‡(1.2).
The total energetic effect of the process 1 in water is negative, which means that the overall
reaction is thermodynamically feasible (Table 8). The free energy of the process when R1=CF3
is also approximately 8 kcal/mol more favorable than for R1=Me. The comparison of values in
Table 9 also reveals that the transformation 1 of substrates with R1=Ph are thermodynamically more
favored by approximately 3 kcal/mol than R1=Me. Thus, the thermodynamic effect of reaction 1
depends on the R1 substituents in the order of: CH3 < Ph < CF3. Table 9 also leads to the conclusion
that the substrates with a trifluoromethyl group in the R1 position systematically show free energy
barriers that are approximately 10–15 kcal/mol lower than those for other substituents R1, due to the
additional stabilization of the trianion 2 by the inductive effect of the strongly electron-withdrawing
CF3 group. This suggests that trifluoromethyl-substituted anions should be more reactive than the
other derivatives.
3. Materials and Methods
3.1. General Information
The 31P NMR spectra were recorded on a Bruker AV 200 spectrometer (Rheinstetten, Germany)
operating at 81.01 MHz and on a Bruker Avance III 600 spectrometer (Bruker BioSpin, Rheinstetten,
Germany) operating at 242.9 MHz. The1H NMR spectra were recorded on a Bruker Avance III
600 spectrometer operating at 600 MHz. The positive chemical shift values of 31P were reported for
compounds that were absorbing at lower fields than H3PO4. The purity of the 1-aminoalkylphosphonic
acids and corresponding 1-(acylamino)alkylphosphonic acids were determined by pH-metric titration
using a computer aided automatic titrator connected to the EMU-meter (Wroclaw University of Science
and Technology, Wrocław, Poland), which was fitted with a combined glass microelectrode Crison 5028.
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3.2. Investigated Compounds
Phosphonoglycine (GlyP) was obtained according to a previous study [64].
The 1-Aminoalkylphosphonic acids of phosphonoalanine (AlaP); phosphonovaline (ValP);
phosphonophenylglycine (PglP) and phosphonophenylalanine (PheP) have been prepared
according to a previous study [65]. 1-(Acetylamino)alkylphosphonic acids (Ac-AAP: Ac-GlyP;
Ac-AlaP; Ac-ValP; Ac-PglP and Ac-PheP) and 1-(benzoylamino)alkylphosphonic acids (Bz-AAP:
Bz-GlyP; Bz-AlaP; Bz-ValP; Bz-PglP and Bz-PheP) were synthesized according to a previous study [36].
1-(Trifluoroacetylamino)alkylphosphonic acids (TFA-AAP: TFA-GlyP; TFA-AlaP; TFA-ValP; TFA-PglP
and TFA-PheP) were synthesized according to a previous study [37]. (Structures, names and
abbreviations of aminophosphonic acids and corresponding 1-(acylamino)phosphonic acids discussed
in this work are given in Table 10). Purity of all (AC)-AAP synthesized was determined by 31P NMR
and 1H NMR in addition to potentiometric titration. Analytical standards (fixanals) and other reagents
were purchased from Aldrich–Sigma (Poznań, Poland).
Table 10. Structures, names and abbreviations of aminophosphonic acids and corresponding
1-(acylamino)phosphonic acids discussed in this work a.






H Aminomethyl-phosphonicacid Phosphono-glycine Gly
P (3a) [64]
Me 1-Aminoethyl-phosphonicacid Phosphono-alanine Ala
P (3b)
[65]




































































a Applied names were in accordance with the IUPAC rules, and the abbreviations were in agreement with the
general rules elaborated by Kudzin et al. [15].
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3.3. Reaction of Deacylation of 1-(acylamino)alkylphosphonic Acids
A sample of (AC)-AAP (0.5 mmol) was placed into 5-mL V-vials, before being dissolved in 5 mL
of appropriate solution fortified with D2O (2 M KOH). The vials were maintained at 25 ◦C ± 0.2 ◦C.
At various time intervals, the vials were removed from the baths and the samples of 0.5 mL were taken
for 3lP NMR analysis. The concentration of the substrate and formed products were determined from
the integration of its NMR signal.
3.4. Computational Methods
All quantum mechanical calculations were performed using the Gaussian 09 suite of programs [66].
Geometries of model compounds in the gas phase and in water solution were optimized using the
B3LYP hybrid functional containing three-parameter Becke (B3) exchange and Lee-Yang-Parr (LYP)
correlation functional and the 6–31+G(d) basis set. All stationary points were identified as stable
minima by frequency calculations. The vibrational analysis also provided the thermal enthalpy and
entropy corrections at 298 K within the rigid rotor/harmonic oscillator/ideal gas approximation.
Computed frequencies were scaled by a factor of 0.98. Transition states were verified by the intrinsic
reaction path (IRC) procedure to confirm if they did link the substrates and products along the
reaction path.
Free energies of the reaction in water were calculated within a continuum (implicit) solvent
approximation using the Conductor-like Polarizable Continuum Model (CPCM) with UFF (Universal
Force Field) cavities (SCRF = CPCM option as defined in Gaussian 09 program) [67]. This approximation
assumes that molecule of the solute is placed in a cavity within the solvent, which is treated as a dielectric
continuum (self-consistent reaction field). Thermodynamic functions in solution were calculated based on
vibrational analysis, which was described above.
4. Conclusions
The analysis of 31P NMR results presented above leads to the following conclusions:
• The alkaline deacylation of (AC)-AAP occurs through the hydroxyl adduct intermediates,
which was observed on 31P NMR spectra of the reaction mixtures;
• The deacylation ability of investigated (AC)-AAP derivatives exhibited strong dependence of
electron-acceptor character of the acyl group, with CF3-C(O)- > CH3-C(O)-;
• The 1-(acylamino)alkylphosphonic acids are present in aqueous solutions with substantial stability
at ambient temperatures, which decreases with temperature elevation;
• The deacylation of (AC)-AAP increases substantially in basic (2 M KOH) solutions;
• The lowest deacylation ability (highest stability) was found for the 1-(benzoylamino acids Bz-AAP;
• For the same type of 1-(acylamino)-derivatives (AC)-AAP, the highest stability was found
in(AC)-ValP and (AC)-PheP; lower stability in (AC)-AlaP; and the lowest in (AC)-GlyP and
(AC)-PglP;
• All examined 31P NMR spectra of deacylation mixtures did not reveal any trace of
H3PO3 and/orH3PO4, which represent the products of dephosphonylation or oxidative
dephosphonylation of (AC)-AAP.
The theoretical calculations lead to the following conclusions:
The substrates with the trifluoromethyl group in R1 position are predicted to be significantly more
reactive than the other phosphonic amino acids studied, which is consistent with the experimental
results. The intermediates and products when R1=CF3 are also more thermodynamically favored
than the other derivatives. This difference in reactivity is due to additional stabilization of the
trianion 2 by the inductive effect of the strongly electron-withdrawing CF3 group. The calculations
did not provide unequivocal information about relative reactivities of other AA derivatives as the
calculated reaction energy barriers are similar (within a computational error), which is shown in
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Table 9 and Figure 12. The calculation results are consistent with those reported for acidic deacylation
of 1-(acylamino)alkylphosphonic acids [51]. As CF3 is strongly electron-withdrawing, this group
plays an activating role in basic media, increasing the acidity of carbonyl moiety. In contrast, it has a
deactivating effect in acidic media, decreasing the basicity of carbonyl oxygen.
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Abstract: Computational calculations have been used successfully to explain the reactivity of
the >C=P- functionality in pyrido-annelated 1,3-azaphospholes. Theoretical investigation at the
Density Functional Theory (DFT) level shows that the lone pair of the bridgehead nitrogen
atoms is involved in extended conjugation, due to which electron density increases considerably
in the five-membered azaphosphole ring. The electron density in the azaphosphole is further
enhanced by the presence of an ester group at the 3-position making the >C=P- functionality
electron-rich. Thus, 1,3-azaphospholo[5,1-a]pyridine, i.e., 2-phosphaindolizine having ester group at
the 3-position only does not undergo Diels-Alder (DA) reaction with an electron rich diene, such as
2,3-dimethyl-1,3-butadiene (DMB). However, an ester group at 1-position acts as electron-sink, due to
which transfer of the electron density to the >C=P- moiety is checked and DA reaction occurs across
the >C=P- functionality. The coordination of the Lewis acid to the carbonyl group at the 3-position
raises the activation barrier, while it is lowered remarkably when it is coordinated to the P atom.
Furthermore, the attack of 1,3-butadiene on the Si face of the P-coordinated (o-menthoxy)aluminum
dichloride complex is a lower activation energy path. Fukui functions could be used to explain relative
reactivities of indolizine and 2-phosphaindolizine towards electrophilic substitution reactions.
Keywords: synergy; 1,3-azaphospholes; Diels-Alder reaction; electrophilic substitution;
DFT calculations
1. Introduction
Almost a century ago, Paul Dirac [1] could foresee the possibility of applying quantum mechanical
concepts to solving the experimental problems in chemistry when he remarked, “The underlying
physical laws necessary for the mathematical theory of a large part of physics and the whole of
chemistry are thus completely known, and the difficulty is only that the exact application of these
laws leads to equations much too complicated to be soluble. It therefore becomes desirable that
approximate practical methods of applying quantum mechanics should be developed, which can lead
to an explanation of the main features of complex atomic systems without too much computation”.
Dirac’s dream inched towards fruition when Kohn, Hohenberg, and Sham [2,3] developed the density
functional theory (DFT). It was followed by dramatic progress when many DFT codes were made
available commercially, which enabled even less experienced persons with modest computational
facilities to do calculations with much accuracy and look into the electronic structures and many other
properties of the substances of interest. During the last two decades, the availability of a variety of
new and more accurate DFT functionals incorporating specific features has brought DFT computations
to the stage where they are used advantageously as a tool not only to explain the experimental
results but also to plan and modify experimental conditions for achieving the desired objectives [4–9].
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In recent years, there has been a perceptible increase in the number of research papers in chemistry
reporting both experimental and theoretical results together. Fristrup and co-workers in a recent
article emphasized the synergy between experimental and theoretical methods in the exploration of
homogeneous transitional metal catalysis [10]. In another interesting review article titled, “Towards
the computational design of solid catalysts”, Norskov et al. [11] commented, “Theoretical methods can be
used to describe surface chemical reactions in detail and to understand variations in catalytic activity from one
catalyst to another.” In spite of many challenges in the field, they added “Computational approaches for
the discovery and development of catalysts hold great promise for the future.” Similar views have
been expressed in other reports [12–14].
In this perspective, we shall present mainly our own results highlighting the application of DFT
calculations to plan and accomplish successfully some reactions of annelated 1,3-azaphospholes. It will
also be illustrated how computational calculations helped to resolve an experimental log jam and
paved the way for the use of catalysts, leading to a successful reaction and asymmetric synthesis.
2. Synthesis of Annelated 1,3-Azaphospholes
Before coming to the reactions, it will be appropriate to describe briefly two general methods of
synthesis of annelated 1,3-azaphospholes that we developed.
2.1. [4+1] Cyclocondensation Method
The reaction of 2-ethyl-1-phenacylpyridinium bromide (1) with PCl3 in the presence of Et3N at
room temperature (r.t.) afforded 3-benzoyl-1-methyl-1,3-azaphospholo[5,1-a]pyridine (2) in very good
yield (Scheme 1). The general skeleton was named as 2-phosphaindolizine perceiving it to result from
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1                                                                                    2
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Scheme 1. Synthesis of 2-phosphaindolizine derivative.
Later, this synthetic strategy made accessible not only variously substituted 2-
phosphaindolizines [15–17], but also 1-aza-2-phosphaindolizines [18], 3-aza-2-phosphaindolizines [19],
and 1,3-diaza-2-phosphaindolizines [20]. Besides, the method could be extended to the synthesis
of 1,3-azaphospholes annelated to pyrazine [15], thiazole [21], benzothiazole [21], and oxazole [22]











3                                           4
H2Z
Scheme 2. Synthesis of annelated 1,3-azaphospholes.
2.2. Synthesis Involving Tandem Pyridinium Ylide generation, Disproportionation, and 1,5-Electrocyclization
We obtained 1,3-bis(alkoxycarbonyl)-1,3-azaphospholo[5,1-a]pyridines (9) serendipitously on
reacting (alkoxycarbonyl)methylpyridinium bromide with Et3N and PCl3. The reaction involved
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tandem pyridinium alkoxycarbonyl-dichlorophosphinomethylide (6) generation, disproportionation,
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Scheme 3. Synthesis of 1,3-bis(alkoxycarbonyl)-1,3-azaphospholo[5,1-a]pyridines.
Subsequently, isoquinoline [26], and phenanthridine [27] analogues of 9 could also be prepared.
3. Reactions Response
3.1. Diels-Alder Reaction
There have been earlier reports about the Diels-Alder (DA) reaction across the >C=P- functionality
as dienophile [28,29]. We investigated theoretically the model DA reactions of ethene and
phosphaethene with 1,3-butadiene at the DFT(B3LYP/6-31+G**) level [30]. The Frontier Molecular
Orbitals (FMO) of the reactants are shown in Figure 1.
Figure 1. The HOMO-LUMO energy differences between FMOs of phosphaethene, 1,3-butadiene, and
ethene calculated at the B3LYP/6-31+G** level.
It may be noted that the HOMOdiene–LUMOphosphaethene gap (4.55 eV) is much lower than the
gap HOMOdiene–LUMOethene (6.32 eV). Furthermore, the activation energy barriers (ΔEact.) for the
two DA reactions are shown in Scheme 4 [30].
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Scheme 4. Model DA reactions of ethene and phosphaethene with 1,3-butadiene computed at
B3LYP/6-31+G** in the gas phase.
Encouraged by these theoretical results, we attempted DA reactions of
1,3-azaphospholo[5,1-a]pyridines, i.e., 2-phosphaindolizines prepared by two methods. However,
to our great surprise, the compounds 3-ethoxycarbonyl-1-methyl-1,3-azaphospholo[5,1-a]pyridine
10a (10, Z=Me, R1=R2=R3=H) obtained through [4+1] cyclocondensation and
1,3-bis(ethoxylcarbonyl)-1,3-azaphospholo[5,1-a]pyridine 10b (10, Z=CO2Et, R1=R2=R3=H) showed
remarkable difference in their reactivity with 2,3-dimethylbuta-1,3-diene (DMB). It was found that
3-(ethoxycarbonyl)-1-methyl-1,3-azaphospholo[5,1-a]pyridine (10a) did not undergo DA reaction with
DMB, even upon boiling in toluene in the presence of sulfur (used to oxidize phosphorus atom of
the initially formed cycloadduct to push the reaction in the forward direction, see later) [31]. But,
1,3-bis(ethoxylcarbonyl)-1,3-azaphospholo[5,1-a]pyridine (10b) underwent DA reaction with DMB at
room temperature (r.t.). However, the reaction at room temperature (ca 25 ◦C) was very slow and could
be completed (δ 31P NMR = 14.1 ppm) after heating at reflux temperature in chloroform for four days.
On carrying out the reaction in the presence of sulfur or methyl iodide, it was complete at r.t. in 4
days [31]. Thus, the DA reactions of 1,3-bis(ethoxycarbonyl)-1,3-azaphospholo[5,1-a]pyridines and also of





























R4 = Me, H
R1, R2 = H, H;
R3 = H, Et
10                         11
12                                              13
I
 
Scheme 5. DA reactions of 1,3-bis-(ethoxycarbonyl)-1,3-azaphospholo[5,1-a]pyridines with
2,3-dimethyl-1,3-butadiene (DMB ) and isoprene.
All the reactions occurred with complete stereo- and regioselectivity, except the reaction of
1,3-bis(ethoxycarbonyl)-1,3-azaphospholo[5,1-a]isoquinoline (14) with isoprene in the presence of
methyl iodide which afforded two regioisomers, the major (62%) being 15 (Scheme 6) [32].
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Scheme 6. Regioselectivity in the DA reaction of 1,3-bis(ethoxycarbonyl)-1,3-azaphospholo[5,1-a]isoquinoline.
The structure of the cycloadduct 12 (R1R2= CH=CH-CH=CH-; R3=R4=H) was confirmed by single
crystal X-ray diffraction studies [32]. That the [2+4]cycloaddition of annelated 1,3-azaphosphole
with DMB precedes the oxidation of the phosphorus atom of the initially formed cycloadduct
by sulfur or methyl iodide could be proved unambiguously by carrying out the DA reaction
of 1,4,2-diazaphospholo[4-a]pyridine derivative 17 in the presence of methyl iodide, when
N-methylated product 18 (R=Me) was formed (Scheme 7) [33]. It has been reported that [1,4,2]




























Scheme 7. DA reaction of 7-methyl-1,4,2-diazaphospholo[4,5-a]pyridine in the presence of
methyl iodide.
The regioselectivity observed in the reaction of 1,3-bis(ethoxycarbonyl)- 1,3-azaphospholo[5,1-a]
pyridine with isoprene was investigated theoretically at the DFT (B3LYP/6-311++G**//
B3LYP/6-31G**) level. Following model reactions were computed (Figure 2). For studying the
solvent effect, single point energy was computed using gas phase-optimized geometry at the
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20                                                                                 21
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Figure 2. Model DA reactions computed at B3LYP/6-311++G**//B3LYP/6-31G**.
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The regioselectivity was calculated by using the formula, k1/k2 = e−ΔE/RT [35]. A difference of
2.4 kcal/mol in the activation energies corresponds to only 2% regioselectivity. It is obvious that the
observed regioselectivity of 100% cannot be accounted for at this theoretical level.
We investigated the reason for the difference in the dienophilic reactivities of 3-ethoxycarbonyl
-1-methyl-1,3-azaphospholo[5,1-a]pyridine (10a) and 1,3-bis(ethoxycarbonyl)-1,3-azaphospholo[5,1-a]
pyridine (10b), theoretically. For this purpose, following four model reactions were computed at the
DFT (B3LYP/6-31G**) level (Scheme 8) [36].
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Scheme 8. Model DA reactions computed at the B3LYP/6-31G** level.
As expected, the activation energy barrier for the DA reaction with 1,3-bis(methoxycarbonyl)-1,
3-azaphospholo[5,1-a]pyridine (29) is lowest. However, it is interesting to find that the activation barrier for
the DA reaction with 3-methoxycarbonyl-1,3-azaphospholo[5,1-a]pyridine (25) is highest (29.49 kcal/mol),
higher than even for the DA reaction with the unsubstituted 1,3-azaphospholo[5,1-a]pyridine (23). It is
rather an unexpected effect of an electron-withdrawing group (EWG). To look into the real cause of this
unusual effect, we carried out the natural bond orbital (NBO) analysis calculations, which revealed the
existence of an interesting phenomenon: due to conjugation of the lone pair of the bridgehead nitrogen
in 23, negative charge density is effectively transferred to the five-membered azaphosphole ring, which
is further enhanced by the presence of an EWG at the 3-position. It is shown in Figure 3A. It makes the
>C=P- functionality electron-rich, which fails to react with electron-rich diene, DMB. However, a CO2Me
group at the 1-position acts as a trap for the negative charge, the latter being delocalized over to the
carbonyl group. It is shown in Figure 3B. Thus in this case, the >C=P- functionality remains unaffected
and is able to undergo the DA reaction with DMB.
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Figure 3. Natural Bond Orbital (NBO) interactions in 3-methoxycarbonyl-1,3-azaphospholo[5,1-a]pyridine
(A) and 1,3-bis(methoxycarbonyl)- 1,3-azaphospholo[5,1-a]pyridine (B1 and B2) with second order
perturbation energies (in parenthesis).
3.2. Lewis Acid Catalyzed Diels-Alder Reaction
Then, we explored the possibility of using a Lewis acid as catalyst to accomplish DA reaction with
3-(alkoxycarbonyl)-1-methyl-1,3-azaphospholo[5,1-a]pyridines and computed the following model
reactions at the DFT (B3LYP/6-31+G**) level (Scheme 9) [37]. For studying the solvent effect, single
point energy was computed using gas phase-optimized geometry with PCM solvation model.
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                              CH2Cl2
Nil        CH             45.68
Nil         P               30.80
AlCl3    CH             46.77
AlCl3     P               33.43
Eact (kcal/mol) = 22.57
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Scheme 9. Model DA reactions computed at the B3LYP/6-31+G** level.
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There was another surprise in store for us. When the catalyst, AlCl3, is coordinated to the
carbonyl group of indolizine or 1,3-azaphospholo[5,1-a]pyridine, the activation energy barrier is
increased further as compared with that in the absence of the catalyst. The NBO studies reveal that
coordination of AlCl3 with the carbonyl group enhances transfer of the negative charge in these
cases, making the >C=C< and >C=P- functionality in indolizine and 1,3-azaphospholo[5,1-a]pyridine,
respectively, electron-rich. This appears to be the reason why no DA reaction across the >C=C< moiety
of indolizine has been reported even in the presence of a catalyst.
In 2-phosphaindolizine, however, there is another site for the coordination of AlCl3: the P atom.
It may be noted that on coordination of the catalyst to the P atom, the activation energy barrier is
lowered remarkably, to 22.57 kcal/mol (in CH2Cl2) only. These results indicated that in contrast to
indolizine, DA reactions across the >C=P- moiety of 2-phosphaindolizine having EWG at 3-position
only should be possible in the presence of a Lewis acid catalyst. However, in this context a question
arises: if coordination of AlCl3 to the carbonyl group is thermodynamically more favorable than its
coordination to the P atom by 3.43 kcal/mol, why should it coordinate to the P atom at all? In our
opinion, in solution, an equilibrium may exist between the C=O- → AlCl3 and P → AlCl3 coordinated
species, making a small concentration of the latter available that undergoes DA reaction with the diene


















Scheme 10. Equilibrium between C=O → and P → coordinated species, and DA reaction with the latter.
Guided by the above results, we accomplished successfully the DA reaction of
3-(alkoxycarbonyl/acyl)-1-methyl-2-phosphaindolizines (38) with DMB in the presence of
ethylaluminium dichloride as a promoter (i.e., using its 1 equiv.) in dichloromethane at r.t. under
nitrogen atmosphere (Scheme 11) [38]. The occurrence of a clean reaction was revealed by 31P NMR
signal at δ = −16.6 to −5.3 ppm, which is in accordance with the 31P NMR chemical shifts reported for












38, 39          a        b        c         d
      R        OMe    OEt    CMe3    Ph
31P (39)   -5.8     -5.3    -16.6    -10.1
 
Scheme 11. DA reaction of 3-(alkoxycarbonyl/acyl)-1-methyl-2-phosphaindolizines in the presence
of EtAlCl2.
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3.3. Asymmetric Diels-Alder Reaction with 2-Phosphaindolizines
The successful results described above motivated us to investigate asymmetric DA reaction
across the >C=P- moiety of 2-phosphaindolizines by using a chiral organoaluminium catalyst, namely,
o-menthoxyaluminium dichloride [40].







































Scheme 12. Attack of 1,3-butadiene on Si and Re faces of the >C=P- functionality of 2-phosphaindolizine
complex computed at the B3LYP/6-31+G* level.
Computational calculations reveal that attack of the diene occurs preferentially from the Si face.
Furthermore, during attack on the Si face, activation energy barrier for the exo approach is smaller than
for the endo approach by ca. 0.3 kcal/mol. Presence of the bulky o-menthoxy group possibly makes the
endo approach comparatively less accessible. All the reactions are moderately exothermic, but due to
decrease in entropy, they are endergonic, Gibbs free energies values being +11.65 to +13.08 kcal/mol.
In accordance with the theoretical results, DA reaction of 2-phosphaindolizines (47) could be
accomplished with complete diastereoselectivity, as indicated by 31P NMR, with a single product being
formed in each case (Scheme 13) [40].

















OMenth = HO Me
45                                                        46                                                             48
47
49
47-49          a           b          c
   R          OMe     OEt      CMe3
31P(48)    196.0   217.4    211.3
31P(49)   -10.2    -9.4      -14.3
27Al(49)    62.3    72.3     100.9
Scheme 13. Diels-Alder reaction of 2-phosphaindolizine-n1-P-aluminium(o-menthoxy) dichloride
with DMB.
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3.4. Electrophilic Substitution
In contrast to indolizines [41], 1-unsubstituted 2-phosphaindolizines failed to react with MeCOCl,
PhCOCl, or Me3SiCl, even on prolonged heating in the presence of Et3N [42]. However, like
indolizines [43], 1-unsubstituted 2-phosphaindolizines reacted with PCl3 or PhPCl2 (but not with
Ph2PCl) in the presence of Et3N to afford the phosphynated products (Scheme 14) [44]. It is noteworthy
that on reacting with PCl3, the initially formed dichlorophosphino product (51, R=Cl) undergoes
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Scheme 14. Reaction of 1-unsubstituted 2-phosphaindolizines with chlorophosphines.
The concept of hard-soft acid-base (HSAB) theory was extended to explain the global and local
reactivity of organic molecules towards nucleophilic and electrophilic reagents [45]. The chemical
reactivity at a particular molecular site could be rationalized using a quantitative descriptor, the Fukui
function (f(r)). We recently used Fukui function to rationalize 1,2- versus 1,4-addition of amines
to maleic anhydride [46]. The difference in the behavior of indolizine and 2-phosphaindolizine
towards electrophilic reagents can be rationalized on the basis of the Fukui functions calculated at the
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Figure 4. Fukui functions calculated at the B3LYP/6-31+G* level.
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Fukui functions reveal that C1 and C3 in indolizine are much harder than C1 and C3 in
2-phosphaindolizine. Thus, hard electrophilic reagents such as acyl chlorides and chlorotrimethylsilane
attack at C1 and C3 positions of indolizine, but they fail to react with 2-phosphaindolizine. On the other
hand, phosphorus trichloride is comparatively softer and hence reacts with 2-phosphaindolizine at C1
(C3 being substituted in our compounds). Being at the borderline, PCl3 reacts with indolizine also.
4. Conclusions
The computational calculations could be used as a useful tool to understand and solve problems
encountered during reactions of annelated 1,3-azaphospholers. Furthermore, this strategy worked
well while planning the reactions such as Lewis acid catalyzed and asymmetric DA reactions across
the >C=P- functionality of 2-phosphaindolizines.
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Abstract: This review summarizes the main synthetic routes towards α-hydroxyphosphonates that
are known as enzyme inhibitors, herbicides and antioxidants, moreover, a number of representatives
express antibacterial or antifungal effect. Special attention is devoted to green chemical aspects.
α-Hydroxyphosphonates are also versatile intermediates for other valuable derivatives. O-Alkylation
and O-acylation are typical reactions to afford α-alkoxy-, or α-acyloxyphosphonates, respectively.
The oxidation of hydroxyphosphonates leads to ketophosphonates. The hydroxy function at the α
carbon atom of hydroxyphosphonates may be replaced by a halogen atom. α-Aminophosphonates
formed in the nucleophilic substitution reaction of α-hydroxyphosphonates with primary or
secondary amines are also potentially bioactive compounds. Another typical reaction is the
base-catalyzed rearrangement of α-hydroxy-phosphonates to phosphates. Hydrolysis of the ester
function of hydroxyphosphonates leads to the corresponding phosphonic acids.
Keywords: α-hydroxyphosphonate; Pudovik reaction; O-derivatization; oxidation; substitution;
rearrangement; hydrolysis
1. Synthetic Routes towards α-Hydroxyphosphonates
Due to the bioactivity of α-hydroxyphosphonates 1, the synthesis of these derivatives is
an evergreen topic in organophosphorus chemistry [1–8]. The main approaches to obtain
α-hydroxyphosphonates 1 are shown in Scheme 1. The most commonly studied method is the
addition of a dialkyl phosphite to an oxo compound (method “A”) [9]. The good atom economy makes
this method the most appealing way to synthesize α-hydroxyphosphonates 1. In the majority of cases,
the addition is carried out in the presence of a base catalyst, but a few acid-catalyzed variations are
also known. An alternative route is the condensation of an oxo compound and a trialkyl phosphite
(method “B”) [10]. In contrast to method “A”, this reaction is usually catalyzed by different acids.
In the literature, the denomination of the reactions is not consistent, as both methods “A” and “B” are
referred to as the Pudovik and Abramov reaction, and also as the phospha-aldol reaction. The third
main approach towards α-hydroxyphosphonates 1 involves the reaction of α-ketophosphonates 2 with
Grignard reagents [11] or other organometallic compounds [11,12], followed by hydrolysis (method
“C”). α-Alkyl phosphonates 3 may also be converted to the corresponding α-hydroxy derivatives by
oxidation (method “D”) [13,14]. In this review, methods “A” and “B” are discussed in detail. Although
the asymmetric synthesis of α-hydroxyphosphonates 1 is of special importance [4–8], in this review
the discussion is limited to racemic derivatives.
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Scheme 1. Synthetic pathways towards α-hydroxyphosphonates 1.
1.1. Synthesis of α-Hydroxyphosphonates by the Reaction of Aldehydes/Ketones and Dialkyl Phosphites
The reaction of oxo compounds and dialkyl phosphites catalyzed by alkali alcoholates (Scheme 1,
method “A”) was first reported by Pudovik [15]. Since then, a number of variants involving different
catalysts and conditions were elaborated to obtain α-hydroxyphosphonates by the reaction under
discussion (Table 1). Recent methods have targeted the use of inexpensive and simple catalysts,
and mild reaction conditions in the spirit of green chemistry. In the great majority of the cases,
the addition was carried out without using any solvent. It is worth mentioning that starting from ketones,
the accomplishment of the reaction is more challenging than in the cases applying aldehydes. The synthesis
of α-alkyl-α-hydroxyphosphonates often requires the use of “exotic” catalysts [16–20], or an excess of a
base. Procedures also applicable for the conversion of ketones are marked by an asterisk in Table 1.
A base-catalyzed variation of the Pudovik reaction was carried out in the presence of 5 mol %
potassium phosphate as the catalyst (Table 1/Entry 1) [21]. This method has the advantage of using an
inexpensive catalyst, requiring short reaction times and an easy work-up procedure that comprises
simple extraction, and, in most cases, provides the products in high yields. Barium hydroxide was also
an efficient catalyst in the addition [22,23]. One method employed 10 mol % Ba(OH)2 (Table 1/Entry
2) [22], while according to another protocol, Ba(OH)2·8H2O was used (Table 1/Entry 3) [23]. The first
Ba(OH)2-catalyzed variation suffers from the drawback of a tedious work-up procedure involving
extraction, and washing, followed by crystallization [22], while in the latter case, the use of THF as the
solvent is a disadvantage [23]. One equivalent of magnesium oxide efficiently catalyzed the addition of
diethyl phosphite to substituted benzaldehydes (Table 1/Entry 4) [24]. The method could be extended
to the conversion of γ-cyanoketones by applying the base in a twofold quantity (Table 1/Entry 5) [25].
The reaction of dimethyl phosphite with oxo compounds including ketones afforded the corresponding
α-hydroxyphosphonates 1 in the presence of three equivalents of aluminum oxide after stirring for 72 h
(Table 1/Entry 6) [26]. The reaction time could be shortened dramatically by using potassium fluoride
with only one equivalent of Al2O3. However, this latter method was efficient only in case of aldehydes
as the starting compounds (Table 1/Entry 7) [27]. The addition was also performed in the presence
of one equivalent of triethylamine as the catalyst (Table 1/Entry 8) [28]. A simple crystallization
afforded the desired products in good to excellent yields. Another method employed three equivalents
of triethylamine together with one equivalent of magnesium chloride (Table 1/Entry 9) [29]. In the
latter case, an extraction was inserted before the crystallization step in the work-up procedure [29].
In agreement with the requirements of environmentally friendly approaches, green activation methods,
such as microwave (MW) irradiation [30,31] and grinding [32,33] were also employed in the synthesis
of α-hydroxyphosphonates 1. According to a MW-assisted procedure, the reaction of benzaldehydes
and diethyl phosphite was carried out without the use of any catalyst or solvent (Table 1/Entry 10) [30],
while another method combined MW irradiation with sodium carbonate as the base (Table 1/Entry
11) [31]. Na2CO3 was also used efficiently in another protocol, when the contact among the reaction
components was promoted by grinding (Table 1/Entry 12) [32]. The drawback of the method is
the complicated work-up procedure comprising washing, extraction, and finally recrystallization.
A similar protocol utilizes the piperazine-catalyzed reaction of aldehydes and diethyl phosphite in a
mill (Table 1/Entry 13) [33]. In the latter case, the work-up involved washing, extraction and column
chromatography. The synthesis of α-hydroxyphosphonates 1 was also carried out in the presence
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of 10 mol % choline hydroxide as an IL catalyst (Table 1/Entry 14) [34]. According to a plausible
mechanism suggested by the authors, the IL promotes the reaction by activation through H-bridges.
An interesting protocol is a special fluoroapatite-catalyzed Pudovik reaction (Table 1/Entry 15) [35].
A mixture of the starting dialkyl phosphite and oxo compound was stirred with a spatula, and then
left standing on the catalyst over 1–1.5 min. The work-up involved extraction with dichloromethane,
and recrystallization of the crude product. Acid-catalyzed variations of the Pudovik reaction occur
rarely in the literature [36,37]. Potassium hydrogensulfate proved to be an efficient catalyst in an
amount of 20 mol % in addition of diethyl phosphite to substituted aldehydes (Table 1/Entry 16) [36].
According to another method, silica-supported tungstic acid was applied as the catalyst (Table 1/Entry
17) [37]. Organometallic compounds may also play the role of the catalyst during the synthesis of
α-hydroxyphosphonates 1 [38–40]. Butyllithium was applied in the amount of 0.1 mol % in hexane as
the solvent (Table 1/Entry 18) [38]. The method not only bears the disadvantages of using an exotic
catalyst in an inert atmosphere, but also the need for a complicated work-up involving quenching,
washing, and finally column chromatography. As for the advantages, mild reaction conditions and
wide substrate scope including ketones can be mentioned. Titanium tetraisopropylate was also
applied to catalyze the reaction of ketones and dimethyl phosphite (Table 1/Entry 19) [39]. Column
chromatography of the crude product afforded α-alkyl α-hydroxyphosphonates 1 in good to excellent
yields. Molybdenum dioxide dichloride (MoO2Cl2) was also tested as the catalyst in the Pudovik
reaction (Table 1/Entry 20) [40]. Using it in an amount of 5 mol % under solvent-free conditions at
80 ◦C, the hydroxyphosphonates 1 were obtained good yields.
1.2. Synthesis of α-Hydroxyphosphonates by the Reaction of Aldehydes/Ketones and Trialkyl Phosphites
Besides the reaction of oxo compounds with dialkyl phosphites discussed in Section 1.1 (Scheme 1,
method “A”), the other widespread method for the synthesis of α-hydroxyphosphonates is the
condensation of aldehydes or ketones with trialkyl phosphites (Scheme 1, method “B”) [10]. This way
is of somewhat less importance due to the reduced atom economy, as compared to the major route
outlined. While the reaction involving dialkyl phosphites is usually catalyzed by different bases,
the typical catalysts for the condensation of oxo compounds with trialkyl phosphites exhibit acidic
character (Table 2).
A method of choice is a solvent- and catalyst-free accomplishment under ultrasonic irradiation
(Table 2/Entry 1) [41]. The reaction of aldehydes and trialkyl phosphites at 25 ◦C was complete
after 10–35 min and provided the α-hydroxyphosphonates 1 in excellent yields after crystallization
(Table 2/Entry 1). The method was successfully applied to ketones as starting materials as well.
Another ultrasound-assisted variation is the potassium dihydrogen phosphate-catalyzed reaction
(Table 2/Entry 2) [42]. According to a plausible mechanism, the role of the acid catalyst is the
protonation of the carbonyl function of the aldehyde making the C=O bond more electrophilic,
and hence facilitating the nucleophilic attack of the (RO)3P reagent. A similar procedure employed
sulphamic acid as the catalyst (Table 2/Entry 3) [43]. Again, the catalytic effect of the sulphamic acid
was attributed to its capability to protonate the oxo compound. The camphorsulfonic acid-catalyzed
syntheses of α-hydroxyphosphonates 1 from aldehydes and triethyl phosphite was carried out
under ultrasonic irradiation on stirring (Table 2/Entry 4) [44]. Applying the ultrasound technique,
the reaction times could be shortened from 30–75 min to 8–15 min after comparing the results with
those obtained without ultrasonication. At the same time, the yields were similar (85–93%) for the
two procedures [44]. Oxalic acid also proved to be an efficient catalyst in the condensation under
discussion at 80 ◦C (Table 2/Entry 5) [45]. A series of organic solvents were tested as the reaction
medium, but the desired products were obtained in low yields (<30%). Under neat conditions,
the α-hydroxyphosphonates 1 were formed efficiently as suggested by the yields of 83–98% obtained
after quenching, extraction and column chromatography. In the hope of synthesizing a new class of
antibiotics, α-hydroxy-phosphonates 1 containing a β-lactam scaffold were prepared in the presence
of tartaric acid as the catalyst (Table 2/Entry 6) [46].
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Among a series of acids (e.g., acetic acid, trifluoroacetic acid, p-toluenesulfonic acid, lactic
acid, fumaric acid and tartaric acid) screened as potential catalysts of the reaction, fumaric acid
and tartaric acid were found to be the most efficient. It was concluded that weak acids (with a
pKa value around 4.5) are the best catalysts of the reaction [46]. According to another procedure,
pyridine-2,6-dicarboxylic acid was applied as the catalyst (Table 2/Entry 7) [47]. The reaction of oxo
compounds including ketones with trimethyl phosphite was carried out in water at 50 ◦C to furnish
hydroxyphosphonates. In another approach, the pyridine-based catalyst was replaced by guanidine
hydrochloride (Table 2/Entry 8) [48]. The drawback of this protocol is the rather complicated work-up
comprising quenching, extraction, and then chromatography. An interesting finding is that iodine may
also be a catalyst in the reaction of aldehydes and triethyl phosphite (Table 2/Entry 9) [49]. The catalytic
effect of I2 was explained similarly as that of the acid catalysts: iodine is able to interact with the
oxygen atom of the carbonyl group, making the C=O bond more electrophilic. β-Cyclodextrin was
found to be a promising and recoverable catalyst of the condensation (Table 2/Entry 10) [50]. However,
it was necessary to use this catalyst in a one equivalent quantity, and completion of the reaction
required longer times (8–12 h) as compared with other protocols. Ammonium metavanadate was
tested as the catalyst in the reaction of benzaldehydes with triethyl phosphite, as well as with diethyl
phosphite [51]. In the first case, the reaction was complete after 12–25 min (Table 2/Entry 11). However,
in the second case, the desired products were only formed in traces. Metal salts were also applied in
the reaction of oxo compounds and trialkyl phosphites with success (Table 2/Entries 12–14) [52–54].
The reaction of slightly electron-rich benzaldehydes and triethyl phosphite in the presence of ZnBr2
afforded the corresponding α-hydroxyphosphonates (Table 2/Entry 12) [52]. Bismuth(III) nitrate
pentahydrate was applied efficiently as the catalyst in the reaction of aldehydes and triethyl phosphite
under MW irradiation at 70 ◦C (Table 2/Entry 13) [53], while the niobium(V)chloride-trimethylsilyl
chloride system was used in an amount of only 0.05 mol % at 25 ◦C to prepare hydroxyphosphonates
(Table 2/Entry 14) [54].
1.3. The “Greenest” Protocol for the Synthesis of α-Hydroxyphosphonates
As it was presented in Sections 1.1 and 1.2, a great number of procedures have been elaborated for
the synthesis of α-hydroxyphosphonates 1 from oxo compounds by reaction with dialkyl or trialkyl
phosphites. Although, several methods involved the use of inexpensive and easily available catalysts
together with mild and solvent-free reaction conditions, the work-up procedures still suffered from
drawbacks. In most cases, the crude product was extracted with organic solvents, and then purified by
column chromatography or recrystallization. The combination of the purification steps mentioned is
also a frequent option [22,32,33,35,38,48].
We aimed at the elaboration of a new, environmentally-friendly, procedure for the synthesis of
α-hydroxyphosphonates 1. As opposed to the procedures already published, we wished to reduce the
amount of volatile organic solvents used not only during the reaction, but also in the course of the
work-up procedure. According to our method, an equimolar mixture of substituted benzaldehyde
and dialkyl phosphite was stirred at reflux in the presence of 10 mol % of triethylamine as the catalyst,
in a minimal amount of acetone (1.0 mL/11.0 mmol of the reagents). Then, n-pentane was added
to the mixture, which was then cooled to 5 ◦C. The desired product crystallized from the reaction
mixture, and the α-hydroxyphosphonates 1 could be obtained easily by a simple filtration in good to
excellent yields (78–99%) in a pure form. The main novelty of our protocol is the absence of further
purification steps, a consequence of the “one-pot” synthesis and precipitation from the reaction mixture
(Scheme 2) [55].
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Scheme 2. A green, solvent-economical synthetic method towards α-hydroxyphosphonates (1).
To reveal the role of triethylamine in the addition, the reaction of benzaldehyde with diethyl
phosphite was investigated by quantum chemical calculations [56]. It was found that in the absence
of a catalyst, the enthalpy of activation is around 85.9 kJ/mol, and the addition is thermoneutral.
The calculations revealed that triethylamine is able to promote the proton transfer from the >P(O)H
reagent to the oxo compound. The amine-catalyzed reaction goes with a decreased enthalpy of
activation of 68.8 kJ/mol, and follows an exothermic route (ΔH = −17.2 kJ/mol). The suggested
mechanism involving transition state 4 and intermediate 5 is shown in Scheme 3.
 
Scheme 3. Calculated mechanism of the triethylamine-catalyzed Pudovik reaction.
In conclusion, we were successful in the elaboration of another green protocol for the synthesis
of α-hydroxyphosphonates 1 from substituted benzaldehydes and a series of dialkyl phosphites
in the presence of triethylamine as the catalyst [55]. The new method involves the preparation in
boiling acetone followed by crystallization of the product in high purity. There was no need for
additional purification. The role of triethylamine in the reaction was justified by quantum chemical
calculations [56].
2. Reactions of α-Hydroxyphosphonates
α-Hydroxyphosphonates 1 deserve interest not only as potential enzyme inhibitors [57],
herbicides [58], antibiotics [59] and antibacterial or antifungal [60] agents, but also as starting
materials for other valuable derivatives [61]. Section 2.1 summarizes the alkylation reactions of
α-hydroxyphosphonates (Scheme 4, Route “A”). Acylation of the hydroxy function is one of the
most extensively studied transformations within this family of compounds (Scheme 4, Route “B”,
Section 2.2). A series of α-acyloxyphosphonates (8) was synthesized applying different acylating agents,
like carboxylic and sulfonyl chlorides, as well as carboxylic anhydrides and acids. The oxidation of
α-hydroxyphosphonates leads to α-ketophosphonates 9 (Scheme 4, Route “C”, Section 2.3). Another
thoroughly studied field is nucleophilic substitution at the α carbon atom of α-hydroxyphosphonates
to afford α-halo-, and α-amino or α-alkylphosphonates 10 (Scheme 4, Route “D”, Section 2.4).
The rearrangement of hydroxyphosphonates to benzyl phosphates 11 is an interesting field (Scheme 4,
Route “E”, Section 2.5). The curiosity of this transformation is the high substrate-dependence. Last but
not least, α-hydroxyphosphonic acids 12 may be obtained by the hydrolysis of the ester function of
α-hydroxyphosphonates (Scheme 4, Route “F”, Section 2.6).
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Scheme 4. Family tree of compounds 7–12 derived from α-hydroxyphosphonates (1).
The derivatives 7–12 synthesized from α-hydroxyphosphonates were summarized in the family
tree shown in Scheme 4. Classes 7–12 represent potentially bioactive compounds.
2.1. Alkylations
Alkylation of the hydroxy function of α-hydroxyphosphonates 1 does not belong to their
extensively studied reactions, as only a few articles reported the synthesis of α-alkoxyphosphonates 7.
A related article targeted antimalarial drugs, and the synthesis involved the O-alkylation of
hydroxyphosphonates 1B with benzyl bromoacetate in the presence of silver oxide (Scheme 5) [62].
 
Scheme 5. O-alkylation of hydroxyphosphonates 1B with benzyl bromoacetate.
The protection of the α-hydroxy function may also occur in the literature as another
utilization of O-alkylation. A tetrahydropyranyl (THP) protecting group was introduced to an
α-hydroxyphosphonate 1B by treatment with 3,4-dihydro-2H-pyran applying p-toluenesulfonic acid as
the catalyst [63]. The silylation of α-hydroxyphosphonates 1 is also a useful tool to protect the hydroxy
function [64–67]. The reaction of hydroxyphosphonates 1B with hexamethyldisilazane (HMDS) was
studied using a great variety of catalysts including iodine (Scheme 6, Route “a”) [65], copper triflate
(Scheme 6, Route “b”) [66] or iron(III) trifluoroacetate (Scheme 6, Route “c”) [67].
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Scheme 6. Possible ways of introducing a silyl protecting group to α-hydroxyphosphonates 1B.
A unique protocol has been reported for the cyclization of α-hydroxyphosphonates bearing an
alkynyl function in the ortho-position of the aromatic ring (15) [68]. Applying Pd(II) acetate as the
catalyst, the nucleophilic attack of the α-O atom occurred on the more distant C-atom of the triple bond
of the alkynyl substituent to form the six-membered product 16 selectively. Surprisingly, changing the
Pd(OAc)2 catalyst to DBU used in 2 equivalents led to a five-membered cyclic product 17. In the latter
case, the attack of the hydroxy group occurred on the nearer C-atom of the triple bond, followed by
isomerization (Scheme 7).
 
Scheme 7. Selective cyclization of ortho-alkynyl α-hydroxyphosphonates 15.
2.2. Acylations
The synthesis of α-acyloxyphosphonates 8 is one of the most thoroughly studied transformations of
α-hydroxyphosphonates 1. α-Acyloxyphosphonates 8 attracted attention as potential herbicides [69–71],
fungicides [69], and insecticides [72]. A number of articles reported the acylation of α-hydroxyphosphonates
1 with carboxylic acid chlorides in the presence of triethylamine [73–75] or pyridine [76,77] as the
hydrochloric acid scavenger. Among the –C(O)Cl reagents, phenoxyacetyl chloride derivatives 18 are
frequently applied acylating agents [70,71,76–84].
In general, the reaction of α-hydroxyphosphonates 1 with phenoxyacetyl chlorides 18 required a
reaction time of 3–7 h, and the corresponding α-acyloxyphosphonates 19 were isolated in yields of
53–89% (Scheme 8) [78]. The compounds 19 thus-obtained are popular target molecules, as a series of
related derivatives exhibited herbicidal activity [70,76–80,83,84].
 
Scheme 8. Synthesis of α-acyloxyphosphonates (19) from α-hydroxyphosphonates (1).
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The reaction of α-hydroxy-phosphonates 1A with 2,6-pyridinedicarboxylic acid chloride (20) led to
bis[dimethyl phosphonomethyl pyridine-2,6-dicarboxylates] 21 containing two α-acyloxyphosphonate
moieties (Scheme 9). The reaction took place under mild conditions, and the products 21 were isolated
with variable yields (38–80%). The derivatives so-obtained 21 also showed herbicidal activity [85].
 
Scheme 9. Acylation of α-hydroxyphosphonates (1A) with 2,6-pyridinedicarboxylic acid chloride (20).
The acylation of α-hydroxyphosphonates 1B has been also performed with acetic anhydride [86–88].
This reaction was carried out in the presence of a catalytic amount (1.3–8 mol %) of Cu(OTf)2 at 25 ◦C
to afford the desired α-acetyloxyphosphonates 22 almost quantitatively (Scheme 10, Route “a”) [86].
In another instance, 1 mol % of TiCl3(OTf) was employed as the catalyst (Scheme 10, Route “b”). In this
case, completion of the reaction required a somewhat higher temperature (70 ◦C) [87]. A more benign
synthetic route to α-acetyloxyphosphonates 22 is the reaction of α-hydroxyphosphonates (1B) and
acetic anhydride under MW irradiation (Scheme 10, Route “c”) [88]. The acylation was complete after
a short reaction time of 5 min, and the products were obtained in excellent yields (90–98%). However,
a lack of control of the reaction temperatures is a shortcoming that prevents reproduction.
 
Scheme 10. Possible ways for the synthesis of α-acetyloxyphosphonates 22.
The synthesis of α-acyloxyphosphonates 8 was also carried out starting from substituted
benzaldehydes, dimethyl phosphite and acetic anhydride in the presence of magnetic nanoparticle-
supported guanidine [89]. In this one-pot procedure, the formation of the α-hydroxyphosphonate 1 in
the Pudovik reaction was followed by acylation of the hydroxy function.
Carboxylic acids may also be efficient acylating agents ofα-hydroxyphosphonates 1 in the presence of
N,N′-dicyclohexylcarbodiimide (DCC) as the coupling reagent, and 4-dimethyl- aminopyridine (DMAP)
as the base [27,90,91]. This is exemplified by the reaction of 2-(4,6-dimethoxypyrimidin- 2-yloxy)benzoic
acid (23) at 25 ◦C to give α-acyloxyphosphonates 24 possessing herbicidal activity (Scheme 11) [27].
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Scheme 11. Coupling reaction of α-hydroxyphosphonates (1) with carboxylic acid 23.
Another method of choice for the acylation of α-hydroxyphosphonates 1B with carboxylic acids,
is the Mitsunobu reaction applying 4,4′-azopyridine (25) and triphenylphosphine in acetonitrile as
the solvent (Scheme 12) [92]. Completion of the reaction required a reaction time of 9–24 h at 80 ◦C,
and the products 26 were obtained in yields of 65–88%.
 
Scheme 12. Synthesis of α-acyloxyphosphonates (26) via Mitsunobu reaction.
The reaction of α-hydroxyphosphonates 1 with isocyanates 27 or isothiocyanates 29 resulted
in the formation of α-carbamoyloxy-28 or α-thiocarbamoyloxyphosphonates 30, respectively [93,94].
One study targeted herbicides by the acylation of α-hydroxyphosphonates (1) with pyrimidine-based
isocyanates 27 (Scheme 13, Route “A”) [93].
 
Scheme 13. The reaction of α-hydroxyphosphonates (1) with isocyanates 27 and isothiocyanates 29.
The reaction took place under benign conditions, and the products 28 so-obtained revealed a
weak herbicidal activity. On reacting hydroxyphosphonates (1) and isothiocyanates 29 in the absence
of a catalyst, the corresponding α-thiocarbamoyl-oxyphosphonates 30 were obtained in modest yields
of 20–30%. However, the application of 15 mol % of sodium methoxide promoted the acylation,
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and the products 30 could be isolated in yields of 74–90% (Scheme 13, Route “B”) [94]. The authors
of the article emphasize the need for mild reaction conditions (25 ◦C, 0.5–3.5 h), as heating of the
reaction mixture resulted in the formation of a by-product through the trimerization of the starting
isothiocyanate. The α-thiocarbamoyl-oxyphosphonates 30 obtained in this way expressed plant growth
regulating activity.
As shown above, the acylation of α-hydroxyphosphonates (1B) was carried out with a wide
range of carboxylic acid derivatives. Besides carboxylic chlorides, anhydrides and acids, sulfonic
acid derivatives may also function as the acylating agents. By analogy with the reaction of
α-hydroxyphosphonates (1B) with carboxylic chlorides, the acylation was also attempted with sulfonyl
chlorides [95–97]. Methanesulfonyl chloride (Scheme 14, Route “a”) [96] and p-toluenesulfonyl chloride
(Scheme 14, Route “b”) [97] worked well as sulfonylating agents in the presence of triethylamine.
Scheme 14. Sulfonylation of α-hydroxyphosphonates 1B.
In contrast to the wide range of α-acyloxy and α-sulfonyloxy phosphonates, α-phosphoryloxy
analogues appear rarely in the literature. A study from the early 1960’s reported the synthesis of a
>P(O)OCHP(O)< type compound 33 by a thermo-induced rearrangement (Scheme 15) [98]. However,
the phosphorylation of α-hydroxyphosphonates (1) with P-chlorides presented a challenge.
Scheme 15. Synthesis of O-phosphoryloxy phosphonate 33 by rearrangement.
Recognizing the lack of O-phosphorylated α-hydroxyphosphonates 34 in the literature, we aimed
at the synthesis of new classes of derivatives by the acylation of α-hydroxyphosphonates 1 with
phosphoryl and phosphinic chlorides. It was observed that by stirring the reaction components at




















25 °C, 24 h
Et3N
R = Me, Et
Y1 = C6H5, 4-MeC6H4, 4-MeOC6H4, 4-ClC6H4, 4-NO2C6H4
Y2 = Ph, OEt, OPh
toluene
1 34
Scheme 16. Phosphorylation of α-hydroxyphosphonates 1 with phosphoryl and phosphinic chlorides.
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2.3. Oxidations
The oxidation of α-hydroxyphosphonates 1B affords the corresponding α-ketophosphonates (35)
that are versatile precursors of a series of organophosphorus compounds [100–102]. The application
of metal compounds with variable valency as the oxidizing agent is predominating in the literature.
Alumina-supported chromium(III) oxide (CrO3/Al2O3) (Scheme 17, Route “a”) [103], and chromium
salts, like zinc dichromate trihydrate (ZnCr2O7·3H2O) (Scheme 17, Route “b”) [104] were found to be
efficient reagents in the oxidation of α-hydroxyphosphonates 1B. In both cases, the reaction took place
at ambient temperature under solvent-free conditions. The procedures provided the desired products
35 in good to excellent yields (up to 96%).
 
Scheme 17. Oxidation of α-hydroxyphosphonates 1B using metal compounds with variable valency.
In other variations, pyridinium dichromate [105] or pyridinium chlorochromate [106] were applied
successfully to give α-ketophosphonates 35. The reaction under discussion was also reported using
KMnO4 as the oxidant (Scheme 18). A shortcoming of this latter protocol is the need for dry benzene
as the reaction medium [107]. Another problem of the chemical oxidating agents is the low atom
efficiency and the lack of “greenness”.
Scheme 18. Synthesis of α-ketophosphonates 35 from α-hydroxyphosphonates 1B with KMnO4 oxidant.
An elegant achievement is the oxidation of dibenzyl α-hydroxyphosphonates 1C with oxygen,
employing a chiral vanadyl(V) complex (37) as the catalyst (Scheme 19) [108]. After a reaction
time of 6–150 h, the corresponding α-ketophosphonates 36 were obtained in conversions of
49–51%, while due to the presence of the optically active catalyst, the (S) enantiomer of the
α-hydroxyphosphonate (S)-1C remained untouched. This protocol offered an efficient way for the
resolution of α-hydroxyphosphonates 1C with high enantiomeric excesses up to 99% (with two
exceptions), in parallel with the formation of α-ketophosphonates 36.
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Scheme 19. Tandem resolution and oxidation of α-hydroxyphosphonates 1C.
2.4. Nucleophilic Substitutions
The nucleophilic substitution of the hydroxy group of α-hydroxyphosphonates 1 represents
one of the most widely studied reaction types of this class of compounds. A typical transformation
is the change of the hydroxy function to a halogen atom. α-Halobenzylphosphonates 38 deserve
interest as potential inhibitors of protein tyrosine phosphatases [109,110]. A chloro or bromo
substituent may be introduced into an α-hydroxyphosphonate 1 molecule by treatment with thionyl
chloride [111] or thionyl bromide (Scheme 20, Route “a”) [110], respectively. Another method of
choice to obtain α-halobenzylphosphonates 38 is the joint application of triphenylphosphine and
the corresponding carbon tetrahalide [112–114]. One procedure applied this synthetic route to
obtain α-chlorobenzylphosphonates (Scheme 20, Route “b”) [114], while another paper reported
the introduction of a chloro atom to both aliphatic and aromatic hydroxyphosphonates under similar
conditions (Scheme 20, Route “c”) [113].
Scheme 20. Synthetic routes to obtain α-halophosphonates 38.
A further variation involves the use of tetrabutylammonium bromide as the nucleophile in the
presence of triphenylphosphine—DDQ (2,3-dichloro-5,6-dicyanobenzoquinone) system, affording
α-bromophosphonates [115,116].
In another protocol, hydroxyphosphonates 1 were converted to their corresponding
α-halo analogues 38 by reaction with molecular halogens (Br2 or I2) applying 4-aminophenyl-
diphenylphosphinite 39 as the acid scavenger (Scheme 21) [117]. The amino function of the phosphinite
39 made possible the removal of the forming hydrogen halogenide as an ammonium salt after a
simple filtration.
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Scheme 21. Synthesis ofα-halophosphonates 38 fromα-hydroxyphosphonates 1 with molecular halogens.
To synthesize α-fluorophosphonates, the most commonly used fluorinating agent is
diethylaminosulfur trifluoride (Et2NSF3) [111,114,118–121]. As a variation of this method,
a protocol applying morpholinosulfur trifluoride was elaborated for the OH → F change in
α-hydroxy-bisphosphonates [122]. N-fluorobisbenzenesulfonimide was used efficiently to introduce
a fluoro function to the α-carbon atom of α-monohalophosphonates 38 in the presence of sodium
hexamethyldisilazane [113,114,116].
Halogens are not the sole nucleophiles that the α-hydroxy function of benzylphosphonates 1B
may be replaced with. One method operated with the above mentioned triphenylphosphine−DDQ
system to catalyze the reaction of α-hydroxyphosphonates 1B with ammonium thiocyanate to obtain
α-thiocyanatophosphonates 40 (Scheme 22, Route “A”) [115]. Another study reported the Mitsunobu
reaction of α-hydroxyphosphonates 1B with hydrazoic acid as the nucleophile. The treatment of the
so-formed α-azidophosphonates 41 with triphenylphosphine and carbon disulfide resulted in the
formation of α-isothiocyanatophosphonates 42 (Scheme 22, Route “B”) [123].
 
Scheme 22. Nucleophilic substitution of α-hydroxyphosphonates 1B with NH4SCN and hydrazoic acid.
α-Aminophosphonates 43 are usually obtained by the three-component condensation
(Kabachnik-Fields reaction) of oxo compounds, amines and dialkyl phosphites or secondary phosphine
oxides [124–127]. However, these compounds may also be synthesized via the nucleophilic substitution
of α-hydroxyphosphonates 1B with primary or secondary amines. According to a simple protocol,
this latter reaction was performed under MW irradiation, in the presence of Al2O3 [128]. After 3–7 min,
a complete conversion was attained (Scheme 23). However, reaction temperatures are missing from
the articles, as the experiments were carried out in a kitchen MW oven.
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Scheme 23. Synthesis of α-aminophosphonates 43 by nucleophilic substitution of 1B with amines.
We found that α-hydroxyphosphonates 1B may be converted to the corresponding
α-aminophosphonates 44–46 under MW conditions without the use of any catalyst or solvent
(Scheme 24) [56,129]. The starting hydroxyphosphonates 1B were reacted with three equivalents
of a primary amine (propyl-, butyl- or cyclohexyl-amine) applying MW irradiation at 100 ◦C.
Following this method, the substitution took place with surprising ease. Starting from substituted
hydroxyphosphonates 1Bb, 1Bc and 1Bg, a short reaction time of 15–30 min was sufficient for complete
conversion (Table 3/Entries 4–12). The unsubstituted analogue 1Ba was even more reactive, and in
this case the reaction took place after 10–15 min (Table 3/Entries 1–3).
 
Scheme 24. MW-Assisted synthesis of α-aminophosphonates 44–46 through nucleophilic substitution.
Table 3. Details of the synthesis of α-aminophosphonates 44–46 from α-hydroxyphosphonates 1B.
Entry Y1 Y2 Reaction Time (min) Yield (%) Product Ref.
1 H nPr 10 78 44a [129]
2 H nBu 15 86 45a [129]
3 H cHex 10 84 46a [129]
4 Cl nPr 15 60 44b [50]
5 Cl nBu 20 50 45b [56]
6 Cl cHex 30 54 46b [56]
7 Me nPr 15 58 44c [56]
8 Me nBu 15 79 45c [56]
9 Me cHex 30 73 46c [56]
10 OMe nPr 15 72 44g [56]
11 OMe nBu 30 66 45g [56]
12 OMe cHex 30 70 46g [56]
Encouraged by the recognition that the reaction of α-hydroxyphosphonates 1B with primary
amines takes place rather easily, we wished to study the mechanism of the substitution by
quantum chemical (DFT) calculations [129]. The nucleophilic attack of methylamine on diethyl
α-hydroxybenzylphosphonate 1Ba was chosen as the model reaction. It was found that the reaction
follows an SN2 mechanism. It was also revealed that a favorable neighboring group effect facilitates
the transfer of the oxygen atom of the hydroxy group from the α-carbon atom to the phosphorus
(transition state 47) [129]. The proposed mechanism is shown on Scheme 25.
440
Molecules 2018, 23, 1493
 
Scheme 25. Calculated mechanism of the substitution of hydroxyphosphonate 1Ba with methylamine.
α-Sulfonamidophosphonates were obtained through the reaction of α-hydroxyphosphonates and
sulfonamides in the presence of HOTf in dioxane. The reaction took place at ambient temperature
within 5 h, and the desired products were obtained in yields of 70–94% [130]. The products so-obtained
were found to be as promising corrosion inhibitors for mild steel [131].
The Friedel-Crafts alkylation using α-hydroxyphosphonates 1 in the presence of an acid catalyst
(e.g., FeCl3 or HOTf) led to α,α-diarylphosphonates 53 [132–134]. Benzene and naphthalene served
as the aromatic substrate. According to the proposed mechanism, the first step is the formation of
benzylphosphonate carbocation 52 that is followed by its electrophilic attack on the aromatic substrate
(Scheme 26) [132].
 
Scheme 26. Friedel-Crafts alkylation of α-hydroxyphosphonates 1 with arene nucleophiles.
An interesting reaction is when α-hydroxyphosphonates 1B function as an alkylating agent
of 1,3-diketones to afford γ-ketophosphonates 54 (Scheme 27) [135]. The reaction of the starting
components in organic solvents in the presence of FeCl3 or Cu(OTf)2 Lewis acids resulted in the
formation of compound 54 (Scheme 27, Route “A”). The optimization of the alkylations was a real
challenge for the authors, as each hydroxyphosphonate—diketone combination required different
reaction conditions regarding the Lewis acid, temperature, time and solvent. However, applying
FeCl3·6H2O as the catalyst, a C–C bond cleavage of the desired product 54 also occurred due to the
presence of the crystal hydrate of the iron salt. In this case, a mixture of compounds 54 and 55 was
attained (Scheme 27, Route “B”).
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Scheme 27. Alkylation of 1,3-diketones with α-hydroxyphosphonates 1B.
2.5. Rearrangements
The rearrangement of α-hydroxyphosphonates 1 to benzyl phosphates was first discovered
through the example of the widely known insecticide prodrug, trichlorofon (O,O-dimethyl
(2,2,2-trichloro-1-hydroxyethyl)phosphonate) that is rearranged to 2,2-dichlorovinyl dimethyl
phosphate (DDVP) acting as an acetylcholinesterase inhibitor [136]. Phosphonate-phosphate
rearrangements were investigated in the presence of strong bases, such as sodium hydroxide [136],
sodium ethoxide [137] and sodium hydride [138]. A number of protocols operated with triethylamine
as the catalyst [139–141]. However, the Et3N-catalyzed rearrangement is not a versatile method, as it
was reported to apply to only six-membered cyclic phosphonates [139–141].
A new approach of this transformation is when the Pudovik reaction of benzaldehydes and
dialkyl phosphites and the subsequent rearrangement of the so-formed α-hydroxyphosphonate 1 take
place in “one-pot”, under the same conditions. The synthesis of benzyl phosphates 56 directly from an
oxo compound and a P-reagent was efficiently catalyzed by butyllithium (Scheme 28, Route “a”) [142]
as well as by DBU (Scheme 28, Route “b”) [143]. The tandem Pudovik reaction and rearrangement
was also reported in the presence of superbases 57 (Scheme 28, Route “c”) [144]. The authors of this
latter article emphasized that both the reaction media and the substituent in the aromatic ring had a
great impact on the reaction. The rearrangement took place faster in alcohols (EtOH or iPrOH) than in
acetonitrile. It was also shown that the presence of electron-withdrawing substituents facilitated the
formation of the benzyl phosphate 56 [144].
 
Scheme 28. Methods of the tandem Pudovik reaction and rearrangement affording benzyl phosphates 56.
In this field, our research targets the accomplishment of the rearrangement of α-hydroxyphosphonates
1 using bases under phase transfer catalytic conditions (Scheme 29) [145].
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Scheme 29. Rearrangement of α-hydroxyphosphonates 1 under phase-transfer catalytic conditions.
Our preliminary results highlighted that the substituent in the aromatic ring has a significant
impact on the reaction. In the presence of electron-withdrawing substituents (Cl and F), the reaction
took place at ambient temperature, whereas the rearrangement of α-hydroxyphosphonates bearing
electron-releasing substituents required 2–3 h of heating [145].
2.6. Hydrolysis
The hydrolysis of α-hydroxyphosphonates 1 is the most common way for the synthesis of
α-hydroxyphosphonic acids 12 that may be inhibitors of a wide variety of enzymes including protein
tyrosine phosphatases [110,146,147], mandelate racemase [148], phosphoglycerate kinase [149], plant
P5C reductase [150] and plant glutamine synthetase [151]. A series of α-hydroxyphosphonic acid (12)
and α-hydroxybisphosphonic acid was recognized as antibiotics against Gram-positive bacteria [152].
α-Hydroxyphosphonic acids 12 bearing an amide function in the para-position of the aromatic ring
were found to be in vivo inhibitors of autotaxin [153].
As for the synthesis of α-hydroxyphosphonic acids 12, most of the related articles reported
the acidic hydrolysis of the corresponding methyl or ethyl ester [149,150,152,154]. A number of
protocols applied hydrochloric acid in an excess at reflux, and the hydrolysis usually required a
prolonged reaction time of 6–24 h [149,150,152]. According to another method, beside the excess of
6 M hydrochloric acid, dioxane was also added as a co-solvent [154].
In the hope of selective hydrolysis of one of the ester functions, the hydrolytic reaction of dimethyl
1-hydroxy-1-phenylmethylphosphonate 1Aa was carried out in aqueous sodium hydroxide at reflux
for 5 h (Scheme 30, Route “A”) [155]. After pH adjustment, the desired product (57) was obtained in
a yield of 85%. This method was suitable only for the synthesis of the racemic target compound 57.
In order to maintain the C chirality center of the starting α-hydroxyphosphonate (R)-1Aa, a milder
protocol had to be elaborated. On stirring the starting optically active α-hydroxyphosphonate (R)-1Aa
in the presence of sodium iodide in acetone at reflux for 22 h, racemization of the hydroxyphosphonate
(R)-1Aa could be avoided (Scheme 30, Route “B”) [155].
Scheme 30. Selective hydrolysis of one ester function of hydroxyphosphonate (R)-1Aa.
Another way of synthesizing α-hydroxyphosphonic acids (12) from α-hydroxyphosphonates
1 involves the cleavage of the C–O bond of the ester function by trimethylsilyl chloride [77,138] or
trimethylsilyl bromide [110]. This reaction is usually carried out at ambient temperature within 2–18 h,
generally in acetonitrile as the solvent.
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3. Conclusions
This review summarizes the synthesis and reactions of α-hydroxyphosphonates that are of
importance due to their bioactivity. The first half of the review presents the most common synthetic
routes towards α-hydroxyphosphonates, with special stress on the addition of dialkyl phosphite
to an oxo compound, and the condensation of trialkyl phosphites with aldehydes or ketones. The
overview is followed by the discussion of the green synthetic protocols for α-hydroxyphosphonates.
Then, the reactions of α-hydroxyphosphonates involving O-alkylation, O-acylation and oxidation of
the hydroxy function, substitutions of the hydroxy group by a chloro or amino function, rearrangements
to phosphate derivatives and hydrolysis of the ester function are discussed. Beside the literature
examples, our own synthetic results are also included.
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Abstract: The continuous flow alcoholysis of dialkyl H-phosphonates by aliphatic alcohols in the
absence of a catalyst was elaborated using a microwave (MW) reactor equipped with a flow cell.
By the precise control of the reaction conditions, the synthesis could be fine-tuned towards dialkyl
H-phosphonates with two different and with two identical alkyl groups. In contrast to the “traditional”
batch alcoholysis, flow approaches required shorter reaction times, and the products became available
at a larger scale.
Keywords: dialkyl H-phosphonates; alcoholysis; transesterification; microwave; continuous flow reactor
1. Introduction
Flow chemistry induced an inevitable revolution in the field of chemical transformations [1].
In modern chemistry, reactions have to be strictly controlled, which requires more and more precise
synthetic techniques. In contrast to the “traditional” batch reactions, flow approaches create a
significantly different processing environment, which enables a more efficient control of the reaction
conditions (such as the reaction time or temperature). Due to this, flow protocols may be significantly
better with respect to purity, selectivity and yields, as compared to batch approaches [2].
In microwave (MW) chemistry, the continuous flow technique represents a special importance.
Although applications of the MW technique proved to be useful in many chemical transformations,
the scale-up of MW-assisted reactions means a challenge due to the limited geometry of the MW
devices [3–6]. One possibility to solve this problem is the use of continuous flow MW reactors,
where the reaction mixture flows through an irradiated flow cell. The MW unit can be of a similar size
used in batch mode. During the last decade, the advantages of the applications of continuous flow
MW reactors were reported in certain transformations; however, in most cases, the usefulness of the
occasional devices may be questionable, as non-professional MW reactors do not allow reproductions,
and what is more important, the temperatures were not reported [7,8].
Esters represent a fundamental family among organic compounds. Esters of carboxylic acids may
be important intermediates, solvents or products in organic chemistry [9].
The most common preparations of simple carboxylic esters comprise the acid-catalyzed reaction
of a carboxylic acid with alcohol (Fischer esterification) and the reaction of an ester with alcohol
(alcoholysis) [10]. Continuous flow Fischer esterifications may be carried out in systems containing
a packed catalyst bed [11–20] or a heated coil [21,22], as well as in microreactors [23]. In a few
cases, the esterifications were performed in continuous flow MW systems based on professional MW
reactors [24–26] or in household MW ovens [27,28]. The continuous flow alcoholysis of carboxylic
esters may also be performed in reactors equipped with a catalyst bed [29] or a heated coil [21,30].
The alcoholysis is also of great importance in biodiesel production, the area of which was recently
summarized by Lee and co-workers [31].
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Organophosphorus esters are also of great importance [32]. Dialkyl esters of phosphorous
acid (dialkyl H-phosphonates) are widely applied building blocks in syntheses [33]. They are
important starting materials of the Kabachnik–Fields condensations and the aza-Pudovik reactions [34]
(towards α-aminophosphonates), the Pudovik reactions [35] (resulting in the formation of
α-hydroxyphosphonates) and further organophosphorus transformations, such as the Hirao
reaction [36] and the phospha-Michael addition [37]. Dialkyl H-phosphonates bearing different
alkoxy groups on the phosphorus atom are valuable intermediates for P-chiral organophosphorus
derivatives [38,39].
The industrial synthesis of dialkyl H-phosphonates is comprised of the reaction of phosphorus
trichloride with alcohols (Scheme 1) [40–45]. Although this transformation is convenient, efficient and
may be scaled up, it requires a solvent, and the liberating HCl decreases the atom efficiency. It is also a
disadvantage that the synthesis of derivatives with different alkyl groups is not possible.
Scheme 1. Synthesis of dialkyl H-phosphonates from phosphorus trichloride.
Another possibility for the preparation of dialkyl H-phosphonates is alcoholysis (Scheme 2),
which provides the products in good yields [46–54]. The only by-product is the leaving alcohol.
The relatively high temperature and the need for the high excess of the alcohol mean disadvantages.
Scheme 2. Synthesis of dialkyl H-phosphonates by alcoholysis.
Besides the two main routes mentioned above, there are a few less important methods for
the synthesis of dialkyl H-phosphonates. Such protocols are the oxidative reaction of elemental
phosphorus with alcohols (Scheme 3a) [55–60] and the Ni-catalyzed oxidation of hypophosphorous
esters (Scheme 3b) [61].
Scheme 3. Miscellaneous synthesis of dialkyl H-phosphonates.
The synthesis of dialkyl-H-phosphonates bearing different alkyl groups is not easy and requires
special methods (Table 1).
454




























































































































Molecules 2018, 23, 1618
Phosphites with different alkyl groups may be synthesized by the partial alcoholysis of dialkyl
H-phosphonates (Table 1, Entry 1). The reaction conditions must be controlled strictly to avoid
complete transesterification.
Dialkyl H-phosphonates with two different alkyl groups may be obtained by the controlled O–C
cleavage of dialkyl H-phosphonates (Table 2, Entries 2 and 3). In the first step of the first method,
a phosphite-ammonium salt is prepared, which is then alkylated with alkyl iodides (Table 2, Entry 2),
or with alcohols in the presence of pivaloyl chloride and pyridine (Table 2 entry 3) to furnish the target
compounds selectively. A serious drawback of these transformations is the low atom efficiency.
Table 2. Alcoholysis of dialkyl H-phosphonates in a batch microwave (MW) reactor [33].
Entry R1 R2 R2OH (equiv) T (◦C) t (min)
Composition (%) a
A B C
1 Me Et 25 100 120 22 56 22
2 Me Et 50 175 40 0 4 96
3 Me nBu 25 125 60 0 40 60
4 Me nBu 50 150 60 0 0 96
5 Et Me 25 125 120 49 38 13
6 Et Me 50 175 40 0 21 79
7 Et iPr 25 125 60 26 57 17
8 Et iPr 50 175 40 0 6 94
9 Et nBu 25 125 60 25 54 21
10 Et nBu 50 175 40 0 2 98
11 Et nPent 25 125 60 3 52 45
12 Et nPent 50 175 40 0 8 92
a Analyzed by GC. Bold numbers indicate the target compounds in the reactions.
Dialkyl H-phosphonates bearing different alkoxy groups can also be obtained in the reaction of
alkyl dichlorophosphites and alcohols. The primarily formed trialkyl phosphite is cleaved by a part of
the hydrochloric acid formed (Table 2, Entry 4).
From these synthetic methods, the alcoholysis may be flow compatible. This solvolytic reaction
may be carried out without any catalyst by fine-tuning the reaction conditions, to afford mixed or
fully-transesterified dialkyl phosphites as the predominant component.
The alcoholysis of dialkyl H-phosphonates in a batch MW reactor was investigated by us
previously (Table 2) [52]. The reaction of dialkyl H-phosphonates (A) with aliphatic alcohols under
mild conditions (lower alcohol excess and lower temperature) afforded the derivatives with different
alkyl groups (B) as the main products, while in the case of applying higher excess of alcohol and higher
temperature, the fully-transesterified dialkyl H-phosphonates (C) predominated in the mixture.
In this paper, we aimed at elaborating an MW-assisted continuous flow method for the alcoholysis
of dialkyl H-phosphonates. Our purpose was to find the optimum conditions for the formation of
dialkyl H-phosphonates bearing different alkyl groups and for the fully-transesterified phosphites in a
flow MW reactor. Furthermore, we wished to prepare new dialkyl H-phosphonates with two different
alkyl groups, which may be valuable building blocks of chiral organophosphorus compounds.
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2. Results and Discussion
In the first case, the alcoholysis of dimethyl H-phosphonate (DMP) (1) with n-butanol was
investigated in the absence of any catalyst, in a CEM® (Matthews, NC, USA) MW reactor equipped
with a commercially available CEM® continuous flow cell (Figures 1 and 2). The mixture of DMP
(1) and a 25-fold excess of n-butanol was fed into the reactor by an HPLC pump at a flow rate of
0.1–1.4 mL/min (corresponding to residence times of 60–5 min, respectively). The temperature was
monitored and controlled by an IR sensor. The mixture leaving the reactor was cooled down using a
spiral-like cooler and was passed through a back pressure regulator operating at 250 psi. Consecutive
fractions of the leaving mixture were analyzed by GC measurements in order to determine the
composition and to identify the stationary operation.
 
Figure 1. Schematic drawing of the continuous flow system developed.
 
Figure 2. Sketch of the continuous flow cell.
The reaction conditions and the results are summarized in Table 3. To find the optimum conditions
for the formation of n-butyl methyl H-phosphonate (nBMP) (2a) and n-dibutyl H-phosphonate (DnBP)
(3a), the alcoholysis was carried out applying different temperatures and residence times. Performing
the reaction at 100 ◦C, at a flow rate of 1.4 mL/min (with a residence time of 5 min), the conversion
was only 26%, and the proportion of nBMP (2a) was 25%, along with 1% of DnBP (3a) (Table 3, Entry 1).
Using a flow rate of 0.45 mL/min (with a residence time of 15 min), the starting DMP (1) was still
the main component of the leaving mixture; however, the proportion of nBMP (2a) was 44% (Table 3,
Entry 2). Increasing the residence time to 30 min (by decreasing the flow rate to 0.25 mL/min), the ratio
of mixed H-phosphonate (2a) was 9% higher (53%) (Table 3, Entry 3). Applying a longer residence time
of 45 or 60 min (flow rate of 0.15 or 0.10 mL/min), the proportion of phosphite 2a was somewhat lower
(50% or 47%), and the ratio of DnBP (3a) increased to 26% or 35%, respectively (Table 3, Entries 4 and 5).
The maximum proportion of nBMP (2a) (53%) was obtained applying a reaction time of 30 min at
100 ◦C (Table 3, Entry 3). Increasing or decreasing the residence time at the same temperature resulted
in lower ratio of product 2a (Table 3, Entries 1, 2 and 4, 5, respectively). In a comparative thermal
experiment at 100 ◦C at a residence time of 30 min, the conversion was only 15% (Table 3, Entry 6).
Next, the effect of the reaction temperature was investigated at a residence time of 30 min (Table 3,
Entries 6–8) (Figure 3). At 125 ◦C, the mixture was comprised of 7% of DMP (1), 43% of nBMP (2a) and
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50% of DnBP (3a) (Table 3, Entry 7). Increasing the temperature to 150 ◦C, the conversion was complete,
and the fully-transesterified product (3a) predominated in a proportion of 78% (Table 3, Entry 8).
Performing the alcoholysis at 175 ◦C, the ratio of DnBP (3a) was 91% (Table 3, Entry 9). Carrying
out the reaction at a longer residence time (45 min) and/or higher excess of the nBuOH (50 equiv),
the composition did not change. Applying common heating at 175 ◦C, the reaction was not complete,
and the ratio of product 3a was 8% lower, than under MW conditions (Table 3, Entry 10). It can
be observed that the difference between MW-assisted and conventionally-heated experiments was
significant at 100 ◦C, while significantly smaller at 175 ◦C. After column chromatography, nBMP (2a)
was obtained in a yield of 48%, while DnBP (3a) was isolated in a yield of 88% (Table 3, Entries 3 and 9).











Composition (%) c Yield
(%) d(mL/min) b 1 2a 3a
1 MW 22 100 1.4 5 26 74 25 1 -
2 MW 14 100 0.45 15 52 48 44 8 -
3 MW 10 100 0.25 30 65 35 53 12 48 (2a)
4 MW 8 100 0.15 45 76 24 50 26 -
5 MW 5 100 0.10 60 83 18 47 35 -
6 Δ - 100 0.25 30 15 85 15 0 -
7 MW 18 125 0.25 30 93 7 43 50 -
8 MW 38 150 0.25 30 100 0 22 78 -
9 MW 59 175 0.25 30 100 0 9 91 e,f 88 (3a)
10 Δ - 175 0.25 30 98 2 15 83 -
a The pressure was 17 bar; b Based on the HPLC pump; c the mixtures from the stationary operation were analyzed
by GC; d after column chromatography; e No change on longer residence time (45 min); f No change on higher
excess (50 equiv) of nBuOH. Bold numbers indicate the target compounds in the reactions.
 
Figure 3. Composition of the reaction mixtures of the MW-assisted alcoholysis of DMP with nBuOH at
different temperatures at a residence time of 30 min (Table 3 entries 3 and 7–9).
Comparative batch experiments were also carried out in the DMP (1)—nBuOH model reaction at
100 ◦C. The alcohol excess (25 equiv) and the reaction time range studied (5–60 min) were the same
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as in the flow approaches. The batch results are listed in Table 4. Similarly to the flow experiments,
the composition was highly reaction time-dependent.
Table 4. Comparative experiments for the alcoholysis of dimethyl H-phosphonate (DMP) with nBuOH
in a batch MW reactor.
Entry t (min) Conversion (%)
Composition (%) a
1 2a 3a
1 5 24 76 20 4
2 15 46 54 37 9
3 30 59 41 47 12
4 45 67 33 49 18
5 60 73 26 45 29
a Based on GC.
Comparing the conversions of the flow and batch processes, the two plots show a similar shape;
however, after a reaction time of 15 min, the batch conversions were 5–10% lower than the flow results
(Figure 4).
Figure 4. Reaction/residence time-dependence of the conversion of the alcoholysis of DMP with
nBuOH at 100 ◦C.
A more significant difference may be observed if the ratio of product 2a is examined separately
(Figure 5). Maximum points are present on both curves: at 30 min and 53% in the flow experiments
and at 45 min 49% in the case of the batch approaches. Based on the comparison, the flow reaction
reaches the optimum point of phosphite 2a under a shorter time, with a higher ratio.
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Figure 5. Reaction/residence time-dependence of the product 2a ratio in the alcoholysis of DMP with
nBuOH at 100 ◦C.
Based on the experiences above, the alcoholysis of DMP (1) was also carried out with n-propanol,
i-butanol, as well as n-pentanol at 100 ◦C and 175 ◦C with a residence time of 30 min. In all cases, a mixture
containing DMP (1) and 25 equivalents of the corresponding alcohol was passed through the continuous
flow system. The data shown in Table 4 are concerned to the stationary operation. In the reaction of DMP
(1) with nPrOH at 100 ◦C, the leaving mixture contained 45% of unreacted DMP (1), 46% of n-propyl
methyl H-phosphonate (PrMP) (2b) and 9% of n-dipropyl H-phosphonate (DPrP) (3b) (Table 5, Entry 1).
At a higher temperature of 175 ◦C, the fully-transesterified product (3b) was the major component (90%)
(Table 5, Entry 2). The outcome of the alcoholysis of DMP (1) with iBuOH and nPentOH was similar
(Table 5, Entries 3–6) However, in the case of the experiments carried out at 100 ◦C, the ratio of i-butyl
methyl H-phosphonate (iBMP) (2c) and n-pentyl methyl H-phosphonate (PeMP) (2d) was above 50%
(Table 5, Entries 3 and 5). After column chromatography, the corresponding mixed phosphonates (2b,
2c and 2d) were obtained in yields of 42–51% (Table 5, Entries 1, 3 and 5), and the fully-transesterified
products (3b, 3c and 3d) were isolated in yields of 85–88% (Table 5, Entries 2, 4 and 6).
Table 5. Continuous flow alcoholysis of DMP with various alcohols.





10 100 45 46 9 42 (2b)
2 57 175 0 10 90 85 (3b)
3 iBu
10 100 38 51 11 46 (2c)
4 71 175 0 10 90 86 (3c)
5 nPent
10 100 32 55 13 51 (2d)
6 55 175 0 8 92 88 (3d)
a The pressure was 17 bar; b the mixtures from the stationary operation were analyzed by GC; c after column
chromatography. Bold numbers indicate the target compounds in the reactions.
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The next model was the continuous flow alcoholysis of diethyl H-phosphonate (DEP) (4) (Table 6).
Based on the experiences from the transesterification of DMP (1), the reactions were carried out using
25 equivalents of the alcohols at a flow rate of 0.25 mL/min (or at a residence time of 30 min). First, the
alcoholysis of DEP (4) by nBuOH was investigated. Performing the reaction at 100 ◦C, the unreacted
DEP (4) was the main component along with 34% of n-butyl ethyl H-phosphonate (nBEP) (5a) and
8% of DBP (3a) (Table 6, Entry 1). At a higher temperature of 125 ◦C, the ratio of nBEP (5a) was 42%,
and after column chromatography, compound 5a could be isolated in a yield of 38% (Table 6, Entry 2).
Increasing the temperature to 150 ◦C and 175 ◦C, the proportion of 5a was decreased, while that
of DBP (3a) increased (Table 6, Entries 3 and 4). In the latter case, the alcoholysis was complete,
and the DBP (3a) was obtained in a yield of 85% (Table 6, Entry 4). The transesterification of DEP
(4) by nPrOH at 125 ◦C took place similarly as the alcoholysis by nBuOH, and the n-propyl ethyl
H-phosphonate (PrEP) (5b) was obtained in a yield of 36% (Table 6, Entries 2 and 5). At 175 ◦C,
the conversion was not complete, and the resulting mixture contained only 74% of DPrP (3b) besides
4% of unreacted DEP (4) and 22% of PrEP (5b) (Table 6, Entry 6). To obtain a higher proportion
of product 3b, the temperature was increased to 200 ◦C. Hence, phosphite 3b was formed in 84%
(Table 6, Entry 7). In the case of iBuOH, the tendency was similar, and the highest amount of mixed
phosphonate (5c) was formed at 125 ◦C, while at 175 and 200 ◦C, the fully-transesterified product (3c)
predominated (Table 6, Entries 8–10). Using PentOH at 125 ◦C, the pentyl ethyl H-phosphonate (PeEP)
(5d) was the main component in the departing mixture, from which it was isolated in a yield of 40%
(Table 6, Entry 11). For the preparation of dipentyl H-phosphonate (DPeP) (3d), the application of
175 ◦C was enough, and compound 3d was obtained in a yield of 80% (Table 6, Entry 12).
Table 6. Continuous flow alcoholysis of DEP with alcohols.






10 100 58 34 8 -
2 17 125 44 42 14 38 (5a)
3 38 150 7 32 61 -
4 57 175 0 11 89 d,e 85 (3a)
5
nPr
18 125 51 41 8 36 (5b)
6 54 175 4 22 74 –
7 83 200 2 14 84 d,e 78 (3b)
8
iBu
21 125 21 40 39 36 (5c)
9 63 175 3 26 71 –
10 105 200 0 16 84 d,e 77 (3c)
11 nPent
10 125 31 44 25 40 (5d)
12 39 175 2 13 85 d,e 80 (3d)
a The pressure was 17 bar; b the mixtures from the stationary operation were analyzed by GC; c after column
chromatography; d no change upon longer residence time (45 min); e no change upon higher excess (50 equiv) of
nBuOH. Bold numbers indicate the target compounds in the reactions.
The catalyst-free alcoholysis of dialkyl H-phosphonates with various aliphatic alcohols was carried
out efficiently in a continuous flow MW reactor. Applying a residence time of 30 min at different
temperatures, the alcoholysis could be fine-tuned towards the dialkyl H-phosphonates with two
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different or with two identical alkyl groups. In the case of the reaction studied, the dimethyl phosphite
proved to be the more reactive starting material. After almost complete conversions, the (RO)2P(O)H
species formed by transesterification were obtained in yields above 85%. The ratio of (RO)(R’O)P(O)H
derivatives with two different alkyl groups was around 50% in all mixtures, affording the target
compounds in a yield range of ca. 40–50%. By the method developed, a series of mixed dialkyl
H-phosphonates, which are valuable building blocks for the preparation of chiral organophosphorus
derivatives, was synthesized.
3. Materials and Methods
3.1. General
GC measurements were performed on an HP5890 Series 2 GC-FID chromatograph, using a
15 m × 0.18 mm Restek, Rtx-5 column with a film layer of 0.20 μm. The temperature of the column
was initially held at 40 ◦C for 1 min, followed by programming at 25 ◦C/min up to 300 ◦C and a final
period at 300 ◦C (isothermal) for 10 min. The temperature of the injector was 290 ◦C and of the FID
detector was 300 ◦C. The carrier gas was N2.
GC-MS measurements were performed on an Agilent 6890 N-GC-5973 N-MSD chromatograph,
using a 30 m × 0.25 mm Restek, Rtx-5SILMS column with a film layer of 0.25 μm. The initial
temperature of the column was 45 ◦C for 1 min, followed by programming at 10 ◦C/min. up to 310 ◦C
and a final period at 310 ◦C (isothermal) for 17 min. The temperature of the injector was 250 ◦C.
The carrier gas was He, and the operation mode was splitless.
High resolution mass spectrometric measurements were performed using a TripleTOF 5600+ mass
spectrometer in positive electrospray mode.
The 13C- and 1H-NMR spectra were obtained in CDCl3 solution on a Bruker DRX-500 spectrometer
operating at 125.7 and 500.1 MHz, respectively. The 13C and 1H chemical shifts are referred to TMS.
31P-NMR spectra were obtained on a Bruker AV-300 spectrometer at 121.5 MHz. Chemical shifts are
downfield relative to 85% H3PO4.
3.2. Equipment
The continuous flow reactions were performed in a self-developed continuous flow system
comprising a 300-W CEM® Discover-focused microwave reactor equipped with a CEM® 10-mL Flow
Cell Accessory continuous flow unit (irradiated volume 7 mL), a Gilson 305 HPLC pump, an HPLC
backpressure regulator with a 250-psi (17.2 bar) cartridge and a cooler. Teflon® (Wilmington, DE, USA)
PFA tubes with an outside diameter of 0.125” (3.175 mm) and an inside diameter of 0.064” (1.575 mm)
were used. The exact lengths and volumes of each tube part are shown in Figure 6. All of the tubes,
screws and ferrules applied were fully compatible with a regular HPLC system.
Figure 6. Design parameters of the continuous flow system.
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3.3. General Procedure for the Continuous Flow Alcoholysis of Dialkyl H-Phosphonates
A mixture of 25.0 mmol of the dialkyl H-phosphonate (2.7 mL of dimethyl H-phosphonate, 3.9 mL
of diethyl H-phosphonate) and 25 equivalents, 0.625 mol of alcohol (47 mL of n-propanol, 57 mL of
n-butanol, 58 mL of i-butanol, 68 mL of n-pentanol) was homogenized by stirring for 5 min at 25 ◦C.
The reactor was flushed with 20 mL of the mixture with a flow rate of 10 mL/min at 25 ◦C and 17 bar.
Next, under the same pressure, the flow rate was set to the desired value, and the vessel was irradiated
with a power of 45–300 W for 3–5 min, until the temperature reached the desired value, then the power
was controlled automatically by the software of the MW reactor. The flow rate and the necessary power
at stationary operation can be seen in Tables 3, 5 and 6. The operation was regarded as the steady
state on the basis of the results of the GC measurements. The products were separated by column
chromatography using silica gel as the absorbent and ethyl acetate as the eluent. Yields were calculated
on the basis of the weights obtained after separation and evaporation taking into consideration the
quantity of the dialkyl H-phosphonate fed in during a given time. The 31P-NMR and mass data for the
dialkyl H-phosphonates are listed in Table 7.
3.4. General Procedure for the Comparative Batch Experiments
A mixture of 0.5 mmol (0.05 mL) of dimethyl H-phosphonate and 25 equivalents, 12.5 mmol
(1.1 mL) of n-butanol was heated at 100 ◦C in a vial in the MW reactor for 5–60 min as shown in Table 4.
The volatile components were removed in vacuum, and the residual oil was analyzed by GC.
Methyl propyl H-phosphonate (2b): Yield: 42%; 31P-NMR and HRMS (see Table 7); 13C-NMR (CDCl3)
δ 10.0 (CH3CH2), 23.8 (J = 6.2, CH2), 52.0 (J = 5.8, CH3O), 67.1 (J = 6.0, CH2O); 1H-NMR (CDCl3) δ 0.98
(t, JHH = 7.4, 3H, CH3CH2), 1.65–1.82 (m, 2H, CH2), 3.78, (d, JPH = 11.9, 3H, CH3O) 3.97–4.12 (m, 2H,
CH2O), 6.79 (d, JPH = 695.4, 1H, PH).
i-Butyl methyl H-phosphonate (2c): Yield: 46%; 31P-NMR and HRMS (see Table 7); 13C-NMR (CDCl3)
δ 18.6 (J = 3.1, CH3CH), 29.2 (J = 6.4, CH), 51.9 (J = 5.7, CH3O), 71.8 (J = 6.3, CH2O); 1H-NMR (CDCl3)
δ 0.89 (d, JHH = 6.8, 6H, CH3CH), 1.84–1.96 (m, 1H, CH), 3.71 (d, JPH = 11.9, 3H, CH3O) 3.74–3.83
(m, 2H, CH2O), 6.72 (d, JPH = 695.8, 1H, PH).
Methyl pentyl H-phosphonate (2d): Yield: 50%; 31P-NMR and HRMS (see Table 7); 13C-NMR (CDCl3)
δ 13.9 (CH3CH2), 22.2 (CH3CH2), 27.6 (CH3CH2CH2), 30.1 (J = 6.2, CH2CH2O), 51.9 (J = 5.7,
CH3O), 67.0 (J = 6.1, CH2O); 1H-NMR (CDCl3) δ 0.91 (t, J = 6.9, 3H, CH3CH2), 1.29–1.44 (m, 4H,
CH2CH2CH3), 1.63–1.78 (m, 2H, CH2CH2O), 3.78, (d, JPH = 11.9, 3H, CH3O) 3.99–4.17 (m, 2H, CH2O),
6.79 (d, JPH = 695.2, 1H, PH).
Ethyl propyl H-phosphonate (5b): Yield: 30%; 31P-NMR and HRMS (see Table 7); 13C-NMR (CDCl3)
δ 10.0 (CH3CH2CH2), 16.3 (J = 6.1, CH3CH2O), 23.8 (J = 6.4, CH3CH2CH2), 61.8 (J = 5.8, CH2CH2O),
67.3 (J = 6.0, CH3CH2O); 1H NMR (CDCl3) δ 0.96 (t, JHH = 7.4, 3H, CH3CH2CH2), 1.35 (t, JHH = 7.1,
3H, CH3CH2O), 1.63–1.78 (m, 2H, CH3CH2CH2), 3.94–4.07, (m, 2H, CH2CH2O) 4.07–4.21 (m, 2H,
CH3CH2O), 6.80 (d, JPH = 692.4, 1H, PH).
i-Butyl ethyl H-phosphonate (5c): Yield: 36%; 31P-NMR and HRMS (see Table 7); 13C-NMR (CDCl3)
δ 16.3 (J = 6.2, CH3CH2), 18.7 (J = 1.7, CH3CH), 29.1 (J = 6.5, CH), 61.8 (J = 5.7, CH3CH2O),
71.6 (J = 6.2, CHCH2O); 1H NMR (CDCl3) δ 0.96 (d, JHH = 6.7, 6H, CH3CH), 1.37 (t, JHH = 7.1,
3H, CH3CH2), 1.89–2.06 (m, 1H, CH), 3.77–3.91, (m, 2H, CHCH2O) 4.09–4.22 (m, 2H, CH3CH2O),
6.82 (d, JPH = 692.7, 1H, PH).
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Table 7. 31P-NMR and mass data for the dialkyl H-phosphonates prepared.
Compound δP (CDCl3) δP [Ref] [M + H]
+
found [M + H]
+
requires
2a 9.3 (695.0) 9.3 [52] 153.0684 153.0681
2b 9.3 (695.4) - 139.0522 139.0523
2c 6.7 (695.7) - 153.0676 153.0681
2d 6.8 (695.2) - 167.0833 167.0837
3a 7.8 7.9 [66] 195.1153 195.1150
3b 7.9 7.8 [67] 167.0833 167.0837
3c 8.1 8.0 [67] 195.1145 195.1150
3d 7.8 8.1 [68] 223.1462 223.1463
5a 7.6 (693.0) 7.6 [52] 167.0840 167.0837
5b 8.6 (692.4) - 153.0673 153.0681
5c 7.8 (692.8) - 167.0832 167.0837
5d 7.7 (692.1) 7.7 [52] 181.0992 181.0994
4. Conclusions
In summary, a MW-assisted continuous flow method was developed for the catalyst-free
alcoholysis of dialkyl H-phosphonates. By the optimization of the reaction parameters, the alcoholysis
was fine-tuned towards dialkyl H-phosphonates with two different or with two identical alkyl
groups. The selectivity of the reaction was similar in the flow and batch approaches; however,
the continuous protocol offered several advantages. The dialkyl H-phosphonates with two different
alkyl groups can be obtained at a shorter reaction time and in a higher ratio. Furthermore, a somewhat
higher productivity (0.8–1.0 g/h) can be attained by the continuous flow method. Five new dialkyl
H-phosphonates with different alkyl groups were isolated and characterized, which may be valuable
building blocks in the synthesis of chiral organophosphorus compounds.
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Abstract: The α-amidoalkylating properties of 1-(N-acylamino)alkyltriarylphosphonium salts with
weakened Cα-P+ bond strength are discussed and examined. It is demonstrated that such type
of phosphonium salts reacts smoothly with a diverse array of carbon- and heteroatom-based
nucleophiles, including 1-morpholinocyclohexene, 1,3-dicarbonyl compounds, benzotriazole sodium
salt, p-toluenesulfinate sodium salt, benzylamine, triarylphosphines, and other P-nucleophiles.
Reactions are conducted at room temperature, in a short time (5–15 min) and mostly without
catalysts. Simple work-up procedures result in good or very good yields of products. The structures
of known compounds were established by spectroscopic methods and all new compounds have
been fully characterized using 1H-, 13C-, 31P-NMR, IR spectroscopy, and high-resolution mass
spectrometry. Mechanistic aspects of described transformations are also performed and discussed.
It was demonstrated that unique properties make 1-(N-acylamino)alkyl-triarylphosphonium salts
with weakened Cα-P+ bond strength interesting building blocks with great potential, especially in
α-amidoalkylation reactions.
Keywords: organophosphorus chemistry; phosphonium salts; α-amidoalkylating agents;
N-acyliminium cation; N-acylimine
1. Introduction
Specific structural features of 1-(N-acylamino)alkylphosphonium salts make them very interesting
reagents. The presence of a positively charged nucleofugal phosphonium moiety in the close
surroundings of the N-acyl group determines its unique chemical properties such as high reactivity
in α-amidoalkylations [1–10]. This type of reactions has enjoyed unflagging interest for years
as a synthetic method with great potential, especially valuable for C-C and C-heteroatom bond
formation [1,11–37].
In general, the reactivity of α-amidoalkylating agents 1 depends on the efficiency of the generation
of N-acyliminium cation 2 or N-acylimine 3 from its precursor and the equilibrium constant of
this reaction. Of course, the reactivity of N-acyliminium cation 2 or N-acylimine 3 toward a
nucleophile is also significant [1–3]. To produce the proper α-amidoalkylating agents, for instance
N-acyliminium cation 2 or N-acylimine 3 from the most popular precursors such as α-amido sulfones
(Z = SO2Ar), N-(1-benzotriazolil)alkylamides (Z = Bt), and N-(1-alkoxyalkyl)amides (Z = OR), it is
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necessary to use catalysts, mainly Lewis acids (route a, Scheme 1 (I)) [18–25,29–37]. In contrast,
1-(N-acylamino)alkyltriphenylphosphonium salts 1 (Z = Ph3P+ X−) do not require the use of acidic
catalysts because of the permanent positive charge on the phosphonium group. However, the relatively
high stability of Cα-P+ bond forces the use of a base catalyst (e.g., Hünig’s base, DBU, TBD; route b,
Scheme 1 (I)) and sometimes microwave radiation [1,4–10].
Recently, we have proven that the use of 1-(N-acylamino)alkyltriarylphosphonium salts 4 derived
from the EWG-substituted triarylphosphines facilitates the cleavage of Cα-P+ bond and thereby the
generation of N-acyliminium cation (Scheme 1 (II)) [2,3]. This phenomenon significantly increases
the reactivity of 1-(N-acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond strength
and allows us to conduct α-amidoalkylation without the need for any catalyst. In this work, we
demonstrate that the abovementioned phosphonium salts 4 react smoothly with various nucleophiles
in a short time under mild conditions and create new carbon-carbon or carbon-heteroatom bonds with
good or very good yields (Scheme 1 (III)).
Scheme 1. α-Amidoalkylation reactions—various synthetic routes.
2. Results and Discussion
In this section, we focus our studies on the reactivity of phosphonium salts 4 with weakened
Cα-P+ bond strength in α-amidoalkylation of various types of carbon- and heteronucleophiles, as
shown in Scheme 2. 1-Morpholinocyclohexene and 1,3-dicarbonyl compounds, such as dimethyl
malonate, diethyl malonate, and ethyl acetoacetate, are used as carbon nucleophiles. In the case
of heteronucleophiles, the reaction toward benzotriazole sodium salt, p-toluenesulfinate sodium
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salt, benzylamine, triarylphosphines, trimethyl phosphite, dimethyl phenylphosphonite, and methyl
diphenylphosphinite is examined.
The synthesis of 1-(N-acylamino)alkyltriarylphosphonium salts 4 from α-amino acids was
performed according to our previously described procedure, for which the electrochemical
decarboxylative α-methoxylation of N-acyl-α-amino acids and substitution of the methoxy group by
triarylphosphonium moiety are crucial steps (see Scheme 2) [2,9].
Scheme 2. 1-(N-Acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond strength
4—preparation and synthetic application.
2.1. 1-(N-Acylamino)alkyltriarylphosphonium Salts with Weakened Cα-P+ Bond Strength in the Selected
Reaction of C-C Bond Formation
One of the crucial issues of organic synthesis is the formation of new C-C bonds. The possibility
of an effective extension of the carbon skeleton is important in many fields, especially in medicinal
chemistry, agrochemical synthesis, or in the synthesis of natural products.
Several years ago, we had proved that 1-(N-acylamino)alkyltriphenylphosphonium salts 4
(Ar = Ph) reacted quite easily with 1,3-dicarbonyl compounds in the presence of a base such as
DBU (1,8-diazabicyclo[5.4.0]undec-7-ene), DBN (1,5-diazabicyclo[4.3.0]non-5-ene), or TBD (1,5,7-triaza-
bicyclo[4.4.0]dec-5-ene) under microwave irradiation at 60 ◦C. However, the use of organic bases (DBU,
DBN, TBD) complicates the course of α-amidoalkylation reaction due to the formation of amidinium
and guanidinium salts [10]. To avoid this, in the current work, we used lithium diisopropylamide
(LDA) as a base to produce enolate anions from the corresponding 1,3-dicarbonyl compounds. In our
protocol, α-amidoalkylation was conducted under argon, in THF, at room temperature. A THF solution
of enolate anions generated using LDA was introduced into the THF solution of the phosphonium salt
4. The reaction was performed for 15 min, and the use of microwave irradiation was not necessary.
In addition, it was found that the most favorable molar ratio of phosphonium salt 4: 1,3-dicarbonyl
compound: LDA was 1:8:1 (compare experiments 1 and 2, Table 1).
Under the abovementioned conditions, phosphonium salts with weakened Cα-P+ bond
strength 4 react with 1,3-dicarbonyl compounds, including diethyl and dimethyl malonate and
ethyl acetoacetate, to give the corresponding products 6 with good yields, regardless of whether
tris(4-trifluoromethylphenyl)- or tris(3-chlorophenyl)phosphonium salts were used as substrates.
Only in the case of phosphonium salts with the benzyloxy carbamate protective group, the yields were
significantly lower and did not exceed 30% (entry 8, Table 1).
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1,3-Dicarbonyl Compound, 5 Molar Ratio of 4:5:LDA 6 Yield, %
R1 R2 Ar
1 t-Bu Me m-C6H4Cl diethyl malonate 1:2:1 6a 40
2 t-Bu Me m-C6H4Cl diethyl malonate 1:8:1 6a 65
3 t-Bu Me p-C6H4CF3 diethyl malonate 1:8:1 6a 67
4 t-Bu Me m-C6H4Cl ethyl acetoacetate 1:8:1 6b 62 a
5 Bn i-Bu m-C6H4Cl ethyl acetoacetate 1:8:1 6c 83 b
6 Bn i-Bu m-C6H4Cl dimethyl malonate 1:8:1 6d 63
7 Bn i-Bu m-C6H4Cl diethyl malonate 1:8:1 6e 52
8 BnO Bn m-C6H4Cl ethyl acetoacetate 1:8:1 6f 30 c
a A mixture of diastereoisomers in a molar ratio of 1.4:1. b A mixture of diastereoisomers in a molar ratio of 1.25:1.
c Attempts to isolate an analytically pure sample failed.
α-Amidoalkylation of carbon nucleophiles was successfully extended to enamines. Based on the
recently described protocol [8], we have demonstrated that 1-(N-acylamino)alkyltriarylphosphonium
salts 4 with weakened Cα-P+ bond strength react with 1-morpholinocyclohexene in Stork-type
enamination to give the expected products 8 with good yields. We have proved that this reaction can
be conducted in acetonitrile, at room temperature and without using any base catalysts. The optimized
reaction time was 60 min, and the molar ratio of phosphonium salt to 1-morpholinocyclohexene
was 1:2. We were able to separate the major diastereoisomer from the mixture using column
chromatography and crystallization technique. Furthermore, the use of phosphonium salts with
the benzyloxy carbamate protective group resulted in the decrease in reaction efficiency, as already
observed for reactions with 1,3-dicarbonyl compounds (see Table 2).






1 t-Bu Me m-C6H4Cl 8a 63 a
2 Bn i-Bu m-C6H4Cl 8b 62 b
3 BnO i-Bu m-C6H4Cl 8c 40 c
4 BnO Bn m-C6H4Cl 8d 33 d
5 BnO CH2Ot-Bu p-C6H4CF3 8e 31 c
a A mixture of diastereoisomers in a molar ratio of 3.5:1. b A mixture of diastereoisomers in a molar ratio of 3.2:1.
c Only one diastereoisomer was detected and isolated. d A mixture of diastereoisomers in a molar ratio of 13.4:1.
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2.2. 1-(N-Acylamino)alkyltriarylphosphonium Salts with Weakened Cα-P+ Bond Strength in
α-Amidoalkylation of Selected Heteronucleophiles
Applications of 1-(N-acylamino)alkyltriphenylphosphonium salts 4 (Ar = Ph) in the
α-amidoalkylation of heteronucleophiles have been reported many times in the literature [5–8,10].
Usually in these types of reactions, it was necessary to use base catalysts, elevated temperature,
and microwave irradiation. The effect of the use of 1-(N-acylamino)alkyltriarylphosphonium salts
with weakened Cα-P+ bond strength 4 (R = m-C6H4Cl, p-C6H4CF3) on α-amidoalkylation has not
been investigated so far. Therefore, we selected several heteronucleophiles such as benzotriazole
sodium salt, p-toluenesulfinate sodium salt, benzylamine, and triphenylphosphine, and examined
their α-amidoalkylation by phosphonium salts with weakened Cα-P+ bond strength. As it was
expected, reactions of salts with a modified structure of the phosphonium group occurred much
faster and under mild conditions. In none of the described examples was it necessary to use a base
catalyst. The reaction time was only 5–15 min. α-Amidoalkylation of benzotriazole sodium salt
and sodium p-toluenesulfinate (entries 1–3, Table 3) was conducted at room temperature in CHCl3.
Similar conditions were used for reaction with benzylamine (entries 4 and 5, Table 3). The obtained
aminal derivatives 10d and 10e exhibited limited stability. Therefore, the use of excess amount of the
nucleophile was required to make the alkaline environment safe for aminals.
Table 3. Conditions and yields for α-amidoalkylation of selected heteronucleophiles by 1-(N-acylamino)
alkyltriarylphosphonium salts 4.
Entry










1 t-Bu Me p-C6H4CF3 Bt−Na+ 20 15 1:1 10a 99
2 BnO Bn m-C6H4Cl Bt−Na+ 20 15 1:1 10b 70
3 t-Bu Me p-C6H4CF3 TolSO2−Na+ 20 15 1:1 10c 88
4 t-Bu Me m-C6H4Cl Bn-NH2 20 5 1:4 10d 91
5 Bn i-Bu p-C6H4CF3 Bn-NH2 20 5 1:4 10e 55
1-(N-Acylamino)alkyltriarylphosphonium salts 4 react also with triarylphosphines.
For example, 1-(N-pivaloylamino)ethyltris(4-trifluoromethylphenyl)phosphonium tetrafluoroborate
(4a) is completely transformed into 1-(N-pivaloylamino)ethyltriphenylphosphonium
tetrafluoroborate (4b) during the reaction with triphenylphosphine. On the other hand, using
tris(3-chlorophenyl)- phosphine as the nucleophile, we obtain a reaction mixture in which both
1-(N-pivaloylamino)ethyltris(4-trifluoromethylphenyl)phosphonium tetrafluoroborate (4a) and
1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium tetrafluoroborate (4c) are present in a
molar ratio of 1:3. A mixture of the same composition can also be obtained by the reaction of salt
4c with tris(4-trifluoromethylphenyl)phosphine. These observations may suggest the existence of
some equilibrium, as described by the equations in Scheme 3. The equilibrium of the reaction is
shifted toward more stable and less reactive phosphonium salts, which is evident for the reaction with
triphenylphosphine (equation a, Scheme 3).
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Scheme 3. 1-(N-Acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond strength
4—reactions with triarylphosphines.
The results described above have encouraged us to extend the range of P-nucleophiles by trimethyl
phosphite, dimethyl phenylphosphonite, and methyl diphenylphosphinite. It was expected that
reactions with these types of phosphorus nucleophiles may occur quickly at room temperature in
a non-catalytic environment, as for earlier tested nucleophiles. Surprisingly, the first experiments
have shown that reactions are much slower. The analysis of reaction kinetics allowed us to explain
these observations. In 2013, we proposed a plausible reaction mechanism wherein the N-acyliminium
cation or N-acylimine, both generated from the 1-(N-acylamino)alkyltriphenylphosphonium salt 4
(Ar = Ph), reacts with phosphorus nucleophile to form alkoxyphosphonium salt 13—the characteristic
intermediate of the Michaelis–Arbuzov reaction. The final step of the reaction is the dealkylation of
the alkoxyphosphonium salt 13 and may occur directly with triphenylphosphine (see Scheme 4) [7].
Although we have not yet been able to isolate or even observe the formation of postulated intermediate
product, we assume that 1-(N-acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond
strength react with phosphorus nucleophiles in an analogous manner. To prove this, we performed
the reaction of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium tetrafluoroborate (4c) with
trimethyl phosphite. The reaction progress was monitored using NMR spectroscopy. In the reaction
mixture, besides substrates, two products were also detected. Changes in their concentration as
a function of time were measured, as shown in Figure 1. The concentration of the first product
quickly reaches its maximum and then rapidly decreases, while the concentration of the second
one at the beginning of the reaction is low and then increases. The induction period, which
is characteristic for the formation of the final product in the consecutive-type reaction, is very
clearly visible. Detailed NMR (1H- and 31P-NMR) and HR-MS analysis confirmed that the first,
fast-growing product was 1-(N-acylamino)alkyltrimethoxyphosphonium tetrafluoroborate (13a) —the
postulated intermediate of the Michaelis–Arbuzov reaction. As a result of its demethylation, dimethyl
1-(N-pivaloylamino)ethanephosphonate (12a) is formed with a much slower reaction. It seems that the
second step determines the overall rate of the process.
 
Scheme 4. α-Amidoalkylation of P-nucleophiles by 1-(N-acylamino)alkyltriarylphosphonium salts
4—a plausible mechanism.
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Figure 1. Concentration of the substrate 4c, intermediate 13a, and product 12a as a function of time for
the reaction of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium tetrafluoroborate (4c) with
trimethyl phosphite at 26 ◦C.
A plausible mechanism that explains the described kinetic facts is shown in Scheme 4 and
is consistent with the mechanism proposed earlier in 2013. The only difference is that the
generation of N-acyliminium cation from 1-(N-acylamino)alkyltriphenylphosphonium salt 4 (Ar = Ph)
is more difficult. On the other hand, the highnucleophilicity of triphenylphosphine facilitates
dealkylation, which makes the first step crucial for the course of the entire reaction. In the case of
1-(N-acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond strength 4 (R = m-C6H4Cl,
p-C6H4CF3), the first step is easier, which facilitates the formation of alkoxyphosphonium salts 13.
However, due to the lower nucleophilicity of phosphines with electron-withdrawing substituents
[P(m-C6H4Cl)3, P(p-C6H4CF3)3], the rate of dealkylation drops. To overcome this drawback, we
decided to add to the reaction mixture the substoichiometric amounts of methyltriphenylphosphonium
iodide as the dealkylating agent (molar ratio of 1:0.25). This protocol allowed us to obtain
a series of phosphorus analogs of α-amino acids 12 (N-acyl-α-aminoalkanephosphonates 12a–c,
N-acyl-α-aminoalkanephosphinate (12d) and N-acyl-α-aminoalkylphosphine oxide (12e)) with good
or very good yields. Usually, reactions occur efficiently at room temperature. Only in the reaction with
dimethyl phenylphosphonite, it was necessary to raise the temperature to 60 ◦C. At room temperature,
the reaction is very slow even after the addition of methyltriphenylphosphonium iodide (see Table 4).
Finally, we tried to isolate and fully characterize the intermediate of the Michaelis–Arbuzov reaction
13. To this end, we conducted the reaction of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium
tetrafluoroborate (4c) with trimethyl phosphite. Unfortunately, the expected 1-(N-pivaloylamino)
ethyltrimethoxyphosphonium tetrafluoroborate (13a, Scheme 4) was too reactive and attempts
to isolate the analytically pure sample failed. To increase the stability of the intermediate
13, we used triethyl phosphite as the phosphorus nucleophile. This allowed us to isolate
1-(N-pivaloylamino)ethyltriethoxyphosphonium tetrafluoroborate (13b) and determine its basic
physicochemical properties.
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Table 4. Conditions and yields for α-amidoalkylation of P-nucleophiles by 1-(N-acylamino)
alkyltriarylphosphonium salts 4.
Entry








%R1 R2 Ar R R3 R4
1 t-Bu Me m-C6H4Cl Me OMe OMe 20 3 1:1.5 12a 47
2 t-Bu Me m-C6H4Cl Me OMe OMe 20 3 1:1.5 a 12a 85
3 Bn i-Bu m-C6H4Cl Me OMe OMe 20 3 1:1.5 a 12b 77
4 BnO CH2Ot-Bu p-C6H4CF3 Me OMe OMe 20 3 1:1.5 a 12c 61
5 t-Bu Me m-C6H4Cl Me Ph OMe 60 2 1:1.5 a 12d 69
6 BnO i-Bu p-C6H4CF3 Me Ph Ph 20 3 1:1.5 a 12e 83




Melting points were determined in capillaries and were uncorrected. IR spectra were measured on
an FT-IR spectrophotometer (ATR method). 1H- and 13C-NMR were recorded at operating frequencies
of 400 and 100 MHz, respectively, using TMS as the resonance shift standard. 31P-NMR spectra were
recorded at an operating frequency of 161.9 MHz without the resonance shift standard, with respect
to H3PO4 as zero ppm. All chemical shifts (δ) are reported in ppm and coupling constants (J) in Hz.
High-resolution mass spectrometry (HR-MS) analyses were performed on a Xevo G2 Q-TOF mass
spectrometer (Waters, Milford, MA, USA) equipped with an ESI source operating in the positive
ion mode. The accurate mass and composition of molecular ion adducts were calculated using the
MassLynx software incorporated within the instrument.
1H, 13C, and 31P NMR spectra of all new compounds 6, 8, 10, 12, 13 as well as the summary table in
which we compare conditions and yields for reactions of 1-(N-acylamino)alkyltriphenylphosphonium
salts (former studies) and 1-(N-acylamino)alkyltriarylphosphonium salts (the current work) with
selected nucleophiles, are placed in the Supplementary data.
3.2. Syntheses
3.2.1. Substrate Synthesis
Electrochemical decarboxylative α-methoxylation of N-acyl-α-amino acids [2,9]
The electrolysis was conducted in an undivided glass electrolyzer (85 cm3) equipped with a
thermostatic jacket, a magnetic stirrer, a concentrically arranged, cylindrical Pt mesh anode (47 cm2)
and cathode (44 cm2). To the thus prepared electrolyzer, N-acyl-α-amino acid (3.0 mmol), SiO2-Pip
(200 mg), and methanol (30 cm3) were added. The electrochemical decarboxylative α-methoxylation
was executed while stirring, at a constant current of 0.15 A, at 10 ◦C until a 3.75 F/mol charge had
passed. Then, SiO2-Pip was filtered off, and methanol was evaporated under reduced pressure to
obtain N-(1-methoxyalkyl)amide, which was used in the next reaction without further purification.
Transformation of N-(1-methoxyalkyl)amides to 1-(N-acylamino)alkyltriarylphosphonium salts 4 [2,10]
To a solution of triarylphosphine (1 mmol) in DCM (2 mL), a tetrafluoroboric acid diethyl
ether complex (HBF4·Et2O, 136 μl, 161.9 mg, 1 mmol) was added at 0 ◦C. The reaction mixture
was stirred for 2 h at room temperature. Thereafter, N-(1-methoxyalkyl)amide (1 mmol) was added
and stirring was continued for 15 min. Evaporation of the solvent yielded the crude 1-(N-acylamino)
alkyltriarylphosphonium salt 4, which was used in the next reaction without further purification.
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3.2.2. Reactivity of 1-(N-acylamino)alkyltriarylphosphonium Salts 4 toward Carbon Nucleophiles
Reaction of 1-(N-acylamino)alkyltriarylphosphonium salts 4 with C-H acids—general procedure
A solution of a nucleophile (1.6 mmol), THF (0.5 mmol), and base LDA (2.0 M solution in THF,
0.1 cm3) was stirred under argon atmosphere. After a few minutes, this mixture was relegated to a
solution of 1-(N-acylamino)alkyltriarylphosphonium salt (0.2 mmol) in THF (0.5 cm3) under argon
atmosphere. The resulting reaction mixture was stirred for 15 min at room temperature, and then it
was evaporated under reduced pressure. The product was separated using column chromatography
[toluene/AcOEt 5:1 v/v].
Diethyl 1-(pivaloylamino)etylpropanedioate (6a) [10]. Colorless oil (38.5 mg, 67% yield). 1H-NMR (CDCl3)
δ 6.80 (d, J = 7.5 Hz, 1H, NH), 4.74–4.62 (m, 1H, CαH), 4.29–4.21 (m, 2H, OCH2), 4.21–4.12 (m, 2H,
OCH2), 3.57 (d, J = 3.4 Hz, 1H, CH), 1.32–1.25 (m, 9H, CH3 and 2 × OCH2CH3), 1.17 (s, 9H, t-Bu) ppm;
13C-NMR (CDCl3) δ 177.6 (NHC = O), 168.7 (C = O), 167.7 (C = O), 61.7 (OCH2), 61.5 (OCH2), 55.6
(CαH), 44.2 (CH), 38.6 (C(CH3)3), 27.4 (C(CH3)3), 19.0 (CH3), 14.0 (OCH2CH3) ppm; IR (ATR) 2977,
1731, 1647, 1510, 1175 cm−1.
Ethyl 2-acetyl-3-(pivaloylamino)butanoate (6b). A mixture of two disatereoisomers in a molar ratio of
1.4:1 (31.9 mg, 62% yield). 1H-NMR (CDCl3) δ 6.92 (d, J = 8.0 Hz, 1H, NH)a, 6.41 (d, J = 7.8 Hz, 1H,
NH)a, 4.85–4.74 (m, 1H, CαH)a, 4.68–4.57 (m, 1H, CαH)a, 4.33–4.10 (m, 2H, OCH2)b, 3.72 (d, J = 4.9 Hz,
1H, CH)a, 3.65 (d, J = 3.6 Hz, 1H, CH)a, 2.26 (s, 3H, CH3CO)a, 2.25 (s, 3H, CH3CO)a, 1.35–1.20 (m,
6H, CH3 and OCH2CH3)b, 1.16 (s, 9H, t-Bu)a, 1.15 (s, 9H, t-Bu)a ppm; 13C-NMR (CDCl3) δ 203.4a
(CH3C = O), 202.1a (CH3C = O), 178.0a (NHC = O), 177.7a (NHC = O), 169.5a (C = O), 168.2a (C = O),
63.4a (CαH), 62.2a (CαH), 61.6a (OCH2), 61.4a (OCH2), 44.3a (CH), 43.4a (CH), 38.6a (C(CH3)3), 38.6a
(C(CH3)3), 30.4a (CH3CO), 29.0a (CH3CO), 27.4a (C(CH3)3), 27.3a (C(CH3)3), 19.7a (CH3), 18.7a (CH3),
14.1a (OCH2CH3), 14.1a (OCH2CH3) ppm; IR (ATR) 3318, 2971, 1730, 1635, 1534, 1301, 1190 cm−1.
HRMS (TOF-ESI) calcd for C13H24NO4 [M + H]+ 258.1705, found 258.1701. a Separate signals from
both diastereoisomers. b Overlapping signals of both diastereoisomers.
Ethyl 2-acetyl-5-methyl-3-(phenylacetylamino)hexanoate (6c). A mixture of two disatereoisomers in a molar
ratio of 1.25:1 (55.4 mg, 83% yield). 1H-NMR (CDCl3) δ 7.39–7.19 (m, 5H, Ph)a, 6.43 (d, J = 9.7 Hz, 1H,
NH)b, 6.02 (d, J = 9.5 Hz, 1H, NH)b, 4.77–4.68 (m, 1H, CαH)b, 4.63–4.54 (m, 1H, CαH)b, 4.21–4.07 (m,
2H, OCH2)a, 3.64 (d, J = 4.9 Hz, 1H, CH)b, 3.60 (d, J = 3.7 Hz, 1H, CH)b, 3.51 (s, 2H, PhCH2)a, 2.23 (s,
3H, CH3CO)b, 2.19 (s, 3H, CH3CO)b, 1.56–1.37 (m, 2H, CH2)a, 1.28–1.14 (m, 4H, CH and OCH2CH3)a,
0.95–0.80 (m, 6H, 2 × CH3)a ppm; 13C-NMR (CDCl3) δ 203.2b (CH3C = O), 202.2b (CH3C = O), 170.6b
(NHC = O), 170.4b (NHC = O), 169.1b (C = O), 168.1b (C = O), aromatic carbons: 134.7b, 134.6b,
129.3b, 129.3b, 128.9b, 128.8b, 127.2b, 127.2b, 62.4b (CαH), 61.8b (CαH), 61.6b (OCH2), 61.3b (OCH2),
47.1b (PhCH2), 46.2b (PhCH2), 43.9b (CH), 43.8b (CH), 42.7b (CH2), 41.9b (CH2), 30.3b (CH3CO), 29.1b
(CH3CO), 25.1b (CH), 25.1b (CH), 23.1b(CH3), 22.7b (CH3), 22.1b (CH3), 21.7b (CH3), 14.0b (OCH2CH3),
14.0b (OCH2CH3) ppm; IR (ATR) 3275, 2956, 1740, 1648, 1496, 1260, 1144 cm−1. HRMS (TOF-ESI) calcd
for C19H28NO4 [M + H]+ 334.2018, found 334.2009. a Overlapping signals of both diastereoisomers.
b Separate signals from both diastereoisomers.
Dimethyl 3-methyl-1-(phenylacetylamino)butylpropanedioate (6d). Colorless crystals (42.3 mg, 63% yield),
mp 78–80 ◦C. 1H-NMR (CDCl3) δ 7.41–7.18 (m, 5H, Ph), 6.25 (d, J = 9.6 Hz, 1H, NH), 4.68–4.59 (m,
1H, CαH), 3.69 (s, 3H, OCH3), 3.62 (s, 3H, OCH3), 3.55 (d, J = 3.9 Hz, 1H, CH), 3.52 (s, 2H, PhCH2),
1.54–1.39 (m, 2H, CH2), 1.28–1.19 (m, 1H, CH), 0.90 (d, J = 6.5 Hz, 3H, CH3), 0.86 (d, J = 6.6 Hz, 3H,
CH3) ppm; 13C-NMR (CDCl3) δ 170.3 (NHC = O), 168.6 (C = O), 168.0 (C = O), aromatic carbons: 134.8,
129.3, 128.8, 127.1, 54.6 (CαH), 52.6 (OCH3), 52.3 (OCH3), 46.8 (PhCH2), 43.9 (CH), 42.1 (CH2), 25.0
(CH), 22.9 (CH3), 21.9 (CH3) ppm; IR (ATR) 3283, 2954, 1736, 1648, 1454, 1263 cm−1. HRMS (TOF-ESI)
calcd for C18H26NO5 [M + H]+ 336.1811, found 336.1805.
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Diethyl 3-methyl-1-(phenylacetylamino)butylpropanedioate (6e). Colorless crystals (37.8 mg, 52% yield), mp
93.5–95.5 ◦C. 1H-NMR (CDCl3) δ 7.42–7.19 (m, 5H, Ph), 6.30 (d, J = 9.6 Hz, 1H, NH), 4.68–4.60 (m, 1H,
CαH), 4.30–4.00 (m, 4H, 2 × OCH2), 3.52 (s, 2H, PhCH2), 3.52 (d, J = 2.8 Hz, 1H, CH), 1.57–1.37 (m, 2H,
CH2), 1.36–1.06 (m, 7H, CH and 2 × OCH2CH3), 0.90 (d, J = 6.5 Hz, 3H, CH3), 0.86 (d, J = 6.6 Hz, 3H,
CH3) ppm; 13C-NMR (CDCl3) δ 170.2 (NHC = O), 168.3 (C = O), 167.7 (C = O), aromatic carbons: 134.9,
129.3, 128.8, 127.1, 61.7 (OCH2), 61.4 (OCH2), 54.9 (CαH), 46.8 (PhCH2), 43.9 (CH), 42.2 (CH2), 25.0
(CH), 22.9 (CH3), 22.0 (CH3), 14.0 (OCH2CH3), 13.9 (OCH2CH3) ppm; IR (ATR) 3362, 2964, 1745, 1656,
1533, 1345, 1144 cm−1. HRMS (TOF-ESI) calcd for C20H30NO5 [M + H]+ 364.2124, found 364.2122.
Reaction of 1-(N-acylamino)alkyltriarylphosphonium salts 4 with 1-morpholinocyclohexene—
general procedure
To a solution of 1-(N-acylamino)alkyltriarylphosphonium salt 4 (0.25 mmol) in MeCN (1 cm3),
1-morpholinocyclohexene (84.1 μL, 83.7 mg, 0.5 mmol) was added. After 1 h of stirring at room
temperature, an aqueous solution of citric acid (20%) (1.125 cm3) was added. Stirring was continued
for 45 min, and then a saturated solution of KHCO3 was added. Thereafter, the mixture was extracted
with DCM (5 × 3 cm3), and the organic layer was combined and dried over MgSO4. Then, the
solvent was evaporated under reduced pressure and the crude product was purified using column
chromatography [toluene/EtOAc 2:1 v/v (8a), 5:1 (8b, 8c, 8e) or 10:1 v/v (8d)].
N-[1-(2-oxocyclohexyl)ethyl]pivalamide (8a). A mixture of two disatereoisomers in a molar ratio of
3.5:1 (35.5 mg, 63% yield). The major diastereoisomers was isolated using column chromatography
[toluene/EtOAc 2:1] and crystallization from toluene. Colorless crystals, mp 124–126 ◦C. 1H-NMR
(CDCl3) δ 6.51 (d, J = 8.1 Hz, 1H, NH), 4.19–4.10 (m, 1H, CαH), 2.56–2.48 (m, 1H, CH), 2.39–2.30 (m,
2H, CH2), 2.11–2.01 (m, 2H, CH2), 1.91–1.83 (m, 1H, CHH), 1.74–1.57 (m, 3H, CHH and CH2), 1.22 (d,
J = 7.0 Hz, 3H, CH3), 1.17 (s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 214.2 (C = O), 178.0 (NHC = O), 55.4
(CαH), 45.6 (CH), 43.1 (CH2), 38.7 (C(CH3)3), 32.7 (CH2), 28.4 (CH2), 27.6 (C(CH3)3), 24.8 (CH2), 20.0
(CH3) ppm; IR (ATR) 3339, 2961, 2869, 1706, 1627, 1526, 1305, 1209, 1117 cm−1. HRMS (TOF-ESI) calcd
for C13H24NO2 [M + H]+ 226.1807, found 226.1800.
N-[1-(2-oxocyclohexyl)-3-methylbutyl]phenylacetamide (8b). A mixture of two disatereoisomers in a
molar ratio of 3.2:1 (46.7 mg, 62% yield). The major diastereoisomers was isolated using column
chromatography [toluene/EtOAc 5:1] and crystallization from toluene. Colorless crystals, mp
115.5–117.5 ◦C. 1H-NMR (CDCl3) δ 7.42–7.09 (m, 5H, Ph), 6.13 (d, J = 9.7 Hz, 1H, NH), 4.10–3.99
(m, 1H, CαH), 3.51 (s, 2H, PhCH2), 2.49–2.40 (m, 1H, CH), 2.31–2.18 (m, 2H, CH2), 2.07–1.96 (m, 2H,
CH2), 1.86–1.75 (m, 1H, CH), 1.65–1.37 (m, 5H, CH and 2 × CH2), 1.21–1.09 (m, 1H, CH), 0.86 (d,
J = 6.5 Hz, 3H, CH3), 0.83 (d, J = 6.6 Hz, 3H, CH3) ppm; 13C-NMR (CDCl3) δ 213.5 (C = O), 170.7
(NHC = O), aromatic carbons: 135.3, 129.1, 128.8, 127.1, 54.8 (CαH), 48.7 (PhCH2), 44.2 (CH), 43.1
(CH2), 43.1 (CH2), 32.6 (CH2), 28.3 (CH2), 25.2 (CH), 25.0 (CH2), 23.1 (CH3), 22.0 (CH3) ppm; IR (ATR)
3273, 2954, 2865, 1702, 1633, 1552, 1455, 1315, 1138 cm−1. HRMS (TOF-ESI) calcd for C19H28NO2
[M + H]+ 302.2120, found 302.2115.
Benzyl N-[1-(2-oxocyclohexyl)-3-methylbutyl]carbamate (8c). Only one disatereoisomer was detected
and isolated. Colorless oil (31.7 mg, 40% yield). 1H-NMR (CDCl3) δ 7.42–7.27 (m, 5H, Ph), 5.42 (d,
J = 10.1 Hz, 1H, NH), 5.09 (d, J = 12.5 Hz, 1H, PhCHHO), 5.06 (d, J = 12.4 Hz, 1H, PhCHHO), 3.83–3.69
(m, 1H, CαH), 2.54–2.44 (m, 1H, CH), 2.38–2.23 (m, 2H, CH2), 2.15–1.99 (m, 2H, CH2), 1.93–1.82 (m, 1H,
CHH), 1.74–1.55 (m, 5H, CHH and 2 × CH2), 1.28–1.16 (m, 1H, CH), 0.91 (d, J = 6.4 Hz, 3H, CH3), 0.89
(d, J = 6.5 Hz, 3H, CH3) ppm; 13C-NMR (CDCl3) δ 213.1 (C = O), 156.5 (NHC = O), aromatic carbons:
136.8, 128.4, 127.9, 127.9, 66.5 (PhCH2O), 54.7 (CαH), 50.8 (CH), 43.4 (CH2), 43.2 (CH2), 32.3 (CH2), 28.1
(CH2), 25.1 (CH2), 25.1 (CH), 23.2 (CH3), 21.9 (CH3) ppm; IR (ATR) 3439, 3333, 2952, 2866, 1699, 1499,
1213, 1052 cm−1. HRMS (TOF-ESI) calcd for C19H28NO3 [M + H]+ 318.2069, found 318.2061.
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Benzyl N-[1-(2-oxocyclohexyl)-2-phenylethyl]carbamate (8d). A mixture of two disatereoisomers in a
molar ratio of 13.4:1 (29.0 mg, 33% yield). The major diastereoisomers was isolated using column
chromatography [toluene/EtOAc 10:1]. Colorless crystals, mp 99–101 ◦C. 1H-NMR (CDCl3) δ 7.42–7.06
(m, 10H, 2 × Ph), 5.65 (d, J = 10.0 Hz, 1H, NH), 5.07 (d, J = 12.3 Hz, 1H, PhCHHO), 5.00 (d, J = 12.4 Hz,
1H, PhCHHO), 3.95–3.87 (m, 1H, CαH), 2.99 (dd, J1 = 13.5, J2 = 7.3 Hz, 1H, PhCHH), 2.92 (dd, J1 = 13.5,
J2 = 8.5 Hz, 1H, PhCHH), 2.51–2.41 (m, 1H, CH), 2.40–2.31 (m, 1H, CH), 2.29–2.17 (m, 1H, CH), 2.09–1.92
(m, 2H, CH2), 1.87–1.78 (m, 1H, CH), 1.77–1.51 (m, 3H, CH and CH2) ppm; 13C-NMR (CDCl3) δ 213.5
(C = O), 156.4 (NHC = O), aromatic carbons: 138.6, 136.7, 129.1, 128.5, 128.4, 127.9, 127.8, 126.4, 66.4
(PhCH2O), 54.2 (CαH), 51.9 (CH), 43.2 (CH2), 40.3 (PhCH2), 32.6 (CH2), 28.1 (CH2), 25.0 (CH2) ppm; IR
(ATR) 3308, 2929, 1721, 1697, 1541, 1341, 1242, 1094, 1051 cm−1. HRMS (TOF-ESI) calcd for C22H26NO3
[M + H]+ 352.1913, found 352.1913.
Benzyl N-[1-(2-oxocyclohexyl)-2-tert-butoxyethyl]carbamate (8e). Only one disatereoisomer was detected
and isolated. Colorless oil (26.9 mg, 31% yield). 1H-NMR (CDCl3) δ 7.38–7.28 (m, 5H, Ph), 5.57 (d,
J = 9.7 Hz, 1H, NH), 5.11 (d, J = 12.3 Hz, 1H, PhCHHO), 5.06 (d, J = 12.3 Hz, 1H, PhCHHO), 3.89–3.79
(m, 1H, CαH), 3.44 (d, J = 7.1 Hz, 2H, CH2Ot-Bu), 2.90–2.82 (m, 1H, CH), 2.38–2.27 (m, 2H, CH2),
2.09–2.00 (m, 2H, CH2), 1.92–1.85 (m, 1H, CHH), 1.78–1.64 (m, 3H, CHH and CH2), 1.12 (s, 9H, t-Bu)
ppm; 13C-NMR (CDCl3) δ 213.8 (C = O), 156.4 (NHC = O), aromatic carbons: 136.6, 128.5, 128.0, 73.1
(OC(CH3)3), 66.6 (PhCH2O), 62.1 (CH2Ot-Bu), 52.5 (CαH), 50.0 (CH), 42.8 (CH2), 31.9 (CH2), 28.1
(CH2), 27.5 (OC(CH3)3), 24.9 (CH2) ppm; IR (ATR) 3432, 2972, 2935, 2867, 1701, 1499, 1363, 1195,
1057 cm−1. HRMS (TOF-ESI) calcd for C20H30NO4 [M + H]+ 348.2175, found 348.2173.
3.2.3. Reactivity of 1-(N-Acylamino)alkyltriarylphosphonium Salts 4 toward Heteronucleophiles
Reaction of 1-(N-acylamino)alkyltriarylphosphonium salts 4 with benzotriazole sodium salt—
general procedure
To a solution of 1-(N-acylamino)alkyltriarylphosphonium salt 4 (0.5 mmol) in CHCl3 (1 cm3),
benzotriazole sodium salt (0.5 mmol) was added. The reaction mixture was stirred at room temperature
for 15 min. Thereafter, it was filtered through a fluted filter and the filtrate was evaporated under
reduced pressure. The residue was crystallized from toluene.
N-[1-(Benzotriazol-1-yl)ethyl]pivalamide (10a) [6]. Colorless crystals (121.9 mg, 99% yield), mp 142–144 ◦C.
1H-NMR (CDCl3) δ 8.06–8.02 (m, 1H, aromatic), 7.85–7.79 (m, 1H, aromatic), 7.54–7.48 (m, 1H, aromatic),
7.41–7.35 (m, 1H, aromatic), 6.88 (dq, J1 = 9.1, J2 = 6.7 Hz, 1H, CαH), 6.63 (d, J = 8.8 Hz, 1H, NH), 2.04
(d, J = 6.7 Hz, 3H, CH3), 1.15 (s, 9H, t-Bu) ppm; 13C-NMR (100 MHz, CDCl3) δ 178.2 (C = O), aromatic
carbons: 145.5, 132.4, 127.7, 124.4, 119.5, 110.4, 58.7 (CαH), 38.7 (C(CH3)3), 27.2 (C(CH3)3), 20.7 (CH3)
ppm; IR (ATR) 3346, 2969, 1668, 1512, 1193, 1152, 1065 cm−1.
Benzyl N-[1-(benzotriazol-1-yl)-2-phenylethyl]carbamate (10b) [6]. Colorless crystals (130.4 mg, 70% yield),
mp 117.5–119.5 ◦C. 1H-NMR (CDCl3) δ 8.00 (d, J = 8.4 Hz, 1H, aromatic), 7.54 (d, J = 7.5 Hz, 1H,
aromatic), 7.42–7.35 (m, 1H, aromatic), 7.33–7.27 (m, 4H, aromatic), 7.27–7.20 (m, 2H, aromatic),
7.19–7.12 (m, 3H, aromatic), 7.11–7.04 (m, 2H, aromatic), 6.71–6.58 (m, 1H, CαH), 6.02 (d, J = 8.9 Hz,
1H, NH), 5.10 (d, J = 12.4 Hz, 1H, PhCHHO), 4.97 (d, J = 12.2 Hz, 1H, PhCHHO), 3.80–3.68 (m, 1H,
PhCHH), 3.63 (dd, J1 = 13.8, J2 = 6.6 Hz, 1H, PhCHH) ppm; 13C-NMR (CDCl3) δ 160.3 (C = O), aromatic
carbons: 145.5, 136.0, 134.7, 131.9, 129.1, 128.7, 128.5, 128.4, 128.1, 127.7, 127.3, 124.1, 119.7, 109.7, 67.5
(PhCH2O), 65.8 (CαH), 41.1 (PHCH2) ppm; IR (ATR) 3177, 3008, 1712, 1548, 1280, 1261, 1244, 1195,
1046, 1022 cm−1.
Reaction of 1-(N-pivaloylamino)ethyltris(4-trifluoromethylphenyl)phosphonium tetrafluoroborate 4a with
sodium p-toluenesulfinate
To a solution of 1-(N-pivaloylamino)ethyltris(4-trifluoromethylphenyl)phosphonium tetrafluoroborate
4a (340.7 mg, 0.5 mmol) in CHCl3 (1 cm3), sodium p-toluenesulfinate (89.1 mg, 0.5 mmol) was added.
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The reaction mixture was stirred at room temperature for 15 min. Thereafter, it was filtered through
a fluted filter and the filtrate was evaporated under reduced pressure. The residue was crystallized
from toluene.
N-[1-(p-Toluenesulfonyl)ethyl]pivalamide (10c) [5]. Colorless crystals (124.7 mg, 88% yield), mp
143–145 ◦C. 1H-NMR (CDCl3) δ 7.77 (d, J = 8.3 Hz, 2H, aromatic), 7.33 (d, J = 7.9 Hz, 2H, aromatic), 5.98
(d, J = 10.2 Hz, 1H, NH), 5.41 (dq, J1 = 10.2, J2 = 7.0 Hz, 1H, CαH), 2.42 (s, 3H, CH3), 1.62 (d, J = 7.0 Hz,
3H, CH3), 1.01 (s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 176.9 (C = O), aromatic carbons: 145.1, 133.5,
129.6, 129.1, 64.3 (CαH), 38.7 (C(CH3)3), 27.2 (C(CH3)3), 21.6 (CH3), 13.2 (CH3) ppm; IR (ATR) 3372,
2973, 1677, 1516, 1308, 1287, 1135, 1083, 1016, 724 cm−1.
Reaction of 1-(N-acylamino)alkyltriarylphosphonium salts 4 with benzylamine—general procedure
To a stirred solution of 1-(N-acylamino)alkyltriarylphosphonium salt 4 (0.25 mmol) in DCM
(1 cm3), benzylamine (109.4 μl, 110 mg, 1 mmol) was added dropwise. Stirring was continued for
5 min at room temperature. Thereafter, the mixture was evaporated under reduced pressure and dried.
The residue was purified using column chromatography [DCM/MeOH/Et3N, 5:1:0.2 v/v/v].
N-[1-(Benzylamino)ethyl]pivalamide (10d). Yellow crystals (53.3 mg, 91% yield), mp 56.5–58.5 ◦C.
1H-NMR (CDCl3) δ 7.35–7.29 (m, 4H, aromatic), 7.26–7.21 (m, 1H, aromatic), 5.67 (d, J = 6.7 Hz,
1H, NH), 4.90 (qd, J1 = 6.2, J2 = 1.6 Hz, 1H, CαH), 3.77 (s, 2H, PhCH2), 1.92 (br s, 1H, NH), 1.32 (d,
J = 6.2 Hz, 3H, CH3), 1.17 (s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 178.1 (C = O), aromatic carbons:
140.1, 128.4, 127.9, 126.9, 60.9 (CαH), 49.8 (PhCH2), 38.6 (C(CH3)3), 27.4 (C(CH3)3), 21.6 ppm (CH3); IR
(ATR) 3328, 2971, 1622, 1527, 1475, 1144, 1097 cm−1. HRMS (TOF-ESI) calcd for C14H23N2O [M + H]+
235.1810, found 235.1802.
N-[1-(Benzylamino)-3-methylbutyl]phenylacetamide (10e). Colorless crystals (42.7 mg, 55% yield), mp
93–95 ◦C. 1H-NMR (CDCl3) δ 7.59–6.96 (m, 10H, 2 × Ph), 5.33 (d, J = 8.3 Hz, 1H, NH), 4.82–4.75 (m,
1H, CαH), 3.68 (s, 2H, PhCH2NH), 3.54 (s, 2H, PhCH2), 1.66 (br s, 1H, NH), 1.64–1.53 (m, 1H, CH),
1.45–1.28 (m, 2H, CH2), 0.87 (d, J = 6.6 Hz, 3H, CH3), 0.84 (d, J = 6.6 Hz, 3H, CH3) ppm; 13C-NMR
(CDCl3) δ 170.9 (C = O), aromatic carbons: 140.3, 135.0, 129.3, 129.0, 128.4, 128.0, 127.3, 126.9, 63.3
(CαH), 49.6 (PhCH2), 44.5 (PhCH2), 44.1 (CH2), 24.9 (CH), 22.6 (CH3), 22.5 (CH3) ppm; IR (ATR) 3306,
2962, 2946, 1632, 1518, 1144, 1009 cm−1. HRMS (TOF-ESI) calcd for C20H27N2O [M + H]+ 311.2123,
found 311.2121.
Reaction of 1-(N-pivaloylamino)ethyltris(4-trifluoromethylphenyl)phosphonium tetrafluoroborate 4a
with triphenylphosphine
To a solution of 1-(N-pivaloylamino)ethyltris(4-trifluromethylphenyl)phosphonium
tetrafluoroborate 4a (102.2 mg, 0.15 mmol) in DCM (1 cm3), triphenylphosphine (39.3 mg,
0.15 mmol) was added. The homogeneous mixture was allowed to react at room temperature for 5 min,
and 1-(N-pivaloylamino)ethyltriphenylphosphonium tetrafluoroborate (4b) [9] was precipitated with
Et2O, separated by decantation, and dried under reduced pressure.
1-(N-Pivaloylamino)ethyltriphenylphosphonium tetrafluoroborate (4b). Colorless crystals
(70.2 mg, 98% yield), mp 160.5–162.5 ◦C. 1H-NMR (CDCl3) δ 7.89–7.64 (m, 16H, 3 × Ph and NH),
5.82–5.73 (m, 1H, CαH), 1.72 (dd, J1 = 17.8, J2 = 7.4 Hz, 3H, CH3), 0.91 (s, 9H, t-Bu) ppm; 13C-NMR
(CDCl3) δ 179.7 (d, J = 2.3 Hz, C = O), aromatic carbons: 134.8 (d, J = 3.0 Hz), 134.5 (d, J = 9.2 Hz), 130.0
(d, J = 12.3 Hz), 118.4 (d, J = 82.5 Hz), 45.0 (d, J = 53.4 Hz, CαH), 38.5 (C(CH3)3), 26.8 (C(CH3)3), 17.4
(d, J = 4.6 Hz, CH3) ppm; 31P NMR (161.9 MHz, CDCl3) δ 29.2 ppm; IR (ATR) 3373, 1684, 1516, 1447,
1136, 1040 cm−1.
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Reaction of 1-(N-acylamino)alkyltriarylphosphonium salts 4 with triarylphosphines—NMR scale
To a solution of 1-(N-acylamino)alkyltriarylphosphonium salt (0.025 mmol) in CDCl3 (0.65 cm3),
the corresponding triarylphosphine (0.025 mmol) was added. Reactions were conducted in NMR tubes
at 26 ◦C, and their course was monitored using NMR spectroscopy.
Reaction of 1-(N-acylamino)alkyltriarylphosphonium salts 4 with phosphorus nucleophiles in
Michaelis–Arbuzov type reaction—general procedure
To a stirred solution of 1-(N-acylamino)alkyltriarylphosphonium salt 4 (0.25 mmol) and
methyltriphenylphosphonium iodide (25.3 mg, 0.0625 mmol) in DCM (2 cm3), phosphorus nucleophile
(0.375 mmol) was added, and the mixture was stirred for 3 h at room temperature (12a–c and 12e)
or for 2 h at 60 ◦C (12d). The mixture was evaporated under reduced pressure and the residue was
extracted with toluene (3 × 1 cm3) at 50 ◦C. The solvent was evaporated under reduced pressure, and
the product was isolated using column chromatography [DCM/MeOH 20:1 v/v].
Dimethyl 1-(N-pivaloylamino)ethanephosphonate (12a) [7]. Colorless crystals (50.4 mg, 85% yield), mp
125.5–127.5 ◦C. 1H-NMR (CDCl3) δ 5.96 (d, J = 8.1 Hz, 1H, NH), 4.65–4.49 (m, 1H, CαH), 3.78 (d,
J = 4.4 Hz, 3H, OCH3), 3.75 (d, J = 4.3 Hz, 3H, OCH3), 1.38 (dd, J1 = 16.8, J2 = 7.4 Hz, 3H, CH3), 1.21
(s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 177.6 (d, J = 5.1 Hz, C = O), 53.1 (d, J = 7.0 Hz, OCH3), 52.9
(d, J = 6.5 Hz, OCH3), 40.1 (d, J = 156.4 Hz, CαH), 38.6 (C(CH3)3), 27.3 (C(CH3)3), 15.5 (CH3) ppm;
31P-NMR (CDCl3) δ 28.5 ppm; IR (ATR) 3281, 2956, 1659, 1529, 1224, 1205, 1057, 1026, 1007 cm−1.
Dimethyl 1-(N-phenylcetylamino)-3-methylbutanephosphonate (12b) [4]. Colorless crystals (60.3 mg, 77%
yield), mp 117–119 ◦C. 1H-NMR (CDCl3) δ 7.39–7.23 (m, 5H, Ph), 5.72 (d, J = 9.9 Hz, 1H, NH), 4.62–4.48
(m, 1H, CαH), 3.73 (d, J = 10.6 Hz, 3H, OCH3), 3.63 (d, J = 10.6 Hz, 3H, OCH3), 3.60 (s, 2H, PhCH2),
1.61–1.44 (m, 3H, CH2 and CH), 0.88 (d, J = 5.9 Hz, 6H, 2 × CH3) ppm; 13C-NMR (CDCl3) δ 170.5
(d, J = 4.3 Hz, C = O), aromatic carbons: 134.6, 129.2, 128.9, 127.4, 53.1 (d, J = 7.2 Hz, OCH3), 53.0 (d,
J = 6.6 Hz, OCH3), 43.7 (PhCH2), 43.2 (d, J = 155.5 Hz, CαH), 38.1 (d, J = 1.8 Hz, CH2), 24.5 (d, J = 13.4
Hz, CH), 23.2 (CH3), 21.1 (CH3) ppm; 31P-NMR (CDCl3) δ 27.6 ppm; IR (ATR) 3243, 2959, 1673, 1540,
1217, 1027, 836, 742 cm−1.
Dimethyl 1-(N-benzyloxycarbonylamino)-2-tert-butoxyethanephosphonate (12c) [4]. Colorless crystals (54.8
mg, 61% yield), mp 59.5–61.5 ◦C. 1H-NMR (CDCl3) δ 7.41–7.28 (m, 5H, Ph), 5.29 (d, J = 8.8 Hz, 1H,
NH), 5.13 (s, 2H, PhCH2O), 4.33–4.19 (m, 1H, CαH), 3.76 (d, J = 10.6 Hz, 3H, OCH3), 3.75 (d, J = 10.3
Hz, 3H, OCH3), 3.61 (dd, J1 = 9.4, J2 = 3.8 Hz, 1H, CHHOt-Bu), 3.54 (dd, J1 = 9.4, J2 = 3.8 Hz, 1H,
CHHOt-Bu), 1.18 (s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 155.7 (C = O), aromatic carbons: 136.2, 128.5,
128.2, 128.1, 73.7 (OC(CH3)3), 67.2 (PhCH2O), 60.6 (CH2Ot-Bu), 53.3 (d, J = 6.0 Hz, OCH3), 52.6 (d,
J = 5.8 Hz, OCH3), 48.3 (d, J = 156.0 Hz, CαH), 27.3 (OC(CH3)3) ppm; 31P-NMR (CDCl3) δ 26.1 ppm;
IR (ATR) 3293, 2974, 1699, 1532, 1278, 1235, 1039, 1023, 756, 697 cm−1.
Methyl phenyl(1-pivaloylaminoethyl)phosphinate (12d). Colorless crystals (48.9 mg, 69% yield), mp
131–133 ◦C. 1H-NMR (CDCl3) δ 7.84–7.75 (m, 2H, aromatic), 7.59–7.43 (m, 3H, aromatic), 5.76 (d,
J = 9.6 Hz, 1H, NH), 4.79–4.67 (m, 1H, CαH), 3.67 (d, J = 10.8 Hz, 3H, OCH3), 1.45 (dd, J1 = 14.6,
J2 = 7.3 Hz, 3H, CH3), 0.92 (s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 177.3 (d, J = 4.7 Hz, C = O), aromatic
carbons: 132.8 (d, J = 2.8 Hz), 132.4 (d, J = 9.4 Hz), 128.5 (d, J = 12.5 Hz), 127.5 (d, J = 124.2 Hz), 51.8
(d, J = 7.1 Hz, OCH3), 42.3 (d, J = 115.5 Hz, CαH), 38.5 (C(CH3)3), 27.1 (C(CH3)3), 14.4 (CH3) ppm;
31P-NMR (CDCl3) δ 42.9 ppm. IR (ATR) 3264, 2954, 1660, 1531, 1198, 1139, 1027, 799 cm−1; HRMS
(TOF-ESI) calcd for C14H23NO3P [M + H]+ 284.1416, found 284.1405.
Diphenyl 1-(N-benzyloxycarbonylamino)-3-methylbutylphosphine oxide (12e) [8]. Colorless crystals (87.5 mg,
83% yield), mp 173.5–175.5 ◦C. 1H-NMR (CDCl3) δ 7.87–7.09 (m, 15H, 3 × Ph), 5.40 (d, J = 10.6 Hz,
1H, NH), 5.02 (d, J = 12.5 Hz, 1H, PhCHHO), 4.89 (d, J = 12.5 Hz, 1H, PhCHHO), 4.83–4.72 (m, 1H,
CαH), 1.83–1.66 (m, 2H, CH2), 1.36–1.21 (m, 1H, CH), 0.90 (d, J = 6.5 Hz, 3H, CH3), 0.86 (d, J = 6.6 Hz,
3H, CH3) ppm; 13C-NMR (CDCl3) δ 156.1 (d, J = 4.5 Hz, C = O), aromatic carbons: 136.4, 132.0 (d,
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J = 2.8 Hz), 131.9 (d, J = 2.8 Hz), 131.5, 131.3, 131.1 (d, J = 9.2 Hz), 130.9 (d, J = 9.0 Hz), 128.8 (d,
J = 11.4 Hz), 128.4 (d, J = 11.6 Hz), 128.4, 127.9, 127.6, 66.8 (PhCH2O), 48.1 (d, J = 79.5 Hz, CαH), 37.5
(d, J = 3.5 Hz, CH2), 24.5 (d, J = 11.0 Hz, CH), 23.4 (CH3), 21.0 (CH3) ppm; 31P-NMR (CDCl3) δ 33.5
ppm; IR (ATR) 3181, 2954, 1702, 1545, 1436, 1263, 1187, 1120 cm−1.
Reaction of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium tetrafluoroborate 4c with trimethyl
phosphite—measurement of changes in concentrations of the substrate 4c, intermediate 13a and product 12a
by NMR
To a solution of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium tetrafluoroborate
4c (29.0 mg, 0.05 mmol) in CDCl3 (0.65 cm3), trimethyl phosphite (8.9 μL, 9.3 mg, 0.075 mmol) was
added. Dimethyldiphenylsilane (5 mg) was used as the internal standard. The reaction mixture was
placed directly into the NMR tube. Changes in the concentrations of substrate 4c, intermediate 13a,
and product 12a were monitored using 1H-NMR spectroscopy.
Reaction of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium tetrafluoroborate 4c with triethyl
phosphite–synthesis of 1-(N-pivaloylamino)ethyltriethoxyphosphonium tetrafluoroborate 13b
To a stirred solution of 1-(N-pivaloylamino)ethyltris(3-chlorophenyl)phosphonium
tetrafluoroborate (4c, 145.2 mg, 0.25 mmol) in DCM (1 cm3), triethyl phosphite (64.6 μL, 62.3 mg,
0.375 mmol) was added. Stirring was continued for 30 min at room temperature. Thereafter the
intermediate product 13b was precipitated with Et2O, separated by decantation, and dried under
reduced pressure. In order to obtain the triethoxyphosphonium salt 13 with a higher purity, the
reaction should be carried out under argon atmosphere.
1-(N-Pivaloylamino)ethyltriethoxyphosphonium tetrafluoroborate (13b). Colorless oil (47.6 mg, 50% yield).
1H-NMR (CDCl3) δ 7.53 (t, J = 8.2 Hz, 1H, NH), 4.69 (dq, J1 = 19.7, J2 = 7.0 Hz, 1H, CαH), 4.62–4.46
(m, 6H, 3 × OCH2), 1.56 (dd, J1 = 20.2, J2 = 7.3 Hz, 3H, CH3), 1.48 (td, J1 = 7.0, J2 = 0.9 Hz, 9H, 3 ×
OCH2CH3), 1.23 (s, 9H, t-Bu) ppm; 13C-NMR (CDCl3) δ 179.9 (C = O), 70.2 (d, J = 9.1 Hz, OCH2), 42.3
(d, J = 148.6 Hz, CαH), 38.5 (C(CH3)3), 27.1 (C(CH3)3), 15.9 (d, J = 6.0 Hz, OCH2CH3), 14.0 (CH3) ppm;
31P-NMR (CDCl3) δ 37.0 ppm; IR (ATR) 3375, 2973, 1664, 1515, 1030 cm−1. HRMS (TOF-ESI) calcd for
C13H29NO4P [M]+ 294.1834, found 294.1829.
4. Conclusions
Modification of the phosphonium group by introducing electron-withdrawing substituents results
in the weakening of the Cα-P+ bond and makes it susceptible to cleavage. This phenomenon is the
cause of the high reactivity of 1-(N-acylamino)alkyltriarylphosphonium salts with weakened Cα-P+
bond strength. As we have demonstrated, these types of phosphonium salts react smoothly, usually at
room temperature with various types of nucleophiles such as 1-morpholinocyclohexene, 1,3-dicarbonyl
compounds, benzotriazole sodium salt, p-toluenesulfinate sodium salt, benzylamine, triarylphosphines,
and other P-nucleophiles. Only in the case of 1,3-dicarbonyl compounds, it was necessary to use
a strong base to generate enolate anions. Reactions with 1-morpholinocyclohexene, benzotriazole
sodium salt, p-toluenesulfinate sodium salt, benzylamine, and triarylphosphines do not require the use
of any catalysts and occur quite fast (5–60 min). Other examined P-nucleophiles also react efficiently
with 1-(N-acylamino)alkyltriarylphosphonium salts. However, the quickly formed intermediate,
in the absence of any dealkylating agent, slowly transforms into a final product. Therefore, to
facilitate the reaction, we used a substoichiometric amount of the dealkylating agent in the form
of methyltriphenylphosphonium iodide.
The use of 1-(N-acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond strength
allowed us to discover interesting mechanistic aspects of the examined reactions. Detection,
isolation, and characterization of 1-(N-acylamino)alkyltrialkoxyphosphonium salt 13b—the reactive
intermediate in the Michaelis–Arbuzov type reaction, were particularly important.
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Futher studies on expanding the range of nucleophiles, which can be used in α-amidoalkylation by
1-(N-acylamino)alkyltriarylphosphonium salts with weakened Cα-P+ bond strength, are in progress.
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/23/10/2453/
s1, Supporting information includes a summary table (comparison of conditions and yields for reactions of
1-(N-acylamino)alkyltriphenylphosphonium salts (former studies) and 1-(N-acylamino)alkyltriarylphosphonium
salts (the current work) with selected nucleophiles), 1H, 13C, and 31P NMR spectra of all new compounds 6, 8, 10,
12, 13. Supplementary data associated with this article can be found in the online version.
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Abstract: The applicability of two types of transition-metal carbonyl complexes as appropriate
candidates for computationally derived Tolman’s ligand electronic parameters were examined with
density functional theory (DFT) calculations employing the B97D3 functional. Both Pd(0)L2(CO)
and HRh(I)L2(CO) complexes correlated well with the experimental Tolman Electronic Parameter
scale. For direct comparison of the electronic effects of diphosphines with those of monophosphines,
the palladium-containing system is recommended. The trans influence of various phosphines
did not show a major difference, but the decrease of the H-Rh-P angle from linear can cause a
significant change.
Keywords: diphosphines; electronic parameters; DFT; QTAIM
1. Introduction
Phosphines, phosphites, and other P-donor ligands are of vital importance in the wide range
of reactions catalyzed by transition-metal (TM) compounds [1–3]. Changing the coordinated
ligands is an effective strategy for modifying the properties of transition metal containing catalysts.
The chemical properties of transition-metal complexes, such as their activity in various catalytic
reactions, are principally determined by the steric and electronic properties of the ligands bound to the
metal center [4–8]. Their structural variation opens the possibility to tune catalytic activity, as well as
chemo-, regio-, and enantioselectivity [9,10]. It has long been known that variation of the substituents
can cause changes upon coordination in the behavior of the ligands as well as their TM complexes.
Information about the nature of the transition metal–phosphorus bond and its influence on other
bonds in the molecule is crucial for the characterization of catalytically active compounds and for the
fine-tuning their properties in order to develop more efficient catalysts.
In the 1960s, Strohmeier et al. investigated the σ-donor ability and π-acceptor strength of
various ligand classes (nitriles, isonitriles, sulfoxides, phosphines). The phosphines were further
divided into four categories designated from I to IV, classified by the frequency regions of 1927–1996,
1946–1982, 2045–2101, and 2060–2110 cm– 1 for complexes C5H5Mn(CO)2L, C5H5V(CO)3L, Fe(CO)4L,
and Ni(CO)3L, respectively, and sorted by wavenumber into increasing order [11]. These classes
constitute the basis for Tolman’s famous formula.
In the 1970s, Tolman reported the A1 carbonyl-stretching frequencies of NiL(CO)3 complexes,
with monodentate P-donor ligands (L = PR1R2R3) [2,12]. The electronic effects of 70 phosphorus-
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containing ligands were compared. It was found that a contribution could be assigned to each
substituent on phosphorus, and the sum of those contributions were equal to the entire influence of
the ligand on ν(CO). This contribution was designated as χi (cm−1), and the most basic ligand
(tri-t-butylphosphine) was chosen as reference on the Tolman electronic parameter (TEP) scale
recognizing that PBut3 is the best σ-donor and the worst π-acceptor ligand (Equation (1)). The NiL(CO)3
scale, that is, the TEP, can be correlated with Strohmeier’s CpMnL(CO)2 system [7,13] (Equation (2)).
ν(CO)Ni = 2056.1 + Σχj (1)
ν(CO)Ni = 0.711 · ν(CO)Mn + 692 (cm−1) R = 0.970 (2)
Chelating ligands, such as diphosphines, however, cannot be described within the framework
of the TEP scale. Crabtree et al. suggested more suitable model complexes for chelating ligands,
for example, MoL2(CO)4 (L2: bidentate phosphine ligand or two monodentate phosphines) [14].
They compared 11 phosphorus ligands of various types and correlated to the existing TEP scale using
Equation (3). Thus, Crabtree proved Tolman’s statement that the choice of transition-metal carbonyl
system is arbitrary and interchangable.
ν(CO)Ni = 0.593 · ν(CO)Mo + 871 R = 0.996 (3)
In a recent study comparing the Rh–Vaska complexes and NiL(CO)3, Otto and Roodt established
a simple quadratic equation [15]. Later, the relationship between the carbonyl-stretching frequencies
of the two reference complexes were revised and, by the basicities of the ligands, the ν(CO) range was
divided into two sections [16]. The slope for the more basic phosphines showed a difference to those
of less basicity.
Arsines and stibines were investigated in order to determine their electronic effects as well [16].
The contributions to the electronic effect of As and Sb, relative to P, were determined, and an additional
term compared to Equation (1) was suggested addressing the effect of the donor atom (CL; L = P,
Sb or As). (Equation (4), CP = 0)
ν(CO)Ni = 2056.1 + Σχj + CL (4)
In the past three decades several attempts have been made for invoking theoretical methods to
characterize the donor and acceptor properties of phosphines and other, mainly P-donor, ligands.
These methods can be divided into two categories. The first approximation deals only with the
isolated ligand, focusing on its electronic and steric properties, while neglecting the influence of the
metal-containing fragment. As a prominent example, the molecular electrostatic potential at the lone
pair of the phosphorus atom should be mentioned, which correlates reasonably well with the TEP
scale, according to Suresh and Koga [17]. Moreover, the method known as quantitative analysis of
ligand effects (QALE) relies on experimental data of known ligands and provides the resolution of
net donating ability into QALE parameters [18,19]. It should be noted that the pnictogen interactions,
as important secondary interactions, of a wide variety of P-donor ligands were studied as well [20–22].
The second category uses approaches that focus on the entire transition-metal complex, thereby
including the possibility to scrutinize ligand–ligand effects as well [23]. Various electronic structure
methods, such as Extended Transition State theory combined with Natural Orbitals of Chemical
Valence (ETS-NOCV) [24–27] and Quantum Theory of Atoms in Molecules (QTAIM) [26] have been
employed as well.
Crabtree and coworkers investigated the CEP, that is, the computationally derived ligand
electronic parameter using the NiL(CO)3 model complex with various neutral, cationic, and anionic
ligands [28]. They found that the CEP correlated well with the Tolman electronic parameter and,
for certain anionic ligands, even with the Hammett meta substituent constant.
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Although the TEP scale achieved a widely accepted status, the limitations of this approximation
should be mentioned as well. The coordinating properties of a ligand are governed together by its
σ-donor and π-acceptor abilities, whereas TEP (or CEP) only gives the net donor strength. Moreover,
through-space ligand interactions may affect the carbonyl-stretching frequencies as reported by Sierra
and coworkers for manganese half-sandwich complexes [29]. The Tolman electronic parameters failed
for linear Au–carbonyl complexes [30].
The goal of this computational study is to establish a relationship between the ligand electronic
effects of late transition-metal–diphosphine complexes with the Tolman’s scale, that is, the totalsymmetric
carbonyl-stretching frequencies of Ni(CO)3L complexes, thereby providing a direct comparison of
the electronic effects of diphosphines and monophosphines. By the selection of appropriate ligands,
the set of ligands employed by Crabtree [14] and Tolman [12] has been adopted, that is, PEt3 (1),
PEt2Ph (2), PMe3 (3), PMe2Ph (4), PPh3 (5), P(OMe)3 (6), P(OPh)3 (7), PCl2(OEt) (8), PCl3 (9), PF3 (10),
and PF2(CF3) (11).
The secondary objective of the study is to find a dependence of the trans influence upon the bite
angle of the diphosphines by scrutinizing the Rh–H bond distance, the rhodium–hydride stretching
frequencies as well as quantum chemical descriptors within the framework of the QTAIM methodology.
Those diphosphines that are involved in this study are depicted in Figure 1. As test complexes,
the Pd(0)L2(CO) and the HRh(I)L2(CO) complexes were selected. The former is supposed to be
sterically less strained in comparison to the Mo(CO)4L2 complexes with a natural bite angle of about
90◦, thereby reducing the possibility of coupling steric and electronic effects and through-space
interactions, whereas the rhodium-containing species are of high importance as the potential catalysts
of Rh-catalyzed hydroformylation. It should be noted that only the theoretical treatment of the
selected test complexes is possible because of their high reactivity, rendering them unsuitable for the
experimental spectroscopical measurements.
Ph2P PPh2Ph2P PPh2 Ph2P PPh2 Ph2P PPh2






































Figure 1. Chelating phosphines considered in this study.
2. Computational Details
All the structures were optimized without symmetry constraints with tight convergence criteria
using the program ORCA 4.0.1 [31] with the exchange and correlation functionals developed by
Grimme [32] containing the D3 empirical dispersion correction with Becke and Johnson damping [33].
For palladium and rhodium atoms the def2-TZVP basis set [34]. was employed with the respective
pseudopotentials [34]. For the other atoms, the def2-SVP basis set [34] was used. The B97D3 functional
was selected for the calculations involving diphosphines as it gave slightly better linear correlations for
monophosphines as compared to other GGA (BP86 [35,36], PBEPBE [37]) and meta-GGA (TPSS [38],
and M06L [39]) functionals (vide infra).
For the complexes containing conformationally flexible ligands, conformational analyses have
been performed in a similar manner reported earlier [26], and the lowest energy species were
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considered. QTAIM analyses of the wave function [40] were carried out with AIMAll software [41].
Topological analyses of the Electron Localization Function (ELF) were completed using the Topmod09
package [42]. For electronic structure calculations, the B97D3/def2-TZVP level of theory was employed
on the equilibrium geometries obtained by the B97D3 calculations with the mixed (def2-TZVP/
def2-SVP) basis set.
3. Results and Discussion
In Table 1, the experimental nickel ν(CO) parameters, as well as the computed palladium,
rhodium ν(CO) parameters were collected for various phosphorus ligands, the same ligands that
had also been used by Crabtree et al. In Figure 2, the 11 calculated (B97D3) carbonyl-stretching
frequencies of PdL2(CO) and HRhL2(CO) training sets are plotted against the experimental ν(CO)
frequencies for NiL(CO)3 [2,12]. The high values of the correlation coefficients r2 = 0.971 and r2 = 0.975,
obtained for PdL2(CO) and HRhL2(CO), respectively, shows that the computed ν(CO) for these systems
(CEP parameters) have reasonable linear correlation with the experimental NiL(CO)3 ν(CO) values
(TEP) according to Equations (5) and (6):
ν(CO)Ni,exp = CEPPd = 0.5144 · ν(CO)PdL2(CO) + 1002.2 (5)
ν(CO)Ni,exp = CEPRh = 0.5744 · ν(CO)HRhL2(CO) + 874.0 (6)
Table 1. Experimental CO-stretching frequencies (Reference [12]) for NiL(CO)3, and computed CO-
stretching frequencies for PdL2(CO) and HRhL2(CO) complexes at the B97D3 level of theory. Carbonyl-
stretching frequencies are given in cm−1.
Ligand ν(CO)NiL(CO)3 ν(CO)PdL2(CO) ν(CO)HRhL2(CO)
PEt3 (1) 2061.7 2059.6 2065.3
PEt2Ph (2) 2063.7 2062.2 2066.5
PMe3 (3) 2064.1 2068.2 2074.7
PMe2Ph (4) 2065.3 2068.4 2074.6
PPh3 (5) 2068.9 2068.9 2078.8
P(OMe)3 (6) 2079.5 2096.5 2107.2
P(OPh)3 (7) 2085.3 2100.2 2109.7
PCl2(OEt) (8) 2092.5 2127.6 2124.5
PCl3 (9) 2097.0 2140.4 2134.5
PF3 (10) 2110.8 2148.9 2152.8
P(CF3)F2 (11) 2112.1 2149.0 2144.4
Figure 2. Carbonyl-stretching frequencies of PdL2(CO) and HRhL2(CO) against Tolman’s parameters
at the B97D3 level. Frequency values are given in Table 1.
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To clarify the role of the theoretical method employed for obtaining CEP parameters, the training
set was recomputed with various GGA and meta-GGA functionals (Figure 3). The B97D3 results were
compared with those obtained with BP86 [35,36], PBEPBE [37], TPSS [38], and M06L [39] functionals
for both the palladium and the rhodium complexes. The r2 correlation coefficients remained within
quite a narrow range, as the worst correlation was found to be r2 = 0.949 for the PBEPBE functional in
the case of the Rh–hydride model systems. For both complexes, the B97D3 functional proved to be
slightly superior; therefore, it was chosen for describing the chelating ligands as well.
The chelating ligands shown in Table 2 were selected to address various geometrical as well as
electronic parameters. Ligands 12–15 were used to illustrate the influence of the P-M-P bite angle while
ligands 16–18 show the effect of the substituents on the phosphorus with ethanediphos backbone.
The chiral ligands 19–21 reveal the substituent effects on the backbone. To address the structural
changes of ligands with axial chirality 22–24 were selected. Finally, 25 and 26 represent ligands
possessing rigid structure with wide bite angles.
Table 2. Computed CO-stretching frequencies and P-M-P bite angles (θPPdP and θPRhP, in degrees) for
diphosphine-containing complexes PdL2(CO), HRhL2(CO), and their respective Computed Tolman
Parameters (CEPs), determined according to Equations (5) and (6). Vibrational frequencies are in cm−1.
Ligand ν(CO)PdL2(CO) CEPPd θPPdP ν(CO)HRhL2(CO) CEPRh θPRhP
dppm (12) 2080.8 2072.6 69.8 2069.8 2062.9 71.0
dppe (13) 2076.1 2070.1 85.1 2071.9 2064.1 84.7
dppp (14) 2068.4 2066.2 90.5 2074.6 2065.7 88.7
dppb (15) 2064.5 2064.2 96.2 2079.0 2068.2 94.6
dmpe (16) 2073.5 2068.8 86.0 2075.1 2065.9 85.5
dcpe (17) 2058.6 2061.1 86.2 2060.6 2057.6 85.3
dtfmpe (18) 2123.1 2094.3 86.3 2125.8 2095.1 84.9
CHIRAPHOS (19) 2074.3 2069.2 85.1 2076.3 2066.6 84.6
BDPP (20) 2067.7 2065.8 89.0 2071.2 2063.7 87.7
DIOP (21) 2069.6 2066.8 101.5 2077.4 2067.3 95.5
BINAP (22) 2069.0 2066.5 93.7 2075.9 2066.4 92.8
BIPHEP (23) 2069.6 2066.8 96.4 2076.8 2066.9 93.8
SEGPHOS (24) 2067.5 2065.7 94.3 2073.9 2065.2 92.8
xantphos (25) 2065.0 2064.4 105.9 2070.1 2063.1 102.8
dppf (26) 2069.3 2066.6 103.6 2078.6 2067.9 97.8
The CEP determined on two different types of carbonyl complexes reveals a remarkable difference
(near 10 cm−1) for the narrow bite-angle case 12. The increase of the bite angle by going in the
direction of dppm → dppe → dppp → dppb also caused a decrease in ν(CO) for the palladium and an
increase in ν(CO) for the rhodium complexes. The replacement of the phenyl substituent in dppe to
the electron-withdrawing trifluoromethyl group resulted in a similar blue-shift for the two systems.
On the other hand, the presence of electron-donating substituents, such as methyl or cyclohexyl, on the
phosphorus results in the expected red-shift in the palladium carbonyls and a mixed effect for the
Rh carbonyls as, in HRh(CO)(dmpe), virtually no change occurs in the carbonyl-stretching frequency.
When the electron-donating methyl groups are introduced in the chiral backbone, such as for the
ligand CHIRAPHOS, a slight blue-shift occurs for HRh(19)(CO), whereas an almost negligible red-shift
takes place for Pd(19)(CO).
The change or the neglect of the condensed ring in the ligands with axial chirality has practically
no effect on ν(CO). Moreover, the predicted CEP is almost identical for both model systems.
This difference is also minor (below 2 cm−1) for the xantphos and dppf ligands. Not surprisingly,
in the three-coordinate palladium systems, all the P-M-P bite angles were somewhat larger than in the
HRh(LL)(CO) complexes, except for the dppm ligand.
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Figure 3. Carbonyl-stretching frequencies of PdL2(CO) (top row) and HRhL2(CO) against Tolman’s
parameter computed with various DFT functionals. Frequency values are given in Table 1.
The trans influence in the four-coordinate, distorted square-planar HRhL2(CO) complexes is
formally based on a nP → σ∗RhH donor–acceptor interaction. Here, it is followed by the metal–hydrogen
stretching frequency (ν(RhH)), the Rh–H distance, and two QTAIM parameters. Both the electron
density at the bond critical point (ρBCP) and the δ(Rh,H) delocalization index, which provides the
number of electron pairs delocalized between the atomic basins of Rh and H [43], were somewhat
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proportional with the bond strength. The delocalization index is, to some extent, related to formal
bond orders for an equally shared pair between two atoms in a polyatomic molecule.
According to the ρBCP(RhH) values in Table 3 the difference in electronic effects caused by the
P-ligand trans to the hydride is rather subtle. As the trend in the delocalization indices is quite the
opposite compared to that obtained from the geometrical parameters, it is likely that the electron
sharing between atomic basins did not reflect the overall bond strengths in these cases.
Table 3. Computed Rh-stretching frequencies, Rh–H bond lengths (in Å), P–Rh–P bond angles (in degrees),
delocalization indices, and electron densities at bond critical points for HRhL2(CO) complexes.
Ligand ν(RhH) rRhH θPRhP δ(Rh,H) ρBCP(RhH)
PEt3 (1) 1920.8 1.618 100.4 0.858 0.131
PEt2Ph (2) 1931.6 1.615 95.6 0.873 0.132
PMe3 (3) 1927.3 1.618 100.9 0.860 0.131
PMe2Ph (4) 1948.3 1.611 98.4 0.876 0.133
PPh3 (5) 1964.7 1.606 102.6 0.849 0.135
P(OMe)3 (6) 1949.0 1.618 100.7 0.844 0.132
P(OPh)3 (7) 1984.5 1.607 106.9 0.831 0.135
PCl2(OEt) (8) 2014.5 1.598 96.4 0.866 0.139
PCl3 (9) 1993.0 1.602 101.2 0.837 0.135
PF3 (10) 1970.6 1.614 99.9 0.841 0.134
P(CF3)F2 (11) 1967.5 1.617 100.2 0.829 0.133
The ν(RhH) frequencies, however, tend to follow the computed electronic parameters, as the largest
red-shift occurs for the more electron donating ligands and the frequencies are increased for the electron
withdrawing ones. Thus, the trans influence increases in the order of the substituent donor strength.
To address the effect of the P–Rh–P bite angle upon the trans influence, the structures and the
Laplacians of the electron density were compared and are illustrated in Figure 4. The structural distortion
caused by the dppm ligand resulted in distortion in the electron-density distribution as well. The stronger
bond in the dppm complex, as compared to the HRh(dppe)(CO) complex, shows that even when the
basicities of the phosphorus atoms of the standalone dppm and dppe ligands should be very similar,
the slight decrease of the H–Rh–P angle causes a notable decrease in the trans influence. It should be
noted that, in the dppm complex, a red-shift can be observed in ν(CO) in comparison to that of the dppe
complex, which may be explained with the less preferred orientation to a nP → π∗CO orbital interaction.
(a) (b)
Figure 4. Laplacian (∇2ρ(r)) of the electron density of complexes HRh(dppm)(CO) (a) and HRh(dppe)
(CO) (b). Charge concentration regions (∇2ρ(r) < 0) are designated with dashed lines.
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It was found previously that, among QTAIM parameters, CO delocalization index gave good
performance, whereas the electron density of the CO bond critical point gives moderate linear
correlation with the computed carbonyl symmetric stretching frequencies in Ni-tricarbonyl phosphine
complexes [26]. To the best of our knowledge, the relationship between the electron localization
function (ELF) and the stretching frequencies in transition-metal carbonyl complexes is unexplored.
The ELF, denoted as η(r) introduced by Becke and Edgecombe [35] and reinterpreted by
Savin et al. [44] using the mathematical scheme from Thom’s catastrophe theory [45] is based on
the conditional pair probability function. It takes values in a range 0  η  1 between 0 and 1, where
values close to 1 are located in regions of space with strong electron localization, whereas values
close to 0 correspond to electron delocalization, and η = 0.5 is the value that would be expected for a
homogeneous electron gas. It is worth mentioning that Putz [46,47] proposed general formulations for
the ELF on the basis of the path integral formulation of Markovian open systems.
The electronic effect of the monodentate ligands was followed by the population of the V(C,O)





The ELF basins, which were the subject of our study, are depicted for complexes HRh(PMe3)2(CO)
and HRh(PF3)2(CO) in Figure 5. The spacial distribution of the V(Rh,H) basin resembles those
representing the H–C bonds, that is, it is localized around the hydrogen and not along the H–Rh bond
path. On the other hand, the V(C,O) basins are situated in the middle between the carbon and oxygen
of the carbonyl ligands.
(a) (b)
Figure 5. Selected electron localization function (ELF) valence basins for complexes HRh(PMe3)2(CO)
(a) and HRh(PF3)2(CO) (b) at isovalue of η = 0.84. Yellow and blue envelopes designate the disynaptic
V(Rh,H) and V(C,O) basins, respectively.
The ELF was computed for all the HRh(monophosphine)2(CO) type of complexes. The basin
population associated with the C ––– O bond revealed fairly good linear correlation (r2 = 0.915) with the
experimental TEP parameters (Figure 6a). The extrema of the N̄(Ω) values are between 2.62 (for ligand
PEt2Ph) and 2.83 (for PF3), indicating the somewhat depleted triple-bond character of the bound
CO. The population change of the Rh–hydride bond, however, shows moderate linear correlation
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(r2 = 0.823) with TEP; only showing that the trans influence generally increases with the greater donor
strength of the P-donor ligand.
(a) (b)
Figure 6. Population of ELF basins (a) V(C,O) and (b) V(Rh,H) for complexes HRhL2(CO) against
Tolman’s parameters at the B97D3 level. Frequency values are given in Table 1.
4. Conclusions
In the present study, two classes of model compounds were scrutinized to check their applicability
as appropriate candidates for computationally derived ligand electronic parameters (CEPs) for
bidentate P-donor ligands employing the B97D3/def2-TZVP(def2-SVP) level of theory. The results of
this work can be summarized as follows:
• For both model systems, no major difference in accuracy can be expected for various DFT methods
in terms of the linear regression coefficient.
• For monophosphines, both Pd(0)L2(CO) and HRh(I)L2(CO) complexes showed high linearity with
the experimental TEP scale.
• For monophosphines, the population of the disynaptic ELF basin V(C,O), associated with the
carbonyl ligand, showed good linearity with the experimental TEP scale.
• For diphosphine-containing systems, the bite angle effect showed the opposite trend, with
PdL2(CO) complexes revealing a decrease in ν(CO) by the increase of bite angle.
• In the case of the Pd complexes, the change of substituents on phosphorus caused a change in
ν(CO) being consistent with the donor character of the substituent.
• For diphosphines possessing axial chirality, the nature of the condensed ring does not alter the
electronic parameter of the ligand.
• The trans effect estimated in the HRhL2(CO) complexes is very sensitive to the H–Rh–P angle.
Supplementary Materials: The following are available online. Cartesian coordinates of palladium-diphosphine
complexes occuring in this study.
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Abstract: Although the triple-decker complex [Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2) was first reported
26 years ago, its reactivity has not yet been explored. Herein, we report a new high-yielding
synthesis of 2 and the isolation of its new polymorph (2’). In addition, we study its
reactivity towards AgI and CuI ions. The reaction of 2 with Ag[BF4] selectively produces
the coordination compound [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][BF4] (3). Its reaction with
Ag[TEF] and Cu[TEF] ([TEF]− = [Al{OC(CF3)3}4]−) leads to the selective formation of the
complexes [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (4) and [Cu{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF]
(5), respectively. The X-ray structures of compounds 3–5 each show an MI ion (MI = AgI, CuI)
bridged by two P atoms from two triple-decker complexes (2). Additionally, four short MI···CO
distances (two to each triple-decker complex 2) participate in stabilizing the coordination sphere
of the MI ion. Evidently, the X-ray structure for compound 3 shows a weak interaction of the AgI
ion with one fluorine atom of the counterion [BF4]−. Such an Ag···F interaction does not exist for
compound 4. These findings demonstrate the possibility of using triple-decker complex 2 as a ligand
in coordination chemistry and opening a new perspective in the field of supramolecular chemistry of
transition metal compounds with phosphorus-rich complexes.
Keywords: triple-decker; cyclo-P5; weakly coordinating; molybdenum; silver; copper
1. Introduction
For more than two decades, the chemistry of transition metal complexes bearing polyphosphorus
ligands has been an active area of research for both inorganic and organometallic chemists [1]. The
interest in this class of compounds does not only originate from the large variety of bonding patterns
in the formed products, but is also due to their potential as building blocks in supramolecular
chemistry [1,2]. Until now, the most successful candidates in this field have been polyphosphorus
(Pn) complexes, such as the Cp* derivative of pentaphosphaferrocene [Cp*Fe(η5-P5)] (1, Cp* =
η5-C5Me5) [3]. Its reaction with AgI, CuI and group 13 metal salts (TlI, InI, GaI) of the weakly
coordinating anion [Al{OC(CF3)3}4]− ([TEF]−) allows the formation of one-dimensional polymers
with various coordination modes of the P5 unit [4–8]. With CuI halides and 1, depending on the
reaction conditions, a set of one- and two-dimensional coordination polymers [9,10], fascinating
fullerene-like spherical aggregates [11–16] as well as an organometallic nanosized capsule [17] are
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accessible. Moreover, when ditopic organic linkers are added to 1 and CuI halides, unprecedented
organometallic–organic hybrid polymers with various dimensionalities can be realized [18,19].
Besides its exciting supramolecular chemistry, the cyclo-P5 complex 1 was used as a suitable
starting compound for the synthesis of a number of triple-decker complexes with cyclo-P5
middle-decks. Based on 1, the Scherer group prepared the 30-electron triple-decker complexes
[CpFe(μ,η5:η5-P5)FeCp*]+3 and [Cp*Fe(μ,η5:η5-P5)M(CO)3] (M = Cr, Mo) [20,21]. Kudinov et al.
reported a few iron-, ruthenium- and molybdenum-containing triple-decker complexes such as
[Cp*Fe(μ,η5:η5-P5)MCp*]+ (M = Fe, Ru) and [(C7H7)Mo(μ,η5:η5-P5)FeCp*]+ [22–24]. More recently,
our group used 1 to synthesize several unique neutral triple-decker sandwich complexes with
functionalized cyclo-P5 middle-decks [25]. In addition to these examples, some others continuously
appear in the literature with cyclo-P5 middle-decks synthesized from starting materials other than
1 [26–28].
Regardless of the ongoing progress in the synthesis of this class of triple-decker compounds,
their reactivity and especially their coordination chemistry are totally unexplored. In fact, to the
best of our knowledge, apart from the few coordination compounds of the [(Cp*Mo)2(μ,η6:η6-P6)]
triple-decker complex recently reported by our group [29], no coordination chemistry of any
other triple-deck with any cyclo-Pn middle-deck has been reported as yet. Accordingly, we
studied the potential of triple-decker complexes with cyclo-P5 middle-decks as multidentate
ligands in supramolecular chemistry. The goal of such studies is to understand the coordination
chemistry of these complexes with transition metal salts and compare it to that of the complex
[Cp*Fe(η5-P5)] (1). Herein, we present a new high-yielding synthesis of the triple-decker complex
[Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2), and we show that its reaction with the coinage metal salts
Ag[BF4], Ag[TEF] and Cu[TEF] allows the formation of the three unprecedented coordination
compounds: [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][BF4] (3), [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (4)
and [Cu{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (5), respectively.
2. Results and Discussion
2.1. Synthesis and X-Ray Structure of [Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2)
The previously reported synthesis of the triple-decker complex 2 from the cyclo-P5 complex 1 and
[Mo(CO)3(CH3CN)4] requires an extended chromatographic purification. Moreover, it is only partially
reproducible, as several attempts isolated 2 with very different yields (10–40%) that were all lower
than the initially reported one (51%) [21], which is probably one reason why the chemistry of this
compound has not been studied despite it having been discovered almost three decades ago. Therefore,
we developed another method for the synthesis of 2, involving the 1:1 reaction of the cyclo-P5 complex
1 with [(η6-C7H8)Mo(CO)3] in THF instead of [Mo(CO)3(CH3CN)4] in CH2Cl2 (Scheme 1). Although
this new method requires a higher temperature than the one previously reported, it only takes 30 min
instead of one night and has a higher yield (57%) and better reproducibility (for further details, see
Section 3.2.1). In addition, chromatographic purification can be avoided by removing the THF solvent
and recrystallizing the product from the crude mixture using the appropriate amount of CH2Cl2.
Interestingly, this procedure additionally allowed the crystallization of a new polymorph, 2’, of the
triple-decker complex 2.
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Scheme 1. Previous and current methods used for the synthesis of triple-decker complex 2.
Compound 2’ crystallizes in the space group C2/c of the orthorhombic crystal system (2;
monoclinic P21/n). The geometry of 2’ is mostly similar to that of 2 (Figure 1). The P–P bond
lengths in 2’ are slightly longer (2.1453(1)–2.1611(1) Å) than those in 2 (2.116(6)–2.138(8) Å). The
average Fe–P distance is also slightly longer in 2’ (2.388(1) Å) than in 2 (2.370(4) Å). The mean Mo–P
distances are identical within the margin of error (2.634(1) Å, 2.630(4) Å). The cyclo-P5 ring in 2’ is
approximately planar as in 2 (maximum deviation: 0.064(1) Å). Due to the slightly longer P–P distances,
a slightly shorter intermetallic distance between Fe and Mo is found for 2’ (3.428 Å) than for 2 (3.443 Å).
The new structure determination of 2’ was carried out at a lower temperature (101 K) than that of 2
(r.t.) and showed better quality factors and a lower residual electron density. For this reason, the metric
data of 2’ are used in this paper for geometric comparisons.
Figure 1. Molecular structure of 2’ in the solid state. Selected bond lengths [Å] and angles [◦]: Fe1–P1
2.3822(8), Fe1–P2 2.3812(8), Fe1–P3 2.4010(8), Fe1–P4 2.3665(8), Fe1–P5 2.4097(7), Mo1–P1 2.6548(8),
Mo1–P2 2.6579(7), Mo1–P3 2.5843(8), Mo1–P4 2.7036(7), Mo1–P5 2.5694(7), P1–P2 2.1611(1), P2–P3
2.1453(1), P3–P4 2.1582(1), P4–P5 2.1561(1), P5–P1 2.1475(1), Mo1–P1-Fe1 85.59(2), Mo1–P2–Fe1 85.53(2),
Mo1–P3–Fe1 86.79(2), Mo1–P4–Fe1 84.80(2), Mo1–P5–Fe1 86.95(2).
2.2. Synthesis and X-Ray Structure of the Coordination Compound
[Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][BF4] (3)
As a first approach, the triple-decker complex 2 was reacted with Ag[BF4]. This reaction was
carried out in CH2Cl2 at room temperature with a 2:1 stoichiometric ratio and led to the selective
isolation of complex [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][BF4] (3) in a good (62%) yield (Scheme 2).
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Scheme 2. The reaction of triple-decker complex 2 with Ag[BF4]. Synthesis of the coordination
compound 3.
Dark red crystals of 3, which are suitable for single crystal X-ray diffraction, were obtained
after layering the crude reaction mixture with n-pentane (Figure 2). Compound 3 crystallizes in the
monoclinic space group P21/c. The asymmetric unit contains one AgI cation, two complexes of 2,
and one BF4− anion. Two P atoms coordinate to the AgI ion, one from each of the two complexes
2 (Figure 2), with Ag–P distances of 2.7149(1) Å and 2.7683(1) Å, respectively. Additionally, four
short distances to the C atoms of the two CO ligands of both complexes 2 were identified (d(Ag···CO)
= 2.726 Å). A possible bonding mode for these CO ligands makes them bind to one Mo atom in a
common terminal fashion and also donate electron density from the CO π bonds to the Ag atom.
This bonding pattern of CO ligands has only been rarely reported in the literature [30]. Moreover,
the Ag1–F1 distance is short (2.622(3) Å) and falls within the limits of van der Waals interactions
(2.30–2.90 Å) [31]. Overall, the AgI cation shows a distorted pentagonal bipyramidal coordination
geometry. The average P–P bond length in 3 is slightly longer than that in the free complex 2’ (2.160 Å
compared to 2.154(1) Å; Table 1). The Mo–C distances of the semi-bridging CO ligands [32] are slightly
longer than the ones of the terminal CO ligands (mean values: 2.008 Å and 1.981 Å). The C–O bond
lengths range between 1.136(5) and 1.147(5) Å. The Mo–C–O angles of the semi-bridging CO ligands
deviate more from a linear geometry (173.6(3)–176.3(3)◦) than those of the terminal ones (179.0(4)◦ and
179.2(3)◦). The CO bands in the IR spectra of 3 are comparable to those of the free ligand. Therefore, it
is supposed that the interaction between the cation Ag+ and the bridging CO ligands is weak. The
Ag···Mo distances are relatively short at 2.8301(4) Å and 2.8442(4) Å. The room temperature 1H and
13C{1H} NMR spectra of 3 in CD2Cl2 show characteristic signals for the Cp* and CO ligands. In the
31P{1H} spectrum, in CD2Cl2, a broad singlet at 25.2 ppm can be detected, which is significantly shifted
to lower field compared to the free ligand (9.7 ppm). The signal for the [BF4]− anion in the 19F{1H}
NMR spectrum in CD2Cl2 at −151.7 ppm is broadened due to the interaction with the Ag+ cation
(ω1/2 = 84 Hz).
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Figure 2. Molecular structure of 3 in the solid state. Selected bond lengths [Å] and angles [◦]: Ag1–P1
2.7683(1), Ag1–P6 2.7149(1), Ag1–F1 2.622(3), P1–P2 2.1670(2), P2–P3 2.1465(2), P3–P4 2.1668(2), P4–P5
2.1368(2), P5–P1 2.1660(2), P6–P7 2.1711(1), P7–P8 2.1429(1), P8–P9 2.1721(1), P9–P10 2.1531(1), P10–P6
2.1745(1), P1–Ag1–P6 175.09(4), P1–Ag1–F1 99.07(7), P6–Ag1–F1 83.45(6), Mo1–Ag1–Mo2 155.93(3).















d(P,P)/Å 2.154(1) 2.160 2.158 2.156 2.154
d(M,P)/Å — 2.742 2.695 2.687 2.662
d(Mo,M)/Å — 2.837 2.824 2.680 2.673
(P,M,P)/◦ — 175.09(3) 177.12(7) 179.61(9) 176.89(8)
(Mo,M,Mo)/◦ — 155.93(3) 173.56(3) 174.92(4) 173.93(4)
δ 31P{1H}/ppm
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2.3. Synthesis and X-Ray Structure of the Coordination Compound
[Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (4)
The result obtained from the reaction of complex 2 with Ag[BF4] raised the question of the
possibility of expanding this chemistry to other AgI salts. Accordingly, we selected the AgI salt
of the weakly coordinating anion [TEF]− because it offers a high solubility, thus allowing a more
detailed study of the formed compounds in solution [33]. The reaction of 2 with Ag[TEF], performed
by applying reaction conditions similar to those used for the reaction with Ag[BF4], afforded the
selective isolation of the complex [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (4) with an excellent yield
(80%, Scheme 3).
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Scheme 3. The reaction of the triple-decker complex 2 with Ag[TEF]. Synthesis of complex 4.
Single crystals of 4 were obtained by layering the CH2Cl2 crude reaction mixture with n-pentane
(Figure 3). Compound 4 crystallizes in the monoclinic space group P21/c. Similar to what was observed
for 3, the crystal structure of 4 shows an AgI cation coordinated by two P atoms with Ag–P distances
of 2.6809(2) Å and 2.7097(2) Å. Additionally, it exhibits four weak interactions with the C atoms of four
CO ligands (d(Ag···CO) = 2.748 Å). In contrast to 3, no additional interactions are observed between the
AgI cation and any fluorine atom from the [TEF]− ion, probably due to the non-coordinating property
of the [TEF]− anion. As a consequence, the AgI ion adopts a distorted square bipyramidal coordination
sphere in contrast to the pentagonal bipyramidal one observed for the AgI ion in 3. Interestingly, the
Mo–Ag–Mo angle in 4 (173.56(3)◦) deviates much less from linearity than that in 3 (155.93(3)◦), and the
Ag···Mo distances in 4 (2.8131(7) Å and 2.8353(7) Å) are slightly shorter than those found in 3.
Figure 3. Molecular structure of the cation of 4 in the solid state. Selected bond lengths [Å] and
angles [◦]: Ag1–P1 2.7097(2), Ag1–P6 2.6809(2), P1–P2 2.173(3), P2–P3 2.139(3), P3–P4 2.159(3), P4–P5
2.147(3), P5–P1 2.168(3), P6–P7 2.166(3), P7–P8 2.137(3), P8–P9 2.164(3), P9–P10 2.159(3), P10–P6 2.169(3),
P1–Ag1–P6 177.12(7), Mo1–Ag1–Mo2 173.56(3).
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As expected, compound 4 is excellently soluble in CH2Cl2 due to its [TEF]− anion, whereas it is
moderately soluble in toluene and insoluble in n-alkanes. The 1H, 13C{1H}, and 19F NMR spectra of 4
in CD2Cl2 at r.t. show characteristic signals for the Cp* and CO ligands as well as for the [TEF]− anion.
In the 31P{1H} NMR spectrum, a singlet at 30.1 ppm is observed, which is significantly shifted to lower
field compared to the free ligand (9.7 ppm). Upon cooling to 183 K, no broadening or significant shift
of the signal occur. The 31P{1H} MAS-NMR spectrum of solid 4 at room temperature shows a singlet at
a chemical shift (28.3 ppm) similar to that in solution. Thus, molecular dynamic processes such as the
rotation of the cyclo-P5 ring take place at low temperatures in solution and in the solid state at room
temperature as well. However, the single-crystal X-ray analysis performed at 100 K did not indicate
a rotation of the cyclo-P5 ring because of the low temperature needed for an appropriate structure
solution. The molecular ion peak can be detected in the cation mode of the ESI mass spectrum as well
as peaks for the intact and partially decarbonylated ligands of 2. In the anion mode, the [TEF]− anion
is detected. Vapor pressure osmometry yields a relatively high value for the mean molecular mass
(1700 g·mol−1 ± 100 g·mol−1), suggesting that the compound is mainly associated in solution. The CO
stretching frequencies in the IR spectrum in the solid state are broadened compared to the one of the
free ligand and are shifted to higher wave numbers, probably due to the positive charge of the complex
(Table 1). In the 13C{1H} MAS-NMR spectrum, the signals for the C atoms of the carbonyl groups are
broadened as well and, interestingly, a differentiation between semi-bridging and non-bridging CO
ligands is not possible.
2.4. Synthesis and X-Ray Structure of the Complex [Cu{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (5)
The successful coordination of triple-decker complex 2 to AgI ions inspired us to study its
coordination behavior towards CuI ions, specifically towards [Cu(1,2-F2C6H4)][TEF]. This reaction was
performed under similar reaction conditions as previously used and selectively yielded the complex
[Cu{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (5) in good isolated yields (55%, Scheme 4).
 
Scheme 4. The reaction of triple-decker complex 2 with Cu(1,2-F2C6H4)[TEF]. Synthesis of the
coordination compound 5.
Compound 5 crystallizes in the monoclinic space group P21/c. The asymmetric unit contains
two independent complexes [Cu(2)2]+ and two [TEF]− anions, which show slightly different bonding
lengths and angles (entitled in the following as 5’ and 5”). The monocationic units in 5 (5’, 5”)
exhibit the same geometry and coordination modes as the related AgI compound 4 (Figure 4). The
Cu–P bond distances in 5 lie between 2.647(2) Å and 2.691(2) Å and the short contacts between Cu
and the semi-bridging CO ligands range from 2.534 Å to 2.645 Å. Table 1 shows a comparison of
selected structural and spectroscopic data of the independent molecules of 5’ and 5” as well as of the
silver-containing compounds 3 und 4 with the same ligand. The average P–P distances in the silver
compounds are slightly larger than in the copper compound, but they are all elongated compared to
the free triple-decker complex 2’. The Cu–P distances are relatively large, but smaller than the Ag–P
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distances, as expected. The P–M–P angle amounts to nearly 180◦ in all cases. The largest deviation from
linearity is observed in the [BF4]− compound 3 with about 5◦. The intermetallic distances within the
copper compound are significantly smaller than those in the silver compounds. The complexes with
[TEF]− as counterion show Mo–M–Mo angles between 173.56(3)◦ and 174.92(4)◦, while compound 3
clearly differs from these (155.93(3)◦).
Figure 4. Molecular structure of the cation of 5 in the solid state.
In the 31P{1H} NMR spectra, all compounds show a low field shift compared to the signal of free
complex 2. The difference in the chemical shift is larger for [TEF]− than for [BF4]− and larger for
copper than for silver. The CO bands in the IR spectra of 3 are almost similar to those of the starting
material. However, in regard to compounds 4 and 5, they are broadened and shifted to higher wave
numbers. In the ESI mass spectra of 5, the molecular ion peak can be detected in the cation mode, as in
the case of 4, as well as peaks for the intact and partially decarbonylated ligands. In the anion mode,
only a single peak can be observed for the [TEF]− anion.
3. Materials and Methods
3.1. General Information
All experiments were performed under an atmosphere of dry argon using standard Schlenk
techniques. [(C7H8)Mo(CO)3] and Ag[BF4] were purchased from Sigma-Aldrich (Darmstadt, Germany)
and used as received without further purification. The compound [Cp*Fe(η5-P5)] (1) [3] and the
salts Ag[Al{OC(CF3)3}4] [33] and Cu(1,2-F2C6H4)[Al{OC(CF3)3}4] [34] were synthesized according to
literature procedures. Solvents were freshly distilled under argon from Na/benzophenone (THF),
from Na (toluene), from CaH2 (CH2Cl2) and from a Na/K alloy (n-pentane, n-hexane). IR spectra
were recorded on a Varian FTS-800 spectrometer (Varian Inc., MA, USA). 1H, 13C, 31P and 19F NMR
spectra were recorded on Bruker Avance 300 and 400 spectrometers (Bruker, Karlsruhe, Germany).
MAS-NMR spectra were performed at 300 K on a Bruker Avance 300 spectrometer (Bruker, Karlsruhe,
Germany). 1H and 13C NMR chemical shifts were reported in parts per million (ppm) relative to
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Me4Si as an external standard. 31P NMR chemical shifts were expressed in ppm relative to external
85% H3PO4 and were decoupled from the proton. 19F NMR chemical shifts were reported relative
to CFCl3. For the ESI-MS, a Finnigan Thermoquest TSQ 7000 mass spectrometer (Thermo Fisher
Scientific, Frankfurt, Germany) was used. Elemental analyses were performed by the microanalytical
laboratory of the University of Regensburg. Molecular mass determination performed by means of
vapor pressure osmometry was carried out using a Knauer K-7000 vapor pressure osmometer (Knauer,
Berlin, Germany) with CH2Cl2 as the solvent.
3.2. Synthesis and Characterization of the Compounds 2 and 3–5
3.2.1. Synthesis and Characterization of [Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2)
To a stirred solution of [Cp*Fe(η5-P5)] (1, 1.28 g, 3.69 mmol) in 75 mL THF, [(C7H8)Mo(CO)3]
(1 g, 3.69 mmol) in 75 mL THF was slowly added. The crude reaction mixture was refluxed for
30 min. The solvent was removed under reduced pressure and the residue was extracted with 50 mL
CH2Cl2. In order to obtain crystals of the polymorph 2’, the crude mixture was stored for three days at
−30 ◦C. Otherwise, the crude residue mixture was purified by column chromatography using silica
gel (10 × 2 cm) and an eluent solvent mixture of hexane:toluene (9:1). The triple-decker complex 2 was
obtained as a dark green solution, the solvent was removed under reduced pressure and 2 was isolated
as an olive-green solid. Yield: (1.11 g, 57%). Crystal Data for C13H15O3P5FeMo, Mr = 525.89 g/mol,
monoclinic, C2/c (No. 15), a = 15.8694(11) Å, b = 14.6679(10) Å, c = 15.9594(12) Å, β = 102.587(7)◦, α =
γ = 90◦, V = 3625.6(5) Å3, T = 101(2) K, Z = 8, Z′ = 1, μ(CuKa) = 16.348, 10281 reflections measured,
3185 unique (Rint = 0.0235), which were used in all calculations. The final wR2 was 0.0699 (all data)
and the R1 was 0.0237 (I > 2(I)).
3.2.2. Synthesis and Characterization of [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][BF4] (3)
A solution of Ag [BF4] (18 mg, 0.09 mmol) and [Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2; 95 mg, 0.18 mmol)
in CH2Cl2 (15 mL) was stirred at r.t. for 1 h in the dark. Subsequently, the deep red solution was
filtered through a G4 filter frit and layered with n-pentane (25 mL) using a Teflon capillary. Within
two weeks, red crystals of 3 had formed after storage at 2 ◦C. These were filtered off, washed with
n-pentane (3 × 2 mL), and dried in a vacuum. Yield (69 mg, 62%)
1H NMR (300 MHz, CD2Cl2): δ = 1.36 ppm (s, C5(CH3)5), 13C{1H} NMR (75.47 MHz, CD2Cl2):
δ = 9.8 (br sext, 3JP,C = 1.8 Hz; C5(CH3)5), 89.0 (br s, C5(CH3)5), 214.3 ppm (br s, CO). 31P{1H} NMR
(121.49 MHz, CD2Cl2): δ = 25.2 ppm (s, ω1/2 = 28 Hz). 19F{1H} NMR (282.40 MHz, CD2Cl2): δ =
−151.7 ppm (br s, ω1/2 = 84 Hz; CF3). IR (KBr): ṽ/cm−1 = 2957 (vw), 2906 (w), 2852 (vw), 1963 (vs),
1955 (vs), 1892 (vs), 1880 (vs), 1477 (w), 1447 (vw), 1427 (w), 1376 (w), 1309 (w) 1242 (m), 1209 (w), 1155
(w), 1124 (w), 1071 (w), 1020 (m), 986 (w), 600 (w), 584 (w), 557 (w), 544 (w) 493 (m), 477 (m), 440 (w). IR
(CH2Cl2): ṽ/cm−1 = 3054 (vs), 2987 (w), 2349 (vw), 2305 (vw), 1970 (vs), 1892 (vs), 1897 (vs), 1422 (m),
1267 (vs). Elemental analysis, calcd. (%) for C26H30AgBF4Fe2Mo2O6P10 (1246.46 g·mol−1): C 25.05, H
2.43; found: C 25.81, H 2.54. Crystal Data for C104H120Ag4B4F16Fe8Mo8O24P40, Mr = 4985.83 g·mol−1,
monoclinic, P21/c (No. 14), a = 8.77020(10) Å, b = 26.5995(3) Å, c = 19.5513(3) Å, β = 116.2050(10)◦, α =
γ = 90◦, V = 4092.20(10) Å3, T = 123(2) K, Z = 1, Z′ = 0.25, μ(CuKa) = 18.417, 16649 reflections measured,
7769 unique (Rint = 0.0232), which were used in all calculations. The final wR2 was 0.0955 (all data)
and R1 was 0.0354 (I > 2(I)).
3.2.3. Synthesis and Characterization of [Ag{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (4)
A solution of [Ag(CH2Cl2)][TEF] (104 mg, 0.09 mmol) and two equivalents of
[Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2; 95 mg, 0.18 mmol) in CH2Cl2 (15 mL) was stirred at r.t. for
1 h in the dark. The deep red solution was then filtered through a G4 filter frit and layered with
n-pentane (25 mL) using a Teflon capillary. Within two weeks, red crystals of 4 had formed at 2 ◦C.
These were filtered off, washed with n-pentane (3 × 2 mL), and dried in a vacuum. The mother liquor
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was further concentrated to 5 mL under vacuum, under which more product precipitated as a reddish
brown precipitate upon addition of n-pentane (45 mL), likewise filtered off, washed with n-pentane (3
× 2 mL), and dried under vacuum. Yield (154 mg, 80%).
1H NMR (400 MHz, CD2Cl2): δ = 1.34 ppm (s, C5(CH3)5), 13C{1H} NMR (100.61 MHz, CD2Cl2): δ
= 9.7 (br sext, 3JP,C = 1.8 Hz; C5(CH3)5), 90.3 (s, C5(CH3)5), 121.6 (q, 1JF,C = 292.1 Hz; CF3), 213.9 ppm
(br sext, 2JP,C = 1.6 Hz; CO). 13C{1H}-MAS-NMR (75.47 MHz): δ = 9.0 (br s, C5(CH3)5), 92.5 (br s,
C5(CH3)5), 122.3 (q, 1JF,C = 337.4 Hz; CF3), 215.1 ppm (br s, CO). 31P{1H} NMR (161.98 MHz, CD2Cl2):
δ = 30.1 ppm (s, ω1/2 = 4 Hz). 31P{1H} NMR (161.98 MHz, CD2Cl2, 183 K): δ = 30.3 ppm (s, ω1/2 =
6 Hz). 31P{1H}-MAS-NMR (121.49 MHz): δ = 28.3 ppm (br s, ω1/2 = 93 Hz). 19F{1H} NMR (282.40
MHz, CD2Cl2): δ = −75.6 ppm (s, CF3). IR (KBr): ṽ/cm−1 = 2962 (vw), 2918 (w), 2851 (vw), 1980(vs),
1928 (vs), 1914 (vs), 1543 (vw), 1480 (w), 1450 (w), 1428 (w), 1381 (m), 1353 (m), 1301 (vs), 1277 (vs),
1242 (vs), 1219 (vs), 1165 (m), 1136 (vw), 1075 (vw), 1021 (m), 974 (vs), 833 (w), 799 (vw), 755 (vw),
727 (s), 587 (m), 559 (w), 538 (m), 492 (w), 476 (w), 444 (m). IR (CH2Cl2): ṽ/cm−1 = 2984 (vw), 2959
(vw), 2915 (vw), 2849 (vw), 1993(vs), 1970 (vs), 1934 (s), 1902 (vs), 1478 (w), 1448 (vw), 1426 (m), 1379
(m), 1352 (m), 1300 (vs), 1277 (vs), 1242 (vs), 1225 (vs), 1167 (m), 1136 (vw), 1072 (vw), 1022 (m), 976
(vs), 833 (vw), 600 (w), 587 (w), 559 (w), 538 (w), 494 (w), 476 (vw), 444 (m). Osmometry (CH2Cl2):
Average molar mass: 1700 g·mol−1 ± 100 g·mol−1. Positive ion ESI-MS (CH2Cl2), m/z (%) = 1159.0 (7)
[Ag{Cp*FeP5Mo(CO)3}2]+, 527.9 (27) [Cp*FeP5Mo(CO)3]+, 499.9 (100) [Cp*FeP5Mo(CO)2]+. negative
ion ESI-MS (CH2Cl2), m/z (%) = 967.2 (100) [Al{OC(CF3)3}4]−. Elemental analysis, calcd. (%) for
C42H30AgAlF36Fe2Mo2O10P10 (2126.79 g·mol−1): C 23.72, H 1.42; found: C 23.73, H 1.44. Melting
point > 200 ◦C. Crystal Data for C42H30AgAlF36Fe2Mo2O10P10, Mr = 2126.79 g·mol−1, monoclinic,
P21/c (No. 14), a = 19.6554(16) Å, b = 9.6564(9) Å, c = 36.745(3) Å, β = 98.912(9)◦, α = γ = 90◦, V =
6889.9(10) Å3, T = 100(2) K, Z = 4, Z′ = 1, μ(CuKa) = 12.144, 26789 reflections measured, 12207 unique
(Rint = 0.0444), which were used in all calculations. The final wR2 was 0.1467 (all data) and R1 was
0.0498 (I > 2(I)).
3.2.4. Synthesis and Characterization of [Cu{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][TEF] (5)
A solution of [Cu(1,2-F2C6H4)][TEF] (92 mg, 0.08 mmol) and [Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2;
84 mg, 0.16 mmol) in CH2Cl2 (15 mL) was stirred at r.t. for 1 h. Subsequently, the deep red solution
was then filtered through a G4 filter frit and layered with n-pentane (25 mL) using a Teflon capillary.
Within two weeks, red crystals of 5 had formed at 2 ◦C, which were filtered off, washed with n-pentane
(3 × 2 mL), and dried in a vacuum (5 h, 10−3 mbar). According to the elemental analysis, half an
equivalent of n-pentane per unit formula could not be removed (The asymmetric unit of 5 also contains
half an n-pentane molecule). Yield (93 mg, 55%).
1H NMR (300 MHz, CD2Cl2): δ = 1.38 ppm (s, C5(CH3)5), 13C{1H} NMR (100.61 MHz, CD2Cl2): δ
= 9.7 (br s; C5(CH3)5), 90.5 (s, C5(CH3)5), 121.6 (q, 1JF,C = 291.4 Hz; CF3), 212.9 ppm (br s; CO). 31P{1H}
NMR (121.49 MHz, CD2Cl2): δ = 31.7 ppm (s, ω1/2 = 41 Hz). 19F{1H} NMR (282.40 MHz, CD2Cl2):
δ = −75.6 ppm (s, CF3). IR (KBr): ṽ/cm−1= 2962 (vw), 2919 (w), 2854 (vw), 1993(vs), 1961(vs), 1923
(vs), 1910 (vs), 1479 (w), 1451 (w), 1428 (w), 1381 (m), 1353 (m), 1302 (vs), 1277 (vs), 1241 (vs), 1220
(vs), 1166 (m), 1139 (vw), 1072 (vw), 1021 (m), 974 (vs), 833 (w), 756 (vw), 728 (vs), 586 (w), 561 (w),
537 (m), 492 (w), 475 (w), 443 (m). IR (CH2Cl2): ṽ/cm−1 = 3054 (vs), 2987 (w), 2348 (w), 2305 (vw),
1995 (s), 1969 (vs), 1925 (m), 1901 (s), 1422 (m), 1269 (vs). Positive ion ESI-MS (CH2Cl2), m/z (%) =
1114.6 (1) [Cu{Cp*FeP5Mo(CO)3}2]+, 527.9 (100) [Cp*FeP5Mo(CO)3]+, 499.9 (94) [Cp*FeP5Mo(CO)2]+.
Negative ion ESI-MS (CH2Cl2), m/z (%) = 967.1 (100) [Al{OC(CF3)3}4]−. Elemental analysis, calcd. (%)
for C42H30CuAlF36Fe2Mo2O10P10 × 0.5C5H12 (2118.55 g·mol−1): C 25.23, H 1.71; found: C 25.36, H
1.73. Crystal Data for C86.5H66Al2Cu2F72Fe4Mo4O20P20, Mr = 4200.99, monoclinic, P21/c (No. 14), a
= 32.1751(3) Å, b = 12.2014(2) Å, c = 35.8672(5) Å, b = 99.6750(10)◦, a = g = 90◦, V = 13880.5(3) Å3, T
= 123(2) K, Z = 4, Z′ = 1, m(CuKa) = 10.176, 50354 reflections measured, 24416 unique (Rint = 0.0606)
which were used in all calculations. The final wR2 was 0.1722 (all data) and R1 was 0.0609 (I > 2(I)).
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3.3. Crystallography
The crystals were selected and mounted on an Oxford Diffraction Gemini R Ultra diffractometer
equipped with a Ruby CCD detector (2, 4) and a SuperNova diffractometer equipped with an Atlas
CCD detector (3, 5), respectively. The crystals of compounds 2 and 4 were kept at T = 100(1) K and the
crystals of the compounds 3 and 5 at T = 123(1) K during data collection, respectively. Data collection
and reduction were performed with CrysAlispro (Version 171.33.41 (2), 171.34.9 (3), 171.33.42 (4),
171.33.61 (5)) [35]. For compounds 2 and 4, a semi-empirical multi-scan absorption correction from
equivalents [35] was applied. For compounds (3, 5), an analytical numeric absorption correction using
a multifaceted crystal model based on expressions derived by R. C. Clark & J. S. Reid was applied [36].
Using Olex2 [37], the structures were solved with SIR97 [38] and a least-square refinement on F2 was
carried out with ShelXL [39]. All non-hydrogen atoms were refined anisotropically. Hydrogen atoms
at the carbon atoms were located in idealized positions and refined isotropically according to the riding
model. CIF files with comprehensive information on the details of the diffraction experiments and full
tables of bond lengths and angles for 2–5 were deposited in Cambridge Crystallographic Data Centre
under the deposition codes CCDC-1884710-1884713.
4. Conclusions
In conclusion, we found a new high-yielding synthesis of the triple-decker complex
[Cp*Fe(μ,η5:η5-P5)Mo(CO)3] (2) and used it as a ligand in coordination chemistry for the first time. Its
reaction with Ag[BF4], Ag[TEF] or Cu[TEF] leads, in each case, to the selective formation of complexes
with the general formula [M{Cp*Fe(μ,η5:η5-P5)Mo(CO)3}2][X] (M = Ag, Cu; X = [BF4]−, [TEF]−). These
results open a new chapter in the reactivity of triple-decker complexes with cyclo-P5 middle-decks as
promising candidates in supramolecular chemistry. Current studies are focused on extending the new
synthesis approach to obtain other triple-decker compounds with cyclo-P5 and cyclo-As5 middle-decks
and studying their coordination chemistry towards transition metal complexes.
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Abstract: A simple, highly efficient synthesis of a series of novel chiral non-racemic rigid tetracyclic
phosphorus ligands, applicable in important chemical asymmetric transformations, was performed.
In a tandem cross-coupling/C-H bond activation reaction, a well-recognised and readily available
ligand (R,R)-NORPHOS was used as the starting material. The palladium complexes of new
ligands were obtained and characterised on the example of a crystalline dichloropalladium
complex of [(1R,2R,9S,10S,11R,12R)-4-phenyltetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-
diyl]bis(diphenylphosphane). A notably high activity and stereoselectivity of the palladium catalysts
based on the new ligands were confirmed in a model asymmetric allylic substitution reaction. Herein,
we discuss the geometry of the palladium complexes formed and its impact on the efficiency of the
catalysts. A comparison of their geometric features with other bis(phosphane) ligand complexes
found in the Cambridge Structural Database and built density functional theory (DFT) commutated
models is also presented and rationalised.
Keywords: bis(phosphane) palladium complex; metallacycle; NORPHOS; allylic alkylation;
asymmetric catalysis; chiral phosphines; C-H bond activation; polycyclic compounds; stereoselective
synthesis; DFT calculations
1. Introduction
One of the most challenging approaches in contemporary synthetic organic chemistry is the
selective activation of C-H bonds leading to the creation of new carbon-carbon bonds in the structure
of fine organic compounds of commercial value. A palladium-catalysed Heck coupling reaction is
one of the major tools used for the C-C bond formation. The reaction is widely used to prepare
drugs, fragrances and agrochemicals [1–3]. An extension of the regular alkenes arylation according
to the Heck coupling mechanism is the palladium-catalysed Heck–Catellani reaction, reported in
1985, which involves an intramolecular C-H bond activation and functionalisation [4]. This discovery
provided the foundation for the majority of recent developments of direct C-H activation/C-C coupling
reactions [5–9] that are conducted to improve the efficiency and atom economy of traditional couplings.
Chiral biphosphine ligands are a powerful synthetic tool for generating complex and diverse
chemical compounds. Recently, we have reported a new methodology for a highly regio- and
stereoselective reaction of the NORPHOS oxide (1) [10,11] with substituted aryl bromides (2), which
Molecules 2019, 24, 571; doi:10.3390/molecules24030571 www.mdpi.com/journal/molecules513
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furnished various pentacyclic NORPHOS oxide derivatives 3 (Scheme 1) [12]. This new type of the
Heck–Catellani reaction proceeded through tandem cross-coupling/cross-dehydrogenative-coupling
stages, mediated by highly active palladium complexes of bulky electron-rich bidentate mono
phosphines (S-Phos, Sym-Phos and MeOSym-Phos) [12,13]. Inspired by these achievements, we have
been prompted to explore some new opportunities that a reaction of the Heck–Catellani type could
provide. It had been mentioned in [12] that in the reaction leading to pentacyclic NORPHOS oxide
derivatives (3), some by-products with molecular weights that formally satisfy chemical formulae
of classical mono-arylated Heck products were formed in trace amounts. Since the formation of
the Heck reaction product is rather non-typical for norbornene substrates, we supposed that the
observed minor by-product could have the structure of a tetracyclic compound (4). Interestingly,
the best chiral ligands used in the transition-metal-mediated asymmetric synthesis display chirality
in the backbones of the ligand and a rigid structure weakly influenced by random conformational
changes [14]. This phenomenon has its roots in the fact that the catalysts with restricted freedom of
conformational movements more significantly differentiate the competitive transition states leading to
enantiomeric reaction products. Thus, C-chiral chelating phosphanes whose stereometry is stabilised
by polycyclic systems, especially those based on five- and four-membered rings, could be considered as
promising candidates for efficient ligands to be used in catalytic transition-metal-mediated asymmetric
transformations. A new, efficient, highly stereo- and regioselective approach to the synthesis of
tetracyclic compound (4), using readily available substrates and inexpensive commercial palladium
catalysts, should be a welcome addition to our previously reported methods for the synthesis of





Scheme 1. Synthesis of polycyclic NORPHOS derivatives.
Herein, we disclose a transition-metal-catalysed, one-pot stereoselective synthesis of
[tetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-diyl]bis(diphenylphosphane) dioxides: novel
NORPHOS oxide derivatives bearing a benzocyclobutene motif. After deoxygenation, the obtained
phosphanes could be used as ligands in transition-metal-mediated asymmetric transformations.
We also present a short summary of the geometry in the pentametallacyclic complexes of
bis(phosphones) with transition metals found in the Cambridge Structural Database, which were
compared with the dichloropalladium complex of phosphane derived from 4.
2. Results and Discussion
Utilisation of most active ligands, such as MeOSym-Phos: Electron-rich and bulky, according
to the basic concept [15,16], should accelerate the oxidative addition of aromatic halides to Pd(0)
species and, therefore, a double addition of aromatic halides should predominate in the reaction [12].
Thus, in order to direct the reaction to an alternative path of mono-arylation, an electron-deficient ligand
of a relatively small steric hindrance, which stabilises intermediate I4 and facilitates the reductive
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elimination to product 4, should be used (Scheme 1). Tetrakis(triphenylphosphine)palladium(0) was
therefore selected to be used as the catalyst. The two-component reactions of racemic NORPHOS
oxide (rac-1) and aryl halides (bromide or iodide) used in an equimolar amount or in a 3-fold excess
were carried out in the presence of Pd(PPh3)4, bases and solvents at 105 ◦C for 12–48 h. We found
that a proper choice of the base and solvent was crucial to achieving high yields. Among the tested
bases, including K3PO4, KOAc, KOtBu, K2CO3 and others (see electronic supplementary information
(ESI)), Cs2CO3 was selected as the most promising, which significantly increased the yield of desirable
product 4. Polar aprotic solvents are often used in the coupling reaction as they allow for the best
solubility of the substrates and the catalysts. In the model reaction between 1 and p-bromotoluene
(1.2 equiv.) run in dimethylformamide (DMF) in the presence of 5 mol% of [Pd(PPh3)4] and caesium
carbonate (3.0 equiv.) at 105 ◦C for 48 h, the isolated yield of product 4b was 83%. A study of the
solvent effects on the yield of the coupling reaction revealed that while the reaction proceeds well
in toluene (yield 79%), in THF (yields 72%) and in acetonitrile (yield 65%), the catalytic process is
greatly affected in DMF (see ESI). Compared to other combination of used bases and solvents, Cs2CO3
solubilised in DMF is less likely to coordinate to the palladium centre and, therefore, less likely to
interfere with the catalyst activity. To obtain a satisfactory conversion in DMF, 5 mol% of [Pd(PPh3)4]
was required. The presence of 1 mol% and 0.1 mol% of the phosphine palladium complex resulted in
the formation of 45% and 21% yields of the product, respectively (see ESI).
Having optimised the conditions, we prepared a series of phosphine oxides 4. Table 1 presents
the isolated yields of products 3 and 4 bearing diversified substituents in the introduced arenes.
The coupling reaction of ortho-substituted aryl halides with 1 gave cyclobutene derivatives 4
with a very good yield. A higher yield of 4 was observed when the proportion of the aryl halide
was increased from 1.2 to 3.0 equiv. Thus, in the reaction of 1 with 1.2 equiv. or with 3.0 equiv. of
o-bromotoluene (2f), the desired product was isolated in 78% and 85% of the yield, respectively
(Table 1, entry 6). Under similar conditions, a tri-substituted aryl halide (Table 1, entry 8) allows
us to achieve a similar 86% yield. Using [Pd(PPh3)4], a generally low-activity catalyst, allows us to
conduct the reaction between 1 and 2-bromochlorobenzene (2g) chemoselectively, and only product
4g was isolated in a 54% yield. In the case of 2-bromobiphenyl (2q), the reaction furnished tetracyclic
product [tetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-diyl]bis(diphenylphosphane) dioxides (4q)
in an excellent 98% yield.
Surprisingly, we have found that the direction of the reaction depends not only on the catalyst
used, but also on the nature of the aryl halide. The NORPHOS oxide underwent the reaction with
highly active aromatic halides, e.g., possessing an electron-withdrawing groups (EWG) (2j, 2k) or
a trimethylsilyl (TMS) group (2l) and with unsubstituted phenyl bromide (2a) furnishing the mixture
of products 3 and 4 (Table 1, entries 1, 10, and 11) with the ratio of 3 to 4 increasing in line with the
increasing excess of substrates 2 in the reaction mixture. This observation supports the suggestion that
the selection of the reaction path depends on the relation of the rates of conversion from intermediates
I4 to 4 and I4 to I3 (Scheme 2). Thus, using “fast”, electron-rich and bulky catalysts and active substrates,
due to rapid halo-arylation of the palladium atom in I4, facilitates the formation of I4 and the next
product 3. In contrast to that, utilisation of less-active, electron-deficient and ligand-based catalysts
and electron-donating group (EDG) substituted substrates resulted in the formation of product 4 in
higher yields.
Our methodology can also be extended to non-benzenoid aromatic bromides (including naphthalenes
and phenanthrenes). Both 1-bromonaphthalene (2m) and 2-bromo-6-methoxynaphthalene (2n) smoothly
underwent the reaction with 1 to give the corresponding carbocyclisation products 4m and 4n in 53%
and 68% yields, respectively (Table 1, entry 13, 14). A similar 54% yield of 4p was obtained in the case
of 9-bromophenanthrene (2p) (Table 1, entry 16). As could be expected, the halides that do not possess
any hydrogen atoms in position ortho- to the aryl–halogen bond did not undergo the studied reaction
(Table 1, entry 15). Moreover, our attempts to obtain heterocyclic products 3e or 4e failed, perhaps due
to the strong coordination of the nitrogen atom of pyridine to palladium (Table 1, entry 5).
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Table 1. Reaction of the NORPHOS oxide with aryl halides (2) in the presence of [Pd(PPh3)4].
























































































































Conditions: NORPHOS oxide (0.2 mmol), aryl halide (3.0 equiv.), Cs2CO3 (3.0 equiv.), [Pd(PPh3)4] (5 mol%) and
DMF (4 mL) at 105 ◦C for 48 h. a The reaction time was 18 h. b Product was not observed.
2.1. General Mechanism and Selectivity of the Reaction
The catalytic carbocyclisation reaction between the NOPHROS oxide and aryl halides that resulted
in cyclobutene derivatives 4 is highly regioselective, giving the cis-exo isomer as the exclusive
product. An unexpected side reaction product 4a (2–10%) was detected in the reaction mixtures
by the 1H-NMR and HPLC-HR-MS spectral analyses in almost all cases when differently substituted
aromatic halides were used (Figure 1). We could assume that, as an exclusive source of phenyls, the
phenylidene fragment originated from triphenylphosphane. The migration of the phenyl substituent
from the phosphorus atom to palladium had already been observed in the course of other studies [17].
The molecular mechanism of this rare transformation is not clear and its elucidation requires additional
theoretical as well as experimental investigations.
Figure 1. Side reaction products 4a and 5.
A tentative mechanism of the reaction leading to products 3–5 includes several stages (Scheme 2).
The first obvious step of the reaction is an oxidative addition of 2 to the palladium catalysts; then,
an insertion of the obtained arylpalladium intermediate into the double bond of the NORPHOS
oxide furnished intermediate I1. Two possible isomeric intermediates I1 and I1’ could be formed.
Nevertheless, only a single type of isomeric product was found in the reaction mixtures, and was
identified as 3 and 4. This could be rationalised by the steric hindrance created by P(O)Ph2 groups,
which forces large aryl substituents to occupy a less-hindered position. Obviously, both isomeric
products of the alternative endo insertion of arylpalladium halides to 1 are significantly unfavorable
and were not formed. The second reaction step is an intramolecular activation of the ortho C-H bond
of the introduced arene by palladium, which resulted in the formation of intermediate I2. A base
facilitated elimination of the hydrogen halide at the next step, which led to the reduction of the
oxidation stage of palladium in intermediate I4. Next, when using electron-rich ligands of the C,P-type
transition metal binding [12,13] or highly active aromatic halides, the oxidative addition of the second
molecule of 2 occurs and the reaction runs via intermediate I3 towards product 3. Thus, in the case of
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Scheme 2. A tentative suggestion for the molecular mechanism of the coupling reaction.
We have also examined the possibility of product 4’s conversion to 3, which theoretically may
occur if an excess of the aromatic halide is present in the reaction mixture by the activation of a strained
cyclobutane ring with reactive palladium species. For this purpose, in the presence of the palladium
complex of the S-Phos ligand and caesium carbonate (3.0 equiv.), compound 4 was subjected to the
reactions with 3.0 equiv. of aryl bromides (2a and 2b). After 48 h in DMF at 105 ◦C, we did not observe
the formation of compound 3 and did not find any evidence that such a reaction could be conducted
under the studied conditions.
Since both products 3 and 4 are formed from the same intermediate I4, it could be anticipated
that a lower rate of the oxidative addition reaction, inherent to the electron-poor, ligand-based catalyst,
will facilitate the formation of product 4.
Additionally, in the cases of Cs2CO3 (due to its notably strong basic character) and polycyclic
aromatic substrates 2m and 2p, trace amounts of reductive Heck reaction products 5, formed by reducing
intermediate I1, presumably by a solvent [18,19], were detected in the postreaction mixtures (Figure 1).
2.2. Preparation of Chiral Non-Racemic Ligand 6q
Having developed such a high-yielding procedure for the synthesis of desirable highly rigid
bis(phosphane) dioxides, we aimed to conduct the synthesis of new chiral ligands to be used in
asymmetric transition metal complex-catalysed reactions. We decided to use our new methodology to
synthesise representative chiral non-racemic phosphane 6q, since the corresponding bis(phosphane)
dioxide 4q was obtained in the highest yield. First of all, the scaleup of the synthesis of 4q was
performed. Notably, the synthesis conducted in a scale that increased up to one gram of (R,R)-1
furnished the product in a 90% yield without the need of further optimisation of the reaction
conditions. The obtained bis(phosphane) dioxide underwent a deoxygenation reaction in the presence
of trichlorosilane and tributylamine, affording ligand (R,R)-6q in an 85% yield (Scheme 3). Ligand
6q appeared to be sufficiently resistant to exposure to air and could be purified chromatographically.
Using the enantiomerically pure, readily available substrate (R,R)-1 in the synthesis allows us to obtain
an enantiomerically pure product with no need of practical-scale enantiopurification.
2.3. Synthesis of the Complex [Pd(6q)Cl2]
Since the validation of the proper geometry of the formed ligand by means of NMR spectroscopy
is not a trivial matter, we have decided to perform it by analysing the single crystal X-ray diffraction
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data of the derived dichloropalladium complex [Pd(6q)Cl2]. The complex was prepared from
[Pd(t-BuCN)2Cl2] and ligand 6q in tetrahydrofuran (THF), and precipitated after a partial replacement
of the solvent with C6H6. A single crystal has been grown from the hot ethanol/benzene mixture.
R,R R,R R,R
 
Scheme 3. Synthesis of the phosphine ligand.
2.4. Molecular and Crystal Structure of the Complex [Pd(6q)Cl2]
The palladium coordination compound [Pd(6q)Cl2] has been characterised by a single crystal
X-ray diffraction analysis (CCDC No.: 1885894). [Pd(6q)Cl2] crystallises in a tetragonal crystal system
in the chiral P43212 space group. The absolute structure assignment of the complex [Pd(6q)Cl2] has
been determined through anomalous scattering with the value of the Flack parameter refined to
-0.007(3), using 2963 quotients (for more details, crystal data and structure refinements see (ESI).
The chiral centers are localised at the C1 (R), C2 (R), C9 (S), C10 (S), C11 (R) and C12 (R)
atoms (Figure 2). The bond lengths and selected angles are given in Tables 2 and 3. An X-ray
analysis confirmed the cis, exo configuration of the hydrocarbon skeleton at the C2–C9 joint atoms.
The hydrogens attached to the C11 and C12 atoms are located in a trans configuration, which is in
accordance with the synthesis route (Tables 2 and 3, Scheme 3, Figure 2). In the four-membered ring,
the valence angles show strains resulting in a distortion of the sp3- and sp2- hybridised carbon atom
centers from the ideal 109.5 and 120◦ to 86 and 94◦, respectively, with higher values being observed
at the side of the aromatic ring (Tables 2 and 3). The phenyl ring E is nearly coplanar with the ring F
(torsion C2E–C1E–C4–C3 14.6(6)◦). The complex [Pd(6q)Cl2] is an example of metallacycles, which
are known to be reactive intermediates in a catalysis. This five-membered ring is formed by one Pd,
two P and two C atoms and has the shape of an envelope with the C12 atom located at the flap,
which deviates by 0.835(4) Å from the mean plane of Pd1–P1–C11–P1′. The puckering amplitude
(maximum out-of-plane deviation) q2 calculated for this metallacycle was 1.142(5) Å and the phase
angle describing the puckering (phase shift) Φ2 was 153.8(1)◦ [20]. The Pd metal center has a planar
square coordination with two cis-located Cl atoms. Ligand 6q acts as a chelating bidentate agent
forming two Pd–P coordination bonds of lengths equal to 2.2463(8) and 2.2722(9) Å. There are no
classic hydrogen bonds in the crystal structure. The molecules interact through C–H . . . Cl contacts
and T-shaped π . . . π interactions (Table 4, Figure 3).
Figure 2. The molecular structure of the complex [Pd(6q)Cl2].
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Table 2. Bond lengths (Å) and valence angles (◦) for [Pd(6q)Cl2].
Bond Length Angle Value
Pd1-Cl1 2.3452(12) P1-Pd1-P1′ 88.62(3)
Pd1-Cl2 2.3337(10) P1-Pd1-Cl1 175.85(4)
Pd1-P1′ 2.2463(8) P1-Pd1-Cl2 89.30(4)
Pd1-P1 2.2722(9) C1A-P1-Pd1′ 120.58(13)
P1′-C1A 1.812(4) C1A-P1′-C12 107.45(17)
P1′-C1B 1.802(4) C1B-P1′-Pd1 113.58(12)
P1‘-C12 1.824(3) C1B-P1′-C1A 105.59(18)
P1-C1C 1.820(4) C1B-P1′-C12 108.17(16)
P1-C1D 1.811(4) C12-P1′-Pd1 100.75(11)
P1-C11 1.836(3) C1C-P1-Pd1 118.19(13)
C1-C2 1.537(5) C1C-P1-C11 105.81(16)
C1-C12 1.563(4) C1D-P1-Pd1 114.56(14)
C1-C13 1.539(4) C1D-P1-C1C 103.96(18)
C1E-C4 1.477(6) C1D-P1-C11 110.03(16)
C2-C3 1.525(4) C11-P1-Pd1 103.92(11)
C2-C9 1.602(5)
C3-C4 1.388(5) The valence angles of the four-membered ring
C3-C8 1.386(5) C2-C3-C8 93.9(3)
C4-C5 1.406(5) C3-C8-C9 94.2(3)
C5-C6 1.389(6) C8-C9-C2 85.8(3)
















Table 4. The geometry of intermolecular interactions in the [Pd(6q)Cl2] (Å,◦) crystal.
D–H . . . A D–H D...A H...A <D–H...A
C2C-H2C . . . Cl2 0.93 3.482(4) 2.73 139
C6-H6 . . . Cl2 i 0.93 3.557(4) 2.87 132
C6E-H6E . . . Cl1 i 0.93 3.623(4) 2.76 154
C7-H7 . . . Cl1 ii 0.93 3.756(4) 2.99 141
C3B-H3B . . . Cg1 ii 0.93 3.689(5) 2.77 169
C5B-H5B . . . Cg2 iii 0.93 3.521(4) 2.71 146
Symmetry codes: i −1 + x, y, z; ii − 12 + y, 12 − x, 14 + z; iii −1 + y, 1 + x, 1 − z. Cg1 ring centroid C1E-C6E; Cg2 ring
centroid C1A-C6A.
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Figure 3. T-shaped π . . . π interactions in the complex [Pd(6q)Cl2].
2.5. Geometry of Five-Membered Metallacycles of the Transition Metals and Bis(phosphine) Ligands Found in
the Cambridge Structural Database (CSD)
In order to better understand the reactivity and stereochemistry of the bis(phosphane)
metalorganic catalysts, a search of the CSD [21] for the structures of five-membered metallacycles with
a transition metal and the P–C(HC)–C(HC)–P fragment of bis(phosphane) has been performed. It gave
a result of 120 hits, 27 of which were the structures of complexes with Pd (CSD Refcodes: DEPXAX,
GEPQUN, HOGBUA, MIDPIY, MIDPOE, NEXHOP, NIDYIK, NURKAM, OFAQET, OFAQIX, OFAQUJ,
OKOHAX, PAQBIS, PAQBOY, POPZEA, QELSAB, QUBGID, QUBGOJ, RIYGUB, RONPOZ, RUDJAC,
RUNVUR, TESBEZ, TIYPAS, VASXUI, WORDIQ and YOBWUH).
The endocyclic torsion angles characterising this system are summarised in Table 5, and the
distribution of their absolute values is presented in Figure 4. There is a clear difference in the
most frequently occurring values. The dihedral angles T4 and the corresponding one T5 (C–P–Tr–P)
were most frequently synperiplanar, whereas torsions T1–T3 were usually synclinal. In most of
the structures, the metallacycle had a conformation of an envelope, as in the presented complex
[Pd(6q)Cl2], with the exception of five entries where the ring was almost flat (CSD Refcodes:
EQUDEA (Ru), HAYREE (Pt), HAYRII (Pt), VISRAR (Os) and ZOVCIY (Fe)) [22,23]. Usually, one
of the carbon atoms was located at the envelope flap (the same as in [Pd(6q)Cl2]), providing
a favourable tetragonal flat coordination environment near the metal atom and the asymmetric
structure of the metallacycle. Only in three palladium complexes was the metal atom positioned
at the flap instead of the carbon atom (in the structures where the carbon atoms belonged to the
four-membered hydrocarbon ring and the exocyclic H–C–C–H torsion indicated a cis configuration;
CSD Refcodes: NIDYIK, QUBGID and QUBGOJ) [24,25]. However, in analogous Pd complexes with
the four-membered hydrocarbon ring and the trans configuration at the same torsion, the metallacycle
ring had, as usual, a carbon atom at the envelope flap (CSD Refcodes: OFAQET, OFAQIX and
OFAQUJ) [26]. This asymmetry observed in the metallacycle structure is probably beneficial for
transition-metal-promoted asymmetric transformations.
The analysis of the orientation of the H atoms within the metallacycle showed that cis
stereoisomers were nearly half of the hits (54 of 120). In the presented complex [Pd(6q)Cl2],
the H–C–C–H torsion showed the trans configuration. To illustrate the differences within this group of
crystal structures, they were divided into four subsets according to the value of the H–C–C–H torsion.
There were 17 hits with synperiplanar torsions, 37 synclinal, 6 anticlinal and 60 antiperiplanar as in the
presented complex [Pd(6q)Cl2] (Tables 2–5). The results showed that the most frequent conformation
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for the five-membered metallacycles of transition metals and bis(phosphane) ligands was the envelope
type conformation, regardless of the transition metal and phosphine substituent types.
Table 5. Absolute values of the endo- and exocyclic torsions within the five-membered metallacycles
found in the Cambridge Structural Database (CSD).
Code Torsion Minimum Maximum Mean
abs(T1 or T3) Tr–P–C–C 0.733 60.136 36.141
abs(T2) P–C–C–P 0.353 69.677 44.108
abs(T4 or T5) P–Tr–P–C 0.921 44.906 17.174
abs(T6) H–C–C–H 0.164 179.96 113.52
T1–T5, endocyclic torsion angles defined in Figure 4; Tr, transition metal.
Figure 4. Distribution of the torsion values T1–T5 in the structures of five-membered metallacycles in
the complexes of transition metals (Tr) with bis(phosphane) ligands found in the CSD.
2.6. Quantum Chemical Considerations
The quantum chemical calculation performed at the M062x/LANL2DZ theoretical level [27,28],
which is specially dedicated to precise energetic considerations and has recently been applied
in the simulation of energetic and structural analyses of molecules with similar structural
moieties [29–33], allows us to compare the geometry of the molecules of phosphines 6, their dioxides
and complexes that were not crystallised in crystals, well-measurable by a single crystal X-ray
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diffraction. The geometry optimisation for the structure [Pd(6q)Cl2] was therefore performed and
the obtained geometry parameters of [Pd(6q)Cl2]calc were compared with those received from the
X-ray diffraction experiments for [Pd(6q)Cl2]xray. It was found that all key interatomic distances
(Table 6) are characterised by the values that are typical for the respective bonds in similar organic
moieties [13,33–35]. The comparison of the obtained geometries with the respective X-ray structures
confirms that the density functional theory (DFT) calculations at the M062x/LANL2DZ theoretical
level illustrate well the key structural aspects of the considered complexes.






A/B 73.3 81.5 81.3 68.9 70.0
C/D 74.3 67.4 67.6 66.7 65.5
B/C 39.6 39.3 43.7 4.2 8.2
A/D 39.3 45.1 39.9 45.4 44.5
Torsion angle, (◦)
C3-C4-C1E-C2E 14.6 30.4 na 29.3 na
P1-C11-C12-P2 −61.2 −67.2 −66.9 −101.5 −103.8
Bond lengths, (Å)
C1-C2 1.537(5) 1.551 1.552 1.550 1.550
C2-C3 1.525(4) 1.529 1.530 1.532 1.532
C3-C4 1.388(5) 1.397 1.390 1.397 1.391
C4-C5 1.406(5) 1.417 1.415 1.418 1.415
C5-C6 1.389(6) 1.406 1.408 1.406 1.407
C6-C7 1.394(6) 1.414 1.413 1.414 1.414
C7-C8 1.374(5) 1.390 1.392 1.391 1.391
C8-C3 1.386(5) 1.403 1.406 1.405 1.407
C8-C9 1.525(5) 1.533 1.532 1.530 1.531
C9-C2 1.602(5) 1.606 1.608 1.600 1.602
C9-C10 1.540(5) 1.549 1.550 1.547 1.546
C10-C11 1.545(4) 1.550 1.549 1.552 1.551
C11-C12 1.555(5) 1.561 1.561 1.564 1.566
C12-C1 1.563(4) 1.560 1.563 1.555 1.555
C1-C13 1.539(5) 1.552 1.552 1.549 1.550
C13-C10 1.550(5) 1.562 1.562 1.555 1.554
C12-P1 1.823(5) 1.881 1.881 1.872 1.878
C11-P2 1.836(5) 1.883 1.884 1.859 1.850
Pd-Cl1 2.345 (1) 2.423 2.425 na na
Pd-Cl2 2.334(1) 2.420 2.419 na na
Pd-P1 2.246 (1) 2.381 2.379 na na
Pd-P2 2.272(1) 2.380 2.379 na na
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The fitting of molecular structures [Pd(6q)Cl2]xray and [Pd(6q)Cl2]calc clearly shows in which
fragments the differences are observed (Figure 5). The molecular overlay indicates that, due to
its rigidity, the polycyclic skeleton is identical both in the experimental and theoretical models.
Thus, some minor differentiation is observed in the position of the phenyl substituted at the phosphorus
atom. This could be explained by the fact that the calculation of a single molecule in vacuum, also with
a consideration of a solvent, cannot correctly reflect all crystal net forces influencing the geometry of a
molecule in a solid state. The structural comparison is summarised in Table 6. The comparison of the
theoretical model and the experimental structure proved that there is a high degree of similarity of
their geometries in the polycyclic core.
Figure 5. The structural overlay of the molecules of the coordination compounds [Pd(6q)Cl2]xray and
[Pd(6q)Cl2]calc: front and side views. Black: measured X-ray structure [Pd(6q)Cl2]xray, white: calculated
geometry of [Pd(6q)Cl2]calc. The fragments that match are marked with thin lines.
Moreover, analogous DFT calculations for the complex [Pd(6a)Cl2]calc and bis(phosphane)
dioxides 4a and 4q were carried out to investigate the influence of the substitutes on the skeleton
geometry. All geometries (experimentally determined and optimised using DFT calculations) were
compared with each other. Selected bond lengths and angles are summarised in Table 6.
We found a regularity regarding the calculated bonds lengths of the molecules: they are slightly
larger than the measured ones. This is a normal phenomenon, considering the fact that the calculation
concerns an isolated molecule [36]. The key bond lengths and other geometrical parameters in
[Pd(6q)Cl2]calc and [Pd(6a)Cl2]calc and the 4q and 4a molecules are the same (within 3σ). The presence of
a phenyl substituent in [Pd(6q)Cl2]calc does not have any influence on the geometry of the hydrocarbon
polycyclic fragment. In the crystal structure [Pd(6q)Cl2]xray, the phenyl ring E is nearly coplanar
with the skeleton moiety (ring F, torsion 14.6◦), while in the optimised model of [Pd(6q)Cl2]calc,
the corresponding planes are twisted by 30◦. The coplanarity of these fragments is stabilised in the
crystal by the C-H···Cl bonds in which the carbon atoms of the phenyl ring are involved, and, therefore,
it could not have been observed in the cases of isolated single molecules nor in the solution.
Some minor differences in the torsion angle P1-C11-C12-P2 were found in the geometries of
molecules 4q and 4a in comparison to those of the complexes [Pd(6q)Cl2]calc and [Pd(6a)Cl2]calc.
A smaller value of this parameter in the complex results from the necessity of flattening this molecular
fragment in the palladium complexation process, but not from introducing a substituent in position C4
of the polycyclic core of the ligand. Differences in the molecular structures related to the position of
the phenyl rings, which are caused by a free rotation around the P-1CPh σ-bonds, are not essential for
the catalytic efficiency of the ligand-derived palladium complexes.
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To summarise, different substitutions did not affect the stereochemistry of the polycyclic
hydrocarbon moiety of the molecules. The main structural differences were observed in the orientation
of the phenyl substituents attached to the phosphorus atoms that were involved in the thermal
movements around single P-C bonds. Even the complexation of the ligand with palladium did not
significantly change the rigid geometry of the ligands. Thus, such unique stereometrical properties of
the ligands allow us to extrapolate, via computer modelling, the geometry of the selected measured
structures to the stereometry of other ligands in this group.
2.7. The Evaluation of the Efficiency of the Ligand 6q Palladium Complexes in the Asymmetric Catalysis
The potential of bis(phosphane) ligand 6q was examined in a model Pd-catalysed allylic alkylation
reaction between rac-(E)-1,3-diphenylallyl acetate and dimethyl malonate using BSA/KOAc and
K2CO3/Cs2CO3 as bases in THF at ambient temperature (Table 7). The catalyst was generated in situ
by pre-mixing allylpalladium(II) chloride dimer with 6q in THF at ambient temperature for 30 min.
The palladium-to-ligand ratios were 2/1 and 1/2. To our delight, bis(phosphane) 6q proved to be
suitable for the asymmetric allylic alkylation reaction, giving the alkylated product in excellent yields
and with very good enantioselectivity (up to 90% ee). The results of the optimisation study show
that the phosphine palladium complex obtained in the reaction with stoichiometry P/Pd = 1/1 was
more beneficial in terms of the stereoselectivity of the reaction (Table 7, entry 1). Thus, it was proven
that, in a benchmark asymmetric allylic alkylation reaction, the catalyst derived from the new R,R-6q
phosphane was slightly more efficient than parent NORPHOS.
The enantiomeric composition and S- absolute configuration of the product of the model
asymmetric reaction were determined by the peak integration and elution order from chiral HPLC
using a Chiralcel OD-H column [37].
Table 7. The model asymmetric allylic substitution reaction.
Entry Ligand, mol% [Pd(allyl)Cl]2, mol% Base Yield, % ee, %
1 2.0 (R,R-6q) 2.0 BSA */KOAc 97 90 **
2 4.0 (R,R-6q) 1.0 BSA/KOAc 98 67
3 2.0 (R,R-6q) 2.0 Cs2CO3/K2CO3 97 81
4 2.0 (R,R-6q) 2.0 Cs2CO3 96 83
5 2.0 (R,R-1) 2.0 BSA/KOAc 95 87
6 2.0 (R,R-1) 2.0 Cs2CO3 92 85
7 1.2 (S,S-1) 0.5 NaH 80 81 ***
6q (2.0 or 4.0 mol%), [Pd(allyl)Cl]2 (1.0 or 2.0 mol%), THF (1.0 mL), 30 min; next 1,3-diphenylallyl acetate
(0.5 mmol), THF (1.0 mL), dimethyl malonate (1.5 mmol), base (1.5 mmol), 12 h, ambient temperature.
* BSA = bis(trimethylsilyl)acetamide. ** [α]20D = −14.8 (c = 1.3, CHCl3). *** Reported previously [38].
3. Materials and Methods
3.1. General Information
Unless specified otherwise, all starting materials and solvents were used as obtained from
commercial suppliers without further purification. Organic solvents used in this study were dried over
appropriate drying agents and distilled prior to use. Thin layer chromatography (TLC) was carried
out using Merck silica gel 60 F254 plates (Merck, Kenilworth, NJ, USA). Visualisation of the TLC plates
was performed by UV light, either KMnO4 or I2 stains. The NMR spectra were recorded on a Bruker
Avance 500 MHz spectrometer, while chemical shifts are reported in ppm and calibrated to the residual
solvent peaks at 7.27 ppm and 77.00 ppm for 1H and 13C, respectively, in CDCl3 or internal reference
compounds. A similar technique was applied recently for the structural analysis of many norbornene
systems [39,40]. The following abbreviations are used in reporting NMR data: s (singlet), d (doublet),
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t (triplet), q (quartet), m (multiplet), br (broad). Coupling constants (J) are given in Hz. The spectra
are reported as follows: chemical shift (δ, ppm), multiplicity, integration, coupling constants (Hz).
The IR spectra were recorded on a Nicolet 8700A FTIR-ATR spectrometer; wave numbers are in cm-1.
Products were purified by flash chromatography on silica gel 60 (230–400 mesh) using a BUCHI
chromatograph. The X-ray diffraction intensities were collected at room temperature on a SuperNova
X-ray diffractometer equipped with an Atlas S2 CCD detector using mirror-monochromatised CuKα
radiation (λ = 1.54184 Å). Low- and high-resolution mass spectra were obtained with a Shimadzu
LC-MS (Kinetex® 2.6 μm Biphenyl 100 Å 50 × 2.1 mm LC-column, acetonitrile/water with the HCO2H
additive mobile phase) IT-TOF spectrometer. Commercially unavailable substrates were obtained
by known literature procedures. The physical properties and spectra of the obtained products are
available free of charge in the Supplementary Data.
3.2. Synthesis and Spectral Data
3.2.1. Typical Procedure for the Coupling Reaction Leading to the Formation of
[(1R,2R,9S,10S,11R,12R)-4-phenyltetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-
diyl]bis(diphenylphosphane) dioxide (R,R-4q)
(R,R)-1 (1.0g, 1.54 mmol), 2q (1.84 mmol), Cs2CO3 (4.63 mmol) and Pd(PPh3)4 (0.07 mmol) were
placed in a Schlenk tube under argon. Dry DMF was added (15 mL) and the mixture was stirred at
105 ◦C for 18–24 h. Then, the mixture was cooled down to root temperature (RT). The solvent was
evaporated under reduced pressure, and 50 mL of water was added. The products were extracted in
DCM (3 × 30 mL). The combined organic phase was dried over MgSO4, filtered and the solvent was
evaporated. The product was purified by silica-gel column chromatography (Hexane/iPrOH 50/1)
and finally crystallised from the mixture of hexane/DCM. The compound was isolated in 98% yield as
a white solid, m.p.: 255–258 ◦C, [α]20D = +79.4 (c = 0.45, CHCl3),
31P-NMR (202 MHz, CDCl3): δ = 32.5
(d, J = 10.1), 28.7 (d, J = 10.1), 1H-NMR (500 MHz, CDCl3): δ = 8.68–8.65 (m, 2H, Ar-H), 7.99–7.42
(m, 20H, Ar-H), 7.13–7.06 (m, 5H, Ar-H), 6.83 (d, 1H, J = 10.0, Ar-H), 4.29 (s, 1H, CH), 3.93–3.83
(m, 2H, CH), 3.52–3.47 (m, 1H, CH), 2.61 (d, 2H, J = 5.0, CH), 1.90 (d, 1H, J = 10.0, CH), 1.01–0.85
(m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 145.3, 141.8, 137.3, 134.1, 133.4, 132.1, 132.0, 131.9, 131.2,
130.9, 130.6, 130.5, 130.4, 130.1, 130.0, 128.8, 128.7, 128.5, 128.5, 128.5, 128.4, 128.3, 128.2, 127.1, 127.0,
126.8, 126.5, 126.1, 125.1, 120.7, 50.0, 49.9, 48.3 (d, J = 6.2), 41.8, 40.4, 38.4, 37.5, 32.8 (d, J = 12.5), LCMS
(ESI) [M + H]+ = 647 Da, HRMS calcd. for C43H36O2P2 647.2259, found 647.2263 (diff. 1.18 ppm).
3.2.2. 1,2,3,4,4a,12b-Hexahydro-1,4-methanotriphenylene-2,3-diylbis(diphenylphosphane)
dioxide (rac-3a)
The compound was isolated in 69% yield as a white solid. The analysis of the product spectra
confirmed its identity with literature data [12].31P-NMR (202 MHz, CDCl3): δ = 31.60 (d, J = 10.1),
28.78 (d, J = 10.1), 1H-NMR (500 MHz, CDCl3): δ = 7.98–7.96 (m, 2H, Ar-H), 7.86–7.85 (m, 2H, Ar-H),
7.76–7.72 (m, 2H, Ar-H), 7.64–7.50 (m, 10H, Ar-H), 7.17–7.05 (m, 10H, Ar-H), 6.81–6.78 (m, 2H, Ar-H),
5.22 (d, 1H, J = 2.0, Ar-H), 4.00 (d, 1H, J = 4.0, CH), 3.95–3.87 (m, 1H, CH-P), 3.86–3.80 (m, 1H, CH-P),




The compound was isolated in 83% yield as a white solid, m.p.: 208–213 ◦C. 31P-NMR (202 MHz,
CDCl3): δ = 32.4 (d, J = 8.08), 28.7 (d, J = 6.06), 1H-NMR (500 MHz, CDCl3): δ = 7.87–7.76 (m, 15H, Ar-H),
7.11–6.55 (m, 8H, Ar-H), 3.93 (s, 1H, CH), 3.87–3.83 (m, 1H, CH), 3.56 (s, 1H, CH), 3.31–3.27 (m, 1H, CH),
2.34 (d, 1H, J = 10.0, CH2), 2.24 (s, 3H, CH3), 2.03 (s, 1H, CH), 1.84 (d, 1H, J = 10.0, CH2), 1.00–0.95
(m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 144.0 (d, J = 3.7), 142.0, 137.1, 134.3, 135.1, 134.4,
134.0, 133.6, 133.3, 132.6, 131.8, 131.2, 131.0, 130.8, 130.5, 130.4, 130.2, 130.1, 129.8, 128.7, 128.6, 128.5,
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128.4, 128.3, 128.2, 128.2, 122.6, 121.4, 50.0 (d, J = 15.0), 45.2 (d, J = 6.2), 41.6 (d, J = 6.2), 38.3, 37.8,
32.5 (d, J = 12.5), 21.9 LCMS (ESI) [M + H]+ = 585 Da, HRMS calcd. for C38H34O2P2 585.2119, found
585.2108 (diff. 1.18 ppm).
3.2.4. (4-Methoxytetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-diyl)bis(diphenylphosphane)
dioxide (rac-4c)
The compound was isolated in 76% yield as a white solid, m.p.: 276–278 ◦C. 31P-NMR (202 MHz,
CDCl3): δ = 32,4 (s), 28.3 (s), 1H-NMR (500 MHz, CDCl3): δ = 7.87–7.79 (m, 4H, Ar-H), 7.55–7.42
(m, 11H, Ar-H), 7.07–7.00 (m, 7H, Ar-H), 6.56 (d, 1H, J = 5.0, Ar-H), 6.45 (d, 1H, J = 5.0, Ar-H),
4.08 (s, 1H, CH), 3.92–3.78 (m, 1H, CH), 3.59 (s, 1H, CH), 3.38–3.30 (m, 1H, CH), 2.93 (s, 3H, OCH3),
2.58 (s, 1H, CH), 2.42 (s, 1H, CH), 1.99–1.97 (m, 1H, CH), 2.31 (s, 3H, CH3), 2.27 (s, 3H, CH3), 2.11–2.09
(m, 1H, CH), 1.15 (s, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 153.2, 146.6, 131.4, 131.3, 131.0, 130.8,
130.5, 130.0, 1329., 128.8, 128.5, 128.4, 128.3, 126.6, 115.6, 114.5, 55.6, 53.4, 45.9, 43.4, 41.5 LCMS (ESI)
[M + H]+ = 601 Da, HRMS calcd. for C38H34 O3P2 601.2056, found 601.2067 (diff. 1.18 ppm).
3.2.5. (4-Methyltetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-diyl)bis(diphenylphosphane)
dioxide (rac-4f)
The compound was isolated in 85% yield as a white solid, m.p.: 270–275 ◦C. 31P-NMR (202 MHz,
CDCl3): δ 32.3 (d, J = 8.08), 28.5 (d, J = 8.08), 1H-NMR (500 MHz, CDCl3): δ = 7.87–7.77 (m, 4H, Ar-H),
7.65–7.45 (m, 11H, Ar-H), 7.17–7.00 (m, 7H, Ar-H), 6.86 (d, 1H, J = 5.0, Ar-H), 6.65 (d, 1H, J = 5.0, Ar-H),
3.93 (s, 1H, CH), 3.81–3.75 (m, 1H, CH), 3.54 (s, 1H, CH), 3.34–3.30 (m, 1H, CH), 2.43 (s, 2H, CH2), 1.90
(d, 1H, J = 10.0, CH), 1.65 (s, 1H, CH3), 1.01–0.97 (m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 144.1
(d, J = 3.7), 143.7, 135.4, 134.7, 134.1, 133.6, 133.4, 132.4, 131.7, 131.4, 131.3, 130.9, 130.7, 130.6, 130.5,
130.1, 130.0, 128.7, 128.6, 128.5, 128.3, 128.3, 128.3, 128.2, 128.2, 127.9, 49.9 (d, J = 3.7), 45.5, 41.3, 40.9,
38.4, 37.8, 32.6 (d, J = 13.7), 15.7 LCMS (ESI) [M + H]+ = 585 Da, HRMS calcd. for C38H34 O2P2 585.2119,
found 585.2107 (diff. 1.18 ppm).
3.2.6. (4-Chlorotetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-diyl)bis(diphenylphosphane)
dioxide (rac-4g)
The compound was isolated in 54% yield as a white solid, m.p.: 250–254 ◦C. 31P-NMR
(202 MHz, CDCl3): δ = 32.2 (d, J = 6.06), 28.7 (d, J = 8.08), 1H-NMR (500 MHz, CDCl3): δ = 7.87–7.73
(m, 4H, Ar-H), 7.67–7.46 (m, 11H, Ar-H), 7.17–7.03 (m, 7H, Ar-H), 6.77 (d, 1H, J = 10.0, Ar-H),
4.03 (s, 1H, CH), 3.83–3.77 (m, 1H, CH), 3.58 (s, 1H, CH), 3.33–3.29 (m, 1H, CH), 2.41 (s, 2H, CH2),
1.93 (d, 1H, J = 10.0, CH), 1.65 (s, 1H, CH), 0.98–0.95 (m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 145.1
(d, J = 3.7), 142.6, 134.7, 134.3, 133.9, 133.7, 133.5, 133.0, 132.2, 131.4 (d, J = 2.5), 131.3 (d, J = 2.5), 131.2
(d, J = 2.5), 130.9 (d, J = 2.5), 130.6, 130.5, 130.4, 130.4, 129.4, 129.3, 128.7, 128.7, 128.6, 128.5, 128.3, 127.5,
127.4, 126.9, 126.8, 120.5, 50.0 (d, J = 2.5), 49.3(d, J = 15), 45.7 (d, J = 6.2), 41.3(d, J = 3.7), 40.4, 38.2,
37.6, 32.6 (d, J = 12.5) LCMS (ESI) [M + H]+ = 605 Da, HRMS calcd. for C37H31O2P2Cl 605.1561, found
605.1561 (diff. 1.18 ppm).
3.2.7. (4,6-Dimethyl-5-nitrotetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-
diyl)bis(diphenylphosphane) dioxide (rac-4h)
The compound was isolated in 86% yield as a white solid, m.p.: 302–304 ◦C. 31P-NMR (202 MHz,
CDCl3): δ = 32.3 (d, J = 8.08), 28.6 (d, J = 10.0), 1H-NMR (500 MHz, CDCl3): δ = 7.88–7.76 (m, 4H, Ar-H),
7.64–7.47 (m, 11H, Ar-H), 7.16–7.01 (m, 5H, Ar-H), 6.65 (s, 1H, Ar-H), 3.94 (d, 1H, J = 5.0, CH),
3.84–3.78 (m, 1H, CH), 3.54 (d, 1H, J = 5.0, CH), 3.34–3.30 (m, 1H, CH), 2.41 (d, 2H, J = 10.0, CH2),
2.10 (s, 3H, CH3), 1.97 (d, 1H, J = 10.0, CH), 1.60 (s, 1H, CH3), 1.00–0.95 (m, 1H, CH), 13C-NMR
(125 MHz, CDCl3): δ = 151.5, 145.0 (d, J = 3.7), 142.4, 135.1, 134.3, 134.1, 133.6, 133.5, 132.8, 132.0, 131.5
(d, J = 2.5), 131.4 (d, J = 2.5), 131.2 (d, J = 2.5), 130.9 (d, J = 2.5), 130.6, 130.5, 130.4, 130.0, 129.8, 128.7,
128.7, 128.5, 128.4, 128.3, 128.3, 128.2, 123.8, 122.7, 49.3 (d, J = 15.0), 45.2(d, J = 6.2), 45.7 (d, J = 6.2),
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41.3, 40.4, 38.3, 37.7, 32.6(d, J = 12.5) LCMS (ESI) [M + H]+ = 644 Da, HRMS calcd. for C39H35NO4P2
644.2120, found 644.2114 (diff. 1.18 ppm).
3.2.8. (5-Methoxytetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-11,12-diyl)bis(diphenylphosphane)
dioxide (rac-4i)
The compound was isolated in 18% yield as a white solid, m.p.: 279–285 ◦C. 31P-NMR
(202 MHz, CDCl3): δ = 32.4(d, J = 8.08), 28.8 (d, J = 10.0), 1H-NMR (500 MHz, CDCl3): δ = 7.87–7.76
(m, 15H, Ar-H), 7.12–6.47 (m, 8H, Ar-H), 4.03 (d, 1H, J = 35.0, CH), 3.88–3.83 (m, 1H, CH), 3.70
(s, 1H, OCH3), 3.59 (d, 1H, J = 35.0, CH), 3.31–3.27 (m, 1H, CH), 2.49–2.33 (m, 2H, CH2), 1.00–0.95
(m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 159.7, 145.3, 134.3, 133.9, 133.5, 133.2, 132.9, 132.5, 132.1,
132.0, 131.9 (d, J = 6.2), 131.1, 131.6, 130.5, 130.4, 130.2, 130.1, 128.7, 128.6, 128.5, 128.4, 128.3 (d, J = 2.5),
128.2 (d, J = 2.5), 127.6, 127.4, 122.8, 122.01, 114.2, 55.3, 50.4 (d, J = 13.5), 49.8 (d, J = 13.5), 46.7, 45.7, 38.5,




The compound was isolated in 84% yield as a white solid, m.p.: 169–171 ◦C. 31P-NMR
(202 MHz, CDCl3): δ = 32.7 (d, J = 8.08), 29.1 (d, J = 8.08), 1H-NMR (500 MHz, CDCl3): δ = 7.87–7.76
(m, 15H, Ar-H), 7.12–6.47 (m, 8H, Ar-H), 4.03 (d, 1H, J = 35.0, CH), 3.88–3.83 (m, 1H, CH),
3.70 (s, 1H, OCH3), 3.59 (d, 1H, J = 35.0, CH), 3.31–3.27 (m, 1H, CH), 2.49–2.33 (m, 2H, CH2), 1.00–0.95
(m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 167.3, 151.0, 144.0 (d, J = 3.7), 135.0, 134.2, 134.1, 133.6,
133.3, 133.3, 132.9, 132.4, 131.7, 130.5, 130.4, 130.4, 130.3, 130.2, 130.1, 129.7, 129.6, 129.9, 129.5, 128.7,
128.6, 128.5, 128.5, 128.3, 128.3, 128.3, 128.2, 123.1, 122.9, 122.0, 121.8, 51.9, 50.0 (d, J = 13.7), 47.9, 41.1,




The compound was isolated in 51% yield as a white solid. The analysis of the product spectra
confirmed its identity with literature data [12]. 31P-NMR (202 MHz, CDCl3): δ = 31.10 (d, J = 10.1),
28.81 (d, J = 8.1), 1H-NMR (500 MHz, CDCl3): δ = 8.50 (d, 1H, J = 10.0, Ar-H), 7.97–7.93 (m, 2H, Ar-H),
7.88–7.85 (m, 2H, Ar-H), 7.74 (d, 1H, J = 5.0, Ar-H), 7.74–7.48 (m, 11H, Ar-H), 7.17–7.04 (m, 6H, Ar-H),
6.86 (d, 1H, J = 10.0, Ar-H), 5.26 (d, 1H, J = 10.0, Ar-H), 4.12 (d, 1H, J = 10.0, CH), 3.95–3.90 (m, 1H, CH-P),
3.87–3.81 (m, 1H, CH-P), 3.93 (s, 3H, CH3), 3.92 (s, 3H, CH3), 3.75 (d, 1H, J = 10.0, CH), 2.64 (s, 1H, CH),
2.42 (d, 1H, J = 10.0, CH2), 2.02 (d, 1H, J = 10.0, CH2), 1.94 (s, 1H, CH). The HNMR spectrum is in
agreement with the literature [12].
3.2.10. [7,10-Bis(trifluoromethyl)-1,2,3,4,4a,12b-hexahydro-1,4-methanotriphenylene-
2,3-diyl]bis(diphenylphosphane) dioxide (rac-3k)
The compound was isolated in a yield of up to 67% as a white solid. The analysis of the product
spectra confirmed its identity with literature data [12]. 31P-NMR (202 MHz, CDCl3): δ = 31.04 (d, J = 8.1),
28.84 (d, J = 8.1), 1H-NMR (500 MHz, CDCl3): δ = 7.89–7.70 (m, 6H, Ar-H), 7.58–7.41 (m, 10H, Ar-H),
7.26 (d, 1H, J = 10.0, Ar-H), 7.10–6.97 (m, 7H, Ar-H), 6.81 (d, 1H, J = 10.0, Ar-H), 5.22 (d, 1H, J = 10.0,
Ar-H), 4.02 (d, 1H, J = 10.0, CH), 3.83–3.76 (m, 1H, CH-P), 3.76–3.70 (m, 1H, CH-P), 3.67 (d, 1H,
J = 10.0, CH), 2.54 (s, 1H, CH), 2.32 (d, 1H, J = 10.0, CH2), 1.97 (d, 1H, J = 10.0, CH2), 1.25–1.19
(m, 1H, CH). The HNMR spectrum is in agreement with the literature [12].
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3.2.11. [7,10-Bis(trimethylsilyl)-1,2,3,4,4a,12b-hexahydro-1,4-methanotriphenylene-
2,3-diyl]bis(diphenylphosphane) dioxide (rac-3l)
The compound was isolated in a yield of 63% as a white solid. The analysis of the product spectra
confirmed its identity with literature data [12]. 31P-NMR (202 MHz, CDCl3): δ = 31.12 (d, J = 6.1),
28.60 (d, J = 10.1), 1H-NMR (500 MHz, CDCl3): δ = 7.98–7.93 (m, 4H, Ar-H), 7.67–7.51 (m, 10H, Ar-H),
7.21–7.05 (m, 6H, Ar-H), 6.93 (d, 1H, J = 5.0, Ar-H), 6.78 (d, 1H, J = 10.0, Ar-H), 5.22 (d, 1H, J = 10.0, Ar-H),
4.03 (d, 1H, J = 10.0, CH), 3.94–3.89 (m, 1H, CH-P), 3.85–3.81 (m, 1H, CH-P), 3.68 (d, 1H, J = 10.0, CH),
2.64 (s, 1H, CH), 2.48 (d, 1H, J = 10.0, CH2), 1.96 (d, 1H, J = 10.0, CH2), 1.66 (s, 1H, CH), 0.28 (s, 9H, CH3),
0.26 (s, 9H, CH3). The HNMR spectrum is in agreement with the literature [12].
3.2.12. 6b,7,8,9,10,10a-Hexahydro-7,10-methanobenzo[a]biphenylene-
8,9-diylbis(diphenylphosphane) dioxide (rac-4m)
The compound was isolated in 68% yield as a white solid, m.p.: 225–227 ◦C. 31P-NMR (202 MHz,
CDCl3): δ = 32.4 (d, J = 8.08), 28.7 (d, J = 6.06), 1H-NMR (500 MHz, CDCl3): δ = 7.96–7.48 (m, 16H, Ar-H),
7.36–6.28 (m, 4H, Ar-H), 7.19–7.03 (m, 6H, Ar-H), 6.83 (d, 1H, J = 10.0, Ar-H), 4.21 (d, 1H, J = 5.0,
CH), 3.87–3.81 (m, 1H, CH), 3.59 (d, 1H, J = 5.0, CH), 3.42–3.39 (m, 1H, CH), 2.57 (s, 1H, CH), 2.46
(d, 1H, J = 15.0, CH2), 1.88 (d, 1H, J = 15.0, CH2), 0.90–0.85 (m, 1H, CH), 13C-NMR (125 MHz, CDCl3):
δ = 145.9, 145.1, 142.6, 134.6, 134.2, 133.9, 133.7, 133.4, 133.3, 132.9, 132.2, 131.4, 131.3, 131.2, 130.9, 130.6,
130.5, 130.4, 130.4, 130.2, 130.1, 129.3, 128.8, 128.7, 128.6, 128.5, 128.3, 128.2, 127.5, 126.8, 120.5, 120.3,
49.8 (d, J = 15.0), 45.7 (d, J = 5.0), 41.3, 41.0, 40.4, 38.2, 37.7, 32.9 LCMS (ESI) [M + H]+ = 621 Da, HRMS
calcd. for C41H38O2P2 621.2139, found 621.2166 (diff. 1.18 ppm).
[5-(naphthalen-1-yl)bicyclo[2.2.1]heptane-2,3-diyl]bis(diphenylphosphane) dioxide (rac-5m)
This minor reaction product was detected in trace amounts in the reaction mixtures by means of
ESI-LC HRMS. HRMS calcd. for C41H36O2P2 623.2312, found 623.2263 (diff. 7.8 ppm).
3.2.13. (7-Methoxy-1,2,3,4,4a,10b-hexahydro-1,4-methanobenzo[b]biphenylene-
2,3-diyl)bis(diphenylphosphane) dioxide (rac-4n)
The compound was isolated in 53% yield as a white solid, m.p.: 209–214 ◦C. 31P-NMR
(202 MHz, CDCl3): δ = 32.4 (d, J = 8.08), 28.8 (d, J = 8.08), 1H-NMR (500 MHz, CDCl3): δ = 7.91–7.42
(m, 16H, Ar-H), 7.28–7.02 (m, 10H, Ar-H), 4.21 (d, 1H, J = 5.0, CH), 3.92–3.85 (m, 1H, CH),
3.88 (s, 1H, OCH3), 3.75 (d, 1H, J = 5.0, CH), 3.38–3.35 (m, 1H, CH), 2.60 (s, 1H, CH), 2.46 (d, 1H, J = 15.0,
CH2), 1.90 (d, 1H, J = 15.0, CH2), 1.08–1.05 (m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 156.7, 144.1,
141.8, 135.2, 135.1, 134.3, 133.9, 133.5, 133.2, 132.5, 131.7, 131.3, 131.1, 130.9, 130.6, 130.5, 130.4, 130.2,
130.1, 129.5, 129.4, 129.3, 128.7, 128.6, 128.5, 128.3, 128.2, 128.2, 120.0, 119.9, 119.0, 117.1, 106.6, 55.2, 50.3,
46.6, 42.9, 42.2, 39.9, 37.8, 32.9 LCMS (ESI) [M + H]+ = 651 Da, HRMS calcd. for C42H36O3P2 651.2206,
found 651.2212 (diff. 1.18 ppm).
3.2.14. 8c,9,10,11,12,12a-Hexahydro-9,12-methanobenzo[3,4]cyclobuta[1,2-l]phenanthrene-10,11-
diylbis(diphenylphosphane) dioxide (rac-4p)
The compound was isolated in 54% yield as a white solid, m.p.: 295–298 ◦C. 31P-NMR
(202 MHz, CDCl3): δ = 32.3 (d, J = 8.08), 28.8 (d, J = 8.08), 1H-NMR (500 MHz, CDCl3): δ = 8.68–8.65
(m, 3H, Ar-H), 7.99–7.42 (m, 20H, Ar-H), 7.13–7.06 (m, 6H, Ar-H), 6.83 (d, 1H, J = 10.0, Ar-H),
4.29 (s, 1H, CH), 3.93–3.83 (m, 2H, CH), 3.52–3.47 (m, 1H, CH), 2.61 (d, 2H, J = 5.0, CH),
1.90 (d, 1H, J = 10.0, CH), 1.01–0.85 (m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 139.3, 138.3
(d, J = 3.7), 135.5, 134.7, 134.4, 133.9, 133.6, 133.1, 132.3, 132.1, 132.0, 131.9 (d, J = 3.7), 131.4, 131.1, 130.9,
130.8, 130.7, 130.5, 130.2, 130.1, 128.7, 128.6, 128.5, 128.4, 128.3, 128.3, 127.8, 127.8, 126.6 (d, J = 3.7), 123.7
(d, J = 8.7), 122.6, 122.3, 49.2 (d, J = 15.0), 45.1 (d, J = 6.2), 40.4, 41.1, 38.7, 32.5 (d, J = 12.5), LCMS (ESI)
[M + H]+ = 671 Da, HRMS calcd. for C45H38O2P2 671.2281, found 671.2263 (diff. 1.18 ppm).
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[5-(phenanthren-9-yl)bicyclo[2.2.1]heptane-2,3-diyl]bis(diphenylphosphane) dioxide (rac-5p)
This minor reaction product was detected in trace amounts in the reaction mixtures by means of
ESI-LC HRMS. HRMS calcd. for C45H38O2P2 673.2422, found 673.2420 (diff. 0.3 ppm).
3.2.15. Synthesis of [(1R,2R,9S,10S,11R,12R)-4-Phenyltetracyclo[8.2.1.02,9.03,8]trideca-3,5,7-triene-
11,12-diyl]bis(diphenylphosphane) ((R,R)-6q)
One gram (1.0 g) of (R,R)-6q (1.54 mmol) and 10 mL of dry toluene were added to a Schlenk flask
and placed under a nitrogen atmosphere. Subsequently, 6 equiv. of SiHCl3 and then 18 equiv. of Bu3N
were added and the mixture was heated at 110 ◦C. After the reaction had been completed, the mixture
was cooled down and 30% NaOH solution was added drop-wise. The organic layer was dried over
Na2SO4 and the crude was subjected to column chromatography with the ethyl acetate/hexane system.
The phosphine was isolated as a white solid in 85% yield. [α]20D = −60 (c = 0.4; CHCl3); 31P-NMR
(202 MHz, CDCl3): δ = 2.53, 1.10, −11.09, −13.67; 1H-NMR (500 MHz, CDCl3): δ = 7.94–7.42 (m, 16H,
Ar-H), 7.23–7.02 (m, 11H, Ar-H), 6.83 (d, 1H, J = 5.0, Ar-H), 4.37 (s, 1H, CH), 3.99–3.93 (m, 1H, 2×CH),
3.69 (s, 1H, CH), 3.44–3.39 (m, 1H, CH), 2.70 (s, 1H, CH), 2.38 (d, 1H, J = 10.0, CH2), 1.90 (d, 1H, J = 10.0,
CH2), 1.05–1.03 (m, 1H, CH), 13C-NMR (125 MHz, CDCl3): δ = 145.8, 141.8, 137.3, 134.3, 133.1, 131.3,
131.3, 130.9, 130.6, 130.5, 130.4, 130.1, 130.0, 128.6, 128.5, 128.3, 128.2, 127.2, 126.8, 126.5, 126.0, 125.1,
124.8, 120.8, 51.4 (d, J = 13.7), 50.0 (d, J = 13.7), 48.3 (d, J = 6.2), 45.3 (d, J = 6.2), 41.8, 41.6, 40.4, 38.4, 38.1,
37.8, 37.5.
3.2.16. Synthesis of [Pd(6q)Cl2]
A solution of 6q (0.1 g) in benzene (2 mL) was added to a stirred solution of [Pd(t-BuCN)2Cl2]
(0.056 g) in 2 mL of THF. The reaction mixture was stirred overnight at ambient temperature, the volume
of the solvents was reduced under reduced pressure down to about 2 mL and the precipitated complex
was filtered off. The compound was isolated in 82% yield as a yellow solid. The samples for the
X-ray measurements were grown from a warm ethanol/benzene mixture. [α]20D = −40.8 (c = 0.25,
CH2Cl2); 31P-NMR (202 MHz, CDCl3): δ = 31.3, 31.2, 28.0, 27.9, 27.9, 27.8, 1H-NMR (500 MHz, CDCl3):
δ = 8.08–8.04 (m, 2H, Ar-H), 8.02–7.98 (m, 2H, Ar-H), 7.93–7.90 (m, 2H, Ar-H), 7.88–7.84 (m, 2H, Ar-H),
7.68–7.65 (m, 1H, Ar-H), 7.59–7.58 (m, 2H, Ar-H), 7.54–7.48 (m, 22H, Ar-H), 7.33–7.27 (m, 3H, Ar-H),
7.21–7.12 (m, 8H, Ar-H), 7.07–7.01 (m, 13H, Ar-H), 6.85 (d, 1H, J = 7.3, CH), 6.55 (d, 1H, J = 7.3,
CH), 4.12–4.11 (m, 1H, CH), 4.00–3.99 (m, 1H, CH), 3.96–3.87 (m, 1H, CH), 3.48–3.43 (m, 2H, CH),
2.66–2.66 (m, 1H, CH), 2.55–2.55 (m, 1H, CH), 2.36–2.34 (m, 1H, CH), 2.27–2.25 (m, 1H, CH), 1.77–1.75
(m, 1H, CH), 1.68–1.66 (m, 1H, CH), 0.75–0.74 (m, 2H, CH). 13C-NMR (dept 135, 125 MHz, CDCl3):
δ = 132.96, 131.81, 131.69, 131.63, 131.54, 131.53, 131.48, 131.46, 131.20, 131.14, 130.90, 130.84, 130.76,
130.70, 130.53, 130.46, 130.40, 130.25, 130.21, 130.18, 130.14, 129.49, 129/42, 129.34, 129.30, 129.28,
129.18, 129.09, 129.07, 128.98, 128.64, 128.62, 128.55, 128.53, 128.02, 127.63, 126.48, 125.96, 125.34, 124.75,
121.32, 121.10, 51.52, 51.41, 49.85, 49.73, 48.35, 48.31, 46.39, 46.35, 41.86, 41.61, 41.13, 41.10, 40.36, 40.18,
40.00, 39.84, 38.77, 38.74, 38.41, 38.36, 38.33, 38.19, 38.16, 37.87, 37.81, 37.77, 37.75, 32.26, 32.23, 32.17,
32.13. LCMS (ESI) [M − Cl]+ = HRMS calcd. for C43H36P2ClPd 755.1010 Da, found 755.1034 Da
(diff. 3.18 ppm).
3.2.17. General Procedure for Allylic Alkylation Reaction
A solution of ligand 6q (2.0 mol % or 4.0 mol %) and [Pd(η3-C3H5)Cl]2 (1.0 mol % or 2.0 mol %)
was stirred in 1.0 mL of dry THF for 30 min. Then, rac-(E)-1,3-diphenylallyl acetate (0.5 mmol)
in 1.0 mL of THF was added, followed by dimethyl malonate (1.5 mmol) and base (1.5 mmol) of
BSA with 2 mol % of KOAc or 1.5 mmol of K2CO3/Cs2CO3 (1:1). After stirring for 12 h at room
temperature, the solution was concentrated and purified by chromatography on silica gel eluted
with hexane/EtOAc (10:1). The product was isolated as a colorless oil. 1H-NMR (500 MHz, CDCl3):
δ = 7.34–7.22 (m, 10H, Ar-H), 6.50 (d, 1H, J = 15.0, -CH=), 6.33 (dd, 1H, J = 10.0, 15.0, -CH=), 4.31–4.27
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(m, 1H, CH), 3.98 (d, 1H, J = 10.0, CH), 3.77 (s, 3H, OCH3), 3.54 (s, 3H, OCH3), HPLC analysis (Chiralcel
OD-H, hexane/iso-PrOH, 98:2, 1.0 mL/min, 254 nm): tr(minor) = 10.9 min, tr(major) = 14.5 min.
3.3. Computational Studies
All DFT calculations were performed using the “Prometheus” cluster in the “Cyfronet”
computational centre in Cracow. A new generation M062x [27] functional, implemented in the Gaussian
09 package (Gaussian Inc.: Wallingford, UK) [28], was used. All stationary structures have been
optimised using the LANL2DZ basis set with one f function for Pd and without pseudopotential.
All structures were characterised by only positive eigenvalues in their diagonalised Hessian matrices.
For the optimised structures, thermochemical data for the temperature T = 298 K and pressure p = 1
atm were computed using vibrational analysis data.
3.4. Crystallographic Studies
An X-ray diffraction experiment for the complex [Pd(6q)Cl2] was conducted at room
temperature on a SuperNova X-ray diffractometer equipped with an Atlas S2 CCD detector using
mirror-monochromatized CuKα radiation (λ = 1.54184 Å). Multiscan absorption correction procedures
were applied to the data [41]. The structure was solved by direct methods using the ShelXT [42]
structure solution program with intrinsic phasing and refined with the Olex2.refine refinement
package using Gauss–Newton minimisation [43]. Non-hydrogen atoms were refined anisotropically.
The C-bound H atoms were positioned geometrically and refined with the ‘riding’ model. A summary
of the experimental details and crystal structure refinement parameters are given in Tables 2–5 and
ESI. The experimental details and final atomic parameters have been deposited with the Cambridge
Crystallographic Data Centre as supplementary material (CCDC: 1885894). Copies of the data can
be obtained free of charge on request via www.ccdc.cam.ac.uk/data_request/cif, or by emailing
data_request@ccdc.cam.ac.uk.
4. Conclusions
Herein, we have demonstrated the design and straightforward synthesis of novel highly rigid
polycyclic bis(phosphanes). The X-ray analysis of the coordination compound obtained with a new
ligand and dichloropalladium complex confirmed the cis, exo configuration of the bis(phosphane)
ligand molecule. The five-membered metallacycle has an envelope conformation with a puckering
amplitude q2 of 1.142(5) Å and a phase angle Φ2 of 153.8(1)◦. The CSD search showed that the most
frequent conformation for the five-membered metallacycles of transition metals and bis(phosphane)
ligands was an envelope with one of the carbon atoms positioned at the flap regardless of the
transition metal and phosphine substituent type, just as in the presented complex [Pd(6q)Cl2].
This stereochemical asymmetry observed in the analysed metallacycles is probably an important
factor for efficient transition-metal-mediated asymmetric transformations. The comparison of the
measured and calculated structures of the palladium complex and corresponding bis(phosphane)
dioxides confirmed that, due to a structural rigidity, the conformation of the ligands depends only
marginally on the substituents that those ligands bear in their polycyclic core. Notable efficiency,
activity and selectivity of the new ligand in a model asymmetric allylic alkylation reaction have also
been confirmed.
Supplementary Materials: The NMR spectra of the obtained compounds and some additional experimental
details are available online.
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Abstract: Phosphonic acids, aminophosphonic acids, and phosphonocarboxylic acids are
characterized by an advanced hyphenated technique, combining potentiometric titration with
NMR spectroscopy. Automated measurements involving 13C, 19F and 31P nuclei lead to “pseudo 2D
NMR” spectra, where chemical shifts or coupling constants are correlated with analytical parameters.
Dissociation constants, stability constants, dynamic and specific chemical shifts are determined.
Macroscopic and microscopic dissociation equilibria are discussed.
Keywords: phosphonic acids; aminophosphonic acids; phosphonocarboxylic acids; NMR-controlled
titration; dissociation constants; stability constants; dynamic and specific NMR parameters
1. Introduction
NMR-controlled titration, also known as NMR titration, a useful tool combining NMR and
analytical aspects, is based on fundamental observations in the dawn of NMR spectroscopy: “Early
phosphorus NMR studies of condensed phosphates showed that raising the acidity of phosphate
solutions increased the shielding of the phosphorus nucleus, causing a shift of the 31P resonances to
higher fields by several ppm” [1]. “Later studies on the short chain condensed phosphates exhibited
that the pH variations of the chemical shifts and spin-coupling constants where, when measured to
sufficient precision, sensitive functions of the molecular structure and the bonding”. A first titration
curve of H3PO4 shown as δP vs. pH was derived in this paper [2]. 13C-NMR measurements on linear
aliphatic acids revealed that COOH groups in CnH2n+1COOH (n = 0 to 4) exhibit higher chemical shifts
δC than COO− groups of corresponding anions CnH2n+1COO−. A characteristic downfield shift of δC
ranging from 5.1 to 4.7 ppm was observed for deprotonation by addition of tetramethylammonium
hydroxide to carboxylic acids [3].
In subsequent years, those phenomena attracted the attention of numerous studies dealing
with inorganic and organic phosphorus chemistry. A higher level of sophistication was achieved
by combining the analytical theory of protolysis and complex formation for acids and bases with
advanced NMR technologies and expanding the range of sensor nuclei to 1H, 13C, 15N, 19F, 31P and
spin active metal nuclei.
The first NMR titration curves for phosphonoacetic acid HOOC-CH2-PO3H2 using 13C
and 31P NMR were reported as δC vs. pH and δP vs. pH functions. For the first time,
a characteristic deprotonation sequence was established: HOOC-CH2-PO3H2 → HOOC-CH2-PO3H−
→ −OOC-CH2-PO3H− → −OOC-CH2-PO32−. In addition, 1JPC was related to the s-electron density
around the central C-atom [4].
Several decades of creative work followed those early observations. Induced by synthetic,
analytical, biological, or technical aspects, interests were concentrated on several classes of
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organophosphorus compounds. Particular attention was drawn towards analogues of amino acids,
e.g., aminophosphonic acids and strong complexing agents like NTMP (N(CH2PO3H2)3) and EDTMP
((H2O3PCH2)2NCH2CH2N(CH2PO3H2)2), which are phospha analogues of the classical complexones
NTA (N(CH2COOH)3) and EDTA ((HOOCCH2)2NCH2CH2N(CH2COOH)2). Dissociation constants,
stability constants for protonation and metal complex formation were studied as quoted with a few
selected key papers [5–16].
Further interests concentrated on phospha analogues of carboxylic acids, e.g., phosphonocarboxylic
acids and geminal bisphosphonic acids. 31P- and 13C-NMR spectra of cyclohexyl- and
phenylphosphonic acid showed that chemical shifts δP and δC including coupling constants nJPC
(n = 1–4) of cyclohexanephosphonic acid and benzenephosphonic acid proved to be pH-dependent [17].
A key paper in understanding the NMR titration of geminal bisphosphonate
structures described three asymmetric esters of chlodronic acid (HO)2(O)P-CCl2-P(O)(OiPr)OH,
(HO)2(O)P-CCl2-P(O)(OiPr)2, and HO(iPrO)(O)P-CCl2-P(O)(OiPr)2. Proton coupled 31P-NMR titration
spectra revealed the coupling constants 2JPP in a range between 15.6 and 17.9 Hz. This significant
parameter is not accessible for the symmetric ester HO(iPrO)(O)P-CCl2-P(O)(OiPr)OH since this
compound gives rise to a dynamic deceptively simple spectrum ranging from singlet to triplet as
a result of the parent symmetric [AM6X]2 spin system [18]. 31P-NMR measurements at 202.5 MHz
showed that the chemical shift δP of CH3C(OH)[P(O)(OH)2]2 (HEDP) is sensitive towards pH and the
concentration of [(CH3)4N]+ when [(CH3)4N]Cl was used as an ion buffer [19].
The determination of high pK values (pK > 13) and low pK values (pK < 1) required specific,
advanced techniques for NMR titration. Comments on measurements at high and low pH were
reported [19,20]. 1H/31P NMR pH indicator series were used to eliminate the glass electrode in NMR
spectroscopic pK determinations, leading to “electrodeless titrations” [21]. Comprehensive guidelines
for NMR measurements for the determination of high and low pK values were given in a IUPAC
Technical Report. Those sophisticated and detailed instructions should be followed for accurate
analytical and NMR measurements, data evaluation and subsequent publications [22].
1.1. Developing Technical Setups for Automated NMR Titrations
In general, NMR titrations for various nuclei were performed in single sample techniques, which
proved to be rather laborious and time consuming. For practical reasons, the number of data points
were limited in those early titration curves. Hence, attempts were made to develop the technology of
automated NMR titrations.
An innovative set up was constructed, which permitted the acquisition of spectra from spinning
20 mm NMR tubes, adding a solution of base under efficient mixing while monitoring the pH.
This apparatus worked together with the wide-bore magnet of a Bruker CXP-300 spectrometer, yielding
approximately 80 titration points within a couple of hours. This technology was successfully used to
titrate H3PO4 vs. KOH and provided a smooth NMR titration curve [23].
Further progress for automated NMR titrations inside spinning 10 mm NMR tubes was described
and the novel installation applied to monitor the complex formation between Tl(I)+ and Cl− in aqueous
solutions. A Bruker CXP-100 spectrometer was used, operating at 51.9 MHz for 205Tl [24].
Very recently, an elegant low-cost construction was developed for a gravity-driven pH adjustment
inside a 5 mm NMR tube. No hardware modifications of the NMR spectrometer were requested.
This technique was applied to site-specific protein pK measurements [25]. It might be useful for future
studies of organophosphorus compounds.
A different route to automated NMR titrations was chosen by the Düsseldorf group. We were
intrigued by the technology of 2D NMR spectra and the graphical representation of such spectra by
standard spectrometer software. Hence, a hyphenated technique was envisaged, replacing the f2 axis
of 2D NMR spectra by analytical parameters.
Bypass constructions were developed in several generations of increasing accuracy. A 10 mm NMR
tube was attached to a special homemade insert and used with a Bruker AM 200 SY NMR spectrometer
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operating at 81 MHz for 31P NMR. This insert acted as bypass to a precision titration equipment.
A series of pH dependent 1D NMR spectra were recorded and processed (using standard spectrometer
software) to yield instructive “pseudo 2D NMR” spectra (e.g., in analogy to COSY spectra). Chemical
shift δP data were correlated with analytical data like pH or the degree of titration τ. The technical setup
and two examples are shown in [26]. Phosphaalanine was used as an example where deprotonation
and complex formation with Zn2+ cations were observed by titrations vs. tetramethylammonium
hydroxide (TMAOH) [26].
This equipment was used to characterize a series of aminomethylphosphine oxides
(CH3)3-n(CH2NH2)nPO (n= 1–3), adding n equivalents of HCl and back-titrating vs. NaOH. Ion-specific
chemical shifts δP and pK data were obtained for those aminomethylphosphine oxide bases. In addition,
technical details of NMR, analytics, software concepts and programs used were described [27].
A brief overview of “31P NMR controlled titrations of Phosphorus-Containing Acids and
Bases in Protolysis and Complex Formation” reported about the 81 MHz 31P{1H} NMR titration
of phosphonoacetic acid [28]. The hardware and software concepts were shown.
Typical “pseudo 2D NMR” spectra correlating the chemical shift δP vs. the degree
of titration τ were obtained for the pair of isomers 1- and 2-aminoethanephosphonic
acids CH3-CH(NH2)-PO3H2 and NH2-CH2-CH2-PO3H2 (α-Ala-P and β-Ala-P) and for
diphosphaasparaginic acid H2O3P-CH(NH2)-CH2-PO3H2 (Asp-P2). Macroscopic dissociation
constants and ion-specific chemical shifts are reported. The p-aminophenylene-substituted phosphonic
acid p-NH2-C6H4-PO3H2 was compared [29]. Hardware and software concepts used in NMR titration
were demonstrated. A subsequent UV-controlled titration revealed the microscopic dissociation scheme
of p-NH2-C6H4-PO3H2. Corresponding deprotonation patterns were discussed [30].
In practice, 13C-NMR titrations in single sample techniques proved to be very time consuming.
Hence, it seemed advisable to use the technology described above for automated 50.29 MHz 13C{1H} or
13C-NMR measurements. As practical examples, the pair of isomers 1- and 2-aminoethanephosphonic
acids were titrated vs. NaOH. Within this context, CH3-CH(NH2)-PO3H2 and the fluorinated analogue
CF3-CH(NH2)-PO3H2 were compared using 31P{1H} and 19F{1H} NMR titrations. Replacing the CH3
by a CF3 group reduces the basicity of the NH2 function, which is reflected in δP vs. τ and in the δF vs.
τ correlations [31].
The experimental set up described above requested individual titrations for each nucleus wanted.
Hence, multinuclear studies (e.g., 1H and 13C and 31P) demanded high spectrometer times.
At this stage, special probe heads were developed by Bruker for another hyphenated technique
combining liquid chromatography with HR NMR. In our laboratory, a Bruker LC probe head
LC-TXO-NMR was successfully introduced to a DRX 500 NMR spectrometer and used for advanced
NMR titrations. It became routine to run consecutively 31P{1H}, 31P, and 1H-NMR spectra for each
titration step, thus saving time, gaining higher sensitivity and reducing the necessary concentrations
(and amounts) of titrands. Excellent spectra resulted with a high S/N ratio and high digital resolution
in the chemical shift or frequency axis.
In addition, a special 19F-LC probe head was available, combining 19F and 1H-NMR techniques.
The high field stability of the supercon magnet allowed measurements in H2O solutions (without D2O),
thus avoiding the problems with “mixed” stability and dissociation constants resulting from D2O/H2O
mixed solvents.
A comprehensive report about the technical designs of NMR and analytical components, software,
data evaluation, error calculations and applications was written in 2002 and incorporated into the
Bruker NMR Guide collection, freely accessible for Bruker spectrometer users [32] only. This detailed
review is now open for free downloads to all interested readers: (a) https://www.theresonance.com/
nmr-controlled-titration-download-the-paper/, (b) https://www.bruker.com/fileadmin/user_upload/8-
PDF-Docs/MagneticResonance/NMR/NMR_controlled_titration.pdf.
NMR titrations using 200 MHz and 500 MHz spectrometers were described using geminal
bisphosphonic acids, e.g., HEDP and Pamidronic acid, as model systems. The TXO-HPLC probe head
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improved the signal-to-noise ratio of “pseudo 2D NMR” spectra and reduced the concentration of
titrand required by this procedure: The following concentrations for sensor nuclei are recommended:
1H: 0.25–0.01 mol/L, 13C: 0.50–0.005 mol/L, 19F: 0.01–0.005 mol/L, 31P: 0.01–0.001 mol/L, and 113Cd:
0.25–0.1 mol/L. 113Cd NMR was used when studying protolytic and complex formation equilibria of
(H2O3P-CH2)2NCH2CH2N(CH2PO3H2)2 (EDTMP).
Within this context, a special computer program MultipleNMRGraphics was developed which
is able to generate four characteristic “pseudo 2D NMR” plots, e.g., δP vs. pH or δP vs. τ either as
contour or as stacked plots, in black-and-white or color design [33]. Those graphics have a lower
storage demand than the previously used “pseudo 2D NMR” spectra generated by the routine Bruker
spectrometer software.
Some examples relevant to phosphorous chemistry and organic chemistry dealt with in [32] are
listed in Table 1:
Table 1. Some examples for NMR-controlled titrations of phosphonic acids, phosphinic acids, and







CH3-C(OH)[P(O)(OH)2]2, HEDP, etidronic acid 31P{1H}




HOOC-CH2-CH2-P(CH3)(O)OH 13C{1H}, 1H 2)
HO(O)(CH3)P-CH2-CH2-P(CH3)(O)OH 13C{1H}
HO(O)(CH3)P-CH2-CH2-C(H)(NH2)COOH 1H 2, 3)
Carboxylic acids
CH3COOH 13C{1H}
CH(CH3)2-CH2-CH(NH2)-C(O)-NH-CH(CH3)-COOH, peptide Leu-Ala 13C{1H}
CH2=CF-CH2-C(CH3)(NH2)-COOH 19F
A modification of our design for automated NMR titrations shown above was adjusted to the
local conditions of a Bruker 250 MHz spectrometer and applied to study the complexation of Zn2+,
Cd2+ and Pb2+ with diazacrown ethers substituted by phosphonate groups [34].
Particular attention was drawn towards microscopic dissociation constants going back to early
studies on NH2-CH2-CH2-NH-CH2-COOH. 60 MHz and 100 MHz 1H-NMR titrations evaluated the
pH dependence of a singlet for the methylene group NH-CH2-COOH, while the ethylene function
N-CH2-CH2-N appeared with the spectral character, changing from a deceptively simple singlet
towards an AA′BB′ ([AB]2) system. The analytical formalism and microscopic dissociation constants
were derived [35]. For deeper reading, an up-to-date and comprehensive survey on the theory and
practice of proton microspeciation based on NMR-pH titrations is recommended [36].
As an example, S-2-amino-4-(methylphosphinoyl)butyric acid (S-phosphinothricine,
GLUFOSINATE) HOOC-CH(NH2)-CH2-CH2-P(CH3)(O)OH was characterized by 31P{1H}- and
1H-NMR titrations. Microscopic dissociation and intramolecular rotational equilibria were
discussed [32,37]. Within this context, a program LAOTIT was developed, which is able to simulate
series of pH-dependent second-order NMR spectra. A practical example for AFGMNQ3X spin systems
of GLUFOSINATE in a pH range from 1 to 6 was shown in [37].
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The ring-chain tautomerism and protolytic equilibria of an effectively three-basic
3-hydroxy-3-phosphonoisobenzofuranone was studied by 1H-, 13C{1H}- and 31P{1H}-NMR-controlled
titrations. A complex pattern of macroscopic and microscopic deprotonation steps leading from the



















Scheme 1. Showing 3-hydroxy-3-phosphonoisobenzofuranone H3L and its terminal anion L3−.
The OPIUM program enabled the simultaneous evaluation of potentiometric, 31P{1H}- and
1H-NMR titrations using the four individual 1H signals from the ABCD system [38]. Macroscopic
dissociation constants, pK1 = 0.445 ± 0.008, pK2 = 5.792 ± 0.003, pK3 = 6.486 ± 0.002. δH, δC, and δP of
H3L (0.2510 mol/L in D2O) and L3− (0.1919 mol/L in 1 mol/L KOD), were determined. For details of the
complex equilibrium system, see [39,40].
NMR-controlled titration was successfully used to analyze the mixture of diastereomers
from 1-phosphonopropane-1,2,3-tricarboxylic acid, HOOC-CH2-CH(COOH)-CH(COOH)-PO3H2
(PPTC). The genuine product from synthesis consisted of 64% of the RS/SR and 36% of the
RR/SS forms. 31P{1H}-NMR-controlled titration revealed two diastereospecific titration curves
which were individually identified by additional 1D and 2D NMR studies using 1H, 31P and 13C
nuclei. Dissociation constants and ion-specific chemical shifts δP were calculated for the pair of
diastereomers [41–43]. It seems evident to use automated NMR titration for production control in
research and industrial chemistry.
1.2. Some Comments on Macroscopic Protolytic Equilibria—Dissociation and Stability Constants
Organophosphorus compounds studied by potentiometric or NMR-controlled titrations may
be described by two numerical indices: a, the number of acidic functions (e.g., P(O)OH, C(O)OH,
etc.) and b, the number of basic functions (e.g., NH2, NHR, NR2, etc.). The minimal protonated
species corresponds to the n-valent base L−a having a anionic centers and b neutral base centers in
(0N)b-R-(O−)a. Total protonation leads to the n-valent acid HnLb+ (n = a + b) having a neutral centers
and b cationic acid centers in (+HN)b-R-(OH0)a.
Protonation equilibria of the n-valent base are described by Equation (1):
iH+ + L−a  HiLi−a i = 1 to n (1)




i = 1 to n β0 = 1 (2)
Stepwise dissociation equilibria of the n-valent acid are described by Equation (3):
Hn+1−iLb+1−i  H+ + Hn−iLb−i i = 1 to n (3)
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i = 1 to n (4)
Stoichiometric stability constants and stoichiometric dissociation constants are connected by
Equations (5) and (6):




pKn+1−j i = 1 to n (6)
This paper will use stoichiometric variables (containing concentrations instead of activities) in
abbreviated forms: pKi—macroscopic acid dissociation constant; pki—microscopic acid dissociation
constant; pKw—ion product of water. pH stands for the concentration-based pH = −lg(cH). Glass
electrodes were calibrated by blank titration. The more complex situation of activities and activity-based
parameters exceeds the scope of this paper and hence will not be discussed at this stage.






i = 0 to n (7)
Each protolytic species HiLi–a present in the equilibrium contributes specific NMR parameters
δ(HiLi–a) in an exchange reaction, which is rapid on the NMR timescale. Effectively, only one signal is
observed when monitoring NMR during the course of titrations. A dynamically averaged chemical




xi · δHiLi−a i = 0 to n (8)
A gradient called the deprotonation shift Δi [ppm] is given by Equation (9):
Δi = δHn−iLb−i − δHn+1−iLb+1−i i = 1 to n (9)
This gradient defines the change of chemical shift for each deprotonation step. Signs and
magnitudes of gradients are used to elucidate the deprotonation and protonation pathways of
multifunctional acids, bases and ligands as shown in examples below.
As deduced above, the dynamically averaged chemical shift δ is a function of pH. Experimentally,
the pH of solutions may be varied by titration with a strong univalent base or a strong univalent acid.
While the experiment directly provides the well-known titration curve pH = f(VTitrator), it is more
convenient to calculate the inverse function VTitrator = f(pH) with suitable computer programs. Within
this paper, a reduced parameter τ, commonly called degree of titration, will be used to describe the





The sign of τ is positive if nTitrator corresponds to the molar amount of a strong monovalent base
(e.g., NaOH, KOH, TMAOH), but is negative for a strong monovalent acid (HCl, HNO3, HClO4).
nTitrand corresponds to the molar amount of a n-basic acid HnL.
Details of the basic principles and experimental equipment with hardware and software are
described in [31,32] and in references given herein.
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2. Results and Discussion
In the following sections, a few examples will be shown for automated NMR-controlled titrations
using hardware and software concepts described above. Chemical shifts δC [ppm] quoted below were
referenced vs. (CH3)3Si-CH2-CH2-SO3Na, while δP [ppm] was virtually referenced towards external
H3PO4. Coupling constants nJXY are given in [Hz].
2.1. Phosphonic Acids
Methanephosphonic acid 1 and phenylphosphonic acid 2 shown in Scheme 2 were chosen
from [31,44], which will be presented below:
 















Scheme 2. Phosphonic acids: methanephosphonic 1 and phenylphosphonic acid 2.
2.1.1. Methanephosphonic Acid 1
The results from a proton-coupled 31P-NMR-controlled titration of methanephosphonic acid 2 vs.
NaOH are shown as a contour plot in Figure 1. A quartet structure from the parent A3X spin system of
the P-CH3 fragment is recognized. Numerical results are given in Table 2. The deprotonation of both
P-OH functions induces a decrease in chemical shifts δP and a decrease in the absolute values of 2JPH.
 
Figure 1. 1H-coupled 31P-NMR-controlled titration of methanephosphonic acid 1 vs. NaOH. Note:
quartet fine structure from X-part of AX3 system of P-CH3 fragment. X-axis: δP [ppm]. Y-axis: degree
of titration τ.
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Table 2. Specific chemical shifts δC, δP and coupling constants 1JPC and 2JPH of methanephosphonic
acid 1 were obtained by 13C{1H}-, 31P{1H}-, and 31P-NMR-controlled titrations in H2O. Δi = δ(Hn-iL)
− δ(Hn+1-iL) or Δi = nJPC(Hn-iL) − nJPC(Hn+1-iL), respectively. i = 1 to n. n = 2. Experimental data:
CTitrand: a) 0.269 mol/L. b) 0.01220 mol. c) 0.0095 mol/L. CTitrator: a) 4.82 mol/L KOH. b) 0.0971 mol/L
NaOH. c) 0.0971 mol/L NaOH. d) Early data from results from titration vs. KOH [45].
1 in H2O
Method 13C{1H} 31P{1H} 31P 31P{1H}
Exp. a) b) c) d)
Species δC
1JPC δP δP 2JPH δP
[ppm] [Hz] [ppm] [ppm] [Hz] [ppm]
H2L 14.27 135.92 33.03 33.03 −17.65 31.76
HL− 15.53 133.82 24.79 24.79 −16.52 24.94
L2− 16.61 129.95 21.08 21.08 −15.52 20.94
Gradients δC
1JPC δP δP 2JPH δP
Δ1 1.26 −2.10 −8.24 −8.24 1.13
Δ2 1.08 −3.87 −3.71 −3.71 1.00
pKi
pK1 2.27 2.06 2.00 2.33
pK2 7.85 7.66 7.68 7.78
pKi values found are consistent with results from potentiometric titrations of CH3P(O)(OH)2 [46].
2.1.2. Phenylphosphonic Acid 2
Chemical shifts δP for protolytic species H2L, HL−, and L2− of phenylphosphonic acid 2 together
with dissociation constants pK1 and pK2 are listed in Table 3. The deprotonation of both P-OH groups
leads to characteristic high field shifts for δP as indicated by negative gradients Δ1 and Δ2.
Table 3. Specific chemical shifts δP [ppm], gradients [ppm] and dissociation constants pKi from
31P{1H}-NMR-controlled titration of phenylphosphonic acid 2 vs. TMAOH and NaOH. Exp.: CTitrator:
a) 0.09894 mol/L TMAOH. b) 0.09925 mol/L NaOH. CTitrand: a) 0.02 mol/L 3. b) 0.008 mol/L 2. Shifts
and gradients given in ppm.
Phenylphosphonic Acid 2











Higher concentrations are required for 13C{1H}-NMR-controlled titrations as shown for the
titration of phenylphosphonic acid 2 vs. KOH in Figure 2:
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Figure 2. 13C{1H}-NMR-controlled titration of phenylphosphonic acid 2 vs. KOH yielded a contour
plot for chemical shift δC as a function of the degree of titration τ. X-axis: δC [ppm]. Y-axis: degree of
titration τ.
The deprotonation of each of the two P-OH functions led to a strong low field shift for the ipso-C1
carbon. For the remaining carbons high field shifts are observed, an effect decreasing in the order
para-C4 > meta-C3/5 > ortho-C2/5.
Semi-empirical calculations with VAMP 4.4 using parameter set AM1 showed that the electron
density at C1 increases with deprotonation in the order PhPO3H2 < PhPO3H− < Ph-PO32−, while the
electron density of C4 decreases in this order [44,47]. In addition, the deprotonation of P-OH led to a
decrease for all nJPC (n = 1 to 4). Particularly indicative is 1JPC from the ipso-carbon C1, which reaches
a minimum at total deprotonation. Numerical results for compound 2 are listed in Table 4:
Table 4. Specific chemical shifts δC [ppm] and coupling constants nJPC (n = 1 to 4) [Hz] for the
13C{1H}-NMR-controlled titration of phenylphosphonic acid 2 vs. KOH. pK1 = 1.75. pK2 = 6.92.
Experimental data: CTitrand: a) 0.237 mol/L 2. CTitrator: 4.53 mol/L KOH.
δC and
nJPC for Species Gradients
Parameters H2L HL− L2− Δ1 Δ2
δC C1 133.66 138.15 143.83 +4.48 +5.69
δC C2/6 133.68 133.45 133.43 −0.24 −0.02
δC C3/5 131.99 131.59 130.95 −0.40 −0.64
δC C4 135.66 134.03 131.98 −1.58 −2.06
1JPC 183.48 177.02 167.32 −6.46 −9.70
2JPC 10.51 9.72 8.79 −0.79 −0.93
3JPC 14.84 13.90 12.65 −0.94 −1.25
4JPC 3.08 2.91 2.74 −0.17 −0.17
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Laborious and time-consuming single sample 31P{1H}- and 13C{1H}-NMR studies on
phenylphosphonic acid 2 were performed, where δP, δC, and nJPC data are consistent with findings
derived from the automated titrations presented in this paper [17].
2.2. Comparison of Aliphatic and Aromatic Aminophosphonic Acids
α-Aminoethylphosphonic acid (α-Ala-P) 3 [29,44], β-aminoethylphosphonic acid (β-Ala-P,
CILIATIN) 4 [29], and p-aminophenylphosphonic acid 5 [29,30,43] shown in Scheme 3 will be studied
as examples in the following section.
 
Scheme 3. Aminophosphonic acids 3 to 5.
2.2.1. Aliphatic Aminophosphonic Acids
Aminophosphonic acids NH2-R-PO3H2, such as examples 3 to 5, exist as betainic forms
+NH3-R-PO3H− in solid and in solution state. Protolytic equilibria of aminophosphonic acids
are described by macroscopic and microscopic formalisms as shown in Table 5 below:









If R is aliphatic (e.g., in 3 and 4), the deprotonation takes place following route a): +NH3-R-PO3H2
→ +NH3-R-PO3H− → +NH3-R-PO32− →NH2-R-PO32−. But if R is aromatic (e.g., in 5. R = p-C6H4-),
the deprotonation dominantly will follow b): +NH3-R-PO3H2 → +NH3-R-PO3H− →NH2-R-PO3H−
→ NH2-R-PO32−. Consistent conclusions are supported by a combination of potentiometric
titrations and 31P{1H}-NMR-controlled titrations as shown for examples 3 to 5, and in addition
by 13C{1H}-NMR-controlled titrations for examples 3 and 4. Owing to its low solubility, 5 was not
suitable for 13C{1H}-NMR-controlled titrations.
Macroscopic dissociation constants pKi of 3 and 4 are listed in Table 6. pKi data of compounds 4
and 5 were discussed in [44,45,48–50].
Specific chemical shifts δP and gradients Δ for compounds 3 to 5 obtained by
31P{1H}-NMR-controlled titrations are given in Table 7:
The deprotonation of the P-OH groups led to high field shifts for δP connected with negative
gradients. The final deprotonation of the NH3+ group gave rise to a low field shift for δP. This effect is
stronger in α-aminophosphonic acid 4 than in β-aminophosphonic acid 5. Earlier results for chemical
shifts δP of H2L, HL− and L2− species of 3 and 4 were mentioned in [5,45]. In addition, δP of H3L+ was
accessible for 4 but not for 3.
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Table 6. Macroscopic dissociation constants pKi of compounds α-Ala-P 3 and β-Ala-P 4 obtained by
13C{1H}- and 31P{1H}-NMR-controlled titrations and by potentiometric titrations [4a]. Note: pK3 −
pK2 > 3 and pK2 − pK1 > 3 for compounds 3 and 4. Exp.: 3: CTitrand: a) 0.0867 mol/L 3 + 0.0834 mol/L
HNO3. b) and c) 0.005 mol/L 3 + 0.00476 HNO3 + 0.0917 mol/L NaNO3. CTitrator: a) 3.98 mol/L NaOH.
b) and c): 0.100 mol/L NaOH. 4: CTitrand: d) 0.139 mol/L 4 + 0.139 mol/L HNO3. e) 0.010 mol/L 4 +
0.010 mol/L HNO3. f) 0.010 mol/L 4 + 9.747 mmol/L HNO3. g) 0.005 mol/L 4 + 0.005 mol/L HNO3 +
0.100 mol/L TMACl. CTitrator: d) 0.98 mol/L NaOH. e): 0.0991 mol/L TMAOH. f): 0.0993 mol/L NaOH.
















NaOH NaOH NaOH NaOH TMAOH NaOH TMAOH
pK1 0.70 0.31 0.3 1.02 1.22 1.26 1.14
pK2 5.72 5.63 5.58 6.38 6.23 6.24 6.34
pK3 10.64 10.21 10.28 11.50 11.06 11.08 11.06
Table 7. Specific chemical shift δP [ppm] and gradients Δ [ppm] for compounds 3 to 5 [44]. *) Not
iterated. Experimental details for 3 and 4 are given in Table 6. Titrator: a) NaOH; b) TMAOH; c) for 5










Species δP δP δP δP
H3L
+ 15 * 22.9 23.4 13 *
H2L 14.92 19.29 19.36 12.16
HL− 13.08 16.80 16.81 15.29
L2− 22.25 19.39 19.72 12.70
Gradients
Δ1 −0.08 −3.61 −4.04 −0.84
Δ2 −1.84 −2.49 −2.55 +3.13
Δ3 +9.17 +2.59 +3.91 −2.59
13C{1H}-NMR-controlled titrations of compounds 4 and 5 led to specific chemical shifts δC,
coupling constants 1JPC, and gradients Δ as listed in Table 8:
Table 8. Specific chemical shifts δC [ppm], coupling constants 1JPC [Hz], and corresponding gradients Δ
forα-aminoethanephosphonic acid (α-Ala-P) 3 andβ-aminoethanephosphonic acid (β-Ala-P, CILIATIN)
4. Spin enumerations: 3: C2-C1(N)-P; 4: (N)C2-C1-P. 1JPC shows a minimum for species HL− of 3 and
4. 2JPC was not resolved for compounds 3 and 4.
3 in H2O 4 in H2O
Species δC(C1)
1JPC δC(C2) δC(C1) 1JPC δC(C2)
H3L
+ 46.80 151.5 16.0 27.50 137.4 37.09
H2L 47.70 143.8 16.43 28.73 131.4 38.22
HL− 49.07 134.5 17.23 29.47 124.8 39.28
L2− 48.15 138.0 19.79 35.45 126.5 39.76
Gradients
Δ1 +0.9 −8.7 +0.43 +1.23 −6.0 +1.13
Δ2 +1.37 +9.3 +0.80 +0.74 −6.6 +1.04
Δ3 −0.92 +3.5 +2.55 +5.98 +1.3 +0.47
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NMR was used to monitor the complex formation of aminophosphonic acids with biorelevant
cations in homogeneous solutions. An instructive example is the 31P{1H}-NMR-controlled titration of
CILIATIN/Mg2+ vs. NaOH where the formation of [MgL] and [MgHL]+ was monitored [44].
2.2.2. Aromatic p-Aminophenylphosphonic Acid 5
The deprotonation of PO3H− in aliphatic aminophosphonic acids 3 and 4 is affiliated with a high
field shift (gradients Δ2 are negative), while the deprotonation of the ammonium function +NH3 leads
to a low field shift (gradients Δ3 are positive).
The aromatic p-aminophenylphosphonic acid 5 exhibits a different pattern: while gradient Δ2 is
positive, Δ3 is negative (Scheme 4).
Scheme 4. Specific chemical shifts δP [ppm] derived from the 31P{1H}-NMR-controlled retro titration
of p-aminophenylphosphonic acid 5. Δ2 = +3.13 ppm. Δ3 = −2.59 ppm.
But is it sufficient to assume a simple first-order macroscopic dissociation scheme for compound
5? Deeper insight might be obtained from the microscopic dissociation scheme. In principle
13C{1H}-NMR-controlled titration should lead to specific chemical shifts and coupling constants
nJPC indicative for microscopic dissociations species of 5. But p-aminophenylphosphonic acid
5 is less soluble in water than the aliphatic aminophosphonic acids 3 and 4. The S/N-ratio of
13C{1H}-NMR spectra of 5 is not sufficient to perform evaluable 13C{1H}-NMR-controlled titrations.
In this situation, UV/VIS-controlled titration, which allows for lower concentrations suitable for
conclusive measurements, will help to study both the macroscopic and the microscopic dissociation
equilibrium of 5 [30]. In addition, the parent compounds C6H5PO3H2 2 and C6H5NH2*HCl 6 were
compared. The following macroscopic pKi data were found by potentiometric titration and listed in
Table 9:
Table 9. Dissociation constants of compounds p-aminophenylphosphonic acid 5, phenylphosphonic
acid 2, and anilinium hydrochloride 6.
5 2 6
pK1 0.44 1.88 4.68
pK2 3.95 7.15
pK3 7.56
Those data point towards a dominating deprotonation sequence for 5 following +NH3-R-PO3H2→
+NH3-R-PO3H− → NH2-R-PO3H− → NH2-R-PO32−. But is it justified to exclude the alternative route
+NH3-R-PO3H2 → +NH3-R-PO3H− → +NH3-R-PO32− → NH2-R-PO32−? Evaluating the macroscopic
dissociation constants of 5 shows that between pH = 1.5 and pH = 10, only three macroscopic species
exist: H2L, HL−, and L2−. The UV/VIS-controlled titration of 5 [30] showed that the maximum
concentration for macroscopic HL− is reached at pH = 5.75, consisting of two microdissociation species
NH2-R-PO3H− and +NH3-R-PO32− in a ratio of 9:1. Thus, the results from the UV/VIS-controlled
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titration of 5 [30] confirm the dominance of NH2-R-PO3H− as previously assumed for the macroscopic
deprotonation sequence derived from the 31P{1H}-NMR-controlled titration of 5 [44].
2.3. Phosphonocarboxylic Acids HOOC-(CH2)n-PO3H2 7a to 7d (n = 0 to 3)
Phosphonocarboxylic acids HOOC-(CH2)n-PO3H2 gave rise to potentiometrically [4,44] and
NMR-controlled titrations [4,28,31,44]. Those neutral acids of type H3L deprotonate dominantly in a
sequence: HOOC-(CH2)n-PO3H2 → −OOC-(CH2)n-PO3H− → −OOC-(CH2)n-PO32−. Corresponding
dissociations constants for compounds shown in Scheme 5 are listed in Table 10 below:
 
Scheme 5. Phosphonocarboxylic acids 7a to 7d.
Table 10. Dissociation constants of phosphonocarboxylic acids HOOC-(CH2)n-PO3H2 (n = 0 to 3) 7a
to 7d [8,44]. Experimental data: a) CTitrand: 0.153 mol/L FOSCARNET (trisodium phosphonoformate
hexahydrate), CTitrator: 2.002 mol/L HNO3, retro titration; b) CTitrand: 0.220 mol/L 7b, CTitrator:
0.980 mol/L NaOH. c) CTitrand: 0.200 mol/L 7c, CTitrator: 3.986 mol/L NaOH. d) CTitrand: 0160 mol/L 7d,
CTitrator: 3.986 mol/L NaOH.
HOOC-(CH2)n-PO3H2
7a 7a [4] 7b 7c 7c [4] 7d
n = 0 a n = 0 n = 1 b n = 2 b n = 2 n = 3 b
pK1 0.78 1.7 ± 0.1 1.22 ± 0.166 2.58 ± 0.013 2.26 ± 0.04 2.276 ± 0.006
pK2 3.60 3.59 ± 0.02 4.942 ± 0.004 4.633 ± 0.004 4.63 ± 0.02 4.776 ± 0.004
pK3 7.57 7.56 ± 0.02 8.099 ± 0.003 7.738 ± 0.003 7.75 ± 0.02 7.969 ± 0.003
13C{1H}-NMR-controlled titrations yielded the specific chemical shift δC and coupling constants
nJPC (n = 1 to 3) of phosphonocarboxylic acids HOOC-(CH2)n-PO3H2 (n = 0 to 3) 7a to 7d as listed in
Table 11a. Gradients are given in Table 11b. Note: The deprotonation of P-OH groups and of C-OH led
to a low field shift for all carbon atoms. Some chemical shifts and coupling constants 1JPC of 7a and 7c
were obtained and discussed in an early key paper [4].
2.3.1. Compound 7c: 13C{1H}-NMR-Controlled Titration of 3-Phosphonopropionic Acid
HOOC-CH2-CH2-PO3H2 7c.
3-Phosphonopropionic acid 7c was chosen as an example to show practical results from
13C{1H}-NMR-controlled titrations (see Figure 3a,b below). The deprotonation of C-OH and of
both P-OH functions induces low field shifts for C1, C2, and C3. Hence, the corresponding gradients
are negative. Lorentzian deconvolution of 13C{1H} signals yielded nJPC, where absolute values follow
the sequence: 1JPC >> 3JPC > 2JPC. See Table 11a,b above.
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Table 11. (a). Specific chemical shifts δC [ppm] and coupling constants nJPC [Hz] of phosphonocarboxylic
acids HOOC-(CH2)n-PO3H2 (n = 0 to 3) 7a to 7d. For experimental data, see preceding Table 10.
Remarks: n. r. = not resolved; (b). Gradients Δi of specific chemical shifts δC [ppm] and coupling
constants nJPC [Hz] of phosphonocarboxylic acids HOOC-(CH2)n-PO3H2 (n = 0 to 3) 7a to 7d. For
experimental data, see preceding Table 10.
(a)
7 n Species δC(C1) δC(C2) δC(C3) δC(C4)
1JPC 2JPC 3JPC 4JPC





b 1 H3L 172.91 37.68 128.6 n. r.
H2L
− 175.44 39.30 117.8 n. r.
HL2− 178.85 41.64 119.2 n. r.
L3− 181.74 43.50 112.6 n. r.
c 2 H3L 179.25 30.09 24.51 138.5 3.6 17.3
H2L
− 180.68 31.40 25.91 135.1 3.2 17.8
HL2− 185.01 34.27 27.50 133.0 4.1 18.7
L3− 186.71 35.61 28.99 130.3 3.6 19.8
d 3 H3L 180.38 36.67 20.44 28.19 135.2 4.0 17.4 n. r.
H2L
− 181.12 37.46 21.58 29.74 133.5 3.8 17.2 n. r.
HL2− 185.86 41.45 23.13 30.46 132.5 3.9 17.7 n. r.
L3− 186.41 42.01 24.08 31.92 130.1 3.4 17.9 n. r.
(b)
7 n Gradients δC(C1) δC(C2) δC(C3) δC(C4)
1JPC 2JPC 3JPC
a 0 Δ1 +1.9 −9.9
Δ2 +3.1 −4.9
Δ3 +5.5 −11.8
b 1 Δ1 +2.53 +1.62 −10.8
Δ2 +3.41 +2.34 +1.4
Δ3 +2.89 +1.86 −6.6
c 2 Δ1 +1.43 +1.31 +1.40 −3.4 −0.3 0.5
Δ2 +4.33 +2.87 +1.59 −2.1 0.9 0.9
Δ3 +1.70 +1.34 +1.49 −2.7 −0.5 1.1
d 3 Δ1 +0.74 +0.79 +1.14 1.56 −1.7 −0.2 −0.2
Δ2 +4.74 +3.99 +1.55 0.72 −1.0 0.1 0.5
Δ3 +0.55 +0.56 +0.95 1.46 −2.4 −0.5 0.2
The 81 MHz 31P{1H}-NMR-controlled titration of 3-phosphonopropionic acid 7c vs. NaOH yielded
Figure 3c. The deprotonation sequence reported in [4] corresponds to: HOOC-CH2-CH2-PO3H2 →
HOOC-CH2-CH2-PO3H− → −OOC-CH2-CH2-PO3H− → −OOC-CH2-CH2-PO32−. Deprotonation at
PO3H2 or PO3H− is affiliated with high field shifts of δP, while deprotonation at HOOC induces a low
field shift for δP.
Specific chemical shifts δP for 7c and corresponding anions together with gradients are listed in
Table 12.
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c 
Figure 3. (a) 13C{1H}-NMR-controlled titration of 3-phosphonopropionic acid 7c vs. NaOH. Contour
plot showing the range of the carboxylic carbon C1. For experimental data, see Table 10. X-axis: δC
[ppm]. Y-axis: degree of titration τ; (b) 13C{1H}-NMR-controlled titration of 3-phosphonopropionic
acid 7c vs. NaOH. Contour plot showing the range of the aliphatic carbons C2 and C3. For experimental
data, see Table 10. X-axis: δC [ppm]. Y-axis: degree of titration τ; (c) 81 MHz 31P{1H}-NMR-controlled
titration of 3-phosphonopropionic acid 7c vs. NaOH X-axis: δP [ppm]. Y-axis: degree of titration τ.
CTitrand: 0.010 mol/L of 7c. CTitrator: 0.10 mol/L TMAOH. Digital resolution: 0.6 Hz/point in x-axis. [51].
Table 12. Gradients Δi of specific chemical shifts δP [ppm] of 7c. Experimental data: CTitrand: 0.010











2.3.2. 19. F-NMR-Controlled Retro Titrations of Lithium Salts LiOOC-CH2-nFn-PO3Li2 8a and 8b
The trilithium salts LiOOC-CH2-nFn-PO3Li2 (8a and 8b; n = 1 and 2, Scheme 6) were used for
retro titrations vs. HNO3, since the parent mono- and difluorophosphonoacetic acids 8c and 8d were
not available for 19F-NMR- and 31P{1H}-NMR titrations. Corresponding dissociation constants pKi of
8c and 8d were calculated as listed in Table 13, while chemical shifts δF and δP and coupling constants
2JPF are given in Table 14. As expected, the introduction of fluorine into the skeleton of the parent
phosphonoacetic acid led to lower pK1 and pK2 values. The deprotonation of P-OH groups induces a
low field shift for δF in fluorinated phosphonic acids 8c and 8d.
550










8a: n = 1 ;   8b: n = 2  . 8c: n = 1 ;   8d: n = 2  .
Scheme 6. Trilithium salts LiOOC-CH2-nFn-PO3Li2 8a and 8b and free acids HOOC-CH2-nFn-PO3H2
8c and 8d.
Table 13. Dissociation constants of fluorinated phosphonocarboxylic acids HOOC-CH2-nFn-PO3H2 (8c
and 8d; n = 1 and 2) obtained by the retro titration of LiOOC-CH2-nFn-PO3Li2 (8a and 8b; n = 1 and 2)
vs. HClO4. Experimental data: CTitrand: 0.85 mol/L 8a or 8b resp. CTitrator: 0.3928 mol/L HClO4. No
ion buffer.
HOOC-CH2-nFn-PO3H2
8c n = 1 8d n = 2
[44] [44] [52]
pK1 1.05 0.52 1.30
pK2 3.43 2.22 1.95
pK3 7.08 6.36 6.16
Table 14. Chemical shifts δF [ppm], coupling constants 2JPF [Hz] and corresponding gradients of
fluorinated phosphonocarboxylic acids HOOC-CH2-nFn-PO3H2 (8c and 8d, n = 1 and 2) obtained
by 19F-NMR-controlled titrations vs. HNO3 of LiOOC-CH2-nFn-PO3Li2 (8c and 8d, n = 1 and 2).
For experimental data, see Table 13. δF is virtually referenced to δF(CF35Cl237Cl) = 0 ppm.
HOOC-CH2-nFn-PO3H2
8c 8d 8c 8d




H3L −38.27 44.24 67.8 76.5
H2L
− −38.72 50.24 65.5 88.6
HL2− −29.31 53.05 70.3 92.8
L3− −27.15 55.24 63.4 82.0
Gradients
Δ1 −0.45 +6.00 −2.3 +12.1
Δ2 −9.41 +2.81 +4.8 +4.2
Δ3 −8.16 +2.19 −6.9 −10.8
2.3.3. 2,4-Diphosphonobutane-1,2-Dicarboxylic Acid (DPBDC) 9
Strong practical interests focused on polyfunctional phosphonocarboxylic acids, e.g.,
phosphonosuccinic acid (PBS), 1-phosphonopropane-1,2,3-tricarboxylic acid (PPTC), and
2-phosphonobutane-1,2,4-tricarboxylic acid (PBTC), which gave rise to analytical and NMR studies of
protolytic and complex formation equilibria [42–44,53].
The following section will deal with 2,4-diphosphonobutane-1,2-dicarboxylic acid (DPBDC) 9 to
demonstrate the potential of automated NMR titrations. Dissociation constants of this 6-valent acid
DPBDC 9 were obtained from precision potentiometric [53] and by 13C{1H}-NMR-controlled titrations
vs. NaOH [44].
13C{1H}-technique yielded Figure 4a–d. The spin enumeration used in subsequent tables and
figures is given in Scheme 7:
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Scheme 7. Spin enumeration in DPBDC 9 used for 13C{1H}-NMR C1* and C2* = COOH, COO−. P2*
and P4* = PO3H2, PO3H−, PO32−.
Results for those six carbon atoms C1*, C2*, and C1 to C4 will be presented as (δ,τ))-contour plots
in four separate spectral ranges shown in Figure 4a–d. Numerical results including specific chemical
shifts δC and coupling constants nJPC of DPBDC are listed in Tables 15 and 16.
Table 15. Dissociation constants of 2,4-diphosphonobutane-1,2-dicarboxylic acid (DPBDC) as obtained
from 13C{1H}-NMR-controlled and potentiometric titrations vs. NaOH. * Concentrations given in
mol/L.
13C{1H} NMR [44] Potentiometric [44] Potentiometric [53]
pK1 1.07 0.6 1.806 ± 0.066
pK2 2.73 2.42 2.250 ± 0.021
pK3 4.82 4.32 4.078 ± 0.005
pK4 7.05 6.46 6.562 ± 0.004
pK5 8.95 8.18 8.664 ± 0.006
pK6 11.62 10.75 12.839 ± 0.007
CTitrand 0.262 (DPBDC) * 0.0050 (DPBDC) * 0.01119 (DPBDC) *
CTitrator 3.986 (NaOH) * 0.0975 (NaOH) * 0.09863 (TMAOH) *
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(d) 
δ δ δ δ δ δ
Figure 4. (a) The carboxylate functions C1* (note: 3JPC) and C2*. δC = 186 to 177 ppm; (b) The skeleton
carbon C2 (note: 1JPC and 3JPC). δC = 56 to 50 ppm.; (c) The skeleton carbon C1. δC = 44 to 38 ppm;
(d) The skeleton carbons C3 and C4 (note: 1JPC). δC = 32 to 23 ppm.
Table 16. Specific chemical shifts δC [ppm], coupling constants nJPC [Hz] and gradients Δi [ppm] of
2,4-diphosphonobutane-1,2-dicarboxylic acid DPBDC 9. For experimental data, see Table 15.
C1 C2 C3 C4 C1* C2*
Species δC δC
1JPC 3JPC δC δC 1JPC 3JPC δC 3JPC δC
H6L 38.29 52.19 124.2 18.4 27.26 25.11 134.0 4.7 177.23 17.5 177.53
H5L
− 38.70 52.42 116.8 18.2 27.51 25.56 132.4 5.1 177.82 15.9 178.66
H4L
2− 39.38 52.98 116.9 17.3 29.09 26.34 131.3 6.3 178.85 12.5 179.18
H3L
3− 41.78 54.06 116.7 16.8 30.95 26.15 131.3 9.0 181.69 6.4 180.70
H2L
4− 43.28 54.66 115.9 16.6 29.98 26.54 130.3 9.9 183.46 4.3 181.53
HL5− 43.26 55.04 115.8 15.9 30.99 27.51 128.3 9.4 184.08 5.3 182.53
L6− 42.70 55.01 111.7 16.3 29.87 28.65 127.7 - 184.82 18.9 186.15
Gradients
Δ1 +0.41 +0.23 −7.4 −0.2 +0.25 +0.45 −1.6 +0.4 +0.59 −1.6 +1.13
Δ2 +0.68 +0.56 +0.1 −0.9 +1.58 +0.78 −1.1 +1.2 +1.03 −3.4 +0.52
Δ3 +1.40 +1.08 −0.2 −0.5 +1.86 −0.19 0.0 +2.7 +2.84 −6.1 +1.52
Δ4 +1.50 +0.60 −0.8 −0.2 −0.97 +0.39 −1.0 +0.9 +1.77 −2.1 +0.83
Δ5 −0.02 +0.38 −0.1 −0.7 +1.01 +0.97 −2.0 −0.5 +0.62 +1.0 +1.00
Δ6 −0.56 −0.03 −4.1 +0.4 −1.12 +1.14 −0.6 - +0.74 +13.6 +3.62
Some Comments on DPBDC 9
A complicated example for NMR-controlled titration which needs some discussion is
2,4-diphosphonobutane-1,2-dicarboxylic acid DPBDC 9. Measurements and data evaluation were
performed according to the state of technique. But it is not possible to explain all the parameters found
for compound 9 by comparison with data from analogous structural elements of HOOC-(CH2)n-PO3H2
(n = 1 to3) 7b to 7d, H2O3P-(CH2)3-PO3H2, and phosphonopolycarboxylic acids 10 to 12 shown in
Scheme 8:
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Scheme 8. Phosphonopolycarboxylic acids 10 to 12 used for comparative 13C{1H}-NMR-controlled
titrations.
In a starting phase, 1D and 2D NMR techniques involving 1H-, 1H{31P}-, 13C-, 13C{1H}-,
and C,H-COSY spectra were combined to assign the carbons C1*, C2*, C1 to C4 and phosphonate
functions P2* and P4*.
For 13C{1H}-NMR-controlled titration, the deprotonation steps may be divided into three sections
(see Table 15 and Figure 4a,d). For τ = 0 to 2 deprotonation PO3H2 → PO3H− takes place, first at P2*
and then at P4*. In the second section for τ = 2 to 4, the carboxylic units C1* and C2* are deprotonated.
Finally for τ = 4 to 6 the deprotonation PO3H− → PO32− takes place at P2* and P4*.
(1) Comments on Chemical Shifts δC of Carbon Atoms in DPBDC 9
The deprotonation of PO3H2, PO3H− and COOH functions in DPBDC 9 leads to a monotonous
down field shift for δC C1* and C2* (see Figure 4a), while carbons C1 to C4 exhibit specific
non-monotonous trends (see Figure 4b,d).
Since gradient Δ6 for δC (C1*) > Δ5 for δC (C1*), the final sixth deprotonation steps is affiliated with
P2*. This conclusion is confirmed by Δ6 for δC (C2*) >> Δ5 for δC (C1*). Hence, the fifth deprotonation
step of 9 is due to PO3H− → PO32− of P4*. Dynamic chemicals shifts δC of C1* span a range from 177.5
to 184.61 ppm, while δC of C2* is found from 178 to 185.1, as shown in Figure 4a.
A tentative explanation may be found using Δ3 for δC (C1*) > Δ4 for δC (C1*) and Δ3 for δC (C2*)
< Δ4 for δC (C1*). These findings imply that the carboxylic function C1* is more acidic than C*2.
Similar arguments for the relative acidity of C1* and C2* may be derived from the chemical shift
δC of the skeleton carbon C2 (see Figure 4b). δC (C2) of H6L corresponds to 52.2 ppm, while the totally
deprotonated form L6− is found at 55 ppm. Deprotonation at C1* and C2* is characterized again by Δ3
of δC (C2) > Δ4 of δC (C2).
Chemical shifts δC of C3 span a range of 38.4 to 43.3 ppm. Surprisingly, the final deprotonation
HL5− → L6−, due to PO3H− → PO32− of P2* reduces δC (C3) from 43.26 to 42.70 ppm. This is the first
observation (within this context) of a negative gradient (Δ6 = −0.56 Hz) connected to deprotonation at
a PO3H− unit.
The situation is even more complex for the chemical shift δC of C2 covering a range from 27.4
to 30.9 ppm (Figure 4d). Two negative gradients are observed: Δ4 = −0.97 ppm for H3L3− →H2L4−
due to deprotonation at C2* and Δ6 = −1.12 ppm for HL5− → L6− induced by deprotonation at P2*.
For simpler compounds CH3-(CH2)n-COOH (n = 0 to 3) and HOOC-(CH2)n-COOH (n = 1 to 3), solely
positive gradients were described [54].
In addition, we did not observe negative gradients for compounds 7b to 7d and 10 (PBC), but in
11 (PPTC) and in 12 (PBTC) [43].
The major RR/SS diastereomer of PPTC 11 exhibited a negative gradient Δ5 (C1) = −0.44 ppm
for the final deprotonation step PO3H− → PO32− at P3*. An upfield shift occurred, since δc (C1) of
HL4− = 42.17 ppm and δc (C1) of L5− = 41.73 ppm. This effect might be due to opening of hydrogen
bridges and conformational changes. In contrast here to is the minor RR/SS diastereomer of PPTC,
it does not show a negative gradient Δ5 (C1) [42,44].
Weaker negative gradients Δ5 = −0.22 ppm are observed for chemical shifts δC of both carbons C1
and C3 in PBTC 12. The final deprotonation PO3H− → PO32− at P2* is affiliated with following data:
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δc (C1) of HL4− = 43.54 ppm, δc (C1) of L5− = 43.32 ppm, and δc (C3) of HL4− = 32.60 ppm, δc (C3) of
L5− = 32.60 ppm. In contrast hereto carbons C2 and C4 in PBTC 12 exhibit positive gradients Δ5.
Those unexpected observations for chemical shifts δc in 9 and conformational aspects will be
mentioned in the following section on coupling constants nJPC as well.
(2) Comments on Coupling Constants nJPC (n = 1 to 3) of DPBDC 9
The vicinal coupling 3JPC (P2*C1*) is remarkably sensitive towards the protonation state
(see Figure 5):
Figure 5. Three coupling constants 3JPC (P2*C1*), 3JPC (P2*C4), and 3JPC (P4*C12) in DPBDC 9.
For the protolytic species H6L to H2L4− of 9, a decrease in 3JPC (P2*C1*) from 17.5 Hz down to
a minimum of 4.3 Hz is observed, followed by an increase from 5.3 Hz to 18.6 Hz due to HL5− and
finally L6−. Between pH = 7 and 8, a maximum of the protolytic species H2L4− is expected, while HL5−
dominates around pH = 9. Those observations indicate changes of the dihedral angle of P2*-C2-C1-C1*
















Scheme 9. Tentative hydrogen bridges for protolytic species H3L3− to HL5−.
A corresponding bridge -C1-P-O—H—O-P-C2- was discussed for the HL3− species of
ethane-1,2-bisphosphonic acid [44].
2JPC (P2*C1), 2JPC (P2*C3), 2JPC (P2*C2*), and 2JPC (P4*C3) were not resolved in 13C{1H}-NMR
spectra obtained by NMR-controlled titrations.
3JPC (P2*C4) shows a monotonous increase from 4.7 Hz to a maximum of 9.9 Hz for the sequence
H6L to H2L4− followed by a decrease to 9.4 Hz for HL5−. This observation points towards an increase
in the dihedral angle in P2*-C2-C3-C4.
3JPC (P4*C2) is less sensitive towards deprotonation but larger than 3JPC (P2*C4) and found in a
range from 18.4 to 16.3 Hz possibly indicating a tendency towards trans-conformation of the fragment
P4*-C4-C3-C2. For comparison, 3JPC in HOOC-(CH2)3-PO3H2 7d appeared in a corresponding range
from 17.2 to 17.9 Hz.
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1JPC (P2*C2), ranging from 124.2 to 111.7 Hz, is markedly smaller than 1JPC (P4*C4), which is
observed from 134.0 to 127.7 Hz. A 1JPC, pH diagram is given in Figure 6 below:
Figure 6. 1JPC (P2*C2) and 1JPC (P4*C4) of DPBDC 9.
1JPC (P2*C2) is very indicative and selective for the deprotonation of the phosphonic functions
PO3H2 → PO3H− and PO3H− → PO32−. It indicates that the first deprotonation (pK1 = 1.07) of
DPBDC 9 takes place at P2* with a strong gradient Δ1 1JPC (P2*C2) = −7.4 Hz. The final deprotonation
(pK6 = 11.62) is affiliated with P2* as well as indicated by Δ6 1JPC (P2*C2) = −4.1 Hz. This assignment
leaves pK2 = 2.73 and pK5 = 8.95 to the deprotonation of P4*. Deprotonation at the carboxylic groups
(pK3 = 4.62) and pK4 = 7.05) does not significantly affect 1JPC (P2*C2) and 1JPC (P4*C4).
Results on 1JPC (P2*C2) of 9 are consistent with observations on phosphonosuccinic acid 10,
where 1JPC (P2*C2) is found in a range from 133.7 to 112.1 Hz. Strong gradients Δ1 = −17.1 Hz and
Δ4 = −4.5 Hz are affiliated with the deprotonation of P2*, while deprotonations of C1* and C2* do not
significantly influence 1JPC (P2*C2).
3. Conclusions
Automated NMR-controlled titrations efficiently combine 1H, 13C-, 19F-, and 31P-NMR
spectroscopy with potentiometric titrations to determine dissociation constants, specific chemicals
shifts and coupling constants. Results are presented in two-dimensional plots, where NMR parameters
(chemical shifts, coupling constants) are correlated with analytical parameters (pH, degree of titration
τ). High digital resolution and high S/N are achieved in time- and material-saving measurements.
These hyphenated techniques are powerful instruments to identify the structure and purity of research
and industrial compounds. Limitations of accuracy due to the nature of glass electrodes occur at
very low and very high pH values, obscuring the lower and higher pKi values. In those situations,
single sample NMR methods are recommended. 13C{1H}-NMR-controlled titrations may be used for
conformational analysis. For more complicated structures, additional studies using pH-dependent
high-resolution 1H- and 1H{31P}-NMR spectra, X-ray diffraction of selected salts and molecular
modelling of acids and anions are needed to solve details of conformational problems. The latter topics
are laborious and beyond the scope of this paper.
4. Experimental
Details of the hardware and software used in NMR-controlled titration together with references
for this field are described in [31,32]. Most model compounds were obtained from external sources
listed under the acknowledgements.
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Abstract: Dinucleoside 5′,5′-polyphosphates (DNPs) are endogenous substances that play
important intra- and extracellular roles in various biological processes, such as cell proliferation,
regulation of enzymes, neurotransmission, platelet disaggregation and modulation of vascular tone.
Various methodologies have been developed over the past fifty years to access these compounds,
involving enzymatic processes or chemical procedures based either on P(III) or P(V) chemistry.
Both solution-phase and solid-support strategies have been developed and are reported here.
Recently, green chemistry approaches have emerged, offering attracting alternatives. This review
outlines the main synthetic pathways for the preparation of dinucleoside 5′,5′-polyphosphates,
focusing on pharmacologically relevant compounds, and highlighting recent advances.
Keywords: phosphorylation; dinucleotides; organophosphorus chemistry; mechanochemistry; dry
eye syndrome; diquafosol; denufosol
1. Introduction
Dinucleoside 5′,5′-polyphosphates (DNPs), commonly abbreviated as NpnNs, are essential to
human biological systems [1,2]. They contain two ribonucleosides, which are linked at the 5′-position
of their sugar moiety through n phosphate groups (Figure 1).
 
Figure 1. General structure of natural dinucleoside 5′,5-polyphosphates and canonical nucleobases.
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Historically, dinucleoside 5′,5′-polyphosphates (i.e., Ap2A and Up2U) were first isolated
by chemists [3]. In 1976, E. Rapaport and P.C. Zamecnik brought to light the presence of
P1,P4-diadenosine-5′-tetraphosphate (Ap4A) in mammals [4]. The authors assumed that this
dinucleotide could have a role in cellular communication as a “signal nucleotide”. Later, Up4A
was the first endogenous dinucleotide, possessing both purine and pyrimidine moieties, to be identified
in living organisms [5,6]. Currently, 17 symmetrical or mixed NpnNs have been isolated from human
tissues and characterized [2]. DNPs are released into the extracellular space from different types
of cells, such as platelets and endothelial cells, where they stimulate several cell-surface purinergic
receptors. They have a strong physiological and pathophysiological impact on the cardiovascular
system [2,7], and may also interact with enzymes, acting as inhibitors (e.g., kinases) or substrates [8–11].
Three classes of enzymes are known to catalyze the degradation of dinucleotides [10–12]: symmetrically
cleaving dinucleoside polyphosphate hydrolases, asymmetrically cleaving dinucleoside polyphosphate
hydrolases, and dinucleoside polyphosphate phosphorylases. Over the years, DNPs have gained
increased attention and their therapeutic potential has been revealed. Likewise, structural analogues
have been developed and some of them are drug candidates.
Herein, we first describe purinergic signalling, i.e., the role of nucleotides as extracellular signal
molecules, with a focus on the P2Y receptor subtypes that interact with dinucleotides. Then, we present
the synthetic strategies to obtain dinucleotides. Pyrophosphate bond formation has been addressed in
some recent reviews and book chapters [1,13–15]. The current review focuses on methods reported for
the synthesis of dinucleoside 5′,5′-polyphosphates, especially those of biological and pharmacological
interest. We also highlight recent advances in the field, such as green chemistry approaches. It should
be noted that methods for preparing cyclic dinucleotides [16] are beyond the scope of this review.
Furthermore, the synthesis of nicotinamide adenine dinucleotides [17] and mRNA cap analogues such
m7GpnN (see reviews [18–20]) are not presented.
2. Interaction of DNPs with Purine and Pyrimidine Receptors
Purinergic receptors are extracellular receptors, currently consisting of four subtypes of P1 (or
adenosine) receptors, seven subtypes of P2X ion channel receptors, and eight subtypes of P2Y receptors
(Figure 2). Specifically, P2Y receptors (P2YRs) are G-protein-coupled receptors (GPCRs) activated by
extracellular nucleotides, which are divided into two groups on the basis of sequence homology and
the type of G protein they are primarily coupled to [21–23].
 
Figure 2. The classification of purine and pyrimidine receptors and their main physiological agonists.
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Purinergic receptors are expressed in nearly all cell types, and have been found to play crucial
roles in many biological processes, e.g., neurotransmission, neuroprotection in hypoxia and ischemia,
regulation of cardiovascular function, platelet aggregation, smooth muscle contraction, secretion of
hormones, modulation of immune response, control of cell proliferation, differentiation, and apoptosis.
In this regard, different aspects of purinergic signaling such as the pathophysiology and the therapeutic
potential have been extensively reviewed [21–28]. Several purinergic compounds are already on
the market to treat thrombosis and stroke, and one dinucleotide is used to treat dry eye disease
(see Section 2.1).
DNPs are strong endogenous agonists of the purinergic system [2]. In particular, they interact
with the P2YRs, a family of high therapeutic relevance [2,23,29,30]. The P2Y1, P2Y11, P2Y12, and P2Y13
receptors are activated by adenosine 5′-di- or triphosphates (ADP and ATP), while uracil nucleotides
(UDP and UTP) are the endogenous agonists for the P2Y4, P2Y6, and P2Y14 receptors. On the other
hand, the P2Y2 receptor responds to both ATP and UTP. Natural dinucleoside tetraphosphates Ap4A
and Up4U have agonist potencies comparable to those of ATP and UTP at P2Y2 receptors [31–34].
It should be noted that dinucleotides are more resistant to hydrolysis than their parent mononucleotides,
but are generally less potent, and lack selectivity in many cases [9,23]. Ligand development for the class
of uracil nucleotide-activated P2Y receptors has been extensively reviewed by Rahefi and Müller in
2018 [23]. They have compiled existing data on, inter alia, dinucleotides such as ApnA (n = 2–6), UpnU
(n = 3–4) and structural analogues, as agonists for the uracil-activated P2YRs. Given the significant
clinical potential of the P2YRs, substantial research efforts directed towards developing P2YR ligands
for use as pharmacological tools and drugs have led to the discovery and development of a significant
number of agonists but, so far, only a moderate number of antagonists. Two relevant dinucleotides,
namely Up4U and Up4dC, have undergone clinical development to cure several diseases involving the
P2Y2 receptor (Figure 3).
 
Figure 3. Dinucleotides with clinical developments.
2.1. Up4U for the Treatment of Dry Eye Disease (DED)
Diquafosol tetrasodium (P1, P4-diuridine 5′,5′-tetraphosphate, Up4U, NS365, Diquas®) is the first
agonist of the P2Y2 receptor subtype that has been approved in Japan as 3% ophthalmic solution
(Santen Pharmaceutical Co, Ltd., Osaka, Japan) for the management of dry eye disease (see reviews
by Lau et al. [35], and Keating [36]). This pathology commonly causes symptoms including dryness,
irritation, itching, and light sensitivity. It is associated with tear film instability, increased tear film
osmolarity, and ocular surface inflammation. It impacts the daily life of patients and has a prevalence
that varies from 5% to 35%. DED results from either decreased aqueous tear production (aqueous
tear-deficient dry eye) or increased tear evaporation (evaporative dry eye), or both. Several studies
demonstrated the presence of P2X and P2Y receptors in ocular tissues (retina, ciliary body, and lens),
and indicated that P2Y2 receptors may be the main subtype of purinergic receptor located at the ocular
surface [33]. Clinical data show that diquafosol tetrasodium improves ocular surface staining and may
improve tear film volume and stability.
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2.2. Up4dC for the Treatment of Cystic Fibrosis
Denufosol tetrasodium (P1-uridine-P4-2′-deoxycytidine 5′,5′-tetraphosphate, Up4dC, dCp4U,
INS37217) is a mixed dinucleoside tetraphosphate. Along with Ap4A and Up4U, dCp4U acts as a
P2Y2 agonist [29,37]. It has been developed by Inspire Pharmaceuticals (now part of Merck) as an
inhaled drug for the treatment of cystic fibrosis [38]. This recessive genetic disease is characterized
by pulmonary and reproductive tract dysfunctions, involving abnormal ion transport and defective
mucociliary clearance. Denufosol acts on P2Y receptors expressed on the surface of airway epithelia
to stimulate chloride secretion independent of the chloride channel, which is dysfunctional in cystic
fibrosis. It was shown to significantly enhance tracheal mucus transport in an animal model [39,40].
The first clinical trials established a good safety profile. It was evaluated in two phase 3 clinical trials,
TIGER-1 and TIGER-2, as a therapy for cystic fibrosis patients [41,42]. In the first trial (TIGER-1), it
was found to significantly improve lung function in cystic fibrosis patients with normal to mildly
impaired lung function. Unfortunately, less than 3 weeks after publication of the TIGER-1 data, Inspire
Pharmaceuticals announced that the 466-patients, 48-week placebo-controlled phase 3 TIGER-2 clinical
trial, had failed to demonstrate any benefit [41,42].
3. Synthesis Based on P(V) Chemistry
To date, the most widely used methods to access dinucleotides involve P(V) chemistry. They are
based on the activation of a 5′-nucleotide (i.e., nucleoside 5′-mono, 5′-di and 5′-triphosphate) and the
reaction of the corresponding intermediate with a second 5′-nucleotide or inorganic pyrophosphate to
form dinucleotides containing up to six bridging phosphate groups. These steps are usually performed
in dry, aprotic solvents (mostly N,N-dimethylformamide, DMF), and, therefore, require the use of
nucleotides, as well as inorganic phosphate or pyrophosphate, in their tri- or tetra-n-butylammonium
forms due to solubility issues. Divalent cations, especially Mg2+ and Zn2+, are sometimes added as
catalysts for anhydride bond formation. It is assumed that the metal ion could serve two roles, namely,
the activation of the electrophilic P(V) center and templating the incoming phosphate nucleophile and
the P(V) electrophilic center [13].
3.1. Synthesis via a Phosphoromorpholidate Intermediate
The first description of a chemical synthesis of dinucleotides was reported in the mid-60s by
Moffatt and Khorana [43,44]. This strategy relies on the conversion of nucleoside 5′-monophosphates
(NMPs) into their phosphoromorpholidate derivatives, followed by reaction with a phosphate salt,
i.e., orthophosphate or pyrophosphate (Scheme 1). Briefly, the acidic form of the nucleotides were
activated with N,N’-dicyclohexylcarbodiimide (DCC) in the presence of morpholine, leading to the
nucleoside 5′-phosphoromorpholidates as 4-morpholine N,N’-dicyclohexylcarboxamide salts 1–3
(Scheme 1) [45]. In the second step, addition of pyrophosphate afforded the symmetrical dinucleoside
tetraphosphates. Similarly, dinucleoside triphosphates were obtained when pyrophosphate was
replaced by orthophosphate.
 
Scheme 1. Synthesis via phosphoromorpholidate intermediates [44].
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Since then, this approach has been adapted by several research groups to access Np2N,
Np3N, as well as some analogues. For example, Ap2A was obtained in 90% yield,
through the condensation of the bis-(tri-n-butylammonium) salt of AMP and the adenosine-5′-
phosphoromorpholidate-4-morpholine-N,N’-dicyclohexylcarboxamide salt in anhydrous pyridine [46].
Mixed dinucleoside triphosphates were obtained in 10–30% yields, by reacting nucleoside
5′-phosphoromorpholidates with nucleoside 5′-diphosphates (NDPs), possibly in the presence of
tetrazole [31,47,48]. However, due to long reaction times and generally low yields, this method has
lost its relevance.
3.2. Synthesis via a Phosphorimidazolide Intermediate
Phosphorimidazolide derivatives exhibit high reactivity toward various nucleophiles. Therefore,
they have been extensively used as intermediates for pyrophosphate bond formation. Typically,
activation of a 5′-nucleotide (NMP, NDP or NTP) with N,N’-carbonyldiimidazole (CDI) in DMF,
followed by the in situ condensation with a second 5′-nucleotide or pyrophosphate, affords
dinucleotides containing two to four bridging phosphate groups in 10–60% yields [47–50]. Accordingly,
the tri-n-butylammonium salt of UMP was activated with CDI to form a phosphorimidazolide
intermediate 4, which reacted with the remaining nucleotide to form Up2U (Scheme 2) [47,49].
Slight modifications of this protocol allowed access to mixed dinucleotides [50]. First, activation of
the bis(tri-n-butylammonium) salt of CMP was performed using ≈ 2 equiv of CDI in DMF for 2 h
at rt, followed by the addition of dry methanol to quench the remaining CDI. Treatment with the
bis(tri-n-butylammonium) salt of GMP for 2 h at rt afforded Gp2C in 54% yield. Addition of GDP
instead of GMP in the second step afforded Gp3C, albeit in only 3% yield. Similarly, activation of NDPs
with CDI followed by reaction with a NMP allowed the isolation of dinucleoside triphosphates in low
yields [48].
 
Scheme 2. Activation of UMP by CDI to access Up2U [47,49].
Alternatively, symmetrical dinucleoside tetraphosphate Up4U was obtained, either by activation
of UMP with CDI followed by coupling with bis(tri-n-butylammmonium) pyrophosphate [47,49] or
dimerization of UDP in the presence of CDI [51] (Scheme 3).
 
Scheme 3. Dimerization of nucleotides to access symmetrical Up4U [49,51].
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Activation of ribonucleotides in the presence of an excess of CDI usually results in the
carbonation of the ribose moiety (Scheme 4). In 1H-decoupled 31P NMR spectroscopy, adenosine
5′-phosphorimidazolide is characterized by a singlet at −7.56 ppm, whereas phosphorimidazolide 5
exhibits a singlet at −7.76 ppm [52]. However, in some of the above-mentioned publications [47,49],
carbonation was not observed, and may be due to the experimental conditions (number of equivalents
of CDI, reaction time, temperature, adventitious presence of water). Nonetheless, the removal of the
2′,3′-carbonate protecting group can be easily performed under basic conditions [52,53].
Scheme 4. Reaction of AMP with 4 equiv CDI [52]. 31P chemical shifts are indicated in ppm together
with their multiplicity.
In 2011, a variant of the CDI method was developed by Yanachkov and co-workers [54], where
the activation of pyrophosphate by CDI gave rise to P1,P2-di(1-imidazolyl)pyrophosphate (Scheme 5).
Using 13C-labeled CDI and monitoring the reaction by 31P NMR (13C-31P and 1H-31P couplings), the
authors proposed a reaction mechanism involving the fast formation of mixed anhydrides, which
react slowly with imidazole to give diimidazolyl pyrophosphate. This activated pyrophosphate was
isolated as its disodium salt 6 by precipitation with sodium perchlorate in acetone, and then reacted
with AMP or UMP to afford the symmetrical 5′,5′-dinucleoside tetraphosphates Ap4A and Up4U in
good yields (Scheme 5). Noteworthy, the use of 1H-tetrazole or zinc chloride during the second step
allowed the reaction time to be shortened from 24–48 h to 3–16 h.
 
Scheme 5. Np4Ns synthesis using P1,P2-di(1-imidazolyl)pyrophosphate 6 [54].
Interestingly, this approach allows the preparation of dinucleotide analogues, starting from
modified pyrophosphate (the central oxygen being replaced with monofluoro, monochloro or
dichloromethylene). These DNPs analogues were obtained in 70–80% yields.
While these methods involving phosphoromidazolides are straightforward and rapid, they all
require dry conditions to prevent side-product formation and most often, use trialkylammonium salts.
To avoid this drawback, our research group has recently developed a one-pot synthesis of dinucleotides,
either in aqueous solution or mechanochemically, through the use of phosphorimidazolides
intermediates [55,56]. These strategies will be detailed in Section 5 and are related to green
chemistry approaches.
3.3. Synthesis via a Cyclic Trimetaphosphate Intermediate
The initial synthesis of trimetaphosphate esters from ATP was described by Khorana [57].
Later, Ng and Orgel reported that adenosine 5′-polyphosphates can react with 1-ethyl-3-(3-dim
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ethylaminopropyl)carbodidimide (EDC) in water to form diadenosine 5′,5′-polyphosphates as the
main products [58]. Yields were improved by performing the reaction in organic solvents such as
DMF or DMSO, in the presence of DCC and using the tris or tetrakis(tri-n-butylammonium) salts
of nucleotides [31,47]. The activation of nucleoside 5′-triphosphates (NTPs) with DCC proceeds via
a cyclic nucleoside 5′-trimetaphosphate intermediates (7–8), which can further react with another
NMP to produce the corresponding dinucleoside tetraphosphates (Scheme 6). Accordingly, Up4U and
Up4A were obtained in low yields starting from UTP and ATP, respectively. One should note that
N,N’-dicyclohexylurea (DCU) may be removed as a precipitate either after the first or the second step
of the reaction.
 
Scheme 6. Synthesis of Np4Ns starting from nucleoside 5′-triphosphates (NTPs) [47].
Similarly, the activation of UTP or ATP with DCC in anhydrous DMF, followed by the addition
of the tris(tri-n-butylammonium) salt of UDP or ADP in the second step of the reaction, afforded
Up5U and Ap5A, in 10–60% yields [8,49,50]. Reactions must be performed under strictly anhydrous
conditions and long reaction times are required.
In 2013, the Taylor research group reported a high-yielding synthesis of dinucleoside
pentaphosphates (Np5N) using the tri(tetra-n-butylammonium) salt of cyclic trimetaphosphate 9
as a phosphorylating agent [59]. The latter was prepared in almost quantitative yield by conversion of
the trisodium salt of trimetaphosphate 10 into its pyridinium form, and then by titration of the solution
to pH 7.0 with a dilute solution of tetrabutylammonium hydroxide and freeze-drying (Scheme 7).
Scheme 7. Preparation of the cyclic trimetaphosphate 9 [59].
Then, the electrophilic reagent 9 was functionalized by a sulfonyl leaving group (LG)
using N-methylimidazole (NMI) in the presence of either 2-mesitylenesulfonyl chloride 11 or
1-benzenesulfonyl-3-methyl-imidazolium triflate 12 in DMF (Scheme 8). Compound 11 was
commercially available, whereas 12 was prepared in two steps starting from benzenesulfonyl chloride
and imidazole [60]. Based on 31P NMR monitoring of the reaction, the authors proposed that the
activation proceeds via a mixed anhydride 13, which reacts with NMI to give rise to intermediate 14.
Addition of sub-stœchiometric amounts of NMPs to the activated cyclic trimetaphosphate 9
allowed their conversion to intermediates 15–18, as suggested by 31P NMR (Scheme 9). Addition of
slight excess of the second NMP and anhydrous MgCl2 gave rise to the corresponding dinucleoside
pentaphosphates. In the absence of Mg2+ ions, the reaction was extremely slow.
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Scheme 8. Activation of the cyclic trimetaphosphate 9 [59].
 
Scheme 9. Synthesis of dinucleoside pentaphosphates via an activated cyclic trimetaphosphate [59].
31P chemical shifts are indicated in ppm, together with their multiplicity.
This method constitutes an interesting approach as it allows formation of symmetric as well
as mixed Np5Ns in high yields, and uses inexpensive reagents (sodium cyclic trimetaphosphate,
mesitylene chloride, NMI). It has recently been applied for the synthesis of dicaptides, used as
substrates for polymerases [61]. However, it requires the preparation of the tetra-n-butylammonium
salts of the cyclic trimetaphosphate and those of the nucleotides, reaction times are long (> 3 days),
and must be performed under strictly anhydrous conditions.
3.4. Synthesis via a Phosphoromethylimidazolium Intermediate
Reacting the free acids of canonical nucleoside 5′-monophosphates with a large excess of NMI
in the presence of triphenylphosphine/2,2′-dipyridyl sulfide as coupling agents and triethylamine in
DMF or DMSO allowed dimerization to Np2N in about 85% yields [62]. Unsymmetrical dinucleotides
could also be obtained, albeit in much lower yields, by using a equimolar amount of the two NMPs to
be coupled.
Another methodology to provide symmetrical and mixed dinucleoside polyphosphates
NpnN (n = 2–4) was inspired by the Bogachev procedure for the synthesis of
deoxynucleoside 5′-triphosphates (dNTPs) [63]. It involves the reaction of nucleoside
5′-monophosphates-N-methylimidazolium as donors with an NMP, NDP or NTP to obtain
dinucleoside di, tri and tetraphosphates (Scheme 10) [64]. These donors were prepared by treatment
of the NMPs (disodium salts dihydrate or free acid hydrate) with a 16-fold excess of trifluoroacetic
anhydride (TFAA) in acetonitrile (ACN) in the presence of excess triethylamine. This step resulted
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in the temporary protection of the hydroxyl and the amino (if present) groups and formation of a
mixed anhydride, as shown by 31P NMR (δ = 2 ppm for the mixed anhydride formed within a few
minutes). It offered the additional benefit of drying the starting materials without deleterious effects
on the reaction outcome. However, in the case of GMP, these conditions resulted in the complete
decomposition of the starting material. This limitation could be circumvented by using GMP in its
tri-n-butylammonium form, together with reducing the number of equivalent of TFAA.
 
Scheme 10. Synthesis of dinucleotides via phosphoromethylimidazolium intermediates [64].
After removal of unreacted TFAA, the mixed anhydride was reacted with excess NMI in the
presence of triethylamine to quantatively afford the highly reactive N-methylimidazolium salt donors
19–22 within 10 min. Formation of the N-methylimidazolium salts could also be easily followed
by 31P NMR spectroscopy as these species exhibit chemical shifts of approximately −9 to −10 ppm.
The crude acetonitrile solutions were used directly in the next step. Thus, addition of the donors
solutions to the bis(tri-n-butylammonium) salts of the nucleotide acceptors in DMF (in acetonitrile
precipitation of the acceptors was observed) led to partially protected products. The latter were treated
with aqueous ammonium acetate to remove the protecting groups, providing the desired compounds.
For dinucleotides involving guanine nucleotides, N,N-dimethylaniline was found to be beneficial.
Using this procedure, up to nine dinucleotides were obtained in yields of 51–68%. It should be noted
that this method cannot be used to activate nucleoside 5′-di- or triphosphates. While the reactions
were performed under argon, the authors pointed out that vigorous drying of the donor precursors
was not always necessary when preparing the dinucleoside di- and triphosphates. Advantages of this
one-pot method are short reaction time and good yields.
The same group also reported the synthesis of symmetrical di- and tetraphosphates by
dimerization of nucleotides, using sulfonyl imidazolium salt 12 as a reagent (Scheme 11) [60,65].
The tetra-n-butylammonium salts of nucleoside 5′-mono or 5′-diphosphates were activated in DMF
with 0.6–0.75 equiv of 12 in presence of 1–3 equiv of NMI and MgCl2 (Scheme 11). Dimerization of the
nucleotides led to Np2N and Np4N in high yields.
31P NMR analyses showed that the reaction proceeds via the formation of the N-methylimidazolium
salt intermediates 23–27 (Figure 4, 31P δ = −9.2 ppm), which are able to react with the remaining
nucleotide to form the corresponding dimer.
Mixed dinucleotides could also be obtained in high yields, by introducing minor modifications
into the protocol. Accordingly, activation was performed in the presence of a small excess of sulfonyl
imidazolium salt 12, and NMI was replaced by diisopropylethylamine (DIPEA) to prevent dimerization
(Scheme 12). Moreover, the time of reaction of the first step was reduced to 1 min. Cp2A and Ap3U
were obtained in similar yields starting from AMP and UMP, respectively.
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Scheme 11. Synthesis of symmetrical Np2N and Np4N [60].
 
Figure 4. Phosphoromethylimidazolium intermediates [60].
 
Scheme 12. Synthesis of mixed dinucleotides [60].
Finally, mixed adenine dinucleotides were obtained in high yields by activating the
tetra-n-butylammonium salt of ATP with sulfonyl imidazolium salt 28, followed by reaction with a
second nucleotide (Scheme 13). Investigation of the first step by 31P NMR revealed that the reaction
proceeds via a cyclic adenosine trimetaphosphate intermediate 8.
 
Scheme 13. Synthesis of mixed dinucleotides starting from ATP [60].
The advantages of this method using sulfonylimidazolium salts as key reagents, include short
reaction times, access to a wide range of NpNs (n = 2–6) and high yields. However, careful attention
must be paid to maintain anhydrous conditions.
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3.5. Synthesis via a Phosphoropiperidate Intermediate
In 2014, the Sun research group developed an approach based on the activation of nucleoside
5′-phosphoropiperidates with 4,5-dicyanoimidazole (DCI) as activator. The phosphoropiperidates
29–32 were obtained beforehand from unprotected NMPs via a redox condensation involving
triphenylphosphine and 2,2′-dithiodianiline (Scheme 14) [66].
 
Scheme 14. Synthesis of nucleoside 5′-phosphoropiperidates [66].
As shown in Scheme 15, the reaction of nucleoside 5′-phosphoropiperidates with the
tri-n-butylammonium salts of nucleotides (NMPs, NDPs, NTPs) in the presence of 2.5–3 equiv of DCI, led
to the formation of more than 20 symmetrical or mixed dinucleoside di-, tri- and tetraphosphates [67,68].
Yields of NpnN’s dropped significantly along with the increase of the polyphosphate chain.
Scheme 15. Synthesis of dinucleotides from nucleoside 5′-phosphoropiperidates [67,68].
Among the polar aprotic solvents, N-methylpyrrolidone exhibited the best solvency for the
tri-n-butylammonium salts of both NDPs and NTPs, while DMF was preferred for NMPs. Considering
the cost of nucleoside 5′-polyphosphates and their similar chromatography properties with the
products, only 0.5 equiv of NDPs or NTPs were used. This P(V) method is an efficient one, allowing
access to a large range of NpnNs (n = 2–4) in short reaction times and good to high isolated yields.
Symmetrical NpnN (n = 3–5) could also be obtained by reacting nucleoside 5′-phosphorop
iperidates with sub-stœchiometric amounts (0.35–0.4 equiv) of inorganic phosphorylating agents in
the presence of excess DCI [69]. In this alternative protocol, bis(tetra-n-butylammonium) hydrogen
phosphate, tris(tetra-n-butylammonium) hydrogen pyrophosphate or tris(tetra-n-butyl-ammonium)
dihydrogen triphosphate were used instead of a nucleotide (Scheme 16). 31P NMR tracking experiments
showed that pyrophosphate reacts first with the starting phosphoropiperidate to form an NTP, and
then, with the remaining phosphoropiperidate to give rise to Np4N. This methodology was also
adapted to the synthesis of nucleotides with a higher number of phosphate groups (such as Np5N),
using inorganic triphosphate instead of pyrophosphate.
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Scheme 16. Synthesis of symmetrical NpN by dimerization [67,68].
Interestingly, this strategy can be adapted to the synthesis of nucleotide analogues such
as dinucleoside P2,P3-(dihalo)methylene tetraphosphates, by replacing pyrophosphate with
bisphosphonate reagents.
4. Synthesis Based on P(III) Chemistry
Several methods involve P(III) reagents to provide phosphite or phosphoramidite intermediates,
which are further oxidized to P(V). Initially developped for the synthesis of oligonucleotides, they
have been adapted to dinucleotides by introducing minor modifications in the last steps of the reaction
sequences. Because of the high reactivity of P(III) species, most of these approaches require the use of
N-, and O-protecting groups on the starting nucleos(t)ides and strictly anhydrous conditions.
4.1. Synthesis via a Salicylphosphite Intermediate
This strategy is based on the well-known Ludwig–Eckstein procedure for NTP synthesis [70],
and allows the one-pot preparation of symmetric dinucleoside tetra- and pentaphosphates
starting from protected nucleosides [71]. Phosphitylation of triacetyl adenosine 33 with
2-chloro-4H-l,3,2-benzo-dioxaphosphorin-4-one (salicylchlorophosphite) led to intermediate 34, then
addition of bis(tri-n-butylammonium) pyrophosphate gave rise to the cyclic intermediate P(III)–P(V)
35 (Scheme 17). Oxidation to the cyclic trimetaphosphate, intermediate 36, followed by reaction with
adenosine 5′-monophosphate (AMP) or adenosine 5′-diphosphate (ADP) in dry DMF in the presence of
ZnCl2 as catalyst, afforded 37 and 38, respectively. Removal of the acetyl groups under basic conditions,
ion exchange to remove the Zn2+ cations and purification led to Ap4A and Ap5A as ammonium salts.
It should be noted that symmetrical Ap4A was obtained in much better yield than Ap5A.
 
Scheme 17. Synthesis of the symmetrical dinucleotides Ap4A and Ap5A by phosphitylation [71].
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The guanosine derivatives Gp4G and Ap4G were prepared in a similar manner, starting from
2′,3′-O-2-N-triacetylguanosine 39 (Scheme 18).
 
Scheme 18. Synthesis of dinucleotides Gp4G and Ap4G by phosphitylation [71].
4.2. Synthesis via a Cyclosaligenyl Phosphite Intermediate
This strategy initially developed by Meier and co-workers for the synthesis of prodrugs of
nucleotides, called cycloSal (for cyclosaligenyl) pronucleotides [72,73], has been applied to the synthesis
of nucleoside 5′-polyphosphates, sugar nucleotides and mixed dinucleotides [74,75]. Phosphochloridite
40 was prepared from the corresponding salicyl alcohol and phosphorus trichloride (Scheme 19).
Reaction with 3′-O-acetylthymidine followed by oxidation with oxone (2 KHSO5.KHSO4.K2SO4)
afforded 5-nitro-cycloSal-3′-O-acetylthymidine phosphotriester 41.
 
Scheme 19. Synthesis of a cycloSal phosphotriester derivative of thymidine [74].
This phosphotriester was too sensitive to moisture to be purified by chromatography. Therefore,
the crude material (obtained after liquid-liquid extraction) was directly engaged in the next step, i.e.,
reaction with rigorously dried tetra-n-butylammonium UMP and tris(tetra-n-butylammonium) ATP in
DMF (Scheme 20). After removal of the acetyl group and ion-exchange (n-NBu4+ to NH4+), Up2T and
Ap4T were obtained in their ammonium form.
 
Scheme 20. Synthesis of the dinucleotides Up2T and Ap4T [74].
This approach has been adapted to solid phase [76]. The key intermediates of the synthesis are
the 5′-substituted cycloSal nucleotides linked to a polystyrene support through the 3′-OH group and a
succinyl linker (42–44, Figure 5).
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Figure 5. Structure of the supported nucleoside phosphotriesters [76].
Preparation of these intermediates started with the anchoring of the succinyl linker
to the 5′-O-(4,4′-dimethoxytrityl)-protected nucleosides, and removal of the protecting group
with trifluoroacetic acid (TFA). The 3′-O-succinylnucleosides were then treated with the
appropriate chlorophosphites, followed by oxidation with oxone, to give rise to compounds
45–47 (Scheme 21). Coupling with the aminomethyl polystyrene support was achieved using
1-hydroxybenzotriazole (HOBt) and N,N’-diisopropylcarbodiimide (DIC) as coupling agents.
Alternatively, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) and
4-ethylmorpholine may be used. Conversion to Up2T and Up2dA was carried out by adding a large
excess of tetra-n-butylammonium UMP, and then cleavage under basic conditions (70–78% purity, no
overall yield was given). Compared to the solution phase synthesis, this supported approach is less
straightforward and involves multiple steps.
Scheme 21. Solid-phase synthesis of dinucleoside 5′,5′-diphosphates [76].
4.3. Synthesis via a Supported Phosphite Intermediate
Another P(III) strategy combined with a solid-phase approach was reported by Ahmadibeni and
Parang [77]. Using these polymer-bound phosphitylating reagents, symmetrical 5‘,5‘-dinucleoside
mono, di, tri, and tetraphosphates were prepared. Compounds 48–51 were obtained in 2 to 5 steps
starting from phosphorus trichloride (Figure 6). Coupling with aminomethyl polystyrene resin-bound
p-acetoxybenzyl alcohol yielded four classes of supported-phosphitylating reagents 52–55 (Figure 6).
 
Figure 6. Synthesis of the immobilized phosphitylating reagents [77].
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These supported reagents were reacted with unprotected nucleosides (e.g., thymidine,
adenosine, cytidine, inosine or the analogue 3′-azido-3′-deoxythymidine) in the presence of
5-(ethylthio)-1H-tetrazole to afford compounds 56–59 (Scheme 22). Polymer-bound nucleotides
underwent oxidation with tert-butyl hydroperoxide to 60–63, then removal of the cyanoethoxy groups
with 1,8-diazabicyclo[5.4.0]undec-7-en (DBU) was performed. Acidic treatment of 60 and 64–66 gave
rise to the corresponding symmetrical dinucleotides in 59–78% yields starting from the supported
reagents 52–55.
Scheme 22. Synthesis of symmetrical dinucleotides using polymer-bound phosphitylating reagents.
Yields are given for the adenine derivatives [77].
This strategy allowed the synthesis of symmetrical dinucleotides starting from unprotected
nucleosides without the need to purify the intermediates. It also offers the advantage of facile recovery
of final products by filtration (trapped linkers on the resins). However, it requires the multistep
synthesis of the supported polyphosphite reagents. It should be highlighted that part of this work
could not be reproduced by others [78].
4.4. Synthesis via a 5′-H-Phosphonate Intermediate
This one-pot strategy developed by Sun et al. [79], and based on their previous work on the synthesis
of nucleoside triphosphates [80], involves the formation of a pyridinium phosphoramidate intermediate
starting from a nucleoside 5′-H-phosphonate monoester. Nucleoside 5′-H-phosphonate monoesters
67–70 were obtained from 2′,3′-O-isopropylidene ribonucleosides 71–74 using diphenylphosphite
as a reagent (Scheme 23). Then, removal of the isopropylidene group with aqueous TFA afforded
5′-H-phosphonate monoesters 75–78 in yields ranging from 68% to 82% over two steps.
 
Scheme 23. Synthesis of nucleoside 5′-H-phosphonates from the 2′,3′-protected nucleosides [79].
575
Molecules 2019, 24, 4334
H-phosphonates were silylated with trimethylsilyl chloride (TMSCl) in pyridine, and in situ
oxidized with iodine to generate the highly reactive zwitterionic pyridinium phosphoramidate
intermediates 79–82 (Scheme 24). Indeed, even trace amounts of water may result in the formation of
polyphosphate by-products. The authors hypothesized that if 50% of the phosphoramidate intermediate
could be hydrolyzed with precise control, NMP generated in situ would react with the remaining
phosphoramidate to afford Np2N as a major product. Accordingly, hydrolysis and coupling steps
were optimized using 31P NMR tracking experiments and accomplished by two sequential additions
of H2O in DMF. After purification and ion exchange, symmetrical dinucleoside diphosphates sodium
salts were obtained in 68–91% yields starting from the nucleoside 5′-H-phosphonates. Advantages of
this method are the short reaction time, simple purification procedure and high yields. However, it
requires the preliminary synthesis of the H-phosphonate starting materials.
Scheme 24. Synthesis of symmetrical dinucleotides from nucleoside 5′-H-phosphonates [79].
4.5. Synthesis via a Phosphoramidite Intermediate
In 2015, the Jessen research group developed a very efficient strategy based on an iterative
phosphoramidite approach to access nucleoside 5′-polyphosphates [81,82] and some derivatives [83].
The phosphoanhydride bond is formed by coupling a phosphoramidite (the donor) to a phosphate (the
acceptor). In contrast to the other P(III) methods, all steps were performed under ambient conditions,
i.e., in open flasks and using non-dried solvents. Regarding of the synthesis of dinucleotides,
2′,3′-O-diacetyl uridine 83 was treated with phosphorodiamidite 84 in the presence of 1H-tetrazole to
afford phosphoramidite 85 (Scheme 25). Addition of the tetra-n-butylammonium salt of UMP and
DCI, followed by oxidation with mCPBA, treatment with piperidine, and cleavage of the acetyl groups
under basic conditions, gave rise to Up2U as a mixed piperidinium/tetra-n-butylammonium salt. The
mixed dinucleotide Ap4U was also obtained by using the tetra-n-butylammonium salt of ATP and
5-ethylthio-1H-tetrazole (ETT) as an activator in the second step of the reaction (Scheme 25). It should
be noted that these experiments were performed on a small scale (10 mg).
Scheme 25. Synthesis of dinucleotides via a phosphoramidite intermediate [83].
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Symmetrical NpnNs (n = 3, 5, 7) could also be accessed via chemoselective homologative
dimerization of two phosphate monoesters with phosphorodiamidites [84]. The general strategy for
the synthesis of dinucleoside triphosphates is shown in Figure 7. First, phosphordiamidites 86 and 87
(donors) were coupled with a NMP (the acceptor), affording terminal mixed phosphoric anhydride
phosphoramidites 88–89 as unstable intermediates. Reaction with another phosphate monoester
resulted in the formation of 90 containing a PV–PIII–PV bridge, which was then oxidized to yield 91.
The corresponding Np3N was obtained after a final deprotection step.
 
Figure 7. General approach for the preparation of symmetrical Np3Ns based on dimerization [84].
The tetra-n-butylammonium salts of the canonical nucleoside 5′-monophosphates were treated
in DMF with 9-fluorenylmethyl-N,N,N’,N’-tetraalkyl phosphorodiamidites 86–87 in the presence of
ETT, followed by oxidation with mCPBA (Scheme 26). Progress of the reaction was monitored by 31P
NMR. The Fm-protected intermediates were isolated by precipitation with Et2O/hexane, treated with
piperidine, and purified by anion exchange chromatography to isolate the symmetrical dinucleoside
triphosphates as ammonium salts in good yields.
 
Scheme 26. Synthesis of dinucleotides via dimerization of phosphates [84].
This methodology was applied to the synthesis of symmetrical dinucleoside penta- and
heptaphosphates by using as acceptor a NDP or a NTP, respectively. However, due to the water-sensivity
of the intermediates, reactions had to be performed under anhydrous conditions, with a shorter reaction
time and low temperature (coupling with ETT 30 s at 0 ◦C, oxidation 5 min at 0 ◦C). Accordingly,
Ap5A and Ap7A were obtained in 50% and 18% yields, respectively. The chemoselective aspect of this
method is a great advantage as it allows to prevent the use of nucleoside protecting groups. Compared
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to other procedures using P(III) chemistry, it offers attractive features, notably these rapid reactions can
be run under ambient conditions.
5. Green Chemistry Approaches
Most of the reported methods present drawbacks, such as the use of non-volatile and toxic solvents
(DMF, pyridine, N-methylpyrrolidone), high sensitivity to moisture, preparation of substrates or
phosphorus reagents with lipophilic counterions due to solubility issues in organic media, anhydrous
conditions (i.e., dry reagents and solvents), fastidious purification and possibly prior synthesis of
the activated nucleotide substrates. An ideal procedure would meet the following requirements:
Applicable to a wide range of substrates where protecting groups are not necessary, and giving rise to
the products in short time and high yields.
In 2017, our research group reported a one-pot synthesis, in water medium, of nucleoside
5′-polyphosphates and dinucleotides starting from the corresponding NMPs [55,56]. This method uses
2-chloro-1,3-dimethylimidazolinium hexafluorophosphate (DMP) and imidazole as coupling reagents
to activate the NMP into their phosphorimidazolides. Dinucleoside diphosphates were obtained by
self-dimerization of the NMPs (Scheme 27).
 
Scheme 27. Preparation of symmetrical dinucleoside diphosphates in aqueous media [56].
Our work originated from the small-scale synthesis of NDP-sugars described by Tanaka et
al. [85]. The authors performed the coupling of a sugar-1-phosphate with a nucleotide in D2O, using
2-chloro-1,3-dimethylimidazolinium chloride (DMC) and imidazole (Scheme 28). Based on 1H and 31P
NMR spectroscopies, the reaction was shown to proceed via a 2-imidazolyl-1,3-dimethylimidazolinium
chloride intermediate 92, formed in situ by reaction of DMC and imidazole (Scheme 28). This
key intermediate was able to activate an NMP into its corresponding phosphorimidazolide 93 (via
intermediate 94), which then reacted with a sugar-1-phosphate salt to form a sugar nucleotide.
 
Scheme 28. Proposed activation mechanism of UMP to UMP-Im by 90 [85].
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The main advantage of these reactions, which occur in D2O [85] or in H2O/CH3CN [55,56]
instead of the usual organic solvents, is that the NMPs are used in their commercially available and
water-soluble forms, i.e., sodium and potassium salts. This greatly simplifies the handling of the
reaction. Moreover, protecting groups on the nucleotide are not required and no carbonation of
ribonucleotides are observed, in contrast to the use of CDI.
Alternatively, mechanochemistry has emerged in the field of nucleosides and, to a lesser extent,
nucleotides [86]. This technique enables solid/solid reactions through mechanical grinding under
solvent-free conditions [87–91]. In 2011, Ravalico et al. reported the mechanosynthesis of dinucleotides,
namely ApnA (with n = 2–4), Ap2dT and nicotinamide adenine dinucleotide (NAD+), starting from
adenosine 5′-phosphoromorpholidate 2, in the presence of magnesium chloride, 1H-tetrazole as the
acidic promoter and water (Scheme 29) [92]. Although advantageous, this methodology requires the
use of costly reagents, namely tetrazole and the phosphoromorpholidate substrate, the latter may be
prepared beforehand in solution using conventional solution synthesis [45].
Scheme 29. Ball-milling route using commercially available nucleotide salts and morpholidate reaction
partners [92].
In the course of our investigations on new strategies for phosphoanhydride bond formation, we
also investigated the ball-milling technique [93]. To begin with, activation of UMP was performed
according to the conditions previously reported in water medium (DMP/imidazole) [55,56], without
adding any solvent in a vibratory ball-mill (vbm) at 30 Hz. A complete conversion to Up2U was
obtained within 30 min, suggesting that UMP was activated to its phosphorimidazolide and reacted
promptly with the remaining UMP to form the dimer. Alternatively, we tested the use of CDI, which
has recently gained interest in the field of mechanosynthesis due to the safety of its by-products (i.e.,
imidazole and carbon dioxide), its efficacy in N-acylation reactions and relatively low cost [94–97].
Activation of UMP (acidic form) to the corresponding 5′-phosphorimidazolide 2′,3-carbonate 95 was
complete by grinding, for 1 h at 30 Hz, in the presence of 4 equiv. of CDI and acetonitrile (0.3 μL.mg−1)
as a liquid assistant (Scheme 30). The absence of reactivity observed using the disodium salt of UMP
suggests that the acid form is required to protonate the imidazole of CDI and to facilitate its substitution
by the phosphate monoester. This activation step was applied successfully to several ribonucleotides
and a 2′-deoxyribonucleotide (dTMP).
In the second step, a nucleoside mono, di or triphosphate was added onto the activated NMP
95–96 in order to form the desired DNPs (Scheme 30). Thus, the mixed dinucleoside 5′,5′-diphosphates
were successfully obtained by adding a slight excess of a NMP and a small amount of acetonitrile
(0.6–0.95μL/mg) in the jar, and then ball-milling for 2 h at 30 Hz. Remarkably, the second grinding
step also removed the carbonate protection. The reaction was less efficient with GMP, UDP and ATP,
and, thus, required a larger excess of reagent to form the corresponding dinucleotides Gp2U, Up3U
and Ap4U, respectively. This user-friendly mechanochemical approach only requires a slight excess of
reagents and limits the formation of side products. While isolated yields of symmetrical and mixed
dinucleoside polyphosphates are similar to other approaches, the set-up of the experiments and the
579
Molecules 2019, 24, 4334
workup are greatly simplified, saving a considerable amount of time. In addition, compared to the
previously reported mechanochemical synthesis [92], this one-pot two steps reaction starts from NMPs,
which are readily available.
 
Scheme 30. Mechanochemical approach to obtain DNPs starting from NMPs [93].
In addition to their simplicity, the mechanochemical approaches alleviate issues associated with
the low solubility of reagents in solution phase synthesis. Therefore, nucleotides and inorganic salts
can be used in their commercially available sodium or potassium forms.
6. Purification and Characterization
6.1. Purification
In this section, we provide a brief overview of the purification procedures for dinucleotides. Due
to their high polarity, they cannot be separated by normal-phase chromatography like most organic
compounds. In addition, the byproducts or side products formed during synthesis share similar
characteristics, resulting in a challenging separation from the desired compounds. The two main
purification methods, reported in Table 1, use ion-exchange or reverse-phase (RP) chromatography.
Table 1. Main methods to isolate dinucleotides.
Types of Chromatography Eluants References
Anion-exchange
DEAE-Sephadex® 0.02 M TEAB, pH 8; 10% ACN [54]
TOYOPEARL® DEAE-650M 0.2 M TEAB, pH 8; 10% ACN [54]
DEAE-Sephadex® Gradient of aq. NH4HCO3 [67,69]
Q Sepharose® Fast Flow Gradient of aq. NH4HCO3 [83,84]
DEAE Sepharose® Fast Flow Gradient of aq. NH4HCO3 [83,84]
C-18 reverse-phase
HPLC 0.01 M NH4HCO2, pH 4, 50% MeOH [46]
Semi-preparative HPLC TEAAc pH 7 or 9; 6–12% ACN [59,60,64]
Preparative HPLC 0.1 M NH4HCO3; ACN [71]
Preparative HPLC TEAB pH 7.8; 65% ACN [92]
RP-18 silica gel column Water [74]
RP-18 silica gel column 0.1 M TEAB, pH 7.5; 20% ACN [55,56]
RP-18 silica gel column 0.1 M TEAAc, pH 7; 5–10% ACN [93]
Gel filtration
Sephadex® LH-20 Deionized water [79]
The first type of ion-exchange support is positively charged, such as diethylaminoethyl (DEAE)
Sephadex, and allows the chemical species to elute according to their number of charges. Elution is often
performed using a gradient of triethylammonium hydrogen carbonate (TEAB) or ammonium hydrogen
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carbonate (NH4HCO3) buffers. Regarding C18 reverse-phase chromatography, either preparative or
semi-preparative high pressure liquid chromatography (HPLC) or chromatography on RP-18 silica
gel may be used. Compounds are often eluted using a gradient from an aqueous buffered solution,
such as triethylammonium acetate (TEAAc) or TEAB, to acetonitrile or methanol. Alternatively, gel
filtration was described for the purification of symmetrical Np2N. Then, the samples are usually
freeze-dried and converted to their sodium form by ion exchange using a Dowex-50W-Na+ resin.
The fact that purification is a time-consuming step is one of the reasons that pushed some research
groups to develop solid phase strategies [76,77]. Indeed, those methods were designed in order to
simplify purification of the final products, which can be collected by simple filtration. However, the
recovered materials showed moderate purity and an additional purification step was required [76].
Consequently, solution-phase approaches are still predominant.
6.2. Physico-Chemical Properties
NMR, UV spectroscopy, and mass spectrometry (MS) are the main tools for the analysis of
dinucleotides. Since the sugar and the phosphate moieties have no significant absorption above 230 nm,
dinucleotides exhibit UV absorption profiles similar to those of their parent nucleosides with λ max
values close to 260 nm [1]. MS analysis of nucleotides and derivatives such as dinucleotides has been
extensively reviewed by Banoub et al. [98]. Alternatively, 31P NMR is a very convenient tool to monitor
reaction courses, characterize reaction intermediates, and study the conformation of dinucleotides
and final compounds [1,50]. The chemical shift (δ) for most endogenous dinucleotides covers −8 to
−24 ppm, and exhibits pH and counter ion dependence [1]. Table 2 summarizes the literature data
for representative NpN (n =1–7). In 1H-decoupled 31P NMR, the phosphorus atoms closest to the
nucleosides are characterized by a singlet at approximately −10 ppm, while the phosphorus atoms
inside the polyphosphate chain exhibit resonance signals around −22 ppm.
Table 2. 31P Chemical shift ranges of dinucleoside polyphosphates in D2O.
NpnN δ Ranges References
Np2N’ 1 singlet (P1 + P2) from −9.6 to −11.5 ppm [47,49,50,53,56,60,64,67,74,76,77,79,83,93]
Np3N
1 doublet (P1 + P3) from −9.2 to −11.7 ppm
1 triplet (P2) from −21.0 to −23.4 ppm [47,49,50,54,60,64,67,69,84,93]
Np4N
1 multiplet or 1 broad singlet or 1 doublet
(P1 + P4) from −8.8 to −11.5 ppm [47,49,50,54,60,64,67,69,71,74,93]
1 multiplet or 1 br singlet or 1 doublet
(P2 + P3) from −20.6 to −23.1 ppm
Np5N
1 multiplet or 1 br singlet or 1 doublet
(P1 + P5) from −8.7 to −11.4 ppm [49,50,59,69,71,84]
1 multiplet or 1 br singlet or 1 doublet
(P2 + P3 + P4) from −20.2 to −22.5 ppm
Np6N
1 doublet at −10.1 ppm (P1 + P6)
1 multiplet at −21.7 ppm (P 2+ P3 + P4 + P5) [49]
Np7N
1 broad singlet or 1 doublet from −10.1 to
−11.6 ppm (P1 + P7) [49,84]
1 multiplet from −21.7 to −23.5 ppm
(P2 + P3 + P4 + P5 + P6)
Interestingly, the study of dinucleotides using NMR techniques (1H, 13C and 31P) can determine the
conformation (syn/anti, sugar puckering), nucleobase properties (tautomerism, H-bonds and π-stacking
interactions), as well as the anomeric α/β configuration. Such data are crucial for understanding the
structure–activity relationship of either natural or synthetic dinucleotides as enzyme inhibitors and
receptor ligands, and the design of potent therapeutic agents based on a dinucleotide scaffold. In this
regard, Stern et al. have performed conformational studies on physiologically active NpnN′ sodium
salts (N=A, G, U, C; N′ =A, G, U, C; n= 2–5) in neutral aqueous solution, using NMR and computational
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techniques [50,98]. While no predominant conformation was observed for the ribose moiety in any
of the studied dinucleotides, natural dinucleoside polyphosphates were more frequently found in a
folded (stacked) rather than an extended conformation. Purine dinucleotides showed greater stacking
interactions than pyrimidine dinucleotides. In addition, dinucleotides with longer phosphate chains
were found to have weaker stacking interactions. Crystal structures of Ap4A sodium salt [99], and some
dinucleotides bound to kinases or hydrolases are available [100,101]. In protein-bound dinucleotides,
the polyphosphate chain adopts various conformations: extended [100–103], S-shaped [101] or
folded [100]. In some cases, the protein-bound dinucleotides coordinate with a Mg2+ ion.
Finally, Chen and Kohler investigated the dynamics of excited electronic states formed by UV
excitation of the several diadenosine polyphosphates by femtosecond transient absorption (TA)
spectroscopy [104]. They found that the excimer states seen in TA experiments on nucleobase dimers
are only observed in π-stacked conformations, but the lifetimes of these states are insensitive to how
the stacked bases are oriented.
7. Conclusions
Naturally occurring dinucleoside 5′,5′-polyphosphates are involved in a variety of cellular
processes. Among them, symmetrical purine-containing dinucleotides are the most known
representatives, whereas pyrimidine-containing and mixed derivatives are still intensively studied.
Therefore, the development of synthetic methods required to obtain these compounds in few steps,
good yields, high purity and comfortable amounts generated interest from the chemists and remains a
field of intensive research. Herein, we have focused our attention on the synthesis of dinucleoside
5′,5′-polyphosphates, either symmetrical or mixed, and including non-modified pyrophosphate bonds.
These methods may involve P(III) and/or P(V) intermediates and solution-phase or supported chemistry.
P(V) synthetic approaches are usually based on the activation of a 5′-nucleotide using inexpensive
reagents but require the conversion of the substrates, as well as the phosphate reactants, into the
corresponding tri- or tetra-alkyl salts due to solubility issues. P(III) synthetic approaches are often
effective processes. However, the presence of protecting groups on the nucleoside is often mandatory,
thus increasing the overall number of steps. In most cases, strictly anhydrous conditions are essential
and the length of the poly-phosphate chain affects the yields of the synthesis. Recently, environmental
friendly alternatives were investigated and may constitute an area of substantial and growing interest
for the preparation of these derivatives in the coming years.
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